,assay_id,doi,year,volume,issue,assay_description,compound_smiles,compound_name,value,unit,relation,log_value,classification_label,scaffold_smiles
0,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,2.0,uM,=,0.3010299956639812,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+],"4-Acetylamino-5-hydroxy-naphthalene-2,7-disulfonic acid sodium",243.0,uM,=,2.385606273598312,1,c1ccc2ccccc2c1
2,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(Br)cn2)c1O,1-(5-Bromo-pyridin-2-yl)-3-[2-(6-fluoro-2-hydroxy-3-propionyl-phenyl)-cyclopropyl]-urea,0.0038,uM,=,-2.42021640338319,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
3,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=c1cc(-c2ccc(O)c(-c3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)c2)oc2cc(O)cc(O)c12,"6-[5-(5,7-Dihydroxy-4-oxo-4H-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",65.0,uM,=,1.812913356642856,1,O=c1cc(-c2cccc(-c3ccc4oc(-c5ccccc5)cc(=O)c4c3)c2)oc2ccccc12
4,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccccc3OC)nc21,"5-Ethyl-7-(2-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.82,uM,=,-0.0861861476162833,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
5,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CNc1ccc2c(c1)C(C#CC1CC1)(C(F)(F)F)OC(=O)N2,"4-Cyclopropylethynyl-6-methylamino-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.608,uM,=,-0.216096420727265,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
6,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccn[nH]3)nc21,"5-Ethyl-10-methyl-7-(2H-pyrazol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.39,uM,=,-0.4089353929735008,0,O=C1Nc2ccc(-c3ccn[nH]3)nc2Nc2ncccc21
7,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)Nc3ccnc(C#N)c3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-N-(2-cyanopyridin-4-yl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.023,uM,=,-1.6382721639824072,0,O=C(Nc1ccncc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
8,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C=C[C@@H](OCP(=O)(O)O)O2)c(=O)[nH]c1=O,"[(2R,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,5-dihydro-furan-2-yloxymethyl]-phosphonic acid",0.39,uM,=,-0.4089353929735008,0,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
9,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.017,uM,=,-1.769551078621726,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
10,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,C[C@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O,"5-Cyclopropylethynyl-7-fluoro-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",1.94,uM,=,0.287801729930226,1,O=C1COC(C#CC2CC2)c2ccccc2N1
11,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)[C@H](OC(=O)c6ccc(O)cc6)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1,"2alpha-hydroxymaprounic acid 2,3-bis-p-hydroxy benzoate",3.7,uM,=,0.568201724066995,1,O=C(O[C@@H]1CC2[C@@H](CCC3C4=CCC5CCCC[C@H]5C4CC[C@@H]32)C[C@H]1OC(=O)c1ccccc1)c1ccccc1
12,858890,10.1021/jm300477h,,,,Inhibition of wild type HIV1 reverse transcriptase RNA-dependent DNA polymerase activity using poly(rA)/oligo(dT)10:1 and [3H]-dTTP substrate,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3cccnc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(pyridin-3-ylmethyl)-1H-indole-2-carboxamide",0.02,uM,=,-1.6989700043360187,0,O=C(NCc1cccnc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
13,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,Cc1cc(C#N)ccc1-c1ccnc(NCc2cc(-c3ccccn3)[nH]n2)c1,3-Methyl-4-(2-((5-(pyridin-2-yl)-1H-pyrazol-3-yl)methylamino)pyridin-4-yl)benzonitrile,0.01,uM,=,-2.0,0,c1ccc(-c2ccnc(NCc3cc(-c4ccccn4)[nH]n3)c2)cc1
14,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,CCOC(=O)c1cccn1S(=O)(=O)c1cc(Cl)ccc1N,1-(2-Amino-5-chloro-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid ethyl ester,0.4,uM,=,-0.3979400086720376,0,O=S(=O)(c1ccccc1)n1cccc1
15,854340,10.1016/j.ejmech.2012.03.032,,,,Inhibition of wild type HIV1 reverse transcriptase activity using poly (rA)/oligo (dT)15 homopolymer template after 1 hr by ELISA,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1NC(=O)c1cc(Cl)cc(C#N)c1,N-[4-(Aminosulfonyl)-2-methylphenyl]-2-[4-chloro-2-(3-chloro-5-cyanobenzoyl)aminophenoxy]acetamide,0.0020499999999999,uM,=,-2.688246138944246,0,O=C(COc1ccccc1NC(=O)c1ccccc1)Nc1ccccc1
16,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,CCNc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"5-Cyclopropyl-9-(4-ethylamino-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.43,uM,=,-0.3665315444204134,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
17,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1ccc(NC(=O)CSc2nc3ccccc3n2S(=O)(=O)c2cc(C)cc(C)c2)cc1,"N-(4-Methylphenyl)-2-{[1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl]sulfanyl}acetamide",0.091,uM,=,-1.0409586076789064,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
18,541098,10.1016/j.bmc.2008.12.028,,,,Inhibition on HIV1 reverse transcriptase p66/p51,C#C[C@@]1(OCP(=O)(O)O)C=C[C@H](n2cnc3c(N)ncnc32)C1,"((1S,4R)-4-(6-amino-9H-purin-9-yl)-1-ethynylcyclopent-2-enyloxy)methylphosphonic acid",0.13,uM,=,-0.8860566476931633,0,C1=C[C@H](n2cnc3cncnc32)CC1
19,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1c(Cl)cc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1Cl,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,4-dichloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-thiourea",0.021,uM,=,-1.6777807052660807,0,S=C(NCCc1ccccc1)Nc1ccccn1
20,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](n3cc(CNCc4cc5cc(Cl)ccc5oc4=O)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,"1-((2R,4S,5S)-4-(4-(((6-chloro-2-oxo-2H-chromen-3-yl)methylamino)methyl)-1H-1,2,3-triazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",101.6,uM,=,2.006893707947901,1,O=c1ccn([C@H]2C[C@H](n3cc(CNCc4cc5ccccc5oc4=O)nn3)CO2)c(=O)[nH]1
21,427350,10.1128/aac.00749-06,,,,Inhibition of reverse transcriptase activity in HIV1 NL4-3 infected MT4 cells after dialysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
22,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(F)c(C#N)c4)c(F)c3)c2=O)n[nH]c1=O,"2,4-Difluoro-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",1.12,uM,=,0.0492180226701816,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
23,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,Br.NC(=O)c1sc(N)nc1-c1ccc(Cl)c(Br)c1,2-amino-4-(3-bromo-4-chlorophenyl)thiazole-5-carboxamide hydrobromide,118.2,uM,=,2.0726174765452368,1,c1ccc(-c2cscn2)cc1
24,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(NS(N)(=O)=O)C3)cc2)nc2ccsc12,"(E)-N-(1-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)phenyl)piperidin-3-yl)sulfonamide",2.411,uM,=,0.3821972103774537,1,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3ccsc23)cc1
25,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,CC(=O)O[C@@H]1c2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)OC(C)(C)C=C3)O[C@H](C)[C@H]1C,"Acetic acid 2,3,10,10-tetramethyl-6-oxo-8-phenyl-3,4-dihydro-2H,6H,10H-dipyrano[2,3-f,2',3'-h]chromen-4-yl ester",0.72,uM,=,-0.1426675035687315,0,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
26,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(CSc3ccc(Br)cc3)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-Ethyl-6-[4-[(4-bromophenylthio)methyl]phenyl]-6,7-dihydrobenzo[b]pyrrolo[1,2-d][1,4]oxazepin-7-one",0.06,uM,=,-1.2218487496163564,0,O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2)cc1
27,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1c(O)nc(SC2CCCCC2)nc1Cc1ccccc1,6-Benzyl-2-cyclohexylsulfanyl-5-methyl-3H-pyrimidin-4-one,4.3,uM,=,0.6334684555795865,1,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
28,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc(Cl)c(F)c23)c1,"N-(1-Amino-1-oxopropan-2-yl)-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-1H-indole-2-carboxamide",0.062,uM,=,-1.207608310501746,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
29,494379,10.1021/jm801071m,,,,Inhibition of HIV1 LAI clade C 93IN101 reverse transcriptase RNase H activity by real time monitoring assay,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccc(Br)cc2)cs1)c1ccc([N+](=O)[O-])o1,5-nitro-furan-2-carboxylic acid [[4-(4-bromo-phenyl)-thiazol-2-yl]-(tetrahydro-furan-2-ylmethyl)-carbamoyl]-methyl ester,32.2,uM,=,1.507855871695831,1,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccccc2)cs1)c1ccco1
30,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(OC)c2)cn1,"3-(4-Hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)propanamide",0.241,uM,=,-0.6179829574251317,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1cccnc1)Cc1ccccc1
31,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(CNC(=O)c2[nH]c3ccc(Cl)cc3c2S(=O)(=O)c2cc(C)cc(C)c2)c1,"5-Chloro-N-(3,5-dimethylbenzyl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",7.0,uM,=,0.8450980400142568,1,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
32,1891833,10.1021/acs.jmedchem.8b00843,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase using poly(rA)-oligo(dT) as template/primer,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.26,uM,=,-0.585026652029182,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
33,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)ccnc21,"5-Ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.8,uM,=,0.255272505103306,1,O=C1Nc2cccnc2Nc2ncccc21
34,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,O=c1cc(Nc2ccc(-c3ccccc3O)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((2'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.46,uM,=,-0.3372421683184259,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
35,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,Cl.O=c1[nH]c2c(c(=O)n1O)C1CCN(Cc3ccccc3)CC1S2,"7-Benzyl-3-hydroxy-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione hydrochloride",0.1,uM,=,-1.0,0,O=c1[nH]c2c(c(=O)[nH]1)C1CCN(Cc3ccccc3)CC1S2
36,856828,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.5 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,COc1ccc2nc3cc(Cl)ccc3c(NCCCNCCCCNCCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)c2c1,Acridine dimer,0.4,uM,=,-0.3979400086720376,0,c1ccc2c(NCCCNCCCCNCCCNc3c4ccccc4nc4ccccc34)c3ccccc3nc2c1
37,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1Cl,3-(4-(4-(2-chloro-4-cyano-6-methylphenoxy)-5-methylpyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.006,uM,=,-2.2218487496163566,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
38,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,Oc1cc(Cc2cccc3ccccc23)nc(SC2CCCC2)n1,2-Cyclopentylsulfanyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,48.7,uM,=,1.6875289612146345,1,c1ccc2c(Cc3ccnc(SC4CCCC4)n3)cccc2c1
39,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCN(c1ncccc1CC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-isobutyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.41,uM,=,-0.3872161432802645,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
40,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)C(=O)O,"3-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-2-oxopropanoic acid",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
41,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.0,uM,=,0.0,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
42,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",1.7,uM,=,0.2304489213782739,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
43,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-(3,5-dimethylphenylsulfonyl)-N-((S)-1-oxo-1-((S)-1-(pyridin-4-yl)ethylamino)propan-2-yl)-1H-indole-2-carboxamide",0.43,uM,=,-0.3665315444204134,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncc1
44,1872150,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of Triton-X-100 by scintillation counting method,NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCCCNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,(S)-1-(6-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-6-oxohexylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,236.0,uM,=,2.3729120029701067,1,O=C(CCCCCNC(=O)CCc1c[nH]c2ccccc12)NCCc1c[nH]c2ccccc12
45,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCCCSc1nc(O)c(C)c(Cc2c(F)cccc2F)n1,"2-Butylsulfanyl-6-(2,6-difluoro-benzyl)-5-methyl-3H-pyrimidin-4-one",0.09,uM,=,-1.0457574905606752,0,c1ccc(Cc2ccncn2)cc1
46,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,C#Cc1ccc2nc(S)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,"5-Ethynyl-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",29.5,uM,=,1.469822015978163,1,c1cc2c3c(c1)ncn3CCNC2
47,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCN(c1ncccc1COC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-methoxymethyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.84,uM,=,-0.0757207139381183,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
48,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nncn2-c2c(C)ccnc21,"8-Ethyl-4-methyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",44.5,uM,=,1.6483600109809315,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
49,543748,10.1128/aac.00145-07,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 expressed in Escherichia coli using calf thymus DNA substrate,BP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OP(=O)(O)OP(=O)(O)O,(R)-9-[2-(boranophosphonomethoxy)propyl]adenine diphosphate,14.5,uM,=,1.1613680022349748,1,c1ncc2nc[nH]c2n1
50,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2c(F)cc(F)c(F)c2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-5,6,8-trifluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.8,uM,=,-0.0969100130080563,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
51,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc(C)c(C)nc2OC)c(O)nc1C,"5-Ethyl-3-[(2-methoxy-5,6-dimethyl-pyridin-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",0.009,uM,=,-2.0457574905606752,0,c1cncc(CNc2cccnc2)c1
52,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(Cn2c(=O)ccn(CC(=O)Nc3ccccc3Cl)c2=O)c1,"2-(3-(3,5-Dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-methoxyphenyl)acetamide",15.68,uM,=,1.1953460583484197,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
53,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCCCNC(=O)[C@H](N)Cc1c[nH]c2ccccc12,(R)-1-(6-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-6-oxohexylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,116.0,uM,=,2.0644579892269186,1,O=C(CCCCCNC(=O)CCc1c[nH]c2ccccc12)NCCc1c[nH]c2ccccc12
54,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nnnn2-c2c(C)ccnc21,"8-Ethyl-4-methyl-8H-1,2,3,3a,7,8,9-heptaaza-dibenzo[e,h]azulene",6.72,uM,=,0.8273692730538252,1,c1cnc2c(c1)-c1nnnn1-c1cccnc1N2
55,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3cccc(Cl)c3)cc2)[nH]c(=O)n1O,"6-((3'-chloro-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
56,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.008,uM,=,-2.096910013008056,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
57,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1[S+]([O-])c1cccc(Br)c1,2-Amino-6-(3-bromo-benzenesulfinyl)-benzonitrile,4.8,uM,=,0.6812412373755872,1,c1ccc([SH+]c2ccccc2)cc1
58,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,Cc1ccc(S(=O)(=O)N/N=C2/C(=O)Nc3c(Cl)cc(Cl)cc32)cc1,"N'-(5,7-dichloro-2-oxoindolin-3-ylidene)-4-methylbenzenesulfonohydrazide",51.0,uM,=,1.7075701760979365,1,O=C1Nc2ccccc2/C1=N\NS(=O)(=O)c1ccccc1
59,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1ccc(-n2nnnc2SCC(=O)Nc2ccccc2[N+](=O)[O-])c(Br)c1,2-(1-(2-bromo-4-methylphenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.003,uM,=,-2.5228787452803374,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
60,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(N)nc3)nc21,"7-(6-Amino-pyridin-3-yl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2ccc(-c3cccnc3)nc2Nc2ncccc21
61,306441,10.1016/j.bmcl.2005.06.036,,,,In vitro inhibitory concentration against HIV-1 recombinant integrase activity in standard 3'-processing assay,O=C(c1ccc([N+](=O)[O-])cc1)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,"{2-[(E)-2-(3,4-Dihydroxy-phenyl)-vinyl]-8-hydroxy-quinolin-7-yl}-(4-nitro-phenyl)-methanone",100.0,uM,=,2.0,1,O=C(c1ccccc1)c1ccc2ccc(/C=C/c3ccccc3)nc2c1
62,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),O=C1Nc2c(CO)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-hydroxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.0,uM,=,0.4771212547196624,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
63,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCCc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-propyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.27,uM,=,-0.5686362358410126,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
64,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)c(C)c1,"N-(2-chloro-4-sulfamoyl-phenyl)-2-[1-(2,4,6-trimethyl-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide",0.004,uM,=,-2.397940008672037,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
65,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3ccc(F)cc3o2)c(O)nc1C,5-Ethyl-3-[2-(6-fluoro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridin-2-one,0.442,uM,=,-0.3545777306509081,0,c1cncc(CCc2nc3ccccc3o2)c1
66,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc2c(CC(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc([N+](=O)[O-])cc3)cc(=O)oc2c1,"N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl-2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetamide",0.3728,uM,=,-0.4285240963180562,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
67,1795826,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CXCR4 tropic HIV1 3B reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(Cl)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-chloro-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.0001246596017166,uM,=,-3.904274264998538,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
68,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,COC(=O)Cn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid methyl ester",3.0,uM,=,0.4771212547196624,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
69,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.2,uM,=,-0.6989700043360187,0,S=c1[nH]c2cccc3c2n1CCNC3
70,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=[N+]([O-])c1ccccc1S(=O)(=O)c1ccccc1,1-Benzenesulfonyl-2-nitro-benzene,16.0,uM,=,1.2041199826559248,1,O=S(=O)(c1ccccc1)c1ccccc1
71,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.528,uM,=,0.1841233542396711,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
72,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),COc1cc(/C=C2/SC(=S)N(CCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc(OC)c1OC,"4-(3-{4-Oxo-2-thioxo-5-[1-(3,4,5-trimethoxy-phenyl)-meth-(Z)-ylidene]-thiazolidin-3-yl}-propionylamino)-benzoic acid",97.0,uM,=,1.9867717342662448,1,O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
73,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OC)C(F)(F)F)c(O)nc1C,3-(3-Cyclopropyl-1-methoxy-1-trifluoromethyl-prop-2-ynyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.77,uM,=,-0.1135092748275181,0,C(#CC1CC1)Cc1cccnc1
74,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccc3ccccc3c2)c(O)nc1C,5-Ethyl-6-methyl-3-[(naphthalen-2-ylmethyl)-amino]-1H-pyridin-2-one,0.46,uM,=,-0.3372421683184259,0,c1cncc(NCc2ccc3ccccc3c2)c1
75,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2cccnc2S[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N12,"(7R,8R,9S,10S,10aR)-8,9,10-trihydroxy-7-(hydroxymethyl)-8,9,10,10a-tetrahydrodipyrido[2,1-b:3',2'-e][1,3]thiazin-5(7H)-one",53.82,uM,=,1.7309436934277358,1,O=C1c2cccnc2S[C@@H]2CCCCN12
76,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",3.1,uM,=,0.4913616938342727,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
77,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.422,uM,=,-0.3746875490383261,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
78,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CSc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenylsulfanylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccccc3)cc21
79,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,"(8S,10S)-8-Acetyl-10-(4-amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione",237.11104833735172,uM,=,2.3749517906722244,1,O=C1c2ccccc2C(=O)c2cc3c(cc21)CCC[C@@H]3O[C@H]1CCCCO1
80,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCOC(=O)CCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,methyl 3-bromo-5-[1-(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-5-propyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,9.15,uM,=,0.9614210940664484,1,C=C(c1ccccc1)c1ccccc1
81,1567954,10.1016/j.bmc.2016.04.018,,,,Inhibition of HIV1 reverse transcriptase using 234-nt long RNA/18-mer DNA oligonucleotide as template/primer preincubated for 15 mins followed by incubation with template/primer for 40 mins by liquid scintillation counting in presence of alpha[P33]-dCTP,Cc1ccc(Nc2nc(O)nc(Nc3ccc(C)cc3)n2)cc1,"Bis[(4-methylphenyl)amino]-1,3,5-triazine-2-ol",55.1,uM,=,1.7411515988517852,1,c1ccc(Nc2ncnc(Nc3ccccc3)n2)cc1
82,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)CC2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[3-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-2-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",1.1,uM,=,0.041392685158225,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
83,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(CCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[2-(4,7-Dichloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.0096,uM,=,-2.017728766960432,0,c1cncc(CCc2nc3ccccc3o2)c1
84,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=c1ccc(Cc2ccc(Cl)c(Oc3ccccc3)c2)n[nH]1,6-(4-chloro-3-phenoxybenzyl)pyridazin-3(2H)-one,0.52,uM,=,-0.2839966563652008,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
85,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,C=CC(=O)N1CCN(Cc2ccc(Nc3nccc(Oc4c(C)cc(C#N)cc4C)n3)cc2)CC1,"4-((2-((4-((4-acryloylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.16,uM,=,-0.7958800173440752,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
86,1872150,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of Triton-X-100 by scintillation counting method,NC(=O)C[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O,"(S)-1-((R)-4-amino-1-((R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-1,4-dioxobutan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium",2.87,uM,=,0.4578818967339924,1,O=C(CCc1c[nH]c2ccccc12)NCC(=O)NCCc1c[nH]c2ccccc12
87,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(-c3cc(Cl)cc(C(F)(F)F)c3)c2)[nH]c(=O)n1O,"6-((3'-chloro-5'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.038,uM,=,-1.42021640338319,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
88,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C(/C=C/CO)=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-(3-hydroxy-propenyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",16.0,uM,=,1.2041199826559248,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
89,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2cc3cnccc3o2)c(O)nc1C,"5-Ethyl-3-(2-furo[3,2-c]pyridin-2-yl-ethyl)-6-methyl-1H-pyridin-2-one",13.5,uM,=,1.130333768495006,1,c1cncc(CCc2cc3cnccc3o2)c1
90,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cc(F)cc(F)c2)nc(SC(C)C)[nH]c1=O,"2-(3,5-difluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",1.288,uM,=,0.1099158630237933,1,O=c1cc(Cc2ccccc2)nc[nH]1
91,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCCCCc3ccccc3)cc2c1=O,"Ethyl 1-(4-Fluorobenzyl)-4-oxo-6-(4-phenylbutoxy)-1,4-dihydroquinoline-3-carboxylate",28.4,uM,=,1.4533183400470375,1,O=c1ccn(Cc2ccccc2)c2ccc(OCCCCc3ccccc3)cc12
92,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CCCN1C(=O)/C(=C\c2cccs2)SC1=S)Nc1ccc(O)c(C(=O)O)c1,2-Hydroxy-5-(4-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-butyrylamino)-benzoic acid,35.0,uM,=,1.5440680443502757,1,O=C(CCCN1C(=O)/C(=C\c2cccs2)SC1=S)Nc1ccccc1
93,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CCCN1CCn2c(=S)[nH]c3cccc(c32)C1C,"6-Methyl-7-propyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",2.43,uM,=,0.3856062735983122,1,S=c1[nH]c2cccc3c2n1CCNC3
94,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,CCS(=O)(=O)CC(C)(O)[C@H]1CCc2c(c(C)cc(O)c(=O)c2O)C1,"(2S)-2-(1-(ethylsulfonyl)-2-hydroxypropan-2-yl)-5,7-dihydroxy-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.24,uM,=,-0.619788758288394,0,O=c1cccc2c(c1)CCCC2
95,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)Cc1ccccc1Cl,"6-Chloro-1-[(2-chlorobenzyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",1.3,uM,=,0.1139433523068367,1,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
96,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCCc1cc(CCc2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-ethyl)-6-methyl-5-propyl-1H-pyridin-2-one,0.083,uM,=,-1.080921907623926,0,c1cncc(CCc2nc3ccccc3o2)c1
97,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(C(F)(F)F)cc1C(=O)O)Nc1ccc(C(F)(F)F)cc1C(=O)O,2-[4-(2-carboxy-4-trifluoromethylphenylcarbamoyl)butylcarboxamido]-5-trifluoromethylbenzoic acid,8.3,uM,=,0.919078092376074,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
98,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1ccn2CO,"4-(4-(4-(hydroxymethyl)-2,6-dimethylphenoxy)pyrrolo[1,2-f][1,2,4]triazin-2-ylamino)benzonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Nc2nc(Oc3ccccc3)c3cc[nH]c3n2)cc1
99,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",1.9,uM,=,0.2787536009528289,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
100,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(-c3ccccc3)cc2)cs1,(Z)-3-(2-(4-(biphenyl-4-yl)thiazol-2-yl)hydrazono)indolin-2-one,22.0,uM,=,1.3424226808222062,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(-c3ccccc3)cc2)cs1
101,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4ncc(-c5cn(C)cn5)cc4c32)CCO1,"Cis-1-(2-Ethyl-tetrahydro-pyran-4-yl)-8-(1-methyl-1H-imidazol-4-yl)-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.007,uM,=,-2.154901959985743,0,O=c1nc(-c2cn[nH]c2)c2oc3ncc(-c4c[nH]cn4)cc3c2n1C1CCOCC1
102,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc(O)cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-hydroxybenzyl)-1H-indole-2-carboxamide",0.061,uM,=,-1.214670164989233,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
103,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,CN(Cc1ccc2occc2c1)c1nc(O)nc(Nc2c(F)cccc2-c2ccccc2)n1,"4-((benzofuran-5-ylmethyl)(methyl)amino)-6-(3-fluorobiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.008,uM,=,-2.096910013008056,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
104,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc3c(=O)n(O)c(=O)[nH]c3c2)cc1,"4-(Tert-butyl)-N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)benzenesulfonamide",5.88,uM,=,0.7693773260761385,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2[nH]1
105,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccccc3Cl)n2)cc1,4-(4-(2-chlorobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.024,uM,=,-1.619788758288394,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
106,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=[N+]([O-])c1ccccc1S(=O)(=O)c1ccccc1[N+](=O)[O-],1-nitro-2-(2-nitrophenylsulfonyl)benzene,14.0,uM,=,1.146128035678238,1,O=S(=O)(c1ccccc1)c1ccccc1
107,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,COc1ccc2ccccc2c1/C=N\NC(=O)c1ccc(C(C)(C)C)cc1,(Z)-4-(tert-butyl)-N'-((2-methoxynaphthalen-1-yl)methylene)benzohydrazide,11.2,uM,=,1.0492180226701815,1,O=C(N/N=C\c1cccc2ccccc12)c1ccccc1
108,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1cc(Cc2ccccc2)nc(SCCc2ccccc2)[nH]1,6-Benzyl-2-(phenethylthio)pyrimidin-4(3H)-one,17.45,uM,=,1.2417954312951986,1,O=c1cc(Cc2ccccc2)nc(SCCc2ccccc2)[nH]1
109,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCc1csc(NC(=S)NCCc2c(F)cccc2F)n1,"1-[2-(2,6-Difluoro-phenyl)-ethyl]-3-(4-ethyl-thiazol-2-yl)-thiourea",0.005,uM,=,-2.3010299956639813,0,S=C(NCCc1ccccc1)Nc1nccs1
110,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)c(C)c1,"N-(2-chloro-4-sulfamoyl-phenyl)-2-[1-(2,4,6-trimethyl-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide",0.00405,uM,=,-2.392544976785332,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
111,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(Br)c1,2-Amino-6-(3-bromo-benzenesulfonyl)-benzonitrile,0.2,uM,=,-0.6989700043360187,0,O=S(=O)(c1ccccc1)c1ccccc1
112,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(/C=C/c2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-vinyl)-5-ethyl-6-methyl-1H-pyridin-2-one,5.9,uM,=,0.7708520116421442,1,C(=C/c1nc2ccccc2o1)\c1cccnc1
113,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)N(C)C)c1=O,"2-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-N,N-dimethyl-acetamide",3.5,uM,=,0.5440680443502757,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
114,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",13.0,uM,=,1.1139433523068367,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
115,195219,10.1021/jm00111a045,,,,In vitro inhibitory activity of compound against human immunodeficiency virus type 1 (HIV-1) Reverse transcriptase,CCN1C(=O)c2ccccc2N(C)c2nc(Cl)ccc21,"2-Chloro-5-ethyl-11-methyl-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one",3.3,uM,=,0.5185139398778875,1,O=C1Nc2cccnc2Nc2ccccc21
116,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1cnccn1,1-Phenethyl-3-pyrazin-2-yl-thiourea,3.9,uM,=,0.5910646070264992,1,S=C(NCCc1ccccc1)Nc1cnccn1
117,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3cn[nH]c3)ccc21,"5-Cyclopropyl-10-methyl-7-(1H-pyrazol-4-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2ccc(-c3cn[nH]c3)nc2N(C2CC2)c2ncccc21
118,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(N)cc3)nc21,"7-(4-Amino-phenyl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
119,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cccc(Sc2cccc(N)c2C#N)c1,2-Amino-6-(3-methoxy-phenylsulfanyl)-benzonitrile,1.5,uM,=,0.1760912590556812,1,c1ccc(Sc2ccccc2)cc1
120,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,Cc1cc(-c2c(O)c3c(=O)oc4ccccc4c3oc2=O)nn1-c1ccccc1,"4-hydroxy-3-(5-methyl-1-phenyl-1H-pyrazol-3-yl)pyrano[3,2-c]chromene-2,5-dione",51.8,uM,=,1.714329759745233,1,O=c1oc2c(cc1-c1ccn(-c3ccccc3)n1)c(=O)oc1ccccc12
121,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,COc1ccc(C(=O)CSc2nc(O)c(C)c(Cc3cccc4ccccc34)n2)cc1,2-[2-(4-Methoxy-phenyl)-2-oxo-ethylsulfanyl]-5-methyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.37,uM,=,-0.431798275933005,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
122,195843,10.1021/jm970096g,,,,The quantity of compound required to reduce WT Reverse transcriptase activity by 50%,Fc1cccc(F)c1C1SCc2nc3ccccc3n21,"1-(2,6-Difluoro-phenyl)-3H-benzo[4,5]imidazo[1,2-c]thiazole",0.5,uM,=,-0.3010299956639812,0,c1ccc(C2SCc3nc4ccccc4n32)cc1
123,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(F)cccc3o2)c(O)nc1C,5-Ethyl-3-[2-(4-fluoro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridin-2-one,0.015,uM,=,-1.8239087409443189,0,c1cncc(CCc2nc3ccccc3o2)c1
124,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,C#CC1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)CC(n2cnc3c(N)nc(Cl)nc32)CC1O,rac-(4-(6-amino-2-chloro-9H-purin-9-yl)-1-ethynyl-2-hydroxycyclopentyl)methyltriphosphoric acid,20.2,uM,=,1.305351369446624,1,c1ncc2ncn(C3CCCC3)c2n1
125,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2coc3ccccc3c2=O)c(O)nc1C,5-Ethyl-6-methyl-3-[(4-oxo-4H-chromen-3-ylmethyl)-amino]-1H-pyridin-2-one,1.1,uM,=,0.041392685158225,1,O=c1c(CNc2cccnc2)coc2ccccc12
126,196795,10.1021/jm00058a009,,,,In vitro for inhibitory activity against HIV-1 Reverse Transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.43,uM,=,-0.3665315444204134,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
127,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(N)=O)[nH]c3ccc([N+](=O)[O-])cc23)c1,"N-(2-Amino-2-oxoethyl)-3-[(3,5-dimethylphenyl)sulfonyl]-5-nitro-1H-indole-2-carboxamide",0.034,uM,=,-1.4685210829577449,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
128,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)c(F)c2[C@@](C#Cc2ccccc2)(C(F)(F)F)N1,"5,6-Difluoro-4-phenylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.181,uM,=,-0.7423214251308154,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)N1
129,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,C=CCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(=O)O)[C@H]2O)c1=O,"5-(1-allyl-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-hydroxy-2-(methoxymethyl)tetrahydrofuran-3-yl methylphosphonate",9.6,uM,=,0.9822712330395684,1,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
130,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CNC3CCN(C(=O)OC(C)(C)C)CC3)cc2)n1,"tert-butyl 4-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)benzylamino)piperidine-1-carboxylate",0.277,uM,=,-0.5575202309355514,0,c1ccc(Oc2ccnc(Nc3ccc(CNC4CCNCC4)cc3)n2)cc1
131,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cccnc2Oc2cc(C)cc(N)c21,"9-Amino-10-ethyl-7-methyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.132,uM,=,-0.8794260687941501,0,O=C1Nc2ccccc2Oc2ncccc21
132,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,COc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-4-methoxy-1H-benzoimidazole",0.0073,uM,=,-2.136677139879544,0,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
133,1795826,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CXCR4 tropic HIV1 3B reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(N)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-amino-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.000130841373786,uM,=,-3.883254904591589,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
134,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1,"8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid (suramin)",13.888386211395265,uM,=,1.1426517849598403,1,O=C(Nc1cccc(C(=O)Nc2cccc(C(=O)Nc3cccc4ccccc34)c2)c1)Nc1cccc(C(=O)Nc2cccc(C(=O)Nc3cccc4ccccc34)c2)c1
135,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4cc(C#N)c(-c5cnn(C)c5)cc4c32)CCO1,"Cis-1-(2-Ethyl-tetrahydro-pyran-4-yl)-4,8-bis-(1-methyl-1H-pyrazol-4-yl)-2-oxo-1,2-dihydro-benzo[4,5]furo[3,2-d]pyrimidine-7-carbonitrile",0.007,uM,=,-2.154901959985743,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4cn[nH]c4)cc3c2n1C1CCOCC1
136,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccc(OCCCCc3ccccc3)cc2)n[nH]1,Ethyl 3-(1-(naphthalen-1-ylmethyl)-4-(3-(4-phenylbutoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,8.5,uM,=,0.9294189257142929,1,c1ccc(CCCCOc2ccc(-c3cn(Cc4cccc5ccccc45)cc3-c3cc[nH]n3)cc2)cc1
137,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1c(C)c(C)c(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c(C)c1C,"6-Chloro-1-(2,3,4,5,6-pentamethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.047,uM,=,-1.3279021420642825,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
138,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc(N)cc3)[nH]c3ccc(Cl)cc23)c1,"N-(4-Aminobenzyl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.0077,uM,=,-2.113509274827518,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
139,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cccn1Cc1ccc(F)cc1,"ethyl 6-(1-(4-fluorobenzyl)-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",8.0,uM,=,0.9030899869919436,1,c1ccc(Cn2cccc2)cc1
140,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,COC(=O)c1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,2-{[1-(5-Methanesulfonylamino-1H-indole-2-carbonyl)-piperidin-4-yl]-methyl-amino}-nicotinic acid methyl ester,21.0,uM,=,1.3222192947339193,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
141,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc(NC(=O)c2cccc([N+](=O)[O-])c2)c(C(N)=O)c1C,"4,5-dimethyl-2-(3-nitrobenzamido)thiophene-3-carboxamide",1.3,uM,=,0.1139433523068367,1,O=C(Nc1cccs1)c1ccccc1
142,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1ccc(/C=C2\SC(=S)N(CC(=O)Nc3cc([N+](=O)[O-])ccc3O)C2=O)cc1,N-(2-Hydroxy-5-nitro-phenyl)-2-{4-oxo-2-thioxo-5-[1-p-tolyl-meth-(Z)-ylidene]-thiazolidin-3-yl}-acetamide,84.0,uM,=,1.9242792860618816,1,O=C(CN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
143,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,COc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methoxy-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0094,uM,=,-2.026872146400301,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
144,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,Nc1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O,"4,6-Diamino-5-hydroxy-naphthalene-1,3-disulfonic acid",45.0,uM,=,1.6532125137753435,1,c1ccc2ccccc2c1
145,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,COC(=O)CCS(=O)(=O)c1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"Methyl 3-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)sulfonyl)propanoate",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
146,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCCC1C(=O)/C(=C/c2cccs2)SC1=S)Nc1nc2ccccc2s1,N-Benzothiazol-2-yl-4-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-tetrahydro-thiophen-3-yl}-butyramide,98.0,uM,=,1.9912260756924949,1,O=C(CCCC1C(=O)/C(=C/c2cccs2)SC1=S)Nc1nc2ccccc2s1
147,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cccc([C@]23SCCN2C(=O)c2ccccc23)c1,"9b-m-Tolyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.035,uM,=,-1.4559319556497243,0,O=C1c2ccccc2[C@@]2(c3ccccc3)SCCN12
148,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(OC)nc3)nc21,"5-Ethyl-7-(6-methoxy-pyridin-3-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.2,uM,=,0.0791812460476248,1,O=C1Nc2ccc(-c3cccnc3)nc2Nc2ncccc21
149,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,CCCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(=O)O)[C@H]2OC)c1=S,oligonucleotide,0.82,uM,=,-0.0861861476162833,0,S=c1[nH]cnc2c1ncn2[C@H]1CCCO1
150,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@H]1Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2C(=O)[C@@H]1C)OC(C)(C)C=C3,"6,6,10,11-Tetramethyl-4-phenyl-10,11-dihydro-6H-dipyrano[2,3-f,2',3'-h]chromene-2,12-dione",10.0,uM,=,1.0,1,O=C1CCOc2c3c(c4c(-c5ccccc5)cc(=O)oc4c21)OCC=C3
151,195358,10.1021/jm00012a014,,,,Inhibitory activity against HIV-1 Reverse transcriptase,CC(=O)OCCOCn1c2c(c(=O)[nH]c1=O)CNc1ccccc1S2,"Acetic acid 2-(1,3-dioxo-2,3,10,11-tetrahydro-1H-5-thia-2,4,10-triaza-dibenzo[a,d]cyclohepten-4-ylmethoxy)-ethyl ester",11.5,uM,=,1.0606978403536118,1,O=c1[nH]c2c(c(=O)[nH]1)CNc1ccccc1S2
152,196795,10.1021/jm00058a009,,,,In vitro for inhibitory activity against HIV-1 Reverse Transcriptase,O=C1c2ccccc2C2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.28,uM,=,-0.5528419686577808,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
153,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(C(F)(F)F)ccc2N(C)C(=O)c2cccnc21,"11-Ethyl-6-methyl-9-trifluoromethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2ccccc2Nc2ncccc21
154,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1[nH]c(SCc2ccccc2)nc(Cc2ccccc2)c1I,6-Benzyl-2-(benzylthio)-5-iodopyrimidin-4(3H)-one,10.12,uM,=,1.0051805125037805,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
155,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2c[nH]c3ccccc23)c(O)nc1C,5-Ethyl-3-[(1H-indol-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,22.5,uM,=,1.3521825181113625,1,c1cncc(NCc2c[nH]c3ccccc23)c1
156,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@@H](CN)c1ncc(CO)s1,(S)-N-(2-Amino-1-(5-(hydroxymethyl)thiazol-2-yl)ethyl)-3-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1H-pyrrole-2-carboxamide,2.3,uM,=,0.3617278360175928,1,O=C(NCc1nccs1)c1ccc(-c2ccccn2)[nH]1
157,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2cncc(C#N)c2)cc1F,"5-(4-((2-((4-Cyanophenyl)amino)-5-methylpyrimidin-4-yl)amino)-3,5-difluorophenyl)nicotinonitrile",0.271,uM,=,-0.5670307091255943,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccnc4)cc3)n2)cc1
158,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(-c2cc(F)cc(C#N)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"5-fluoro-3'-methyl-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",5.34,uM,=,0.7275412570285564,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
159,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=C(CCl)Nc1ccc(Cl)cc1NS(=O)(=O)c1cc(Cl)cc(Cl)c1,"2-Chloro-N-[4-chloro-2-(3,5-dichloro-benzenesulfonylamido)-phenyl]acetamide",15.88,uM,=,1.2008504980910777,1,O=S(=O)(Nc1ccccc1)c1ccccc1
160,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2ccccc2[N+](=O)[O-])(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-(2-nitro-phenylethynyl)-3,4-dihydro-1H-quinazolin-2-one",0.0128,uM,=,-1.892790030352132,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)(C2CC2)N1
161,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SCC(C)C)nc1Cc1c(F)cccc1F,"6-(2,6-Difluoro-benzyl)-2-isobutylsulfanyl-5-methyl-3H-pyrimidin-4-one",0.09,uM,=,-1.0457574905606752,0,c1ccc(Cc2ccncn2)cc1
162,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(NCCO)nc21,"5-Ethyl-7-(2-hydroxy-ethylamino)-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncccc21
163,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2nc3c(cc2OC)CCCC3)c(O)nc1C,"5-Ethyl-3-[(3-methoxy-5,6,7,8-tetrahydro-quinolin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",0.047,uM,=,-1.3279021420642825,0,c1cncc(NCc2ccc3c(n2)CCCC3)c1
164,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(CCCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-(3-(4-fluorophenyl)propyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",3.8,uM,=,0.5797835966168101,1,O=c1cc(Cc2ccccc2)n(CCCc2ccccc2)c(=O)[nH]1
165,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccc(S(N)(=O)=O)cc3)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(4-sulfamoylphenyl)acetamide",0.116,uM,=,-0.9355420107730816,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
166,2119941,10.1016/j.ejmech.2021.113681,,,,Inhibition of recombinant HIV1 reverse transcriptase by colorimetric assay,NC[C@H](NC(=O)c1cc2ccc(Cl)cc2[nH]1)c1ncc(CO)s1,(S)-N-(2-amino-1-(5-(hydroxymethyl)thiazol-2-yl)ethyl)-6-chloro-1H-indole-2-carboxamide,245.0,uM,=,2.3891660843645326,1,O=C(NCc1nccs1)c1cc2ccccc2[nH]1
167,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3ccc(Cl)c(C(N)=O)c3)CC2)n1,"2-chloro-5-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.009,uM,=,-2.0457574905606752,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
168,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,O=C1Nc2ccccc2S(=O)(=O)n2cccc21,"4,4-Dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
169,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)c1[nH]cnc1-c1ccccc1,4-phenyl-1H-imidazole-5-carboxamide,300.0,uM,=,2.4771212547196626,1,c1ccc(-c2c[nH]cn2)cc1
170,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccc(C)cc2OC)c(O)nc1C,5-Ethyl-3-(2-methoxy-4-methyl-benzylamino)-6-methyl-1H-pyridin-2-one,0.032,uM,=,-1.494850021680094,0,c1ccc(CNc2cccnc2)cc1
171,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,N#CCC(=O)c1cccc(-c2ccccc2)c1,3-phenyl-3-oxopropanenitrile,33.4,uM,=,1.5237464668115646,1,c1ccc(-c2ccccc2)cc1
172,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,Nc1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O,"4,6-Diamino-5-hydroxy-naphthalene-1,3-disulfonic acid",48.0,uM,=,1.6812412373755872,1,c1ccc2ccccc2c1
173,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,C=CCc1c(C)nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc1C,"2-(2-Chloro-6-fluorophenyl)-3-(5-allyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",2.92,uM,=,0.4653828514484183,1,O=C1CSC(c2ccccc2)N1c1ncccn1
174,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,Cc1n[nH]c2c(CO)ccc(Oc3cc(C#N)cc(C#N)c3)c12,5-(7-(hydroxymethyl)-3-methyl-1H-indazol-4-yloxy)isophthalonitrile,0.071,uM,=,-1.1487416512809248,0,c1ccc(Oc2cccc3[nH]ncc23)cc1
175,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1[nH]c(=O)n(COCc2ccccc2)c(COCc2ccc(Cl)cc2)c1Br,"1-[(Benzyloxy)methyl]-5-bromo-6-{[(4-chlorobenzyl)oxy]methyl}pyrimidine-2,4(1H,3H)-dione",9.6,uM,=,0.9822712330395684,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
176,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,O=[N+]([O-])c1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-4-nitro-1H-benzoimidazole",1.88,uM,=,0.2741578492636798,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
177,526428,10.1021/np050510c,,,,Inhibition of HIV1 RT at 200 uM,CCC[C@@H](OC(C)=O)C1=C(Br)/C(=C/I)OC1=O,"(R,Z)-1-(4-bromo-5-(iodomethylene)-2-oxo-2,5-dihydrofuran-3-yl)butyl acetate",700.0,uM,=,2.845098040014257,1,C=C1C=CC(=O)O1
178,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2)nc2ccsc12,"(E)-3-(3,5-dimethyl-4-((2-((4-(4-(methylsulfonyl)piperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.211,uM,=,-0.6757175447023073,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3ccsc23)cc1
179,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(NS(C)(=O)=O)cc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-6-yl}-methanesulfonamide,0.5,uM,=,-0.3010299956639812,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
180,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Cl)c(Cl)c3)cc2c1=O,"6-((3,4-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",2.0,uM,=,0.3010299956639812,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
181,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccccc1-c1ccc(Oc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",2.8,uM,=,0.4471580313422192,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
182,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(C#N)c2c(c1)Oc1ncccc1C(=O)N2C,"7,10-Dimethyl-11-oxo-10,11-dihydro-5-oxa-4,10-diaza-dibenzo[a,d]cycloheptene-9-carbonitrile",0.055,uM,=,-1.259637310505756,0,O=C1Nc2ccccc2Oc2ncccc21
183,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1ccccc1CCNC(=S)Nc1nccs1,1-[2-(2-Methoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.04,uM,=,-1.3979400086720375,0,S=C(NCCc1ccccc1)Nc1nccs1
184,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
185,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(OCc4ccccc4)ccc3[nH]2)CC1,(5-Benzyloxy-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,4.3,uM,=,0.6334684555795865,1,O=C(c1cc2cc(OCc3ccccc3)ccc2[nH]1)N1CCN(c2ccccn2)CC1
186,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)c1,"4-((2-((1-(4-(aminocarbonyl)benzyl)piperidin-4-yl)amino)-6-chloropyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.09,uM,=,-1.0457574905606752,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
187,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CS(=O)(=O)c1ccc2c(c1)c(=O)c(C(=O)O)cn2Cc1ccc(F)cc1,"1-(4-Fluorobenzyl)-6-(methylsulfonyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",100.0,uM,=,2.0,1,O=c1ccn(Cc2ccccc2)c2ccccc12
188,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1[nH]nc(OCC(=O)Nc2ccc(C#CC(C)(C)C(=O)O)cc2Cl)c1-c1ccc(C(C)(C)C)cc1Cl,"4-(4-(2-(4-(4-tert-butyl-2-chlorophenyl)-5-methyl-1H-pyrazol-3-yloxy)acetamido)-3-chlorophenyl)-2,2-dimethylbut-3-ynoic acid",2.403,uM,=,0.3807537708039001,1,O=C(COc1n[nH]cc1-c1ccccc1)Nc1ccccc1
189,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2c(F)cccc2F)nc(SC(C)C)[nH]c1=O,"2-(2,6-difluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.079,uM,=,-1.1023729087095586,0,O=c1cc(Cc2ccccc2)nc[nH]1
190,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(Oc2c(C(F)(F)F)ccn(Cc3n[nH]c(=O)n3C)c2=O)ccc1-c1ccc(F)c(C#N)c1,"4-Fluoro-2'-methyl-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-y1)oxy)-[1,1'-biphenyl]-3-carbonitrile",1.46,uM,=,0.1643528557844371,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
191,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,Cc1cc(C)cc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"6-(3',5'-Dimethyl-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.063,uM,=,-1.2006594505464183,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
192,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,Cc1cc(C)cc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)c1,"4-[1-(3,5-Dimethylphenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid",37.8,uM,=,1.577491799837225,1,O=c1ccn(Cc2ccccc2)c2ccccc12
193,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",0.003,uM,=,-2.5228787452803374,0,c1ccc(Oc2cccc(OCc3n[nH]c4ncccc34)c2)cc1
194,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cnco3)nc21,"5-Ethyl-10-methyl-7-oxazol-5-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.56,uM,=,-0.2518119729937995,0,O=C1Nc2ccc(-c3cnco3)nc2Nc2ncccc21
195,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",9.6,uM,=,0.9822712330395684,1,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
196,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccccc2)n[nH]1,3-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,75.0,uM,=,1.8750612633917,1,c1ccc(Cn2cc(-c3ccccc3)c(-c3cc[nH]n3)c2)cc1
197,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,COc1cc(-c2ccc(F)c(C#N)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"4-fluoro-3'-methoxy-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",42.47,uM,=,1.6280822609906795,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
198,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3ccccc3s2)c(O)nc1C,3-[(Benzo[b]thiophen-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.5,uM,=,-0.3010299956639812,0,c1cncc(NCc2cc3ccccc3s2)c1
199,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(C#N)cc(-c4ccc(F)c(C#N)c4)c3)c2=O)n[nH]c1=O,"4-fluoro-5'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3,3'-dicarbonitrile",0.29,uM,=,-0.5376020021010439,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
200,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,CCC(C)Oc1ccc(/C=C2\NC(=O)NC2=O)cc1,"5-(4-sec-butoxybenzylidene)imidazolidine-2,4-dione",52.8,uM,=,1.7226339225338123,1,O=C1NC(=O)/C(=C/c2ccccc2)N1
201,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),COc1ccc2c(c1)C(=O)N1CCSC21c1ccccc1,"7-Methoxy-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.0,uM,=,0.6020599913279624,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
202,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(F)c(CC/N=C(\S)Nc2ccc(Br)cn2)c1OC,"1-(5-Bromo-pyridin-2-yl)-3-[2-(6-fluoro-2,3-dimethoxy-phenyl)-ethyl]-thiourea",0.007,uM,=,-2.154901959985743,0,C(=NCCc1ccccc1)Nc1ccccn1
203,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cccc(F)c4)c(F)c3)c2=O)n[nH]c1=O,"3-(2,3'-Difluoro-[1,1'-biphenyl]-4-yl)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",2.33,uM,=,0.367355921026019,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
204,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(OC)nc21,"8-Ethyl-6-methoxy-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.156,uM,=,-0.8068754016455384,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
205,1565176,10.1016/j.bmcl.2016.02.049,,,,Inhibition of HIV1 reverse transcriptase using DIG-labeled dNTPs as substrate after 1 hr by ELISA,C[C@@H]1C(=O)N2C[C@@H](O)[C@@H](O)[C@@H]2[C@@H]2Sc3ccccc3C(=O)N12,"(1S,2R,6R,13aS,13bR)-1,2-dihydroxy-6-methyl-1,2,3,13b-tetrahydrobenzo[e]pyrrolo[2',1':3,4]pyrazino[2,1-b][1,3]thiazine-5,8(6H,13aH)-dione",2.01,uM,=,0.3031960574204888,1,O=C1CN2C(=O)c3ccccc3S[C@H]2[C@H]2CCCN12
206,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCc2ccc(-c3ccncc3)cc2)c2cccnc2n1O,"1-Hydroxy-4-({[4-(4-pyridinyl)phenyl]methyl}amino)pyrido[2,3-d]pyrimidin-2(1H)-one",0.016,uM,=,-1.7958800173440752,0,O=c1nc(NCc2ccc(-c3ccncc3)cc2)c2cccnc2[nH]1
207,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C(C)C1C,"8,9-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",2.22,uM,=,0.3463529744506387,1,S=c1[nH]c2cccc3c2n1CCNC3
208,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cn[nH]c3)nc21,"5-Ethyl-10-methyl-7-(1H-pyrazol-4-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2ccc(-c3cn[nH]c3)nc2Nc2ncccc21
209,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1cccnc1,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-(pyridin-3-ylmethoxy)-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.438,uM,=,-0.3585258894959005,0,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1cccnc1
210,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,Cc1cc(C)cc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)c1,"6-[1-(3,5-Dimethylphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoic Acid",16.0,uM,=,1.2041199826559248,1,c1ccc(Cn2cccc2)cc1
211,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,Nc1ncnc2c1ncn2CCc1nc(O)c(O)c(C(=O)O)n1,"2-(2-(6-Amino-9H-purin-9-yl)ethyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",41.0,uM,=,1.6127838567197357,1,c1cnc(CCn2cnc3cncnc32)nc1
212,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1cccc(C(OCCn2c([N+](=O)[O-])cnc2C)c2ccccc2)c1,2-Methyl-5-nitro-1-[2-(phenyl-m-tolyl-methoxy)-ethyl]-1H-imidazole,0.3,uM,=,-0.5228787452803376,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
213,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(/C=C/C(N)=O)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nn2cccc12,"(E)-3-(4-((2-((4-Cyanophenyl)amino)pyrrolo[2,1-f][1,2,4]triazin-4-yl)oxy)-3,5-dimethylphenyl)acrylamide",0.053,uM,=,-1.275724130399211,0,c1ccc(Nc2nc(Oc3ccccc3)c3cccn3n2)cc1
214,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,C#CCNC(=O)CSc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(prop-2-yn-1-yl)acetamide",0.023,uM,=,-1.6382721639824072,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
215,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,COC(=O)c1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"methyl 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)benzimidazole-4-carboxylate",157.8,uM,=,2.198106998873401,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
216,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,CC1=CC(=O)/C(=C/Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)C(=O)O1,"6-methyl-3-((4-(3-nitrophenyl)thiazol-2-ylamino)methylene)-3H-pyran-2,4-dione",29.0,uM,=,1.462397997898956,1,O=C1C=COC(=O)/C1=C\Nc1nc(-c2ccccc2)cs1
217,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3cccc(Cl)c3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-N-(3-chlorophenethyl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.083,uM,=,-1.080921907623926,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
218,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nccn2-c2ccc(O)nc21,"8-Ethyl-7H,8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-one",6.98,uM,=,0.8438554226231612,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
219,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)-pyrimidine-2,4(1H,3H)-dione",6.5,uM,=,0.8129133566428556,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
220,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1ccc(Cl)cc1C(=O)O,2-[5-(2-carboxy-4-chlorophenylcarbamoyl)pentylcarboxamido]-5-chlorobenzoic acid,2.6,uM,=,0.414973347970818,1,O=C(CCCCCC(=O)Nc1ccccc1)Nc1ccccc1
221,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(CCc2cc(CC)c(C)nc2O)c(O)nc1C,"5-ethyl-3-[2-(5-ethyl-6-methyl-2-oxo-1,2-dihydro-3-pyridinyl)ethyl]-6-methyl-1,2-dihydro-2-pyridinone",0.4,uM,=,-0.3979400086720376,0,c1cncc(CCc2cccnc2)c1
222,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,O=C(NCc1ccc(O)c(O)c1)C1C(=O)N(O)C(=O)c2ccccc21,"N-(3,4-dihydroxybenzyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",0.9,uM,=,-0.0457574905606751,0,O=C1NC(=O)C(C(=O)NCc2ccccc2)c2ccccc21
223,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),CN(C)C(=O)/C=C/CSc1nc(N)cc(Cl)n1,(E)-4-(4-Amino-6-chloro-pyrimidin-2-ylsulfanyl)-but-2-enoic acid dimethylamide,0.2,uM,=,-0.6989700043360187,0,c1cncnc1
224,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,COc1cc(Oc2c(C)cc(C#N)cc2C)cc(NC2CCN(Cc3ccccc3)CC2)n1,"4-((2-((1-benzylpiperidin-4-yl)amino)-6-methoxypyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.264,uM,=,-0.5783960731301689,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
225,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CN(C)c1ccc(CC/N=C(\S)Nc2ccc(Br)cn2)c(F)c1C#N,1-(5-Bromo-pyridin-2-yl)-3-[2-(3-cyano-4-dimethylamino-2-fluoro-phenyl)-ethyl]-thiourea,0.008,uM,=,-2.096910013008056,0,C(=NCCc1ccccc1)Nc1ccccn1
226,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NS(=O)(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-sulfonic acid (2-{4-[ethyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.38,uM,=,-0.4202164033831898,0,O=C(c1cc2cc(NS(=O)(=O)N3CCNCC3)ccc2[nH]1)N1CCC(Nc2ccccn2)CC1
227,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCCO)c1Cc1cccc(C)c1,5-Ethyl-3-[(3-hydroxy-propyl)-methyl-amino]-6-methyl-4-(3-methyl-benzyl)-1H-pyridin-2-one,0.003,uM,=,-2.5228787452803374,0,O=c1cc(Cc2ccccc2)cc[nH]1
228,465754,10.1016/j.bmcl.2007.11.114,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(C(=CCCCSC)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"3',3''-Dichloro-4',4''-dimethoxy-5',5''-di(methoxycarbonyl)-1,1-diphenyl-5-(methylthio)-pent-1-ene",100.0,uM,=,2.0,1,C=C(c1ccccc1)c1ccccc1
229,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1ccc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)cc1,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(4-methoxyphenyl)acetonitrile",20.669,uM,=,1.3153194652587508,1,O=c1cc(Cc2ccccc2)nc[nH]1
230,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N(C1CC1)C1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,{4-[Cyclopropyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidin-1-yl}-(1H-indol-2-yl)-methanone,0.7,uM,=,-0.1549019599857432,0,O=C(c1cc2ccccc2[nH]1)N1CCC(N(c2ccccn2)C2CC2)CC1
231,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,Cc1ccc(S(=O)(=O)N/N=C/c2c(O)ccc3ccccc23)cc1,N'-((2-hydroxynaphthalen-1-yl)methylene)-4-methylbenzenesulfonohydrazide,58.0,uM,=,1.7634279935629371,1,O=S(=O)(N/N=C/c1cccc2ccccc12)c1ccccc1
232,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)Cn1ccnc1)CC2,"(2S)-5,7-dihydroxy-2-(2-hydroxy-1-(1H-imidazol-1-yl)propan-2-yl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",1.9,uM,=,0.2787536009528289,1,O=c1cccc2c(c1)CC[C@H](CCn1ccnc1)C2
233,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1CCC2,"3,5-Dimethyl-4-((2-((1-(4-nitrobenzyl)piperidin-4-yl)amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)oxy)benzonitrile",0.241,uM,=,-0.6179829574251317,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCC4)CC2)cc1
234,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCOC(=O)c2ccccc2)n2nc(Cl)ccc12,"Benzoic acid 5-(2-chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-pentyl ester",1.3,uM,=,0.1139433523068367,1,O=C(OCCCCCc1ncc2cccnn12)c1ccccc1
235,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,O=C1Nc2c(CNc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-phenylaminomethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.37,uM,=,0.1367205671564068,1,O=C1Nc2c(CNc3ccccc3)ccnc2N(C2CC2)c2ncccc21
236,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,COc1ccc2c(c1)[C@@](C#CC(C)C)(C(F)(F)F)NC(=O)N2,"6-Methoxy-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.401,uM,=,-0.3968556273798176,0,O=C1NCc2ccccc2N1
237,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2C1(O)C(F)(F)F,5-Chloro-3-hydroxy-2-oxo-3-trifluoromethylindole,7.1,uM,=,0.8512583487190752,1,O=C1Cc2ccccc2N1
238,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SC2CCCC2)nc1Cc1ccccc1,6-Benzyl-2-cyclopentylsulfanyl-5-methyl-3H-pyrimidin-4-one,0.5,uM,=,-0.3010299956639812,0,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
239,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cccc(CC)c3o2)c(O)nc1C,5-Ethyl-3-[(7-ethyl-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.26,uM,=,-0.585026652029182,0,c1cncc(NCc2nc3ccccc3o2)c1
240,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"S-2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.001,uM,=,-3.0,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
241,743750,10.1021/jm101536x,,,,Inhibition of wild type HIV-1 reverse transcriptase-mediated polymerization reaction after 30 mins,Nc1nc2c(ncn2[C@H]2CC[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1,"2-Amino-9-(5-methyloxy-triphosphate-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one (ddGTP)",0.2240322074636104,uM,=,-0.6496895418523007,0,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
242,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.008,uM,=,-2.096910013008056,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
243,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CC(C)(C)CO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"1-[2-(4,4-Dimethyl-tetrahydro-furan-2-yl)-ethyl]-4-(6-methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0081999999999999,uM,=,-2.086186147616284,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
244,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2ccc(F)c(F)c2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-5,6-difluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.084,uM,=,-1.0757207139381184,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
245,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,C[N+]1(C)C[C@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c(c2c2c4c4c6c6c8c%10c8c%12c%10c%14c(c%15%19)c%12c%20c2c2c4c6c8c%10c%122)[C@@H]%18[C@H]2c4c6c8c%10c(c4-%17)[C@@H]%16[C@H]%13[C@@]%114C[N+](C)(C)C[C@]%104C=9[C@H]8[C@@H]7C5=C6[C@]23C1.[I-].[I-],Fullerene Derivative,1.4,uM,=,0.1461280356782379,1,C1[NH2+]C[C@@]23C4=C5c6c7c8c9c(c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c(c6c6c8c8c%24c9c%11c9c(c%16%12)c%17c%11c%19c%12c%21c%23c6c8c%12c%11c9%24)[C@@H]5[C@@H]5C=%22[C@]68C[NH2+]C[C@]%206[C@@H]%18[C@H]%15c6c-%14c(c4c5c68)[C@@H]2[C@H]%13%10)[C@]173
246,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1c(O)nc(SC2CCCC2)nc1Cc1ccccc1,6-Benzyl-2-cyclopentylsulfanyl-5-methyl-3H-pyrimidin-4-one,3.4,uM,=,0.5314789170422551,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
247,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cccc(C23SCCN2C(=O)c2ccccc23)n1,"9b-(6-Methyl-pyridin-2-yl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.1,uM,=,0.6127838567197355,1,O=C1c2ccccc2C2(c3ccccn3)SCCN12
248,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccc(S(C)(=O)=O)cc3Cl)nc3ccc(Cl)cc32)c1,"2-{[6-Chloro-1-(3,5-dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-[2-chloro-4-(methylsulfonyl)phenyl]-acetamide",70.55,uM,=,1.8484970180903664,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
249,197440,10.1016/s0960-894x(99)00664-2,,,,Compound dose required to inhibit HIV-1 reverse transcriptase enzyme(rRT) activity,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1ccc(Cl)cc1Cl,"1-{2-[(2,4-Dichloro-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole",1.4,uM,=,0.1461280356782379,1,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
250,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.78,uM,=,0.250420002308894,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
251,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)N1CC[C@H](NC(=O)OC(C)(C)C)C1,"Tert-butyl(S)-(1-(2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetyl)pyrrolidin-3-yl)carbamate",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)N1CCCC1
252,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCc1c(O)nc(SCC(=O)OC)nc1Cc1cccc2ccccc12,"(5-Ethyl-4-naphthalen-1-ylmethyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-acetic acid methyl ester",4.72,uM,=,0.6739419986340878,1,c1ccc2c(Cc3ccncn3)cccc2c1
253,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.96,uM,=,-0.0177287669604316,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
254,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4ccc(-c5cncn5C)cc4c32)CCO1,"Cis-1-(2-Ethyl-tetrahydro-pyran-4-yl)-8-(3-methyl-3H-imidazol-4-yl)-4-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[4,5]furo[3,2-d]pyrimidin-2-one",0.024,uM,=,-1.619788758288394,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4cnc[nH]4)cc3c2n1C1CCOCC1
255,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,CC1=C(Cc2cc(O)ccc2O)[C@]2(C)CCC[C@@](C)(CC[C@@]3(O)[C@H](C)CC[C@@H]4OC(C)(C)CCC[C@@]43C)[C@H]2CC1,"2-(((4aR,5S,8aR)-5-(2-((5aS,6R,7R,9aS)-6-hydroxy-2,2,5a,7-tetramethyldecahydrobenzo[b]oxepin-6-yl)ethyl)-2,5,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methyl)benzene-1,4-diol",2.5,uM,=,0.3979400086720376,1,C1=C(Cc2ccccc2)C2CCCC(CCC3CCC[C@@H]4OCCCCC34)[C@H]2CC1
256,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,CC(C)OC(=O)OCn1nc(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n(C)c1=O,"(3-((3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)methyl isopropyl carbonate",2.11,uM,=,0.3242824552976926,1,O=c1[nH]nc(Cn2cccc(Oc3ccccc3)c2=O)[nH]1
257,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cn1cc(-c2cnc3oc4c(-c5cscn5)nc(=O)n(CCC5CCCO5)c4c3c2)cn1,"8-(1-Methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-4-thiazol-4-yl-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0099,uM,=,-2.00436480540245,0,O=c1nc(-c2cscn2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
258,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,CCCCCCCCCC[N@+]1(C)C[C@@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c(c2c2c4c4c6c9c6c4c4c2c%21c2c%19c(c%18%14)c9c%13c%10c6c9c24)C2=C4c6c(c-%16c9c%10c6[C@H]([C@@H]5C7=C%10[C@]5(C[N+](C)(C)C[C@]8%115)[C@H]9[C@H]%15%12)[C@@]43C1)[C@@H]%17[C@H]2%20.[I-].[I-],Fullerene Derivative,1.3,uM,=,0.1139433523068367,1,C1[NH2+]C[C@@]23C4=C5c6c7c8c9c(c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c%24c(c6c6c%23c%23c(c86)c6c9c%11c8c(c%16%12)c%17c9c%19c%22c%23c9c86)[C@@H]5[C@H]5c6c8c(c-%14c(c64)[C@@H]2[C@H]%13%10)[C@@H]%15[C@@H]%18C%20=C8[C@]52C[NH2+]C[C@@]%24%212)[C@]173
259,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2cccc(C)c2)n1,2-sec-Butylsulfanyl-5-methyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,2.7,uM,=,0.4313637641589873,1,c1ccc(Cc2ccncn2)cc1
260,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,CC1OC(Cc2ccc(Cl)c(Oc3cc(Cl)cc(C#N)c3)c2F)=NNC1=O,"3-chloro-5-(6-chloro-2-fluoro-3-((6-methyl-5-oxo-5,6-dihydro-4H-1,3,4-oxadiazin-2-yl)methyl)phenoxy)benzonitrile",0.013,uM,=,-1.8860566476931635,0,O=C1COC(Cc2cccc(Oc3ccccc3)c2)=NN1
261,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,methyl 3-bromo-5-[1-(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-1-heptenyl]-2-methoxybenzoate,0.38,uM,=,-0.4202164033831898,0,C=C(c1ccccc1)c1ccccc1
262,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CN(c1ncccc1NC1CC1)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Cyclopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.09,uM,=,-1.0457574905606752,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ncccc2NC2CC2)CC1
263,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1O,"6-([1,1'-Biphenyl]-4-ylmethyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.6,uM,=,-0.2218487496163563,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
264,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3cccc4[nH]ccc34)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(1H-indol-4-yloxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.36,uM,=,0.1335389083702175,1,O=C1Nc2cccnc2Nc2ncc(COc3cccc4[nH]ccc34)cc21
265,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccco2)c(O)nc1C,5-Ethyl-3-[(furan-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,29.0,uM,=,1.462397997898956,1,c1cncc(NCc2ccco2)c1
266,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
267,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,"N-Benzyl-1-(hydroxy)-4-(ethylamino)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.042,uM,=,-1.3767507096020994,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
268,80145,10.1016/0960-894X(95)00302-A,,,,Tested for the inhibition towards HIV-reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.01,uM,=,-2.0,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
269,1299150,10.1039/C3MD00036B,,,,Inhibition of HIV1 wild type reverse transcriptase using poly rC.dG and [3H]dGTP as substrate,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,1.2,uM,=,0.0791812460476248,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
270,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CSc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-6-methyl-5-methylsulfanyl-1H-pyridin-2-one",0.043,uM,=,-1.3665315444204136,0,c1cncc(NCc2nc3ccccc3o2)c1
271,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.1,uM,=,-1.0,0,c1cncc(NCc2nc3ccccc3o2)c1
272,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CC(=O)CSc1nc(O)c(C(C)C)c(Cc2cccc3ccccc23)n1,5-Isopropyl-6-naphthalen-1-ylmethyl-2-(2-oxo-propylsulfanyl)-3H-pyrimidin-4-one,0.41,uM,=,-0.3872161432802645,0,c1ccc2c(Cc3ccncn3)cccc2c1
273,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(O)nc21,"8-Ethyl-3-methyl-7H,8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-one",12.2,uM,=,1.0863598306747482,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
274,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1C#N,"4-(4-Cyano-2,6-dimethyl-phenylamino)-2-(4-cyano-phenylamino)-pyrimidine-5-carbonitrile",0.0005,uM,=,-3.3010299956639813,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
275,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(F)c(C#N)c2)nc(SC(C)C)[nH]c1=O,"5-(cyano(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)methyl)-2-fluorobenzonitrile",83.82,uM,=,1.9233476564978256,1,O=c1cc(Cc2ccccc2)nc[nH]1
276,539717,10.1021/jm800473d,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,O=S(=O)(Nc1n[nH]cc1Br)c1cccc2nsnc12,"N-(4-bromo-1Hpyrazol-3-yl)-2,1,3-benzothiadiazole-4-sulfonamide",3.3,uM,=,0.5185139398778875,1,O=S(=O)(Nc1cc[nH]n1)c1cccc2nsnc12
277,195342,10.1021/jm00076a005,,,,Inhibition of reverse transcriptase activity of HIV-1 in the presence of [alpha35 S] TTP as cosubstrate,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
278,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SCc2cc3c(cc2Cl)OCO3)n1,"6-Chloro-2-(6-chloro-benzo[1,3]dioxol-5-ylmethylsulfanyl)-pyrimidin-4-ylamine",0.016,uM,=,-1.7958800173440752,0,c1cnc(SCc2ccc3c(c2)OCO3)nc1
279,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2c1=O,"6-([1,1'-Biphenyl]-4-ylmethoxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",7.47,uM,=,0.8733206018153987,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc(-c4ccccc4)cc3)cc12
280,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@@H]1[C@H](O)c2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)OC(C)(C)C=C3)O[C@@H]1C,"(10R,11R,12S)-12-hydroxy-6,6,10,11-tetramethyl-4-phenyl-6,10,11,12-tetrahydro-2H-1,5,9-trioxatriphenylen-2-one",30.0,uM,=,1.4771212547196624,1,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
281,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1cc(Cl)cc(Cl)c1,"6-Chloro-1-(3,5-dichlorophenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.003,uM,=,-2.5228787452803374,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
282,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Fc1cccc(CCNC(=S)Nc2nccs2)c1,1-[2-(3-Fluoro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.15,uM,=,-0.8239087409443188,0,S=C(NCCc1ccccc1)Nc1nccs1
283,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,CCC(C)[C@H](NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)C,"((S)-1-{(1S,2S)-1-Benzyl-2-hydroxy-3-[N'-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-N-(4-pyridin-2-yl-benzyl)-hydrazino]-propylcarbamoyl}-2-methyl-butyl)-carbamic acid methyl ester",0.028,uM,=,-1.5528419686577808,0,c1ccc(CCCCNCc2ccc(-c3ccccn3)cc2)cc1
284,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cccc(F)c3o2)c(O)nc1C,5-Ethyl-3-[(7-fluoro-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.092,uM,=,-1.0362121726544449,0,c1cncc(NCc2nc3ccccc3o2)c1
285,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,O=C(Nc1ccc(Cl)cn1)NC1CC1c1c(F)ccc(O)c1Cl,1-[2-(2-Chloro-6-fluoro-3-hydroxy-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea,0.135,uM,=,-0.8696662315049939,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
286,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccnc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-3-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2cccnc2Nc2ncc(COc3cccnc3)cc21
287,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cc(C(N)=O)ccc3Cl)CC2)ncc1Br,"3-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)-4-chlorobenzamide",0.076,uM,=,-1.1191864077192086,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
288,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccccc2)n1,6-Benzyl-2-sec-butylsulfanyl-5-methyl-3H-pyrimidin-4-one,2.4,uM,=,0.380211241711606,1,c1ccc(Cc2ccncn2)cc1
289,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,"6-Benzyl-1-ethoxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.8,uM,=,-0.0969100130080563,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
290,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cc(OC)cc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",0.6,uM,=,-0.2218487496163563,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
291,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(F)c2)[nH]c(=O)n1O,"6-((3-Fluorophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.014,uM,=,-1.853871964321762,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
292,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncccc21
293,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,3-(5-((1H-indazol-3-yl)methoxy)-2-chlorophenoxy)-5-chlorobenzonitrile,0.00135,uM,=,-2.869666231504994,0,c1ccc(Oc2cccc(OCc3n[nH]c4ccccc34)c2)cc1
294,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC1Cn2c(S)nc3cccc(c32)CN1CC1CC1,"7-Cyclopropylmethyl-8-methyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.06,uM,=,-1.2218487496163564,0,c1cc2c3c(c1)ncn3CCN(CC1CC1)C2
295,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccccc1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",1.2,uM,=,0.0791812460476248,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
296,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)c1cc(C(=CCC2OCCO2)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-3-(1,3-dioxolan-2-yl)-1-propenyl]-2-methoxybenzoate",3.2,uM,=,0.505149978319906,1,C(CC1OCCO1)=C(c1ccccc1)c1ccccc1
297,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1ccn2CC(=O)N1CCOCC1,"4-((2-((4-cyanophenyl)amino)-7-(2-morpholino-2-oxoethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-3,6-dimethylbenzonitrile",0.155,uM,=,-0.8096683018297085,0,O=C(Cn1ccc2c(Oc3ccccc3)nc(Nc3ccccc3)nc21)N1CCOCC1
298,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](O)[C@H](O)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1,2alpha-hydroxymaprounic acid,3.4,uM,=,0.5314789170422551,1,C1=C2C(CC[C@H]3C2CC[C@H]2CCCCC23)[C@@H]2CCCCC2C1
299,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4-[2-(4-Cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.0011,uM,=,-2.958607314841775,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
300,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1O,"4-(4-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)phenyl)pyridin-1-ium 4-methylbenzenesulfonate",0.8,uM,=,-0.0969100130080563,0,O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1.c1ccccc1
301,1364717,10.1016/j.ejmech.2014.06.061,,,,Inhibition of HIV1 reverse transcriptase strand transfer activity,O=C(NCc1ccc(F)cc1)c1nc(N2CCCCS2(=O)=O)c2cccnc2c1O,"5-(1,1-Dioxo-1lambda*6*-[1,2]thiazinan-2-yl)-8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluoro-benzylamide",0.005,uM,=,-2.3010299956639813,0,O=C(NCc1ccccc1)c1cc2ncccc2c(N2CCCCS2(=O)=O)n1
302,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",1.2,uM,=,0.0791812460476248,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
303,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-cyano-benzenesulfonyl)-benzonitrile,1.8,uM,=,0.255272505103306,1,O=S(=O)(c1ccccc1)c1ccccc1
304,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cnc(Nc2ccc(C#N)cc2)nc1OCC(=O)Nc1ccc(C#N)cc1,N-(4-Cyanophenyl)-2-((2-((4-cyanophenyl)amino)-5-methylpyrimidin-4-yl)oxy)acetamide,17.58,uM,=,1.245018870737753,1,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
305,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCN(S(C)(=O)=O)CC3)cc2)n1,"(E)-3-(3,5-dimethyl-4-(2-(4-((4-(methylsulfonyl)piperazin-1-yl)methyl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylonitrile",0.067,uM,=,-1.1739251972991736,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
306,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.098,uM,=,-1.0087739243075051,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
307,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCc1c(C)nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc1C,"2-(2,6-Dichlorophenyl)-3-(5-ethyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",0.26,uM,=,-0.585026652029182,0,O=C1CSC(c2ccccc2)N1c1ncccn1
308,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,C#Cc1ccc2nc(O)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,"5-Ethynyl-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",437.1,uM,=,2.6405808064896528,1,c1cc2c3c(c1)ncn3CCNC2
309,1982639,10.1021/acsmedchemlett.9b00623,,,,Inhibition of recombinant HIV-1 BH10 reverse transcriptase p51/p66 expressed in Escherichia coli assessed as reduction in recovery of DNA polymerase activity preincubated with 15% acetonitrile for 15 hrs followed by compound addition and acetonitrile reduced to <1% using poly(rA)/oligo(dT)16 as template/primer in presence of [3H]dTTP,CC[C@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,"(4R,7S,10S,13S,16S,19R)-19-amino-10,13-bis(2-amino-2-oxo-ethyl)-7-(2-carboxyethyl)-16-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxylic acid",203.0,uM,=,2.307496037913213,1,O=C1CCSSCCNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
310,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3S(C)(=O)=O)nc3ccccc32)c1,"2-{[1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl]sulfanyl}-N-[2-(methylsulfonyl)phenyl]acetamide",60.61,uM,=,1.78254428401001,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
311,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CN(C)c1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[2-(3-dimethylamino-2,6-difluoro-phenyl)-ethyl]-thiourea",0.007,uM,=,-2.154901959985743,0,S=C(NCCc1ccccc1)Nc1ccccn1
312,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CSCN1c2ncccc2C(=O)N(C)c2cccnc21,"10-Methyl-5-methylsulfanylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.85,uM,=,-0.0705810742857072,0,O=C1Nc2cccnc2Nc2ncccc21
313,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccc(Br)c2)nc(SC(C)C)[nH]c1=O,"2-(3-bromophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.57,uM,=,-0.2441251443275086,0,O=c1cc(Cc2ccccc2)nc[nH]1
314,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCNc1ccc2c(n1)N(CC)c1ncccc1C(=O)N2C,"5-Ethyl-7-ethylamino-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2Nc2ncccc21
315,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(C#N)cc1,"6-[1-(4-Cyanophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",8.0,uM,=,0.9030899869919436,1,c1ccc(Cn2cccc2)cc1
316,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1cccc(Sc2cc(=O)n(O)c(=O)[nH]2)c1,"3-Hydroxy-6-((3-methoxyphenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.013,uM,=,-1.8860566476931635,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
317,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,Cc1cn(C2CC(O)C(C#N)(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2)c(=O)[nH]c1=O,"rac-(1-cyano-2-hydroxy-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopentyl)methyltriphosphoric acid",0.523,uM,=,-0.2814983111327257,0,O=c1ccn(C2CCCC2)c(=O)[nH]1
318,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",0.4,uM,=,-0.3979400086720376,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
319,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C(F)(F)F)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(trifluoromethyl)benzyl)isoquinoline-1,3(2H,4H)-dione",2.0,uM,=,0.3010299956639812,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
320,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCOc1ccccc1CNc1cc(CC)c(C)nc1O,3-(2-Ethoxy-benzylamino)-5-ethyl-6-methyl-1H-pyridin-2-one,0.35,uM,=,-0.4559319556497244,0,c1ccc(CNc2cccnc2)cc1
321,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C(C)(C)C)c2ncccc21,"5-tert-Butyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",11.0,uM,=,1.0413926851582251,1,O=C1Nc2cccnc2Nc2ncccc21
322,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(Cc2ccc(Cl)cc2)nc(O)c1O,"2-(4-Chlorobenzyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",97.0,uM,=,1.9867717342662448,1,c1ccc(Cc2ncccn2)cc1
323,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3nc4ccccc4o3)cc2C(=O)Nc2c(C)cc(Cl)nc21,"2-(Benzooxazol-2-ylsulfanylmethyl)-7-chloro-5-ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.008,uM,=,-2.096910013008056,0,O=C1Nc2cccnc2Nc2ncc(CSc3nc4ccccc4o3)cc21
324,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc(C)c1CCC#N,"2-(2,6-Dichlorophenyl)-3-(5-propanenitrile-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",1.02,uM,=,0.0086001717619175,1,O=C1CSC(c2ccccc2)N1c1ncccn1
325,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2cc(OC)cc(OC)c2)C(F)(F)F)c(O)nc1C,"3-[3-Cyclopropyl-1-(3,5-dimethoxy-benzyloxy)-1-trifluoromethyl-prop-2-ynyl]-5-ethyl-6-methyl-1H-pyridin-2-one",3.843,uM,=,0.5846703844643487,1,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
326,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#CCN(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-((cyanomethyl)(2-(4-cyanophenylamino)pyrimidin-4-yl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.021,uM,=,-1.6777807052660807,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
327,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1nc(O)c(CCc2nc3ccccc3o2)cc1C(C)C,3-(2-Benzooxazol-2-yl-ethyl)-5-isopropyl-6-methyl-1H-pyridin-2-one,0.048,uM,=,-1.3187587626244128,0,c1cncc(CCc2nc3ccccc3o2)c1
328,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),COC(=O)c1cccc(CSc2nc(N)cc(Cl)n2)c1,3-(4-Amino-6-chloro-pyrimidin-2-ylsulfanylmethyl)-benzoic acid methyl ester,0.33,uM,=,-0.4814860601221125,0,c1ccc(CSc2ncccn2)cc1
329,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,CCNC(=O)OCCCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,Bis(3-Chloro-2-methoxy-benzoic acid methyl ester)Ethyl-carbamic acid hex-5-enyl ester,3.2,uM,=,0.505149978319906,1,C=C(c1ccccc1)c1ccccc1
330,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(Cl)ccc(Cl)c3o2)c(S)nc1C,"3-[2-(4,7-Dichloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridine-2-thione",0.03,uM,=,-1.5228787452803376,0,c1cncc(CCc2nc3ccccc3o2)c1
331,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1nc(F)ccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(6-fluoro-3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.46,uM,=,-0.3372421683184259,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
332,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Oc1cc(Cc2ccccc2)nc(SC2CCCC2)n1,6-Benzyl-2-cyclopentylsulfanyl-3H-pyrimidin-4-one,1.6,uM,=,0.2041199826559248,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
333,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cccc(C)c3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(7-methyl-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,0.055,uM,=,-1.259637310505756,0,c1cncc(NCc2nc3ccccc3o2)c1
334,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccccc2F)n1,2-sec-Butylsulfanyl-6-(2-fluoro-benzyl)-5-methyl-3H-pyrimidin-4-one,0.41,uM,=,-0.3872161432802645,0,c1ccc(Cc2ccncn2)cc1
335,197449,10.1016/s0960-894x(98)00250-9,,,,Compound was evaluated for enzymatic inhibitory activity against recombinant HIV reverse transcriptase,CSCSc1nc(O)c(C)c(Cc2ccccc2)n1,6-Benzyl-5-methyl-2-methylsulfanylmethylsulfanyl-3H-pyrimidin-4-one,18.8,uM,=,1.2741578492636798,1,c1ccc(Cc2ccncn2)cc1
336,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2nccs2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-thiazol-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.0109,uM,=,-1.9625735020593764,0,O=C1Nc2ccccc2C(C#Cc2nccs2)(C2CC2)N1
337,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1cccc(CCNC(=S)Nc2nccs2)c1,1-[2-(3-Methoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.15,uM,=,-0.8239087409443188,0,S=C(NCCc1ccccc1)Nc1nccs1
338,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1cc(F)cc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)c1,"2-(3-fluoro-5-methoxyphenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.236,uM,=,-0.6270879970298934,0,O=c1cc(Cc2ccccc2)nc[nH]1
339,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCCCCCCc1c(O)n(O)c(=O)c2ccccc12,"4-heptyl-2,3-dihydroxyisoquinolin-1(2H)-one",45.0,uM,=,1.6532125137753435,1,O=c1[nH]ccc2ccccc12
340,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,COc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,"5-(3,4-Dichlorophenyl)-2-(3-(4-methoxyphenyl)ureido)-thiophene-3-carboxylic Acid",0.8,uM,=,-0.0969100130080563,0,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
341,950904,10.1016/j.bmc.2012.12.049,,,,Inhibition of HIV 1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly rA.dT by ELISA,Cc1cc(Br)c(Oc2cc(Nc3ccc(C#N)cc3)nnc2Cl)c(Br)c1,"4-((6-Chloro-5-(2,6-dibromo-4-methylphenoxy)pyridazin-3-yl)amino)benzonitrile",3.18,uM,=,0.5024271199844327,1,c1ccc(Nc2cc(Oc3ccccc3)cnn2)cc1
342,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,S=C(NCCc1ccccc1Cl)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-chloro-phenyl)-ethyl]-thiourea,0.7,uM,=,-0.1549019599857432,0,S=C(NCCc1ccccc1)Nc1ccccn1
343,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccc([N+](=O)[O-])c3)SCCN12,"9b-(3-Nitro-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.86,uM,=,-0.0655015487564322,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
344,856829,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 25 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay in presence of 340 uM base pair of calf thymus DNA,Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCNCCNCCC[n+]1c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc31)c1cc(N)ccc21.[Cl-].[Cl-],Ethidium homodimer-1,8.5,uM,=,0.9294189257142929,1,c1ccc(-c2c3ccccc3c3ccccc3[n+]2CCCNCCNCCC[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
345,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(F)cccc3o2)c(S)nc1C,5-Ethyl-3-[2-(4-fluoro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridine-2-thione,0.013,uM,=,-1.8860566476931635,0,c1cncc(CCc2nc3ccccc3o2)c1
346,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",2.4,uM,=,0.380211241711606,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
347,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1cc(OC)cc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)c1,"2-(3,5-dimethoxyphenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",2.585,uM,=,0.4124605474299613,1,O=c1cc(Cc2ccccc2)nc[nH]1
348,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccnc3ccccc23)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2,6-Dimethyl-4-(quinolin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0407,uM,=,-1.39040559077478,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccnc5ccccc45)cc3)n2)cc1
349,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CNC(=O)Nc1ccc2[nH]c(C(=O)N3CCC(N(C)c4ncccc4NC(C)C)CC3)cc2c1,1-(2-{4-[(3-Isopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-3-methyl-urea,0.18,uM,=,-0.744727494896694,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
350,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),COc1ccc2c(C)nc(CCCCCCC(=O)c3ccccc3)n2n1.Cl,"7-(2-Methoxy-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one hydrochloride",0.64,uM,=,-0.1938200260161128,0,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
351,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(=O)NCc3ccncc3)[nH]c3ccc(Cl)cc23)c1,"(S)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide",0.506,uM,=,-0.2958494831602009,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncc1
352,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2cc(NS(=O)(=O)c3ccc(-c4ccc(S(=O)(=O)Nc5ccc6cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c6c5)cc4)cc3)ccc2c1.[Na+].[Na+].[Na+].[Na+],"7-{4-[4-(6,8-disulfo-2-naphthylsulfamoyl)phenyl]phenylsulfonamido}-1,3-naphthalenedisulfonic acidTetrasodium salt",374.0,uM,=,2.5728716022004803,1,O=S(=O)(Nc1ccc2ccccc2c1)c1ccc(-c2ccc(S(=O)(=O)Nc3ccc4ccccc4c3)cc2)cc1
353,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1cccc(F)c1,2-Amino-6-(3-fluoro-phenylsulfanyl)-benzonitrile,12.0,uM,=,1.0791812460476249,1,c1ccc(Sc2ccccc2)cc1
354,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cccc(CCS(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-{[2-(3-methylphenyl)ethyl]sulfonyl}-1,3-dihydro-2H-benzimidazol-2-one",39.0,uM,=,1.591064607026499,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
355,1299033,10.1039/C3MD00028A,,,,Inhibition of purified recombinant HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation using poly(rC)-oligo(dG) as template primer,O=C(CSc1nnccc1-c1cccc2ccccc12)Nc1ccccc1[N+](=O)[O-],2-(4-(naphthalen-1-yl)pyridazin-3-ylthio)-N-(2-nitrophenyl)acetamide,4.06,uM,=,0.608526033577194,1,O=C(CSc1nnccc1-c1cccc2ccccc12)Nc1ccccc1
356,508733,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA/DNAM duplex primed substrate by scintillation proximity assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.45,uM,=,-0.3467874862246563,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
357,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3cccc(F)c3)cc2)[nH]c(=O)n1O,"6-((3'-fluoro-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.028,uM,=,-1.5528419686577808,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
358,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Brc1ccccc1-c1nc2ccccn2c1NC1CCCCC1,"2-(2-Bromophenyl)-N-cyclohexylimidazo[1,2-a]pyridin-3-amine",10.0,uM,=,1.0,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
359,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NC1Cc2ccccc2C1,"2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl 5-nitrofuran-2-carboxylate",5.5,uM,=,0.7403626894942439,1,O=C(COC(=O)c1ccco1)NC1Cc2ccccc2C1
360,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncc(Cl)cc2C(=O)N(C)c2cccnc21,"2-Chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.5,uM,=,0.5440680443502757,1,O=C1Nc2cccnc2Nc2ncccc21
361,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc2c(cc1C)N(C)C(=O)c1cc(N)cnc1O2,"2-Amino-7,8,10-trimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.322,uM,=,-0.4921441283041691,0,O=C1Nc2ccccc2Oc2ncccc21
362,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CS(=O)(=O)c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzenesulfonylmethyl-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CS(=O)(=O)c3ccccc3)cc21
363,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-({6-[(4-bromo-2-carboxyphenyl)amino]-6-oxohexanoyl}amino)benzoic acid,1.7,uM,=,0.2304489213782739,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
364,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),COc1cccc(CSc2nc(N)cc(Cl)n2)c1,6-Chloro-2-(3-methoxy-benzylsulfanyl)-pyrimidin-4-ylamine,0.98,uM,=,-0.0087739243075051,0,c1ccc(CSc2ncccn2)cc1
365,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3cccnc3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(pyridin-3-yl)acetamide,133.0,uM,=,2.123851640967086,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1cccnc1
366,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.17,uM,=,-0.7695510786217261,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
367,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(OC)nc21,"8-Ethyl-6-methoxy-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.19,uM,=,-0.721246399047171,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
368,80130,10.1016/S0960-894X(01)80437-6,,,,The compound was evaluated as inhibitor of recombinant HIV-l reverse transcriptase,Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)CF)O2)c(=O)[nH]c1=O,"Fluoromethyl-phosphonic acid mono-[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester",110.17025770704848,uM,=,2.0420643653223096,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
369,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cccc(C)c1C(C#N)c1nc(SC(C)C)[nH]c(=O)c1C,"2-(2,6-dimethylphenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",6.587000000000001,uM,=,0.8186876634415138,1,O=c1cc(Cc2ccccc2)nc[nH]1
370,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",17.0,uM,=,1.230448921378274,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
371,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccc(F)cc1F)CC(=O)C(=O)O,"6-[1-(2,4-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",10.0,uM,=,1.0,1,c1ccc(Cn2cccc2)cc1
372,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(toluene-3-sulfonyl)-benzonitrile,0.2,uM,=,-0.6989700043360187,0,O=S(=O)(c1ccccc1)c1ccccc1
373,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.0,uM,=,0.4771212547196624,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
374,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,COc1cc(-c2ccc(C#N)cc2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methoxy-[1,1'-biphenyl]-4-carbonitrile",0.036,uM,=,-1.4436974992327127,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
375,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",6.9,uM,=,0.8388490907372553,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
376,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,Nc1cc(S(=O)(=O)O)c2ccccc2c1N,"3,4-Diamino-naphthalene-1-sulfonic acid",28.0,uM,=,1.4471580313422192,1,c1ccc2ccccc2c1
377,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(C)nc21,"5-Ethyl-7,9-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncccc21
378,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)OCCN12,"9b-Phenyl-2,3-dihydro-9bH-oxazolo[2,3-a]isoindol-5-one",6.1,uM,=,0.785329835010767,1,O=C1c2ccccc2C2(c3ccccc3)OCCN12
379,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(F)c(C#N)c4)cc3F)c2=O)n[nH]c1=O,"3',4-difluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",7.0,uM,=,0.8450980400142568,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
380,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,O=C(c1ccccc1)c1ccc2c(c1)N=CCC(c1c(O)c3c(=O)oc4ccccc4c3oc1=O)=N2,"3-(7-benzoyl-3H-benzo[b][1,4]diazepin-2-yl)-4-hydroxypyrano[3,2-c]chromene-2,5-dione",38.4,uM,=,1.5843312243675307,1,O=C(c1ccccc1)c1ccc2c(c1)N=CCC(c1cc3c(=O)oc4ccccc4c3oc1=O)=N2
381,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,Cc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-(4'-methyl-[1,1'-biphenyl]-4-carbonyl)pyrimidine-2,4(1H,3H)-dione",0.021,uM,=,-1.6777807052660807,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
382,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2ccccc2S[C@H]2[C@@H](O)[C@@H](O)[C@H](O)CN12,"(5aS,6S,7S,8R)-6,7,8-trihydroxy-6,7,8,9-tetrahydro-5aH,11H-pyrido[2,1-b][1,3]benzothiazin-11-one",1.58,uM,=,0.1986570869544226,1,O=C1c2ccccc2S[C@H]2CCCCN12
383,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCOCn1c(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc(=O)n(O)c1=O,"1-(ethoxymethyl)-3-hydroxy-6-((4'-(trifluoromethyl)-[1,10-biphenyl]-4-yl)methyl)pyrimidine-2,4(1H,3H)-dione",2.1,uM,=,0.3222192947339193,1,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
384,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2F)c2ccccc2c1=O,"4-[1-(2,4-Difluorophenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid",35.9,uM,=,1.5550944485783191,1,O=c1ccn(Cc2ccccc2)c2ccccc12
385,1501272,10.1016/j.bmc.2015.03.037,,,,Inhibition of wild-type HIV1 Reverse transcriptase p66/p51 assessed as relative fluorescence signal after 40 mins,CC(C)Cn1cc(C(=O)O)c(=O)c2ccc(Oc3ccnc(Nc4ccc(C#N)cc4)n3)cc21,"7-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)oxy)-1-isobutyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",13.98,uM,=,1.1455071714096627,1,O=c1cc[nH]c2cc(Oc3ccnc(Nc4ccccc4)n3)ccc12
386,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,C#Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,"4-[5-Ethynyl-4-(2,4,6-trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",0.0042,uM,=,-2.3767507096021,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
387,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3ccc(NC)nc3)c3oc4ncc(-c5cnn(C)c5)cc4c32)CCO1,"(+/-)-cis-1-(-2-Ethyl-tetrahydro-pyran-4-yl)-4-(6-methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0035,uM,=,-2.4559319556497243,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1C1CCOCC1
388,953195,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dGTP incorporation after 15 mins by PAGE,C#CCOCCOCCOCCOCCOCC#Cc1cc(C)c(Oc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-(4-(2,6-dimethyl-4-(4,7,10,13,16-pentaoxanonadeca-1,18-diynyl)phenoxy)pyrimidin-2-ylamino)benzonitrile",0.064,uM,=,-1.193820026016113,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
389,666605,10.1128/aac.01795-09,,,,Inhibition of DNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by gel-based primer extension assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.126,uM,=,-0.8996294548824371,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
390,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N2CCOCC2)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-3-morpholin-4-yl-1H-pyridin-2-one",0.158,uM,=,-0.8013429130455774,0,O=c1[nH]ccc(Cc2ccccc2)c1N1CCOCC1
391,502868,10.1021/np960322+,,,,Inhibition of HIV1 reverse transcriptase,COc1cc2cc3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)COC3=O,"4-Benzo[1,3]dioxol-5-yl-6,7-dimethoxy-3H-naphtho[2,3-c]furan-1-one",5.5,uM,=,0.7403626894942439,1,O=C1OCc2c1cc1ccccc1c2-c1ccc2c(c1)OCO2
392,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CC[C@@H]3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[(S)-2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0026,uM,=,-2.5850266520291822,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CC[C@@H]1CCCO1
393,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N(C)C)nc21,"7-Dimethylamino-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncccc21
394,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccccc2C(F)(F)F)nc(SC(C)C)[nH]c1=O,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(2-(trifluoromethyl)phenyl)acetonitrile",5.992000000000001,uM,=,0.7775718046914102,1,O=c1cc(Cc2ccccc2)nc[nH]1
395,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,C=CCC1(c2ccccc2)Oc2ccccc2-n2cccc2C1=O,5-Allyl-5-phenyl-6-oxa-10b-aza-benzo[e]azulen-4-one,25.0,uM,=,1.3979400086720375,1,O=C1c2cccn2-c2ccccc2OC1c1ccccc1
396,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(O)c2)cn1,"3-(3, 4-Dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0025,uM,=,-2.6020599913279625,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1cccnc1)Cc1ccccc1
397,989557,10.1016/j.bmc.2013.08.040,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 (1:1.2) as template/primer after 40 mins by spectrofluorometric analysis,COc1ccc(CSc2nc(C(=O)c3ccccc3F)c(C)c(=O)[nH]2)cc1,2-(4-Methoxybenzylthio)-6-(2-fluorobenzoyl)-5-methylpyrimidin-4(3H)-one,2.41,uM,=,0.3820170425748684,1,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
398,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)NN(Cc1ccc(-c2ccccc2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"((S)-1-{(1S,2S)-1-Benzyl-3-[N-biphenyl-4-ylmethyl-N'-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-hydrazino]-2-hydroxy-propylcarbamoyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.085,uM,=,-1.0705810742857071,0,c1ccc(CCCCNCc2ccc(-c3ccccc3)cc2)cc1
399,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,S=C(NCCc1ccccc1)Nc1ccc(Cl)cn1,1-(5-Chloro-pyridin-2-yl)-3-phenethyl-thiourea,0.003,uM,=,-2.5228787452803374,0,S=C(NCCc1ccccc1)Nc1ccccn1
400,701790,10.1021/ml1002162,,,,Inhibition of HIV1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"6-Benzyl-1-benzyloxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.04,uM,=,-1.3979400086720375,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
401,718271,10.1021/jm101052g,,,,Inhibition of HIV1 reverse transcriptase,NS(=O)(=O)c1ccc(NC(=O)CSc2nnc(Br)n2-c2ccc(C3CC3)c3ccccc23)c(Cl)c1,"{2-[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio]-N-(2-chloro-4-sulfamoylphenyl)acetamide}",0.004,uM,=,-2.397940008672037,0,O=C(CSc1nncn1-c1ccc(C2CC2)c2ccccc12)Nc1ccccc1
402,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CCCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Hexanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",0.35,uM,=,-0.4559319556497244,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
403,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(C(N)=O)cc2C)c(C)c1,4-(2-(1-mesityl-1H-tetrazol-5-ylthio)acetamido)-3-methylbenzamide,0.055,uM,=,-1.259637310505756,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
404,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,CC(C)=CCN1Cc2cccc3nc(S)n(c23)C[C@H]1C,"(R)-8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.9,uM,=,-0.0457574905606751,0,c1cc2c3c(c1)ncn3CCNC2
405,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,Cc1ccc2c(c1)C(C#CC1CC1)(C(F)(F)F)OC(=O)N2,"4-Cyclopropylethynyl-6-methyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.133,uM,=,-0.8761483590329142,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
406,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccsc3)nc21,"5-Ethyl-10-methyl-7-thiophen-3-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2ccc(-c3ccsc3)nc2Nc2ncccc21
407,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=C(CCl)Nc1ccc(Cl)cc1NS(=O)(=O)c1c(Cl)cccc1Cl,"2-Chloro-N-[4-chloro-2-(2,6-dichloro-phenylsulfonamido)-phenyl]acetamide",32.7,uM,=,1.5145477526602862,1,O=S(=O)(Nc1ccccc1)c1ccccc1
408,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1ccccc1F,1-{2-[(2-Fluoro-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole,0.4,uM,=,-0.3979400086720376,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
409,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3ccncc3o2)c(O)nc1C,"5-Ethyl-3-[(furo[2,3-c]pyridin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",105.0,uM,=,2.0211892990699383,1,c1cncc(NCc2cc3ccncc3o2)c1
410,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cccc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)c1,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(m-tolyl)acetonitrile",0.271,uM,=,-0.5670307091255943,0,O=c1cc(Cc2ccccc2)nc[nH]1
411,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(Cl)cc1C(=O)C1CCCC1)Nc1ccccc1,2-(4-Chloro-2-cyclopentanecarbonyl-phenoxy)-N-phenyl-acetamide,5.040418963132347,uM,=,0.7024666368054944,1,O=C(COc1ccccc1C(=O)C1CCCC1)Nc1ccccc1
412,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),S=C(NCCc1c[nH]c2ccccc12)Nc1nccs1,1-[2-(1H-Indol-3-yl)-ethyl]-3-thiazol-2-yl-thiourea,2.2,uM,=,0.3424226808222063,1,S=C(NCCc1c[nH]c2ccccc12)Nc1nccs1
413,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)CCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,methyl 3-bromo-5-[1-(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-5-methyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,1.0,uM,=,0.0,0,C=C(c1ccccc1)c1ccccc1
414,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccc4c3CCC4)SCCN12,"9b-Indan-4-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.9,uM,=,-0.0457574905606751,0,O=C1c2ccccc2C2(c3cccc4c3CCC4)SCCN12
415,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1,"(E)-6-[1-(4-Fluoro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",10.1,uM,=,1.0043213737826426,1,c1ccc(Cn2cccc2)cc1
416,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)C[C@@H](O)[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1,1beta-hydroxymaprounic acid 3-p-hydroxy-benzoate,3.7,uM,=,0.568201724066995,1,O=C(O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@H]5C4CC[C@@H]32)C1)c1ccccc1
417,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(CCc2nc3c(C)ccc(C)c3o2)c(O)nc1C,"3-[2-(4,7-Dimethyl-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.023,uM,=,-1.6382721639824072,0,c1cncc(CCc2nc3ccccc3o2)c1
418,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccc(F)c(F)c1)CC(=O)C(=O)O,"6-[1-(3,4-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",86.0,uM,=,1.934498451243568,1,c1ccc(Cn2cccc2)cc1
419,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cc(F)cc(C#N)c4)c(F)c3)c2=O)n[nH]c1=O,"2',5-Difluoro-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-bipheny1]-3-carbonitrile",1.02,uM,=,0.0086001717619175,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
420,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",15.0,uM,=,1.1760912590556811,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
421,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,"6-Benzyl-1-ethoxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.04,uM,=,-1.3979400086720375,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
422,306520,10.1016/j.bmcl.2004.07.050,,,,Inhibitory activity against 3'-processing step in wild-type HIV-1 integrase was determined using 21-mer oligonucleotide substrate,Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O)O2)c(=O)n1,Phosphorylated dinucleotide derivative,19.0,uM,=,1.2787536009528289,1,O=c1ncccn1[C@H]1CC[C@@H](CO[PH](=O)O[C@@H]2CO[C@@H](n3cnc4cncnc43)C2)O1
423,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cn1cc(-c2cnc3oc4c(-c5ccncc5)nc(=O)n(CCC5CCCO5)c4c3c2)cn1,"8-(1-Methyl-1H-pyrazol-4-yl)-4-pyridin-4-yl-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.01,uM,=,-2.0,0,O=c1nc(-c2ccncc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
424,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2nccs2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-2-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester",0.033,uM,=,-1.4814860601221125,0,c1ccc(CCCCNCc2ccc(-c3nccs3)cc2)cc1
425,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CSc3ncccn3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyrimidin-2-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(CSc3ncccn3)cc21
426,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(O)c2)C2CC2)cc1,"(E)-N-((2S,3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(3, 4-dihydroxyphenyl)acrylamide",0.0315,uM,=,-1.5016894462103996,0,O=C(/C=C/c1ccccc1)N[C@H](CCN(C1CC1)S(=O)(=O)c1ccccc1)Cc1ccccc1
427,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,O=C1CSC(c2c(F)cccc2F)N1c1ccc(Cl)cn1,"3-(5-Chloro-pyridin-2-yl)-2-(2,6-difluoro-phenyl)-thiazolidin-4-one",67.0,uM,=,1.8260748027008264,1,O=C1CSC(c2ccccc2)N1c1ccccn1
428,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CSC1=N/C(=C/c2ccccc2)C(C)(C)C(=O)N1,"5,5-Dimethyl-2-methylsulfanyl-6-[1-phenyl-meth-(E)-ylidene]-5,6-dihydro-3H-pyrimidin-4-one",6.1,uM,=,0.785329835010767,1,O=C1C/C(=C\c2ccccc2)N=CN1
429,195839,10.1021/jm00023a007,,,,Inhibition of HIV-1 reverse transcriptase (RT),CCc1c(Sc2cc(C)cc(C)c2)cc(O)nc1C,"4-(3,5-Dimethyl-phenylsulfanyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.4,uM,=,-0.3979400086720376,0,c1ccc(Sc2ccncc2)cc1
430,561277,10.1021/jm8007085,,,,Inhibition of HIV1 reverse transcriptase,O=C1Cc2ccccc2C(=O)N1O,"2-Hydroxy-4H-isoquinoline-1,3-dione",40.0,uM,=,1.6020599913279625,1,O=C1Cc2ccccc2C(=O)N1
431,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,COc1ccc(C(C)=O)c(F)c1CCNC(=O)Nc1ccc(Cl)cn1,1-[2-(3-Acetyl-2-fluoro-6-methoxy-phenyl)-ethyl]-3-(5-chloro-pyridin-2-yl)-urea,0.109,uM,=,-0.9625735020593764,0,O=C(NCCc1ccccc1)Nc1ccccn1
432,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2ccn(COCc3ccccc3)c12,"4-((5-((benzyloxy)methyl)-2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.189,uM,=,-0.7235381958267558,0,c1ccc(COCn2ccc3nc(NC4CCN(Cc5ccccc5)CC4)nc(Oc4ccccc4)c32)cc1
433,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=S)c2cccnc2Oc2cc(C)cc(C)c21,"10-Ethyl-7,9-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cycloheptene-11-thione",0.09,uM,=,-1.0457574905606752,0,S=C1Nc2ccccc2Oc2ncccc21
434,734861,10.1016/j.bmc.2011.01.024,,,,Inhibition of HIV1 3B reverse transcriptase activity infected in human H9 cells assessed as level of p24 antigen,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]2(C)C(=O)C[C@@H]13,limonin,2.11,uM,=,0.3242824552976926,1,O=C1C[C@@H]2OC[C@@H]3CC(=O)C4[C@H](CCC5[C@H](c6ccoc6)OC(=O)[C@H]6O[C@]546)[C@]32CO1
435,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(C(C)C)nc21,"5-Ethyl-7-isopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.0,uM,=,0.0,0,O=C1Nc2cccnc2Nc2ncccc21
436,197449,10.1016/s0960-894x(98)00250-9,,,,Compound was evaluated for enzymatic inhibitory activity against recombinant HIV reverse transcriptase,CSCSc1nc(O)c(C(C)C)c(Cc2ccccc2)n1,6-Benzyl-5-isopropyl-2-methylsulfanylmethylsulfanyl-3H-pyrimidin-4-one,6.1,uM,=,0.785329835010767,1,c1ccc(Cc2ccncn2)cc1
437,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)c1scnc1-c1ccccc1,4-phenylthiazole-5-carboxamide,283.4,uM,=,2.4523998459114416,1,c1ccc(-c2cscn2)cc1
438,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1C(=O)c2cccnc2N(CC)c2ccccc21,"6,11-Diethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.38,uM,=,-0.4202164033831898,0,O=C1Nc2ccccc2Nc2ncccc21
439,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,Cc1ccc(-c2nc(O)c(O)c(C(=O)O)n2)cc1Br,"2-(3-Bromo-4-methylphenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",1.4,uM,=,0.1461280356782379,1,c1ccc(-c2ncccn2)cc1
440,195343,10.1021/jm00076a005,,,,Inhibition of reverse transcriptase activity of HIV-1 in the presence of [alpha35 S] TTP as cosubstrate.,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.85,uM,=,-0.0705810742857072,0,c1cncc(NCc2nc3ccccc3o2)c1
441,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,COc1ccc(-c2cc(C)c(Oc3cc(N)nc(Nc4ccc(C#N)cc4)n3)c(C)c2)cc1,"4-((4-Amino-6-((4'-methoxy-3,5-dimethyl-[1,1'-biphenyl]-4-yl)-oxy)pyrimidin-2-yl)amino)benzonitrile",0.054,uM,=,-1.2676062401770314,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
442,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2cccc(-c3cccc(O)c3)c2)cc(=O)n(O)c1=O,"3-hydroxy-6-(3'-hydroxybiphenyl-3-yloxy)-1-methylpyrimidine-2,4(1H,3H)-dione",12.0,uM,=,1.0791812460476249,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
443,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)CCC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"N-(2-chloro-4-sulfamoylphenyl)-4-(6,8-dichloro-3,4-dihydroquinolin-1(2H)-yl)-4-oxobutanamide",0.194,uM,=,-0.712198270069774,0,O=C(CCC(=O)N1CCCc2ccccc21)Nc1ccccc1
444,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1[nH]nc(OCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c1-c1ccc(C(C)(C)C)cc1Cl,2-(4'-(2-(4-(4-tert-butyl-2-chlorophenyl)-5-methyl-1H-pyrazol-3-yloxy)acetamido)-3'-chlorobiphenyl-4-yl)acetic acid,2.089,uM,=,0.3199384399803086,1,O=C(COc1n[nH]cc1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
445,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(Nc1ccc(Br)cc1C(=O)O)c1cccc(C(=O)Nc2ccc(Br)cc2C(=O)O)c1,5-bromo-2-[(3-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}benzoyl)amino]benzoic acid,14.0,uM,=,1.146128035678238,1,O=C(Nc1ccccc1)c1cccc(C(=O)Nc2ccccc2)c1
446,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3ccc(Cl)cc3)cc2)cc(=O)n(O)c1=O,"6-((4'-Chloro-[1,1'-biphenyl]-4-yl)oxy)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",2.4,uM,=,0.380211241711606,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
447,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2ccccc2Oc2ccccc21,"10-Ethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.56,uM,=,-0.2518119729937995,0,O=C1Nc2ccccc2Oc2ccccc21
448,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CC(C)Cc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isobutyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.51,uM,=,-0.2924298239020636,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
449,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)nc2c1CCCC2,"3,5-Dimethyl-4-((2-((4-(methylsulfonyl)phenyl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)benzonitrile",0.069,uM,=,-1.1611509092627446,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
450,1982636,10.1021/acsmedchemlett.9b00623,,,,Inhibition of HIV-1 reverse transcriptase His-tagged p51 heterodimerization with HIV-1 reverse transcriptase p66 incubated for 16 hrs by ELISA,CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)O)NC(=O)C(CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)C(CC(N)=O)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC1=O,,137.0,uM,=,2.1367205671564067,1,O=C1CCSSCCNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCN2C(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCN2C(=O)CN1
451,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,CCNC(=O)OCCCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,Bis(3-Chloro-2-methoxy-benzoic acid methyl ester)Ethyl-carbamic acid hex-5-enyl ester,1.2,uM,=,0.0791812460476248,1,C=C(c1ccccc1)c1ccccc1
452,1454138,10.1016/j.bmc.2014.07.018,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 using dsDNA by microplate reader based assay,Cn1cc(C(=O)O)c(=O)c2cc(N)c(N3CCN(c4ccccn4)CC3)cc21,"6-Amino-1-methyl-4-oxo-7-(4-pyridin-2-yl-piperazin-1-yl)-1,4-dihydro-quinoline-3-carboxylic acid",800.0,uM,=,2.903089986991944,1,O=c1cc[nH]c2cc(N3CCN(c4ccccn4)CC3)ccc12
453,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2cccnc2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-pyridin-3-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.0645,uM,=,-1.1904402853647322,0,O=C1Nc2ccccc2C(C#Cc2cccnc2)(C2CC2)N1
454,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,Cc1c(O)nc(SCC(=O)c2ccc(F)cc2)nc1Cc1cccc2ccccc12,2-[2-(4-Fluoro-phenyl)-2-oxo-ethylsulfanyl]-5-methyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.18,uM,=,-0.744727494896694,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
455,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(OCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-(4,7-Dichloro-benzooxazol-2-ylmethoxy)-5-ethyl-6-methyl-1H-pyridin-2-one",0.088,uM,=,-1.055517327849831,0,c1cncc(OCc2nc3ccccc3o2)c1
456,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1nc(F)ccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(=O)(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-sulfonic acid (2-{4-[(3-tert-butylamino-6-fluoro-pyridin-2-yl)-ethyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.83,uM,=,-0.0809219076239261,0,O=C(c1cc2cc(NS(=O)(=O)N3CCNCC3)ccc2[nH]1)N1CCC(Nc2ccccn2)CC1
457,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccc(S(C)(=O)=O)cc3Cl)nc3ccccc32)c1,"2-{[1-(3,5-Dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-[2-chloro-4-(methylsulfonyl)phenyl]-acetamide",1.93,uM,=,0.2855573090077737,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
458,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCc1cc(OCCCN(C)C)ccc1NC(=O)Cc1ccc(Cl)cc1C(=O)c1ccccc1,2-(2-Benzoyl-4-chloro-phenyl)-N-[4-(3-dimethylamino-propoxy)-2-ethyl-phenyl]-acetamide,5.227912732039339,uM,=,0.7183283294230272,1,O=C(Cc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
459,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(SC)nc21,"5-Ethyl-9-methyl-7-methylsulfanyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncccc21
460,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(C#N)cc4)cc3)c2=O)n[nH]c1=O,"4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-y1)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)[1,1'-bipheny1]-4-carbonitrile",15.92,uM,=,1.20194306340165,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
461,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(CCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-(4-fluorophenethyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Cc2ccccc2)n(CCc2ccccc2)c(=O)[nH]1
462,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccc(C23SCCN2C(=O)c2ccccc23)cc1C,"9b-(3,4-Dimethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.39,uM,=,-0.4089353929735008,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
463,1879993,10.1021/acs.jmedchem.9b01769,,,,Inhibition of recombinant HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation in to cDNA chain incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)c(F)c2)nc2ccsc12,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)-2-fluorobenzonitrile",0.0362,uM,=,-1.4412914294668342,0,c1ccc(Nc2nc(Oc3ccccc3)c3sccc3n2)cc1
464,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4F)cc3)ccc2C(=O)N1O,"6-((2',4'-Difluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.5,uM,=,0.1760912590556812,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
465,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(Cc2ccccc2)n(COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,"4-(4-(((6-benzyl-5-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.2347,uM,=,-0.6294869104014075,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
466,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)c3ccccc3)[nH]c3ccc(Cl)cc23)c1,"(R)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-phenylethyl)-1H-indole-2-carboxamide",0.039,uM,=,-1.408935392973501,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
467,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",0.1,uM,=,-1.0,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
468,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1c(F)c(F)c(F)c(F)c1F)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(perfluorobenzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,6.8,uM,=,0.8325089127062363,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
469,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2cc(N)ccc2Oc2cccc(C)c21,"2-Amino-9-methyl-10-propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.26,uM,=,-0.585026652029182,0,O=C1Nc2ccccc2Oc2ccccc21
470,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,Fc1cccc(F)c1Cn1c(-c2c(F)cccc2F)nc2ccccc21,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazole",0.11,uM,=,-0.958607314841775,0,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
471,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,Fc1cccc(CC/N=C(\S)Nc2ccc(Br)cn2)c1,1-(5-Bromo-pyridin-2-yl)-3-[2-(3-fluoro-phenyl)-ethyl]-thiourea,0.7,uM,=,-0.1549019599857432,0,C(=NCCc1ccccc1)Nc1ccccn1
472,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,"Ethyl 6-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",3.0,uM,=,0.4771212547196624,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
473,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2cccc(C#N)c2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-3-carbonitrile",0.0409999999999999,uM,=,-1.3872161432802643,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
474,197433,10.1021/jm990205m,,,,Antiviral activity was tested in cells acutely infected with HIV-1 RT (reverse transcriptase),CN1N=C(N)c2cn([C@H]3CC[C@@H](CO)O3)c3ncnc1c23,"[5-(3-Amino-5-methyl-5H-1,4,5,6,8-pentaaza-acenaphthylen-1-yl)-tetrahydro-furan-2-yl]-methanol",21.0,uM,=,1.3222192947339193,1,C1=NNc2ncnc3c2c1cn3[C@H]1CCCO1
475,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1ncc(Cl)s1,1-(5-Chloro-thiazol-2-yl)-3-phenethyl-thiourea,2.4,uM,=,0.380211241711606,1,S=C(NCCc1ccccc1)Nc1nccs1
476,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)n1O,"6-([1,1'-biphenyl]-3-ylmethyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
477,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=O)[nH]c3ccc(Cl)c(c32)C1C,"5-Chloro-6-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",0.145,uM,=,-0.8386319977650252,0,O=c1[nH]c2cccc3c2n1CCNC3
478,196366,10.1016/s0960-894x(98)00214-5,,,,Compound was evaluated for inhibition of HIV-2 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 ug/mL,O=C(CCCCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-[6-(4-bromo-2-carboxyphenylcarbamoyl)hexylcarboxamido]benzoic acid,7.4,uM,=,0.8692317197309762,1,O=C(CCCCCCC(=O)Nc1ccccc1)Nc1ccccc1
479,1501272,10.1016/j.bmc.2015.03.037,,,,Inhibition of wild-type HIV1 Reverse transcriptase p66/p51 assessed as relative fluorescence signal after 40 mins,CCCCn1cc(C(=O)O)c(=O)c2ccc(Oc3ccnc(Nc4ccc(C#N)cc4)n3)cc21,"1-Butyl-7-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",3.49,uM,=,0.5428254269591799,1,O=c1cc[nH]c2cc(Oc3ccnc(Nc4ccccc4)n3)ccc12
480,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(Br)c(Oc2cnc([N+](=O)[O-])c(Nc3ccc(C#N)cc3)c2)c(Br)c1,"4-((5-(2,6-dibromo-4-methylphenoxy)-2-nitropyridin-3-yl)amino)benzonitrile",0.28,uM,=,-0.5528419686577808,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
481,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccc(C(F)(F)F)cc2C2(c3ccccc3)SCCN12,"9b-Phenyl-8-trifluoromethyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",17.7,uM,=,1.2479732663618066,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
482,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,C=CCN1C(=O)c2ccccc2Oc2ccccc21,"10-Allyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.465,uM,=,-0.332547047110046,0,O=C1Nc2ccccc2Oc2ccccc21
483,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)C(=CC[C@@]5(C(=O)O)CCC(C)(C)C[C@H]54)[C@]3(C)CC[C@H]2C1(C)C,3-acetylaleuritolic acid,136.0,uM,=,2.133538908370217,1,C1=C2C(CC[C@H]3C2CC[C@H]2CCCCC23)[C@@H]2CCCCC2C1
484,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1[nH]c(Sc2ccc(Br)cc2)c(Br)c(=O)n1O,"5-Bromo-6-((4-bromophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.07,uM,=,-1.154901959985743,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
485,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cnc(Nc2ccc(C#N)cc2)nc1OCC(=O)Nc1ccccc1F,2-((2-((4-Cyanophenyl)amino)-5-methylpyrimidin-4-yl)oxy)-N-(2-fluorophenyl)acetamide,0.083,uM,=,-1.080921907623926,0,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
486,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccn(COCc3ccccc3)c12,"4-((4-((5-((benzyloxy)methyl)-4-(4-cyano-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.163,uM,=,-0.7878123955960422,0,c1ccc(COCn2ccc3nc(NC4CCN(Cc5ccccc5)CC4)nc(Oc4ccccc4)c32)cc1
487,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1ccncc1,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-(pyridin-4-ylmethoxy)-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.129,uM,=,-0.889410289700751,0,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccncc1
488,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,Cc1cc(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)n[nH]c1=O,6-(3-(3-bromophenoxy)-4-chlorobenzyl)-4-methylpyridazin-3(2H)-one,0.13,uM,=,-0.8860566476931633,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
489,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(C#Cc1ccccc1)(OCc1ccccc1)C(F)(F)F,3-(1-Benzyloxy-3-phenyl-1-trifluoromethyl-prop-2-ynyl)-1H-pyridin-2-one,0.011691,uM,=,-1.9321483394876475,0,C(#CC(OCc1ccccc1)c1cccnc1)c1ccccc1
490,306454,10.1016/j.bmcl.2004.07.050,,,,Inhibitory activity against strand transfer in wild-type HIV-1 integrase was determined using 21-mer oligonucleotide substrate,Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O)O2)c(=O)n1,Phosphorylated dinucleotide derivative,25.0,uM,=,1.3979400086720375,1,O=c1ncccn1[C@H]1CC[C@@H](CO[PH](=O)O[C@@H]2CO[C@@H](n3cnc4cncnc43)C2)O1
491,439842,10.1021/jm070236e,,,,Inhibition of HIV1 recombinant reverse transcriptase,COC(=O)CCCC=C(c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,methyl 2-methoxy-5-[1-(4-methoxy-3-methyl-5-methyloxycarbonylphenyl)-5-methyloxycarbonyl-1-pentenyl]-3-methylbenzoate,1.0,uM,=,0.0,0,C=C(c1ccccc1)c1ccccc1
492,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3Cl)CC2)ncc1Br,"4-((4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)methyl)-3-chlorobenzamide",0.131,uM,=,-0.8827287043442358,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
493,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccn[nH]3)nc21,"5-Ethyl-10-methyl-7-(2H-pyrazol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.29,uM,=,-0.5376020021010439,0,O=C1Nc2ccc(-c3ccn[nH]3)nc2Nc2ncccc21
494,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)cc2[C@@](C#Cc2ccccn2)(C(F)(F)F)N1,"6-Fluoro-4-pyridin-2-ylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.126,uM,=,-0.8996294548824371,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)N1
495,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc2c(cc1C)N(C(C)C)C(=O)c1cc(N)cnc1O2,"2-Amino-10-isopropyl-7,8-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.045,uM,=,-1.3467874862246565,0,O=C1Nc2ccccc2Oc2ncccc21
496,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.023,uM,=,-1.6382721639824072,0,c1cncc(CCc2nc3ccccc3o2)c1
497,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.0,uM,=,0.0,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
498,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3cnccc3o2)c(O)nc1C,"5-Ethyl-3-[(furo[3,2-c]pyridin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",32.3,uM,=,1.509202522331103,1,c1cncc(NCc2cc3cnccc3o2)c1
499,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(Br)c2)[nH]c(=O)n1O,"6-(3-Bromobenzyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.013,uM,=,-1.8860566476931635,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
500,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,N#Cc1ccc(Nc2nc(Oc3ccc(-c4ccc(C#N)c(Cl)c4)cc3Cl)c3sccc3n2)cc1,"3,3'-dichloro-4'-(2-(4-cyanophenylamino)thieno[3,2-d]pyrimidin-4-yloxy)biphenyl-4-carbonitrile",0.031,uM,=,-1.5086383061657274,0,c1ccc(Nc2nc(Oc3ccc(-c4ccccc4)cc3)c3sccc3n2)cc1
501,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CSc1cc(NCc2nc3ccccc3o2)c(O)nc1C,3-[(Benzooxazol-2-ylmethyl)-amino]-6-methyl-5-methylsulfanyl-1H-pyridin-2-one,0.19,uM,=,-0.721246399047171,0,c1cncc(NCc2nc3ccccc3o2)c1
502,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,COc1cccc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-(3-methoxyphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.052,uM,=,-1.2839966563652008,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
503,534522,10.1016/j.bmc.2007.12.046,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase,Cc1ccc(NC(=S)OC(C)COc2ccccc2)cc1,rac-O-(1-Methyl-2-phenoxyethyl)N-(4-tolyl)thiocarbamate,1.4,uM,=,0.1461280356782379,1,S=C(Nc1ccccc1)OCCOc1ccccc1
504,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C#N)cc3)CC2)ncc1Br,"4-(5-bromo-2-(1-(4-cyanobenzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.021,uM,=,-1.6777807052660807,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
505,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(=O)(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-sulfonic acid (2-{4-[ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.24,uM,=,-0.619788758288394,0,O=C(c1cc2cc(NS(=O)(=O)N3CCNCC3)ccc2[nH]1)N1CCC(Nc2ccccn2)CC1
506,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,CNc1ccccc1C(=O)N/N=C/c1cccc([N+](=O)[O-])c1,2-(methylamino)-N'-(3-nitrobenzylidene)benzohydrazide,19.0,uM,=,1.2787536009528289,1,O=C(N/N=C/c1ccccc1)c1ccccc1
507,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCCCSc1nc(O)cc(Cc2c(F)cccc2F)n1,"2-Butylsulfanyl-6-(2,6-difluoro-benzyl)-3H-pyrimidin-4-one",0.2,uM,=,-0.6989700043360187,0,c1ccc(Cc2ccncn2)cc1
508,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SCc2ccccc2)n1,2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine,1.47,uM,=,0.1673173347481761,1,c1ccc(CSc2ncccn2)cc1
509,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccc(O)cc3)C2=O)SC1=S)Nc1ccc(O)cc1,"N-(4-Hydroxy-phenyl)-2-{(E)-3''-[(4-hydroxy-phenylcarbamoyl)-methyl]-4,4''-dioxo-2,2''-dithioxo-[5,5'']bithiazolidinyliden-3-yl}-acetamide",59.0,uM,=,1.7708520116421442,1,O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccccc3)C2=O)SC1=S)Nc1ccccc1
510,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,O=C(O)c1cnc2ccccc2c1,Quinoline-3-carboxylic acid,2400.0,uM,=,3.380211241711606,1,c1ccc2ncccc2c1
511,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccc4[nH]ccc4c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(1H-indol-5-yloxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncc(COc3ccc4[nH]ccc4c3)cc21
512,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccccc2-c2ccc(F)cc2)[nH]c(=O)n1O,"6-((4'-fluoro-[1,1'-biphenyl]-2-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Sc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
513,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,Cc1ccc(-c2csc(N/N=C3\C(=O)Nc4ccccc43)n2)cc1,(Z)-3-(2-(4-p-tolylthiazol-2-yl)hydrazono)indolin-2-one,45.0,uM,=,1.6532125137753435,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
514,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,CCCCC(=O)N/N=C/c1cc(Cl)ccc1[N+](=O)[O-],N'-(5-chloro-2-nitrobenzylidene)pentanehydrazide,85.0,uM,=,1.9294189257142929,1,c1ccccc1
515,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3ccncc3C)cc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-5-ethyl-9-methyl-2-(3-methyl-pyridin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.011,uM,=,-1.958607314841775,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
516,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2ccc(C)nc2N(C)C(=O)c2cccnc21,"5-Ethyl-2,11-dimethyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",1.76,uM,=,0.2455126678141498,1,O=C1Nc2ncccc2Nc2ncccc21
517,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-hydroxy-6-(4'-methylbiphenyl-3-ylamino)pyrimidine-2,4(1H,3H)-dione",0.38,uM,=,-0.4202164033831898,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
518,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),COC(=O)/C=C/CSc1nc(N)cc(Cl)n1,(E)-4-(4-Amino-6-chloro-pyrimidin-2-ylsulfanyl)-but-2-enoic acid methyl ester,5.25,uM,=,0.7201593034059569,1,c1cncnc1
519,1281575,10.1021/ml4002979,,,,Inhibition of HIV-1 6His-tagged reverse transcriptase p66/p51-mediated TTP incorporation into D23/D36 primer/template preincubated for 15 mins followed by D23/D36 primer/template and TTP addition measured after 15 mins by PAGE analysis,Cc1cc(C#CCCCCCCCC(=O)NCc2cn([C@H]3C[C@H](O)[C@@H](CO[PH](=O)O)O3)c(=O)[nH]c2=O)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"((2R,3S,5R)-5-(5-((10-(4-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethylphenyl)dec-9-ynamido)methyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl hydrogen phosphonate",0.0043,uM,=,-2.3665315444204134,0,O=C(CCCCCCCC#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1)NCc1cn([C@H]2CCCO2)c(=O)[nH]c1=O
520,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCN)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"4-Amino-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene",63.0,uM,=,1.7993405494535817,1,C=C(c1ccccc1)c1ccccc1
521,370933,10.1016/j.bmcl.2006.04.012,,,,Inhibition of HIV1 reverse transcriptase,COc1ccc([C@H]2CC(=O)N(c3cccc(N)c3)C2)cc1OC1CCCC1,(R)-1-(3-aminophenyl)-4-(3-(cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one,2.0,uM,=,0.3010299956639812,1,O=C1C[C@H](c2cccc(OC3CCCC3)c2)CN1c1ccccc1
522,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",2.5,uM,=,0.3979400086720376,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
523,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=C(CCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+].[Na+].[Na+].[Na+],"4-Decanoylamino-5-hydroxy-naphthalene-2,7-disulfonic acid; compound with 4-formylamino-5-hydroxy-naphthalene-2,7-disulfonic acid Tetrasodium salt",122.0,uM,=,2.0863598306747484,1,O=C(CCCCCCCCC(=O)Nc1cccc2ccccc12)Nc1cccc2ccccc12
524,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,"(E)-4-((4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.1009999999999999,uM,=,-0.9956786262173576,0,c1ccc(CN2CCC(Nc3nc(Oc4ccccc4)c4sccc4n3)CC2)cc1
525,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cccc2c1C(=O)N1CCSC21c1ccccc1,"6-Methyl-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",8.0,uM,=,0.9030899869919436,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
526,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1ccccc1F,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-(2-fluoro-benzyloxy)-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.296,uM,=,0.1126050015345745,1,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
527,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-3-(ethyl-methyl-amino)-6-methyl-1H-pyridin-2-one",0.008,uM,=,-2.096910013008056,0,O=c1cc(Cc2ccccc2)cc[nH]1
528,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,O=c1[nH]nc(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)o1,"5-(3-(3-bromophenoxy)-4-chlorobenzyl)-1,3,4-oxadiazol-2(3H)-one",5.8,uM,=,0.7634279935629373,1,O=c1[nH]nc(Cc2cccc(Oc3ccccc3)c2)o1
529,541098,10.1016/j.bmc.2008.12.028,,,,Inhibition on HIV1 reverse transcriptase p66/p51,Nc1ncnc2c1ncn2[C@@H]1O[C@H](OCP(=O)(O)O)C=C1F,"((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yloxy)methylphosphonic acid",1.9,uM,=,0.2787536009528289,1,C1=C[C@H](n2cnc3cncnc32)OC1
530,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1ncc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)cn1,"4-((4-((4-(2-Methoxypyrimidin-5-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0378,uM,=,-1.422508200162775,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
531,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)C#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(F)c(F)c21,"5,6-Difluoro-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.091,uM,=,-1.0409586076789064,0,O=C1NCc2ccccc2N1
532,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4ccc(-c5cnn(C)c5)nc4c32)CCO1,"cis-4-(2-Ethyl-tetrahydro-pyran-4-yl)-1,6-bis-(1-methyl-1H-pyrazol-4-yl)-4H-9-oxa-2,4,5-triaza-fluoren-3-one",0.0032,uM,=,-2.494850021680094,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4cn[nH]c4)nc3c2n1C1CCOCC1
533,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(S(N)(=O)=O)c3)CC2)ncc1Br,"3-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzenesulfonamide",0.019,uM,=,-1.7212463990471711,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
534,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),COc1cc(/C=C2\SC(=S)N(CC(=O)Nc3cc(Cl)ccc3O)C2=O)cc(OC)c1OC,"N-(5-Chloro-2-hydroxy-phenyl)-2-{4-oxo-2-thioxo-5-[1-(3,4,5-trimethoxy-phenyl)-meth-(Z)-ylidene]-thiazolidin-3-yl}-acetamide",17.0,uM,=,1.230448921378274,1,O=C(CN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
535,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1cc(Cl)cc(Cl)c1,"2-Amino-6-(3,5-dichloro-phenylsulfanyl)-benzonitrile",0.12,uM,=,-0.9208187539523752,0,c1ccc(Sc2ccccc2)cc1
536,195504,10.1021/jm001095i,,,,Inhibitory activity against wild-type HIV-1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.0222202900538673,uM,=,-1.6532502762695047,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
537,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc(Cl)c3Cl)cc2c1=O,"6-((2,3-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",8.19,uM,=,0.9132839017604184,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
538,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(Cc3ccccc3O)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-(2-hydroxy-benzyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2c(Cc3ccccc3)ccnc2N(C2CC2)c2ncccc21
539,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(CCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)c(OC)cc1O,"N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3, 5-dimethoxyphenyl)propanamide",0.113,uM,=,-0.9469215565165804,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
540,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(C)c(F)c1,"4-Amino-N-benzyl-1-(hydroxy)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.02,uM,=,-1.6989700043360187,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
541,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-(3-Amino-phenoxymethyl)-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
542,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)CCc1ccccc1Cl,"6-Chloro-1-{[2-(2-chlorophenyl)ethyl]sulfonyl}-1,3-dihydro-2H-benzimidazol-2-one",116.0,uM,=,2.0644579892269186,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
543,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1ccc(F)cc1,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-(4-fluoro-benzyloxy)-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.899,uM,=,-0.0462403082667712,0,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
544,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(C#N)cn2)c1O,1-[2-(3-Acetyl-6-fluoro-2-hydroxy-phenyl)-cyclopropyl]-3-(5-cyano-pyridin-2-yl)-urea,0.0053,uM,=,-2.275724130399211,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
545,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CCC1OC(/C=C/C2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O,"5-((E)-2-Cyclopropyl-vinyl)-3-ethyl-7-fluoro-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.151,uM,=,-0.8210230527068306,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
546,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2[C@@]2(c3cccc4ccccc34)SCCN12,"9b-Naphthalen-1-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.15,uM,=,-0.8239087409443188,0,O=C1c2ccccc2[C@@]2(c3cccc4ccccc34)SCCN12
547,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,CN(Cc1ccc2occc2c1)c1nc(O)nc(Nc2ccccc2N2CCOCC2)n1,"4-((benzofuran-5-ylmethyl)(methyl)amino)-6-(2-morpholinophenylamino)-1,3,5-triazin-2-ol",4.1,uM,=,0.6127838567197355,1,c1ccc(N2CCOCC2)c(Nc2ncnc(NCc3ccc4occc4c3)n2)c1
548,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCC(=O)N2CCCCC2)c2cc(C)c(OC)c(C(=O)OC)c2)cc(C)c1OC,"6,6-Bis(3-methyl-4-methoxy-5-methoxycarbonylphenyl)-1-piperidylhex-5-en-1-one",7.12,uM,=,0.8524799936368563,1,O=C(CCCC=C(c1ccccc1)c1ccccc1)N1CCCCC1
549,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(S(N)(=O)=O)ccc1NC(=O)CN1CCC(Nc2nccc(Oc3c(C)cc(C#N)cc3C)n2)CC1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(2-methyl-4-sulfamoylphenyl)acetamide",0.166,uM,=,-0.7798919119599449,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
550,989993,10.1016/j.bmc.2013.09.009,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotinylated dUTP incorporation after 1 hr by ELISA,N#Cc1ccccc1CN1C(=O)N(Cc2cccc(F)c2)S(=O)(=O)n2cccc21,"N2-(m-Fluorobenzyl)-N4-(o-cyanobenzyl)-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine",58.3,uM,=,1.765668554759014,1,O=C1N(Cc2ccccc2)c2cccn2S(=O)(=O)N1Cc1ccccc1
551,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccccc3)CC2)n1,"4-(2-(1-benzylpiperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.087,uM,=,-1.0604807473813815,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
552,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,CCOP(=O)(OCC)Oc1cccc(C(=O)CC#N)c1,3-(2-cyanoacetyl)phenyl diethyl Phosphate,64.3,uM,=,1.8082109729242224,1,c1ccccc1
553,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,COc1cccc(CC/N=C(\S)Nc2ccc(Br)cn2)c1,1-(5-Bromo-pyridin-2-yl)-3-[2-(3-methoxy-phenyl)-ethyl]-thiourea,0.4,uM,=,-0.3979400086720376,0,C(=NCCc1ccccc1)Nc1ccccn1
554,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCc2nnc(C)o2)c2cc(C)c3on(C)c(=O)c3c2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(2,7-dimethyl-3-oxo-2,3-dihydrobenzo[d]-isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",9.2,uM,=,0.9637878273455552,1,O=c1[nH]oc2ccc(/C(=C/CCc3nnco3)c3ccccc3)cc12
555,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=S)[nH]c3cc(Cl)cc(c32)C1C,"4-Chloro-6-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.023,uM,=,-1.6382721639824072,0,S=c1[nH]c2cccc3c2n1CCNC3
556,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2c(C#N)ccc3nc(O)n(c23)C[C@@H]1C,"8-Methyl-7-(3-methyl-but-2-enyl)-1-oxo-1,2,6,7,8,9-hexahydro-2,7,9a-triaza-benzo[cd]azulene-5-carbonitrile",1140.0,uM,=,3.0569048513364727,1,c1cc2c3c(c1)ncn3CCNC2
557,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(COc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-ethyl-6-[4-(phenyloxymethyl)phenyl]pyrrolo[2,1-d][1,5]benzoxazepine-7(6H)-one",0.15,uM,=,-0.8239087409443188,0,O=C1c2cccn2-c2ccccc2OC1c1ccc(COc2ccccc2)cc1
558,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(Cl)nc(SCc2ccc(Cl)c(Cl)c2)n1,"6-Chloro-2-(3,4-dichloro-benzylsulfanyl)-pyrimidin-4-ylamine",0.49,uM,=,-0.3098039199714864,0,c1ccc(CSc2ncccn2)cc1
559,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),C/C=C/Nc1ccc2c(n1)N(CC)c1ncccc1C(=O)N2C,"5-Ethyl-10-methyl-7-[((E)-propenyl)amino]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.39,uM,=,-0.4089353929735008,0,O=C1Nc2cccnc2Nc2ncccc21
560,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2cncs2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-5-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester",0.013,uM,=,-1.8860566476931635,0,c1ccc(CCCCNCc2ccc(-c3cncs3)cc2)cc1
561,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"3-Hydroxy-6-(3'-methoxybiphenyl-4-ylamino)-1H-pyrimidine-2,4-dione",0.15,uM,=,-0.8239087409443188,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
562,195688,10.1021/jm00042a004,,,,The 50% inhibitory concentration was measured as inhibition of Ribonuclease H activity of reverse transcriptase,O=S(=O)(O)c1ccc2c(OS(=O)(=O)c3cccc4c(S(=O)(=O)Oc5cc(S(=O)(=O)O)cc6cc(S(=O)(=O)O)ccc56)cccc34)cc(S(=O)(=O)O)cc2c1,"4-[5-(3,6-disulfo-1-naphthyloxysulfonyl)-1-naphthylsulfonyloxy]-2,7-naphthalenedisulfonic acid",215.0,uM,=,2.3324384599156054,1,O=S(=O)(Oc1cccc2ccccc12)c1cccc2c(S(=O)(=O)Oc3cccc4ccccc34)cccc12
563,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cc(OC)cc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.4,uM,=,0.1461280356782379,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
564,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,NS(=O)(=O)c1ccc(NC(=O)CSc2nnnn2-c2cccc(Cl)c2Cl)c(Cl)c1,"N-(2-chloro-4-sulfamoyl-phenyl)-2-[1-(2,3-dichloro-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide",0.009,uM,=,-2.0457574905606752,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
565,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cccc3ccccc23)c(O)nc1C,5-Ethyl-6-methyl-3-[(naphthalen-1-ylmethyl)-amino]-1H-pyridin-2-one,2.1,uM,=,0.3222192947339193,1,c1cncc(NCc2cccc3ccccc23)c1
566,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-3-[(5-hydroxy-pentyl)-methyl-amino]-6-methyl-1H-pyridin-2-one",0.004,uM,=,-2.397940008672037,0,O=c1cc(Cc2ccccc2)cc[nH]1
567,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCCn1c(=O)[nH]c2cccc(Oc3cc(Cl)cc(C#N)c3)c21,"3-chloro-5-(2-oxo-3-propyl-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)benzonitrile",0.05,uM,=,-1.3010299956639813,0,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
568,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,O=c1cc(Nc2ccc(-c3ccc(O)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.37,uM,=,-0.431798275933005,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
569,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,CSc1nc2ncnc(NC(P(=O)(O)O)P(=O)(O)O)c2cc1-c1ccc(OC(C)C)cc1,"(((6-(4-Isopropoxyphenyl)-7-(methylthio)pyrido[2,3-d]-pyrimidin-4-yl)amino)methylene)diphosphonic Acid",1.8,uM,=,0.255272505103306,1,c1ccc(-c2cnc3ncncc3c2)cc1
570,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-c2nnsc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,"2-(3'-chloro-4'-(2-(4-(2-chloro-4-methylphenyl)-1,2,3-thiadiazol-5-ylthio)acetamido)biphenyl-4-yl)acetic acid",0.002,uM,=,-2.6989700043360187,0,O=C(CSc1snnc1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
571,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(Cl)nc(SCc2cccc(Br)c2)n1,2-(3-Bromo-benzylsulfanyl)-6-chloro-pyrimidin-4-ylamine,0.76,uM,=,-0.1191864077192086,0,c1ccc(CSc2ncccn2)cc1
572,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,N/C(=C\C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1)C(=O)O,(E/Z)-2-Amino-4-(1-(4-fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-4-oxobut-2-enoic Acid,2.0,uM,=,0.3010299956639812,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
573,2297017,10.1016/j.ejmech.2016.07.056,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O,"(+)-(10R,11S,12S)-12-jydroxy-4,6,6,10,11-pentamethyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",12.3,uM,=,1.089905111439398,1,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
574,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1[nH]c(=O)n(COCc2ccccc2)c(COCc2ccccc2)c1Cl,"1,6-Bis[(benzyloxy)methyl]-5-chloropyrimidine-2,4(1H,3H)-dione",9.7,uM,=,0.9867717342662448,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
575,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,O=C(N/N=C\c1cc([N+](=O)[O-])c(O)cc1O)c1ccccc1O,"N'-(2,4-dihydroxy-5-nitrobenzylidene)-2-hydroxybenzohydrazide",49.9,uM,=,1.69810054562339,1,O=C(N/N=C\c1ccccc1)c1ccccc1
576,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CSc1nc(O)c(C)c(Cc2c(F)cccc2F)n1,"6-(2,6-Difluoro-benzyl)-5-methyl-2-methylsulfanyl-3H-pyrimidin-4-one",0.2,uM,=,-0.6989700043360187,0,c1ccc(Cc2ccncn2)cc1
577,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",0.8,uM,=,-0.0969100130080563,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
578,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(Cn2c(=O)ccn(CC(=O)NCc3ccccc3)c2=O)c1,"N-Benzyl-2-(3-(3,5-dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",193.87,uM,=,2.287510610303745,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)NCc1ccccc1
579,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(/C=C/C#N)c1,"3-(3-{5-Ethyl-3-[(2-methoxy-ethyl)-methyl-amino]-6-methyl-2-oxo-1,2-dihydro-pyridin-4-ylmethyl}-phenyl)-acrylonitrile",0.001,uM,=,-3.0,0,O=c1cc(Cc2ccccc2)cc[nH]1
580,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(O)c2ccccc2)n2nc(-n3ccnc3)ccc12,"7-(2-Imidazol-1-yl-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-ol",0.23,uM,=,-0.6382721639824072,0,c1ccc(CCCCCCCc2ncc3ccc(-n4ccnc4)nn23)cc1
581,989993,10.1016/j.bmc.2013.09.009,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotinylated dUTP incorporation after 1 hr by ELISA,N#Cc1ccccc1CN1C(=O)N(Cc2ccccc2)S(=O)(=O)n2cccc21,"N2-Benzyl-N4-(o-cyanobenzyl)-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine",56.9,uM,=,1.7551122663950711,1,O=C1N(Cc2ccccc2)c2cccn2S(=O)(=O)N1Cc1ccccc1
582,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3ccc(S(N)(=O)=O)cc3)CC2)n1,"4-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzenesulfonamide",0.024,uM,=,-1.619788758288394,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
583,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(Nc2ccc(CN3CCOCC3)cc2)c2cccnc2n1O,"1-Hydroxy-4-((4-(morpholinomethyl)phenyl)amino)pyrido[2,3-d]pyrimidin-2(1H)-one",0.2,uM,=,-0.6989700043360187,0,O=c1nc(Nc2ccc(CN3CCOCC3)cc2)c2cccnc2[nH]1
584,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",0.75,uM,=,-0.1249387366082999,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
585,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(N(CCF)c3c(F)cc(-c4ccc(C#N)cc4)cc3F)n2)cc1,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(2-fluoroethyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.029,uM,=,-1.537602002101044,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
586,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),Cc1cc(C)cc(S(=O)(=O)Nc2cc(Cl)ccc2NC(=O)CCl)c1,"2-Chloro-N-[4-chloro-2-(3,5-dimethyl-phenylsulfonamido)-phenyl]acetamide",3.36,uM,=,0.5263392773898441,1,O=S(=O)(Nc1ccccc1)c1ccccc1
587,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1COC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro-[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.051,uM,=,-1.2924298239020635,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
588,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCCC1(CC)Oc2ccccc2-n2cccc2C1=O,5-Ethyl-5-propyl-6-oxa-10b-aza-benzo[e]azulen-4-one,10.0,uM,=,1.0,1,O=C1COc2ccccc2-n2cccc21
589,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(C(F)(F)F)nc(SCc2ccc3ccccc3c2)n1,2-(Naphthalen-2-ylmethylsulfanyl)-6-trifluoromethyl-pyrimidin-4-ylamine,0.43,uM,=,-0.3665315444204134,0,c1cnc(SCc2ccc3ccccc3c2)nc1
590,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CC(=O)CC[C@@H]1[C@](C)(CC[C@@]2(O)[C@H](C)CC[C@@H]3OC(C)(C)CCC[C@@]32C)CCC[C@@]1(C)C(=O)Cc1cc(OS(=O)(=O)[O-])ccc1OS(=O)(=O)[O-].[Na+].[Na+],shaagrockol B,6.7,uM,=,0.8260748027008264,1,O=C(Cc1ccccc1)C1CCCC(CCC2CCC[C@@H]3OCCCCC23)C1
591,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,COC(=O)c1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,2-{[1-(5-Methanesulfonylamino-1H-indole-2-carbonyl)-piperidin-4-yl]-methyl-amino}-nicotinic acid methyl ester,0.25,uM,=,-0.6020599913279624,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
592,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(NS(C)(=O)=O)cc3)CC2)nc2c1CSC2,"N-(4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)-methyl)phenyl)methanesulfonamide",0.14,uM,=,-0.8538719643217619,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSC4)CC2)cc1
593,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)CCc1ccc(Cl)cc1,"6-Chloro-1-{[2-(4-chlorophenyl)ethyl]sulfonyl}-1,3-dihydro-2H-benzimidazol-2-one",95.0,uM,=,1.977723605288848,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
594,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(CN3CCCC3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-pyrrolidin-1-ylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.7,uM,=,-0.1549019599857432,0,O=C1Nc2c(CN3CCCC3)ccnc2N(C2CC2)c2ncccc21
595,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1cc(F)cc(F)c1)CC(=O)C(=O)O,"6-[1-(3,5-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",14.0,uM,=,1.146128035678238,1,c1ccc(Cn2cccc2)cc1
596,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1CCCC2,"4-((2-((4-Cyanophenyl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.052,uM,=,-1.2839966563652008,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
597,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccc(F)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(4-fluoro-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.66,uM,=,0.220108088040055,1,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
598,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-c2ccccc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(2'-chloro-4'-methylbiphenyl-2-ylthio)acetamido)biphenyl-4-yl)acetic acid,0.018,uM,=,-1.744727494896694,0,O=C(CSc1ccccc1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
599,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",11.0,uM,=,1.0413926851582251,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
600,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3F)ccc2C(=O)N1O,"6-(2,4-Difluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
601,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCCN(c1ncccc1NCC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethylamino-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.15,uM,=,-0.8239087409443188,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
602,582812,10.1021/jm900597q,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 heterodimer in presence of Mg2+,COc1ccc(Cc2nc(O)c(O)c(C(=O)O)n2)cc1Br,"2-(3'-Bromo-4'-methoxybenzyl)-5, 6-dihydroxypyrimidine-4-carboxylic acid",70.0,uM,=,1.845098040014257,1,c1ccc(Cc2ncccn2)cc1
603,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1CCCC2,"3,5-Dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)-benzonitrile",0.089,uM,=,-1.0506099933550872,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCCC4)CC2)cc1
604,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,O=C(CC/N=C(\S)Nc1ccc(Br)cn1)c1ccc(F)cc1,1-(5-Bromo-pyridin-2-yl)-3-[3-(4-fluoro-phenyl)-3-oxo-propyl]-thiourea,0.047,uM,=,-1.3279021420642825,0,O=C(CCN=CNc1ccccn1)c1ccccc1
605,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CCc3ccccn3)[nH]c(=O)c2Cl)c1,"3-chloro-5-(3-chloro-2-oxo-6-(2-(pyridin-2-yl)ethyl)-1,2-dihydropyridin-4-yloxy)benzonitrile",0.021,uM,=,-1.6777807052660807,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccn2)[nH]1
606,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1ncnc2c1ncn2C1C=CC(OCP(=O)(O)OP(=O)(O)C(F)(F)P(=O)(O)OP(=O)(O)COC2C=CC(n3cnc4c(N)ncnc43)C2)C1,"P,P'-Bis {[4-(adenine-9-yl)cyclopent-2-enyl]oxy-methylphosphonyl}difluorodiphosphonate",20.0,uM,=,1.3010299956639813,1,O=[PH](COC1C=CC(n2cnc3cncnc32)C1)O[PH](=O)C[PH](=O)O[PH](=O)COC1C=CC(n2cnc3cncnc32)C1
607,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)n1,"3-chloro-4-((4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.084,uM,=,-1.0757207139381184,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
608,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,Cc1ccc(C(=O)CSc2nc(O)c(C(C)C)c(Cc3cccc4ccccc34)n2)cc1,5-Isopropyl-6-naphthalen-1-ylmethyl-2-(2-oxo-2-p-tolyl-ethylsulfanyl)-3H-pyrimidin-4-one,0.24,uM,=,-0.619788758288394,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
609,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3ccnc(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-methyl-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
610,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,COc1c(Br)ccc(Cc2n[nH]c(=O)n2C)c1F,"5-(4-bromo-2-fluoro-3-methoxybenzyl)-4-methyl-2H-1,2,4-triazol-3(4H)-one",34.0,uM,=,1.5314789170422551,1,O=c1[nH]nc(Cc2ccccc2)[nH]1
611,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccc(C23SCCN2C(=O)c2ccccc23)cc1,"9b-p-Tolyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.77,uM,=,-0.1135092748275181,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
612,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCc1cc(C)c2c(n1)N(CC)c1ncccc1C(=O)N2,"5,7-Diethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.7,uM,=,0.2304489213782739,1,O=C1Nc2cccnc2Nc2ncccc21
613,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCOc1cccc(F)c1CCNC(=S)Nc1ccc(C)cn1,1-[2-(2-Ethoxy-6-fluoro-phenyl)-ethyl]-3-(5-methyl-pyridin-2-yl)-thiourea,0.0045,uM,=,-2.3467874862246565,0,S=C(NCCc1ccccc1)Nc1ccccn1
614,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,SID26752991,2.1,uM,=,0.3222192947339193,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
615,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2scc(-c3ccccc3)c2c(=O)n1O,"3-Hydroxy-5-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione",0.1,uM,=,-1.0,0,O=c1[nH]c(=O)c2c(-c3ccccc3)csc2[nH]1
616,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2cc(C)cnc21,"5-Ethyl-8,10-dimethyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.76,uM,=,-0.1191864077192086,0,O=C1Nc2cccnc2Nc2ncccc21
617,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCc1cc(/C=C/N2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[2-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-vinyl]-isoindole-1,3-dione",54.0,uM,=,1.7323937598229686,1,O=C1c2ccccc2C(=O)N1/C=C/c1cccnc1
618,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cc(N)cnc2Oc2cc(C)cc(C)c21,"2-Amino-10-ethyl-7,9-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.027,uM,=,-1.5686362358410126,0,O=C1Nc2ccccc2Oc2ncccc21
619,195839,10.1021/jm00023a007,,,,Inhibition of HIV-1 reverse transcriptase (RT),Cc1c(Sc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"1-Benzyloxymethyl-5-methyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",0.4,uM,=,-0.3979400086720376,0,O=c1cc(Sc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
620,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)C2CC2C(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"cis-N-(2-chloro-4-sulfamoylphenyl)-2-(6,8-dichloro-1,2,3,4-tetrahydroquinoline-1-carbonyl)cyclopropanecarboxamide",0.21,uM,=,-0.6777807052660807,0,O=C(Nc1ccccc1)C1CC1C(=O)N1CCCc2ccccc21
621,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,O=C(O)c1cc(NC(=O)c2cc3cc([N+](=O)[O-])c(O)c(O)c3oc2=O)ccc1O,"5-(7,8-dihydroxy-6-nitro-2-oxo-2H-chromene-3-carboxamido)-2-hydroxybenzoic acid",20.8,uM,=,1.3180633349627615,1,O=C(Nc1ccccc1)c1cc2ccccc2oc1=O
622,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2SC)c(O)nc1C,5-Ethyl-6-methyl-3-(2-methylsulfanyl-benzylamino)-1H-pyridin-2-one,1.5,uM,=,0.1760912590556812,1,c1ccc(CNc2cccnc2)cc1
623,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccco2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4-(Furan-2-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0381,uM,=,-1.4190750243243806,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccco4)cc3)n2)cc1
624,989993,10.1016/j.bmc.2013.09.009,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotinylated dUTP incorporation after 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",6.2,uM,=,0.7923916894982539,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
625,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(=O)NCc3ccco3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-((furan-2-ylmethyl)amino)-2-oxoethyl)-1H-indole-2-carboxamide",0.145,uM,=,-0.8386319977650252,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccco1
626,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3cc(Cl)cc(C(F)(F)F)c3)cc2)[nH]c(=O)n1O,"6-((3'-chloro-5'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.015,uM,=,-1.8239087409443189,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
627,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1C(=O)c2cccc(C)c2N(CC)c2ncccc21,"5,11-Diethyl-10-methyl-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one",0.65,uM,=,-0.1870866433571444,0,O=C1Nc2cccnc2Nc2ccccc21
628,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CC1(C)CCC[C@]2(C)OC3CC[C@](C)(C4CC[C@]5(C)C4CC[C@]4(C)C6=C(CC54)C(=O)C=CC6=O)[C@]3(C)CCC12,"(5aS,10bR)-5a,10b-dimethyl-3-((1R,4aS,10aS)-1,4a,8,8,10a-pentamethyldodecahydro-1H-benzo[b]cyclopenta[f]oxepin-1-yl)-1,2,3,3a,4,5,5a,10,10a,10b-decahydrocyclopenta[a]fluorene-6,9-dione",4.5,uM,=,0.6532125137753437,1,O=C1C=CC(=O)C2=C1CC1C2CCC2C1CCC2C1CCC2OC3CCCCC3CCC21
629,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,Cn1cccc1CC/N=C(\S)Nc1ccc(Cl)cn1,1-(5-Chloro-pyridin-2-yl)-3-[2-(1-methyl-1H-pyrrol-2-yl)-ethyl]-thiourea,0.09,uM,=,-1.0457574905606752,0,C(=NCCc1ccc[nH]1)Nc1ccccn1
630,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3ccccc3)CC2)ncc1Br,"4-(5-bromo-2-(1-phenylpiperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.192,uM,=,-0.7166987712964504,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
631,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CN(/C(S)=N/CCc1ccccc1)c1nccs1,1-Methyl-3-phenethyl-1-thiazol-2-yl-thiourea,1.5,uM,=,0.1760912590556812,1,C(=N/CCc1ccccc1)\Nc1nccs1
632,466146,10.1016/j.bmcl.2007.12.015,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)CCCC=C(c1cc(C)c2oc(=O)n(C)c2c1)c1cc(C)c2oc(=O)n(C)c2c1,"methyl 6,6-bis(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)hex-5-enoate",0.5,uM,=,-0.3010299956639812,0,C=C(c1ccc2oc(=O)[nH]c2c1)c1ccc2oc(=O)[nH]c2c1
633,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccccc3F)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(2-fluorophenyl)acetamide",0.207,uM,=,-0.6840296545430823,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
634,465754,10.1016/j.bmcl.2007.11.114,,,,Inhibition of HIV1 reverse transcriptase,CO/N=C(\Cl)CCC/C=C(\c1cc(C)c(OC)c(/C(Cl)=N/OC)c1)c1cc(C)c2oc(=O)n(C)c2c1,"(Z)-5-((1E,6Z)-6-chloro-1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-6-(methoxyimino)hex-1-enyl)-N,2-dimethoxy-3-methylbenzimidoyl chloride",0.6,uM,=,-0.2218487496163563,0,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
635,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(O)c1cc(N2C(=O)c3ccc(Oc4ccc5c(c4)C(=O)N(c4ccc(O)c(C(=O)O)c4)C5=O)cc3C2=O)ccc1O,"5-{5-[2-(3-carboxy-4-hydroxyphenyl)-1,3-dioxo-2,3-dihydro-1H-5-isoindolyloxy]-1,3-dioxo-2,3,3a,7a-tetrahydro-1H-2-isoindolyl}-2-hydroxybenzoic acid",12.0,uM,=,1.0791812460476249,1,O=C1c2ccc(Oc3ccc4c(c3)C(=O)N(c3ccccc3)C4=O)cc2C(=O)N1c1ccccc1
636,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.21,uM,=,-0.6777807052660807,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
637,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCCCCCc3ccccc3)cc2)n[nH]1,Ethyl 3-(1-(4-fluorobenzyl)-4-(4-((5-phenylpentyl)oxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,25.8,uM,=,1.4116197059632305,1,c1ccc(CCCCCOc2ccc(-c3cn(Cc4ccccc4)cc3-c3cc[nH]n3)cc2)cc1
638,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2cccc(-c3ccc(O)cc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",2.7,uM,=,0.4313637641589873,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
639,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,COc1cc(OC)c2c(c1)OCC(OC(=O)c1cc(O)c(O)c(O)c1)C2,"3,4,5-Trihydroxy-benzoic acid 5,7-dimethoxy-chroman-3-yl ester",72.8,uM,=,1.8621313793130367,1,O=C(OC1COc2ccccc2C1)c1ccccc1
640,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=O)[nH]c3cc(Cl)cc(c32)C1C,"4-Chloro-6-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",0.16,uM,=,-0.7958800173440752,0,O=c1[nH]c2cccc3c2n1CCNC3
641,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,"N,N,N',N'-Tetramethyl-acridine-3,6-diamine",200.0,uM,=,2.3010299956639813,1,c1ccc2nc3ccccc3cc2c1
642,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(C)cccc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(4-methyl-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,0.12,uM,=,-0.9208187539523752,0,c1cncc(NCc2nc3ccccc3o2)c1
643,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,Cc1nc(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)n[nH]c1=O,"3-(3-(3-bromophenoxy)-4-chlorobenzyl)-5-methyl-1,2,4-triazin-6(1H)-one",0.33,uM,=,-0.4814860601221125,0,O=c1cnc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
644,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3cccc(C#N)c3)CC2)n1,"4-(2-(1-(3-cyanophenyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.051,uM,=,-1.2924298239020635,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
645,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+],"4-Hexadecanoylamino-5-hydroxy-naphthalene-2,7-disulfonic acid sodium",3.7,uM,=,0.568201724066995,1,c1ccc2ccccc2c1
646,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccccc3C#N)CC2)ncc1Br,"4-(5-bromo-2-(1-(2-cyanobenzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.029,uM,=,-1.537602002101044,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
647,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,NC(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carboxamide",1.5,uM,=,0.1760912590556812,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
648,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,Cc1cc(C#N)cc(Oc2ccc(Cc3n[nH]c4nnccc34)cc2Br)c1,"3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Oc2ccc(Cc3n[nH]c4nnccc34)cc2)cc1
649,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.6,uM,=,0.414973347970818,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
650,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCc1c(O)nc(SCC(=O)c2ccc(Cl)cc2)nc1Cc1cccc2ccccc12,2-[2-(4-Chloro-phenyl)-2-oxo-ethylsulfanyl]-5-ethyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.26,uM,=,-0.585026652029182,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
651,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CCC(C)(C)N(Cc1cccc([N+](=O)[O-])c1)C(=O)COC(=O)c1ccc([N+](=O)[O-])s1,2-((3-nitrobenzyl)(tert-pentyl)amino)-2-oxoethyl 5-nitrothiophene-2-carboxylate,25.8,uM,=,1.4116197059632305,1,O=C(COC(=O)c1cccs1)NCc1ccccc1
652,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1ccn2COCC[Si](C)(C)C,"4-(2-(4-cyanophenylamino)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.171,uM,=,-0.7670038896078462,0,c1ccc(Nc2nc(Oc3ccccc3)c3cc[nH]c3n2)cc1
653,909469,10.1007/s00044-005-0135-x,,,,Inhibition of Human immunodeficiency virus 1 RT using Poly(vC)oligo (dG) as template/primer after 30 min,COc1cc(Cc2cnc(/N=C3\C(=O)N(CN4CCN(c5cc6c(cc5F)c(=O)c(C(=O)O)cn6C5CC5)CC4)c4ccc(Cl)cc43)nc2N)cc(OC)c1OC,"l-Cyclopropyl-6-fluoro-l,4-dihydro-4-oxo-7-[[N4-[3'-(4'-amino-5'-trimethoxybenzylpyrimidin-2'-yl)imino-l'-(5-chloroisatinyl)|methyl)N'-piperazinyl|-3-quinolinecarboxylicacid",18.4,uM,=,1.2648178230095364,1,O=C1/C(=N\c2ncc(Cc3ccccc3)cn2)c2ccccc2N1CN1CCN(c2ccc3c(=O)ccn(C4CC4)c3c2)CC1
654,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,C/C(C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1)=C(/O)C(=O)O,4-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-2-hydroxy-3-methyl-4-oxobut-2-enoic Acid,64.0,uM,=,1.806179973983887,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
655,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCOC(=O)CCCC=C(c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,methyl 2-methoxy-5-[1-(4-methoxy-3-methyl-5-methyloxycarbonylphenyl)-5-propyloxycarbonyl-1-pentenyl]-3-methylbenzoate,29.7,uM,=,1.4727564493172125,1,C=C(c1ccccc1)c1ccccc1
656,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3ccccc3o2)c(O)nc1C,3-[(Benzofuran-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.33,uM,=,-0.4814860601221125,0,c1cncc(NCc2cc3ccccc3o2)c1
657,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N=C(N)N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"N-[(5R,6R,8R,9R)-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-8-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-4-yl]-guanidine",14.0,uM,=,1.146128035678238,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
658,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
659,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CN(c1nc(F)ccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-tert-Butylamino-6-fluoro-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.53,uM,=,-0.2757241303992109,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
660,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CCNc1cccnc1N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(1H-indol-2-yl)-methanone,4.0,uM,=,0.6020599913279624,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
661,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc(C)c1C,"2-(2,6-dichlorophenyl)-3-(4,5,6-trimethylpyrimidin-2-yl)thiazolidin-4-one",0.83,uM,=,-0.0809219076239261,0,O=C1CSC(c2ccccc2)N1c1ncccn1
662,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,O=c1c2ccccc2c(Cc2ccccc2)c(O)n1O,"4-benzyl-2,3-dihydroxyisoquinolin-1(2H)-one",14.9,uM,=,1.173186268412274,1,O=c1[nH]cc(Cc2ccccc2)c2ccccc12
663,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](n3cc(CNCC(=O)N(Cc4ccccc4)Cc4cc5cc(Br)ccc5oc4=O)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,"N-benzyl-N-((6-bromo-2-oxo-2H-chromen-3-yl)methyl)-2-((1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methylamino)acetamide",4.24,uM,=,0.6273658565927327,1,O=C(CNCc1cn([C@@H]2CO[C@@H](n3ccc(=O)[nH]c3=O)C2)nn1)N(Cc1ccccc1)Cc1cc2ccccc2oc1=O
664,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CCNC(=S)Nc2ccc(I)cn2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-3-(5-iodo-pyridin-2-yl)-thiourea,0.008,uM,=,-2.096910013008056,0,S=C(NCCc1ccccc1)Nc1ccccn1
665,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2ccncc2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-pyridin-4-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.45,uM,=,-0.3467874862246563,0,O=C1Nc2ccccc2C(C#Cc2ccncc2)(C2CC2)N1
666,1448161,10.1016/j.bmc.2014.08.001,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation using hybrid poly (A).oligo (dT)15 template primer incubated for 1 hr at 37 degC by ELISA method,CCOC(=O)CNC(=O)c1ccc(NC(=O)CSc2ncncc2-c2cccc3ccccc23)c(Cl)c1,Ethyl 2-(3-chloro-4-(2-(5-(naphthalen-1-yl)pyrimidin-4-ylthio)acetamido)-benzamido)acetate,1.31,uM,=,0.1172712956557642,1,O=C(CSc1ncncc1-c1cccc2ccccc12)Nc1ccccc1
667,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc4ccccc34)cc2c1=O,"1-(4-Fluorobenzyl)-6-(naphthalen-1-ylmethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",1.51,uM,=,0.1789769472931694,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3cccc4ccccc34)cc12
668,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCc1c(O)nc(SCC(=O)c2ccc(C)cc2)nc1Cc1cccc2ccccc12,5-Ethyl-6-naphthalen-1-ylmethyl-2-(2-oxo-2-p-tolyl-ethylsulfanyl)-3H-pyrimidin-4-one,0.32,uM,=,-0.494850021680094,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
669,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCCN1CCOCC1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(2-morpholinoethyl)acetamide",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCCN1CCOCC1
670,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),CC(/C=C1\SC(=S)N(CCC(=O)Nc2ccc(O)c(C(=O)O)c2)C1=O)=C\c1ccccc1,2-Hydroxy-5-(3-{5-[(E)-2-methyl-3-phenyl-prop-2-en-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-benzoic acid,23.0,uM,=,1.3617278360175928,1,O=C(CCN1C(=O)/C(=C/C=C/c2ccccc2)SC1=S)Nc1ccccc1
671,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,Nc1ccc(CO[C@H]2C(=O)Nc3ccc(Cl)cc3[C@@]2(C#CC2CC2)C(F)(F)F)cc1F,"(3R,4R)-3-(4-Amino-3-fluoro-benzyloxy)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.241,uM,=,-0.6179829574251317,0,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
672,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,COc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,"6-[1-(2-Methoxyphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",16.0,uM,=,1.2041199826559248,1,c1ccc(Cn2cccc2)cc1
673,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccccc2F)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(2-fluorophenyl)acetamide",24.3,uM,=,1.385606273598312,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
674,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)C(C)C)cc1,"(E)-3-(4-hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.199,uM,=,-0.7011469235902933,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
675,508728,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated RNA-dependent minus-strand DNA synthesis after 5 mins by gel-based assay,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",1.405,uM,=,0.1476763242410987,1,c1cncc(NCc2nc3ccccc3o2)c1
676,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,Cc1ccc(Sc2cc(CCc3ccccc3)[nH]c(=O)c2Br)cc1,3-Bromo-6-phenethyl-4-(p-tolylthio)pyridin-2(1H)-one,16.89,uM,=,1.2276296495710086,1,O=c1cc(Sc2ccccc2)cc(CCc2ccccc2)[nH]1
677,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCC[N+](C)(C)C)c1=O.[I-],"(3-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-propyl)-trimethyl-ammonium iodide",11.0,uM,=,1.0413926851582251,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
678,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=[N+]([O-])c1cc(I)cc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)c1O,4-chloro-N'-(2-hydroxy-5-iodo-3-nitrobenzylidene)benzenesulfonohydrazide,44.0,uM,=,1.6434526764861874,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
679,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,O=C1CSC(c2c(Cl)cccc2Cl)N1c1ccc(Br)cn1,"3-(5-Bromo-pyridin-2-yl)-2-(2,6-dichloro-phenyl)-thiazolidin-4-one",56.6,uM,=,1.7528164311882717,1,O=C1CSC(c2ccccc2)N1c1ccccn1
680,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)nc1,5-bromo-2-{[(5-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}pyridin-2-yl)carbonyl]amino}benzoic acid,5.5,uM,=,0.7403626894942439,1,O=C(Nc1ccccc1)c1ccc(C(=O)Nc2ccccc2)nc1
681,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccccc1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",2.8,uM,=,0.4471580313422192,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
682,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2c(C)c(C(C)C)[nH]c(=O)c2N(C)C)c1,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-6-isopropyl-5-methyl-1H-pyridin-2-one",0.794,uM,=,-0.1001794975729037,0,O=c1cc(Cc2ccccc2)cc[nH]1
683,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1ccc(S(=O)(=O)N/N=C/c2cccc([N+](=O)[O-])c2O)cc1,N'-(2-hydroxy-3-nitrobenzylidene)-4-methoxybenzenesulfonohydrazide,100.0,uM,=,2.0,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
684,197432,10.1021/jm990236h,,,,Antiviral activity was evaluated by Reverse transcriptase activity in cells acutely infected with HIV-1,CCCCCCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Nonanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",0.8,uM,=,-0.0969100130080563,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
685,465754,10.1016/j.bmcl.2007.11.114,,,,Inhibition of HIV1 reverse transcriptase,Cc1nnc(CC/C=C(/c2cccc(C#N)c2)c2cc(C)c3on(C)c(=O)c3c2)o1,"3-(1-(2,7-dimethyl-3-oxo-2,3-dihydrobenzo[d]isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)benzonitrile",40.0,uM,=,1.6020599913279625,1,O=c1[nH]oc2ccc(/C(=C\CCc3nnco3)c3ccccc3)cc12
686,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ccc([N+](=O)[O-])cc3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(4-nitrophenyl)acetamide,1.27,uM,=,0.1038037209559568,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccccc1
687,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)c1scnc1-c1cccc(C(=O)c2ccccc2)c1,4-(3-benzoylphenyl)thiazole-5-carboxamide,16.3,uM,=,1.212187604403958,1,O=C(c1ccccc1)c1cccc(-c2cscn2)c1
688,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)CCC/C=C(\c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c2onc(OC)c2c1,methyl (Z)-2-methoxy-5-[5-methoxycarbonyl-1-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)-pent-1-enyl]-3-methylbenzoate,0.91,uM,=,-0.0409586076789063,0,C=C(c1ccccc1)c1ccc2oncc2c1
689,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COCN(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(methoxymethyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.025,uM,=,-1.6020599913279625,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
690,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,CNc1ccccc1C(=O)N/N=C/c1cccc([N+](=O)[O-])c1,2-(methylamino)-N'-(3-nitrobenzylidene)benzohydrazide,51.0,uM,=,1.7075701760979365,1,O=C(N/N=C/c1ccccc1)c1ccccc1
691,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(Cc2ccc3c(c2)CC(=O)N(O)C3=O)cc1,"2-Hydroxy-6-(4-methylbenzyl)isoquinoline-1,3(2H,4H)-dione",0.9,uM,=,-0.0457574905606751,0,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
692,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.39,uM,=,-0.4089353929735008,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
693,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3cc[nH]c3)ccc21,"5-Cyclopropyl-10-methyl-7-(1H-pyrrol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2ccc(-c3cc[nH]c3)nc2N(C2CC2)c2ncccc21
694,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,O=C(NCc1ccc(F)cc1)c1c(O)c(=O)[nH]c2ccccc12,N-(4-Fluorobenzyl)-3-hydroxy-2-oxoquinoline-4-carboxamide,19.0,uM,=,1.2787536009528289,1,O=C(NCc1ccccc1)c1cc(=O)[nH]c2ccccc12
695,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2nc(C)c(C)cc2NC(=O)c2cccnc21,"5-Ethyl-7,8-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.41,uM,=,-0.3872161432802645,0,O=C1Nc2cccnc2Nc2ncccc21
696,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CSc3[nH]cnc4nncc3-4)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(1H-pyrazolo[3,4-d]pyrimidin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(CSc3[nH]cnc4nncc3-4)cc21
697,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccccc1-c1ccc(Oc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",22.0,uM,=,1.3424226808222062,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
698,195688,10.1021/jm00042a004,,,,The 50% inhibitory concentration was measured as inhibition of Ribonuclease H activity of reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Nc1ccc(S(=O)(=O)O)c2cccc(S(=O)(=O)O)c12,"4-Hexadecanoylamino-naphthalene-1,5-disulfonic acid",27.5,uM,=,1.4393326938302626,1,c1ccc2ccccc2c1
699,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.0019,uM,=,-2.721246399047171,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
700,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(-c4ccccc4)cc3)cc2c1=O,"6-([1,1'-Biphenyl]-4-ylmethoxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",11.6,uM,=,1.0644579892269186,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc(-c4ccccc4)cc3)cc12
701,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccncc34)ccc2Cl)c1,"3-Chloro-5-[2-chloro-5-(1H-pyrazolo[4,3-c]pyridine-3-yl-methoxy)phenoxy]benzonitrile",0.0012,uM,=,-2.920818753952376,0,c1ccc(Oc2cccc(OCc3n[nH]c4ccncc34)c2)cc1
702,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCCCN(CCCC)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"3-Dibutylamino-4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-1H-pyridin-2-one",50.119,uM,=,1.700002397142254,1,O=c1cc(Cc2ccccc2)cc[nH]1
703,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1ccc(F)cc1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(4-fluorobenzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,8.5,uM,=,0.9294189257142929,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
704,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,NC(=O)c1c(NC(=O)COc2ccccc2)sc2c1CCCCC2,"2-(2-phenoxyacetamido)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide",6.9,uM,=,0.8388490907372553,1,O=C(COc1ccccc1)Nc1cc2c(s1)CCCCC2
705,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1ccc(N2C(=O)CSC2c2c(C)cccc2Cl)nc1,2-(2-Chloro-6-methyl-phenyl)-3-(5-methyl-pyridin-2-yl)-thiazolidin-4-one,42.4,uM,=,1.6273658565927327,1,O=C1CSC(c2ccccc2)N1c1ccccn1
706,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),COC(=O)[C@H]1CSC2(c3ccccc3)c3ccccc3C(=O)N12,"5-Oxo-9b-phenyl-2,3,5,9b-tetrahydro-thiazolo[2,3-a]isoindole-3-carboxylic acid methyl ester",0.22,uM,=,-0.6575773191777937,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
707,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccc(F)cc3)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(4-fluorophenyl)acetamide",0.204,uM,=,-0.6903698325741012,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
708,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,Nc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"9-(4-Amino-phenoxymethyl)-5-cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.01,uM,=,0.0043213737826425,1,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
709,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(Cl)c(Cl)c2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(3,4-dichlorophenyl)acetamide",0.177,uM,=,-0.7520267336381934,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
710,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1cc(C)cc(Cn2c(=O)[nH]c3ccc(Cl)cc32)c1,"1-(3,5-dimethylbenzyl)-6-chloro-1H-benzo[d]imidazol-2(3H)-one",0.15,uM,=,-0.8239087409443188,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
711,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,NS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-sulfonamide",0.4,uM,=,-0.3979400086720376,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
712,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,O=C(c1cc2cc([N+](=O)[O-])c(O)c(O)c2oc1=O)N1CCCN(S(=O)(=O)c2ccc3ccncc3c2)CC1,"7,8-dihydroxy-3-(4-(isoquinolin-7-ylsulfonyl)-1,4-diazepane-1-carbonyl)-6-nitro-2H-chromen-2-one",68.5,uM,=,1.8356905714924256,1,O=C(c1cc2ccccc2oc1=O)N1CCCN(S(=O)(=O)c2ccc3ccncc3c2)CC1
713,2026095,10.1021/acsmedchemlett.0c00612,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated for 1 hr followed by substrate addition measured after 30 mins by pico-green reagent based fluorescence analysis,N#C/C=C/c1cc(Cl)cc(Oc2ccc(Cl)cc2OCCn2ccc(=O)[nH]c2=O)c1,"(E)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)phenyl)acrylonitrile",0.003,uM,=,-2.5228787452803374,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
714,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,CNC(=O)CCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"5-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-pentanoic acid methylamide",6.8,uM,=,0.8325089127062363,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
715,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(F)ccc(F)c3o2)c(O)nc1C,"3-[2-(4,7-Difluoro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.014,uM,=,-1.853871964321762,0,c1cncc(CCc2nc3ccccc3o2)c1
716,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C(N)=O)c3)CC2)nc2c1CSCC2,"3-((4-(4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzamide",0.144,uM,=,-0.8416375079047503,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
717,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccccc1C(=O)O)Nc1ccccc1C(=O)O,2-({6-[(2-carboxyphenyl)amino]-6-oxohexanoyl}amino)benzoic acid,21.0,uM,=,1.3222192947339193,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
718,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),COc1ccccc1/C=C1/SC(=S)N(CCC(=O)Nc2ccc(O)cc2)C1=O,N-(4-Hydroxy-phenyl)-3-{5-[1-(2-methoxy-phenyl)-meth-(E)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionamide,100.0,uM,=,2.0,1,O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
719,2297017,10.1016/j.ejmech.2016.07.056,,,,Inhibition of HIV1 reverse transcriptase,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)C3=O,"(10R,11R)-6,6,10,11-Tetramethyl-4-propyl-10,11-dihydro-6H-dipyrano[2,3-f,2',3'-h]chromene-2,12-dione",19.0,uM,=,1.2787536009528289,1,O=C1CCOc2c3c(c4ccc(=O)oc4c21)OCC=C3
720,1336117,10.1021/jm5001503,,,,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(C)CC3)ccc2c1=O,4-[1-[(4-Fluorophenyl)methyl]-7-(N-methylpiperazin-1-yl)-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid Ethyl Ester,18.5,uM,=,1.2671717284030135,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCNCC3)ccc12
721,542167,10.1016/j.ejmech.2008.02.047,,,,Inhibition of polymerase activity of HIV1 recombinant reverse transcriptase expressed in Escherichia coli,Cc1c(C(=O)OC[C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@H]2OCc2ccccc2)nnn1Cc1ccccc1,"1-Benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 5-(3-O-benzyl-1,2-O-isopropylidene)-alpha-D-xylofuranose ester",1.98,uM,=,0.2966651902615311,1,O=C(OC[C@H]1O[C@@H]2OCO[C@@H]2[C@H]1OCc1ccccc1)c1cn(Cc2ccccc2)nn1
722,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(/C=C(\O)C(=O)O)/C=C/c1ccn(Cc2ccc(F)cc2)c1,"6-(1-(4-Fluorobenzyl)-1H-pyrrol-3-yl)-2-hydroxy-4-oxohexa-2,5-dienoic Acid",69.0,uM,=,1.8388490907372552,1,c1ccc(Cn2cccc2)cc1
723,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2cc(Cl)cc(Cl)c2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(3,5-dichlorophenyl)acetamide",0.918,uM,=,-0.0371573187987575,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
724,1567015,10.1021/acs.jmedchem.5b01979,,,,Inhibition of recombinant HIV1 His-tagged p66/p51 reverse transcriptase expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)-oligo(dT) (12 to 18 bp) as template/primer incubated for 20 mins by scintillation counting method,Cc1c(Cc2c(Cl)cccc2Cl)nc(N(C)Cc2ccc([N+](=O)[O-])cc2)[nH]c1=O,"6-(2,6-dichlorobenzyl)-5-methyl-2-(methyl(4-nitrobenzyl)amino)pyrimidin-4(3H)-one",0.00785,uM,=,-2.105130343254748,0,O=c1cc(Cc2ccccc2)nc(NCc2ccccc2)[nH]1
725,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(N)=O)[nH]c3ccc(Br)cc23)c1,"N-(2-Amino-2-oxoethyl)-5-bromo-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.026,uM,=,-1.585026652029182,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
726,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(Cl)cc2[N+](=O)[O-])c(C)c1,N-(4-chloro-2-nitrophenyl)-2-(1-mesityl-1H-tetrazol-5-ylthio)acetamide,0.004,uM,=,-2.397940008672037,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
727,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1ncnc2c1ncn2C1C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C1,9-[4-(Diphosphoryloxyphosphonylmethoxy)-cyclopent-2-enyl]adenine,0.2,uM,=,-0.6989700043360187,0,C1=CC(n2cnc3cncnc32)CC1
728,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cc(N)ccc2Oc2ccccc21,"2-Amino-10-ethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.145,uM,=,-0.8386319977650252,0,O=C1Nc2ccccc2Oc2ccccc21
729,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(NC2CCCCC2)c1I,4-(Cyclohexylamino)-3-iodo-6-phenethylpyridin-2(1H)-one,15.22,uM,=,1.182414652434554,1,O=c1cc(NC2CCCCC2)cc(CCc2ccccc2)[nH]1
730,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,COc1ccc(CSc2nc(C(C#N)c3ccccc3Cl)c(C)c(=O)[nH]2)cc1,"2-(2-(4-methoxybenzylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(2-chlorophenyl)acetonitrile",0.51,uM,=,-0.2924298239020636,0,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
731,701790,10.1021/ml1002162,,,,Inhibition of HIV1 reverse transcriptase,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)n(O)c1=O,"6-Benzyl-1-(ethoxymethyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",13.0,uM,=,1.1139433523068367,1,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
732,196795,10.1021/jm00058a009,,,,In vitro for inhibitory activity against HIV-1 Reverse Transcriptase,O=C1c2ccccc2[C@H]2SCCN1c1ccccc12,"16-thia-9-azatetracyclo[7.6.3.02,7.010,15]octadeca-2(7),3,5,10(15),11,13-hexaen-8-one",0.83,uM,=,-0.0809219076239261,0,O=C1c2ccccc2[C@H]2SCCN1c1ccccc12
733,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),COc1cc(S(=O)(=O)Nc2ccc(C(=O)O)c(O)c2)cc(/C=C/C(=O)O)c1OC,"4-[3-(2-Carboxy-vinyl)-4,5-dimethoxy-benzenesulfonylamino]-2-hydroxy-benzoic acid",78.0,uM,=,1.8920946026904804,1,O=S(=O)(Nc1ccccc1)c1ccccc1
734,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
735,2215045,10.1016/j.ejmech.2022.114199,,,,Inhibition of HIV-1 reverse transcriptase using rC.dG as primer/template,CCc1cc(NCc2cc3ccccc3o2)c(O)nc1C,3-[(Benzofuran-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.00033,uM,=,-3.4814860601221125,0,c1cncc(NCc2cc3ccccc3o2)c1
736,2201751,10.1016/j.ejmech.2022.114217,,,,Inhibition of HIV-1 LTR reverse transcriptase infected in human CEM cells using RNA template incubated for 1 hr by RT-PCR based cell-free assay,O=C(OCc1ccccc1)N1OCCC1n1cc(COCc2ccccc2)c(=O)[nH]c1=O,"Benzyl 3-(2,4-dioxo-5-((benzyloxy)methyl)-3,4-dihydropyrimidin-1(2H)-yl)isoxazolidine-2-carboxylate",1.0,uM,=,0.0,0,O=C(OCc1ccccc1)N1OCCC1n1cc(COCc2ccccc2)c(=O)[nH]c1=O
737,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(I)nc21,"5-Ethyl-7-iodo-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.43,uM,=,-0.3665315444204134,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
738,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CC(C)CSc1nc(O)cc(Cc2c(Cl)cccc2Cl)n1,"6-(2,6-Dichloro-benzyl)-2-isobutylsulfanyl-3H-pyrimidin-4-one",0.6,uM,=,-0.2218487496163563,0,c1ccc(Cc2ccncn2)cc1
739,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1cccc([N+](=O)[O-])c1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(3-nitrobenzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,9.8,uM,=,0.9912260756924948,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
740,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCC(=O)OC(C)C)c2cc(Br)c(OC)c(C(=O)OC)c2)cc(Br)c1OC,"isopropyl 6,6-di(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-5-hexenoate",70.8,uM,=,1.850033257689769,1,C=C(c1ccccc1)c1ccccc1
741,471455,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.42,uM,=,-0.3767507096020995,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
742,1862051,10.1016/j.ejmech.2019.111619,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H]3CCN(CC(N)=O)C3)[nH]c3ccc(Cl)cc23)c1,"(R)-N-(1-(2-amino-2-oxoethyl)pyrrolidin-3-yl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",1.49,uM,=,0.173186268412274,1,O=C(N[C@@H]1CCNC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
743,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3cccc(N)c3)[nH]c3ccc(Cl)cc23)c1,"N-(3-Aminobenzyl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.041,uM,=,-1.3872161432802643,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
744,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,Cc1cc(-c2ccc(Oc3nc(Nc4ccc(C#N)cc4)nc4ccsc34)cc2C)ccc1C#N,"4'-(2-(4-cyanophenylamino)thieno[3,2-d]pyrimidin-4-yloxy)-2',3-dimethylbiphenyl-4-carbonitrile",0.042,uM,=,-1.3767507096020994,0,c1ccc(Nc2nc(Oc3ccc(-c4ccccc4)cc3)c3sccc3n2)cc1
745,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1C#N,"6-[1-(2-Cyanophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",32.0,uM,=,1.505149978319906,1,c1ccc(Cn2cccc2)cc1
746,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCC(C)(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,"N-[2-(4-{[3-(1,1-Dimethyl-propylamino)-pyridin-2-yl]-methyl-amino}-piperidine-1-carbonyl)-1H-indol-5-yl]-methanesulfonamide",0.35,uM,=,-0.4559319556497244,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
747,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3ccnc(C)c3)cc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-5-ethyl-9-methyl-2-(2-methyl-pyridin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.027,uM,=,-1.5686362358410126,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
748,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1cccc(C(F)(F)F)c1,2-Amino-6-(3-trifluoromethyl-phenylsulfanyl)-benzonitrile,7.1,uM,=,0.8512583487190752,1,c1ccc(Sc2ccccc2)cc1
749,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3)ccc2C(=O)N1O,"6-(4-Fluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.8,uM,=,-0.0969100130080563,0,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
750,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=S(=O)([O-])c1cc(O)c2c(O)cc(S(=O)(=O)[O-])cc2c1.[Na+].[Na+],"4,5-Dihydroxy-naphthalene-2,7-disulfonic acid; disodium salt",201.0,uM,=,2.303196057420489,1,c1ccc2ccccc2c1
751,734864,10.1016/j.bmc.2011.01.024,,,,Inhibition of HIV1 3B reverse transcriptase activity,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]2(C)C(=O)C[C@@H]13,limonin,4.23,uM,=,0.6263403673750424,1,O=C1C[C@@H]2OC[C@@H]3CC(=O)C4[C@H](CCC5[C@H](c6ccoc6)OC(=O)[C@H]6O[C@]546)[C@]32CO1
752,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-n2nccc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(1-(2-chloro-4-methylphenyl)-1H-pyrazol-5-ylthio)acetamido)biphenyl-4-yl)acetic acid,0.0079,uM,=,-2.1023729087095586,0,O=C(CSc1ccnn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
753,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2c(F)cccc2OC)C(F)(F)F)c(O)nc1C,3-[3-Cyclopropyl-1-(2-fluoro-6-methoxy-benzyloxy)-1-trifluoromethyl-prop-2-ynyl]-5-ethyl-6-methyl-1H-pyridin-2-one,1.951,uM,=,0.290257269394518,1,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
754,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCCN(c1ncccc1CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethyl-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.91,uM,=,-0.0409586076789063,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
755,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4F)cc3)ccc2C(=O)N1O,"6-((2',4'-Difluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.4,uM,=,0.1461280356782379,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
756,195660,10.1021/jm030116g,,,,Inhibitory concentration required against Reverse transcriptase (RT),Cc1cn([C@H]2C=C[C@]3(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])C[C@H]23)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+],"1-(5-Hydroxymethyl-bicyclo[3.1.0]hex-3-en-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; triphosphate",0.65,uM,=,-0.1870866433571444,0,O=c1ccn([C@H]2C=CC3C[C@@H]32)c(=O)[nH]1
757,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cc(C(F)(F)F)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-methoxy-5-trifluoromethyl-benzenesulfonyl)-benzonitrile,0.04,uM,=,-1.3979400086720375,0,O=S(=O)(c1ccccc1)c1ccccc1
758,195843,10.1021/jm970096g,,,,The quantity of compound required to reduce WT Reverse transcriptase activity by 50%,Fc1cccc(F)c1Cn1c(-c2ccccc2)nc2ccccc21,"1-(2,6-Difluoro-benzyl)-2-phenyl-1H-benzoimidazole",16.0,uM,=,1.2041199826559248,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
759,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCc1ccc(O)cc1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(4-hydroxybenzyl)acetamide",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCc1ccccc1
760,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,CN(C)c1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-4-(N,N-dimethylamino)benzimidazole",40.0,uM,=,1.6020599913279625,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
761,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1cc(Cl)c(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,"2-(2-Benzoyl-4,5-dichloro-phenoxy)-N-phenyl-acetamide",0.0350839472287544,uM,=,-1.454891550903797,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
762,2104796,10.1016/j.bmc.2021.116239,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into cDNA measured after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.048,uM,=,-1.3187587626244128,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
763,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)ccc2Cl)c1,2-[4-chloro-3-(3-chloro-5-cyano-phenoxy)-phenoxy]-N-(2-chloro-4-sulfamoyl-phenyl)-acetamide,0.00014,uM,=,-3.853871964321762,0,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ccccc1
764,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccccc1-c1nc2cccc(Br)n2c1NC1CCCCC1,"5-Bromo-2-(2-chlorophenyl)-N-cyclohexylimidazo[1,2-a]pyridin-3-amine",4.62,uM,=,0.6646419755561255,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
765,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3ccccc3s2)c(O)nc1C,3-(2-Benzothiazol-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.37,uM,=,-0.431798275933005,0,c1cncc(CCc2nc3ccccc3s2)c1
766,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccccc1-c1ccc(Oc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",6.2,uM,=,0.7923916894982539,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
767,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,C=C(C)CN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)C(C)C1,"4-Chloro-9-methyl-7-(2-methyl-allyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.67,uM,=,-0.1739251972991735,0,S=c1[nH]c2cccc3c2n1CCNC3
768,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(/C=C/C(=O)c3ccccc3)cc2c1=O,"(E)-Ethyl 1-(4-Fluorobenzyl)-4-oxo-6-(3-oxo-3-phenylprop-1-en-1-yl)-1,4-dihydroquinoline-3-carboxylate",15.3,uM,=,1.1846914308175989,1,O=C(/C=C/c1ccc2c(c1)c(=O)ccn2Cc1ccccc1)c1ccccc1
769,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4)cc3)ccc2C(=O)N1O,"6-((4'-Fluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.8,uM,=,0.4471580313422192,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
770,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(O)ccc3[nH]2)CC1,(5-Hydroxy-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,1.3,uM,=,0.1139433523068367,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
771,197423,10.1021/jm00001a001,,,,Ability to inhibit the HIV-1 reverse transcriptase in cord blood mononuclear cells.,Nc1nc(=O)n([C@H]2CS[C@@H](CO)C2)cc1F,"4-Amino-5-fluoro-1-((3R,5R)-5-hydroxymethyl-tetrahydro-thiophen-3-yl)-1H-pyrimidin-2-one",0.2,uM,=,-0.6989700043360187,0,O=c1ncccn1[C@@H]1CCSC1
772,953195,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dGTP incorporation after 15 mins by PAGE,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4-[2-(4-Cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.009,uM,=,-2.0457574905606752,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
773,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.037,uM,=,-1.431798275933005,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
774,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,Cc1cc(-c2cccc(Cc3cc(=O)n(O)c(=O)[nH]3)c2)ccc1F,"6-((4'-fluoro-3'-methyl-[1,1'-biphenyl]-3-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.0088,uM,=,-2.055517327849832,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
775,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,CCOc1cccc2cc(CN(Cc3ccccc3)C(=O)CNCc3cn([C@H]4C[C@H](n5cc(C)c(=O)[nH]c5=O)O[C@@H]4CO)nn3)c(=O)oc12,"N-benzyl-N-((8-ethoxy-2-oxo-2H-chromen-3-yl)methyl)-2-((1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methylamino)acetamide",2.86,uM,=,0.456366033129043,1,O=C(CNCc1cn([C@@H]2CO[C@@H](n3ccc(=O)[nH]c3=O)C2)nn1)N(Cc1ccccc1)Cc1cc2ccccc2oc1=O
776,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,CCc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-4-ethyl-1H-benzoimidazole",17.5,uM,=,1.2430380486862944,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
777,2226592,10.1016/j.ejmech.2022.114471,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction of biotin-dUTP incorporation into protein using ABTS as substrate incubated for 1 hrs by ELISA analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC3CC4(CCN(CC(N)=O)C4)C3)[nH]c3ccc(Cl)cc23)c1,"N-(6-(2-amino-2-oxoethyl)-6-azaspiro [3.4]octan-2-yl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.13,uM,=,-0.8860566476931633,0,O=C(NC1CC2(CCNC2)C1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
778,468352,10.1016/j.bmcl.2007.11.125,,,,Inhibition of wild type HIV 3B reverse transcriptase in MT2 cells,CO[C@@H]1C=C(F)[C@H](n2cnc3c(N)ncnc32)O1,"9-((2R,5S)-3-fluoro-5-methoxy-2,5-dihydrofuran-2-yl)-9H-purin-6-amine",0.4,uM,=,-0.3979400086720376,0,C1=C[C@H](n2cnc3cncnc32)OC1
779,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",3.5,uM,=,0.5440680443502757,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
780,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O,DORAVIRINE,0.019,uM,=,-1.7212463990471711,0,O=c1[nH]nc(Cn2cccc(Oc3ccccc3)c2=O)[nH]1
781,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1cc(=O)n(O)c(=O)[nH]1,"3-Hydroxy-6-(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-carbonyl)pyrimidine-2,4(1H,3H)-dione",0.026,uM,=,-1.585026652029182,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
782,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC2CO2)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-3-oxiranylmethyl-1H-pyrimidine-2,4-dione",5.0,uM,=,0.6989700043360189,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)n1CC1CO1
783,197449,10.1016/s0960-894x(98)00250-9,,,,Compound was evaluated for enzymatic inhibitory activity against recombinant HIV reverse transcriptase,CCc1c(O)nc(SCSC)nc1Cc1ccccc1,6-Benzyl-5-ethyl-2-methylsulfanylmethylsulfanyl-3H-pyrimidin-4-one,9.7,uM,=,0.9867717342662448,1,c1ccc(Cc2ccncn2)cc1
784,1849529,10.1016/j.bmc.2019.06.044,,,,Inhibition of HIV1 reverse transcriptase RNase H using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate measured after 1 hr by FRET based assay,NC(=O)c1c(N)sc2c1CCCCC2,SID3712084,28.1,uM,=,1.44870631990508,1,c1cc2c(s1)CCCCC2
785,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",1.8,uM,=,0.255272505103306,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
786,197423,10.1021/jm00001a001,,,,Ability to inhibit the HIV-1 reverse transcriptase in cord blood mononuclear cells.,Nc1nc(=O)n([C@@H]2CC[C@H](CO)S2)cc1F,"4-Amino-5-fluoro-1-((2S,5R)-5-hydroxymethyl-tetrahydro-thiophen-2-yl)-1H-pyrimidin-2-one",0.25,uM,=,-0.6020599913279624,0,O=c1ncccn1[C@@H]1CCCS1
787,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,COc1ccc2nc3cc(Cl)ccc3c(NCCCNCCCCNCCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)c2c1,Acridine dimer,0.22,uM,=,-0.6575773191777937,0,c1ccc2c(NCCCNCCCCNCCCNc3c4ccccc4nc4ccccc34)c3ccccc3nc2c1
788,475592,10.1021/jm7011134,,,,Inhibition of HIV1 reverse transcriptase,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,"3-(3,4-Dihydroxy-phenyl)-acrylic acid 1-carboxy-2-(3,4-dihydroxy-phenyl)-ethyl ester",100.0,uM,=,2.0,1,O=C(/C=C/c1ccccc1)OCCc1ccccc1
789,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CCc1ccc(O)c(O)c1)S(=O)(=O)c1ccc(OC)cc1,"3-(3, 4-Dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0075,uM,=,-2.1249387366083,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
790,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Br,2-Amino-6-(2-bromo-benzenesulfonyl)-benzonitrile,12.0,uM,=,1.0791812460476249,1,O=S(=O)(c1ccccc1)c1ccccc1
791,1769209,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 RNase H preincubated for 10 mins followed by PBS-22dpol/radiolabeled PBS-14r8d addition measured after 5 mins,Cc1ccc(-c2nc(O)c(O)c(C(=O)O)n2)cc1Cl,"2-(3-Chloro-4-methylphenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",25.0,uM,=,1.3979400086720375,1,c1ccc(-c2ncccn2)cc1
792,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=S)[nH]c3cc(Cl)cc(c32)C1,"4-Chloro-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.16,uM,=,-0.7958800173440752,0,S=c1[nH]c2cccc3c2n1CCNC3
793,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nc(O)c1O,"2-(3,5-Bis(trifluoromethyl)phenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",20.0,uM,=,1.3010299956639813,1,c1ccc(-c2ncccn2)cc1
794,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,COc1ccc(-c2cc3c(NCc4nc(O)c(O)c(C(=O)O)n4)ncnc3nc2SC)cc1,"5,6-Dihydroxy-2-(((6-(4-methoxyphenyl)-7-(methylthio)pyrido[2,3-d]pyrimidin-4-yl)amino)methyl)pyrimidine-4-carboxylic acid",62.0,uM,=,1.792391689498254,1,c1ccc(-c2cnc3ncnc(NCc4ncccn4)c3c2)cc1
795,2294755,10.1016/j.bmcl.2023.129216,,,,Inhibition of recombinant wildtype HIV-1 reverse transcriptase using r(A)350 as template and d(T)16 as primer preincubated with compound for 1 hrs followed by template/primer addition and measured after 30 mins by picogreen based plate reader analysis,N#Cc1ccc(Nc2ncc(Cc3c(F)cc(-c4ccc(C5CO5)cc4)cc3F)o2)cc1Cl,"2-chloro-4-((5-((3,5-difluoro-4'-(oxiran-2-yl)-[1,1'-biphenyl]-4-yl)methyl)oxazol-2-yl)amino)benzonitrile",0.44,uM,=,-0.3565473235138126,0,c1ccc(Nc2ncc(Cc3ccc(-c4ccc(C5CO5)cc4)cc3)o2)cc1
796,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCc1ccc2c(c1)OCO2)Nc1ccc(Br)cn1,"1-(2-Benzo[1,3]dioxol-5-yl-ethyl)-3-(5-bromo-pyridin-2-yl)-thiourea",0.7,uM,=,-0.1549019599857432,0,S=C(NCCc1ccc2c(c1)OCO2)Nc1ccccn1
797,80130,10.1016/S0960-894X(01)80437-6,,,,The compound was evaluated as inhibitor of recombinant HIV-l reverse transcriptase,Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)C(F)(F)F)O2)c(=O)[nH]c1=O,"Trifluoromethyl-phosphonic acid mono-[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester",30.07100105964132,uM,=,1.478147885946934,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
798,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)c(C)n1,"4-(2-Methyl-6-methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.72,uM,=,-0.1426675035687315,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
799,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12,(R)-1-((R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,42.6,uM,=,1.6294095991027189,1,O=C(CCc1c[nH]c2ccccc12)NCCc1c[nH]c2ccccc12
800,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,Cc1cc(C)c(S(=O)(=O)Nc2ccc3c(=O)n(O)c(=O)[nH]c3c2)c(C)c1,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-2,4,6-trimethylbenzenesulfonamide",3.24,uM,=,0.5105450102066121,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2[nH]1
801,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2c(F)cccc2F)c2ccccc2c1=O,"(Z)-4-(1-(2,6-difluorobenzyl)-4-oxo-1,4-dihydroquinolin-3-yl)-2-hydroxy-4-oxobut-2-enoic acid",10.8,uM,=,1.0334237554869496,1,O=c1ccn(Cc2ccccc2)c2ccccc12
802,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,Cl.O=C1NC2CN(Cc3ccccc3)CCC2C(=O)N1O,"7-Benzyl-3-hydroxyhexahydropyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione hydrochloride",0.33,uM,=,-0.4814860601221125,0,O=C1NC(=O)C2CCN(Cc3ccccc3)CC2N1
803,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCc2cccc(CN3CCOCC3)c2)c2cccnc2n1O,"1-Hydroxy-4-({[3-(4-morpholinylmethyl)phenyl]methyl}amino)pyrido[2,3-d]pyrimidin-2(1H)-one",0.398,uM,=,-0.4001169279263121,0,O=c1nc(NCc2cccc(CN3CCOCC3)c2)c2cccnc2[nH]1
804,638659,10.1016/j.bmc.2010.05.004,,,,Inhibition of HIV 3B reverse transcriptase using [3H]TTP as a tracer by scintillation counting,CCc1c(Cc2cc(C)cc(C)c2)n(COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c(=O)[nH]c1=O,"(Z)-4-(3-(4-(((6-(3,5-Dimethylbenzyl)-5-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)benzyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.028,uM,=,-1.5528419686577808,0,O=c1cc(Cc2ccccc2)n(COCc2ccc(Cc3ccccc3)cc2)c(=O)[nH]1
805,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(F)c(CCNC(=O)Nc2ccc(Br)cn2)c1Cl,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-urea,1.7,uM,=,0.2304489213782739,1,O=C(NCCc1ccccc1)Nc1ccccn1
806,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",17.0,uM,=,1.230448921378274,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
807,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CCc1n[nH]c2ccc(F)c(Oc3cc(C#N)cc(C#N)c3)c12,5-(3-ethyl-5-fluoro-1H-indazol-4-yloxy)isophthalonitrile,0.025,uM,=,-1.6020599913279625,0,c1ccc(Oc2cccc3[nH]ncc23)cc1
808,1567954,10.1016/j.bmc.2016.04.018,,,,Inhibition of HIV1 reverse transcriptase using 234-nt long RNA/18-mer DNA oligonucleotide as template/primer preincubated for 15 mins followed by incubation with template/primer for 40 mins by liquid scintillation counting in presence of alpha[P33]-dCTP,Cc1ccc(Nc2nc(N)nc(Nc3ccc(C)cc3)n2)cc1,"4,6-bis(p-tolylamino)-1,3,5-triazin-2-aminium",116.0,uM,=,2.0644579892269186,1,c1ccc(Nc2ncnc(Nc3ccccc3)n2)cc1
809,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCc3ccccc3)cc2)n[nH]1,Ethyl 3-(1-(4-fluorobenzyl)-4-(4-(benzyloxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,5.4,uM,=,0.7323937598229685,1,c1ccc(COc2ccc(-c3cn(Cc4ccccc4)cc3-c3cc[nH]n3)cc2)cc1
810,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCN(CC(=O)O)CC(=O)O)c1=O,"[(3-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-propyl)-carboxymethyl-amino]-acetic acid",5.2,uM,=,0.7160033436347992,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
811,195358,10.1021/jm00012a014,,,,Inhibitory activity against HIV-1 Reverse transcriptase,CC(=O)OCCOCn1c2c(c(=O)[nH]c1=O)CN(C)c1ccccc1S2,"Acetic acid 2-(10-methyl-1,3-dioxo-2,3,10,11-tetrahydro-1H-5-thia-2,4,10-triaza-dibenzo[a,d]cyclohepten-4-ylmethoxy)-ethyl ester",14.7,uM,=,1.167317334748176,1,O=c1[nH]c2c(c(=O)[nH]1)CNc1ccccc1S2
812,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.15,uM,=,0.0606978403536116,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
813,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,C=CCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(=O)O)[C@H]2OC)c1=O,"5-(1-allyl-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxy-2-(methoxymethyl)tetrahydrofuran-3-yl methylphosphonate",50.5,uM,=,1.7032913781186614,1,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
814,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCN(c1ncccc1COC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-methoxymethyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.14,uM,=,-0.8538719643217619,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
815,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(OCCCN(C)C)cc2Cl)c(C)c1,N-(2-chloro-4-(3-(dimethylamino)propoxy)phenyl)-2-(1-mesityl-1H-tetrazol-5-ylthio)acetamide,0.013,uM,=,-1.8860566476931635,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
816,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),COc1ccc(OC)c(CCNC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2-fluoro-3,6-dimethoxy-phenyl)-ethyl]-urea",0.14,uM,=,-0.8538719643217619,0,O=C(NCCc1ccccc1)Nc1ccccn1
817,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3cc(Cl)cc(C#N)c3)c21,"3-chloro-5-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)benzonitrile",0.026,uM,=,-1.585026652029182,0,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
818,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2ccccc2)c(O)nc1C,5-Ethyl-6-methyl-3-phenethyl-1H-pyridin-2-one,50.0,uM,=,1.6989700043360187,1,c1ccc(CCc2cccnc2)cc1
819,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(COc1ccc(-c2cn(Cc3cccc4ccccc34)cc2-c2cc(C(=O)O)[nH]n2)cc1)Nc1ccccc1,3-(1-(Naphthalen-1-ylmethyl)-4-(4-(2-oxo-2-(phenylamino)ethoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,5.8,uM,=,0.7634279935629373,1,O=C(COc1ccc(-c2cn(Cc3cccc4ccccc34)cc2-c2cc[nH]n2)cc1)Nc1ccccc1
820,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1ccc(/C=C2/SC(=S)N(CC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1,3-(2-{4-Oxo-2-thioxo-5-[1-p-tolyl-meth-(Z)-ylidene]-thiazolidin-3-yl}-acetylamino)-benzoic acid,98.0,uM,=,1.9912260756924949,1,O=C(CN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
821,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(thiophen-2-yl)benzyl)isoquinoline-1,3(2H,4H)-dione",0.7,uM,=,-0.1549019599857432,0,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1
822,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
823,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,Cc1cc(-c2ccc(Cc3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,"6-((4'-fluoro-3'-methyl-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
824,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C1/C(=C/c2c(NCCO)nc3ccccn3c2=O)SC(=S)N1Cc1ccco1,"3-[3-Furan-2-ylmethyl-4-oxo-2-thioxo-thiazolidin-(5E)-ylidenemethyl]-2-(2-hydroxy-ethylamino)-pyrido[1,2-a]pyrimidin-4-one",100.0,uM,=,2.0,1,O=C1/C(=C/c2cnc3ccccn3c2=O)SC(=S)N1Cc1ccco1
825,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CN1C(=O)c2cccnc2N(Cc2ccccc2)c2ccccc21,"11-Benzyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",9.0,uM,=,0.9542425094393248,1,O=C1Nc2ccccc2N(Cc2ccccc2)c2ncccc21
826,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,CCc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-ethyl-1H-pyrimidine-2,4-dione",8.5,uM,=,0.9294189257142929,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
827,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(NCc2ccc3cc[nH]c3c2)n1,"4-((1H-indol-6-yl)methylamino)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.5,uM,=,-0.3010299956639812,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4cc[nH]c4c3)n2)cc1
828,465754,10.1016/j.bmcl.2007.11.114,,,,Inhibition of HIV1 reverse transcriptase,COc1noc2c(C)cc(/C(=C/CCc3nnc(C)o3)c3cccc(C#N)c3)cc12,"3-(1-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)benzonitrile",73.0,uM,=,1.863322860120456,1,C(\CCc1nnco1)=C(\c1ccccc1)c1ccc2oncc2c1
829,539716,10.1021/jm800473d,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,O=S(=O)(Nc1n[nH]cc1Br)c1cccc2nsnc12,"N-(4-bromo-1Hpyrazol-3-yl)-2,1,3-benzothiadiazole-4-sulfonamide",2.8,uM,=,0.4471580313422192,1,O=S(=O)(Nc1cc[nH]n1)c1cccc2nsnc12
830,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc3ccccc23)[nH]c(=O)n1O,"3-Hydroxy-6-(naphthalen-1-ylthio)pyrimidine-2,4(1H,3H)-dione",0.007,uM,=,-2.154901959985743,0,O=c1cc(Sc2cccc3ccccc23)[nH]c(=O)[nH]1
831,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.076,uM,=,-1.1191864077192086,0,c1ccc(CN2CCC(Nc3nc(Oc4ccccc4)c4sccc4n3)CC2)cc1
832,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),Cc1ccc(/C=C2\SC(=S)N(CC(=O)Nc3cc([N+](=O)[O-])ccc3O)C2=O)cc1,N-(2-Hydroxy-5-nitro-phenyl)-2-{4-oxo-2-thioxo-5-[1-p-tolyl-meth-(Z)-ylidene]-thiazolidin-3-yl}-acetamide,80.0,uM,=,1.9030899869919435,1,O=C(CN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
833,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",0.6,uM,=,-0.2218487496163563,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
834,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C(C)C1,"9-Methyl-7-(2-methyl-allyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",32.1,uM,=,1.506505032404872,1,O=c1[nH]c2cccc3c2n1CCNC3
835,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,COc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-(4'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrimidine-2,4(1H,3H)-dione",0.53,uM,=,-0.2757241303992109,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
836,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1ccc(Cl)cc1C(=O)O,2-[5-(2-carboxy-4-chlorophenylcarbamoyl)pentylcarboxamido]-5-chlorobenzoic acid,9.0,uM,=,0.9542425094393248,1,O=C(CCCCCC(=O)Nc1ccccc1)Nc1ccccc1
837,2114055,10.1016/j.bmc.2021.116195,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation in presence of template-primer incubated for 60 mins followed by transferring to streptavidin-coated plate and further incubation for 60 mins by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.059,uM,=,-1.2291479883578558,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
838,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccc(N)c3)nc21,"7-(3-Amino-phenyl)-5-ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
839,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1CC1=NCCc2cc(OC)c(OC)cc21.O=S(=O)(O)O,O-methylpsychotrine sulfate,17.353562996914214,uM,=,1.2393886567081371,1,c1ccc2c(c1)CCN=C2C[C@@H]1CCN2CCc3ccccc3[C@@H]2C1
840,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(Cl)ccc21,"7-Chloro-5-cyclopropyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
841,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1[nH]c(=O)n([C@@H]2O[C@H](CNCc3ccccc3Cl)[C@@H](O)[C@H]2O)cc1F,5'-(2-chlorobenzylamino)methyl-5-fluorouridine,3.53,uM,=,0.5477747053878226,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
842,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",13.0,uM,=,1.1139433523068367,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
843,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccccc1-c1ccccc1Oc1cc(=O)n(O)c(=O)n1C,"3-(Benzyloxy)-6-((2'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",13.0,uM,=,1.1139433523068367,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
844,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(O)c1cc(NCc2cccc(C#Cc3ccccc3)c2)ccc1O,2-Hydroxy-5-(3-phenylethynyl-benzylamino)-benzoic acid,61.0,uM,=,1.7853298350107671,1,C(#Cc1cccc(CNc2ccccc2)c1)c1ccccc1
845,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc3ccccc3nc2OC)c(O)nc1C,5-Ethyl-3-[(2-methoxy-quinolin-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.034,uM,=,-1.4685210829577449,0,c1cncc(NCc2cnc3ccccc3c2)c1
846,195359,10.1016/0960-894X(94)00478-X,,,,Inhibitory activity against HIV-1 Reverse transcriptase (RT) was determined,CCN1c2cnccc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-5,10-dihydro-3,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",6.4,uM,=,0.8061799739838872,1,O=C1Nc2cccnc2Nc2cnccc21
847,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C)c(Oc2nc(Nc3ccc(C#N)cc3)nc3c2CCCC3)c(C)c1,"4-((4-(Mesityloxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)-benzonitrile",0.241,uM,=,-0.6179829574251315,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
848,195674,10.1021/jm0009437,,,,Tested for inhibitory concentration on HIV-1 Reverse transcriptase in the presence of poly(c)-oligo-(dG),CCc1c(C)nc(O)c(N)c1Cc1cc(C)cc(C)c1,"3-Amino-4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.1,uM,=,-1.0,0,c1ccc(Cc2ccncc2)cc1
849,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2ccc(F)cc2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-6-fluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
850,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,COc1cncc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)c1,"4-(5-Methoxy-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.12,uM,=,-0.9208187539523752,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
851,1294279,10.1016/j.ejmech.2014.02.047,,,,Inhibition of wild type HIV-1 reverse transcriptase using poly (rC)/oligo (dG) as template/primer assessed as inhibition of biotin-dUTP incorporation after 1 hr by microtiter plate ELISA reader analysis,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1[N+](=O)[O-],"4-(2-(4-Cyanophenylamino)-5-nitropyridin-4-yloxy)-3,5-dimethylbenzonitrile",8.5,uM,=,0.9294189257142929,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
852,758401,10.1016/j.bmc.2011.05.062,,,,Inhibition of HIV1 reverse transcriptase assessed as residual enzyme activity at 50 uM after 1 hr by ELISA,Cc1c(Br)ccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n12,"6-Bromo-2-(2-chlorophenyl)-N-cyclohexyl-5-methylimidazo[1,2-a]pyridin-3-amine",18.89,uM,=,1.2762319579218335,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
853,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(Cc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"9-Benzyl-5-cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2c(Cc3ccccc3)ccnc2N(C2CC2)c2ncccc21
854,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",3.1,uM,=,0.4913616938342727,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
855,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2CC[C@@H](OCP(=O)(O)O)O2)c(=O)[nH]c1=O,"(2R,5R)-[5-(5-methyl-2,4-dioxo-3,4-dihydro-2Hpyrimidin-1-yl)-tetrahydro-furan-2-yloxymethyl]-phosphonic acid",5.4,uM,=,0.7323937598229685,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
856,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,CCN1CCC2c3c([nH]c(=O)n(O)c3=O)SC2C1.Cl,"7-Ethyl-3-hydroxy-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione hydrochloride",0.2,uM,=,-0.6989700043360187,0,O=c1[nH]c2c(c(=O)[nH]1)C1CCNCC1S2
857,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CS(=O)(=O)c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzenesulfonylmethyl-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(CS(=O)(=O)c3ccccc3)cc21
858,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,COc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cc1,"4-(4-Methoxy-phenyl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0052,uM,=,-2.283996656365201,0,O=c1nc(-c2ccccc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
859,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,COc1cc(Oc2c(C)cc(C#N)cc2C)cc(NC2CCN(Cc3ccncc3)CC2)n1,"4-((2-Methoxy-6-((1-(pyridin-4-ylmethyl)piperidin-4-yl)amino)pyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.081,uM,=,-1.0915149811213505,0,c1ccc(Oc2ccnc(NC3CCN(Cc4ccncc4)CC3)c2)cc1
860,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1ccccc1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,SID57266501,0.9,uM,=,-0.0457574905606751,0,O=C(COC(=O)c1ccco1)NCc1ccccc1
861,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(N)ccc3[nH]2)CC1,(5-Amino-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,1.0,uM,=,0.0,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
862,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(NS(N)(=O)=O)C3)cc2)nc2sccc12,"(E)-N-(1-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[2,3-d]pyrimidin-2-yl)amino)phenyl)piperidin-3-yl)sulfonamide",4.79,uM,=,0.6803355134145632,1,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3sccc23)cc1
863,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,Cc1cc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,"6-(4'-Fluoro-3'-methyl-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.019,uM,=,-1.7212463990471711,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
864,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,O=[N+]([O-])c1ccc(C2c3c(O)nc(S)nc3Oc3nc(S)nc(O)c32)cc1,"2,8-Dimercapto-5-(4-nitro-phenyl)-5H-pyrano[2,3-d;6,5-d'']dipyrimidine-4,6-diol",4.8,uM,=,0.6812412373755872,1,c1ccc(C2c3cncnc3Oc3ncncc32)cc1
865,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,CC(=O)Nc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,"2-(3-(4-Acetamidophenyl)ureido)-5-(3,4-dichlorophenyl)-thiophene-3-carboxylic Acid",0.6,uM,=,-0.2218487496163563,0,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
866,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)CCCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-6-methyloxycarbonyl-1-hexenyl]-2-methoxybenzoate,3.35,uM,=,0.5250448070368452,1,C=C(c1ccccc1)c1ccccc1
867,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,Nc1cc(S(=O)(=O)O)c2ccccc2c1N,"3,4-Diamino-naphthalene-1-sulfonic acid",50.0,uM,=,1.6989700043360187,1,c1ccc2ccccc2c1
868,1338882,10.1016/j.bmc.2014.02.029,,,,Inhibition of recombinant HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation in to poly [A] x oligo[dT]15 by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.083,uM,=,-1.080921907623926,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
869,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(O)/C(O)=C/C(=O)c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,4-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxobut-2-enoic Acid,14.0,uM,=,1.146128035678238,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
870,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCCc1csc(NC(=S)NCCc2ccccc2)n1,1-Phenethyl-3-(4-propyl-thiazol-2-yl)-thiourea,0.35,uM,=,-0.4559319556497244,0,S=C(NCCc1ccccc1)Nc1nccs1
871,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cccc(CCNC(=O)c2[nH]c3ccc(Cl)cc3c2S(=O)(=O)c2cc(C)cc(C)c2)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(3-methylphenethyl)-1H-indole-2-carboxamide",0.19,uM,=,-0.721246399047171,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
872,743750,10.1021/jm101536x,,,,Inhibition of wild type HIV-1 reverse transcriptase-mediated polymerization reaction after 30 mins,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@]3(C=CS(=O)(=O)O3)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-methylthymine]-3'-spiro-5''-(1'',2''-oxathiole-2'',2''-dioxide)",3.3,uM,=,0.5185139398778875,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
873,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(-c2ccc(Br)cc2)nc(O)c1O,"2-(4-Bromophenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",2.8,uM,=,0.4471580313422192,1,c1ccc(-c2ncccn2)cc1
874,1551159,10.1016/j.ejmech.2015.11.039,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-dUTP/biotin-dUTP/dTTP nucleotides incubated for 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",8.8,uM,=,0.9444826721501688,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
875,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cccc(C#N)c4)cc3Cl)c2=O)n[nH]c1=O,"3'-chloro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",7.21,uM,=,0.857935264719429,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
876,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnc(C)o2)c2cc(C)c(OC)c(C(=O)SC)c2)cc(C)c1OC,"(Z)-methyl 2-methoxy-5-[1-(4-methoxy-3-methyl-5-methylsulfanylcarbonylphenyl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-1-enyl]-3-methylbenzoate",32.0,uM,=,1.505149978319906,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
877,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,CS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3ccc(Cl)cc3)s2)cc1,"2-[[5-[2-(4-Chlorophenyl)-4-oxo-thiazolidin-3-yl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-methylsulfonylphenyl)acetamide",39.43,uM,=,1.5958267770732233,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
878,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,O=C(NCc1ccc(F)cc1)c1c(O)c(=O)[nH]c2c(F)cccc12,N-(4-Fluorobenzyl)-8-fluoro-3-hydroxy-2-oxoquinoline-4-carboxamide,75.0,uM,=,1.8750612633917,1,O=C(NCc1ccccc1)c1cc(=O)[nH]c2ccccc12
879,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(N(C)Cc2nc3c(C)ccc(C)c3o2)c(O)nc1C,"3-[(4,7-Dimethyl-benzooxazol-2-ylmethyl)-methyl-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.103,uM,=,-0.9871627752948278,0,c1cncc(NCc2nc3ccccc3o2)c1
880,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(C)c2c(c1)Oc1ncc(N)cc1C(=O)N2C,"2-Amino-7,9,10-trimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.046,uM,=,-1.337242168318426,0,O=C1Nc2ccccc2Oc2ncccc21
881,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(OCc2ccc3occc3c2)n1,"4-(benzofuran-5-ylmethoxy)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",23.6,uM,=,1.3729120029701067,1,c1ccc(-c2ccccc2Nc2ncnc(OCc3ccc4occc4c3)n2)cc1
882,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2cnccn2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-pyrazin-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.27,uM,=,-0.5686362358410126,0,O=C1Nc2ccccc2C(C#Cc2cnccn2)(C2CC2)N1
883,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(=O)COC(=O)c1ccc([N+](=O)[O-])s1,2-oxopropyl 5-nitrothiophene-2-carboxylate,9.5,uM,=,0.9777236052888478,1,c1ccsc1
884,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccc(C)c(C23SCCN2C(=O)c2ccccc23)c1,"9b-(2,5-Dimethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.97,uM,=,-0.0132282657337551,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
885,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",1.6,uM,=,0.2041199826559248,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
886,2026094,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 48 hrs by pico-green reagent based fluorescence analysis,Cn1c(=O)ccn(CCOc2cc(OS(=O)(=O)F)ccc2Oc2cccn3cc(C#N)cc23)c1=O,"4-((2-Cyanoindolizin-8-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",1.115,uM,=,0.0472748673841794,1,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
887,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=C([O-])CCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+].[Na+].[Na+],"9-(8-Hydroxy-3,6-disulfo-naphthalen-1-ylcarbamoyl)-nonanoic acid; trisodium salt",135.0,uM,=,2.130333768495006,1,c1ccc2ccccc2c1
888,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)c1cc(C(=CCCCCBr)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 5-[6-bromo-1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-1-hexenyl]-3-chloro-2-methoxybenzoate,1.9,uM,=,0.2787536009528289,1,C=C(c1ccccc1)c1ccccc1
889,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCN1CCCC1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyrrolidin-1-yl-ethyl)-thiourea,4.9,uM,=,0.6901960800285137,1,S=C(NCCN1CCCC1)Nc1ccccn1
890,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2cc3ccccc3o2)c(O)nc1C,3-(2-Benzofuran-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.13,uM,=,-0.8860566476931633,0,c1cncc(CCc2cc3ccccc3o2)c1
891,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1,"8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid (suramin)",15.0,uM,=,1.1760912590556811,1,O=C(Nc1cccc(C(=O)Nc2cccc(C(=O)Nc3cccc4ccccc34)c2)c1)Nc1cccc(C(=O)Nc2cccc(C(=O)Nc3cccc4ccccc34)c2)c1
892,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CC(C)CSC1=N/C(=C/c2ccccc2)C(C)(C)C(=O)N1,"2-Isobutylsulfanyl-5,5-dimethyl-6-[1-phenyl-meth-(E)-ylidene]-5,6-dihydro-3H-pyrimidin-4-one",4.6,uM,=,0.6627578316815741,1,O=C1C/C(=C\c2ccccc2)N=CN1
893,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,COCc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Methoxymethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.14,uM,=,-0.8538719643217619,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
894,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(Cc1cccc(C(=O)Nc2ccc(Br)cc2C(=O)O)c1)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-{[(3-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}phenyl)acetyl]amino}benzoic acid,21.0,uM,=,1.3222192947339193,1,O=C(Cc1cccc(C(=O)Nc2ccccc2)c1)Nc1ccccc1
895,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCOC(=O)NCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,"4-(N-Ethoxycarbonyl)amino-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",1.93,uM,=,0.2855573090077737,1,C=C(c1ccccc1)c1ccccc1
896,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),NS(=O)(=O)c1ccc(NC(=O)CCN2C(=O)/C(=C/c3ccc(F)cc3)SC2=S)cc1,3-{5-[1-(4-Fluoro-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-N-(4-sulfamoyl-phenyl)-propionamide,88.0,uM,=,1.944482672150169,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
897,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCCCSc1nc(O)c(C)c(Cc2c(Cl)cccc2Cl)n1,"2-Butylsulfanyl-6-(2,6-dichloro-benzyl)-5-methyl-3H-pyrimidin-4-one",1.15,uM,=,0.0606978403536116,1,c1ccc(Cc2ccncn2)cc1
898,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-n2nnnc2SCC(=O)Nc2ccccc2Cl)c(Cl)c1,2-(1-(2-chloro-4-methylphenyl)-1H-tetrazol-5-ylthio)-N-(2-chlorophenyl)acetamide,0.0088,uM,=,-2.055517327849832,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
899,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CCOC1(c2ccccc2)c2cc(Cl)ccc2NC(=O)N1C,"6-chloro-4-ethoxy-3-methyl-4-phenyl-3,4-dihydroquinazolin-2(1H)-one",0.056,uM,=,-1.2518119729937995,0,O=C1Nc2ccccc2C(c2ccccc2)N1
900,817161,10.1016/j.bmc.2012.02.037,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by colorimetry,CC1=N/C(=C/c2ccc(Cl)cc2)C(=O)N1Cc1ccncc1,4-(4-Chlorobenzylidene)-2-methyl-1-(pyridin-4-ylmethyl)-1H-imidazol-5(4H)-one,3.9,uM,=,0.5910646070264992,1,O=C1/C(=C\c2ccccc2)N=CN1Cc1ccncc1
901,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccccc1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",3.8,uM,=,0.5797835966168101,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
902,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(OCc4ccccc4)cc3[nH]2)CC1,(6-Benzyloxy-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,37.0,uM,=,1.568201724066995,1,O=C(c1cc2ccc(OCc3ccccc3)cc2[nH]1)N1CCN(c2ccccn2)CC1
903,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2cc(C)c(C)nc21,"5-Ethyl-7,8,10-trimethyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.24,uM,=,-0.619788758288394,0,O=C1Nc2cccnc2Nc2ncccc21
904,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)c3ccccc3F)[nH]c3ccc(Cl)cc23)c1,"(S)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(2-fluorophenyl)ethyl)-1H-indole-2-carboxamide",0.175,uM,=,-0.7569619513137056,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
905,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(-n2cccc2)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-3-pyrrol-1-yl-1H-pyridin-2-one",0.0126,uM,=,-1.899629454882437,0,O=c1[nH]ccc(Cc2ccccc2)c1-n1cccc1
906,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2ccc(Cl)cc2n1Cc1c(F)cccc1F,"6-Chloro-1-(2,6-difluoro-benzyl)-1,3-dihydro-benzoimidazol-2-one",0.7,uM,=,-0.1549019599857432,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
907,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2cccc(F)c2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(3-fluorophenyl)acetamide",0.22,uM,=,-0.6575773191777937,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
908,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(2-hydroxy-ethyl)-5-methyl-1H-pyrimidine-2,4-dione",3.1,uM,=,0.4913616938342727,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
909,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(N=[N+]=[N-])ccc2N(C)C(=O)c2cccnc21,"9-Azido-11-ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2ccccc2Nc2ncccc21
910,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(Cl)c3)CC2)ncc1Br,"4-(5-bromo-2-(1-(3-chlorobenzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.241,uM,=,-0.6179829574251317,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
911,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CN(c1ncccc1NC1(C)CC1)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-[2-(4-{Methyl-[3-(1-methyl-cyclopropylamino)-pyridin-2-yl]-amino}-piperidine-1-carbonyl)-1H-indol-5-yl]-methanesulfonamide,0.16,uM,=,-0.7958800173440752,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ncccc2NC2CC2)CC1
912,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(O)cc1C(=O)O)Nc1ccc(O)cc1C(=O)O,2-({6-[(2-carboxy-4-hydroxyphenyl)amino]-6-oxohexanoyl}amino)-5-hydroxybenzoic acid,6.7,uM,=,0.8260748027008264,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
913,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1[nH]c(SCCc2ccccc2)nc(Cc2ccccc2)c1I,6-Benzyl-5-iodo-2-(phenethylthio)pyrimidin-4(3H)-one,2.4,uM,=,0.380211241711606,1,O=c1cc(Cc2ccccc2)nc(SCCc2ccccc2)[nH]1
914,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCOCn1c(Cc2ccc(-c3cc(OC)cc(OC)c3)cc2)c(C)c(=O)n(O)c1=O,"6-((3',5'-dimethoxy-[1,10-biphenyl]-4-yl)methyl)-1-(ethoxymethyl)-3-hydroxy-5-methylpyrimidine-2,4(1H,3H)-dione",6.7,uM,=,0.8260748027008264,1,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
915,471469,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 by heteropolymeric DNA polymerase assay,C[C@@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,tenofovir diphosphate,1.2,uM,=,0.0791812460476248,1,c1ncc2nc[nH]c2n1
916,195504,10.1021/jm001095i,,,,Inhibitory activity against wild-type HIV-1 reverse transcriptase,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",6.1096588099909255,uM,=,0.7860169580206937,1,O=c1ccn([C@H]2CC3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
917,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2c(C)ccc3nc(S)n(c23)C[C@@H]1C,"5,8-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",13.6,uM,=,1.1335389083702174,1,c1cc2c3c(c1)ncn3CCNC2
918,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCN)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-amino-propyl)-5-methyl-1H-pyrimidine-2,4-dione",7.2,uM,=,0.8573324964312685,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
919,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccc(F)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(4-fluoro-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
920,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2ccccc2Oc2nc(Cl)ccc21,"3-Chloro-11-propyl-11H-5-oxa-4,11-diaza-dibenzo[a,d]cyclohepten-10-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2cccnc2Oc2ccccc21
921,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C(CCC)C1,"7-(2-Methyl-allyl)-9-propyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",48.1,uM,=,1.6821450763738317,1,O=c1[nH]c2cccc3c2n1CCNC3
922,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CC(C)c1cccc(C23SCCN2C(=O)c2ccccc23)c1,"9b-(3-Isopropyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",2.1,uM,=,0.3222192947339193,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
923,2294755,10.1016/j.bmcl.2023.129216,,,,Inhibition of recombinant wildtype HIV-1 reverse transcriptase using r(A)350 as template and d(T)16 as primer preincubated with compound for 1 hrs followed by template/primer addition and measured after 30 mins by picogreen based plate reader analysis,N#Cc1ccc(Nc2ncc(Cc3c(F)cc(-c4ccccc4)cc3F)o2)cc1,"4-((5-((3,5-difluoro-[1,1'-biphenyl]-4-yl)methyl)oxazol-2-yl)amino)benzonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2ncc(Cc3ccc(-c4ccccc4)cc3)o2)cc1
924,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccc(O)cc3)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(4-hydroxyphenyl)acetamide",0.102,uM,=,-0.9913998282380824,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
925,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CCc3ccncc3)[nH]c(=O)c2Cl)c1,"3-chloro-5-(3-chloro-2-oxo-6-(2-(pyridin-4-yl)ethyl)-1,2-dihydropyridin-4-yloxy)benzonitrile",0.019,uM,=,-1.7212463990471711,0,O=c1cc(Oc2ccccc2)cc(CCc2ccncc2)[nH]1
926,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,Cc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"5-Cyclopropyl-9-p-tolyloxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.58,uM,=,-0.2365720064370627,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
927,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Oc1nc(NCc2ccc3occc3c2)nc(Nc2c(F)cccc2-c2ccccc2)n1,"4-(benzofuran-5-ylmethylamino)-6-(3-fluorobiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.09,uM,=,-1.0457574905606752,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
928,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.55,uM,=,0.4065401804339551,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
929,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCC(c1ccccc1)n1c(=O)[nH]c2ccc(Cl)cc21,"(+/-)-6-chloro-1-(1-phenylpropyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one",0.036,uM,=,-1.4436974992327127,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
930,1982619,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant HIV-1 reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 5'-[gamma32P]ATP-labeled-tC5U RNA oligonucleotide/p12 DNA oligonucleotide hybrid as substrate incubated for 30 mins,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cccn1Cc1ccccc1Cl,"ethyl (2Z,5E)-6-[1-[(2-chlorophenyl)methyl]pyrrol-2-yl]-2-hydroxy-4-oxo-hexa-2,5-dienoate",7.3,uM,=,0.8633228601204559,1,c1ccc(Cn2cccc2)cc1
931,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COC(=O)c1cc(/C(=C/CCN2CCOC2=O)c2cc(C)c3onc(OC)c3c2)cc(C)c1OC,(E)-2-Methoxy-5-[1-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(2-ox-oxazolidin-3-yl)-but-1-enyl]-3-methylbenzoic acid methyl ester,18.2,uM,=,1.260071387985075,1,O=C1OCCN1CC/C=C(/c1ccccc1)c1ccc2oncc2c1
932,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3ccc(CO)cc3[nH]2)CC1,(6-Hydroxymethyl-1H-indol-2-yl)-{4-[(3-isopropylamino-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-methanone,0.17,uM,=,-0.7695510786217261,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
933,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1ccc(-c2ccc(Cl)c(F)c2)cc1)c1cc(=O)n(O)c(=O)[nH]1,"6-(4'-Chloro-3'-fluoro-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.023,uM,=,-1.6382721639824072,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
934,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccccc2)[nH]c(=O)n1O,"3-Hydroxy-6-(phenylthio)pyrimidine-2,4(1H,3H)-dione",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
935,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(Oc3ccc(C(=O)c4ccc(O)cc4)cc3)n2)cc1,4-{4-[4-(4-Hydroxybenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,7.13,uM,=,0.8530895298518656,1,O=C(c1ccccc1)c1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1
936,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cccc(Oc2cc(Cl)cc(OCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)c2)c1,2-[3-chloro-5-(3-cyano-phenoxy)-phenoxy]-N-(2-chloro-4-sulfamoyl-phenyl)-acetamide,0.0009599999999999,uM,=,-3.017728766960432,0,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ccccc1
937,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.26,uM,=,-0.585026652029182,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
938,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCN(c1ncccc1COC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-methoxymethyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.3,uM,=,-0.5228787452803376,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
939,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1O,"6-(4-Cyclopropylbenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.6,uM,=,-0.2218487496163563,0,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1
940,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CCCC1OC(C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-cyclopropylethynyl-3-propyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.799,uM,=,-0.0974532206860085,0,O=C1COC(C#CC2CC2)c2ccccc2N1
941,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)Cc2cc(=O)oc3cc(O)ccc23)cc1,"2-(7-Hydroxy-2-oxo-2H-chromen-4-yl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acetamide",0.4586,uM,=,-0.3385659496060799,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
942,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(CNc2cc(CC)c(C)nc2O)c(O)nc1C,"5-ethyl-3-(5-ethyl-6-methyl-2-oxo-1,2-dihydro-3-pyridinylaminomethyl)-6-methyl-1,2-dihydro-2-pyridinone",0.091,uM,=,-1.0409586076789064,0,c1cncc(CNc2cccnc2)c1
943,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccc([N+](=O)[O-])cc2)n1,2-sec-Butylsulfanyl-5-methyl-6-(4-nitro-benzyl)-3H-pyrimidin-4-one,1.8,uM,=,0.255272505103306,1,c1ccc(Cc2ccncn2)cc1
944,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(O)c2)cc1,"(E)-3-(3, 4-dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0407999999999999,uM,=,-1.3893398369101202,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
945,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,CSc1nc2ncnc(NCC(P(=O)(O)O)P(=O)(O)O)c2cc1-c1ccc(OC(C)C)cc1,"(2-((6-(4-Isopropoxyphenyl)-7-(methylthio)pyrido[2,3-d]-pyrimidin-4-yl)amino)ethane-1,1-diyl)diphosphonic Acid",7.1,uM,=,0.8512583487190752,1,c1ccc(-c2cnc3ncncc3c2)cc1
946,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CS(N)(=O)=O)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-(1-sulfamoylpropan-2-yl)-1H-indole-2-carboxamide",0.028,uM,=,-1.5528419686577808,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
947,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2F)nc2c1CSCC2,"(E)-4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)-3-fluorobenzonitrile",0.051,uM,=,-1.2924298239020635,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CSCC3)cc1
948,2201744,10.1016/j.ejmech.2022.114217,,,,Inhibition of HIV-1 reverse transcriptase preincubated for 45 mins followed by substrate addition by immunoassay,O=C1CSC(c2ccc(O)cc2)N1c1nc2ccc(Cl)cc2s1,3-(6-Chloro-benzo[d]thiazol-2-yl)-2-(4-hydroxyphenyl)thiazolidin-4-one,0.3,uM,=,-0.5228787452803376,0,O=C1CSC(c2ccccc2)N1c1nc2ccccc2s1
949,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1cccc(Sc2cccc(N)c2C#N)c1,2-Amino-6-(3-cyano-phenylsulfanyl)-benzonitrile,1.1,uM,=,0.041392685158225,1,c1ccc(Sc2ccccc2)cc1
950,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccc4ccccc34)SCCN12,"9b-Naphthalen-1-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.13,uM,=,-0.8860566476931633,0,O=C1c2ccccc2C2(c3cccc4ccccc34)SCCN12
951,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccc(C(F)(F)F)c2)nc(SC(C)C)[nH]c1=O,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(3-(trifluoromethyl)phenyl)acetonitrile",2.705,uM,=,0.4321672694425882,1,O=c1cc(Cc2ccccc2)nc[nH]1
952,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=C(Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12)c1ccccc1.[Na+].[Na+],"4-Benzoylamino-5-hydroxy-naphthalene-2,7-disulfonic acid; disodium salt",464.0,uM,=,2.666517980554881,1,O=C(Nc1cccc2ccccc12)c1ccccc1
953,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(N(CC)Cc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-ethyl-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.654,uM,=,-0.1844222516757327,0,c1cncc(NCc2nc3ccccc3o2)c1
954,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccnc2)nc(SC(C)C)[nH]c1=O,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(pyridin-3-yl)acetonitrile",317.725,uM,=,2.5020513883710063,1,O=c1cc(Cc2cccnc2)nc[nH]1
955,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CCCN1Cc2cccc3[nH]c(=O)n(c23)CC1C,"8-Methyl-7-propyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",59.7,uM,=,1.7759743311293692,1,O=c1[nH]c2cccc3c2n1CCNC3
956,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(C(C)=O)cc2c1=O,"Ethyl 6-Acetyl-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",11.0,uM,=,1.0413926851582251,1,O=c1ccn(Cc2ccccc2)c2ccccc12
957,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(Br)cc2)[nH]c(=O)n1O,"6-((4-Bromophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.01,uM,=,-2.0,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
958,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,Cc1c(C(=O)O)sc2[nH]c(=O)n(O)c(=O)c12,"3-Hydroxy-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylic acid",0.1,uM,=,-1.0,0,O=c1[nH]c(=O)c2ccsc2[nH]1
959,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(C[S+]([O-])c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzenesulfinylmethyl-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(C[SH+]c3ccccc3)cc21
960,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(CCc2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.02,uM,=,-1.6989700043360187,0,c1cncc(CCc2nc3ccccc3o2)c1
961,196795,10.1021/jm00058a009,,,,In vitro for inhibitory activity against HIV-1 Reverse Transcriptase,O=C1c2ccccc2C2(c3cccc4ccccc34)SCCN12,"9b-Naphthalen-1-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.15,uM,=,-0.8239087409443188,0,O=C1c2ccccc2C2(c3cccc4ccccc34)SCCN12
962,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3cccc(Cl)c3o2)c(O)nc1C,3-[(7-Chloro-benzofuran-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.335,uM,=,-0.4749551929631547,0,c1cncc(NCc2cc3ccccc3o2)c1
963,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(=O)Oc1ccc(CN(C(=O)COC(=O)c2ccc([N+](=O)[O-])o2)C(C)(C)C)cc1,2-((4-acetoxybenzyl)(tert-butyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,8.7,uM,=,0.9395192526186184,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
964,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCc1cnc2n1-c1cccnc1N(CC)c1ncccc1-2,"3,8-Diethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",5.63,uM,=,0.7505083948513462,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
965,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cnc(Nc2ccc(C#N)cc2)nc1OCC(=O)Nc1ccc(F)cc1,2-((2-((4-Cyanophenyl)amino)-5-methylpyrimidin-4-yl)oxy)-N-(4-fluorophenyl)acetamide,18.92,uM,=,1.276921132065774,1,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
966,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",1.0,uM,=,0.0,0,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
967,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,CCS(=O)(=O)N1CCN(Cc2ccc(Nc3nccc(Oc4c(C)cc(/C=C/C#N)cc4C)n3)cc2)CC1,"(E)-3-(4-((2-((4-((4-(ethylsulfonyl)piperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile",0.052,uM,=,-1.2839966563652008,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
968,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1cccc(F)c1)CC(=O)C(=O)O,"6-[1-(3-Fluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",14.0,uM,=,1.146128035678238,1,c1ccc(Cn2cccc2)cc1
969,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3c(F)cc(-c4ccc(F)c(C#N)c4)cc3F)c2=O)n[nH]c1=O,"3',4,5'-trifluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",1.65,uM,=,0.2174839442139062,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
970,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(C(=O)c2cc(Cl)ccc2Oc2ccnc(Nc3ccc(C#N)cc3)n2)c1,"4-{4-[4-Chloro-2-(3,5-dimethylbenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile",3.22,uM,=,0.5078558716958309,1,O=C(c1ccccc1)c1ccccc1Oc1ccnc(Nc2ccccc2)n1
971,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCOCn1c(Cc2ccc(-c3ccc(C#N)cc3)cc2)c(C)c(=O)n(O)c1=O,"4'-((3-(ethoxymethyl)-1-hydroxy-5-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)-[1,1'-biphenyl]-4-carbonitrile",5.2,uM,=,0.7160033436347992,1,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
972,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc(C(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"3-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzamide",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
973,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",1.7,uM,=,0.2304489213782739,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
974,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1,5-Ethyl-3-[(2-methoxy-ethyl)-methyl-amino]-6-methyl-4-(3-methyl-benzyl)-1H-pyridin-2-one,0.001,uM,=,-3.0,0,O=c1cc(Cc2ccccc2)cc[nH]1
975,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCCSC)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-3-[methyl-(3-methylsulfanyl-propyl)-amino]-1H-pyridin-2-one",0.025,uM,=,-1.6020599913279625,0,O=c1cc(Cc2ccccc2)cc[nH]1
976,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCOc1ccc(Cl)c(C2CC2NC(=O)Nc2cc(Cl)cnn2)c1F,1-[2-(6-Chloro-3-ethoxy-2-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridazin-3-yl)-urea,0.0052,uM,=,-2.283996656365201,0,O=C(Nc1cccnn1)NC1CC1c1ccccc1
977,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,Fc1cccc(F)c1Cn1c(-c2c(F)cccc2F)nc2c(Cl)cccc21,"4-Chloro-1-(2,6-difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazole",2.63,uM,=,0.4199557484897578,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
978,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2ccccc2C(=O)N1O,"2-Hydroxy-4H-isoquinoline-1,3-dione",0.6,uM,=,-0.2218487496163563,0,O=C1Cc2ccccc2C(=O)N1
979,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,Cc1csc2[nH]c(=O)n(O)c(=O)c12,"3-Hydroxy-5-methyl-4a,7a-dihydro-1H-thieno[2,3-d]pyrimidine-2,4-dione",0.1,uM,=,-1.0,0,O=c1[nH]c(=O)c2ccsc2[nH]1
980,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2nc3c(cc2OC)CCC3)c(O)nc1C,"5-Ethyl-3-[(3-methoxy-6,7-dihydro-5H-[1]pyrindin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",0.04,uM,=,-1.3979400086720375,0,c1cncc(NCc2ccc3c(n2)CCC3)c1
981,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CCC1(c2ccccc2)Sc2ccccc2-n2cccc2C1=O,5-Ethyl-5-phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,0.47,uM,=,-0.3279021420642826,0,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
982,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccccc1-c1nc2cccc(Cl)n2c1NC1CCCC1,"DG 402-49760::US8501787, 48",5.14,uM,=,0.7109631189952758,1,c1ccc(-c2nc3ccccn3c2NC2CCCC2)cc1
983,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,N#Cc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carbonitrile",0.5,uM,=,-0.3010299956639812,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
984,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),COc1cc(/C=C2/SC(=S)N(CCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc(OC)c1OC,"4-(3-{4-Oxo-2-thioxo-5-[1-(3,4,5-trimethoxy-phenyl)-meth-(Z)-ylidene]-thiazolidin-3-yl}-propionylamino)-benzoic acid",85.0,uM,=,1.9294189257142929,1,O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
985,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(C#N)cc(-c4ccc(C#N)cc4)c3)c2=O)n[nH]c1=O,"5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3,4'-dicarbonitrile",0.52,uM,=,-0.2839966563652008,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
986,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2cccc(-c3cncnc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((3-(pyrimidin-5-yl)phenyl)amino)-pyrimidine-2,4(1H,3H)-dione",1.4,uM,=,0.1461280356782379,1,O=c1cc(Nc2cccc(-c3cncnc3)c2)[nH]c(=O)[nH]1
987,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCOC(=O)c2ccccc2)n2nc(Cl)ccc12,"Benzoic acid 5-(2-chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-pentyl ester",1.34,uM,=,0.1271047983648076,1,O=C(OCCCCCc1ncc2cccnn12)c1ccccc1
988,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,C[C@@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O,"5-Cyclopropylethynyl-7-fluoro-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.095,uM,=,-1.0222763947111522,0,O=C1COC(C#CC2CC2)c2ccccc2N1
989,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CNc1ccc2c(c1)C(C#CC(C)C)(C(F)(F)F)OC(=O)N2,"6-Methylamino-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.473,uM,=,-0.3251388592621884,0,O=C1Nc2ccccc2CO1
990,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccccc1,"N-Benzyl-1-(hydroxy)-1,2,3,6-tetrahydro-4-(methylamino)-2,6-dioxopyrimidine-5-carboxamide",0.061,uM,=,-1.214670164989233,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
991,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,C=CCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(O)=S)[C@H]2OC)c1=O,"O-[5-(1-allyl-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxy-2-(methoxymethyl)tetrahydrofuran-3-yl] methylphosphonothioate",0.039,uM,=,-1.408935392973501,0,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
992,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,Cc1ccc(CC2C(=O)N(O)C(=O)c3ccccc32)cc1,"2-Hydroxy-4-(4-methylbenzyl)isoquinoline-1,3(2H,4H)-dione",80.0,uM,=,1.9030899869919435,1,O=C1NC(=O)C(Cc2ccccc2)c2ccccc21
993,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc4c(c3)OCO4)cc2c1=O,"6-(Benzo[d][1,3]dioxol-5-ylmethoxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",13.5,uM,=,1.130333768495006,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc4c(c3)OCO4)cc12
994,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccco3)SCCN12,"9b-Furan-2-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",1.35,uM,=,0.1303337684950061,1,O=C1c2ccccc2C2(c3ccco3)SCCN12
995,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,COC(=O)/C=C/Cn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"4-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-but-2-enoic acid methyl ester",30.0,uM,=,1.4771212547196624,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
996,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CC(=O)c1ccc2c(c1)c(=O)c(C(=O)O)cn2Cc1ccc(F)cc1,"6-Acetyl-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",16.3,uM,=,1.212187604403958,1,O=c1ccn(Cc2ccccc2)c2ccccc12
997,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3Cl)nc3ccc(Cl)cc32)c1,"2-({6-Chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl}sulfanyl)-N-2-chlorophenylacetamide",18.64,uM,=,1.2704459080179626,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
998,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.64,uM,=,-0.1938200260161128,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
999,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)c1scnc1-c1ccc(Cl)c(Br)c1,4-(3-bromo-4-chlorophenyl)thiazole-5-carboxamide,87.5,uM,=,1.9420080530223127,1,c1ccc(-c2cscn2)cc1
1000,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,NS(=O)(=O)c1ccc(NC(=O)COc2cccc(Oc3ccccc3)c2)c(Cl)c1,N-(2-chloro-4-sulfamoyl-phenyl)-2-(3-phenoxy-phenoxy)-acetamide,0.0517,uM,=,-1.2865094569060576,0,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ccccc1
1001,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cn1cc(-c2cnc3oc4c(-c5ccn(C)n5)nc(=O)n(CCC5CCCO5)c4c3c2)cn1,"8-(1-Methyl-1H-pyrazol-4-yl)-4-(1-methyl-1H-pyrazol-3-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.13,uM,=,-0.8860566476931633,0,O=c1nc(-c2cc[nH]n2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1002,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3nccn3)ccc12,"7-(5-Methyl-2-[1,2,3]triazol-2-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",1.3,uM,=,0.1139433523068367,1,O=C(CCCCCCc1ncc2ccc(-n3nccn3)nn12)c1ccccc1
1003,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCC1C(=O)N(O)C(=O)c2ccccc21,"2-Hydroxy-4-ethylisoquinoline-1,3(2H,4H)-dione",70.0,uM,=,1.845098040014257,1,O=C1Cc2ccccc2C(=O)N1
1004,543620,10.1016/j.ejmech.2008.02.039,,,,Inhibition of HIV1 3B reverse transcriptase after 30 mins,O=C1CSC(c2c(Cl)cccc2Cl)N1CCC12CC3CC(CC(C3)C1)C2,"3-(2-Adamantan-1-ylethyl)-2-(2,6-dichlorophenyl)-thiazolidin-4-one",226.0,uM,=,2.3541084391474008,1,O=C1CSC(c2ccccc2)N1CCC12CC3CC(CC(C3)C1)C2
1005,1899209,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase polymerase using deoxynucleotide triphosphates and 18 nucleotide DNA primer annealed to 100 nucleotide DNA template after 30 mins,Cc1cc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,"6-(4'-Fluoro-3'-methyl-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",8.3,uM,=,0.919078092376074,1,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
1006,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3ccccc3[nH]2)c(O)nc1C,5-Ethyl-3-[(1H-indol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,4.4,uM,=,0.6434526764861874,1,c1cncc(NCc2cc3ccccc3[nH]2)c1
1007,305627,10.1021/jm049252r,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase (IIIB),O=C(O)c1ccccc1C(=O)NCCO/C(S)=N\c1ccc(I)cc1,N-[2-(4-Iodo-phenylthiocarbamoyloxy)-ethyl]-phthalamic acid,1.7,uM,=,0.2304489213782739,1,O=C(NCCO/C=N\c1ccccc1)c1ccccc1
1008,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(/C=C\c2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-vinyl)-5-ethyl-6-methyl-1H-pyridin-2-one,3.0,uM,=,0.4771212547196624,1,C(=C\c1nc2ccccc2o1)\c1cccnc1
1009,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.25,uM,=,-0.6020599913279624,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1010,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.25,uM,=,-0.6020599913279624,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1011,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,CC(C)OC(=O)c1cccn1S(=O)(=O)c1cc(Cl)ccc1N,1-(2-Amino-5-chloro-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid isopropyl ester,0.27,uM,=,-0.5686362358410126,0,O=S(=O)(c1ccccc1)n1cccc1
1012,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2cccnc2)cc1F,"4-((4-((2,6-Difluoro-4-(pyridin-3-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.197,uM,=,-0.7055337738384071,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccnc4)cc3)n2)cc1
1013,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ncccc2OC)c(O)nc1C,5-Ethyl-3-[(3-methoxy-pyridin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,1.55,uM,=,0.1903316981702915,1,c1ccc(CNc2cccnc2)nc1
1014,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccc(F)cc3F)n2)cc1,"4-(4-(2,4-difluorobenzylamino)pyrimidin-2-ylamino)benzonitrile",0.056,uM,=,-1.2518119729937995,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
1015,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,COc1ccc(OCCOCCOCC#Cc2cn([C@H]3C=C[C@@H](CO)O3)c(=O)[nH]c2=O)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"5-{9-[2-(2-(5-Bromo-2-pyridinylaminothiocarbonylamino)-ethyl)-4-methoxyphenoxy]nona-4,7-dioxa-1-ynyl}-2',3'-didehydro-2',3'-dideoxyuridine",0.85,uM,=,-0.0705810742857072,0,O=c1[nH]c(=O)n([C@H]2C=CCO2)cc1C#CCOCCOCCOc1ccccc1CCNC(=S)Nc1ccccn1
1016,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4cc(C#N)c(-c5cnn(C)c5)nc4c32)CCO1,"Cis-4-(2-Ethyl-tetrahydro-pyran-4-yl)-1,6-bis-(1-methyl-1H-pyrazol-4-yl)-3-oxo-3,4-dihydro-9-oxa-2,4,5-triaza-fluorene-7-carbonitrile",0.0060999999999999,uM,=,-2.214670164989233,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4cn[nH]c4)nc3c2n1C1CCOCC1
1017,196377,10.1021/jm0309856,,,,Inhibitory concentration required to inhibit the HIV-1 reverse transcriptase activity,CC(c1cc(=O)[nH]c(NC2CCCC2)n1)c1c(F)cccc1F,"2-Cyclopentylamino-6-[1-(2,6-difluoro-phenyl)-ethyl]-3H-pyrimidin-4-one",0.04,uM,=,-1.3979400086720375,0,O=c1cc(Cc2ccccc2)nc(NC2CCCC2)[nH]1
1018,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,O=C(CSc1nnnn1-c1ccc(Cl)c(Cl)c1)Nc1ccccc1[N+](=O)[O-],"2-(1-(3,4-dichlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide",0.23,uM,=,-0.6382721639824072,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1019,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1cccc(Cl)c1)CC(=O)C(=O)O,"6-[1-(3-Chlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",9.0,uM,=,0.9542425094393248,1,c1ccc(Cn2cccc2)cc1
1020,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2sc(Cc3ccccc3)cc2c(=O)n1O,"6-Benzyl-3-hydroxythieno[2,3-d]pyrimidine-2,4(1H,3H)-dione",0.043,uM,=,-1.3665315444204136,0,O=c1[nH]c(=O)c2cc(Cc3ccccc3)sc2[nH]1
1021,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccc(O)c3)nc21,"5-Ethyl-7-(3-hydroxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.18,uM,=,-0.744727494896694,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
1022,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,O=C(NCCc1ccc(O)c(O)c1)C1C(=O)N(O)C(=O)c2ccccc21,"N-[2-(3,4-Dihydroxyphenyl)ethyl]-2-hydroxy-1,3-dioxoisoquinoline-4-carboxamide",0.13,uM,=,-0.8860566476931633,0,O=C1NC(=O)C(C(=O)NCCc2ccccc2)c2ccccc21
1023,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),C[C@@H]1CN2C(=O)c3ccccc3C2(c2ccccc2)O1,"2-Methyl-9b-phenyl-2,3-dihydro-9bH-oxazolo[2,3-a]isoindol-5-one",37.6,uM,=,1.575187844927661,1,O=C1c2ccccc2C2(c3ccccc3)OCCN12
1024,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2ncc(N)cc2C(=O)N(C)c2cccnc21,"2-Amino-5-ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncccc21
1025,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1cccc(N2C(=O)CSC2c2c(C)cccc2F)n1,2-(2-Fluoro-6-methyl-phenyl)-3-(6-methyl-pyridin-2-yl)-thiazolidin-4-one,2.85,uM,=,0.4548448600085102,1,O=C1CSC(c2ccccc2)N1c1ccccn1
1026,817161,10.1016/j.bmc.2012.02.037,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by colorimetry,CC1=N/C(=C/c2ccco2)C(=O)N1Cc1ccncc1,4-(Furan-2-ylmethylene)-2-methyl-1-(pyridin-4-ylmethyl)-1H-imidazol-5(4H)-one,2.5,uM,=,0.3979400086720376,1,O=C1/C(=C\c2ccco2)N=CN1Cc1ccncc1
1027,638659,10.1016/j.bmc.2010.05.004,,,,Inhibition of HIV 3B reverse transcriptase using [3H]TTP as a tracer by scintillation counting,Cc1cc(C)cc(Cc2c(C(C)C)c(=O)[nH]c(=O)n2COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c1,"((Z)-4-(3-(4-(((6-(3,5-Dimethylbenzyl)-5-isopropyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)benzyl)-phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.1,uM,=,-1.0,0,O=c1cc(Cc2ccccc2)n(COCc2ccc(Cc3ccccc3)cc2)c(=O)[nH]1
1028,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(S(C)(=O)=O)c3)CC2)ncc1Br,"4-(5-bromo-2-(1-(3-(methylsulfonyl)phenyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.042,uM,=,-1.3767507096020994,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1029,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3)ccc2C(=O)N1O,"6-(4-Fluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.5,uM,=,-0.3010299956639812,0,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
1030,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc4ccccc34)cc2c1=O,"Ethyl 1-(4-Fluorobenzyl)-6-(naphthalen-1-ylmethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylate",1.49,uM,=,0.173186268412274,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3cccc4ccccc34)cc12
1031,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccc(F)cc2)n1,2-sec-Butylsulfanyl-6-(4-fluoro-benzyl)-5-methyl-3H-pyrimidin-4-one,13.0,uM,=,1.1139433523068367,1,c1ccc(Cc2ccncn2)cc1
1032,532312,10.1021/jm701218j,,,,Inhibition of HIV1 reverse transcriptase in human LAI cells,CCc1c(C)[nH]c(=O)c(NC(N)=S)c1Cc1cccc(C)c1,"[5-Ethyl-6-methyl-4-(3-methyl-benzyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-thiourea",0.316,uM,=,-0.5003129173815962,0,O=c1cc(Cc2ccccc2)cc[nH]1
1033,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1ccccc1Sc1cccc(N)c1C#N,2-Amino-6-(2-methoxy-phenylsulfanyl)-benzonitrile,2.7,uM,=,0.4313637641589873,1,c1ccc(Sc2ccccc2)cc1
1034,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(S(C)(=O)=O)cc2Cl)c(Cl)c1,2-(1-(4-tert-butyl-2-chlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-chloro-4-(methylsulfonyl)phenyl)acetamide,0.0031,uM,=,-2.508638306165728,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1035,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cccnc2Oc2cc(C)cc(C)c21,"10-Ethyl-7,9-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.029,uM,=,-1.537602002101044,0,O=C1Nc2ccccc2Oc2ncccc21
1036,195358,10.1021/jm00012a014,,,,Inhibitory activity against HIV-1 Reverse transcriptase,CCOCn1c2c(c(=O)[nH]c1=O)CNc1ccccc1S2,"4-Ethoxymethyl-10,11-dihydro-4H-5-thia-2,4,10-triaza-dibenzo[a,d]cycloheptene-1,3-dione",50.2,uM,=,1.7007037171450194,1,O=c1[nH]c2c(c(=O)[nH]1)CNc1ccccc1S2
1037,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cccc(C23SCCN2C(=O)c2ccccc23)c1,"9b-m-Tolyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.035,uM,=,-1.4559319556497243,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1038,1763334,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 3B reverse transcriptase using polyC/oligo(dG12) as template/primer in presence of [3H]dGTP and calf thymus DNA after 30 mins,COC(=O)P(=O)([O-])OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O.[Na+],"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-[[[(methoxycarbonyl)hydroxyphosphonyl]oxy]-propyl]thymine]-3''-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide); Sodium ion",3.7,uM,=,0.568201724066995,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1039,1567015,10.1021/acs.jmedchem.5b01979,,,,Inhibition of recombinant HIV1 His-tagged p66/p51 reverse transcriptase expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)-oligo(dT) (12 to 18 bp) as template/primer incubated for 20 mins by scintillation counting method,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.125,uM,=,-0.9030899869919436,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1040,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,N#Cc1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"S-2-(2-chloro-4-cyanophenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.007,uM,=,-2.154901959985743,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
1041,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc([N+](=O)[O-])c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(3-nitro-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.17,uM,=,-0.7695510786217261,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
1042,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N(C(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethylamino-pyridin-2-yl)-isopropyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.38,uM,=,-0.4202164033831898,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1043,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(O)c2ccccc2)n2nc(Cl)ccc12,"7-(2-Chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-ol hydrochloride",0.38,uM,=,-0.4202164033831898,0,c1ccc(CCCCCCCc2ncc3cccnn23)cc1
1044,545205,10.1016/j.ejmech.2008.10.032,,,,Inhibition of wild-type HIV1 reverse transcriptase,Cc1ccc2c(c1)C(=O)N(CCOC(=S)N(C(=O)c1ccc(Cl)cc1)c1ccc([N+](=O)[O-])cc1)C2=O,"O-[2-(5-Methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl]4-chlorobenzoyl(4-nitrophenyl)thiocarbamate",0.3,uM,=,-0.5228787452803376,0,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1ccccc1)c1ccccc1
1045,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,4-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-2-hydroxy-4-oxobut-2-enoic Acid,7.5,uM,=,0.8750612633917001,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
1046,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(N3CCC(O)C3)nc21,"5-Ethyl-7-(3-hydroxy-pyrrolidin-1-yl)-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2ccc(N3CCCC3)nc2Nc2ncccc21
1047,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.06,uM,=,0.0253058652647702,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1048,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccc(Cl)cc2C2(c3ccccc3)SCCN12,"8-Chloro-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.19,uM,=,-0.721246399047171,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1049,195841,10.1021/jm980510s,,,,The compound was tested for inhibitory activity against Recombinant HIV-1 reverse transcriptase,Nc1ccc([C@@H]2CS[C@H](OP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(O)n1,2'-Deoxy-3'-thiacytidine-triphosphate,3.6,uM,=,0.5563025007672873,1,c1cncc([C@@H]2CSCO2)c1
1050,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1ccc(C(F)(F)F)cc1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(4-(trifluoromethyl)benzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,8.0,uM,=,0.9030899869919436,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
1051,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,Cc1nc(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)sc1/N=N/c1ccccc1,"4-(4-Chlorophenyl)-5-(4-methyl-5-(phenyldiazenyl)thiazol-2-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",1.9e-05,uM,=,-4.721246399047171,0,c1ccc(/N=N/c2cnc(N3Nc4onc(-c5ccccc5)c4C3c3ccccc3)s2)cc1
1052,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CSc1nc(O)c(C)c(Cc2cccc(C)c2)n1,5-Methyl-6-(3-methyl-benzyl)-2-methylsulfanyl-3H-pyrimidin-4-one,2.5,uM,=,0.3979400086720376,1,c1ccc(Cc2ccncn2)cc1
1053,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)[nH]2)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",1.7,uM,=,0.2304489213782739,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1054,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,Cc1cccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)c1,"6-[1-(3-Methylphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",4.6,uM,=,0.6627578316815741,1,c1ccc(Cn2cccc2)cc1
1055,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(OCC)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,5-diethoxy-phenyl)-ethyl]-thiourea",0.18,uM,=,-0.744727494896694,0,S=C(NCCc1ccccc1)Nc1ccccn1
1056,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nccn2-c2cccnc21,"8-Ethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",11.2,uM,=,1.0492180226701815,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
1057,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1ccccc1F,6-chloro-1-(2-fluorophenylsulfonyl)-1H-benzo[d]imidazol-2(3H)-one,0.85,uM,=,-0.0705810742857072,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
1058,2297017,10.1016/j.ejmech.2016.07.056,,,,Inhibition of HIV1 reverse transcriptase,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@H]3O,"(10R,11S,12R)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",15.0,uM,=,1.1760912590556811,1,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
1059,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=[N+]([O-])c1cccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)c1O,4-chloro-N'-(2-hydroxy-3-nitrobenzylidene)benzenesulfonohydrazide,96.0,uM,=,1.9822712330395684,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
1060,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CC(C)SC1=N/C(=C/c2ccccc2)C(C)(C)C(=O)N1,"2-Isopropylsulfanyl-5,5-dimethyl-6-[1-phenyl-meth-(E)-ylidene]-5,6-dihydro-3H-pyrimidin-4-one",4.3,uM,=,0.6334684555795865,1,O=C1C/C(=C\c2ccccc2)N=CN1
1061,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,S=C(NCCc1c[nH]c2ccccc12)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[2-(1H-indol-3-yl)-ethyl]-thiourea,0.03,uM,=,-1.5228787452803376,0,S=C(NCCc1c[nH]c2ccccc12)Nc1ccccn1
1062,542167,10.1016/j.ejmech.2008.02.047,,,,Inhibition of polymerase activity of HIV1 recombinant reverse transcriptase expressed in Escherichia coli,CO[C@@H]1O[C@H](COC(=O)c2nnn(Cc3ccccc3)c2C)[C@H]2OC(C)(C)O[C@@H]12,"1-Benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 5-(1-methoxy-2,3-O-isopropylidene)-beta-D-ribofuranose ester",2.2,uM,=,0.3424226808222063,1,O=C(OC[C@H]1OC[C@@H]2OCO[C@@H]21)c1cn(Cc2ccccc2)nn1
1063,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c3ncccc23)c1,"4-(2-((1H-Pyrazolo[3,4-b]pyridin-3-yl)methylamino)pyridin-4-yl)-3-methylbenzonitrile",0.0012,uM,=,-2.920818753952376,0,c1ccc(-c2ccnc(NCc3n[nH]c4ncccc34)c2)cc1
1064,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cc(OCC(=O)Nc2cccc(Cl)c2)nc(Nc2ccc(C#N)cc2)n1,N-(3-Chlorophenyl)-2-((2-((4-cyanophenyl)amino)-6-methylpyrimidin-4-yl)oxy)acetamide,0.54,uM,=,-0.2676062401770315,0,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
1065,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(Nc2ccccc2)c1I,3-Iodo-6-phenethyl-4-(phenylamino)pyridin-2(1H)-one,8.14,uM,=,0.9106244048892012,1,O=c1cc(Nc2ccccc2)cc(CCc2ccccc2)[nH]1
1066,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",7.2,uM,=,0.8573324964312685,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1067,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCC(NS(N)(=O)=O)CC3)cc2)n1,"N-(1-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)-amino)benzyl)piperidin-4-yl)aminosulfonamide",0.152,uM,=,-0.8181564120552275,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCCCC4)cc3)n2)cc1
1068,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,C[C@H]1CC(Cc2ccc(Cl)c(Oc3cc(Cl)cc(C#N)c3)c2F)=NNC1=O,"(S)-3-chloro-5-(6-chloro-2-fluoro-3-((5-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)methyl)phenoxy)benzonitrile",0.017,uM,=,-1.769551078621726,0,O=C1CCC(Cc2cccc(Oc3ccccc3)c2)=NN1
1069,1294279,10.1016/j.ejmech.2014.02.047,,,,Inhibition of wild type HIV-1 reverse transcriptase using poly (rC)/oligo (dG) as template/primer assessed as inhibition of biotin-dUTP incorporation after 1 hr by microtiter plate ELISA reader analysis,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",6.5,uM,=,0.8129133566428556,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1070,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),O=C(CCCCCCc1ncc2ccc(Cl)nn12)c1ccccc1,"7-(2-Chloro-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one hydrochloride",0.34,uM,=,-0.4685210829577448,0,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
1071,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CC(=O)N3CCc4ccccc4C3)[nH]c(=O)c2Cl)c1,"3-chloro-5-(3-chloro-6-(2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl)-2-oxo-1,2-dihydropyridin-4-yloxy)benzonitrile",0.03,uM,=,-1.5228787452803376,0,O=C(Cc1cc(Oc2ccccc2)cc(=O)[nH]1)N1CCc2ccccc2C1
1072,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,CC(=O)Nc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"N-[1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazol-4-yl]-acetamide",54.7,uM,=,1.737987326333431,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
1073,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1sc(C(CO)NC(=O)c2[nH]c(-c3ccc4c(c3)OCO4)cc2CN)nc1S,"3-(aminomethyl)-5-(benzo[d][1,3]dioxol-5-yl)-N-(2-hydroxy-1-(4-mercapto-5-methylthiazol-2-yl)ethyl)-1H-pyrrole-2-carboxamide",30.6,uM,=,1.48572142648158,1,O=C(NCc1nccs1)c1ccc(-c2ccc3c(c2)OCO3)[nH]1
1074,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,C#CCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(=O)O)[C@H]2O)c1=O,"4-hydroxy-2-(methoxymethyl)-5-(6-oxo-1-prop-2-ynyl-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl methylphosphonate",0.0223,uM,=,-1.6516951369518391,0,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
1075,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,COc1ccc(/N=N/c2sc(N3Nc4onc(-c5ccccc5)c4C3c3ccc(Cl)cc3)nc2C)cc1,"4-(4-Chlorophenyl)-5-(5-((4-methoxyphenyl)diazenyl)-4-methylthiazol-2-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",3.5999999999999994e-05,uM,=,-4.443697499232713,0,c1ccc(/N=N/c2cnc(N3Nc4onc(-c5ccccc5)c4C3c3ccccc3)s2)cc1
1076,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1ccccc1C(C#N)c1nc(SC(C)C)[nH]c(=O)c1C,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(2-methoxyphenyl)acetonitrile",0.158,uM,=,-0.8013429130455774,0,O=c1cc(Cc2ccccc2)nc[nH]1
1077,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ccncc3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(pyridin-4-yl)acetamide,32.5,uM,=,1.5118833609788744,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccncc1
1078,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,CCOCn1c(C(C#N)c2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"2-([1,1'-Biphenyl]-4-yl)-2-(3-(ethoxymethyl)-1-hydroxy-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)acetonitrile",0.76,uM,=,-0.1191864077192086,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1079,196377,10.1021/jm0309856,,,,Inhibitory concentration required to inhibit the HIV-1 reverse transcriptase activity,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,"1-(2-Hydroxy-ethoxymethyl)-5-methyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",17.0,uM,=,1.230448921378274,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1080,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,0.6,uM,=,-0.2218487496163563,0,S=C(NCCc1ccccn1)Nc1ccccn1
1081,1899209,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase polymerase using deoxynucleotide triphosphates and 18 nucleotide DNA primer annealed to 100 nucleotide DNA template after 30 mins,N#Cc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"4'-(1-Hydroxy-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-[1,1'-biphenyl]-4-carbonitrile",7.7,uM,=,0.8864907251724818,1,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
1082,1276829,10.1021/jm401232v,,,,Inhibition of HIV1 reverse transcriptase-mediated [H3]TTP incorporation into poly(rA)-oligo(dT)16 DNA preincubated for 5 mins prior to primer/template and substrate addition by liquid scintillation spectrometric analysis,Cc1cn([C@H]2C[C@H](n3nncc3-c3cc4ccccc4c4ccccc34)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+],"Trisodium Mono(((2S,3S,5R)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-(5-(phenanthren-9-yl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)methyl triphosphate)",11.8,uM,=,1.0718820073061257,1,O=c1ccn([C@H]2C[C@H](n3nncc3-c3cc4ccccc4c4ccccc34)CO2)c(=O)[nH]1
1083,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccccc2[N+](=O)[O-])n1,2-sec-Butylsulfanyl-6-(2-nitro-benzyl)-3H-pyrimidin-4-one,0.3,uM,=,-0.5228787452803376,0,c1ccc(Cc2ccncn2)cc1
1084,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2ccccc2Oc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",6.4,uM,=,0.8061799739838872,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
1085,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,6-difluoro-3-methoxy-phenyl)-ethyl]-thiourea",0.006,uM,=,-2.2218487496163566,0,S=C(NCCc1ccccc1)Nc1ccccn1
1086,822365,10.1016/j.ejmech.2012.04.004,,,,Inhibition of HIV1 wildtype reverse transcriptase using poly(rA)/oligo(dT)15 as template by colometric streptavidin alkaline phosphate reporter assay,N#Cc1ccc(Nc2nccc(C(O)c3ccccc3Cl)n2)cc1,4-((4-((2-chlorophenyl)(hydroxy)methyl)pyrimidin-2-yl)amino)-benzonitrile,0.45,uM,=,-0.3467874862246563,0,c1ccc(Cc2ccnc(Nc3ccccc3)n2)cc1
1087,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,CCOc1ccc(F)c(CC/N=C(\N)Nc2ccc(Br)cn2)c1Cl,N-(5-Bromo-pyridin-2-yl)-N'-[2-(2-chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-guanidine,0.4,uM,=,-0.3979400086720376,0,C(=NCCc1ccccc1)Nc1ccccn1
1088,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCN1C(=O)/C(=C/c2cccs2)SC1=S)Nc1ccc(O)c(C(=O)O)c1,2-Hydroxy-5-(3-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-propionylamino)-benzoic acid,38.0,uM,=,1.57978359661681,1,O=C(CCN1C(=O)/C(=C/c2cccs2)SC1=S)Nc1ccccc1
1089,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,"5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",443.0,uM,=,2.646403726223069,1,O=c1cc(-c2ccccc2)oc2ccccc12
1090,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,O=C(O)CN1C[C@@]23C4=C5c6c7c8c9c(c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c(c6c6c8c8c%24c9c%11c9c(c%16%12)c%17c%11c%19c%12c%21c%23c6c8c%12c%11c9%24)[C@@H]5[C@@H]5C=%22[C@H]6c8c(c-%14c(c4c85)[C@@H]2[C@H]%13%10)[C@H]%15[C@@H]%18[C@@H]%206)[C@]73[C@@H]1C(=O)O,Fullerene Derivative,1.0,uM,=,0.0,0,C1NC[C@@]23C4=C5c6c7c8c9c(c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c(c6c6c8c8c%24c9c%11c9c(c%16%12)c%17c%11c%19c%12c%21c%23c6c8c%12c%11c9%24)[C@@H]5[C@@H]5C=%22[C@H]6c8c(c-%14c(c4c85)[C@@H]2[C@H]%13%10)[C@H]%15[C@@H]%18[C@@H]%206)[C@]173
1091,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2cc(C)[nH]c(=O)c2N(C)C)c1,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-6-methyl-1H-pyridin-2-one",0.398,uM,=,-0.4001169279263121,0,O=c1cc(Cc2ccccc2)cc[nH]1
1092,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)c(F)c2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3-fluoro-3',5'-dimethyl-[1,1'-biphenyl]-4-carbonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1093,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,N#CCC(=O)c1cccc(C(=O)c2ccccc2)c1,3-benzoyl-3-oxopropanenitrile,9.8,uM,=,0.9912260756924948,1,O=C(c1ccccc1)c1ccccc1
1094,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1ccccc1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1095,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,CC1(C)CCC[C@]2(C)OC3CC[C@](C)(C4CC[C@]5(C)C4CC[C@]4(C)C6=C(CC54)C(=O)C=CC6=O)[C@]3(C)CCC12,"(5aS,10bR)-5a,10b-dimethyl-3-((1R,4aS,10aS)-1,4a,8,8,10a-pentamethyldodecahydro-1H-benzo[b]cyclopenta[f]oxepin-1-yl)-1,2,3,3a,4,5,5a,10,10a,10b-decahydrocyclopenta[a]fluorene-6,9-dione",13.2,uM,=,1.1205739312058498,1,O=C1C=CC(=O)C2=C1CC1C2CCC2C1CCC2C1CCC2OC3CCCCC3CCC21
1096,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@H]1[C@@H](C)Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2[C@@H]1O)OC(C)(C)C=C3,"(10R,11R,12R)-12-hydroxy-6,6,10,11-tetramethyl-4-phenyl-6,10,11,12-tetrahydro-2H-1,5,9-trioxatriphenylen-2-one",11.0,uM,=,1.0413926851582251,1,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
1097,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,CCOC(=O)N[C@H](C(=O)NN(Cc1ccc(-c2cncs2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"((S)-1-{(1S,2S)-1-Benzyl-3-[N'-((S)-2-ethoxycarbonylamino-3-methyl-butyryl)-N-(4-thiazol-5-yl-benzyl)-hydrazino]-2-hydroxy-propylcarbamoyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.022,uM,=,-1.6575773191777938,0,c1ccc(CCCCNCc2ccc(-c3cncs3)cc2)cc1
1098,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3cc(C#N)cc(/C=C/C#N)c3)c21,"(E)-3-(2-cyanovinyl)-5-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)benzonitrile",0.049,uM,=,-1.3098039199714864,0,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
1099,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",7.0,uM,=,0.8450980400142568,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1100,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",6.0,uM,=,0.7781512503836436,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1101,743750,10.1021/jm101536x,,,,Inhibition of wild type HIV-1 reverse transcriptase-mediated polymerization reaction after 30 mins,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione (TASO-m3T)",2.4,uM,=,0.380211241711606,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1102,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(OC)c2)cc1,"3-(4-Hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.206,uM,=,-0.6861327796308466,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1103,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCOCn1c(C(=O)c2ccccc2)c(CC)c(=O)n(O)c1=O,"6-Benzoyl-1-(ethoxymethyl)-5-ethyl-3-hydroxypyrimidine-2,4(1H,3H)-dione",43.0,uM,=,1.6334684555795866,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
1104,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",0.0002,uM,=,-3.6989700043360174,0,c1ccc(Oc2cccc(OCc3n[nH]c4ncccc34)c2)cc1
1105,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC[C@@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O,"5-Cyclopropylethynyl-3-ethyl-7-fluoro-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.171,uM,=,-0.7670038896078462,0,O=C1COC(C#CC2CC2)c2ccccc2N1
1106,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc2cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(N)cc3)c(=O)oc2c1,"N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-7-methoxy-2-oxo-2H-chromene-3-carboxamide",0.7057,uM,=,-0.1513798825658661,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
1107,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,CCc1ccc(Sc2cc(=O)n(O)c(=O)[nH]2)cc1,"6-((4-Ethylphenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.01,uM,=,-2.0,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1108,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Fc1ccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n2c1,"2-(2-Chlorophenyl)-N-cyclohexyl-6-fluoroimidazo[1,2-a]pyridin-3-amine",11.28,uM,=,1.0523090996473234,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
1109,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1F,"6-[1-(2-Fluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",6.3,uM,=,0.7993405494535817,1,c1ccc(Cn2cccc2)cc1
1110,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(C)nc21,"5-Ethyl-7,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncccc21
1111,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(N)cc3)CC2)nc2c1CSC2,"4-((2-((1-(4-Aminobenzyl)piperidin-4-yl)amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.115,uM,=,-0.9393021596463884,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSC4)CC2)cc1
1112,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2ccc(-c3ccc(Cl)cc3)cc2)[nH]c(=O)n1O,"6-((4'-Chloro-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.99,uM,=,-0.00436480540245,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1113,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
1114,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,NCc1ccc(-c2cccc(-c3cc(=O)n(O)c4ncccc34)c2)cc1,"4-(4'-(aminomethyl)biphenyl-3-yl)-1-hydroxy-1,8-naphthyridin-2(1H)-one",0.13,uM,=,-0.8860566476931633,0,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2[nH]1
1115,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccc(Cl)cc2)n1,2-sec-Butylsulfanyl-6-(4-chloro-benzyl)-3H-pyrimidin-4-one,4.8,uM,=,0.6812412373755872,1,c1ccc(Cc2ccncn2)cc1
1116,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(NC2CCCC2)c1I,4-(Cyclopentylamino)-3-iodo-6-phenethylpyridin-2(1H)-one,24.01,uM,=,1.3803921600570273,1,O=c1cc(NC2CCCC2)cc(CCc2ccccc2)[nH]1
1117,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1[nH]c(SCc2ccc3ccccc3c2)nc(Cc2ccccc2)c1I,6-Benzyl-5-iodo-2-(naphthalen-2-ylmethylthio)pyrimidin-4(3H)-one,2.04,uM,=,0.3096301674258988,1,O=c1cc(Cc2ccccc2)nc(SCc2ccc3ccccc3c2)[nH]1
1118,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.848,uM,=,0.6855626111582298,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1119,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.011,uM,=,-1.9586073148417749,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
1120,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1ccc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)s1,"4-((4-((2,6-Dimethyl-4-(5-methylthiophen-2-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0438,uM,=,-1.3585258894959005,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccs4)cc3)n2)cc1
1121,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)C#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(Cl)cc21,"6-Chloro-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.281,uM,=,-0.5512936800949201,0,O=C1NCc2ccccc2N1
1122,1927897,10.1016/j.bmc.2016.09.025,,,,Inhibition of recombinant HIV1 RT,O=C(c1ccc(Cl)cc1)c1nc(SCc2ccccc2)[nH]c(=O)c1O,2-(benzylthio)-6-(4-chlorobenzoyl)-5-hydroxypyrimidin-4(3H)-one,113.1,uM,=,2.053462604925455,1,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
1123,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(C(=CCCc2nnn(C)n2)c2cc(C)c(OC)c(C(=O)OC)c2)cc(C)c1OC,methyl 2-methoxy-5-[1-(4-methoxy-3-methyl-5-methoxycarbonyl-phenyl)-4-(2-methyl-2H-tetrazol-5-yl)-but-1-enyl]-3-methylbenzoate,53.0,uM,=,1.7242758696007892,1,C(CCc1nn[nH]n1)=C(c1ccccc1)c1ccccc1
1124,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cn1c(Nc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",5.0,uM,=,0.6989700043360189,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1125,2111169,10.1016/j.ejmech.2020.113063,,,,"Inhibition of HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into cDNA incubated for 1 hr with DIG-dUTP, biotin-dUTP and dTTP followed by transferring onto streptavidin-coated plate and measured after 1 hr by ELISA",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.35,uM,=,-0.4559319556497244,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1126,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cccc(Cl)c3o2)c(O)nc1C,3-[(7-Chloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.065,uM,=,-1.1870866433571443,0,c1cncc(NCc2nc3ccccc3o2)c1
1127,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,2-Amino-6-(2-methoxy-benzenesulfonyl)-benzonitrile,1.4,uM,=,0.1461280356782379,1,O=S(=O)(c1ccccc1)c1ccccc1
1128,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(Oc2c(C(F)(F)F)ccn(Cc3n[nH]c(=O)n3C)c2=O)ccc1-c1cccc(F)c1,"3-((3'-Fluoro-2-methyl-[1,1'-bipheny1]-4-yl)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",4.71,uM,=,0.6730209071288962,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1129,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,CSc1nc2ncnc(NCC(P(=O)(O)O)P(=O)(O)O)c2cc1-c1ccccc1,"(2-((7-(Methylthio)-6-phenylpyrido[2,3-d]pyrimidin-4-yl)-amino)ethane-1,1-diyl)diphosphonic Acid",1.1,uM,=,0.041392685158225,1,c1ccc(-c2cnc3ncncc3c2)cc1
1130,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cc1noc(C)c1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,"6-((4-(3,5-Dimethylisoxazol-4-yl)phenyl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",3.8,uM,=,0.5797835966168101,1,O=c1cc(Nc2ccc(-c3cnoc3)cc2)[nH]c(=O)[nH]1
1131,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cnc(Nc2ccc(C#N)cc2)nc1OCC(=O)Nc1ccccc1Cl,N-(2-Chlorophenyl)-2-((2-((4-cyanophenyl)amino)-5-methylpyrimidin-4-yl)oxy)acetamide,0.046,uM,=,-1.337242168318426,0,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
1132,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2c(F)cccc2F)C(F)(F)F)c(O)nc1C,"3-[3-Cyclopropyl-1-(2,6-difluoro-benzyloxy)-1-trifluoromethyl-prop-2-ynyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.613,uM,=,-0.2125395254815849,0,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
1133,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(C)cccc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[2-(4-methyl-benzooxazol-2-yl)-ethyl]-1H-pyridin-2-one,0.033,uM,=,-1.4814860601221125,0,c1cncc(CCc2nc3ccccc3o2)c1
1134,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OC1COc2cc(O)cc(O)c2C1)c1cc(O)cc(O)c1,"3,5-Dihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",96.3,uM,=,1.9836262871245345,1,O=C(OC1COc2ccccc2C1)c1ccccc1
1135,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(C(=CCCc2nnn(C)n2)c2cc(C)c(OC)c(C(=O)SC)c2)cc1C(=O)SC,2-methoxy-5-[1-(4-methoxy-3-methyl-5-methylsulfanylcarbonyl-phenyl)-4-(2-methyl-2H-tetrazol-5-yl)-but-1-enyl]-3-methylthiobenzoic acid S-methyl ester,67.0,uM,=,1.8260748027008264,1,C(CCc1nn[nH]n1)=C(c1ccccc1)c1ccccc1
1136,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,C[C@@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-cyclopropylethynyl-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.082,uM,=,-1.0861861476162833,0,O=C1COC(C#CC2CC2)c2ccccc2N1
1137,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.55,uM,=,0.1903316981702915,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1138,546494,10.1021/np50121a006,,,,Inhibition of HIV1 reverse transcriptase p66/p51,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O,"(10R,11S,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",1.0,uM,=,0.0,0,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
1139,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1CCCC2,"5-((4-(4-Cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)picolinonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Oc2nc(Nc3cccnc3)nc3c2CCCC3)cc1
1140,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(Cn3cccn3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-pyrazol-1-ylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.2,uM,=,0.3424226808222063,1,O=C1Nc2c(Cn3cccn3)ccnc2N(C2CC2)c2ncccc21
1141,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C,"((S)-1-{N'-Biphenyl-4-ylmethyl-N'-[(2S,3S)-2-hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-hydrazinocarbonyl}-2-methyl-propyl)-carbamic acid methyl ester",0.035,uM,=,-1.4559319556497243,0,c1ccc(CCCCNCc2ccc(-c3ccccc3)cc2)cc1
1142,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCC#CC1(C(F)(F)F)OC(=O)Nc2ccc([N+](=O)[O-])cc21,"4-But-1-ynyl-6-nitro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.276,uM,=,-0.5590909179347823,0,O=C1Nc2ccccc2CO1
1143,1899209,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase polymerase using deoxynucleotide triphosphates and 18 nucleotide DNA primer annealed to 100 nucleotide DNA template after 30 mins,COc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-(4'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrimidine-2,4(1H,3H)-dione",5.9,uM,=,0.7708520116421442,1,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
1144,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.084,uM,=,-1.0757207139381184,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1145,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)NC(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butylamino)-2-oxoethyl 5-nitrofuran-2-carboxylate,18.0,uM,=,1.255272505103306,1,c1ccoc1
1146,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(OC)cc1,"(E)-6-[1-(4-Methoxy-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",6.7,uM,=,0.8260748027008264,1,c1ccc(Cn2cccc2)cc1
1147,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,COCCc1ccc(Oc2cc(C)nc(Nc3ccc(C#N)cc3)n2)cc1,4-{6-Methyl-4-[4-(2-methoxylethyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,11.64,uM,=,1.0659529803138696,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1148,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)ccc2C(=O)N1O,"6-((2',4'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",8.7,uM,=,0.9395192526186184,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1149,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-n2c(C)cnc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(1-(2-chloro-4-methylphenyl)-5-methyl-1H-imidazol-2-ylthio)acetamido)biphenyl-4-yl)acetic acid,0.0095,uM,=,-2.0222763947111524,0,O=C(CSc1nccn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
1150,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2cc(NS(=O)(=O)c3ccc4ccccc4c3)ccc2c(=O)n1O,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)naphthalene-2-sulfonamide",20.1,uM,=,1.3031960574204888,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2[nH]1
1151,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(N(C)CCO)nc21,"5-Ethyl-7-[(2-hydroxy-ethyl)-methyl-amino]-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.01,uM,=,-2.0,0,O=C1Nc2cccnc2Nc2ncccc21
1152,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(COc3ccccc3O)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-(2-hydroxy-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.46,uM,=,-0.3372421683184259,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
1153,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2cccs2)cc1F,"4-((4-((2,6-Difluoro-4-(thiophen-2-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.012,uM,=,-1.9208187539523751,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccs4)cc3)n2)cc1
1154,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)N1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.111,uM,=,-0.9546770212133424,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
1155,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,N#Cc1ccc(Nc2cc(Oc3c(Br)cc(Br)cc3Br)cnc2N)cc1,"4-((2-amino-5-(2,4,6-tribromophenoxy)pyridin-3-yl)amino)benzonitrile",0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
1156,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,O=C(Nc1ccc(Cl)cn1)N[C@@H]1C[C@@H]1c1c(F)cccc1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(2,6-difluoro-phenyl)-cyclopropyl]-urea",0.002,uM,=,-2.6989700043360187,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
1157,1927897,10.1016/j.bmc.2016.09.025,,,,Inhibition of recombinant HIV1 RT,O=C(c1ccccc1)c1nc(SCc2ccccc2)[nH]c(=O)c1O,6-benzoyl-2-(benzylthio)-5-hydroxypyrimidin-4(3H)-one,95.09,uM,=,1.9781348473982896,1,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
1158,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-hydroxy-6-(4'-methylbiphenyl-3-ylamino)pyrimidine-2,4(1H,3H)-dione",0.45,uM,=,-0.3467874862246563,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1159,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(F)c1,"6-[1-(3-Fluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",9.0,uM,=,0.9542425094393248,1,c1ccc(Cn2cccc2)cc1
1160,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccccc1O,2-hydroxy-N'-((5-nitrothiophen-2-yl)methylene)benzohydrazide,55.0,uM,=,1.740362689494244,1,O=C(N/N=C/c1cccs1)c1ccccc1
1161,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccc(OCc3cccc4ccccc34)cc2)n[nH]1,Ethyl 3-(4-(4-(naphthalen-8-ylmethoxy)phenyl)-1-(naphthalene-1-ylmethyl)1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,4.15,uM,=,0.6180480967120927,1,c1ccc2c(COc3ccc(-c4cn(Cc5cccc6ccccc56)cc4-c4cc[nH]n4)cc3)cccc2c1
1162,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(F)cc2)[nH]c(=O)n1O,"6-((4-Fluorophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.037,uM,=,-1.431798275933005,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1163,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)nc3ccc(Cl)cc32)c1,"2-{[6-Chloro-1-(3,5-dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-(2-chloro-4-sulfamoylphenyl)-acetamide",86.64,uM,=,1.937718443617264,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
1164,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1cc(OC)c(O)c(OC)c1)S(=O)(=O)c1ccc(OC)cc1,"(E)-3-(4-hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0905,uM,=,-1.0433514207947967,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1165,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,"4-(4-(((6-benzyl-5-isopropyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.05698,uM,=,-1.244277555096542,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1166,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(Cl)cc1C(=O)c1cccnc1)Nc1ccccc1,2-[4-Chloro-2-(pyridine-3-carbonyl)-phenoxy]-N-phenyl-acetamide,0.4370663754983066,uM,=,-0.3594526034788813,0,O=C(COc1ccccc1C(=O)c1cccnc1)Nc1ccccc1
1167,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCc1nnc2n1-c1cccnc1N(CC)c1ncccc1-2,"3,8-Diethyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",56.6,uM,=,1.7528164311882717,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
1168,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1nc(F)ccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-tert-Butylamino-6-fluoro-pyridin-2-yl)-ethyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.73,uM,=,-0.1366771398795441,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1169,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.4,uM,=,-0.3979400086720376,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1170,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",5.1,uM,=,0.7075701760979364,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1171,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(Cc1cccc(C(=O)Nc2ccc(Br)cc2C(=O)O)c1)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-{[(3-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}phenyl)acetyl]amino}benzoic acid,15.0,uM,=,1.1760912590556811,1,O=C(Cc1cccc(C(=O)Nc2ccccc2)c1)Nc1ccccc1
1172,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CC1C(=O)N(O)C(=O)c2ccccc21,"2-Hydroxy-4-methylisoquinoline-1,3(2H,4H)-dione",38.8,uM,=,1.5888317255942073,1,O=C1Cc2ccccc2C(=O)N1
1173,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,CC(C)c1ccc(O)c(=O)c(O)c1,"(2E,4Z,6E)-2,7-dihydroxy-4-isopropylcyclohepta-2,4,6-trienone",2.5,uM,=,0.3979400086720376,1,O=c1cccccc1
1174,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(3-ethoxy-2,6-difluoro-phenyl)-cyclopropyl]-urea",0.08,uM,=,-1.0969100130080565,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
1175,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC(=O)c1cc2c(-c3ccc(N(C)C)cc3)c3c(nc2[nH]1)-c1ccccc1C3=O,"2-acetyl-4-(4-(dimethylamino)phenyl)indeno[2,1-e]pyrrolo[2,3-b]pyridin-5(1H)-one",15.0,uM,=,1.1760912590556811,1,O=C1c2ccccc2-c2nc3[nH]ccc3c(-c3ccccc3)c21
1176,196795,10.1021/jm00058a009,,,,In vitro for inhibitory activity against HIV-1 Reverse Transcriptase,Cc1cccc(C23SCCN2C(=O)c2ccccc23)c1,"9b-m-Tolyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.03,uM,=,-1.5228787452803376,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1177,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(Cc3ccccc3)c[nH]c(=O)c2Br)c1,"3-(5-benzyl-3-bromo-2-oxo-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.034,uM,=,-1.4685210829577449,0,O=c1cc(Oc2ccccc2)c(Cc2ccccc2)c[nH]1
1178,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-n3cccn3)nc21,"5-Ethyl-10-methyl-7-pyrazol-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.31,uM,=,-0.5086383061657274,0,O=C1Nc2ccc(-n3cccn3)nc2Nc2ncccc21
1179,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(-c2ccccc2Oc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",5.7,uM,=,0.7558748556724915,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
1180,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCc2ccc(F)cc2)c2cccnc2n1O,"4-{[(4-Fluorophenyl)methyl]amino}-1-hydroxypyrido[2,3-d]pyrimidin-2(1H)-one",0.158,uM,=,-0.8013429130455774,0,O=c1nc(NCc2ccccc2)c2cccnc2[nH]1
1181,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,Cc1nc(O)c(NCc2nc3ccccc3o2)cc1[S+](C)[O-],3-[(Benzooxazol-2-ylmethyl)-amino]-5-methanesulfinyl-6-methyl-1H-pyridin-2-one,31.5,uM,=,1.4983105537896004,1,c1cncc(NCc2nc3ccccc3o2)c1
1182,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(OC)cccc3o2)c(O)nc1C,5-Ethyl-3-[(4-methoxy-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.18,uM,=,-0.744727494896694,0,c1cncc(NCc2nc3ccccc3o2)c1
1183,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(SC)c1cc(C)cc(C)c1,"rac-Ethyl 5-chloro-3-((3,5-dimethylphenyl)(methylthio)methyl)-1H-indole-2-carboxylate",0.06,uM,=,-1.2218487496163564,0,c1ccc(Cc2c[nH]c3ccccc23)cc1
1184,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,O=C(CSC(=O)N1CCCc2cc(Cl)cc(Cl)c21)Nc1ccccc1Cl,"S-2-(2-chlorophenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.004,uM,=,-2.397940008672037,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
1185,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COC(=O)c1cc(/C(=C\CCN2CCOC2=O)c2cc(C)c3onc(OC)c3c2)cc(C)c1OC,(Z)-2-Methoxy-5-[1-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(2-oxo-oxazolidin-3-yl)-but-1-enyl]-3-methyl-benzoic acid methyl ester,0.63,uM,=,-0.2006594505464183,0,O=C1OCCN1CC/C=C(\c1ccccc1)c1ccc2oncc2c1
1186,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCCc2ccccc2)n2nc(Cl)ccc12,"2-Chloro-5-methyl-7-(7-phenyl-heptyl)-imidazo[1,5-b]pyridazine hydrochloride",14.0,uM,=,1.146128035678238,1,c1ccc(CCCCCCCc2ncc3cccnn23)cc1
1187,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.36,uM,=,-0.4436974992327127,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1188,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCC1CCCO1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-((tetrahydrofuran-2-yl)methyl)acetamide",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCC1CCCO1
1189,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),C#Cc1ccc2c(n1)N(CC)c1ncccc1C(=O)N2C,"5-Ethyl-7-ethynyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2cccnc2Nc2ncccc21
1190,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2cc(OC)c(O)cc2OC)C(C)C)cc1,"3-(4-hydroxy-2,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-(N-isopropyl-4-methoxyphenylsulfonamido)-1-phenylbutan-2-yl)propanamide",0.299,uM,=,-0.5243288116755703,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1191,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1c(Cl)cccc1Cl)CC(=O)C(=O)O,"6-[1-(2,6-Dichlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",28.0,uM,=,1.4471580313422192,1,c1ccc(Cn2cccc2)cc1
1192,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(O)c(O)c2)cs1,"3-(2-(4-(3,4-dihydroxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one",0.9,uM,=,-0.0457574905606751,0,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
1193,2104796,10.1016/j.bmc.2021.116239,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into cDNA measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Nc1cc(N)nc(Nc2ccc(C#N)cc2)n1,Rilpivirine,0.23,uM,=,-0.6382721639824072,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
1194,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,Oc1nc2ccc(Cl)cc2n1Cc1ccc2ccccc2c1,"6-Chloro-1-naphthalen-2-ylmethyl-1,3-dihydro-benzoimidazol-2-one",5.2,uM,=,0.7160033436347992,1,c1ccc2cc(Cn3cnc4ccccc43)ccc2c1
1195,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2cc(N)ccc2Oc2cc(C)c(C)cc21,"2-Amino-7,8-dimethyl-10-propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.165,uM,=,-0.7825160557860937,0,O=C1Nc2ccccc2Oc2ccccc21
1196,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCc1cc(NCCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[2-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-ethyl]-isoindole-1,3-dione",45.0,uM,=,1.6532125137753435,1,O=C1c2ccccc2C(=O)N1CCNc1cccnc1
1197,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(F)ccc(F)c3o2)c(S)nc1C,"3-[2-(4,7-Difluoro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridine-2-thione",0.015,uM,=,-1.8239087409443189,0,c1cncc(CCc2nc3ccccc3o2)c1
1198,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,C=Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C)cc1C,"4-[4-(2,4,6-Trimethyl-phenylamino)-5-vinyl-pyrimidin-2-ylamino]-benzonitrile",0.0025,uM,=,-2.6020599913279625,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
1199,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCOC(=O)CCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,"Ethyl 3',3''-Dichloro-4',4''-dimethoxy-5',5''-bis(methoxy-carbonyl)-6,6-diphenylhexenoate",0.233,uM,=,-0.632644078973981,0,C=C(c1ccccc1)c1ccccc1
1200,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCNC(=O)OCC(C)C)c2cc(C)c(OC)c(C(=O)OC)c2)cc(C)c1OC,"4-(N-Isobutyloxycarbonyl)amino-3',3''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",2.95,uM,=,0.469822015978163,1,C=C(c1ccccc1)c1ccccc1
1201,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,COc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Cl,3-(4-(5-chloro-4-(4-cyano-2-methoxy-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.019,uM,=,-1.7212463990471711,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1202,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1CCC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)-benzenesulfonamide",0.091,uM,=,-1.0409586076789064,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCC4)CC2)cc1
1203,2297017,10.1016/j.ejmech.2016.07.056,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@H]3O,Cardatolide B,19.0,uM,=,1.2787536009528289,1,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
1204,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Oc1nc(O)nc(NCc2ccc3occc3c2)n1,"4-(benzofuran-5-ylmethylamino)-6-(3-methylbiphenyl-2-yloxy)-1,3,5-triazin-2-ol",9.7,uM,=,0.9867717342662448,1,c1ccc(-c2ccccc2Oc2ncnc(NCc3ccc4occc4c3)n2)cc1
1205,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CSc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
1206,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CC(C)c1c(O)nc(SCC(=O)c2ccc(Cl)cc2)nc1Cc1cccc2ccccc12,2-[2-(4-Chloro-phenyl)-2-oxo-ethylsulfanyl]-5-isopropyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.32,uM,=,-0.494850021680094,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
1207,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=[N+]([O-])c1ccc(S(=O)(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)cc1,N'-(2-hydroxy-5-nitrobenzylidene)-4-nitrobenzenesulfonohydrazide,78.0,uM,=,1.8920946026904804,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
1208,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(C#N)cc4)c(F)c3)c2=O)n[nH]c1=O,"2-fluoro-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-bipheny1]-4-carbonitrile",1.52,uM,=,0.1818435879447725,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1209,1542247,10.1021/acsmedchemlett.5b00254,,,,Inhibition of wild-type HIV-1 reverse transcriptase by fluorescence assay,N#C/C=C/c1cc(Cl)cc(Oc2ccccc2OCCn2ccc(=O)[nH]c2=O)c1,"(E)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)phenyl)acrylonitrile",0.0033,uM,=,-2.4814860601221125,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
1210,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(CC#N)cc2)nc2c1CCCC2,"4-((2-((4-(Cyanomethyl)phenyl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.053,uM,=,-1.275724130399211,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
1211,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,N#Cc1ccc(Nc2nc(N)cc(Cc3c(Cl)cccc3Cl)n2)cc1,"4-[4-Amino-6-(2,6-dichloro-benzyl)-pyrimidin-2-ylamino]-benzonitrile",0.001,uM,=,-3.0,0,c1ccc(Cc2ccnc(Nc3ccccc3)n2)cc1
1212,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,CC(C)C#CC1(C2CC2)NS(=O)(=O)Nc2ccc(Cl)cc21,"6-Chloro-4-cyclopropyl-4-(3-methyl-but-1-ynyl)-3,4-dihydro-1H-benzo[1,2,6]thiadiazine 2,2-dioxide",4.627,uM,=,0.6652994994998971,1,O=S1(=O)Nc2ccccc2C(C2CC2)N1
1213,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc(Br)cc23)c1,"N-(1-Amino-1-oxopropan-2-yl)-5-bromo-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.016,uM,=,-1.7958800173440752,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1214,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1O,"6-Benzyl-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.1,uM,=,0.041392685158225,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
1215,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,Ethyl 4-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-2-hydroxy-4-oxobut-2-enoate,10.0,uM,=,1.0,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
1216,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCc3nc4cccc(Cl)c4s3)ccc2Cl)c1,3-chloro-5-(2-chloro-5-((7-chlorobenzo[d]thiazol-2-yl)methoxy)phenoxy)benzonitrile,0.00306,uM,=,-2.51427857351842,0,c1ccc(Oc2cccc(OCc3nc4ccccc4s3)c2)cc1
1217,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NC(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-carboxylic acid (2-{4-[ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.14,uM,=,-0.8538719643217619,0,O=C(Nc1ccc2[nH]c(C(=O)N3CCC(Nc4ccccn4)CC3)cc2c1)N1CCNCC1
1218,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(OCCc1ccc([N+](=O)[O-])cc1)c1ccc([N+](=O)[O-])o1,4-nitrophenethyl 5-nitrofuran-2-carboxylate,2.1,uM,=,0.3222192947339193,1,O=C(OCCc1ccccc1)c1ccco1
1219,1278689,10.1016/j.bmc.2013.09.051,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin dUTP incorporation by primer extension assay,COc1ccnc(Nc2ccc(Cl)c(OCc3cccc(F)c3)c2)n1,N-(4-Chloro-3-((3-fluorobenzyl)oxy)phenyl)-4-methoxypyrimidin-2-amine,1.5,uM,=,0.1760912590556812,1,c1ccc(COc2cccc(Nc3ncccn3)c2)cc1
1220,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OCCc1ccccc1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid phenethyl ester",72.9,uM,=,1.8627275283179747,1,O=C(OCCc1ccccc1)c1ccccc1
1221,195663,10.1021/jm00132a002,,,,Inhibitory effect on HIV-1 reverse transcriptase activity using poly(rA)-oligo(dT) template primer,Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)P(=O)(O)P(=O)(O)O)O2)c(=O)[nH]c1=O,"1-(4-azido-5-{[(1,2,3,3-tetrahydroxy-1,2,3-trioxidotriphosphanyl)oxy]methyl}tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",0.034,uM,=,-1.4685210829577449,0,O=c1ccn(C2CCCO2)c(=O)[nH]1
1222,508734,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA PPT primed substrate by scintillation proximity assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.32,uM,=,-0.494850021680094,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1223,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,Oc1nc2cc(Cl)ccc2n1Cc1c(F)cccc1F,"5-Chloro-1-(2,6-difluoro-benzyl)-1,3-dihydro-benzoimidazol-2-one",60.0,uM,=,1.7781512503836436,1,c1ccc(Cn2cnc3ccccc32)cc1
1224,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(CCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(SC)cc2)c(OC)cc1O,"3-(4-Hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0607,uM,=,-1.2168113089247423,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1225,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCN(S(N)(=O)=O)CC3)cc2)nc2ccsc12,"(E)-4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-ylamino)phenyl)piperazine-1-sulfonamide",0.214,uM,=,-0.6695862266508091,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3ccsc23)cc1
1226,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(/C=C/C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)cc(OC)c1O,"(E)-N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamide",0.0015,uM,=,-2.8239087409443187,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1227,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1,"4-(3-{5-[1-Benzo[1,3]dioxol-5-yl-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid",33.0,uM,=,1.5185139398778875,1,O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccccc1
1228,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SCc2ccc(Cl)c(Cl)c2)n1,"6-Chloro-2-(3,4-dichloro-benzylsulfanyl)-pyrimidin-4-ylamine",0.062,uM,=,-1.207608310501746,0,c1ccc(CSc2ncccn2)cc1
1229,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2c(Cl)ccc3[nH]c(=S)n(c23)C[C@@H]1C,"5-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.005,uM,=,-2.3010299956639813,0,S=c1[nH]c2cccc3c2n1CCNC3
1230,2294755,10.1016/j.bmcl.2023.129216,,,,Inhibition of recombinant wildtype HIV-1 reverse transcriptase using r(A)350 as template and d(T)16 as primer preincubated with compound for 1 hrs followed by template/primer addition and measured after 30 mins by picogreen based plate reader analysis,C=Cc1ccc(-c2cc(F)c(Cc3cnc(Nc4ccc(C#N)c(Cl)c4)o3)c(F)c2)cc1,"2-chloro-4-((5-((3,5-difluoro-4'-vinyl-[1,1'-biphenyl]-4-yl)methyl)oxazol-2-yl)amino)benzonitrile",0.017,uM,=,-1.769551078621726,0,c1ccc(Nc2ncc(Cc3ccc(-c4ccccc4)cc3)o2)cc1
1231,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(NC(=O)COC(=O)c1ccc([N+](=O)[O-])o1)c1ccccc1,2-oxo-2-(2-phenylpropan-2-ylamino)ethyl 5-nitrofuran-2-carboxylate,8.2,uM,=,0.9138138523837168,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
1232,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Br)cc3)ccc2C(=O)N1O,"6-(4-Bromobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.0,uM,=,0.0,0,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
1233,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2-c2ccccc2)c(C)c1,"4-[5-Phenyl-4-(2,4,6-trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",0.024,uM,=,-1.619788758288394,0,c1ccc(Nc2ncc(-c3ccccc3)c(Nc3ccccc3)n2)cc1
1234,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2cccc([N+](=O)[O-])c2)n1,2-sec-Butylsulfanyl-6-(3-nitro-benzyl)-3H-pyrimidin-4-one,0.3,uM,=,-0.5228787452803376,0,c1ccc(Cc2ccncn2)cc1
1235,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccnc(F)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4-(2-Fluoropyridin-4-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0329,uM,=,-1.4828041020500258,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
1236,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,Cc1c(O)nc(SC2CCCC2)nc1Cc1cccc2ccccc12,2-Cyclopentylsulfanyl-5-methyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,45.0,uM,=,1.6532125137753435,1,c1ccc2c(Cc3ccnc(SC4CCCC4)n3)cccc2c1
1237,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#Cc2cccnc2)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,"4-((4-((4-(2,6-dimethyl-4-(pyridin-3-ylethynyl)phenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.28,uM,=,-0.5528419686577808,0,C(#Cc1cccnc1)c1ccc(Oc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccsc23)cc1
1238,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,COc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1C,3-(4-(4-(4-cyano-2-methoxy-6-methylphenoxy)-5-methylpyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.021,uM,=,-1.6777807052660807,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1239,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(O)c2)C(C)C)cc1,"3-(3, 4-Dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0205,uM,=,-1.6882461389442458,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1240,471453,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.3,uM,=,-0.5228787452803376,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1241,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,C[N+]1(C)C[C@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c(c2c2c4c4c6c9c6c4c4c2c%21c2c(c%16%20)c%15c9c%13c%10c6c9c24)[C@@H]%19[C@H]2c4c6c9c%10c(c4-%18)[C@@H]%17[C@@H]%14C%12=C%10[C@]4(C[N+](C)(C)C[C@@]8%114)[C@H]9[C@@H]7C5=C6[C@]23C1.[I-].[I-],Fullerene Derivative,1.7,uM,=,0.2304489213782739,1,C1[NH2+]C[C@@]23C4=C5c6c7c8c9c(c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c%24c(c6c6c%23c%23c(c86)c6c9c%11c8c(c%16%12)c%17c9c%19c%22c%23c9c86)[C@@H]5[C@H]5c6c8c(c-%14c(c64)[C@@H]2[C@H]%13%10)[C@@H]%15[C@@H]%18C%20=C8[C@]52C[NH2+]C[C@@]%24%212)[C@]173
1242,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(NC3CCN(Cc4ccccc4)CC3)c2)c(C)c1,N-(1-benzylpiperidin-4-yl)-6-chloro-4-(mesityloxy)pyridin-2-amine,0.287,uM,=,-0.5421181032660077,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
1243,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,"(8S,10S)-10-(4-Amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxy-acetyl)-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione",52.0,uM,=,1.7160033436347992,1,O=C1c2ccccc2C(=O)c2cc3c(cc21)CCC[C@@H]3O[C@H]1CCCCO1
1244,1551159,10.1016/j.ejmech.2015.11.039,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-dUTP/biotin-dUTP/dTTP nucleotides incubated for 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",3.1,uM,=,0.4913616938342727,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1245,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=C1C[C@@H](c2ccc(O)cc2)Oc2c1c(O)cc(O)c2[C@H]1C(=O)c2c(O)cc(O)cc2O[C@@H]1c1ccc(O)cc1,"(2S,2'S,3R)-5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-3,8'-bichroman-4,4'-dione",236.0,uM,=,2.3729120029701067,1,O=C1C[C@@H](c2ccccc2)Oc2c1cccc2[C@H]1C(=O)c2ccccc2O[C@@H]1c1ccccc1
1246,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,NC(=O)[C@H](CCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1)NC(=O)CCCCCNC(=O)[C@@H](N)CCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1,"N-[(4S)-4-amino-5-[[6-[[(1S)-1-carbamoyl-4-[[4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzoyl]amino]butyl]amino]-6-oxo-hexyl]amino]-5-oxo-pentyl]-4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzamide",0.0049,uM,=,-2.309803919971486,0,O=C(CCCCCNC(=O)CCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1)NCCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
1247,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(CNc2ncnc3ncccc23)nc(O)c1O,"5,6-Dihydroxy-2-((pyrido[2,3-d]pyrimidin-4-ylamino)methyl)pyrimidine-4-carboxylic acid",65.0,uM,=,1.812913356642856,1,c1cnc(CNc2ncnc3ncccc23)nc1
1248,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccccc1)CC(=O)C(=O)O,"(E)-6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-hex-5-enoic acid",15.0,uM,=,1.1760912590556811,1,c1ccc(Cn2cccc2)cc1
1249,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc(C(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"3-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzamide",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
1250,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1ccccc1C(=O)c1cc(Cl)ccc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,4-{4-[4-Chloro-2-(2-methylbenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,3.45,uM,=,0.5378190950732742,1,O=C(c1ccccc1)c1ccccc1Oc1ccnc(Nc2ccccc2)n1
1251,306090,10.1021/jm040071z,,,,Concentration required for 50% inhibition of human immunodeficiency virus type 1 reverse transcriptase Ile100,CCCc1c(SC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6-Chloro-4-cyclohexylsulfanyl-3-propyl-1H-quinolin-2-one,1.61,uM,=,0.2068258760318497,1,O=c1cc(SC2CCCCC2)c2ccccc2[nH]1
1252,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCOCCN(C)c1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,3-[(2-Ethoxy-ethyl)-methyl-amino]-5-ethyl-6-methyl-4-(3-methyl-benzyl)-1H-pyridin-2-one,0.013,uM,=,-1.8860566476931635,0,O=c1cc(Cc2ccccc2)cc[nH]1
1253,543620,10.1016/j.ejmech.2008.02.039,,,,Inhibition of HIV1 3B reverse transcriptase after 30 mins,O=C1CSC(c2c(F)cccc2F)N1CC12CC3CC(CC(C3)C1)C2,"3-Adamantan-1-ylmethyl-2-(2,6-difluorophenyl)-thiazolidin-4-one",495.0,uM,=,2.694605198933569,1,O=C1CSC(c2ccccc2)N1CC12CC3CC(CC(C3)C1)C2
1254,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NCCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)n1,"N-(2-chloro-4-sulfamoylphenyl)-3-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)propanamide",0.9,uM,=,-0.0457574905606751,0,O=C(CCNc1nccc(Oc2ccccc2)n1)Nc1ccccc1
1255,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CC(C)CSc1nc(O)cc(Cc2c(F)cccc2F)n1,"6-(2,6-Difluoro-benzyl)-2-isobutylsulfanyl-3H-pyrimidin-4-one",0.2,uM,=,-0.6989700043360187,0,c1ccc(Cc2ccncn2)cc1
1256,306024,10.1021/jm0402014,,,,Inhibitory concentration against human immunodeficiency virus type 1 reverse transcriptase,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3nnnc1c23,"(2R,3R,4S,5R)-2-(3-Amino-5-methyl-5H-1,4,5,6,7,8-hexaaza-acenaphthylen-1-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol",2.2,uM,=,0.3424226808222063,1,C1=NNc2nnnc3c2c1cn3[C@H]1CCCO1
1257,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",3.5,uM,=,0.5440680443502757,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1258,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc([N+](=O)[O-])cc2Cl)c(C)c1,N-(2-chloro-4-nitrophenyl)-2-(1-mesityl-1H-tetrazol-5-ylthio)acetamide,0.022,uM,=,-1.6575773191777938,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1259,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(o2)CCCC3)c(O)nc1C,"5-Ethyl-6-methyl-3-[(4,5,6,7-tetrahydro-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one",0.28,uM,=,-0.5528419686577808,0,c1cncc(NCc2nc3c(o2)CCCC3)c1
1260,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,COc1ccc(OC)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(2-fluoro-3,6-dimethoxy-phenyl)-cyclopropyl]-urea",0.002,uM,=,-2.6989700043360187,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
1261,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1ccn([C@@H]2O[C@H](CNCc3ccccc3Cl)[C@@H](O)[C@H]2O)c(=O)[nH]1,5'-(2-chlorobenzylamino)methyl-uridine,6.13,uM,=,0.787460474518415,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
1262,306286,10.1021/jm0496077,,,,Concentration required to inhibit catalytic activity of human immuno deficiency virus type 1 integrase,O=C(/C=C(\O)c1ccc(Cc2ccc(F)cc2)o1)c1nc[nH]n1,"(Z)-1-[5-(4-Fluoro-benzyl)-furan-2-yl]-3-hydroxy-3-(1H-[1,2,4]triazol-3-yl)-propenone",0.02,uM,=,-1.6989700043360187,0,O=C(C=Cc1ccc(Cc2ccccc2)o1)c1nc[nH]n1
1263,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCc3ccccc3)cc2)n[nH]1,3-(1-(4-Fluorobenzyl)-4-(4-(benzyloxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,3.21,uM,=,0.5065050324048721,1,c1ccc(COc2ccc(-c3cn(Cc4ccccc4)cc3-c3cc[nH]n3)cc2)cc1
1264,196934,10.1021/jm00115a022,,,,Inhibition of HIV-1 reverse transcriptase from peripheral blood mononuclear cells,Cc1c([Se]c2ccccc2)n(COCCO)c(=O)[nH]c1=O,"1-(2-Hydroxy-ethoxymethyl)-5-methyl-6-phenylselanyl-1H-pyrimidine-2,4-dione",90.3,uM,=,1.9556877503135053,1,O=c1cc([Se]c2ccccc2)[nH]c(=O)[nH]1
1265,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SCc2cccc(Br)c2)n1,2-(3-Bromo-benzylsulfanyl)-6-chloro-pyrimidin-4-ylamine,0.14,uM,=,-0.8538719643217619,0,c1ccc(CSc2ncccn2)cc1
1266,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,O=c1cc(O)c2c(=O)oc3ccc4ccccc4c3c2o1,"4-hydroxybenzo[f]pyrano[3,2-c]chromene-2,5-dione",61.3,uM,=,1.787460474518415,1,O=c1ccc2c(=O)oc3ccc4ccccc4c3c2o1
1267,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,NS(=O)(=O)c1ccc(NC(=O)COc2cc(Cl)cc(Oc3ccccc3)c2)c(Cl)c1,2-(3-chloro-5-phenoxy-phenoxy)-N-(2-chloro-4-sulfamoyl-phenyl)-acetamide,0.0105,uM,=,-1.978810700930062,0,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ccccc1
1268,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)CCCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-6-methyloxycarbonyl-1-hexenyl]-2-methoxybenzoate,0.47,uM,=,-0.3279021420642826,0,C=C(c1ccccc1)c1ccccc1
1269,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,Fc1cc(F)c(CC/N=C(\S)Nc2ccc(Cl)cn2)c(F)c1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2,4,6-trifluoro-phenyl)-ethyl]-thiourea",0.002,uM,=,-2.6989700043360187,0,C(=NCCc1ccccc1)Nc1ccccn1
1270,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2CC[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(5-Hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.12,uM,=,-0.9208187539523752,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1271,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2ccccc2Oc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",2.3,uM,=,0.3617278360175928,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
1272,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccc(F)cc2)C1,"1-benzyl-4-(4-fluorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",2.9,uM,=,0.4623979978989561,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
1273,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCC(=O)O)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"3',3''-Dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoic Acid",100.0,uM,=,2.0,1,C=C(c1ccccc1)c1ccccc1
1274,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N2CCCCC2)c1Cc1cc(C)cc(C)c1,"4''-(3,5-Dimethyl-benzyl)-5''-ethyl-6''-methyl-3,4,5,6-tetrahydro-2H,1''H-[1,3'']bipyridinyl-2''-one",0.631,uM,=,-0.1999706407558656,0,O=c1[nH]ccc(Cc2ccccc2)c1N1CCCCC1
1275,197432,10.1021/jm990236h,,,,Antiviral activity was evaluated by Reverse transcriptase activity in cells acutely infected with HIV-1,CCCCCCCCCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Dodecanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",1.0,uM,=,0.0,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
1276,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CSCN1c2ccccc2N(C)C(=O)c2cccnc21,"6-Methyl-11-methylsulfanylmethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",6.6,uM,=,0.8195439355418687,1,O=C1Nc2ccccc2Nc2ncccc21
1277,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,COc1cccc(CSc2nc(Cc3ccccc3)c(I)c(=O)[nH]2)c1,6-Benzyl-2-(3-methoxybenzylthio)-5-iodo pyrimidin-4(3H)-one,8.29,uM,=,0.9185545305502736,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
1278,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)c1cc(C(=CCC2OCCO2)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-3-(1,3-dioxolan-2-yl)-1-propenyl]-2-methoxybenzoate",20.5,uM,=,1.3117538610557542,1,C(CC1OCCO1)=C(c1ccccc1)c1ccccc1
1279,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2-hydroxy-2-oxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-hydroxy-propyl)-5-methyl-1H-pyrimidine-2,4-dione",3.0,uM,=,0.4771212547196624,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1280,2119941,10.1016/j.ejmech.2021.113681,,,,Inhibition of recombinant HIV1 reverse transcriptase by colorimetric assay,O=C(NC1(c2nc(CO)cs2)CCNCC1)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1,N-(4-(4-(hydroxymethyl)thiazol-2-yl)piperidin-4-yl)-5-(4-(trifluoromethyl)phenyl)-1H-pyrrole-2-carboxamide,1.7,uM,=,0.2304489213782739,1,O=C(NC1(c2nccs2)CCNCC1)c1ccc(-c2ccccc2)[nH]1
1281,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1ccccn1,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-(pyridin-2-ylmethoxy)-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.572,uM,=,0.1964525417033891,1,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccn1
1282,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1ccc(Sc2cc(=O)n(O)c(=O)[nH]2)cc1,"3-Hydroxy-6-((4-methoxyphenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1283,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NCC1CCCO1,2-oxo-2-((tetrahydrofuran-2-yl)methylamino)ethyl 5-nitrofuran-2-carboxylate,4.2,uM,=,0.6232492903979004,1,O=C(COC(=O)c1ccco1)NCC1CCCO1
1284,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+],"4-Hexadecanoylamino-5-hydroxy-naphthalene-2,7-disulfonic acid sodium",4.8,uM,=,0.6812412373755872,1,c1ccc2ccccc2c1
1285,195674,10.1021/jm0009437,,,,Tested for inhibitory concentration on HIV-1 Reverse transcriptase in the presence of poly(c)-oligo-(dG),Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.2,uM,=,-0.6989700043360187,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1286,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(/C=C/C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(SC)cc2)cc(OC)c1O,"(E)-3-(4-hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0515,uM,=,-1.288192770958809,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1287,195512,10.1021/jm960056x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,"6-Benzyl-1-ethoxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.008,uM,=,-2.096910013008056,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
1288,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,O=C(NCc1ccc(F)cc1)c1c(O)c(=O)[nH]c2ccc(Cl)cc12,N-(4-Fluorobenzyl)-6-chloro-3-hydroxy-2-oxoquinoline-4-carboxamide,18.0,uM,=,1.255272505103306,1,O=C(NCc1ccccc1)c1cc(=O)[nH]c2ccccc12
1289,508748,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization using chimeric substrate with RNA PPT primer extended at 3' end with upto 12 deoxyribonucleotides,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.13,uM,=,-0.8860566476931633,0,c1cncc(NCc2nc3ccccc3o2)c1
1290,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,Cn1c(=O)[nH]c2cccc(Oc3cc(Cl)cc(C#N)c3)c21,"3-chloro-5-(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)benzonitrile",0.029,uM,=,-1.537602002101044,0,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
1291,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2ccc3ccccc3n2)c(O)nc1C,5-Ethyl-6-methyl-3-(2-quinolin-2-yl-ethyl)-1H-pyridin-2-one,2.45,uM,=,0.3891660843645325,1,c1cncc(CCc2ccc3ccccc3n2)c1
1292,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,"2-(3-Amino-5-methyl-5H-1,4,5,6,8-pentaaza-acenaphthylen-1-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol",0.04,uM,=,-1.3979400086720375,0,C1=NNc2ncnc3c2c1cn3[C@H]1CCCO1
1293,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCc2nnc(C)o2)c2cc(C)c3onc(OC)c3c2)cc1C(=O)SC,"(Z)-S-methyl 2-methoxy-5-(1-(3-methoxy-7-methylbenzo[d]-isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-3-methylbenzothioate",0.9,uM,=,-0.0457574905606751,0,C(\CCc1nnco1)=C(\c1ccccc1)c1ccc2oncc2c1
1294,768443,10.1016/j.ejmech.2011.06.034,,,,Inhibition of wild-type HIV1 subtype B reverse transcriptase assessed as incorporation of [3H]dTTP,Nc1ncnc2c1ncn2CCOCP(=O)([S-])OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],tetrasodium [({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}(sulfanidyl)phosphoryl phosphonato)oxy]phosphonate,6.8,uM,=,0.8325089127062363,1,c1ncc2nc[nH]c2n1
1295,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)nc3ccccc32)c1,"2-{[1-(3,5-Dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-(2-chloro-4-sulfamoylphenyl)-acetamide",1.02,uM,=,0.0086001717619175,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
1296,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,COc1ccc(-c2csc(N/N=C3\C(=O)Nc4ccccc43)n2)cc1,(Z)-3-(2-(4-(4-methoxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one,26.0,uM,=,1.414973347970818,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
1297,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,NS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-sulfonamide",0.5,uM,=,-0.3010299956639812,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1298,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2nc(SC(C)C)nc(O)c2C)c1,2-Isopropylsulfanyl-5-methyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,2.5,uM,=,0.3979400086720376,1,c1ccc(Cc2ccncn2)cc1
1299,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)cc(Cl)c1,"2-Amino-6-(3,5-dichloro-benzenesulfonyl)-benzonitrile",0.03,uM,=,-1.5228787452803376,0,O=S(=O)(c1ccccc1)c1ccccc1
1300,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3ccccc3)C2)ncc1Br,"4-(5-bromo-2-(1-phenylpyrrolidin-3-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.067,uM,=,-1.1739251972991736,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)C3)n2)cc1
1301,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc4[nH]ccc34)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(1H-indol-4-yloxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.71,uM,=,-0.1487416512809247,0,O=C1Nc2cccnc2Nc2ncc(COc3cccc4[nH]ccc34)cc21
1302,80139,10.1016/s0960-894x(98)00249-2,,,,Compound was tested for its inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,O=C(NCCc1c(F)cccc1F)Nc1ccc(Cl)cn1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2,6-difluoro-phenyl)-ethyl]-urea",0.003,uM,=,-2.5228787452803374,0,O=C(NCCc1ccccc1)Nc1ccccn1
1303,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,Cc1ccc2oc(=O)c3cc(C4=Nc5ccc(C(=O)c6ccccc6)cc5N=CC4)c(=O)oc3c2c1,"3-((1E,4Z)-7-benzoyl-3H-benzo[b][1,4]diazepin-2-yl)-9-methylpyrano[3,2-c]chromene-2,5-dione",42.9,uM,=,1.6324572921847242,1,O=C(c1ccccc1)c1ccc2c(c1)N=CCC(c1cc3c(=O)oc4ccccc4c3oc1=O)=N2
1304,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CCNc1cccnc1N1CCN(C(=O)c2cc3cc(O)ccc3[nH]2)CC1,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-hydroxy-1H-indol-2-yl)-methanone,2.0,uM,=,0.3010299956639812,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
1305,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Cc1cccc(CSc2nc(N)cc(Cl)n2)c1,6-Chloro-2-(3-methyl-benzylsulfanyl)-pyrimidin-4-ylamine,0.05,uM,=,-1.3010299956639813,0,c1ccc(CSc2ncccn2)cc1
1306,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1OC,"6-((3',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",5.8,uM,=,0.7634279935629373,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1307,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2cc(Cl)cc3nc(O)n(c23)CC1C,"4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",0.18,uM,=,-0.744727494896694,0,c1cc2c3c(c1)ncn3CCNC2
1308,1862051,10.1016/j.ejmech.2019.111619,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(C)cc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid amide",0.56,uM,=,-0.2518119729937995,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1309,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccc(OCC(=O)Nc3ccccc3)cc2)n[nH]1,Ethyl 3-(1-(naphthalen-1-yl-methyl)-4-(4-(2-oxo-2-(phenylamino)ethoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,7.9,uM,=,0.8976270912904415,1,O=C(COc1ccc(-c2cn(Cc3cccc4ccccc34)cc2-c2cc[nH]n2)cc1)Nc1ccccc1
1310,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,N#CC1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)CC(n2cnc3c(=O)[nH]c(N)nc32)CC1O,rac-(4-(2-amino-6-oxo-1H-purin-9(6H)-yl)-1-cyano-2-hydroxycyclopentyl)methyltriphosphoric acid,0.444,uM,=,-0.3526170298853802,0,O=c1[nH]cnc2c1ncn2C1CCCC1
1311,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",6.3,uM,=,0.7993405494535817,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1312,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3cnccn3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(pyrazin-2-yl)acetamide,63.4,uM,=,1.802089257881733,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1cnccn1
1313,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccc2c(c1)C1(c3ccccc3)SCCN1C2=O,"8-Methyl-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.72,uM,=,-0.1426675035687315,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1314,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2Cl)c(O)nc1C,3-(2-Chloro-benzylamino)-5-ethyl-6-methyl-1H-pyridin-2-one,1.45,uM,=,0.1613680022349748,1,c1ccc(CNc2cccnc2)cc1
1315,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"((S)-1-{N'-Biphenyl-4-ylmethyl-N'-[(2S,3S)-2-hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-hydrazinocarbonyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.051,uM,=,-1.2924298239020635,0,c1ccc(CCCCNCc2ccc(-c3ccccc3)cc2)cc1
1316,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccc(F)cc2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-(4-Fluorobenzyl)-1-((4-fluorobenzyloxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",6.2,uM,=,0.7923916894982539,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1317,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(CCc1ccccc1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(phenethyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,14.2,uM,=,1.1522883443830565,1,O=C(COC(=O)c1ccco1)NCCc1ccccc1
1318,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(C)c2c(c1)Oc1ccc(O)cc1C(=O)N2C,"2-Hydroxy-7,9,10-trimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.063,uM,=,-1.2006594505464183,0,O=C1Nc2ccccc2Oc2ccccc21
1319,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2ccc(-c3cccc(O)c3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.22,uM,=,-0.6575773191777937,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1320,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)pyrimidine-2,4(1H,3H)-dione",0.047,uM,=,-1.3279021420642825,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1321,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",4.6,uM,=,0.6627578316815741,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1322,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cc(N)ccc2Oc2cccc(C)c21,"2-Amino-10-ethyl-9-methyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2ccccc2Oc2ccccc21
1323,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NC(C)c2cc3ccccc3o2)c(O)nc1C,3-(1-Benzofuran-2-yl-ethylamino)-5-ethyl-6-methyl-1H-pyridin-2-one,0.97,uM,=,-0.0132282657337551,0,c1cncc(NCc2cc3ccccc3o2)c1
1324,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-3-propylamino-1H-pyridin-2-one",0.02,uM,=,-1.6989700043360187,0,O=c1cc(Cc2ccccc2)cc[nH]1
1325,196512,10.1021/jm9801049,,,,Inhibitory activity against wild type HIV-1 reverse transcriptase (WT-RT),CC(Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,"6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine",0.024,uM,=,-1.619788758288394,0,c1cnc(SCc2cc3ccoc3cn2)nc1
1326,545205,10.1016/j.ejmech.2008.10.032,,,,Inhibition of wild-type HIV1 reverse transcriptase,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1cccnc1Cl)c1ccc(Br)cc1,"O-[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl]4-bromophenyl[(2-chloropyridin-3-yl)carbonyl]thiocarbamate",0.7,uM,=,-0.1549019599857432,0,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1cccnc1)c1ccccc1
1327,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,NCc1ccccc1-c1cccc(-c2cc(=O)n(O)c3ncccc23)c1,"4-(2'-(aminomethyl)biphenyl-3-yl)-1-hydroxy-1,8-naphthyridin-2(1H)-one",0.67,uM,=,-0.1739251972991735,0,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2[nH]1
1328,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,Cc1ccc(Cc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)c(O)c1,"5-Cyclopropyl-9-(2-hydroxy-4-methyl-benzyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.2,uM,=,-0.6989700043360187,0,O=C1Nc2c(Cc3ccccc3)ccnc2N(C2CC2)c2ncccc21
1329,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Oc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(OC(=O)CCCCCCCCCCCCCCC)c12.[Na+].[Na+],"Hexadecanoic acid 8-hexadecanoyloxy-3,6-disulfo-naphthalen-1-yl ester; disodium salt",2.4,uM,=,0.380211241711606,1,c1ccc2ccccc2c1
1330,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(/C=C/CO)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-((E)-3-hydroxy-propenyl)-5-methyl-1H-pyrimidine-2,4-dione",1.9,uM,=,0.2787536009528289,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1331,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccccc2)C1,"1-benzyl-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",0.73,uM,=,-0.1366771398795441,0,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
1332,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[2-(3-ethoxy-2,6-difluoro-phenyl)-ethyl]-thiourea",0.004,uM,=,-2.397940008672037,0,S=C(NCCc1ccccc1)Nc1ccccn1
1333,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1ccn2COCC[Si](C)(C)C,"5-((4-(4-Cyano-2,6-dimethylphenoxy)-7-((2-(trimethylsilyl)-ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-picolinonitrile",7.4,uM,=,0.8692317197309762,1,c1ccc(Oc2nc(Nc3cccnc3)nc3[nH]ccc23)cc1
1334,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",4.3,uM,=,0.6334684555795865,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1335,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CCc1c(Sc2ccccc2)n(COCCOCc2ccccc2)c(=O)[nH]c1=O,"1-(2-Benzyloxy-ethoxymethyl)-5-ethyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",0.003,uM,=,-2.5228787452803374,0,O=c1cc(Sc2ccccc2)n(COCCOCc2ccccc2)c(=O)[nH]1
1336,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nnnn2-c2c(C)ccnc21,"8-Ethyl-4-methyl-8H-1,2,3,3a,7,8,9-heptaaza-dibenzo[e,h]azulene",75.1,uM,=,1.8756399370041683,1,c1cnc2c(c1)-c1nnnn1-c1cccnc1N2
1337,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)ncc1Br,"4-(5-bromo-2-(1-(2-chloro-4-(methylsulfonyl)benzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.045,uM,=,-1.3467874862246565,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
1338,842481,10.1016/j.bmc.2012.07.026,,,,Inhibition of recombinant HIV-1 RT assessed as inhibition of biotin-dUTP incorporation by colorimetric analysis,Cc1cc(C)c(-n2c(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3Br)nc3cnccc32)c(C)c1,"N-(4-sulfonamide-2-bromophenyl)-2-(1-mesityl-1H-imidazo[4,5-c]pyridin-2-ylthio)acetamide",4.4,uM,=,0.6434526764861874,1,O=C(CSc1nc2cnccc2n1-c1ccccc1)Nc1ccccc1
1339,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,CCCCCC1OC1(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,"3',3''-Dibromo-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-heptene Epoxide",5.6,uM,=,0.7481880270062004,1,c1ccc(C2(c3ccccc3)CO2)cc1
1340,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(Oc3ccccc3)cc2c1=O,"1-(4-Fluorobenzyl)-4-oxo-6-phenoxy-1,4-dihydroquinoline-3-carboxylic Acid",32.0,uM,=,1.505149978319906,1,O=c1ccn(Cc2ccccc2)c2ccc(Oc3ccccc3)cc12
1341,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-n3cccc3)nc21,"5-Ethyl-10-methyl-7-pyrrol-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2ccc(-n3cccc3)nc2Nc2ncccc21
1342,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCCCC=C(c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,"4',4''-Dimethoxy-3',3''-di(methoxycarbonyl)-5',5''-dimethyl-1,1-diphenyl-1-heptene",1.0,uM,=,0.0,0,C=C(c1ccccc1)c1ccccc1
1343,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,C=CC(=O)N1CCN(Cc2ccc(Nc3nccc(Oc4c(C)cc(/C=C/C#N)cc4C)n3)cc2)CC1,"(E)-3-(4((2-((4-((4-acryloylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile",0.071,uM,=,-1.1487416512809248,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
1344,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3Br)nc3ccc(Cl)cc32)c1,"2-({6-Chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl}sulfanyl)-N-2-bromophenylacetamide",63.5,uM,=,1.802773725291976,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1345,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,Cc1ccc2c(c1)CCCN2C(=O)SCC(=O)Nc1ccc(S(N)(=O)=O)cc1Cl,"S-2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",0.003,uM,=,-2.5228787452803374,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
1346,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12,"5,11-Dimethyl-6H-pyrido[4,3-b]carbazole (ellipticine)",182.0,uM,=,2.2600713879850747,1,c1ccc2c(c1)[nH]c1cc3ccncc3cc12
1347,1551159,10.1016/j.ejmech.2015.11.039,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-dUTP/biotin-dUTP/dTTP nucleotides incubated for 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1cc(NCCN(C)C)nc(Nc2ccc(C#N)cc2)c1,"4-((2-((4-cyanophenyl)amino)-6-((2-(dimethylamino)ethyl)amino)pyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",3.4,uM,=,0.5314789170422551,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
1348,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CC(N)=O)[nH]c3ccc(Br)cc23)c1,"N-(4-Amino-4-oxobutan-3-yl)-5-bromo-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.081,uM,=,-1.0915149811213505,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1349,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CCc1ccc(O)c(O)c1)S(=O)(=O)c1ccc(N)cc1,"N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(3, 4-dihydroxyphenyl)propanamide",0.0095,uM,=,-2.0222763947111524,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1350,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,COc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)nc1,"4-(5-Methoxy-pyridin-2-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.013,uM,=,-1.8860566476931635,0,O=c1nc(-c2ccccn2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1351,140625,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 variant with Y181C plus K103N mutations in RT (reverse transcriptase),S=C(NCCc1c[nH]c2ccccc12)Nc1nccs1,1-[2-(1H-Indol-3-yl)-ethyl]-3-thiazol-2-yl-thiourea,3.7,uM,=,0.568201724066995,1,S=C(NCCc1c[nH]c2ccccc12)Nc1nccs1
1352,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,Cc1ccc(NC(=O)CCCCC(=O)Nc2ccc(C)cc2C(=O)O)c(C(=O)O)c1,2-[4-(2-carboxy-4-methylphenylcarbamoyl)butylcarboxamido]-5-methylbenzoic acid,14.0,uM,=,1.146128035678238,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
1353,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1cccc(-c2ccccc2)c1)c1cc(=O)n(O)c(=O)[nH]1,"6-([1,1'-Biphenyl]-3-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.017,uM,=,-1.769551078621726,0,O=C(c1cccc(-c2ccccc2)c1)c1cc(=O)[nH]c(=O)[nH]1
1354,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",4.7,uM,=,0.6720978579357175,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1355,195674,10.1021/jm0009437,,,,Tested for inhibitory concentration on HIV-1 Reverse transcriptase in the presence of poly(c)-oligo-(dG),CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,"N-[4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl]-formamide",0.2,uM,=,-0.6989700043360187,0,O=c1cc(Cc2ccccc2)cc[nH]1
1356,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,[(R)-2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid,0.38,uM,=,-0.4202164033831898,0,c1ncc2nc[nH]c2n1
1357,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)C(=NNc1ccc(Cl)cc1)C(=O)O,2-(2-(4-chlorophenyl)hydrazono)malonic acid,1.5,uM,=,0.1760912590556812,1,c1ccccc1
1358,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(Cl)cc1Cl,"6-[1-(2,4-Dichlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",9.0,uM,=,0.9542425094393248,1,c1ccc(Cn2cccc2)cc1
1359,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(Cl)c1Nc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,3-(4-(4-(2-chloro-4-cyano-6-methylphenylamino)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.036,uM,=,-1.4436974992327127,0,c1ccc(Nc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1360,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(=O)N[C@H](C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-(3,5-dimethylphenylsulfonyl)-N-((S)-1-oxo-1-((R)-1-(pyridin-4-yl)ethylamino)propan-2-yl)-1H-indole-2-carboxamide",0.61,uM,=,-0.2146701649892329,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncc1
1361,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1SCC2,"3,5-Dimethyl-4-((2-((1-(4-nitrobenzyl)piperidin-4-yl)amino)-6,7-dihydrothien[3,2-d]pyrimidin-4-yl)oxy)benzonitrile",0.175,uM,=,-0.7569619513137056,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)SCC4)CC2)cc1
1362,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(-c2ccc(F)c(C#N)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"4-fluoro-3'-methyl-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",5.49,uM,=,0.7395723444500919,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1363,630077,10.1016/j.bmcl.2009.04.051,,,,Inhibition of biotin-dUTP labeled HIV-1 reverse transcriptase after 30 mins colorimetric streptavidin alkaline phosphatase reporter system,Cc1ccccc1CSc1nc(N)cc(Cc2ccccc2)n1,6-benzyl-2-(2-methylbenzylthio)pyrimidin-4-amine,29.89,uM,=,1.4755259150392808,1,c1ccc(CSc2nccc(Cc3ccccc3)n2)cc1
1364,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)c(Cl)c2[C@@](C#CC2CC2)(C(F)(F)F)N1,"5-Chloro-4-cyclopropylethynyl-6-fluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.059,uM,=,-1.2291479883578558,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
1365,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,N#Cc1ccc(NC(=O)COc2ccnc(Nc3ccc(C#N)cc3)n2)cc1,N-(4-Cyanophenyl)-2-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)acetamide,23.88,uM,=,1.3780343224573317,1,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
1366,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3ncccc3o2)c(O)nc1C,"5-Ethyl-6-methyl-3-[(oxazolo[4,5-b]pyridin-2-ylmethyl)-amino]-1H-pyridin-2-one",1.9,uM,=,0.2787536009528289,1,c1cncc(NCc2nc3ncccc3o2)c1
1367,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ncn[nH]3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(1H-pyrazol-5-yl)acetamide,0.522,uM,=,-0.2823294969977378,0,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ncn[nH]1
1368,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(Cl)cn2)c1O,1-(5-Chloro-pyridin-2-yl)-3-[2-(6-fluoro-2-hydroxy-3-propionyl-phenyl)-cyclopropyl]-urea,0.009,uM,=,-2.0457574905606752,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
1369,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccoc3)nc21,"5-Ethyl-7-furan-3-yl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2ccc(-c3ccoc3)nc2Nc2ncccc21
1370,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2oc3ccccc3c2C)c(O)nc1C,5-Ethyl-6-methyl-3-[(3-methyl-benzofuran-2-ylmethyl)-amino]-1H-pyridin-2-one,1.95,uM,=,0.290034611362518,1,c1cncc(NCc2cc3ccccc3o2)c1
1371,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1372,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,Cc1[nH]c(=O)c(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1CCOc1ccccc1,"3-Chloro-5-(3-chloro-6-methyl-2-oxo-5-(2-phenoxyethyl)-1,2-dihydropyridin-4-yloxy)benzonitrile",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Oc2ccccc2)c(CCOc2ccccc2)c[nH]1
1373,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1cnc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(5-Methylamino-pyrazin-2-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.013,uM,=,-1.8860566476931635,0,O=c1nc(-c2cnccn2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1374,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CC(C)N1C(=O)c2ccccc2Oc2ccccc21,"10-Isopropyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.34,uM,=,-0.4685210829577448,0,O=C1Nc2ccccc2Oc2ccccc21
1375,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Cl)c(Cl)c3)cc2c1=O,"Ethyl 6-((3,4-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",37.2,uM,=,1.5705429398818975,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
1376,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,C[N+]1(C)C[C@@]23C4=C5C6=C7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c%24c%25c%26c%27c(c(c8c8c%10c%13c(c%278)c8c%14c%17c(c%24c%22%18)c%268)[C@@]72C1)[C@H]%25[C@@H]3C=%23[C@@H]4[C@H]%21c1c5c2c3c(c1-%20)[C@H]([C@H]%19%16)[C@@]1(C[N+](C)(C)C[C@]%12%151)C3=C%11[C@H]9[C@H]62.[I-].[I-],Fullerene Derivative,1.6,uM,=,0.2041199826559248,1,C1[NH2+]C[C@@]23C4=C5c6c7c8c9c(c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c%21c%22c%23c%24c%25c(c6c6c%24c%21c(c86)c6c9c%11c(c%18c%16%12)c%206)[C@@H]5[C@@H]5C6=C%25[C@]%238C[NH2+]C[C@@]89C8=C6c6c(c-%14c(c4c65)[C@@H]2[C@H]%13%10)[C@@H]%15[C@H]8C=%17[C@H]9[C@H]%22%19)[C@]173
1377,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2F)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((2'-fluoro-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.046,uM,=,-1.337242168318426,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1378,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CCc1ccc(O)c(OC)c1)S(=O)(=O)c1ccc(OC)cc1,"3-(4-Hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-(4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.234,uM,=,-0.6307841425898572,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1379,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COC(=O)CCC/C=C(/c1cc(C)c2onc(OC)c2c1)c1cc(C)c2oc(=O)n(C)c2c1,"(Z)-methyl 6-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-6-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)hex-5-enoate",0.25,uM,=,-0.6020599913279624,0,C=C(c1ccc2oncc2c1)c1ccc2oc(=O)[nH]c2c1
1380,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C/CCc2nnc(C)o2)c2cc(C)c3oc(=O)n(C)c3c2)cc(C)c1OC,"(E)-5-[1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzooxazol-5-yl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-2-enyl]-2-methoxy-3-methylbenzoic acid methyl ester",1.0,uM,=,0.0,0,O=c1[nH]c2cc(/C(=C\CCc3nnco3)c3ccccc3)ccc2o1
1381,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)c(C#N)c2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3',5'-dimethyl-[1,1'-biphenyl]-3,4-dicarbonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1382,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",34.0,uM,=,1.5314789170422551,1,S=c1[nH]c2cccc3c2n1CCNC3
1383,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](O)CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1,aleuritolic acid,24.9,uM,=,1.3961993470957363,1,C1=C2C(CC[C@H]3C2CC[C@H]2CCCCC23)[C@@H]2CCCCC2C1
1384,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,COc1cc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)ccn1,"4-(2-Methoxy-pyridin-4-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0087,uM,=,-2.0604807473813813,0,O=c1nc(-c2ccncc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1385,722004,10.1128/aac.00800-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild-type Human immunodeficiency virus 1 subtype B reverse transcriptase by filter-based filtration assay,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-[4-(2,4,6-Trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",0.37,uM,=,-0.431798275933005,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
1386,953196,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dTTP incorporation after 15 mins by PAGE,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4-[2-(4-Cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1387,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=C1Cc2cc(-c3ccccc3)ccc2C(=O)N1O,"2-Hydroxy-6-phenylisoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(-c3ccccc3)ccc2C(=O)N1
1388,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3ccc(C)cc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[2-(6-methyl-benzooxazol-2-yl)-ethyl]-1H-pyridin-2-one,0.172,uM,=,-0.7644715530924511,0,c1cncc(CCc2nc3ccccc3o2)c1
1389,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OC1COc2cccc(O)c2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 5-hydroxy-chroman-3-yl ester",8.7,uM,=,0.9395192526186184,1,O=C(OC1COc2ccccc2C1)c1ccccc1
1390,80270,10.1016/s0960-894x(98)00249-2,,,,Compound was tested for its inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),O=C(NCCc1c(F)cccc1F)Nc1ccc(Cl)cn1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2,6-difluoro-phenyl)-ethyl]-urea",0.42,uM,=,-0.3767507096020995,0,O=C(NCCc1ccccc1)Nc1ccccn1
1391,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2cccc(F)c2[C@@](C#CC2CC2)(C(F)(F)F)N1,"4-Cyclopropylethynyl-5-fluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.062,uM,=,-1.207608310501746,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
1392,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1cc(C)cc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"6-chloro-1-(3,5-dimethylphenylsulfonyl)-1H-benzo[d]imidazol-2(3H)-one",0.005,uM,=,-2.3010299956639813,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
1393,541098,10.1016/j.bmc.2008.12.028,,,,Inhibition on HIV1 reverse transcriptase p66/p51,Nc1ncnc2c1ncn2[C@H]1C=C[C@@H](OCP(=O)(O)O)O1,"[(2R,5R)-5-(6-Amino-purin-9-yl)-2,5-dihydro-furan-2-yloxymethyl]-phosphonic acid",0.6,uM,=,-0.2218487496163563,0,C1=C[C@H](n2cnc3cncnc32)OC1
1394,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CN(c1ncccc1CO)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Hydroxymethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,15.0,uM,=,1.1760912590556811,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1395,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CCc3nc4ccccc4o3)[nH]c(=O)c2Cl)c1,"3-(6-(2-(Benzo[d]oxazol-2-yl)ethyl)-3-chloro-2-oxo-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Oc2ccccc2)cc(CCc2nc3ccccc3o2)[nH]1
1396,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nncn2-c2cccnc21,"8-Ethyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",72.8,uM,=,1.8621313793130367,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
1397,442659,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rC.dG template,Cc1cccc(N2C(=O)CSC2C23CC4CC(CC(C4)C2)C3)n1,2-adamantan-1-yl-3-(6-methyl-pyridin-2-yl)-thiazolidin-4-one,40.0,uM,=,1.6020599913279625,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
1398,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(CN3CCOCC3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-morpholin-4-ylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.03,uM,=,0.0128372247051722,1,O=C1Nc2c(CN3CCOCC3)ccnc2N(C2CC2)c2ncccc21
1399,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2ccccc2Oc2ccccc21,"10-Propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.375,uM,=,-0.4259687322722811,0,O=C1Nc2ccccc2Oc2ccccc21
1400,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2c(C)c(C)[nH]c(=O)c2N(C)C)c1,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-5,6-dimethyl-1H-pyridin-2-one",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Cc2ccccc2)cc[nH]1
1401,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(OC)c2)cn1,"(E)-3-(4-hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.124,uM,=,-0.906578314837765,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1cccnc1)Cc1ccccc1
1402,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,COc1ccc2cc(C(=O)N3CCN(c4ncccc4NC(C)C)CC3)[nH]c2c1,[4-(3-Isopropylamino-pyridin-2-yl)-piperazin-1-yl]-(6-methoxy-1H-indol-2-yl)-methanone,1.3,uM,=,0.1139433523068367,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
1403,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1,"4-(3-{5-[1-Benzo[1,3]dioxol-5-yl-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid",23.0,uM,=,1.3617278360175928,1,O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccccc1
1404,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,CC(C)Oc1ccc(-c2cnc3ncnc(NC(P(=O)(O)O)P(=O)(O)O)c3c2)cc1,"(((6-(4-Isopropoxyphenyl)pyrido[2,3-d]pyrimidin-4-yl)-amino)methylene)diphosphonic Acid",10.0,uM,=,1.0,1,c1ccc(-c2cnc3ncncc3c2)cc1
1405,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1cc2c(Oc3ccc(OS(=O)(=O)F)cc3OCCn3ccc(=O)[nH]c3=O)cc(F)cn2c1,"4-((2-Cyano-6-fluoroindolizin-8-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.064,uM,=,-1.193820026016113,0,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
1406,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CCc3cccc(Cl)c3)[nH]c(=O)c2Cl)c1,"3-Chloro-5-(3-chloro-6-(3-chlorophenethyl)-2-oxo-1,2-dihydropyridin-4-yloxy)benzonitrile",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccc2)[nH]1
1407,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,COc1cc2c(cc1O)CC[n+]1cc3c(OC)c(OC)ccc3cc1-2.[Cl-],"3-Hydroxy-2,9,10-trimethoxy-5,6-dihydro-isoquino[3,2-a]isoquinolinylium chloride",190.29338334430705,uM,=,2.2794236877772263,1,c1ccc2c(c1)CC[n+]1cc3ccccc3cc1-2
1408,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",6.9,uM,=,0.8388490907372553,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1409,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,O=C(Nc1cccc(F)c1)C1C(=O)N(O)C(=O)c2ccccc21,"N-(3-Fluorophenyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",7.31,uM,=,0.8639173769578604,1,O=C1NC(=O)C(C(=O)Nc2ccccc2)c2ccccc21
1410,1336117,10.1021/jm5001503,,,,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCNCC3)ccc2c1=O,4-[1-[(4-Fluorophenyl)methyl]-7-(piperazin-1-yl)-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,28.7,uM,=,1.4578818967339924,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCNCC3)ccc12
1411,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(/C=C/C(N)=O)nc21,"(E)-3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-7-yl)-acrylamide",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncccc21
1412,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=C(N/N=C/c1ccc(O)c(O)c1)c1ccccc1,"N'-(3,4-dihydroxybenzylidene)benzohydrazide",9.0,uM,=,0.9542425094393248,1,O=C(N/N=C/c1ccccc1)c1ccccc1
1413,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1cccc(Cl)c1,1-{2-[(3-Chloro-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole,0.5,uM,=,-0.3010299956639812,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
1414,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(OC1COc2cc(O)cc(O)c2C1)c1ccc(O)cc1O,"2,4-Dihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",96.3,uM,=,1.9836262871245345,1,O=C(OC1COc2ccccc2C1)c1ccccc1
1415,1769209,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 RNase H preincubated for 10 mins followed by PBS-22dpol/radiolabeled PBS-14r8d addition measured after 5 mins,COc1ccc(-c2cnc3ncnc(NCc4nc(O)c(O)c(C(=O)O)n4)c3c2)cc1,"5,6-Dihydroxy-2-(((6-(4-methoxyphenyl)pyrido[2,3-d]pyrimidin-4-yl)amino)methyl)pyrimidine-4-carboxylic acid",1.5,uM,=,0.1760912590556812,1,c1ccc(-c2cnc3ncnc(NCc4ncccn4)c3c2)cc1
1416,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1cccc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-(3-methylphenylsulfonyl)-1,3-dihydro-2Hbenzimidazol-2-one",0.021,uM,=,-1.6777807052660807,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
1417,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1cccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1418,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4F)cc3)ccc2C(=O)N1O,"6-((2',4'-Difluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.9,uM,=,-0.0457574905606751,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1419,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)C2CC2)cc1,"(E)-N-((2S,3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3, 5-dimethoxyphenyl)acrylamide",0.0335,uM,=,-1.4749551929631548,0,O=C(/C=C/c1ccccc1)N[C@H](CCN(C1CC1)S(=O)(=O)c1ccccc1)Cc1ccccc1
1420,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCCCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"3-Butylamino-4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.126,uM,=,-0.8996294548824371,0,O=c1cc(Cc2ccccc2)cc[nH]1
1421,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3cn[nH]c3)ccc21,"5-Cyclopropyl-10-methyl-7-(1H-pyrazol-4-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2ccc(-c3cn[nH]c3)nc2N(C2CC2)c2ncccc21
1422,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccccc3[N+](=O)[O-])nc3ccccc32)c1,"2-{[1-(3,5-Dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-2-nitrophenylacetamide",3.91,uM,=,0.5921767573958668,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
1423,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2cc(Br)cnc2N(C)C(=O)c2cccnc21,"3-Bromo-5-ethyl-11-methyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",0.55,uM,=,-0.2596373105057561,0,O=C1Nc2ncccc2Nc2ncccc21
1424,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2cccc(F)c2)n1,2-sec-Butylsulfanyl-6-(3-fluoro-benzyl)-3H-pyrimidin-4-one,0.6,uM,=,-0.2218487496163563,0,c1ccc(Cc2ccncn2)cc1
1425,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(Cc2ccc3c(c2)CC(=O)N(O)C3=O)cc1,"2-Hydroxy-6-(4-methylbenzyl)isoquinoline-1,3(2H,4H)-dione",1.1,uM,=,0.041392685158225,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
1426,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(NNC(=S)Nc2ccccc2)c1Cc1cccc(C)c1,"3-({5-ethyl-6-methyl-4-[(3-methylphenyl)methyl]-2-oxo-1,2-dihydropyridin-3-yl}amino)-1-phenylthiourea",3.162,uM,=,0.4999618655961902,1,O=c1[nH]ccc(Cc2ccccc2)c1NNC(=S)Nc1ccccc1
1427,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)NCc1ccccc1)CC2,"(2S)-2-(1-(benzylamino)ethyl)-5,7-dihydroxy-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.96,uM,=,-0.0177287669604316,0,O=c1cccc2c(c1)CC[C@H](CNCc1ccccc1)C2
1428,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",3.9,uM,=,0.5910646070264992,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1429,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",11.0,uM,=,1.0413926851582251,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1430,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Cl,2-Amino-6-(2-chloro-benzenesulfonyl)-benzonitrile,5.9,uM,=,0.7708520116421442,1,O=S(=O)(c1ccccc1)c1ccccc1
1431,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2cc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)ccc2c(=O)n1O,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-3-(trifluoromethyl)benzenesulfonamide",5.33,uM,=,0.7267272090265723,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2[nH]1
1432,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(NS(C)(=O)=O)C3)cc2)nc2ccsc12,"(E)-N-(1-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)phenyl)piperidin-3-yl)methanesulfonamide",0.775,uM,=,-0.1106982974936897,0,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3ccsc23)cc1
1433,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)-methanone,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
1434,196945,10.1021/jm00115a022,,,,Inhibition of HIV-1 reverse transcriptase from peripheral blood mononuclear cells.,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,"1-(2-Hydroxy-ethoxymethyl)-5-methyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",17.5,uM,=,1.2430380486862944,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1435,306454,10.1016/j.bmcl.2004.07.050,,,,Inhibitory activity against strand transfer in wild-type HIV-1 integrase was determined using 21-mer oligonucleotide substrate,Nc1ccn([C@@H]2CO[C@H](COP(=O)(O)O[C@H]3C[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O)[C@H]2O)c(=O)n1,Phosphoric acid 5-(6-amino-purin-9-yl)-2-phosphonooxymethyl-tetrahydro-furan-3-yl ester 4-(6-amino-purin-9-yl)-tetrahydro-furan-2-ylmethyl ester,65.0,uM,=,1.812913356642856,1,O=c1ncccn1[C@@H]1CO[C@H](CO[PH](=O)O[C@@H]2CO[C@@H](n3cnc4cncnc43)C2)C1
1436,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1cccc(CSc2nc(Cc3ccccc3)c(Br)c(=O)[nH]2)c1,6-Benzyl-5-bromo-2-(3-methylbenzylthio)pyrimidin-4(3H)-one,26.65,uM,=,1.4256972133625911,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
1437,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,COc1ccc(CNc2ccnc(Nc3ccc(C#N)cc3)n2)cc1,4-(4-(4-methoxybenzylamino)pyrimidin-2-ylamino)benzonitrile,0.085,uM,=,-1.0705810742857071,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
1438,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,COc1cc(-c2cccc(C#N)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"3'-methoxy-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",28.63,uM,=,1.4568213480215986,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1439,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CC#N)c1Cc1cccc(C)c1,"{[5-Ethyl-6-methyl-4-(3-methyl-benzyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-methyl-amino}-acetonitrile",0.004,uM,=,-2.397940008672037,0,O=c1cc(Cc2ccccc2)cc[nH]1
1440,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccccc3[N+](=O)[O-])CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(2-nitrophenyl)acetamide",0.193,uM,=,-0.7144426909922262,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
1441,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccc3ccccc3c2)c(=O)n(C)c1C,"5-Ethyl-1,6-dimethyl-3-[(naphthalen-2-ylmethyl)-amino]-1H-pyridin-2-one",11.0,uM,=,1.0413926851582251,1,O=c1[nH]cccc1NCc1ccc2ccccc2c1
1442,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CC(=O)CC(=O)c1c(O)c2c(=O)oc3ccc4ccccc4c3c2oc1=O,"4-hydroxy-3-(3-oxobutanoyl)benzo[f]pyrano[3,2-c]chromene-2,5-dione",13.8,uM,=,1.1398790864012365,1,O=c1ccc2c(=O)oc3ccc4ccccc4c3c2o1
1443,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,"6-((4'-Fluoro-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.3,uM,=,-0.5228787452803376,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1444,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2cc[nH]c12,"4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.108,uM,=,-0.9665762445130504,0,c1ccc(CN2CCC(Nc3nc(Oc4ccccc4)c4[nH]ccc4n3)CC2)cc1
1445,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=[N+]([O-])c1cc(I)c(O)c(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)c1,4-chloro-N'-(2-hydroxy-3-iodo-5-nitrobenzylidene)benzenesulfonohydrazide,62.0,uM,=,1.792391689498254,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
1446,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(Br)cc2)[nH]c(=O)n1O,"6-(4-Bromobenzyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
1447,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccnc(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-methyl-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
1448,768443,10.1016/j.ejmech.2011.06.034,,,,Inhibition of wild-type HIV1 subtype B reverse transcriptase assessed as incorporation of [3H]dTTP,Nc1ncnc2c1ncn2CCOCP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],tetrasodium [({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}phosphinato phosphonato)oxy]phosphonate,7.0,uM,=,0.8450980400142568,1,c1ncc2nc[nH]c2n1
1449,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cc(C)cc(C23SCCN2C(=O)c2ccccc23)c1,"9b-(3,5-Dimethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.084,uM,=,-1.0757207139381184,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1450,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3cccc([N+](=O)[O-])c3)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(3-nitrophenyl)acetamide",0.156,uM,=,-0.8068754016455384,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
1451,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3)nc3ccccc32)c1,"2-{[1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl]sulfanyl}-N-(4-sulfamoylphenyl)acetamide",0.05,uM,=,-1.3010299956639813,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1452,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)N1CC[S+]2[O-],"1-Oxo-9b-phenyl-1,2,3,9b-tetrahydro-1lambda*4*-thiazolo[2,3-a]isoindol-5-one",1.45,uM,=,0.1613680022349748,1,O=C1c2ccccc2C2(c3ccccc3)[SH+]CCN12
1453,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)c(C#N)c2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-3,4-dicarbonitrile",0.09,uM,=,-1.0457574905606752,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1454,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-({5-[(4-bromo-2-carboxyphenyl)amino]-5-oxopentanoyl}amino)benzoic acid,7.3,uM,=,0.8633228601204559,1,O=C(CCCC(=O)Nc1ccccc1)Nc1ccccc1
1455,195505,10.1016/s0960-894x(99)00235-8,,,,Inhibition of purified recombinant HIV-1 reverse transcriptase,CSCSc1cc(Cc2cc(C)cc(C)c2)c(C(C)C)c(O)n1,"4-(3,5-Dimethyl-benzyl)-3-isopropyl-6-methylsulfanylmethylsulfanyl-1H-pyridin-2-one",7.0,uM,=,0.8450980400142568,1,c1ccc(Cc2ccncc2)cc1
1456,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1cc2c(Oc3ccc(OS(=O)(=O)F)cc3OCCn3ccc(=O)[nH]c3=O)cc(Cl)cn2c1,"4-((6-Chloro-2-cyanoindolizin-8-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.0424,uM,=,-1.3726341434072673,0,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
1457,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,Oc1cc(Cc2ccc3ccccc3c2)nc(SC2CCCCC2)n1,2-Cyclohexylsulfanyl-6-naphthalen-2-ylmethyl-3H-pyrimidin-4-one,33.1,uM,=,1.5198279937757189,1,c1ccc2cc(Cc3ccnc(SC4CCCCC4)n3)ccc2c1
1458,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2c(Cl)cccc2Cl)n1,"2-sec-Butylsulfanyl-6-(2,6-dichloro-benzyl)-3H-pyrimidin-4-one",0.1,uM,=,-1.0,0,c1ccc(Cc2ccncn2)cc1
1459,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(O)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4-hydroxyphenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1460,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cccc([S+]([O-])c2cccc(N)c2C#N)c1,2-Amino-6-(3-methoxy-benzenesulfinyl)-benzonitrile,19.0,uM,=,1.2787536009528289,1,c1ccc([SH+]c2ccccc2)cc1
1461,2201730,10.1016/j.ejmech.2022.114217,,,,Inhibition of recombinant HIV-1 reverse transcriptase using ABTS as substrate incubated for 1 hr by ELISA,O=C(O)[C@]1(O)C[C@H](O)[C@@H](O)[C@@H](O)C1,(-)-quinic acid,280.1158540995224,uM,=,2.447337689877066,1,C1CCCCC1
1462,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1COC2,"3,5-Dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl)oxy)-benzonitrile",0.077,uM,=,-1.1135092748275182,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
1463,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3cccc(F)c3)cc2)[nH]c(=O)n1O,"6-((3'-fluoro-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1464,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,CCN(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(ethyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
1465,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(C#CC(=O)O)cc2Cl)c(Cl)c1,3-(4-(2-(1-(4-tert-butyl-2-chlorophenyl)-1H-tetrazol-5-ylthio)acetamido)-3-chlorophenyl)propiolic acid,0.0029,uM,=,-2.537602002101044,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1466,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CN1C(=O)c2cccnc2N(CCF)c2ccccc21,"11-(2-Fluoro-ethyl)-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",1.0,uM,=,0.0,0,O=C1Nc2ccccc2Nc2ncccc21
1467,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=C([O-])c1cc(NS(=O)(=O)c2ccc(-c3ccc(S(=O)(=O)Nc4cc(C(=O)[O-])c(O)c(S(=O)(=O)[O-])c4)cc3)cc2)cc(S(=O)(=O)[O-])c1O.[Na+].[Na+].[Na+].[Na+],5-{4-[4-(3-carboxy-4-hydroxy-5-sulfophenylsulfamoyl)phenyl]phenylsulfonamido}-2-hydroxy-3-sulfobenzoic acidTetrasodium salt,427.0,uM,=,2.630427875025024,1,O=S(=O)(Nc1ccccc1)c1ccc(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc1
1468,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,COC(=O)C(=O)NC1=CS(=O)(=O)O[C@@]12[C@@H](COCc1ccccc1)O[C@@H](n1cc(C)c(=O)n(C)c1=O)[C@@H]2O[Si](C)(C)C(C)(C)C,"N-[(5R,6R,8R,9R)-6-benzyloxymethyl-9-(tert-butyl-dimethyl-silanyloxy)-8-(3,5-dimethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-4-yl]-oxalamic acid methyl ester",7.2,uM,=,0.8573324964312685,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)[C@@H](COCc3ccccc3)O2)c(=O)[nH]1
1469,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Oc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(OC(=O)CCCCCCCCCCCCCCC)c12.[Na+].[Na+],"Hexadecanoic acid 8-hexadecanoyloxy-3,6-disulfo-naphthalen-1-yl ester; disodium salt",0.86,uM,=,-0.0655015487564322,0,c1ccc2ccccc2c1
1470,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2ccc(-c3cccc(O)c3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.43,uM,=,-0.3665315444204134,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1471,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cccc(-c2cc(C#N)cc(Oc3c(C(F)(F)F)ccn(Cc4n[nH]c(=O)n4C)c3=O)c2)c1,"3'-methyl-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",0.0409999999999999,uM,=,-1.3872161432802643,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
1472,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCOc1cccc(F)c1CCNC(=S)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-ethoxy-6-fluoro-phenyl)-ethyl]-thiourea,0.006,uM,=,-2.2218487496163566,0,S=C(NCCc1ccccc1)Nc1ccccn1
1473,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(O)C(=O)CC(=O)c1ccc(NC(=O)c2ccccc2)s1,"N-(5-(4,4-dihydroxy-3-oxobutanoyl)thiophen-2-yl)benzamide",3.2,uM,=,0.505149978319906,1,O=C(Nc1cccs1)c1ccccc1
1474,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(Cl)c1,2-Amino-6-(3-chloro-benzenesulfonyl)-benzonitrile,0.4,uM,=,-0.3979400086720376,0,O=S(=O)(c1ccccc1)c1ccccc1
1475,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(C)c(C)c2N(C)C(=O)c2cccnc21,"11-Ethyl-6,7,8-trimethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.036,uM,=,-1.4436974992327127,0,O=C1Nc2ccccc2Nc2ncccc21
1476,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(COCc3ccccc3)cc(OC)nc21,"9-Benzyloxymethyl-5-ethyl-7-methoxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.92,uM,=,-0.0362121726544447,0,O=C1Nc2c(COCc3ccccc3)ccnc2Nc2ncccc21
1477,526428,10.1021/np050510c,,,,Inhibition of HIV1 RT at 200 uM,CCC[C@@H](OC(C)=O)C1=C(Br)C(=C(Br)Br)OC1=O,"(R)-1-(4-bromo-5-(dibromomethylene)-2-oxo-2,5-dihydrofuran-3-yl)butyl acetate",700.0,uM,=,2.845098040014257,1,C=C1C=CC(=O)O1
1478,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,COc1ccc(NC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1Cl,"N-(3-Chloro-4-methoxyphenyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",16.6,uM,=,1.2201080880400552,1,O=C1NC(=O)C(C(=O)Nc2ccccc2)c2ccccc21
1479,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc(CC)c(C)nc2OC)c(O)nc1C,5-Ethyl-3-[(5-ethyl-2-methoxy-6-methyl-pyridin-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.019,uM,=,-1.7212463990471711,0,c1cncc(CNc2cccnc2)c1
1480,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n2c1,"6-Chloro-2-(2-chlorophenyl)-N-cyclohexylimidazo[1,2-a]pyridin-3-amine",14.47,uM,=,1.1604685311190377,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
1481,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCN2CCOC2=O)c2cc(Br)c(OC)c(C(=O)OC)c2)cc(Br)c1OC,"Methyl 5-{1-[3-Bromo-4-methoxy-5-(methoxycarbonyl)phenyl]-4-(2-oxo(1,3-oxazolindin-3-yl))but-1-enyl}-3-bromo-2-methoxybenzoate",0.499,uM,=,-0.3018994543766101,0,O=C1OCCN1CCC=C(c1ccccc1)c1ccccc1
1482,526428,10.1021/np050510c,,,,Inhibition of HIV1 RT at 200 uM,CCC[C@@H](O)C1=C(Br)/C(=C/Cl)OC1=O,"(R,Z)-4-bromo-5-(chloromethylene)-3-(1-hydroxybutyl)furan-2(5H)-one",700.0,uM,=,2.845098040014257,1,C=C1C=CC(=O)O1
1483,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nc(C)cn2-c2cccnc21,"8-Ethyl-2-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",2.75,uM,=,0.4393326938302626,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
1484,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1ccc(Cl)cc1C(=O)O,2-({6-[(2-carboxy-4-chlorophenyl)amino]-6-oxohexanoyl}amino)-5-chlorobenzoic acid,8.7,uM,=,0.9395192526186184,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
1485,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(O)cc2c1=O,"1-(4-Fluorobenzyl)-6-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",74.0,uM,=,1.869231719730976,1,O=c1ccn(Cc2ccccc2)c2ccccc12
1486,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)ccc2C(=O)N1O,"6-((2',4'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.5,uM,=,0.3979400086720376,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1487,140625,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 variant with Y181C plus K103N mutations in RT (reverse transcriptase),S=C(NCC12CC3CC(CC(C3)C1)C2)Nc1nccs1,1-Adamantan-1-ylmethyl-3-thiazol-2-yl-thiourea,1.3,uM,=,0.1139433523068367,1,S=C(NCC12CC3CC(CC(C3)C1)C2)Nc1nccs1
1488,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1F,"6-((3'-Fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.7,uM,=,-0.1549019599857432,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1489,2034655,10.1016/j.bmc.2020.115927,,,,Inhibition of recombinant HIV-1 BH10 reverse transcriptase using D38/[32P]25PGA as template-primer incubated for 5 mins in presence of DTT followed by dTTP addition and measured after 15 to 30 sec by nucleotide incorporation assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.18,uM,=,-0.744727494896694,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
1490,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCc2nnc(C)o2)c2cccc(C#N)c2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(3-cyanophenyl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",9.3,uM,=,0.9684829485539352,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
1491,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C(C)=O)c2cccnc21,"10-Acetyl-5-ethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.36,uM,=,-0.4436974992327127,0,O=C1Nc2cccnc2Nc2ncccc21
1492,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CC(C)C#CC1(C(F)(F)F)OC(=O)Nc2ccc([N+](=O)[O-])cc21,"4-(3-Methyl-but-1-ynyl)-6-nitro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.199,uM,=,-0.7011469235902933,0,O=C1Nc2ccccc2CO1
1493,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,C=CCC1(CC)Oc2ccccc2-n2cccc2C1=O,5-Allyl-5-ethyl-6-oxa-10b-aza-benzo[e]azulen-4-one,5.0,uM,=,0.6989700043360189,1,O=C1COc2ccccc2-n2cccc21
1494,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(/C=C(\O)C(=O)O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1Cc1ccccc1,"6-(1-Benzyl-4-(4-fluorobenzoyl)-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoic Acid",7.5,uM,=,0.8750612633917001,1,O=C(c1ccccc1)c1ccn(Cc2ccccc2)c1
1495,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Cc1csc(NC(=S)NCCc2ccccc2)n1,1-(4-Methyl-thiazol-2-yl)-3-phenethyl-thiourea,0.1,uM,=,-1.0,0,S=C(NCCc1ccccc1)Nc1nccs1
1496,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCCCCc3ccccc3)cc2c1=O,"1-(4-Fluorobenzyl)-4-oxo-6-(4-phenylbutoxy)-1,4-dihydroquinoline-3-carboxylic Acid",8.27,uM,=,0.9175055095525466,1,O=c1ccn(Cc2ccccc2)c2ccc(OCCCCc3ccccc3)cc12
1497,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CCCCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Heptanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",0.035,uM,=,-1.4559319556497243,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
1498,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1OC,"6-((3',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",2.2,uM,=,0.3424226808222063,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1499,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)c1cc2ccccc2[nH]1,2-(2-Benzoyl-4-chloro-phenoxy)-1-(1H-indol-2-yl)-ethanone,0.161919649017983,uM,=,-0.7907004462293661,0,O=C(COc1ccccc1C(=O)c1ccccc1)c1cc2ccccc2[nH]1
1500,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nccn2-c2ccc(OC)nc21,"8-Ethyl-6-methoxy-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.258,uM,=,-0.5883802940367698,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
1501,546494,10.1021/np50121a006,,,,Inhibition of HIV1 reverse transcriptase p66/p51,COc1cc(O)c2c(=O)c3c(O)c(-c4c(O)c([C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(O)c5c(=O)cc(-c6ccc(O)c(O)c6)oc45)cc(O)c3oc2c1,"1,5,8-trihydroxy-3-methoxy-7-(5',7',3'',4''-tetrahydroxy-6'-C-beta-D-glucopyranosyl-4'-oxy-8'-flavyl)-xanthone",42.9,uM,=,1.6324572921847242,1,O=c1c2ccccc2oc2ccc(-c3cc([C@H]4CCCCO4)cc4c(=O)cc(-c5ccccc5)oc34)cc12
1502,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,NC(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carboxamide",2.4,uM,=,0.380211241711606,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1503,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,O=c1cc(Nc2ccc(-c3ccc(Cl)cc3)cc2)[nH]c(=O)n1O,"6-((4'-Chloro-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.6,uM,=,-0.2218487496163563,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1504,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3ccc(Cl)cc3)cc2)[nH]c(=O)n1O,"6-((4'-chloro-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.007,uM,=,-2.154901959985743,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1505,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccnc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-3-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.26,uM,=,-0.585026652029182,0,O=C1Nc2cccnc2Nc2ncc(COc3cccnc3)cc21
1506,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",1.7,uM,=,0.2304489213782739,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1507,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCc1csc(NC(=S)NCCc2ccccc2)n1,1-(4-Ethyl-thiazol-2-yl)-3-phenethyl-thiourea,0.6,uM,=,-0.2218487496163563,0,S=C(NCCc1ccccc1)Nc1nccs1
1508,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,COC(=O)CCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"5-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-pentanoic acid methyl ester",327.0,uM,=,2.514547752660286,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1509,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Fc1cccc(F)c1CCNC(=S)Nc1nccs1,"1-[2-(2,6-Difluoro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea",0.01,uM,=,-2.0,0,S=C(NCCc1ccccc1)Nc1nccs1
1510,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,CCC1(CCCC=C(c2cc(Cl)c(OC)c(CO)c2)c2cc(Cl)c(OC)c(CO)c2)OCCO1,"{3-Chloro-5-[1-(3-chloro-5-hydroxymethyl-4-methoxy-phenyl)-5-(2-ethyl-[1,3]dioxolan-2-yl)-pent-1-enyl]-2-methoxy-phenyl}-methanol",3.2,uM,=,0.505149978319906,1,C(CCCC1OCCO1)=C(c1ccccc1)c1ccccc1
1511,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2nnn(C(C)(C)C)n2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,"((S)-1-{N'-[4-(2-tert-Butyl-2H-tetrazol-5-yl)-benzyl]-N'-[(2S,3S)-2-hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-hydrazinocarbonyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.072,uM,=,-1.1426675035687317,0,c1ccc(CCCCNCc2ccc(-c3nn[nH]n3)cc2)cc1
1512,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1cccc(OC(F)(F)F)c1,"6-Chloro-1-(3trifluoromethoxyphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.305,uM,=,-0.5157001606532141,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
1513,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2NC(=O)c2cccnc21,"5-Ethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.44,uM,=,-0.3565473235138126,0,O=C1Nc2cccnc2Nc2ncccc21
1514,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),CCOc1cc(/C=C2\SC(=S)N(NC(=O)c3ccccc3O)C2=O)ccc1O,N-{5-[1-(3-Ethoxy-4-hydroxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-2-hydroxy-benzamide,38.0,uM,=,1.57978359661681,1,O=C(NN1C(=O)/C(=C/c2ccccc2)SC1=S)c1ccccc1
1515,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(/C=C/C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(SC)cc2)ccc1O,"(E)-3-(4-hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0995,uM,=,-1.0021769192542744,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1516,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,CN(Cc1ccc2occc2c1)c1nc(O)nc(Nc2c(F)cc(F)cc2-c2ccccc2)n1,"4-((benzofuran-5-ylmethyl)(methyl)amino)-6-(3,5-difluorobiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.07,uM,=,-1.154901959985743,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
1517,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cn(S(C)(=O)=O)cn3)CC2)nc2ccsc12,"3,5-dimethyl-4-((2-((1-((1-(methylsulfonyl)-1H-imidazol-4-yl)methyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)benzonitrile",0.053,uM,=,-1.275724130399211,0,c1ccc(Oc2nc(NC3CCN(Cc4c[nH]cn4)CC3)nc3ccsc23)cc1
1518,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(NC(C)=O)c1Cc1cc(C)cc(C)c1,"N-[4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl]-acetamide",0.398,uM,=,-0.4001169279263121,0,O=c1cc(Cc2ccccc2)cc[nH]1
1519,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,COC(=O)c1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,2-{[1-(5-Methanesulfonylamino-1H-indole-2-carbonyl)-piperidin-4-yl]-methyl-amino}-nicotinic acid methyl ester,13.0,uM,=,1.1139433523068367,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1520,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-n2nnnc2SCC(=O)Nc2ccc(-c3ccc(OCC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(1-(2-chloro-4-methylphenyl)-1H-tetrazol-5-ylthio)acetamido)biphenyl-4-yloxy)acetic acid,0.0019,uM,=,-2.721246399047171,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
1521,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2cccc(-c3cncnc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((3-(pyrimidin-5-yl)phenyl)amino)-pyrimidine-2,4(1H,3H)-dione",3.9,uM,=,0.5910646070264992,1,O=c1cc(Nc2cccc(-c3cncnc3)c2)[nH]c(=O)[nH]1
1522,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2ccccc2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-phenylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.0177,uM,=,-1.7520267336381934,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)(C2CC2)N1
1523,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CNC(=O)c1ccc(F)c(CC/N=C(\S)Nc2ccc(Br)cn2)c1F,"3-{2-[3-(5-Bromo-pyridin-2-yl)-thioureido]-ethyl}-2,4-difluoro-N-methyl-benzamide",0.023,uM,=,-1.6382721639824072,0,C(=NCCc1ccccc1)Nc1ccccn1
1524,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3c(F)cc(-c4ccc(C#N)cc4)cc3F)c2=O)n[nH]c1=O,"3',5'-difluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",3.13,uM,=,0.4955443375464484,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1525,195664,10.1021/jm00132a002,,,,Inhibitory effect on HIV-1 reverse transcriptase activity using poly(rC)-oligo(dG) template primer,Cc1c(Sc2ccccc2)n(COCCOP(=O)(O)P(=O)(O)P(=O)(O)O)c(=O)[nH]c1=O,"5-methyl-6-(phenylthio)-1-({2-[(1,2,3,3-tetrahydroxy-1,2,3-trioxidotriphosphanyl)oxy]ethoxy}methyl)pyrimidine-2,4(1H,3H)-dione",500.0,uM,=,2.6989700043360187,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
1526,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccccc1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",1.0,uM,=,0.0,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1527,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(Cc3ccccc3)cc(O)nc21,"9-Benzyl-5-ethyl-7-hydroxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.34,uM,=,-0.4685210829577448,0,O=C1Nc2c(Cc3ccccc3)ccnc2Nc2ncccc21
1528,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(Cl)cc1,"(E)-6-[1-(4-Chloro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",8.0,uM,=,0.9030899869919436,1,c1ccc(Cn2cccc2)cc1
1529,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3S(N)(=O)=O)nc3ccccc32)c1,"2-{[1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl]sulfanyl}-N-(2-sulfamoylphenyl)acetamide",7.68,uM,=,0.885361220031512,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1530,195674,10.1021/jm0009437,,,,Tested for inhibitory concentration on HIV-1 Reverse transcriptase in the presence of poly(c)-oligo-(dG),CCc1c(C)nc(O)c(N)c1C(=O)c1cc(C)cc(C)c1,"3-Amino-4-(3,5-dimethylbenzoyl)-5-ethyl-6-methylpyridin-2-(1H)-one",0.1,uM,=,-1.0,0,O=C(c1ccccc1)c1ccncc1
1531,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])c(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-methyl-1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
1532,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,CC(OCn1c(COCc2ccccc2)cc(=O)[nH]c1=O)c1ccccc1,"6-[(Benzyloxy)methyl]-1-[(1-phenylethoxy)methyl]pyrimidine-2,4(1H,3H)-dione",184.0,uM,=,2.2648178230095364,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1533,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCC(=O)Nc3ccccc3)cc2)n[nH]1,Ethyl 3-(1-(4-fluorobenzyl)-4-(4-(2-oxo-2-(phenylamino)ethoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,6.8,uM,=,0.8325089127062363,1,O=C(COc1ccc(-c2cn(Cc3ccccc3)cc2-c2cc[nH]n2)cc1)Nc1ccccc1
1534,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3Cl)nc3ccccc32)c1,"2-({1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)-N-2-chlorophenylacetamide",51.93,uM,=,1.7154183225950563,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1535,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2ccccc2Sc2ccccc21,"10-Propyl-10H-dibenzo[b,f][1,4]thiazepin-11-one",0.4,uM,=,-0.3979400086720376,0,O=C1Nc2ccccc2Sc2ccccc21
1536,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2[C@@]2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.28,uM,=,-0.5528419686577808,0,O=C1c2ccccc2[C@@]2(c3ccccc3)SCCN12
1537,195504,10.1021/jm001095i,,,,Inhibitory activity against wild-type HIV-1 reverse transcriptase,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione (TASO-m3T)",4.641551314042965,uM,=,0.666663156099795,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1538,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=C([O-])CCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+].[Na+].[Na+],"9-(8-Hydroxy-3,6-disulfo-naphthalen-1-ylcarbamoyl)-nonanoic acid; trisodium salt",170.0,uM,=,2.230448921378274,1,c1ccc2ccccc2c1
1539,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1ccccn1,1-Phenethyl-3-pyridin-2-yl-thiourea,0.02,uM,=,-1.6989700043360187,0,S=C(NCCc1ccccc1)Nc1ccccn1
1540,947897,10.1021/np3006887,,,,Inhibition of HIV-1 reverse transcriptase assessed as decrease in incorporation of [3H]TTP into polyA template,C=C1C(=O)O[C@@H]2C[C@@H]3[C@]4(CC[C@]5(C)[C@@H]([C@H](C)CC(=O)C=C(C)C)CC[C@@]35C)C[C@]4(CCC(=O)O)[C@H]12,rel-Carinatin C,85.7,uM,=,1.932980821923198,1,C=C1C(=O)O[C@@H]2C[C@H]3C4CCCC4CC[C@]34CC4[C@H]12
1541,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(O)c1cc(-c2ccc(C=C3C(=O)c4ccccc4C3=O)o2)ccc1O,"5-[5-(1,3-Dioxo-indan-2-ylidenemethyl)-furan-2-yl]-2-hydroxy-benzoic acid",40.0,uM,=,1.6020599913279625,1,O=C1C(=Cc2ccc(-c3ccccc3)o2)C(=O)c2ccccc21
1542,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2)nc2sccc12,"(E)-3-(3,5-dimethyl-4((2-((4-(4-(methylsulfonyl)piperazin-1-yl)phenyl)amino)thieno[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.239,uM,=,-0.6216020990518624,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3sccc23)cc1
1543,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1CSC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)-methyl)benzenesulfonamide",0.41,uM,=,-0.3872161432802645,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSC4)CC2)cc1
1544,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,Cc1c(O)c([N+](=O)[O-])cc2cc(C(=O)Nc3ccc(O)c(C(=O)O)c3)c(=O)oc12,2-hydroxy-5-(7-hydroxy-8-methyl-6-nitro-2-oxo-2H-chromene-3-carboxamido)benzoic acid,9.9,uM,=,0.99563519459755,1,O=C(Nc1ccccc1)c1cc2ccccc2oc1=O
1545,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C=O)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1CCCC2,"5-((4-(4-Formyl-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)picolinonitrile",0.043,uM,=,-1.3665315444204136,0,c1ccc(Oc2nc(Nc3cccnc3)nc3c2CCCC3)cc1
1546,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2cc(C)c(C)nc2N(C)C(=O)c2cccnc21,"5-Ethyl-2,3,11-trimethyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2ncccc2Nc2ncccc21
1547,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,CCCO[C@H]1C(=O)Nc2ccc(Cl)cc2[C@@]1(C#CC1CC1)C(F)(F)F,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-propoxy-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.051,uM,=,0.0216027160282421,1,O=C1CC(C#CC2CC2)c2ccccc2N1
1548,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(Br)cc(Cn2c(=O)ccn(CC(=O)Nc3ccccc3)c2=O)c1,"2-(3-(3-Bromo-5-methylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-chlorophenyl)acetamide",12.08,uM,=,1.082066934285113,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
1549,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,CCOCn1c(C(=O)c2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-carbonyl)-1-(ethoxymethyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.42,uM,=,-0.3767507096020995,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
1550,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(OCC(=O)N(Cc1ccc(O)cc1)CC1CCCO1)c1ccc([N+](=O)[O-])o1,2-((4-hydroxybenzyl)((tetrahydrofuran-2-yl)methyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,5.0,uM,=,0.6989700043360189,1,O=C(OCC(=O)N(Cc1ccccc1)CC1CCCO1)c1ccco1
1551,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c([N+](=O)[O-])cccc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(4-nitro-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,24.5,uM,=,1.3891660843645326,1,c1cncc(NCc2nc3ccccc3o2)c1
1552,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2O)c(O)nc1C,5-Ethyl-3-(2-hydroxy-benzylamino)-6-methyl-1H-pyridin-2-one,4.6,uM,=,0.6627578316815741,1,c1ccc(CNc2cccnc2)cc1
1553,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1cc(COCc2ccccc2)n(COCc2cc(Cl)cc(Cl)c2)c(=O)[nH]1,"6-[(Benzyloxy)methyl]-1-{[(3,5-dichlorobenzyl)oxy]methyl}pyrimidine-2,4(1H,3H)-dione",0.41,uM,=,-0.3872161432802645,0,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1554,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1Cl,"4-[5-Chloro-2-(4-cyano-phenylamino)-pyrimidin-4-ylamino]-3,5-dimethyl-benzonitrile",0.0012,uM,=,-2.920818753952376,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
1555,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnc(C)o2)c2ccc(C#N)cc2)cc(C)c1OC,"(Z)-methyl 5-[1-(4-cyanophenyl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-1-enyl]-2-methoxy-3-methylbenzoate",24.0,uM,=,1.380211241711606,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
1556,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnc(C)o2)c2cccc(C#N)c2)cc(C)c1OC,"(Z)-methyl 5-[1-(3-cyanophenyl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-1-enyl]-2-methoxy-3-methylbenzoate",29.0,uM,=,1.462397997898956,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
1557,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,COc1cc2c(ccc3c4cc(OC)c(OC)cc4c[n+](C)c23)cc1O.[Cl-],"2-Hydroxy-3,8,9-trimethoxy-5-methyl-benzo[c]phenanthridinium chloride",46.74012482134179,uM,=,1.669689867858253,1,c1ccc2c(c1)c[nH+]c1c3ccccc3ccc21
1558,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),COc1ccccc1/C=C1/SC(=S)N(CCC(=O)Nc2ccc(O)cc2)C1=O,N-(4-Hydroxy-phenyl)-3-{5-[1-(2-methoxy-phenyl)-meth-(E)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionamide,99.0,uM,=,1.99563519459755,1,O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
1559,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1O,"6-(4-Cyclopropylbenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.9,uM,=,-0.0457574905606751,0,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1
1560,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,Cc1ccnc2c1-n1ccnc1-c1cccnc1N2C1CC1,"8-Cyclopropyl-4-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.217,uM,=,-0.6635402661514705,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2C1CC1
1561,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCC1CC1,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-cyclopropylmethoxy-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.434,uM,=,0.1565491513317813,1,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCC1CC1
1562,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCc1c(-c2ccc(F)cc2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,"5-ethyl-1-(((4-fluorobenzyl)oxy)methyl)-6-(4-fluorophenyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",17.0,uM,=,1.230448921378274,1,O=c1cc(-c2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1563,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,C[C@@H]1O[C@](/C=C/C2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"(3S,5S)-7-chloro-5-(2-cyclopropylvinyl)-3-methyl-5-(trifluoromethyl)-3,5-dihydrobenzo[e][1,4]oxazepin-2(1H)-one",0.046,uM,=,-1.337242168318426,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
1564,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(ccc4ccccc43)o2)c(O)nc1C,"5-Ethyl-6-methyl-3-[(naphtho[1,2-d]oxazol-2-ylmethyl)-amino]-1H-pyridin-2-one",2.7,uM,=,0.4313637641589873,1,c1cncc(NCc2nc3c(ccc4ccccc43)o2)c1
1565,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccc(C#N)nc2)cc1F,"5-(4-((2-((4-Cyanophenyl)amino)-5-methylpyrimidin-4-yl)amino)-3,5-difluorophenyl)picolinonitrile",0.022,uM,=,-1.6575773191777938,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccnc4)cc3)n2)cc1
1566,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(CCOc3ccncc3)c[nH]c(=O)c2Br)c1,"3-(3-bromo-2-oxo-5-(2-(pyridin-4-yloxy)ethyl)-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.01,uM,=,-2.0,0,O=c1cc(Oc2ccccc2)c(CCOc2ccncc2)c[nH]1
1567,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(Br)c(Oc2cnc(N)c(Nc3ccc(C#N)cc3)c2)c(Br)c1,"4-((2-amino-5-(2,6-dibromo-4-methylphenoxy)pyridin-3-yl)amino)benzonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
1568,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(CNc2ncnc3ncc(Br)cc23)nc(O)c1O,"2-(((6-Bromopyrido[2,3-d]pyrimidin-4-yl)amino)methyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",49.0,uM,=,1.6901960800285136,1,c1cnc(CNc2ncnc3ncccc23)nc1
1569,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CSc1nc(O)cc(Cc2c(Cl)cccc2Cl)n1,"6-(2,6-Dichloro-benzyl)-2-methylsulfanyl-3H-pyrimidin-4-one",3.0,uM,=,0.4771212547196624,1,c1ccc(Cc2ccncn2)cc1
1570,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,N#CCC(=O)c1cccc(Cl)c1,3-(3-chlorophenyl)-3-oxopropanenitrile,4.1,uM,=,0.6127838567197355,1,c1ccccc1
1571,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.43,uM,=,-0.3665315444204134,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1572,195055,10.1021/jm00171a023,,,,Compound was evaluated for the 50% inhibitory concentration on human immunodeficiency virus associated reverse transcriptase,C=C1C(C)C(=O)NC(=O)N1[C@H]1C[C@H](N=[N+]=[N-])[C@@H](COCP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1,"alpha,beta-methylene AzddTPP",4.6,uM,=,0.6627578316815741,1,C=C1CC(=O)NC(=O)N1[C@H]1CCCO1
1573,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,"6-[1-(2-Ethoxyphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",64.0,uM,=,1.806179973983887,1,c1ccc(Cn2cccc2)cc1
1574,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,COC(=O)CSc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"Methyl 2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetate",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1575,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=C(CCCCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c12)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c12.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],"8-[10-(6,8,11-trisulfo-1-naphthylcarbamoyl)decylcarboxamido]-1,3,7-naphthalenetrisulfonic acid: hexasodium salt",136.0,uM,=,2.133538908370217,1,O=C(CCCCCCCCCCC(=O)Nc1cccc2ccccc12)Nc1cccc2ccccc12
1576,1934378,10.1016/j.bmc.2016.07.041,,,,Inhibition of HIV-1 reverse transcriptase assessed as reduction in biotin-duTP incorporation using biotin-labeled dUTP and hybrid poly(A)-oligo (dT)15 template primer after 2 hrs by ELISA,CC(Sc1nc2cnc(Cl)nc2n1-c1cccc2ccccc12)C(=O)Nc1ccc(S(N)(=O)=O)cc1Br,N-(2-Bromo-4-sulfamoylphenyl)-2-((2-chloro-9-(naphthalen-1-yl)-9H-purin-8-yl)thio)propanamide,6.42,uM,=,0.8075350280688532,1,O=C(CSc1nc2cncnc2n1-c1cccc2ccccc12)Nc1ccccc1
1577,80130,10.1016/S0960-894X(01)80437-6,,,,The compound was evaluated as inhibitor of recombinant HIV-l reverse transcriptase,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)C(F)(F)F)O2)cc1F,"Trifluoromethyl-phosphonic acid mono-[5-(5-fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3-hydroxy-tetrahydro-furan-2-ylmethyl] ester",47.6160243539605,uM,=,1.677753131656529,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1578,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccc3cc[nH]c3c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4-(1H-Indol-6-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0533999999999999,uM,=,-1.2724587429714436,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccc5cc[nH]c5c4)cc3)n2)cc1
1579,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(OS(C)(=O)=O)ccc3[nH]2)CC1,Methanesulfonic acid 2-[4-(3-isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl ester,5.5,uM,=,0.7403626894942439,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
1580,546494,10.1021/np50121a006,,,,Inhibition of HIV1 reverse transcriptase p66/p51,CC1=C(C#C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(\C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)C(C)(C)C[C@H](O)C1,halocynthiaxanthin,7.2,uM,=,0.8573324964312685,1,O=C(C=C/C=C/C=C/C=C/C=C/C=C/C=C/C#CC1=CCCCC1)C[C@]12CCCCC1O2
1581,1565176,10.1016/j.bmcl.2016.02.049,,,,Inhibition of HIV1 reverse transcriptase using DIG-labeled dNTPs as substrate after 1 hr by ELISA,C[C@H]1C(=O)N2C[C@@H](O)[C@@H](O)[C@@H]2[C@@H]2Sc3ccccc3C(=O)N12,"(1S,2R,6S,13aS,13bR)-1,2-dihydroxy-6-methyl-1,2,3,13b-tetrahydrobenzo[e]pyrrolo[2',1':3,4]pyrazino[2,1-b][1,3]thiazine-5,8(6H,13aH)-dione",9.65,uM,=,0.9845273133437926,1,O=C1CN2C(=O)c3ccccc3S[C@H]2[C@H]2CCCN12
1582,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccccc2Cl)c(Cl)c1,2-(1-(4-tert-butyl-2-chlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-chlorophenyl)acetamide,0.0078,uM,=,-2.10790539730952,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1583,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccncc2OC)c(O)nc1C,5-Ethyl-3-[(3-methoxy-pyridin-4-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,110.0,uM,=,2.041392685158225,1,c1cncc(NCc2ccncc2)c1
1584,1792973,10.1016/j.bmcl.2018.10.010,,,,Inhibition of recombinant wild-type HIV1 GST-fused reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,CCOC(=O)c1cnc(N2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc1Oc1c(C)cc(-c2ccc(C#N)cc2)cc1C,"ethyl 4-((4'-cyano-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-2-(4-(4-sulfamoylbenzyl)piperazin-1-yl)pyrimidine-5-carboxylate",63.52,uM,=,1.80291048941904,1,c1ccc(CN2CCN(c3nccc(Oc4ccc(-c5ccccc5)cc4)n3)CC2)cc1
1585,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CCc3ccccc3)[nH]c(=O)c2Cl)c1,"3-chloro-5-(3-chloro-2-oxo-6-phenethyl-1,2-dihydropyridin-4-yloxy)benzonitrile",0.008,uM,=,-2.096910013008056,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccc2)[nH]1
1586,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)Cc1cccc(Cl)c1,"6-Chloro-1-[(3-chlorobenzyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",6.0,uM,=,0.7781512503836436,1,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
1587,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1ncccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NC(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-carboxylic acid (2-{4-[(3-tert-butylamino-pyridin-2-yl)-ethyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.22,uM,=,-0.6575773191777937,0,O=C(Nc1ccc2[nH]c(C(=O)N3CCC(Nc4ccccn4)CC3)cc2c1)N1CCNCC1
1588,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCN(c1ncccc1CC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-isobutyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.43,uM,=,-0.3665315444204134,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1589,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(NCc2ccc3c(c2)OCCCO3)n1,"4-((3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)methylamino)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",4.4,uM,=,0.6434526764861874,1,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4c(c3)OCCCO4)n2)cc1
1590,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(/C=C/C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)ccc1O,"(E)-N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide",0.0435,uM,=,-1.3615107430453628,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1591,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.32,uM,=,0.3654879848908996,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1592,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(NC2CCCCC2)c1Br,3-Bromo-4-(cyclohexylamino)-6-phenethylpyridin-2(1H)-one,40.26,uM,=,1.6048737705526357,1,O=c1cc(NC2CCCCC2)cc(CCc2ccccc2)[nH]1
1593,80573,10.1016/0960-894X(95)00311-G,,,,Inhibitory activity was evaluated in vitro against HIV- I reverse transcriptase (RT),CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
1594,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,O=C(CSc1nnnn1-c1cccc2ccccc12)Nc1ccccc1[N+](=O)[O-],2-(1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.005,uM,=,-2.3010299956639813,0,O=C(CSc1nnnn1-c1cccc2ccccc12)Nc1ccccc1
1595,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CCC1(CC=C(C)C)Sc2ccccc2-n2cccc2C1=O,"6-ethyl-6-(3-methylbut-2-enyl)benzo[b]pyrrolo[1,2-d][1,4]thiazepin-7(6H)-one",1.35,uM,=,0.1303337684950061,1,O=C1CSc2ccccc2-n2cccc21
1596,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1[N+](=O)[O-],"3-(4-(4-(4-cyano-2,6-dimethylphenoxy)-5-nitropyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.109,uM,=,-0.9625735020593764,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1597,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCC1=C(C)NC(OC)C(CCN2C(=O)c3ccccc3C2=O)=C1,"2-[2-(5-Ethyl-2-methoxy-6-methyl-1,2-dihydro-pyridin-3-yl)-ethyl]-isoindole-1,3-dione",6.2,uM,=,0.7923916894982539,1,O=C1c2ccccc2C(=O)N1CCC1=CC=CNC1
1598,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=C1/C(=C\c2cccc(O)c2O)SC(=S)N1Cc1ccco1,"5-(2,3-dihydroxybenzylidene)-3-(furan-2-ylmethyl)-2-thioxothiazolidin-4-one",100.0,uM,=,2.0,1,O=C1/C(=C\c2ccccc2)SC(=S)N1Cc1ccco1
1599,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.404,uM,=,-0.393618634889395,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1600,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#Cc2ccccn2)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,"4-((4-((4-(2,6-dimethyl-4-(pyridin-2-ylethynyl)phenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.29,uM,=,-0.5376020021010439,0,C(#Cc1ccccn1)c1ccc(Oc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccsc23)cc1
1601,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(O)cc2)c2ccccc2c1=O,4-[1-(4-Hydroxyphenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,9.5,uM,=,0.9777236052888478,1,O=c1ccn(Cc2ccccc2)c2ccccc12
1602,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,C[C@@H]1CC=C2[C@@H](CCC[C@@]2(C)CC[C@@]2(C)C3=CCCC(C)(C)[C@H]3CC[C@@H]2C)[C@]1(C)Cc1cc(OS(=O)(=O)[O-])ccc1OS(=O)(=O)[O-].[Na+].[Na+],toxiusol,6.6,uM,=,0.8195439355418687,1,C1=C2C(CCC3CCC[C@@H]4C3=CCCC4Cc3ccccc3)CCC[C@@H]2CCC1
1603,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,O=S1(=O)Nc2ccc(F)c(F)c2C(C#CC2CC2)(C(F)(F)F)N1,"4-Cyclopropylethynyl-5,6-difluoro-4-trifluoromethyl-3,4-dihydro-1H-benzo[1,2,6]thiadiazine 2,2-dioxide",24.667,uM,=,1.39211633381601,1,O=S1(=O)Nc2ccccc2C(C#CC2CC2)N1
1604,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,O=C(O)c1ccnc2ccccc12,4-Quinoline carboxylic acid,9600.0,uM,=,3.982271233039568,1,c1ccc2ncccc2c1
1605,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc([S+]([O-])Cc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-(4,7-Dichloro-benzooxazol-2-ylmethanesulfinyl)-5-ethyl-6-methyl-1H-pyridin-2-one",1.4,uM,=,0.1461280356782379,1,c1cncc([SH+]Cc2nc3ccccc3o2)c1
1606,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCN(S(N)(=O)=O)CC3)cc2)nc2sccc12,"(E)-4-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[2,3-d]pyrimidin-2-yl)amino)benzyl)piperazine-1-sulfonamide",0.299,uM,=,-0.5243288116755703,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3sccc23)cc1
1607,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)-pyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1608,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CCc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Ethyl-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.011,uM,=,-1.958607314841775,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1609,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=S)[nH]c3ccc(Cl)c(c32)C1C,"5-Chloro-6-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.012,uM,=,-1.9208187539523751,0,S=c1[nH]c2cccc3c2n1CCNC3
1610,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2nc(SC3CCCC3)nc(O)c2C)c1,2-Cyclopentylsulfanyl-5-methyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,3.4,uM,=,0.5314789170422551,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
1611,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=c1ccc(Cc2cc(Cc3cccc(Cl)c3)c3occc3c2)n[nH]1,6-((7-(3-chlorobenzyl)benzofuran-5-yl)methyl)pyridazin-3(2H)-one,3.9,uM,=,0.5910646070264992,1,O=c1ccc(Cc2cc(Cc3ccccc3)c3occc3c2)n[nH]1
1612,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,COC(=O)CS(=O)(=O)c1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"Methyl 2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)sulfonyl)acetate",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1613,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)C[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O,"(S)-1-((R)-4-amino-1-((R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-1,4-dioxobutan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium",3.82,uM,=,0.5820633629117087,1,O=C(CCc1c[nH]c2ccccc12)NCC(=O)NCCc1c[nH]c2ccccc12
1614,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccc3c2OCO3)nc(SC(C)C)[nH]c1=O,"2-(benzo[d][1,3]dioxol-4-yl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",1.354,uM,=,0.1316186643491255,1,O=c1cc(Cc2cccc3c2OCO3)nc[nH]1
1615,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Oc1cc(Cc2c(Cl)cccc2Cl)nc(SC2CCCCC2)n1,"2-Cyclohexylsulfanyl-6-(2,6-dichloro-benzyl)-3H-pyrimidin-4-one",0.4,uM,=,-0.3979400086720376,0,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
1616,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cc(Sc2cccc(N)c2C#N)cc(C(F)(F)F)c1,2-Amino-6-(3-methoxy-5-trifluoromethyl-phenylsulfanyl)-benzonitrile,13.0,uM,=,1.1139433523068367,1,c1ccc(Sc2ccccc2)cc1
1617,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1ccc(CS(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)cc1,"6-Chloro-1-[(4-methylbenzyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",2.25,uM,=,0.3521825181113625,1,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
1618,508744,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization using chimeric substrate with RNA PPT primer extended at 3' end with upto 2 deoxyribonucleotides,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.28,uM,=,-0.5528419686577808,0,c1cncc(NCc2nc3ccccc3o2)c1
1619,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2ccc(OC(F)(F)F)cc2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-6-trifluoromethoxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",1.249,uM,=,0.0965624383741355,1,O=C1Nc2ccccc2C(C#CC2CC2)O1
1620,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCc3nc4cccc(Cl)c4o3)ccc2Cl)c1,3-chloro-5-(2-chloro-5-((7-chlorobenzo[d]oxazol-2-yl)methoxy)phenoxy)benzonitrile,0.0005899999999999,uM,=,-3.229147988357856,0,c1ccc(Oc2cccc(OCc3nc4ccccc4o3)c2)cc1
1621,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,N#Cc1ccc(Nc2nccc(OCC(=O)Nc3cccc(Cl)c3)n2)cc1,N-(3-Chlorophenyl)-2-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)acetamide,0.12,uM,=,-0.9208187539523752,0,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
1622,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,O=C(CC/N=C(\S)Nc1ccc(Br)cn1)c1ccccc1F,1-(5-Bromo-pyridin-2-yl)-3-[3-(2-fluoro-phenyl)-3-oxo-propyl]-thiourea,0.004,uM,=,-2.397940008672037,0,O=C(CCN=CNc1ccccn1)c1ccccc1
1623,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,Fc1cccc(F)c1Cn1c(-c2c(F)cccc2F)nc2c(Br)cccc21,"4-Bromo-1-(2,6-difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazole",1.61,uM,=,0.2068258760318497,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
1624,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1625,195843,10.1021/jm970096g,,,,The quantity of compound required to reduce WT Reverse transcriptase activity by 50%,Fc1cccc(F)c1-c1nc2ccccc2n1Cc1ccccc1,"1-Benzyl-2-(2,6-difluoro-phenyl)-1H-benzoimidazole",18.6,uM,=,1.2695129442179165,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
1626,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(C#N)cc2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(4-cyanophenyl)acetamide",0.065,uM,=,-1.1870866433571443,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
1627,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)c(F)c23)c1,"5-chloro-4-fluoro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.003,uM,=,-2.5228787452803374,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1628,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccnc(C(F)(F)F)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2,6-Dimethyl-4-(2-(trifluoromethyl)pyridin-4-yl)phenyl)amino)Pyrimidin-2-yl)amino)benzonitrile",0.0685,uM,=,-1.1643094285075744,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
1629,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccccc2-c2ccc(C(F)(F)F)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)-oxy)pyrimidine-2,4(1H,3H)-dione",21.0,uM,=,1.3222192947339193,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
1630,545152,10.1021/np50073a012,,,,Inhibition of HIV1 RT using poly A oligo(dT) template primer,COc1cc2c[n+](C)c3c4cc5c(cc4ccc3c2cc1OC)OCO5.[Cl-],"2,3-Dimethoxy-12-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridin-12-ium chloride",127.90646702762704,uM,=,2.106892503223059,1,c1ccc2c(c1)c[nH+]c1c3cc4c(cc3ccc21)OCO4
1631,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,N#Cc1ccc(COCn2c(COCc3ccccc3)cc(=O)[nH]c2=O)cc1,"4-[({6-[(Benzyloxy)methyl]-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methoxy)methyl]benzonitrile",1.97,uM,=,0.2944662261615929,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1632,195844,10.1021/jm00020a026,,,,antiviral activity in Human immunodeficiency virus-1 as reverse transcriptase activity in culture supernatant,NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c2ncnc(N)c12,"4-Amino-7-(3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid amide",0.02,uM,=,-1.6989700043360187,0,c1ncc2ccn([C@H]3CCCO3)c2n1
1633,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@H](n2c(=O)nc(-c3ccc(NC)nc3)c3oc4ncc(-c5cnn(C)c5)cc4c32)CCO1,"(+/-)-trans-1-(-2-Ethyl-tetrahydro-pyran-4-yl)-4-(6-methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.013,uM,=,-1.8860566476931635,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1C1CCOCC1
1634,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
1635,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)N[C@@H](C)C(=O)O)c1=O,"(S)-2-(2-{3-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetylamino)-propionic acid",12.0,uM,=,1.0791812460476249,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
1636,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CCC#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(F)c(F)c21,"4-But-1-ynyl-5,6-difluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.074,uM,=,-1.1307682802690238,0,O=C1NCc2ccccc2N1
1637,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(N)=O)[nH]c3ccc(Br)cc23)c1,"(R)-N-(1-amino-1-oxopropan-2-yl)-5-bromo-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.016,uM,=,-1.7958800173440752,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1638,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1cccc(OC)c1CCNC(=S)Nc1nccs1,"1-[2-(2,6-Dimethoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea",0.09,uM,=,-1.0457574905606752,0,S=C(NCCc1ccccc1)Nc1nccs1
1639,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,CN1CC(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)=NNC1=O,"6-(3-(3-bromophenoxy)-4-chlorobenzyl)-4-methyl-4,5-dihydro-1,2,4-triazin-3(2H)-one",0.15,uM,=,-0.8239087409443188,0,O=C1NCC(Cc2cccc(Oc3ccccc3)c2)=NN1
1640,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2nc(C)ccc2C(=O)N(C)c2cccnc21,"5-Ethyl-3,10-dimethyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",1.0,uM,=,0.0,0,O=C1Nc2cccnc2Nc2ncccc21
1641,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CN1C(=O)c2cccn2S(=O)(=O)c2ccccc21,"9-Methyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
1642,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)CC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-3-methyloxycarbonyl-1-propenyl]-2-methoxybenzoate,2.2,uM,=,0.3424226808222063,1,C=C(c1ccccc1)c1ccccc1
1643,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"N-[4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl]-butyramide",100.0,uM,=,2.0,1,O=c1cc(Cc2ccccc2)cc[nH]1
1644,1565176,10.1016/j.bmcl.2016.02.049,,,,Inhibition of HIV1 reverse transcriptase using DIG-labeled dNTPs as substrate after 1 hr by ELISA,O=C1CN2C(=O)c3ccccc3S[C@@H]2[C@H]2[C@H](O)[C@H](O)CN12,"(1S,2R,13aR,13bR)-1,2-dihydroxy-1,2,3,13b-tetrahydrobenzo[e]pyrrolo[2',1':3,4]pyrazino[2,1-b][1,3]thiazine-5,8(6H,13aH)-dione",0.82,uM,=,-0.0861861476162833,0,O=C1CN2C(=O)c3ccccc3S[C@@H]2[C@H]2CCCN12
1645,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(Cl)cc2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((4'-chloro-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.102,uM,=,-0.9913998282380824,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1646,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(C#CCCO)cc2Cl)c(Cl)c1,2-(1-(4-tert-butyl-2-chlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-chloro-4-(4-hydroxybut-1-ynyl)phenyl)acetamide,0.0055,uM,=,-2.2596373105057563,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1647,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc[nH]3)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrol-2-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2ccc(-c3ccc[nH]3)nc2Nc2ncccc21
1648,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCOC(=O)c1cc(NCc2nc3ccccc3o2)c(O)nc1C,"5-[(Benzooxazol-2-ylmethyl)-amino]-2-methyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid ethyl ester",1.75,uM,=,0.2430380486862944,1,c1cncc(NCc2nc3ccccc3o2)c1
1649,953195,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dGTP incorporation after 15 mins by PAGE,Cc1cc(C#CCOCCOCCOCCOCCOCC#Cc2cn([C@H]3C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)c(=O)[nH]c2=O)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"((2S,5R)-5-(5-(19-(4-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethylphenyl)-4,7,10,13,16-pentaoxanonadeca-1,18-diynyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl tetrahydrogen triphosphate",0.042,uM,=,-1.3767507096020994,0,O=c1[nH]c(=O)n([C@H]2C=CCO2)cc1C#CCOCCOCCOCCOCCOCC#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1
1650,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
1651,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCc1cnc2n1-c1cccnc1N(CC)c1ncccc1-2,"3,8-Diethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",1.1,uM,=,0.041392685158225,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
1652,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,O=C1c2ccccc2C(=O)N1CCNC(=S)Nc1ccc(Cl)cn1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl]-thiourea",0.001,uM,=,-3.0,0,O=C1c2ccccc2C(=O)N1CCNC(=S)Nc1ccccn1
1653,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccc(O)cc2oc1=O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1,"7-Hydroxy-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl)-2-oxo-2H-chromene-3-carboxamide",0.1886999999999999,uM,=,-0.7242280998350688,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
1654,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1onc(-c2ccccc2)c1C(=O)Nc1sc(C)c(C)c1C(N)=O,"N-(3-carbamoyl-4,5-dimethylthiophen-2-yl)-5-methyl-3-phenylisoxazole-4-carboxamide",2.9,uM,=,0.4623979978989561,1,O=C(Nc1cccs1)c1conc1-c1ccccc1
1655,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,O=S1(c2ccccc2)=NC(=S)Nc2ccccc21,"5-oxo-5-phenyl-5'6-thia-2,4-diazabicyclo[4.4.0]deca-1(10),4,6,8-tetraene-3-thione",0.95,uM,=,-0.0222763947111522,0,O=S1(c2ccccc2)=NC(=S)Nc2ccccc21
1656,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,Cc1ccc(C(=O)CSc2nc(O)c(C)c(Cc3cccc4ccccc34)n2)cc1,5-Methyl-6-naphthalen-1-ylmethyl-2-(2-oxo-2-p-tolyl-ethylsulfanyl)-3H-pyrimidin-4-one,0.67,uM,=,-0.1739251972991735,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
1657,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1Cl)Nc1nccs1,1-[2-(2-Chloro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.6,uM,=,-0.2218487496163563,0,S=C(NCCc1ccccc1)Nc1nccs1
1658,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,CCCCCCNC(=O)c1c(O)c(=O)[nH]c2c(F)cccc12,N-Hexyl-8-fluoro-3-hydroxy-2-oxoquinoline-4-carboxamide,49.0,uM,=,1.6901960800285136,1,O=c1ccc2ccccc2[nH]1
1659,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCCc1cc(NCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[(6-Methyl-2-oxo-5-propyl-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",0.058,uM,=,-1.2365720064370629,0,O=C1c2ccccc2C(=O)N1CNc1cccnc1
1660,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2ccc(-c3ccc(O)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.18,uM,=,-0.744727494896694,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1661,2125951,10.1021/acs.jmedchem.1c00268,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.51,uM,=,-0.2924298239020636,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1662,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2ccc(-c3cccc(C#N)c3)cc2)c2nccnc2n(O)c1=O,"Methyl 8-((3'-cyano-[1,1'-biphenyl]-4-yl)amino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",13.32,uM,=,1.1245042248342825,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)c2nccnc2[nH]1
1663,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,N#Cc1ccoc1CCNC(=S)Nc1ccc(Cl)cn1,1-(5-Chloro-pyridin-2-yl)-3-[2-(3-cyano-furan-2-yl)-ethyl]-thiourea,0.06,uM,=,-1.2218487496163564,0,S=C(NCCc1ccco1)Nc1ccccn1
1664,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(COc3ccc([N+](=O)[O-])cc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-(4-nitro-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.13,uM,=,0.0530784434834196,1,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
1665,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(COCc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"9-Benzyloxymethyl-5-cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.27,uM,=,-0.5686362358410126,0,O=C1Nc2c(COCc3ccccc3)ccnc2N(C2CC2)c2ncccc21
1666,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)NCCC=C(c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,"4-(N-Methoxycarbonyl)amino-3',3''-dimethyl-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",4.93,uM,=,0.69284691927723,1,C=C(c1ccccc1)c1ccccc1
1667,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cn2)nc2c1ccn2CO,"5-((4-(4-Cyano-2,6-dimethylphenoxy)-7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)picolinonitrile",0.036,uM,=,-1.4436974992327127,0,c1ccc(Oc2nc(Nc3ccccn3)nc3[nH]ccc23)cc1
1668,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,COc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)c(OC)c1,"N-(2,4-Dimethoxybenzyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",0.63,uM,=,-0.2006594505464183,0,O=C1NC(=O)C(C(=O)NCc2ccccc2)c2ccccc21
1669,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccccc2N(C)C(=O)c2cc(Cl)cnc21,"3-Chloro-11-ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",7.6,uM,=,0.8808135922807914,1,O=C1Nc2ccccc2Nc2ncccc21
1670,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)c1cc(C(=CCCCC=O)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-5-formyl-1-pentenyl]-2-methoxybenzoate,4.9,uM,=,0.6901960800285137,1,C=C(c1ccccc1)c1ccccc1
1671,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid amide",4.0,uM,=,0.6020599913279624,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
1672,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(NC3CCN(Cc4ccc(S(N)(=O)=O)cc4)CC3)c2)c(C)c1,4-((4-((6-chloro-4-(mesityloxy)pyridin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide,0.159,uM,=,-0.7986028756795485,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
1673,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,COCCc1ccc(Oc2nc(Nc3ccc(C#N)cc3)ncc2C)cc1,4-{5-Methyl-4-[4-(2-methoxylethyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,1.27,uM,=,0.1038037209559568,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1674,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccc(-c3ccncc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-(4-(pyridin-4-yl)phenoxy)pyrimidine-2,4-(1H,3H)-dione",10.0,uM,=,1.0,1,O=c1cc(Oc2ccc(-c3ccncc3)cc2)[nH]c(=O)[nH]1
1675,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C(N)=O)c3)CC2)nc2c1CCC2,"3-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)-benzamide",0.241,uM,=,-0.6179829574251317,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCC4)CC2)cc1
1676,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(N(CCCO)c3c(F)cc(-c4ccc(C#N)cc4)cc3F)n2)cc1,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(3-hydroxypropyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
1677,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N(C)C)nc21,"7-Dimethylamino-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.77,uM,=,-0.1135092748275181,0,O=C1Nc2cccnc2Nc2ncccc21
1678,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,COC(=O)c1ccc(NC(=O)CSc2nc3ccccc3n2Cc2cc(C)cc(C)c2)c(Cl)c1,"methyl 3-chloro-4-(2-(1-(3,5-dimethylbenzyl)-1H-benzo[d]imidazol-2-ylthio)acetamido)benzoate",40.3,uM,=,1.6053050461411094,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
1679,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(COc1ccc(-c2cn(Cc3ccc(F)cc3)cc2-c2cc(C(=O)O)[nH]n2)cc1)Nc1ccc(C(=O)O)cc1,3-(4-(4-(2-((4-Carboxyphenyl)amino)-2-oxoethoxy)phenyl)-1-(4-fluorobenzyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,70.0,uM,=,1.845098040014257,1,O=C(COc1ccc(-c2cn(Cc3ccccc3)cc2-c2cc[nH]n2)cc1)Nc1ccccc1
1680,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCc1cc(CN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylmethyl)-isoindole-1,3-dione",26.5,uM,=,1.423245873936808,1,O=C1c2ccccc2C(=O)N1Cc1cccnc1
1681,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1ccc2c(c1)Oc1ccc(C#N)cc1C(=O)N2C,"7,10-Dimethyl-11-oxo-10,11-dihydro-dibenzo[b,f][1,4]oxazepine-2-carbonitrile",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2ccccc2Oc2ccccc21
1682,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCC(=O)Nc3ccc(C(=O)O)cc3)cc2)n[nH]1,4-(2-(4-(4-(5-(Ethoxycarbonyl)-1H-pyrazol-3-yl)-1-(4-fluorobenzyl)-1H-pyrrol-3-yl)phenoxy)acetamido)benzoic acid,8.1,uM,=,0.9084850188786496,1,O=C(COc1ccc(-c2cn(Cc3ccccc3)cc2-c2cc[nH]n2)cc1)Nc1ccccc1
1683,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2nnn(C)n2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,"((S)-1-{N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-N'-[4-(2-methyl-2H-tetrazol-5-yl)-benzyl]-hydrazinocarbonyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.027,uM,=,-1.5686362358410126,0,c1ccc(CCCCNCc2ccc(-c3nn[nH]n3)cc2)cc1
1684,508729,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent plus-strand DNA polymerization after 5 mins by gel-based assay,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.035,uM,=,-1.4559319556497243,0,c1cncc(NCc2nc3ccccc3o2)c1
1685,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(NCc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzylamino-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.39,uM,=,-0.4089353929735008,0,O=C1Nc2cccnc2Nc2ncc(NCc3ccccc3)cc21
1686,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ncc[nH]3)nc21,"5-Ethyl-7-(1H-imidazol-2-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2ccc(-c3ncc[nH]3)nc2Nc2ncccc21
1687,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2ccc(-c3ccc(Cl)cc3)cc2)[nH]c(=O)n1O,"6-((4'-Chloro-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.66,uM,=,-0.1804560644581313,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1688,1567954,10.1016/j.bmc.2016.04.018,,,,Inhibition of HIV1 reverse transcriptase using 234-nt long RNA/18-mer DNA oligonucleotide as template/primer preincubated for 15 mins followed by incubation with template/primer for 40 mins by liquid scintillation counting in presence of alpha[P33]-dCTP,Cc1ccc(Nc2nc(NCC3CCCO3)nc(Nc3ccc(C)cc3)n2)cc1,"2-N,4-N-Bis(4-methylphenyl)-6-N-(oxolan-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine",105.7,uM,=,2.024074987307426,1,c1ccc(Nc2nc(NCC3CCCO3)nc(Nc3ccccc3)n2)cc1
1689,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(N)=O,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetamide",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1690,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3(C)CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(2-methyl-tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.005,uM,=,-2.3010299956639813,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1691,197432,10.1021/jm990236h,,,,Antiviral activity was evaluated by Reverse transcriptase activity in cells acutely infected with HIV-1,CCCCCCCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Decanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",0.25,uM,=,-0.6020599913279624,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
1692,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1SCC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)-methyl)benzenesulfonamide",0.074,uM,=,-1.1307682802690238,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)SCC4)CC2)cc1
1693,1477014,10.1021/np5006696,,,,"Inhibition of human immunodeficiency virus-1 reverse transcriptase associated RNase H activity using using 18-nucleotide 3,-fluorescein-labeled RNA substrate by fluorescence resonance energy transfer assay",CC(C)c1ccc(O)c(=O)c(O)c1,"(2E,4Z,6E)-2,7-dihydroxy-4-isopropylcyclohepta-2,4,6-trienone",0.26,uM,=,-0.585026652029182,0,O=c1cccccc1
1694,195843,10.1021/jm970096g,,,,The quantity of compound required to reduce WT Reverse transcriptase activity by 50%,Fc1cccc(F)c1Cn1c(-c2c(F)cccc2F)nc2ccccc21,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazole",110.0,uM,=,2.041392685158225,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
1695,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(Cl)ccc2N(C)C(=O)c2cccnc21,"9-Chloro-11-ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.17,uM,=,-0.7695510786217261,0,O=C1Nc2ccccc2Nc2ncccc21
1696,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,C/C=C/CN1C(=O)c2cccn2S(=O)(=O)c2cc(Cl)ccc21,"9-((E)-But-2-enyl)-6-chloro-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",3.1,uM,=,0.4913616938342727,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
1697,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccc(O)cc3)C2=O)SC1=S)Nc1ccc(O)cc1,"N-(4-Hydroxy-phenyl)-2-{(E)-3''-[(4-hydroxy-phenylcarbamoyl)-methyl]-4,4''-dioxo-2,2''-dithioxo-[5,5'']bithiazolidinyliden-3-yl}-acetamide",69.0,uM,=,1.8388490907372552,1,O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccccc3)C2=O)SC1=S)Nc1ccccc1
1698,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cnc[nH]3)nc21,"5-Ethyl-7-(3H-imidazol-4-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.74,uM,=,-0.1307682802690238,0,O=C1Nc2ccc(-c3cnc[nH]3)nc2Nc2ncccc21
1699,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nccn2-c2ccc(N(C)C)nc21,"(8-Ethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-yl)-dimethyl-amine",2.19,uM,=,0.3404441148401183,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
1700,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)CN1CCCCC1)CC2,"(2S)-5,7-dihydroxy-2-(2-hydroxy-1-(piperidin-1-yl)propan-2-yl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.82,uM,=,-0.0861861476162833,0,O=c1cccc2c(c1)CC[C@H](CCN1CCCCC1)C2
1701,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(NS(C)(=O)=O)C3)cc2)nc2sccc12,"(E)-N-(1-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[2,3-d]pyrimidin-2-yl)amino)phenyl)piperidin-3-yl)methanesulfonamide",1.015,uM,=,0.0064660422492316,1,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3sccc23)cc1
1702,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),CCN(CC)C(=O)/C=C/CSc1nc(N)cc(Cl)n1,(E)-4-(4-Amino-6-chloro-pyrimidin-2-ylsulfanyl)-but-2-enoic acid diethylamide,0.06,uM,=,-1.2218487496163564,0,c1cncnc1
1703,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccccc2Cl)nc(SC(C)C)[nH]c1=O,"2-(2-chlorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.079,uM,=,-1.1023729087095586,0,O=c1cc(Cc2ccccc2)nc[nH]1
1704,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(N(C)C)nc21,"(8-Ethyl-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-yl)-dimethyl-amine",1.1,uM,=,0.041392685158225,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
1705,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccccc2Cl)n1,"N-(2-Chlorophenyl)-2-((4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)acetamide",143.0,uM,=,2.155336037465062,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
1706,471455,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2CO[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,1-(beta-D-dioxolane)thymine triphosphate,0.3,uM,=,-0.5228787452803376,0,O=c1ccn([C@H]2COCO2)c(=O)[nH]1
1707,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2c(F)ccc(F)c2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-5,8-difluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.796,uM,=,-0.0990869322623309,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
1708,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Oc1nc(NCc2ccc3cc[nH]c3c2)nc(Nc2cccc(Br)c2)n1,"4-((1H-indol-6-yl)methylamino)-6-(3-bromophenylamino)-1,3,5-triazin-2-ol",40.0,uM,=,1.6020599913279625,1,c1ccc(Nc2ncnc(NCc3ccc4cc[nH]c4c3)n2)cc1
1709,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccccc2NC(=O)c2cccnc21,"11-Ethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.38,uM,=,-0.4202164033831898,0,O=C1Nc2ccccc2Nc2ncccc21
1710,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCC(=O)N(C)C)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"N,N-Dimethyl-3',3''-Dichloro-4',4''-dimethoxy-5',5''-bis(methoxy-carbonyl)-6,6-diphenyl-5-hexenamide",0.687,uM,=,-0.1630432629404495,0,C=C(c1ccccc1)c1ccccc1
1711,195359,10.1016/0960-894X(94)00478-X,,,,Inhibitory activity against HIV-1 Reverse transcriptase (RT) was determined,CCN1c2ccncc2N(C)C(=O)c2cccnc21,"5-Ethyl-11-methyl-5,11-dihydro-2,5,6,11-tetraaza-dibenzo[a,d]cyclohepten-10-one",1.6,uM,=,0.2041199826559248,1,O=C1Nc2cnccc2Nc2ncccc21
1712,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,COc1ccc(NC(=O)CCCCC(=O)Nc2ccc(OC)cc2C(=O)O)c(C(=O)O)c1,2-[4-(2-carboxy-4-methoxyphenylcarbamoyl)butylcarboxamido]-5-methoxybenzoic acid,10.6,uM,=,1.0253058652647702,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
1713,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(Cl)cc2)n1,"N-(4-Chlorophenyl)-2-((4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)acetamide",0.72,uM,=,-0.1426675035687315,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
1714,2111169,10.1016/j.ejmech.2020.113063,,,,"Inhibition of HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into cDNA incubated for 1 hr with DIG-dUTP, biotin-dUTP and dTTP followed by transferring onto streptavidin-coated plate and measured after 1 hr by ELISA",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCCCN1CCOCC1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(3-morpholinopropyl)acetamide",0.035,uM,=,-1.4559319556497243,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCCCN1CCOCC1
1715,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3cnnc3)ccc12,"7-(5-Methyl-2-[1,2,4]triazol-4-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",2.6,uM,=,0.414973347970818,1,O=C(CCCCCCc1ncc2ccc(-n3cnnc3)nn12)c1ccccc1
1716,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,COc1ccc(CCNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1OC,"N-[2-(3,4-Dimethoxyphenyl)ethyl]-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",3.85,uM,=,0.5854607295085007,1,O=C1NC(=O)C(C(=O)NCCc2ccccc2)c2ccccc21
1717,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3nccs3)nc21,"5-Ethyl-10-methyl-7-thiazol-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2ccc(-c3nccs3)nc2Nc2ncccc21
1718,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.11,uM,=,0.3242824552976926,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1719,195062,10.1021/jm990383f,,,,In vitro ability to inhibit wild type resistant (WT) reverse transcriptase,Cc1nn(-c2ccccc2)c(-c2ccccc2)c1CC#N,"(3-Methyl-1,5-diphenyl-1H-pyrazol-4-yl)-acetonitrile",2.31,uM,=,0.3636119798921443,1,c1ccc(-c2ccnn2-c2ccccc2)cc1
1720,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCN=[N+]=[N-])c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"4-Azido-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene",2.0,uM,=,0.3010299956639812,1,C=C(c1ccccc1)c1ccccc1
1721,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,O=C(CCNC(=S)Nc1ccc(Br)cn1)c1ccccc1Cl,1-(5-Bromo-pyridin-2-yl)-3-[3-(2-chloro-phenyl)-3-oxo-propyl]-thiourea,0.01,uM,=,-2.0,0,O=C(CCNC(=S)Nc1ccccn1)c1ccccc1
1722,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(CO)cc(O)nc21,"5-Ethyl-7-hydroxy-9-hydroxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2cccnc2Nc2ncccc21
1723,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1ccc(OC)c(CNc2cc(CC)c(C)nc2O)c1,5-Ethyl-3-(5-ethyl-2-methoxy-benzylamino)-6-methyl-1H-pyridin-2-one,0.032,uM,=,-1.494850021680094,0,c1ccc(CNc2cccnc2)cc1
1724,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,CN(C)C(=O)c1cnnn1[C@@H]1O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]2(OS(=O)(=O)C=C2N)[C@H]1O[Si](C)(C)C(C)(C)C,"3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3H-[1,2,3]triazole-4-carboxylic acid dimethylamide",11.7,uM,=,1.0681858617461617,1,O=S1(=O)C=C[C@]2(CO[C@@H](n3ccnn3)C2)O1
1725,734861,10.1016/j.bmc.2011.01.024,,,,Inhibition of HIV1 3B reverse transcriptase activity infected in human H9 cells assessed as level of p24 antigen,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC(=O)[C@]3(C)[C@H](CC[C@@]4(C)[C@@H](c5ccoc5)OC(=O)[C@H]5O[C@]543)[C@@]12C,nomilin,3.56,uM,=,0.5514499979728752,1,O=C1CCC2[C@H](CO1)CC(=O)C1[C@@H]2CCC2[C@@H](c3ccoc3)OC(=O)[C@H]3O[C@@]123
1726,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3oc(=O)ccc3c2)cc1,"N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)-2-oxo-2H-chromene-6-carboxamide",0.5973999999999999,uM,=,-0.2237347817318905,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1ccc2oc(=O)ccc2c1
1727,539717,10.1021/jm800473d,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CCCOCCCNC(=S)Nc1cc(OC)c(Cl)cc1OC,"1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea",0.94,uM,=,-0.0268721464003013,0,c1ccccc1
1728,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccco2)cc1F,"4-((4-((2,6-Difluoro-4-(furan-2-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.012,uM,=,-1.9208187539523751,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccco4)cc3)n2)cc1
1729,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cncs3)nc21,"5-Ethyl-10-methyl-7-thiazol-5-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.1,uM,=,0.041392685158225,1,O=C1Nc2ccc(-c3cncs3)nc2Nc2ncccc21
1730,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-oxopropyl 5-nitrofuran-2-carboxylate,7.1,uM,=,0.8512583487190752,1,c1ccoc1
1731,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCCCCc1c(C)nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc1C,"2-(2-Chloro-6-fluorophenyl)-3-(5-pentyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",16.15,uM,=,1.2081725266671215,1,O=C1CSC(c2ccccc2)N1c1ncccn1
1732,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nn2cccc12,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)pyrrolo[2,1-f][1,2,4]triazin-2-yl)amino)benzonitrile",0.043,uM,=,-1.3665315444204136,0,c1ccc(Nc2nc(Oc3ccccc3)c3cccn3n2)cc1
1733,1567015,10.1021/acs.jmedchem.5b01979,,,,Inhibition of recombinant HIV1 His-tagged p66/p51 reverse transcriptase expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)-oligo(dT) (12 to 18 bp) as template/primer incubated for 20 mins by scintillation counting method,COc1ccc(CN(C)c2nc(Cc3c(Cl)cccc3Cl)c(C)c(=O)[nH]2)cc1,"6-(2,6-Dichlorobenzyl)-2-((4-methoxybenzyl)(methyl)-amino)-5-methylpyrimidin-4(3H)-one",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Cc2ccccc2)nc(NCc2ccccc2)[nH]1
1734,306454,10.1016/j.bmcl.2004.07.050,,,,Inhibitory activity against strand transfer in wild-type HIV-1 integrase was determined using 21-mer oligonucleotide substrate,Nc1ncnc2c1ncn2[C@@H]1CO[C@H](COP(=O)(O)O[C@H]2C[C@H](n3cnc4c(N)ncnc43)O[C@@H]2COP(=O)(O)O)C1,Phosphoric acid 5-(6-amino-purin-9-yl)-2-phosphonooxymethyl-tetrahydro-furan-3-yl ester 4-(6-amino-purin-9-yl)-tetrahydro-furan-2-ylmethyl ester,114.0,uM,=,2.0569048513364727,1,O=[PH](OC[C@@H]1C[C@H](n2cnc3cncnc32)CO1)O[C@@H]1CO[C@@H](n2cnc3cncnc32)C1
1735,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCCc2nnc(C)o2)c2ccc(C#N)cc2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(4-cyanophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-2-methoxy-3-methylbenzothioate",3.2,uM,=,0.505149978319906,1,C(CCCc1nnco1)=C(c1ccccc1)c1ccccc1
1736,2125951,10.1021/acs.jmedchem.1c00268,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)ncc1-c1ccncc1,"(E)-4-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5-(pyridin-4-yl)pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.143,uM,=,-0.8446639625349381,0,c1ccc(CN2CCC(Nc3ncc(-c4ccncc4)c(Oc4ccccc4)n3)CC2)cc1
1737,532312,10.1021/jm701218j,,,,Inhibition of HIV1 reverse transcriptase in human LAI cells,CCNC(=S)Nc1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,"1-Ethyl-3-[5-ethyl-6-methyl-4-(3-methyl-benzyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-thiourea",25.119,uM,=,1.400002345927956,1,O=c1cc(Cc2ccccc2)cc[nH]1
1738,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccccc3oc2=O)cc1,"N-((25,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)-2-oxo-2H-chromene-3-carboxamide",0.4738,uM,=,-0.3244049436132537,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
1739,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),CCc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccc(O)c(C(=O)O)c3)C2=O)cc1,5-(3-{5-[1-(4-Ethyl-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid,11.0,uM,=,1.0413926851582251,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
1740,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(C(=O)O)cc2Cl)c(Cl)c1,4-(2-(1-(4-tert-butyl-2-chlorophenyl)-1H-tetrazol-5-ylthio)acetamido)-3-chlorobenzoic acid,0.005,uM,=,-2.3010299956639813,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1741,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(O)/C(O)=C/C(=O)c1ccn(Cc2ccc(F)cc2)c1,4-(1-(4-Fluorobenzyl)-1H-pyrrol-3-yl)-2-hydroxy-4-oxobut-2-enoic Acid,41.0,uM,=,1.6127838567197357,1,c1ccc(Cn2cccc2)cc1
1742,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,COc1ccc(CSc2nc(C(C#N)c3c(Cl)cccc3Cl)c(C)c(=O)[nH]2)cc1,"2-(2-(4-methoxybenzylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(2,6-dichlorophenyl)acetonitrile",0.23,uM,=,-0.6382721639824072,0,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
1743,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(NCc2ccccc2)c1Cc1cc(C)cc(C)c1,"3-Benzylamino-4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.251,uM,=,-0.6003262785189619,0,O=c1[nH]ccc(Cc2ccccc2)c1NCc1ccccc1
1744,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1ccc(S(=O)(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)cc1,N'-(2-hydroxy-5-nitrobenzylidene)-4-methoxybenzenesulfonohydrazide,90.0,uM,=,1.954242509439325,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
1745,601565,10.1016/j.bmc.2009.06.060,,,,Inhibition of HIV1 reverse transcriptase,CCN(CC)CCOc1ccc(NC(=O)COc2ccccc2C(=O)c2ccc(OC)cc2)cc1,N-[4-(2-Diethylamino-ethoxy)-phenyl]-2-[2-(4-methoxy-benzoyl)-phenoxy]-acetamide,20.998207667318773,uM,=,1.3221822264761578,1,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
1746,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)c1cc(C(=CCCCCN=[N+]=[N-])c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 5-[6-azido-1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-1-hexenyl]-3-chloro-2-methoxybenzoate,1.3,uM,=,0.1139433523068367,1,C=C(c1ccccc1)c1ccccc1
1747,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,C=C(O)C[C@@H]1[C@@H](C(=O)O)[C@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c(c2c2c4c4c6c6c8c%10c8c%12c%10c%14c(c%15%19)c%12c%20c2c2c4c6c8c%10c%122)[C@@H]%18[C@H]2c4c6c8c%10c(c4-%17)[C@H]%16[C@@H]%13[C@@H]%11[C@H]%10C=9[C@H]8[C@@H]7C5=C6[C@]23[C@@H]1C(=O)O,Fullerene Derivative,0.029,uM,=,-1.537602002101044,0,C1C[C@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c(c2c2c4c4c6c6c8c%10c8c%12c%10c%14c(c%15%19)c%12c%20c2c2c4c6c8c%10c%122)[C@@H]%18[C@H]2c4c6c8c%10c(c4-%17)[C@H]%16[C@@H]%13[C@@H]%11[C@H]%10C=9[C@H]8[C@@H]7C5=C6[C@]23C1
1748,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccccc2)Sc2ccccc2-n2cccc2C1=O,5-Ethyl-5-phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,15.0,uM,=,1.1760912590556811,1,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
1749,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2C(=O)Nc2c(C)ccnc21,"5-Ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.5,uM,=,0.1760912590556812,1,O=C1Nc2cccnc2Nc2ncccc21
1750,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(Sc2ccccc2)c1Br,3-Bromo-6-phenethyl-4-(phenylthio)pyridin-2(1H)-one,57.14,uM,=,1.756940236046724,1,O=c1cc(Sc2ccccc2)cc(CCc2ccccc2)[nH]1
1751,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc(O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(3-hydroxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
1752,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(Nc2ccc(-c3ccccc3)cc2)c2cccnc2n1O,"4-([1,10-Biphenyl]-4-ylamino)-1-hydroxypyrido[2,3-d]pyrimidin-2(1H)-one",0.032,uM,=,-1.494850021680094,0,O=c1nc(Nc2ccc(-c3ccccc3)cc2)c2cccnc2[nH]1
1753,442659,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rC.dG template,CCN(CC)CCN1C(=O)CSC1C12CC3CC(CC(C3)C1)C2,2-adamantan-1-yl-3-(2-diethylamino-ethyl)-thiazolidin-4-one,475.0,uM,=,2.676693609624867,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1
1754,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),COc1ccc(OC)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(2-fluoro-3,6-dimethoxy-phenyl)-cyclopropyl]-urea",0.27,uM,=,-0.5686362358410126,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
1755,532312,10.1021/jm701218j,,,,Inhibition of HIV1 reverse transcriptase in human LAI cells,CCc1c(C)[nH]c(=O)c(N(C)CCO)c1Cc1cccc(C)c1,5-Ethyl-3-[(2-hydroxy-ethyl)-methyl-amino]-6-methyl-4-(3-methyl-benzyl)-1H-pyridin-2-one,0.005,uM,=,-2.3010299956639813,0,O=c1cc(Cc2ccccc2)cc[nH]1
1756,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CCC1(c2ccc3ccccc3c2)Sc2ccccc2-n2cccc2C1=O,"6-ethyl-6-(naphthalen-2-yl)benzo[b]pyrrolo[1,2-d][1,4]thiazepin-7(6H)-one",0.85,uM,=,-0.0705810742857072,0,O=C1c2cccn2-c2ccccc2SC1c1ccc2ccccc2c1
1757,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3ccccc3o2)c(S)nc1C,3-(2-Benzooxazol-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridine-2-thione,0.024,uM,=,-1.619788758288394,0,c1cncc(CCc2nc3ccccc3o2)c1
1758,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,Nc1ccc(CO[C@H]2C(=O)Nc3ccc(Cl)cc3[C@@]2(C#CC2CC2)C(F)(F)F)cc1,"(3R,4R)-3-(4-Amino-benzyloxy)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.412,uM,=,-0.3851027839668654,0,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
1759,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1cccc(Cl)c1,2-Amino-6-(3-chloro-phenylsulfanyl)-benzonitrile,16.0,uM,=,1.2041199826559248,1,c1ccc(Sc2ccccc2)cc1
1760,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,COc1ccccc1NC(=O)Cn1ccc(=O)n(Cc2cc(C)cc(C)c2)c1=O,"N-(2-Chlorophenyl)-2-(3-(3,5-dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",210.96,uM,=,2.324200116785378,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
1761,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)c1cc(C(=CCCCCN=[N+]=[N-])c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 5-[6-azido-1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-1-hexenyl]-3-chloro-2-methoxybenzoate,0.8,uM,=,-0.0969100130080563,0,C=C(c1ccccc1)c1ccccc1
1762,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,NCc1cc(-c2ccc3c(c2)OCO3)[nH]c1C(=O)NC(CO)c1nc(S)cs1,"3-(aminomethyl)-5-(benzo[d][1,3]dioxol-5-yl)-N-(2-hydroxy-1-(4-mercaptothiazol-2-yl)ethyl)-1H-pyrrole-2-carboxamide",39.5,uM,=,1.5965970956264603,1,O=C(NCc1nccs1)c1ccc(-c2ccc3c(c2)OCO3)[nH]1
1763,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4)cc3)ccc2C(=O)N1O,"6-((4'-Fluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",4.9,uM,=,0.6901960800285137,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1764,196375,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1/138Lys reverse transcriptase (RT) using [3H]dGTP as a radioligand,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCOP(=O)(O)C(=O)OCc2ccccc2)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[(3-[[[(benzyloxycarbonyl)hydroxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",312.0,uM,=,2.494154594018443,1,O=C(OCc1ccccc1)[PH](=O)OCCCn1c(=O)ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c1=O
1765,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1ccc(C(=O)N/N=C/c2cccc([N+](=O)[O-])c2)cc1,N'-(3-nitrobenzylidene)-4-methoxybenzohydrazide,22.0,uM,=,1.3424226808222062,1,O=C(N/N=C/c1ccccc1)c1ccccc1
1766,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(C)nc21,"5-Ethyl-7,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.2,uM,=,0.0791812460476248,1,O=C1Nc2cccnc2Nc2ncccc21
1767,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccccc2-c2ccc(Cl)cc2)cc(=O)n(O)c1=O,"6-((4'-Chloro-[1,1'-biphenyl]-2-yl)oxy)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",13.0,uM,=,1.1139433523068367,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
1768,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,COc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,"(E)-6-[1-(4-Methoxy-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid",3.0,uM,=,0.4771212547196624,1,c1ccc(Cn2cccc2)cc1
1769,442660,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rA.dT template,Cc1ccnc(N2C(=O)CSC2C23CC4CC(CC(C4)C2)C3)c1,2-adamantan-1-yl-3-(4-methyl-pyridin-2-yl)-thiazolidin-4-one,88.0,uM,=,1.944482672150169,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
1770,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1n[nH]c2ccc(F)c(Oc3cc(C#N)cc(C#N)c3)c12,5-(5-fluoro-3-methyl-1H-indazol-4-yloxy)isophthalonitrile,0.05,uM,=,-1.3010299956639813,0,c1ccc(Oc2cccc3[nH]ncc23)cc1
1771,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,COc1cccc(/C=C2\NC(=O)NC2=O)c1-c1ccc(OC(=O)Nc2ccccc2)cc1,"2'-((2,5-dioxoimidazolidin-4-ylidene)methyl)-6'-methoxybiphenyl-4-yl phenylcarbamate",28.11,uM,=,1.4488608456074408,1,O=C1NC(=O)/C(=C/c2ccccc2-c2ccc(OC(=O)Nc3ccccc3)cc2)N1
1772,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,NCc1ccc(-c2cccc(Cc3cc(=O)n(O)c4ncccc34)c2)cc1,"4-((4'-(aminomethyl)biphenyl-3-yl)methyl)-1-hydroxy-1,8-naphthyridin-2(1H)-one",0.1,uM,=,-1.0,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)c2cccnc2[nH]1
1773,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)CS(=O)(=O)c1ccccc1)CC2,"(2S)-5,7-dihydroxy-2-(2-hydroxy-1-(phenylsulfonyl)propan-2-yl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.51,uM,=,-0.2924298239020636,0,O=c1cccc2c(c1)CC[C@H](CCS(=O)(=O)c1ccccc1)C2
1774,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(Oc2c(C(F)(F)F)ccn(Cc3n[nH]c(=O)n3C)c2=O)ccc1-c1cccc(C#N)c1,"2,methyl-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-ypoxy)-[1,1'-bipheny1]-3-carbonitrile",1.53,uM,=,0.1846914308175988,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1775,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(Cc2ccccc2)Cc2ccccc2)c1Cc1cc(C)cc(C)c1,"3-Dibenzylamino-4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-1H-pyridin-2-one",100.0,uM,=,2.0,1,O=c1[nH]ccc(Cc2ccccc2)c1N(Cc1ccccc1)Cc1ccccc1
1776,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2cc(Cl)cc3nc(S)n(c23)CC1C,"4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.043,uM,=,-1.3665315444204136,0,c1cc2c3c(c1)ncn3CCNC2
1777,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",1.9,uM,=,0.2787536009528289,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1778,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)c1,"4-((4-((6-chloro-4-(4-cyano-2,6-dimethylphenoxy)pyridin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.057,uM,=,-1.2441251443275083,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
1779,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2cc(OC)c(O)cc2OC)cc1,"3-(4-Hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.073,uM,=,-1.136677139879544,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1780,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",1.1,uM,=,0.041392685158225,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1781,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1ccccc1Sc1cccc(N)c1C#N,2-Amino-6-(2-cyano-phenylsulfanyl)-benzonitrile,9.1,uM,=,0.9590413923210936,1,c1ccc(Sc2ccccc2)cc1
1782,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.7,uM,=,-0.1549019599857432,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1783,1888835,10.1016/j.bmcl.2019.06.047,,,,Inhibition of recombinant HIV1 reverse transcriptase p66/p51 expressed in Escherichia coli BL21 (DE3) pLysS cells preincubated followed by primer/template addition and measured after 30 mins by picogreen dye-based fluorescence assay,N#Cc1cc2c(Oc3ccc(F)cc3OCCn3ccc(=O)[nH]c3=O)cc(F)cn2c1,"8-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)-4-fluorophenoxy)-6-fluoroindolizine-2-carbonitrile",0.0045,uM,=,-2.3467874862246565,0,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
1784,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1-c1ccccc1,"Ethyl 6-(4-(4-Fluorobenzoyl)-1-phenyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",1.8,uM,=,0.255272505103306,1,O=C(c1ccccc1)c1ccn(-c2ccccc2)c1
1785,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1csc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)c1,"4-((4-((2,6-Dimethyl-4-(4-methylthiophen-2-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.056,uM,=,-1.2518119729937995,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccs4)cc3)n2)cc1
1786,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(NC)nc21,"5-Ethyl-10-methyl-7-methylamino-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2cccnc2Nc2ncccc21
1787,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(Cl)c(CC/N=C(\S)Nc2ccc(Br)cn2)c1F,1-(5-Bromo-pyridin-2-yl)-3-[2-(6-chloro-3-ethoxy-2-fluoro-phenyl)-ethyl]-thiourea,0.002,uM,=,-2.6989700043360187,0,C(=NCCc1ccccc1)Nc1ccccn1
1788,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,Cc1nc(O)c(NCc2nc3c(Cl)ccc(Cl)c3o2)cc1C(C)O,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-(1-hydroxy-ethyl)-6-methyl-1H-pyridin-2-one",1.05,uM,=,0.021189299069938,1,c1cncc(NCc2nc3ccccc3o2)c1
1789,705547,10.1128/aac.01559-08,,,,Inhibition of HIV1 isolate R8 reverse transcriptase after 90 mins,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1,"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",0.00023,uM,=,-3.638272163982407,0,c1ccc(Oc2cccc(OCc3n[nH]c4ncccc34)c2)cc1
1790,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(=S)[nH]c3ccccc32)c1,"1-(3,5-Dimethylphenylsulfonyl)-1,3-dihydro-2Hbenzimidazole-2-thione",1.35,uM,=,0.1303337684950061,1,O=S(=O)(c1ccccc1)n1c(=S)[nH]c2ccccc21
1791,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)nc1,5-bromo-2-{[(5-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}pyridin-2-yl)carbonyl]amino}benzoic acid,35.0,uM,=,1.5440680443502757,1,O=C(Nc1ccccc1)c1ccc(C(=O)Nc2ccccc2)nc1
1792,195052,10.1016/s0960-894x(01)00239-6,,,,Inhibition of HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CCC1OC(C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-cyclopropylethynyl-3-ethyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.391,uM,=,-0.4078232426041331,0,O=C1COC(C#CC2CC2)c2ccccc2N1
1793,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2c(F)cccc2Cl)C(F)(F)F)c(O)nc1C,3-[1-(2-Chloro-6-fluoro-benzyloxy)-3-cyclopropyl-1-trifluoromethyl-prop-2-ynyl]-5-ethyl-6-methyl-1H-pyridin-2-one,6.093,uM,=,0.7848311781244692,1,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
1794,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc(NC(=O)C2CC3CCC2C3)c(C(N)=O)c1C,"2-(bicyclo[2.2.1]heptane-2-carboxamido)-4,5-dimethylthiophene-3-carboxamide",21.9,uM,=,1.3404441148401185,1,O=C(Nc1cccs1)C1CC2CCC1C2
1795,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,N#Cc1ccc(F)c(CC/N=C(\S)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[2-(3-cyano-2,6-difluoro-phenyl)-ethyl]-thiourea",0.009,uM,=,-2.0457574905606752,0,C(=NCCc1ccccc1)Nc1ccccn1
1796,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,COc1c(C(C)=O)ccc(F)c1CCNC(=O)Nc1ccc(Cl)cn1,1-[2-(3-Acetyl-6-fluoro-2-methoxy-phenyl)-ethyl]-3-(5-chloro-pyridin-2-yl)-urea,0.224,uM,=,-0.6497519816658371,0,O=C(NCCc1ccccc1)Nc1ccccn1
1797,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)c(Cl)c1,2-[1-(4-tert-butyl-2-chloro-phenyl)-1H-tetrazol-5-ylsulfanyl]-N-(2-chloro-4-sulfamoyl-phenyl)-acetamide,0.0058,uM,=,-2.2365720064370627,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
1798,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2cccnc2Nc2ncccc21
1799,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.032,uM,=,-1.494850021680094,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
1800,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1SCC2,"3,5-Dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl)oxy)-benzonitrile",0.13,uM,=,-0.8860566476931633,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)SCC4)CC2)cc1
1801,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccc([N+](=O)[O-])cc2)n1,2-sec-Butylsulfanyl-6-(4-nitro-benzyl)-3H-pyrimidin-4-one,1.2,uM,=,0.0791812460476248,1,c1ccc(Cc2ccncn2)cc1
1802,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(O)c2)cc1,"3-(3, 4-Dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0035,uM,=,-2.4559319556497243,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
1803,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),CCOc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1,3-(3-{5-[1-(4-Ethoxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-benzoic acid,93.0,uM,=,1.9684829485539352,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
1804,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(N)nc3)nc21,"7-(6-Amino-pyridin-3-yl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.26,uM,=,-0.585026652029182,0,O=C1Nc2ccc(-c3cccnc3)nc2Nc2ncccc21
1805,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,NC(=O)C(CNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1)NC(=O)[C@@H](N)CCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1,"3,8-diamino-5-(4-(3-amino-2-((S)-2-amino-5-(4-((3,8-diamino-6-phenylphenanthridinium-5-yl)methyl)benzamido)pentanamido)-3-oxopropylcarbamoyl)benzyl)-6-phenylphenanthridinium",0.0223,uM,=,-1.6516951369518391,0,O=C(CCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1)NCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
1806,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=C([O-])c1cc(NS(=O)(=O)c2ccc(-c3ccc(S(=O)(=O)Nc4cc(C(=O)[O-])c(O)c(S(=O)(=O)[O-])c4)cc3)cc2)cc(S(=O)(=O)[O-])c1O.[Na+].[Na+].[Na+].[Na+],5-{4-[4-(3-carboxy-4-hydroxy-5-sulfophenylsulfamoyl)phenyl]phenylsulfonamido}-2-hydroxy-3-sulfobenzoic acidTetrasodium salt,478.0,uM,=,2.6794278966121188,1,O=S(=O)(Nc1ccccc1)c1ccc(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc1
1807,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CCCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-pyran-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0031,uM,=,-2.508638306165728,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCCO1
1808,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,C#CC1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)CC(n2cnc3c(=O)[nH]c(N)nc32)CC1O,rac-(4-(2-amino-6-oxo-1H-purin-9(6H)-yl)-1-ethynyl-2-hydroxycyclopentyl)methyltriphosphoric acid,0.324,uM,=,-0.4894549897933878,0,O=c1[nH]cnc2c1ncn2C1CCCC1
1809,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2c(Cl)cccc2Cl)c2ccccc2c1=O,"4-[1-(2,6-Dichlorophenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid",10.0,uM,=,1.0,1,O=c1ccn(Cc2ccccc2)c2ccccc12
1810,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)c3ccccc3)[nH]c3ccc(Cl)cc23)c1,"rac-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-phenylethyl)-1H-indole-2-carboxamide",0.04,uM,=,-1.3979400086720375,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
1811,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccc3ccccc3c2)c(S)nc1C,5-Ethyl-6-methyl-3-[(naphthalen-2-ylmethyl)-amino]-1H-pyridine-2-thione,0.3,uM,=,-0.5228787452803376,0,c1cncc(NCc2ccc3ccccc3c2)c1
1812,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1ccc(NC(=O)CS(=O)(=O)c2nccc(Oc3c(C)cc(C#N)cc3C)n2)cc1C,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(3,4-dimethylphenyl)acetamide",27.3,uM,=,1.436162647040756,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
1813,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCc1ccnc2c1NC(=O)c1cccnc1N2CC,"5,9-Diethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2Nc2ncccc21
1814,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,C/C(=C/CCC(=O)Nc1ccc(-c2ccc(CC(=O)O)cc2)cc1Cl)c1ccc(C)cc1Cl,(Z)-2-(3'-chloro-4'-(5-(2-chloro-4-methylphenyl)hex-4-enamido)biphenyl-4-yl)acetic acid,0.0024,uM,=,-2.619788758288394,0,O=C(CCC=Cc1ccccc1)Nc1ccc(-c2ccccc2)cc1
1815,1281575,10.1021/ml4002979,,,,Inhibition of HIV-1 6His-tagged reverse transcriptase p66/p51-mediated TTP incorporation into D23/D36 primer/template preincubated for 15 mins followed by D23/D36 primer/template and TTP addition measured after 15 mins by PAGE analysis,Cc1cc(C#CCCCCCCCC(=O)NCc2cn([C@H]3C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)c(=O)[nH]c2=O)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"((2R,3S,5R)-5-(5-((10-(4-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethylphenyl)dec-9-ynamido)methyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate",0.006,uM,=,-2.2218487496163566,0,O=C(CCCCCCCC#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1)NCc1cn([C@H]2CCCO2)c(=O)[nH]c1=O
1816,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCc2nnc(C)o2)c2ccc3oc(=O)n(C)c3c2)cc1C(=O)SC,"(E)-S-methyl 5-(1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]-oxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",2.6,uM,=,0.414973347970818,1,O=c1[nH]c2cc(/C(=C\CCc3nnco3)c3ccccc3)ccc2o1
1817,195074,10.1016/s0960-894x(98)00369-2,,,,Compound was tested for inhibitory activity against HIV-1 wild type reverse transcriptase,C1=Cc2cccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-5H-4,5,6-triaza-dibenzo[a,d]cycloheptene",0.02,uM,=,-1.6989700043360187,0,C1=Cc2cccnc2N(C2CC2)c2ncccc21
1818,768443,10.1016/j.ejmech.2011.06.034,,,,Inhibition of wild-type HIV1 subtype B reverse transcriptase assessed as incorporation of [3H]dTTP,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)([S-])OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],tetrasodium {[({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(sulfanidyl)phosphoryl phosphonato]oxy}phosphonate,13.9,uM,=,1.1430148002540952,1,c1ncc2nc[nH]c2n1
1819,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Cc1cccn2c(NC3CCCCC3)c(-c3ccccc3Cl)nc12,"2-(2-Chlorophenyl)-N-cyclohexyl-8-methylimidazo[1,2-a]pyridin-3-amine",7.18,uM,=,0.8561244442423004,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
1820,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cnco3)nc21,"5-Ethyl-10-methyl-7-oxazol-5-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2ccc(-c3cnco3)nc2Nc2ncccc21
1821,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3cccc(F)c3)n2)cc1,4-(4-(3-fluorobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.016,uM,=,-1.7958800173440752,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
1822,638659,10.1016/j.bmc.2010.05.004,,,,Inhibition of HIV 3B reverse transcriptase using [3H]TTP as a tracer by scintillation counting,CCc1c(Cc2ccccc2)n(COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c(=O)[nH]c1=O,"(Z)-4-(3-(4-(((6-Benzyl-5-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)benzyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.71,uM,=,-0.1487416512809247,0,O=c1cc(Cc2ccccc2)n(COCc2ccc(Cc3ccccc3)cc2)c(=O)[nH]1
1823,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1ccccc1-c1ccc(Oc2c(C(F)(F)F)ccn(Cc3n[nH]c(=O)n3C)c2=O)cc1F,"3-((2-Fluoro-2'-methy1-[1,1'-biphenyl]-4-y1)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",3.21,uM,=,0.5065050324048721,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1824,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3F)ccc2C(=O)N1O,"6-(2,4-Difluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.5,uM,=,0.1760912590556812,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
1825,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cccnc2Oc2cc(C)cc([N+](=O)[O-])c21,"10-Ethyl-7-methyl-9-nitro-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.031,uM,=,-1.5086383061657274,0,O=C1Nc2ccccc2Oc2ncccc21
1826,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccccc1-c1nc2ccc3ccccc3n2c1NC1CCCCC1,"2-(2-Chlorophenyl)-N-cyclohexylimidazo[1,2-a]quinolin-1-amine",7.52,uM,=,0.8762178405916422,1,c1ccc(-c2nc3ccc4ccccc4n3c2NC2CCCCC2)cc1
1827,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-hydroxy-6-(4'-methylbiphenyl-3-ylamino)pyrimidine-2,4(1H,3H)-dione",0.44,uM,=,-0.3565473235138126,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1828,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CS(N)(=O)=O)[nH]c3ccc(Cl)c(F)c23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-N-(1-sulfamoylpropan-2-yl)-1H-indole-2-carboxamide",0.036,uM,=,-1.4436974992327127,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1829,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-c2ncsc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(4-(2-chloro-4-methylphenyl)thiazol-5-ylthio)acetamido)biphenyl-4-yl)acetic acid,0.2,uM,=,-0.6989700043360187,0,O=C(CSc1scnc1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
1830,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,CSc1nc2ncnc(NCC(P(=O)(O)O)P(=O)(O)O)c2cc1-c1ccsc1,"(2-((7-(Methylthio)-6-(thiophen-3-yl)pyrido[2,3-d]pyrimidin-4-yl)amino)ethane-1,1-diyl)diphosphonic Acid",8.3,uM,=,0.919078092376074,1,c1ncc2cc(-c3ccsc3)cnc2n1
1831,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCCc1c(C)nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc1C,"2-(2,6-Dichlorophenyl)-3-(5-propyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",0.77,uM,=,-0.1135092748275181,0,O=C1CSC(c2ccccc2)N1c1ncccn1
1832,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.044,uM,=,-1.3565473235138126,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
1833,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,O=C(OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1)c1ccccc1,"(+/-)-4-(3-benzyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopent-2-enyl benzoate",13.4,uM,=,1.1271047983648077,1,O=C(OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1)c1ccccc1
1834,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,CS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1835,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(F)cc2F)cs1,"(Z)-3-(2-(4-(2,4-difluorophenyl)thiazol-2-yl)hydrazono)indolin-2-one",2.6,uM,=,0.414973347970818,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
1836,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,O=C1c2c(Cl)ccc(Cl)c2C(=O)N1CCNC(=S)Nc1ccc(Cl)cn1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(4,7-dichloro-1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl]-thiourea",0.002,uM,=,-2.6989700043360187,0,O=C1c2ccccc2C(=O)N1CCNC(=S)Nc1ccccn1
1837,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,C=CCOC(=O)c1cccn1S(=O)(=O)c1cc(Cl)ccc1N,1-(2-Amino-5-chloro-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid allyl ester,0.9,uM,=,-0.0457574905606751,0,O=S(=O)(c1ccccc1)n1cccc1
1838,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",1.0,uM,=,0.0,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
1839,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cc(F)cc(C#N)c4)cc3Cl)c2=O)n[nH]c1=O,"3'-chloro-5-fluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",4.37,uM,=,0.6404814369704218,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
1840,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2c(F)cccc2F)C1,"1-benzyl-4-(2,6-difluorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",0.36,uM,=,-0.4436974992327127,0,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
1841,725037,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 reverse transcriptase,CC(C)c1ccc(O)c(=O)c(O)c1,"(2E,4Z,6E)-2,7-dihydroxy-4-isopropylcyclohepta-2,4,6-trienone",0.25,uM,=,-0.6020599913279624,0,O=c1cccccc1
1842,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=[N+]([O-])c1cc(I)c(O)c(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)c1,4-chloro-N'-(2-hydroxy-3-iodo-5-nitrobenzylidene)benzenesulfonohydrazide,67.0,uM,=,1.8260748027008264,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
1843,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Oc1ccccc1CCNC(=S)Nc1nccs1,1-[2-(2-Hydroxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,1.1,uM,=,0.041392685158225,1,S=C(NCCc1ccccc1)Nc1nccs1
1844,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,CCOC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCC)C(C)C)C(C)C,"((S)-1-{N'-Cyclohexylmethyl-N'-[(2S,3S)-3-((S)-2-ethoxycarbonylamino-3-methyl-butyrylamino)-2-hydroxy-4-phenyl-butyl]-hydrazinocarbonyl}-2-methyl-propyl)-carbamic acid ethyl ester",0.177,uM,=,-0.7520267336381934,0,c1ccc(CCCCNCC2CCCCC2)cc1
1845,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione-5`-triphosphate (d4T-TP)",0.39,uM,=,-0.4089353929735008,0,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
1846,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=[N+]([O-])c1cc(I)cc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)c1O,4-chloro-N'-(2-hydroxy-5-iodo-3-nitrobenzylidene)benzenesulfonohydrazide,63.0,uM,=,1.7993405494535817,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
1847,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(NN1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S)c1ccccc1O,N-{5-[1-(4-Bromo-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-2-hydroxy-benzamide,52.0,uM,=,1.7160033436347992,1,O=C(NN1C(=O)/C(=C/c2ccccc2)SC1=S)c1ccccc1
1848,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2C(F)(F)F)c(O)nc1C,5-Ethyl-6-methyl-3-(2-trifluoromethyl-benzylamino)-1H-pyridin-2-one,12.5,uM,=,1.0969100130080565,1,c1ccc(CNc2cccnc2)cc1
1849,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,O=c1cc(Cc2c(F)cccc2F)nc(SC2CCCC2)[nH]1,"2-Cyclopentylsulfanyl-6-(2,6-difluoro-benzyl)-3H-pyrimidin-4-one",0.08,uM,=,-1.0969100130080565,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
1850,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(N(CCO)c3c(F)cc(-c4ccc(C#N)cc4)cc3F)n2)cc1,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(2-hydroxyethyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.015,uM,=,-1.8239087409443189,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
1851,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(C)cc3Cl)nc3ccccc32)c1,"2-({1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)-N-2-chloro-4-methylphenylacetamide",0.55,uM,=,-0.2596373105057561,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1852,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1,"(E)-6-[1-(4-Fluoro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",11.2,uM,=,1.0492180226701815,1,c1ccc(Cn2cccc2)cc1
1853,705547,10.1128/aac.01559-08,,,,Inhibition of HIV1 isolate R8 reverse transcriptase after 90 mins,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.0006,uM,=,-3.2218487496163566,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1854,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(N)=O)[nH]c3ccc(Br)cc23)c1,"(S)-N-(1-amino-1-oxopropan-2-yl)-5-bromo-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.013,uM,=,-1.8860566476931635,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1855,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)n(O)c1=O,"6-Benzyl-1-(benzyloxymethyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",2.5,uM,=,0.3979400086720376,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
1856,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,N#Cc1cccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n12,"2-(2-Chlorophenyl)-3-(cyclohexylamino)imidazo[1,2-a]pyridine-5-carbonitrile",3.47,uM,=,0.5403294747908738,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
1857,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cc1nc2cc(-c3nc(=O)n(CCC4CCCO4)c4c3oc3ncc(-c5cnn(C)c5)cc34)ccc2n1C,"4-(1,2-Dimethyl-1H-benzoimidazol-5-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0047,uM,=,-2.3279021420642825,0,O=c1nc(-c2ccc3[nH]cnc3c2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1858,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OC1COc2ccccc2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid chroman-3-yl ester",6.1,uM,=,0.785329835010767,1,O=C(OC1COc2ccccc2C1)c1ccccc1
1859,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCC(=O)Nc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"N-[4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl]-propionamide",3.981,uM,=,0.599992177584098,1,O=c1cc(Cc2ccccc2)cc[nH]1
1860,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(Cc3ccccc3)cc(O)nc21,"9-Benzyl-5-ethyl-7-hydroxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.3,uM,=,0.1139433523068367,1,O=C1Nc2c(Cc3ccccc3)ccnc2Nc2ncccc21
1861,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccc(F)cc2)n1,2-sec-Butylsulfanyl-6-(4-fluoro-benzyl)-3H-pyrimidin-4-one,7.4,uM,=,0.8692317197309762,1,c1ccc(Cc2ccncn2)cc1
1862,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCN(C(=O)OC(C)(C)C)CC3)cc2)n1,"(E)-tert-butyl 4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-ylamino)benzyl)piperazine-1-carboxylate",0.297,uM,=,-0.5272435506827877,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
1863,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCCCCc3ccccc3)cc2)n[nH]1,3-(1-(4-Fluorobenzyl)-4-(4-(4-phenylbutoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,0.27,uM,=,-0.5686362358410126,0,c1ccc(CCCCOc2ccc(-c3cn(Cc4ccccc4)cc3-c3cc[nH]n3)cc2)cc1
1864,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccoc3)nc21,"5-Ethyl-7-furan-3-yl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2ccc(-c3ccoc3)nc2Nc2ncccc21
1865,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1ccc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)cc1,"6-Chloro-1-(4-methylphenylsulfonyl)-1,3-dihydro-2Hbenzimidazol-2-one",0.149,uM,=,-0.826813731587726,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
1866,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1C,"Ethyl 6-(4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",28.0,uM,=,1.4471580313422192,1,O=C(c1ccccc1)c1cc[nH]c1
1867,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1cc(Cl)cc(Oc2cc(OS(=O)(=O)F)ccc2Cl)c1,4-Chloro-3-(3-chloro-5-cyanophenoxy)phenyl sulfurofluoridate,0.833,uM,=,-0.0793549985932124,0,c1ccc(Oc2ccccc2)cc1
1868,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2ncc(Br)cc2C(=O)N(C)c2cccnc21,"2-Bromo-5-ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",1.3,uM,=,0.1139433523068367,1,O=C1Nc2cccnc2Nc2ncccc21
1869,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1ccc(C(F)(F)F)cc1)c1cc(=O)n(O)c(=O)[nH]1,"3-Hydroxy-6-(4-(trifluoromethyl)benzoyl)pyrimidine-2,4(1H,3H)-dione",0.081,uM,=,-1.0915149811213505,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
1870,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,N#Cc1ccc(Nc2cc(Oc3c(Cl)cc(Cl)cc3Cl)cnc2N)cc1,"4-((2-amino-5-(2,4,6-trichlorophenoxy)pyridin-3-yl)amino)benzonitrile",0.16,uM,=,-0.7958800173440752,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
1871,769639,10.1016/j.ejmech.2011.08.011,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into enzyme by colorimetry,COC(=O)c1ccc(NC(=O)CSc2ncnn2-c2ccc(Cl)cc2Cl)c(Br)c1,"Methyl 3-bromo-4-(2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)acetamido)benzoate",385.32,uM,=,2.5858215516141274,1,O=C(CSc1ncnn1-c1ccccc1)Nc1ccccc1
1872,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,CCOCn1c(C(=O)c2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-carbonyl)-1-(ethoxymethyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",1.1,uM,=,0.041392685158225,1,O=C(c1cccc(-c2ccccc2)c1)c1cc(=O)[nH]c(=O)[nH]1
1873,1769209,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 RNase H preincubated for 10 mins followed by PBS-22dpol/radiolabeled PBS-14r8d addition measured after 5 mins,O=C(Nc1ccc(-c2cccc(NC(P(=O)(O)O)P(=O)(O)O)c2)cc1)C1CC1,(4'-(cyclopropanecarboxamido)biphenyl-3-ylamino)methylenediphosphonic acid,0.8,uM,=,-0.0969100130080563,0,O=C(Nc1ccc(-c2ccccc2)cc1)C1CC1
1874,2201730,10.1016/j.ejmech.2022.114217,,,,Inhibition of recombinant HIV-1 reverse transcriptase using ABTS as substrate incubated for 1 hr by ELISA,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,"(8S,10S)-10-(4-Amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxy-acetyl)-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione",74.21193851652171,uM,=,1.8704737760981875,1,O=C1c2ccccc2C(=O)c2cc3c(cc21)CCC[C@@H]3O[C@H]1CCCCO1
1875,1336117,10.1021/jm5001503,,,,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,CN(C)c1ccc2c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc3ccc(F)cc3)c2c1,4-[1-[(4-Fluorophenyl)methyl]-7-(dimethylamino)-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,6.6,uM,=,0.8195439355418687,1,O=c1ccn(Cc2ccccc2)c2ccccc12
1876,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,COc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,3-(4-(5-bromo-4-(4-cyano-2-methoxy-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.056,uM,=,-1.2518119729937995,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1877,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCS(N)(=O)=O)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-sulfamoylethyl)-1H-indole-2-carboxamide",0.002,uM,=,-2.6989700043360187,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1878,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1ccnc(N2C(=O)CSC2c2c(F)cccc2F)c1,"2-(2,6-Difluoro-phenyl)-3-(4-methyl-pyridin-2-yl)-thiazolidin-4-one",2.84,uM,=,0.4533183400470376,1,O=C1CSC(c2ccccc2)N1c1ccccn1
1879,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,COc1nc(NCc2ccc3occc3c2)nc(Nc2c(C)cccc2-c2ccccc2)n1,"N2-(benzofuran-5-ylmethyl)-6-methoxy-N4-(3-methylbiphenyl-2-yl)-1,3,5-triazine-2,4-diamine",2.57,uM,=,0.4099331233312945,1,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
1880,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC(C)(C)n1cc(C#N)c2cc(C=O)cnc21,"1-tert-butyl-5-formyl-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile",14.0,uM,=,1.146128035678238,1,c1cnc2[nH]ccc2c1
1881,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1CSC2,"3,5-Dimethyl-4-((2-((1-(4-nitrobenzyl)piperidin-4-yl)amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl)oxy)benzonitrile",0.129,uM,=,-0.889410289700751,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSC4)CC2)cc1
1882,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,C=C(C)CN1Cc2cccc3nc(S)n(c23)CC1C,"8-Methyl-7-(2-methyl-allyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.026,uM,=,-1.585026652029182,0,c1cc2c3c(c1)ncn3CCNC2
1883,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CNc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[(3-Amino-phenylamino)-methyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CNc3ccccc3)cc21
1884,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Pentanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",0.8,uM,=,-0.0969100130080563,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
1885,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1cccc(F)c1,"(3R,4R)-6-Chloro-4-cyclopropylethynyl-3-(3-fluoro-benzyloxy)-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.776,uM,=,0.2494429614425822,1,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
1886,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",2.3,uM,=,0.3617278360175928,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1887,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCO)c2cc(Br)c(OC)c(C(=O)OC)c2)cc(Br)c1OC,"3',3''-Dibromo-4-hydroxy-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene",31.6,uM,=,1.499687082618404,1,C=C(c1ccccc1)c1ccccc1
1888,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCc1c(O)nc(SCC(=O)c2ccc(F)cc2)nc1Cc1cccc2ccccc12,5-Ethyl-2-[2-(4-fluoro-phenyl)-2-oxo-ethylsulfanyl]-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.078,uM,=,-1.1079053973095196,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
1889,1565176,10.1016/j.bmcl.2016.02.049,,,,Inhibition of HIV1 reverse transcriptase using DIG-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",20.14,uM,=,1.3040594662175993,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1890,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"N-[1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-propionamide",8.4,uM,=,0.9242792860618816,1,C1=NNc2ncnc3c2c1cn3C1CCCO1
1891,1891833,10.1021/acs.jmedchem.8b00843,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase using poly(rA)-oligo(dT) as template/primer,CCNc1cccnc1N1CCN(Cc2cc(C)c(OC)c(C)c2)CC1,"N-ethyl-2-(4-(4-methoxy-3,5-dimethylbenzyl)piperazin-1-yl)pyridin-3-amine",20.0,uM,=,1.3010299956639813,1,c1ccc(CN2CCN(c3ccccn3)CC2)cc1
1892,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CCCC1C(=O)/C(=C/c2cccs2)SC1=S)Nc1nc2ccccc2s1,N-Benzothiazol-2-yl-4-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-tetrahydro-thiophen-3-yl}-butyramide,100.0,uM,=,2.0,1,O=C(CCCC1C(=O)/C(=C/c2cccs2)SC1=S)Nc1nc2ccccc2s1
1893,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(C(C)CC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[1-methyl-2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.086,uM,=,-1.0655015487564323,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1894,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc(NC(=O)c2ccc3c(c2)OCO3)c(C(N)=O)c1C,"N-(3-carbamoyl-4,5-dimethylthiophen-2-yl)benzo[d][1,3]dioxole-5-carboxamide",5.1,uM,=,0.7075701760979364,1,O=C(Nc1cccs1)c1ccc2c(c1)OCO2
1895,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1cc(C)cc(Cn2c(=O)[nH]c3ccc(C(F)(F)F)cc32)c1,"6-Trifluoromethyl-1-(3,5-dimethylbenzyl)-1,3-dihydro-2H-benzimidazol-2-one",0.28,uM,=,-0.5528419686577808,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
1896,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,CN(C)c1ccc2c(c1)C(C#CC1CC1)(C(F)(F)F)OC(=O)N2,"4-Cyclopropylethynyl-6-dimethylamino-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.816,uM,=,-0.0883098412461388,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
1897,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CC(C)Oc1cccc(CCNC(=S)Nc2nccs2)c1,1-[2-(3-Isopropoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.4,uM,=,-0.3979400086720376,0,S=C(NCCc1ccccc1)Nc1nccs1
1898,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,C#CC1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)CC(n2cnc3c(N)nc(F)nc32)CC1O,rac-(4-(6-amino-2-fluoro-9H-purin-9-yl)-1-ethynyl-2-hydroxycyclopentyl)methyltriphosphoric acid,3.46,uM,=,0.5390760987927766,1,c1ncc2ncn(C3CCCC3)c2n1
1899,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(F)cc2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((4'-fluoro-3-methyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1900,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1c(F)cccc1F,"6-Chloro-1-(2,6-difluorophenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",30.0,uM,=,1.4771212547196624,1,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
1901,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),CC(=O)OCCCCCc1nc(C)c2ccc(Cl)nn12,"Acetic acid 5-(2-chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-pentyl ester hydrochloride",110.0,uM,=,2.041392685158225,1,c1cnn2cncc2c1
1902,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CCC#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(Cl)cc21,"4-But-1-ynyl-6-chloro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.11,uM,=,-0.958607314841775,0,O=C1NCc2ccccc2N1
1903,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(CCc2cc3ccccc3o2)c(O)nc1C,3-(2-Benzofuran-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.077,uM,=,-1.1135092748275182,0,c1cncc(CCc2cc3ccccc3o2)c1
1904,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,Cn1c(Cc2ccc(Cl)c(Oc3cc(Cl)cc(C#N)c3)c2F)n[nH]c1=O,"3-chloro-5-(6-chloro-2-fluoro-3-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)phenoxy)benzonitrile",0.011,uM,=,-1.958607314841775,0,O=c1[nH]nc(Cc2cccc(Oc3ccccc3)c2)[nH]1
1905,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,Cc1ccc(-c2csc(N/N=C3\C(=O)Nc4ccccc43)n2)cc1,(Z)-3-(2-(4-p-tolylthiazol-2-yl)hydrazono)indolin-2-one,9.0,uM,=,0.9542425094393248,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
1906,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)nc1,"4-(5-Methylamino-pyridin-2-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0059,uM,=,-2.229147988357856,0,O=c1nc(-c2ccccn2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1907,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccc(Cl)cc2)n1,2-sec-Butylsulfanyl-6-(4-chloro-benzyl)-5-methyl-3H-pyrimidin-4-one,8.5,uM,=,0.9294189257142929,1,c1ccc(Cc2ccncn2)cc1
1908,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,Nc1ccn([C@@H]2CS[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)n1,"[(2R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl]methyl tetrahydrogen triphosphate",0.015,uM,=,-1.8239087409443189,0,O=c1ncccn1[C@@H]1CSCO1
1909,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.64,uM,=,-0.1938200260161128,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
1910,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1O,"4-(4-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)phenyl)pyridin-1-ium 4-methylbenzenesulfonate",1.0,uM,=,0.0,0,O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1.c1ccccc1
1911,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(F)c(CC(=O)N3CCc4ccccc4C3)[nH]c(=O)c2Br)c1,"3-(3-bromo-6-(2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl)-5-fluoro-2-oxo-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.012,uM,=,-1.9208187539523751,0,O=C(Cc1cc(Oc2ccccc2)cc(=O)[nH]1)N1CCc2ccccc2C1
1912,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.65,uM,=,0.667452952889954,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1913,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccccc1-c1nc2ccc(Br)cn2c1NC1CCCCC1,"6-Bromo-2-(2-chlorophenyl)-N-cyclohexylimidazo[1,2-a]pyridin-3-amine",12.2,uM,=,1.0863598306747482,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
1914,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,C[C@@H]1CC=C2[C@@H](CCC[C@@]2(C)CC[C@@]2(C)C3=CCCC(C)(C)[C@H]3CC[C@@H]2C)[C@]1(C)Cc1cc(O)ccc1O,"2-(((1R,2R,5S,8aS)-1,2,5-trimethyl-5-(2-((1R,2S,4aR)-1,2,5,5-tetramethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-1-yl)ethyl)-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl)methyl)benzene-1,4-diol",2.8,uM,=,0.4471580313422192,1,C1=C2C(CCC3CCC[C@@H]4C3=CCCC4Cc3ccccc3)CCC[C@@H]2CCC1
1915,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(N(C)Cc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-methyl-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.058,uM,=,-1.2365720064370629,0,c1cncc(NCc2nc3ccccc3o2)c1
1916,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc([N+](=O)[O-])cc23)c1,"N-(1-Amino-1-oxopropan-2-yl)-3-[(3,5-dimethylphenyl)sulfonyl]-5-nitro-1H-indole-2-carboxamide",0.022,uM,=,-1.6575773191777938,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
1917,539717,10.1021/jm800473d,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.63,uM,=,-0.2006594505464183,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1918,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccccc2)nc(SC(C)C)[nH]c1=O,"6-(alpha-cyanobenzyl)-3,4-dihydro-2-isopropylthio-5-methylpyrimidin-4(3H)-one",1.513,uM,=,0.1798389280231867,1,O=c1cc(Cc2ccccc2)nc[nH]1
1919,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(Cl)ccc21,"7-Chloro-5-cyclopropyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.92,uM,=,-0.0362121726544447,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1920,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,COC(=O)c1cc(C)cc2c1N(C)C(=O)c1cccnc1O2,"7,10-Dimethyl-11-oxo-10,11-dihydro-5-oxa-4,10-diaza-dibenzo[a,d]cycloheptene-9-carboxylic acid methyl ester",0.022,uM,=,-1.6575773191777938,0,O=C1Nc2ccccc2Oc2ncccc21
1921,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1c(O)nc(SC(C)C)nc1Cc1ccccc1,6-Benzyl-2-isopropylsulfanyl-5-methyl-3H-pyrimidin-4-one,2.5,uM,=,0.3979400086720376,1,c1ccc(Cc2ccncn2)cc1
1922,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1[C@H](C)Cn2c(S)nc3cc(Cl)cc(c32)[C@@H]1C,"(6S,8R)-4-Chloro-6,8-dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.48,uM,=,-0.3187587626244128,0,c1cc2c3c(c1)ncn3CCNC2
1923,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccc(C(=O)O)cc3)C2=O)SC1=S)Nc1ccc(C(=O)O)cc1,"4-{5-[3-(4-carboxyphenylcarbamoylmethyl)-4-oxo-2-thioxo-1,3-thiazolan-5-yliden]-4-oxo-2-thioxo-1,3-thiazolan-3-ylmethylcarboxamido}benzoic acid",75.0,uM,=,1.8750612633917,1,O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccccc3)C2=O)SC1=S)Nc1ccccc1
1924,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",1.1,uM,=,0.041392685158225,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
1925,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)OC1CC(F)(F)F,"7-Chloro-5-cyclopropylethynyl-3-(2,2,2-trifluoro-ethyl)-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.235,uM,=,-0.6289321377282637,0,O=C1COC(C#CC2CC2)c2ccccc2N1
1926,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),CCN(CC)C(=O)/C=C/CSc1nc(N)cc(Cl)n1,(E)-4-(4-Amino-6-chloro-pyrimidin-2-ylsulfanyl)-but-2-enoic acid diethylamide,0.05,uM,=,-1.3010299956639813,0,c1cncnc1
1927,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCCN(S(=O)(=O)N(C)C)CC3)cc2)n1,"(E)-4-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)benzyl)-N,N-dimethyl-1,4-diazepane-1-sulfonamide",0.094,uM,=,-1.0268721464003014,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCCNCC4)cc3)n2)cc1
1928,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,NS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3cccc(Cl)c3)s2)cc1,"2-[[5-[2-(3-Chlorophenyl)-4-oxo-thiazolidin-3-yl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-sulfamoylphenyl)acetamide",19.17,uM,=,1.2826221128780626,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
1929,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
1930,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid (2R,3R)-2-(3,4-dihydroxy-phenyl)-5,7-dihydroxy-chroman-3-yl ester",0.76,uM,=,-0.1191864077192086,0,O=C(O[C@@H]1Cc2ccccc2O[C@@H]1c1ccccc1)c1ccccc1
1931,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,CC(C)(C)c1ccc(CSc2nc(Cc3ccccc3)c(I)c(=O)[nH]2)cc1,6-Benzyl-2-(4-tert-butylbenzylthio)-5-iodo pyrimidin-4(3H)one,5.62,uM,=,0.7497363155690611,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
1932,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),C#Cc1ccc2c(n1)N(CC)c1ncccc1C(=O)N2C,"5-Ethyl-7-ethynyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2cccnc2Nc2ncccc21
1933,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(S(C)(=O)=O)cc3Cl)nc3ccccc32)c1,"2-({1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl]sulfanyl}-N-[2-chloro-4-(methylsulfonyl)phenyl]-acetamide",0.12,uM,=,-0.9208187539523752,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1934,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(Nc3ccc(CN4CCOCC4)cc3)c2)c(C)c1,6-Chloro-4-(mesityloxy)-N-(4-(morpholinomethyl)phenyl)pyridin-2-amine,2.62,uM,=,0.4183012913197454,1,c1ccc(Oc2ccnc(Nc3ccc(CN4CCOCC4)cc3)c2)cc1
1935,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CN(C)c1ncc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(2-Dimethylamino-pyrimidin-5-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0064,uM,=,-2.193820026016113,0,O=c1nc(-c2cncnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
1936,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CN1C(=O)/C(=C/c2ccccc2Cl)SC1=S)Nc1cc([N+](=O)[O-])ccc1O,2-{5-[1-(2-Chloro-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-N-(2-hydroxy-5-nitro-phenyl)-acetamide,20.0,uM,=,1.3010299956639813,1,O=C(CN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
1937,508745,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization using chimeric substrate with RNA PPT primer extended at 3' end with upto 3 deoxyribonucleotides,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.27,uM,=,-0.5686362358410126,0,c1cncc(NCc2nc3ccccc3o2)c1
1938,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3cn[nH]c3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(1H-pyrazol-4-yl)acetamide,1.25,uM,=,0.0969100130080564,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1cn[nH]c1
1939,1504947,10.1016/j.bmc.2015.06.048,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin deoxyuridine triphosphate (biotin-dUTP) incorporation using poly(rA)/oligo (dT)16 template and primer by spectrofluorometry,Cc1cc(S(N)(=O)=O)ccc1NC(=O)CSc1nccc(Oc2c(C)cc(C#N)cc2C)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)thio)-N-(2-methyl-4-sulfamoylphenyl)acetamide",2.775,uM,=,0.443262987458695,1,O=C(CSc1nccc(Oc2ccccc2)n1)Nc1ccccc1
1940,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3C)nc3ccccc32)c1,"N-(2-Methylphenyl)-2-{[1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl]sulfanyl}acetamide",0.222,uM,=,-0.6536470255493614,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1941,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(NCc2ccc3occc3c2)n1,"4-(benzofuran-5-ylmethylamino)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.07,uM,=,-1.154901959985743,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
1942,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-3-[(2-methoxy-ethyl)-methyl-amino]-6-methyl-1H-pyridin-2-one",0.002,uM,=,-2.6989700043360187,0,O=c1cc(Cc2ccccc2)cc[nH]1
1943,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NCCCNC(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"S-2-(4-(3-aminopropylcarbamoyl)-2-chlorophenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.002,uM,=,-2.6989700043360187,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
1944,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,COc1ccc2c(c1)[C@@](C#Cc1ccccc1)(C(F)(F)F)NC(=O)N2,"6-Methoxy-4-phenylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.219,uM,=,-0.6595558851598816,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)N1
1945,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCC(NC(=O)OC(C)(C)C)CC3)cc2)n1,"(E)-tert-butyl 1-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-ylamino)benzyl)piperidin-4-ylcarbamate",0.499,uM,=,-0.3018994543766101,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCCCC4)cc3)n2)cc1
1946,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCCC(=O)c2ccccc2)n2nc(Cl)ccc12,"8-(2-Chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-octan-1-one hydrochloride",3.0,uM,=,0.4771212547196624,1,O=C(CCCCCCCc1ncc2cccnn12)c1ccccc1
1947,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,Cc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,"(E)-6-[1-(4-Methyl-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid",17.0,uM,=,1.230448921378274,1,c1ccc(Cn2cccc2)cc1
1948,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"N-[1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-acetamide",6.8,uM,=,0.8325089127062363,1,C1=NNc2ncnc3c2c1cn3C1CCCO1
1949,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,COC(=O)c1ccc(NC(=O)CSc2nc3ccc(Cl)cc3n2S(=O)(=O)c2cc(C)cc(C)c2)c(Cl)c1,"Methyl-3-chloro-4-{[({6-chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)acetyl]amino}benzoate",37.56,uM,=,1.5747255835940734,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
1950,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3ccccc3[nH]2)c(O)nc1C,3-[(1H-Benzoimidazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,7.58,uM,=,0.8796692056320535,1,c1cncc(NCc2nc3ccccc3[nH]2)c1
1951,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(CCc2cc(CC)c(C)nc2OC)c(O)nc1C,5-Ethyl-3-[2-(5-ethyl-2-methoxy-6-methyl-pyridin-3-yl)-ethyl]-6-methyl-1H-pyridin-2-one,0.065,uM,=,-1.1870866433571443,0,c1cncc(CCc2cccnc2)c1
1952,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,COCc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Methoxymethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,11.0,uM,=,1.0413926851582251,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1953,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,Cc1cc(Cc2ccc(Cl)c(Oc3ccccc3)c2F)n[nH]c1=O,6-(4-chloro-2-fluoro-3-phenoxybenzyl)-4-methylpyridazin-3(2H)-one,0.02,uM,=,-1.6989700043360187,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
1954,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=C(CCl)Nc1ccc(Cl)cc1NS(=O)(=O)c1cc(F)cc(F)c1,"2-Chloro-N-[4-chloro-2-(3,5-difluoro-phenylsulfonamido)-phenyl]acetamide",27.83,uM,=,1.444513206334043,1,O=S(=O)(Nc1ccccc1)c1ccccc1
1955,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,COc1ccc(-c2cnc3ncnc(NCc4nc(O)c(O)c(C(=O)O)n4)c3c2)cc1,"5,6-Dihydroxy-2-(((6-(4-methoxyphenyl)pyrido[2,3-d]pyrimidin-4-yl)amino)methyl)pyrimidine-4-carboxylic acid",25.0,uM,=,1.3979400086720375,1,c1ccc(-c2cnc3ncnc(NCc4ncccn4)c3c2)cc1
1956,195502,10.1016/s0960-894x(99)00460-6,,,,Inhibitory activity against recombinant HIV-1 reverse transcriptase (rRT),FC(F)(F)c1ccc(/N=C(\S)NCCC2=CCCCC2)nc1,1-(2-Cyclohex-1-enyl-ethyl)-3-(5-trifluoromethyl-pyridin-2-yl)-thiourea,4.0,uM,=,0.6020599913279624,1,C(=Nc1ccccn1)NCCC1=CCCCC1
1957,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1OC,"6-((3',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",3.0,uM,=,0.4771212547196624,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1958,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(F)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,3-(4-(5-bromo-4-(4-cyano-2-fluoro-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.006,uM,=,-2.2218487496163566,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
1959,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.65,uM,=,0.2174839442139062,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1960,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3c[nH]cn3)CC2)nc2ccsc12,"4-((2-((1-((1H-imidazol-4-yl)methyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.052,uM,=,-1.2839966563652008,0,c1ccc(Oc2nc(NC3CCN(Cc4c[nH]cn4)CC3)nc3ccsc23)cc1
1961,534522,10.1016/j.bmc.2007.12.046,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase,CC(COc1ccccc1)OC(=S)Nc1ccccc1,rac-O-(1-Methyl-2-phenoxyethyl)N-phenylthiocarbamate,1.0,uM,=,0.0,0,S=C(Nc1ccccc1)OCCOc1ccccc1
1962,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2cccc(Cl)c2)n1,2-sec-Butylsulfanyl-6-(3-chloro-benzyl)-3H-pyrimidin-4-one,1.9,uM,=,0.2787536009528289,1,c1ccc(Cc2ccncn2)cc1
1963,526428,10.1021/np050510c,,,,Inhibition of HIV1 RT at 200 uM,CCC[C@@H](O)C1=C(Br)/C(=C/I)OC1=O,"(R,Z)-4-bromo-3-(1-hydroxybutyl)-5-(iodomethylene)furan-2(5H)-one",700.0,uM,=,2.845098040014257,1,C=C1C=CC(=O)O1
1964,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CC(C)Cc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isobutyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,2.6,uM,=,0.414973347970818,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
1965,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(O)c(C(=O)O)c1,"5-(3-{5-[1-Benzo[1,3]dioxol-5-yl-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid",15.0,uM,=,1.1760912590556811,1,O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccccc1
1966,140625,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 variant with Y181C plus K103N mutations in RT (reverse transcriptase),S=C(NCc1ccco1)Nc1nccs1,1-Furan-2-ylmethyl-3-thiazol-2-yl-thiourea,0.6,uM,=,-0.2218487496163563,0,S=C(NCc1ccco1)Nc1nccs1
1967,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCCCCCC1C(=O)N(O)C(=O)c2ccccc21,"4-Hexyl-2-hydroxy-isoquinoline-1,3(2H,4H)-dione",38.0,uM,=,1.57978359661681,1,O=C1Cc2ccccc2C(=O)N1
1968,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1[C@H](C)Cn2c(=S)[nH]c3cccc(c32)[C@@H]1C,"(6S,8R)-6,8-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",1.15,uM,=,0.0606978403536116,1,S=c1[nH]c2cccc3c2n1CCNC3
1969,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccc3ccccc3c2)Oc2ccccc2-n2cccc2C1=O,5-Ethyl-5-naphthalen-2-yl-6-oxa-10b-aza-benzo[e]azulen-4-one,0.5,uM,=,-0.3010299956639812,0,O=C1c2cccn2-c2ccccc2OC1c1ccc2ccccc2c1
1970,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2nc(SCC(C)C)nc(O)c2C)c1,2-Isobutylsulfanyl-5-methyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,4.6,uM,=,0.6627578316815741,1,c1ccc(Cc2ccncn2)cc1
1971,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Nc1cccc(C23SCCN2C(=O)c2ccccc23)c1,"9b-(3-Amino-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.6,uM,=,0.6627578316815741,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
1972,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CSc3[nH]cnc4nncc3-4)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(1H-pyrazolo[3,4-d]pyrimidin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(CSc3[nH]cnc4nncc3-4)cc21
1973,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCCN1c2ncccc2C(=O)N(C)c2cccnc21,"10-Methyl-5-propyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.45,uM,=,-0.3467874862246563,0,O=C1Nc2cccnc2Nc2ncccc21
1974,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,CC(=O)Nc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"N-[4-(4-Cyano-2,6-dimethyl-phenoxy)-2-(4-cyano-phenylamino)-pyrimidin-5-yl]-acetamide",0.0019,uM,=,-2.721246399047171,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1975,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(C#CC1CC1)(OCc1ccncc1)C(F)(F)F,3-[3-Cyclopropyl-1-(pyridin-4-ylmethoxy)-1-trifluoromethyl-prop-2-ynyl]-1H-pyridin-2-one,8.115,uM,=,0.9092885241622508,1,C(#CC(OCc1ccncc1)c1cccnc1)C1CC1
1976,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)pyrimidin-2-yl)amino)benzonitrile",0.045,uM,=,-1.3467874862246565,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
1977,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccc(OCc3cccc4ccccc34)cc2)n[nH]1,3-(4-(4-(Naphthalen-8-ylmethoxy)phenyl)-1-(naphthalene-1ylmethyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,1.73,uM,=,0.2380461031287954,1,c1ccc2c(COc3ccc(-c4cn(Cc5cccc6ccccc56)cc4-c4cc[nH]n4)cc3)cccc2c1
1978,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,COc1ccccc1Cn1cc(C(=O)/C=C(\O)C(=O)O)c(=O)c2ccccc21,"(Z)-2-hydroxy-4-(1-(2-methoxybenzyl)-4-oxo-1,4-dihydroquinolin-3-yl)-4-oxobut-2-enoic acid",16.3,uM,=,1.212187604403958,1,O=c1ccn(Cc2ccccc2)c2ccccc12
1979,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,COc1cccc(C(=O)CC/N=C(\S)Nc2ccc(Br)cn2)c1,1-(5-Bromo-pyridin-2-yl)-3-[3-(3-methoxy-phenyl)-3-oxo-propyl]-thiourea,0.08,uM,=,-1.0969100130080565,0,O=C(CCN=CNc1ccccn1)c1ccccc1
1980,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,O=C1c2ccccc2C(Cc2ccc(C(F)(F)F)cc2)C(=O)N1O,"2-Hydroxy-4-(4-trifluoromethylbenzyl)isoquinoline-1,3(2H,4H)-dione",42.7,uM,=,1.6304278750250238,1,O=C1NC(=O)C(Cc2ccccc2)c2ccccc21
1981,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,O=C1Nc2ccc(Cl)c3c2C(C(F)(F)F)(C=C(c2cccnc2)O3)N1,"7-Chloro-5-pyridin-3-yl-3a-trifluoromethyl-3,3a-dihydro-1H-6-oxa-1,3-diaza-phenalen-2-one",0.122,uM,=,-0.9136401693252518,0,O=C1Nc2cccc3c2C(C=C(c2cccnc2)O3)N1
1982,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,CC1=C(/N=N/c2ccc(Cl)cc2)N=C(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)NN1,"4-(4-Chlorophenyl)-5-(5-((4-chlorophenyl)diazenyl)-6-methyl-1,2-dihydro-1,2,4-triazin-3-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",2.8e-05,uM,=,-4.552841968657781,0,C1=C(/N=N/c2ccccc2)N=C(N2Nc3onc(-c4ccccc4)c3C2c2ccccc2)NN1
1983,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,Cc1ccc(Cc2ccc(=O)[nH]n2)cc1Oc1cccc(Cl)c1,6-(3-(3-chlorophenoxy)-4-methylbenzyl)pyridazin-3(2H)-one,0.64,uM,=,-0.1938200260161128,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
1984,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",4.3,uM,=,0.6334684555795865,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1985,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2cc(OC)c(O)cc2OC)C2CC2)cc1,"N-((2S,3R)-4-(N-cyclopropyl-4-methoxyphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-2,5-dimethoxyphenyl)propanamide",0.009,uM,=,-2.0457574905606752,0,O=C(CCc1ccccc1)N[C@H](CCN(C1CC1)S(=O)(=O)c1ccccc1)Cc1ccccc1
1986,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",3.5,uM,=,0.5440680443502757,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
1987,911152,10.1007/s00044-009-9192-x,,,,Inhibition of wild type Human immunodeficiency virus 1 reverse transcriptase after 30 min by fluorescence microplate reader analysis,O=C(OCCN1C(=O)c2ccccc2C1=O)c1ccc(Cl)c([N+](=O)[O-])c1,"2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl 4-chloro-3-nitrobenzoate",0.0011,uM,=,-2.958607314841775,0,O=C(OCCN1C(=O)c2ccccc2C1=O)c1ccccc1
1988,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,S=C(Nc1ccc(Br)cn1)N[C@@H]1C[C@@H]1c1ccccc1,1-((R)-5-Bromo-pyridin-2-yl)-3-((R)-2-phenyl-cyclopropyl)-thiourea,0.008,uM,=,-2.096910013008056,0,S=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
1989,195669,10.1021/jm00048a021,,,,Tested against HIV-1 reverse transcriptase (HIV-1 RT) with poly(rA)/(dT)12-18 as template and [methyl-3H]-dTTP as competing substrate,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.003,uM,=,-2.5228787452803374,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
1990,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)C(C(C)C)C1,"9-Isopropyl-7-(2-methyl-allyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",12.6,uM,=,1.100370545117563,1,O=c1[nH]c2cccc3c2n1CCNC3
1991,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.07,uM,=,-1.154901959985743,0,S=c1[nH]c2cccc3c2n1CCNC3
1992,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(C#N)c1,"6-[1-(3-Cyanophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",5.0,uM,=,0.6989700043360189,1,c1ccc(Cn2cccc2)cc1
1993,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1F,2-Amino-6-(2-fluoro-benzenesulfonyl)-benzonitrile,5.0,uM,=,0.6989700043360189,1,O=S(=O)(c1ccccc1)c1ccccc1
1994,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),Cc1cc(Cl)nc2c1NC(=O)c1cccnc1N2C1CC1,"7-Chloro-5-cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
1995,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1ccc2[nH]c(/C(C#N)=C/c3ccc(-c4ccc(O)c(C(=O)O)c4)o3)nc2c1,5-{5-[(E)-2-Cyano-2-(5-methyl-1H-benzoimidazol-2-yl)-vinyl]-furan-2-yl}-2-hydroxy-benzoic acid,16.0,uM,=,1.2041199826559248,1,C(=C/c1ccc(-c2ccccc2)o1)\c1nc2ccccc2[nH]1
1996,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,COCCNC(=O)CSc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(2-methoxyethyl)acetamide",0.026,uM,=,-1.585026652029182,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
1997,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,Br.NC(=O)c1sc(N)nc1-c1cccc(-c2ccccc2)c1,2-amino-4-(3-phenylphenyl)thiazole-5-carboxamide hydrobromide,59.2,uM,=,1.7723217067229198,1,c1ccc(-c2cccc(-c3cscn3)c2)cc1
1998,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(O)c1ccc(S(=O)(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)c(C(=O)O)c2)C3=O)cc1,"5-[5-(4-Carboxy-benzenesulfonyl)-1,3-dioxo-1,3-dihydro-isoindol-2-yl]-2-hydroxy-benzoic acid",44.0,uM,=,1.6434526764861874,1,O=C1c2ccc(S(=O)(=O)c3ccccc3)cc2C(=O)N1c1ccccc1
1999,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",5.5,uM,=,0.7403626894942439,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2000,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=C(Nc1ccc2c(=O)n(O)c(=O)[nH]c2c1)c1ccccc1,"N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)benzamide",2.52,uM,=,0.4014005407815441,1,O=C(Nc1ccc2c(=O)[nH]c(=O)[nH]c2c1)c1ccccc1
2001,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3N)[nH]c3ccc(Cl)cc23)c1,"N-(2-aminobenzyl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.019,uM,=,-1.7212463990471711,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2002,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(N2CCC(F)(F)CC2)c2cccnc2n1O,"4-(4,4-Difluoropiperidin-1-yl)-1-hydroxypyrido[2,3-d]pyrimidin-2(1H)-one",0.501,uM,=,-0.3001622741327542,0,O=c1nc(N2CCCCC2)c2cccnc2[nH]1
2003,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1ccc(-c2cc(C#N)cc(Oc3c(C(F)(F)F)ccn(Cc4n[nH]c(=O)n4C)c3=O)c2)cc1,"4'-methyl-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",1.53,uM,=,0.1846914308175988,1,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
2004,1872150,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of Triton-X-100 by scintillation counting method,NCC1NC(=O)C[C@@H](C(N)=O)NC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC1=O,"((20S)-20-carbamoyl-3,6,9,12,15,18,22-heptaoxo-5,17-bis((quinoxaline-2-carboxamido)methyl)-1,4,7,10,13,16,19-heptaazacyclodocosan-2-yl)methanaminium",7.0,uM,=,0.8450980400142568,1,O=C1CCNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CN1
2005,196960,10.1016/S0960-894X(01)81224-5,,,,Tested for the inhibition of HIV-1 reverse transcriptase using a ribosomal RNA template,CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.0155711507603527,uM,=,-1.807679290424593,0,S=c1[nH]c2cccc3c2n1CCNC3
2006,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+],"4-Acetylamino-5-hydroxy-naphthalene-2,7-disulfonic acid sodium",584.0,uM,=,2.7664128471124,1,c1ccc2ccccc2c1
2007,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(/C=C(\O)C(=O)O)/C=C/c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,"6-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-2-hydroxy-4-oxohexa-2,5-dienoic Acid",7.0,uM,=,0.8450980400142568,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
2008,1792973,10.1016/j.bmcl.2018.10.010,,,,Inhibition of recombinant wild-type HIV1 GST-fused reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,CCOC(=O)c1cnc(N2CCN(Cc3cccc([N+](=O)[O-])c3)CC2)nc1Oc1c(C)cc(-c2ccc(C#N)cc2)cc1C,"ethyl 4-((4'-cyano-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-2-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-5-carboxylate",113.697,uM,=,2.055749005579252,1,c1ccc(CN2CCN(c3nccc(Oc4ccc(-c5ccccc5)cc4)n3)CC2)cc1
2009,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1ccc(COCc2cc(=O)[nH]c(=O)n2COCc2ccccc2)cc1,"1-[(Benzyloxy)methyl]-6-{[(4-methylbenzyl)oxy]-methyl}pyrimidine-2,4(1H,3H)-dione",0.82,uM,=,-0.0861861476162833,0,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2010,858890,10.1021/jm300477h,,,,Inhibition of wild type HIV1 reverse transcriptase RNA-dependent DNA polymerase activity using poly(rA)/oligo(dT)10:1 and [3H]-dTTP substrate,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3cccnc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-(pyridin-3-yl)ethyl)-1H-indole-2-carboxamide",0.04,uM,=,-1.3979400086720375,0,O=C(NCCc1cccnc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2011,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CS(N)(=O)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(1-sulfamoylpropan-2-yl)-1H-indole-2-carboxamide",0.0004,uM,=,-3.397940008672037,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
2012,2125951,10.1021/acs.jmedchem.1c00268,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)ncc1-c1ccncc1,"(E)-4-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5-(pyridin-4-yl)pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzamide",0.102,uM,=,-0.9913998282380824,0,c1ccc(CN2CCC(Nc3ncc(-c4ccncc4)c(Oc4ccccc4)n3)CC2)cc1
2013,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCOC(=O)CSc1nc(O)c(C)c(Cc2cccc3ccccc23)n1,"(5-Methyl-4-naphthalen-1-ylmethyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-acetic acid ethyl ester",7.0,uM,=,0.8450980400142568,1,c1ccc2c(Cc3ccncn3)cccc2c1
2014,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2nc(C)c(C)cc2OC)c(O)nc1C,"5-Ethyl-3-[(3-methoxy-5,6-dimethyl-pyridin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",0.07,uM,=,-1.154901959985743,0,c1ccc(CNc2cccnc2)nc1
2015,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,CC(=O)N(C)c1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"N-[1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazol-4-yl]-N-methyl-acetamide",0.32,uM,=,-0.494850021680094,0,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
2016,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)C[S+]([O-])c1ccccc1)CC2,"(2S)-5,7-dihydroxy-2-(2-hydroxy-1-(phenylsulfinyl)propan-2-yl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",1.3,uM,=,0.1139433523068367,1,O=c1cccc2c(c1)CC[C@H](CC[SH+]c1ccccc1)C2
2017,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nccn2-c2cccnc21,"8-Ethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.775,uM,=,-0.1106982974936897,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2018,769639,10.1016/j.ejmech.2011.08.011,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into enzyme by colorimetry,CCOC(=O)c1ccc(NC(=O)CSc2ncnn2-c2ccc(Cl)cc2Cl)c(Br)c1,"Ethyl 3-bromo-4-(2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)acetamido)benzoate",297.42,uM,=,2.4733701692887946,1,O=C(CSc1ncnn1-c1ccccc1)Nc1ccccc1
2019,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.85,uM,=,0.2671717284030138,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
2020,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC1CN(CC2CC2)Cc2cc(Cl)cc3[nH]c(=S)n1c23,"4-Chloro-7-cyclopropylmethyl-9-methyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",2.18,uM,=,0.3384564936046048,1,S=c1[nH]c2cccc3c2n1CCN(CC1CC1)C3
2021,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1ccc(C(=O)Nc2sc(C)c(C)c2C(N)=O)cc1,"4,5-dimethyl-2-(4-methylbenzamido)thiophene-3-carboxamide",2.8,uM,=,0.4471580313422192,1,O=C(Nc1cccs1)c1ccccc1
2022,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CCN1C(=O)c2cccn2S(=O)(=O)c2ccccc21,"9-Ethyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
2023,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CCCCn1cc(C#N)c2c(-c3ccc(C(F)(F)F)cc3F)c3c(nc21)-c1ccccc1C3=O,"1-butyl-4-(2-fluoro-4-(trifluoromethyl)phenyl)-5-oxo-1,5-dihydroindeno[2,1-e]pyrrolo[2,3-b]pyridine-3-carbonitrile",0.58,uM,=,-0.2365720064370627,0,O=C1c2ccccc2-c2nc3[nH]ccc3c(-c3ccccc3)c21
2024,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,N#Cc1ccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)cc1,"6-[1-(4-Cyanophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",6.0,uM,=,0.7781512503836436,1,c1ccc(Cn2cccc2)cc1
2025,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-N'-(4-pyridin-2-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester",0.026,uM,=,-1.585026652029182,0,c1ccc(CCCCNCc2ccc(-c3ccccn3)cc2)cc1
2026,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cccnc2Oc2cccc([N+](=O)[O-])c21,"10-Ethyl-9-nitro-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.343,uM,=,-0.4647058799572294,0,O=C1Nc2ccccc2Oc2ncccc21
2027,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1CSCC2,"(E)-3-(3,5-dimethyl-4-(2-(1-(4-(methylsulfonyl)benzyl)piperidin-4-ylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",363.0,uM,=,2.5599066250361124,1,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
2028,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)CCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-4-methyloxycarbonyl-1-butenyl]-2-methoxybenzoate,7.2,uM,=,0.8573324964312685,1,C=C(c1ccccc1)c1ccccc1
2029,1982636,10.1021/acsmedchemlett.9b00623,,,,Inhibition of HIV-1 reverse transcriptase His-tagged p51 heterodimerization with HIV-1 reverse transcriptase p66 incubated for 16 hrs by ELISA,CC[C@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,"(3S,6S,9S,12S,15S,18S,21S,26R,29S)-21-amino-9,12-bis(2-amino-2-oxo-ethyl)-6-(2-carboxyethyl)-3-[(1R)-1-hydroxyethyl]-18-(hydroxymethyl)-15-[(1S)-1-methylpropyl]-2,5,8,11,14,17,20,28-octaoxo-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carboxylic acid",61.0,uM,=,1.7853298350107671,1,O=C1CCSSCCNC(=O)[C@@H]2CCCN2C(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
2030,502847,10.1021/np960250m,,,,Inhibition of HIV1 reverse transcriptase,C=CC(C)(C)C1(CC=C(C)C)C(=O)Nc2ccccc2C1=O,buchapine,12.0,uM,=,1.0791812460476249,1,O=C1CC(=O)c2ccccc2N1
2031,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3ccccc3)c21,"1-ethyl-7-phenoxy-1,3-dihydro-2H-benzo[d]imidazol-2-one",3.88,uM,=,0.5888317255942073,1,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
2032,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(C)c2c(c1)Oc1ccc(C#N)cc1C(=O)N2C,"7,9,10-Trimethyl-11-oxo-10,11-dihydro-dibenzo[b,f][1,4]oxazepine-2-carbonitrile",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2ccccc2Oc2ccccc21
2033,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ncccc34)ccc2Cl)c1,"3-Chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridine-3-ylmethoxy)-phenoxy]benzonitrile",0.0004,uM,=,-3.397940008672037,0,c1ccc(Oc2cccc(OCc3n[nH]c4ncccc34)c2)cc1
2034,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,C/C(=C/CCC(=O)Nc1ccc(-c2ccc(OCC(=O)O)cc2)cc1Cl)c1ccc(C)cc1Cl,(Z)-2-(3'-chloro-4'-(5-(2-chloro-4-methylphenyl)hex-4-enamido)biphenyl-4-yloxy)acetic acid,0.015,uM,=,-1.8239087409443189,0,O=C(CCC=Cc1ccccc1)Nc1ccc(-c2ccccc2)cc1
2035,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(C#N)cc(-c4ccc(F)cc4)c3)c2=O)n[nH]c1=O,"4'-fluoro-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",0.11,uM,=,-0.958607314841775,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
2036,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)cc2[C@@](C#Cc2ccccc2)(C(F)(F)F)N1,"6-Fluoro-4-phenylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.143,uM,=,-0.8446639625349383,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)N1
2037,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2ccc3ccccc3c2)c2nccnc2n(O)c1=O,"Methyl 5-hydroxy-8-(naphthalen-2-ylamino)-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",5.11,uM,=,0.7084209001347128,1,O=c1cc(Nc2ccc3ccccc3c2)c2nccnc2[nH]1
2038,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,O=P(O)(O)C(CNc1ncnc2ncc(-c3ccsc3)cc12)P(=O)(O)O,"(2-((6-(Thiophen-3-yl)pyrido[2,3-d]pyrimidin-4-yl)amino)-ethane-1,1-diyl)diphosphonic Acid",9.0,uM,=,0.9542425094393248,1,c1ncc2cc(-c3ccsc3)cnc2n1
2039,195846,10.1021/jm9800806,,,,inhibitory activity against HIV-1 reverse transcriptase (wild type,Nc1cc(Cl)nc(SCc2cc3c(cc2Cl)OCO3)n1,"6-Chloro-2-(6-chloro-benzo[1,3]dioxol-5-ylmethylsulfanyl)-pyrimidin-4-ylamine",0.085,uM,=,-1.0705810742857071,0,c1cnc(SCc2ccc3c(c2)OCO3)nc1
2040,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(C(F)(F)F)cc(Cl)c2N(C)C(=O)c2cccnc21,"7-Chloro-11-ethyl-6-methyl-9-trifluoromethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.29,uM,=,-0.5376020021010439,0,O=C1Nc2ccccc2Nc2ncccc21
2041,508743,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization using chimeric substrate with RNA PPT primer extended at 3' end with upto one deoxyribonucleotide,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.22,uM,=,-0.6575773191777937,0,c1cncc(NCc2nc3ccccc3o2)c1
2042,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3cc(F)ccc3o2)c(O)nc1C,5-Ethyl-3-[2-(5-fluoro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridin-2-one,1.7,uM,=,0.2304489213782739,1,c1cncc(CCc2nc3ccccc3o2)c1
2043,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OCCc1ccc(O)cc1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 2-(4-hydroxy-phenyl)-ethyl ester",7.9,uM,=,0.8976270912904415,1,O=C(OCCc1ccccc1)c1ccccc1
2044,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3c(F)cc(-c4cccc(C#N)c4)cc3F)c2=O)n[nH]c1=O,"3',5'-difluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",2.57,uM,=,0.4099331233312945,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2045,1763334,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 3B reverse transcriptase using polyC/oligo(dG12) as template/primer in presence of [3H]dGTP and calf thymus DNA after 30 mins,CCOC(=O)P(=O)(O)OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[(3-[[[(ethyloxycarbonyl)hydroxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",3.7,uM,=,0.568201724066995,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
2046,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CC(N)=O)[nH]c3ccc([N+](=O)[O-])cc23)c1,"N-(4-Amino-4-oxobutan-3-yl)-3-[(3,5-dimethylphenyl)sulfonyl]-5-nitro-1H-indole-2-carboxamide",0.033,uM,=,-1.4814860601221125,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
2047,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(F)cc3[nH]2)CC1,(6-Fluoro-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,4.4,uM,=,0.6434526764861874,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
2048,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cccc(C23SCCN2C(=O)c2cccnc23)n1,"9b-(6-Methyl-pyridin-2-yl)-2,3-dihydro-9bH-thiazolo[3',2':1,2]pyrrolo[3,4-b]pyridin-5-one",6.6,uM,=,0.8195439355418687,1,O=C1c2cccnc2C2(c3ccccn3)SCCN12
2049,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,Cc1ccc(-c2nc(O)c(O)c(C(=O)O)n2)cc1,"5,6-Dihydroxy-2-(p-tolyl)pyrimidine-4-carboxylic acid",6.3,uM,=,0.7993405494535817,1,c1ccc(-c2ncccn2)cc1
2050,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cn2)nc2c1CSCC2,"6-(4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)nicotinonitrile",0.053,uM,=,-1.275724130399211,0,c1ccc(Oc2nc(Nc3ccccn3)nc3c2CSCC3)cc1
2051,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CC/N=C(\S)Nc2nc(C(F)(F)F)cs2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-3-(4-trifluoromethyl-thiazol-2-yl)-thiourea,0.047,uM,=,-1.3279021420642825,0,C(=NCCc1ccccc1)Nc1nccs1
2052,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,NC(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carboxamide",2.9,uM,=,0.4623979978989561,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
2053,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(C)c2c(c1)Oc1ccccc1C(=O)N2C,"7,9,10-Trimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.057,uM,=,-1.2441251443275083,0,O=C1Nc2ccccc2Oc2ccccc21
2054,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2ccc(-c3ccc(O)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.82,uM,=,-0.0861861476162833,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2055,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)c3ccccc3F)[nH]c3ccc(Cl)cc23)c1,"(R)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(2-fluorophenyl)ethyl)-1H-indole-2-carboxamide",0.087,uM,=,-1.0604807473813815,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2056,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,FC(F)(F)c1cccc(NC2=Nc3ccc(Cl)cc3C(C#CC3CC3)(C(F)(F)F)N2)c1,"6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-N-(3-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-2-amine",0.0045,uM,=,-2.3467874862246565,0,C(#CC1NC(Nc2ccccc2)=Nc2ccccc21)C1CC1
2057,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cc(C)cc(Sc2cccc(N)c2C#N)c1,2-Amino-6-(3-methoxy-5-methyl-phenylsulfanyl)-benzonitrile,0.14,uM,=,-0.8538719643217619,0,c1ccc(Sc2ccccc2)cc1
2058,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NC1CCN(C(=O)OC(C)(C)C)CC1,"Tert-butyl4-(2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetamido)piperidine-1-carboxylate",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NC1CCNCC1
2059,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(NC3CCN(Cc4ccncc4)CC3)c2)c(C)c1,6-Chloro-4-(mesityloxy)-N-(1-(pyridin-4-ylmethyl)piperidin-4-yl)pyridin-2-amine,0.082,uM,=,-1.0861861476162833,0,c1ccc(Oc2ccnc(NC3CCN(Cc4ccncc4)CC3)c2)cc1
2060,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccc2c(c1)C(=O)N1CCSC21c1ccccc1,"7-Methyl-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",10.0,uM,=,1.0,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2061,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2nccs2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-2-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester",0.018,uM,=,-1.744727494896694,0,c1ccc(CCCCNCc2ccc(-c3nccs3)cc2)cc1
2062,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCOc1ccc(Cl)c(C2CC2NC(=O)Nc2ccc(Cl)cn2)c1F,1-[2-(6-Chloro-3-ethoxy-2-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea,0.0013,uM,=,-2.886056647693163,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
2063,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(-c3cccc(Cl)c3)c2)[nH]c(=O)n1O,"6-((3'-chloro-[1,1'-biphenyl]-3-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.02,uM,=,-1.6989700043360187,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2064,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2cc[nH]c(=O)c2N(C)C)c1,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-1H-pyridin-2-one",7.943,uM,=,0.899984562549391,1,O=c1cc(Cc2ccccc2)cc[nH]1
2065,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCc3nc4ccccc4s3)ccc2Cl)c1,3-(5-(benzo[d]thiazol-2-ylmethoxy)-2-chlorophenoxy)-5-chlorobenzonitrile,0.0192899999999999,uM,=,-1.7146677723561154,0,c1ccc(Oc2cccc(OCc3nc4ccccc4s3)c2)cc1
2066,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccc(Cl)cc2[C@@]2(c3ccccc3)SCCN12,"8-Chloro-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.09,uM,=,-1.0457574905606752,0,O=C1c2ccccc2[C@@]2(c3ccccc3)SCCN12
2067,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3ccccc3C(N)=O)CC2)ncc1Br,"2-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.032,uM,=,-1.494850021680094,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2068,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)cn1,"(E)-3-(4-hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0115,uM,=,-1.9393021596463884,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1cccnc1)Cc1ccccc1
2069,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,COc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,3-(4-(4-(4-cyano-2-methoxy-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.018,uM,=,-1.744727494896694,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2070,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccccc1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",2.1,uM,=,0.3222192947339193,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2071,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,COc1ccccc1-c1cc(C)c(Oc2cc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-((4-Amino-6-((2'-methoxy-3,5-dimethyl-[1,1'-biphenyl]-4-yl)-oxy)pyrimidin-2-yl)amino)benzonitrile",0.122,uM,=,-0.9136401693252518,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2072,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O,DORAVIRINE,0.044,uM,=,-1.3565473235138126,0,O=c1[nH]nc(Cn2cccc(Oc3ccccc3)c2=O)[nH]1
2073,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(Sc2ccccc2)c1I,3-Iodo-6-phenethyl-4-(phenylthio)pyridin-2(1H)-one,20.29,uM,=,1.307282047033346,1,O=c1cc(Sc2ccccc2)cc(CCc2ccccc2)[nH]1
2074,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1cc(F)cc(F)c1,"6-Chloro-1-(3,5-difluorophenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.1,uM,=,-1.0,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
2075,1558481,10.1016/j.bmc.2016.02.038,,,,Inhibition of recombinant HIV-1 reverse transcriptase using 234 nt long RNA template after 10 mins by liquid scintillation analysis,CCOC(=O)c1c2cccccc-2c(C(=O)OCC)c1O,"diethyl 2-hydroxyazulene-1,3-dicarboxylate",104.2,uM,=,2.017867718963505,1,c1ccc2cccc-2cc1
2076,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-n3cccn3)nc21,"5-Ethyl-10-methyl-7-pyrazol-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.56,uM,=,-0.2518119729937995,0,O=C1Nc2ccc(-n3cccn3)nc2Nc2ncccc21
2077,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,N/N=C(\N)N1Nc2onc(-c3ccccc3)c2C1c1ccc(Cl)cc1,"4-(4-chlorophenyl)-3-phenyl-4H-pyrazolo[4,3-d]isoxazole-5(6H)-carbohydrazonamide",1.7999999999999997e-05,uM,=,-4.744727494896694,0,c1ccc(-c2noc3c2C(c2ccccc2)NN3)cc1
2078,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2N)c(O)nc1C,3-(2-Amino-benzylamino)-5-ethyl-6-methyl-1H-pyridin-2-one,28.0,uM,=,1.4471580313422192,1,c1ccc(CNc2cccnc2)cc1
2079,306441,10.1016/j.bmcl.2005.06.036,,,,In vitro inhibitory concentration against HIV-1 recombinant integrase activity in standard 3'-processing assay,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,"2-[2-(3,4-Dihydroxy-phenyl)-vinyl]-8-hydroxy-quinoline-7-carboxylic acid",2.0,uM,=,0.3010299956639812,1,C(=C/c1ccc2ccccc2n1)\c1ccccc1
2080,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,Br.NC(=O)c1sc(N)nc1-c1cccc(I)c1,2-amino-4-(3-iodophenyl)thiazole-5-carboxamide hydrobromide,125.4,uM,=,2.0982975364946976,1,c1ccc(-c2cscn2)cc1
2081,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCNc1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"4-(3,5-Dimethyl-benzyl)-5-ethyl-3-ethylamino-6-methyl-1H-pyridin-2-one",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccccc2)cc[nH]1
2082,471467,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type LAI by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.08,uM,=,-1.0969100130080565,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2083,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)Nc3ccc(O)cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-hydroxyphenyl)-1H-indole-2-carboxamide",0.069,uM,=,-1.1611509092627446,0,O=C(Nc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2084,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2cccc([N+](=O)[O-])c2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(3-nitrophenyl)acetamide",1.41,uM,=,0.1492191126553798,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
2085,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc2c(=O)n1O,"4-Fluoro-N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)benzenesulfonamide",5.68,uM,=,0.7543483357110189,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2[nH]1
2086,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,CCCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(=O)O)[C@H]2OC)c1=O,oligonucleotide,6.7,uM,=,0.8260748027008264,1,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
2087,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2ccccc2S[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)N12,"(5aR,6S,7S,8R,9S)-6,7,8-trihydroxy-9-(hydroxymethyl)-6,7,8,9-tetrahydro-5aH,11H-pyrido[2,1-b][1,3]benzothiazin-11-one",1.32,uM,=,0.1205739312058498,1,O=C1c2ccccc2S[C@@H]2CCCCN12
2088,305627,10.1021/jm049252r,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase (IIIB),O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(I)cc1,"(4-Iodo-phenyl)-thiocarbamic acid 2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl ester",0.09,uM,=,-1.0457574905606752,0,O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccccc1
2089,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,COc1ccccc1CC/N=C(\S)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-methoxy-phenyl)-ethyl]-thiourea,1.0,uM,=,0.0,0,C(=NCCc1ccccc1)Nc1ccccn1
2090,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,C[C@@H]1CC=C2[C@@H](CCC[C@@]2(C)CC[C@@]2(C)C3=CCCC(C)(C)[C@H]3CC[C@@H]2C)[C@]1(C)Cc1cc(O)ccc1O,"2-(((1R,2R,5S,8aS)-1,2,5-trimethyl-5-(2-((1R,2S,4aR)-1,2,5,5-tetramethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-1-yl)ethyl)-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl)methyl)benzene-1,4-diol",4.2,uM,=,0.6232492903979004,1,C1=C2C(CCC3CCC[C@@H]4C3=CCCC4Cc3ccccc3)CCC[C@@H]2CCC1
2091,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(S)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridine-2-thione",0.042,uM,=,-1.3767507096020994,0,c1cncc(NCc2nc3ccccc3o2)c1
2092,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCOC(=O)CSc1nc(O)c(C(C)C)c(Cc2cccc3ccccc23)n1,"(5-Isopropyl-4-naphthalen-1-ylmethyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-acetic acid ethyl ester",1.41,uM,=,0.1492191126553798,1,c1ccc2c(Cc3ccncn3)cccc2c1
2093,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,CN(C)c1c(Oc2cc(Cl)cc(C#N)c2)cc(CC(=O)N2CCc3ccccc3C2)[nH]c1=O,"3-chloro-5-(6-(2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl)-3-(dimethylamino)-2-oxo-1,2-dihydropyridin-4-yloxy)benzonitrile",0.22,uM,=,-0.6575773191777937,0,O=C(Cc1cc(Oc2ccccc2)cc(=O)[nH]1)N1CCc2ccccc2C1
2094,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,Cc1csc(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)n1,"4-(4-chlorophenyl)-5-(4-methylthiazol-2-yl)-3-phenyl-5,6-dihydro-4Hpyrazolo[4,3-d]isoxazole",4.6e-05,uM,=,-4.337242168318426,0,c1ccc(-c2noc3c2C(c2ccccc2)N(c2nccs2)N3)cc1
2095,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,1.5,uM,=,0.1760912590556812,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2096,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC1Cn2c(S)nc3cc(Cl)cc(c32)CN1CC1CC1,"4-Chloro-7-cyclopropylmethyl-8-methyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.034,uM,=,-1.4685210829577449,0,c1cc2c3c(c1)ncn3CCN(CC1CC1)C2
2097,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc4ccccc4c3)cc2c1=O,"1-(4-Fluorobenzyl)-6-(naphthalen-2-ylmethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",30.3,uM,=,1.481442628502305,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc4ccccc4c3)cc12
2098,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(Br)cc2)nc(SC(C)C)[nH]c1=O,"2-(4-bromophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",1.779,uM,=,0.250175948083925,1,O=c1cc(Cc2ccccc2)nc[nH]1
2099,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2ccccc2C(=O)N1O,"2-Hydroxy-4H-isoquinoline-1,3-dione",1.0,uM,=,0.0,0,O=C1Cc2ccccc2C(=O)N1
2100,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2OC)c(O)nc1C,5-Ethyl-3-(2-methoxy-benzylamino)-6-methyl-1H-pyridin-2-one,0.265,uM,=,-0.5767541260631921,0,c1ccc(CNc2cccnc2)cc1
2101,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(F)cc2)cs1,(Z)-3-(2-(4-(4-fluorophenyl)thiazol-2-yl)hydrazono)indolin-2-one,6.4,uM,=,0.8061799739838872,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2102,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(C(F)(F)F)nc(SCc2ccc3ccccc3c2)n1,2-(Naphthalen-2-ylmethylsulfanyl)-6-trifluoromethyl-pyrimidin-4-ylamine,0.28,uM,=,-0.5528419686577808,0,c1cnc(SCc2ccc3ccccc3c2)nc1
2103,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,NC[C@@H](NC(=O)c1ccc(-c2ccc(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,(R)-N-(2-amino-1-(5-(hydroxymethyl)thiazol-2-yl)ethyl)-5-(4-chloro-3-fluorophenyl)-1H-pyrrole-2-carboxamide,13.7,uM,=,1.136720567156407,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
2104,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccc(Cl)cc3)n2)cc1,4-(4-(4-chlorobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.048,uM,=,-1.3187587626244128,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2105,195507,10.1021/jm0203276,,,,Inhibitory activity of compound against reverse transcriptase (RT) in cell free RT.,C#CCn1cnc2c(ncn2[C@@H]2O[C@H](COC)[C@@H](OP(C)(=O)O)[C@H]2OC)c1=O,"4-methoxy-2-(methoxymethyl)-5-(6-oxo-1-prop-2-ynyl-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl methylphosphonate",0.15,uM,=,-0.8239087409443188,0,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
2106,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)c1cccn1Cc1ccc(F)cc1,Ethyl 4-(1-(4-Fluorobenzyl)-1H-pyrrol-2-yl)-2-hydroxy-4-oxobut-2-enoate,21.0,uM,=,1.3222192947339193,1,c1ccc(Cn2cccc2)cc1
2107,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCCc2nnc(C)o2)c2cccc(C#N)c2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(3-cyanophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-2-methoxy-3-methylbenzothioate",0.52,uM,=,-0.2839966563652008,0,C(CCCc1nnco1)=C(c1ccccc1)c1ccccc1
2108,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCC2CC2)c2cccnc2n1O,"4-((Cyclopropylmethyl)amino)-1-hydroxypyrido[2,3-d]pyrimidin-2(1H)-one",0.398,uM,=,-0.4001169279263121,0,O=c1nc(NCC2CC2)c2cccnc2[nH]1
2109,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccc(C(F)(F)F)cc3)n2)cc1,4-(4-(4-(trifluoromethyl)benzylamino)pyrimidin-2-ylamino)benzonitrile,0.07,uM,=,-1.154901959985743,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2110,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2c(c(=O)n1O)C1CCCCC1S2,"3-Hydroxy-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione",0.1,uM,=,-1.0,0,O=c1[nH]c2c(c(=O)[nH]1)C1CCCCC1S2
2111,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CCC(C)SC1=N/C(=C/c2ccccc2)C(C)(C)C(=O)N1,"2-sec-Butylsulfanyl-5,5-dimethyl-6-[1-phenyl-meth-(E)-ylidene]-5,6-dihydro-3H-pyrimidin-4-one",4.3,uM,=,0.6334684555795865,1,O=C1C/C(=C\c2ccccc2)N=CN1
2112,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc4c(c3)OCO4)cc2c1=O,"6-(Benzo[d][1,3]dioxol-5-ylmethoxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",5.1,uM,=,0.7075701760979364,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc4c(c3)OCO4)cc12
2113,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(=O)Nc1ccc2[nH]c(C(=O)N3CCN(c4ncccc4NC(C)C)CC3)cc2c1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-acetamide,1.8,uM,=,0.255272505103306,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
2114,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=S)c2ccccc2Oc2ccccc21,"10-Propyl-10H-dibenzo[b,f][1,4]oxazepine-11-thione",2.2,uM,=,0.3424226808222063,1,S=C1Nc2ccccc2Oc2ccccc21
2115,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCCc2nnc(C)o2)c2ccc(C#N)cc2)cc1C(=O)SC,"(E)-S-methyl 5-(1-(4-cyanophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-2-methoxy-3-methylbenzothioate",0.45,uM,=,-0.3467874862246563,0,C(CCCc1nnco1)=C(c1ccccc1)c1ccccc1
2116,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SCC(C)C)nc1Cc1c(Cl)cccc1Cl,"6-(2,6-Dichloro-benzyl)-2-isobutylsulfanyl-5-methyl-3H-pyrimidin-4-one",1.1,uM,=,0.041392685158225,1,c1ccc(Cc2ccncn2)cc1
2117,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[Br-],"8-Amino-6-ethyl-3-methyl-5-phenyl-benzo[c][2,7]naphthyridin-6-ium bromide",2.0,uM,=,0.3010299956639812,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
2118,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cn[nH]c3)nc21,"5-Ethyl-10-methyl-7-(1H-pyrazol-4-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2ccc(-c3cn[nH]c3)nc2Nc2ncccc21
2119,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CCN1C(=O)c2cccn2S(=O)(=O)c2cc(Cl)ccc21,"6-Chloro-9-ethyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",2.7,uM,=,0.4313637641589873,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
2120,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)-pyrimidine-2,4(1H,3H)-dione",1.9,uM,=,0.2787536009528289,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2121,195844,10.1021/jm00020a026,,,,antiviral activity in Human immunodeficiency virus-1 as reverse transcriptase activity in culture supernatant,N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c2ncnc(N)c12,"4-Amino-7-(3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile",12.0,uM,=,1.0791812460476249,1,c1ncc2ccn([C@H]3CCCO3)c2n1
2122,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,Cc1ccc(NCN2C(=O)c3ccccc3C2=O)c(O)n1,"2-[(6-Methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",8.1,uM,=,0.9084850188786496,1,O=C1c2ccccc2C(=O)N1CNc1cccnc1
2123,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Nc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,"3-(4-(4-(4-cyano-2,6-dimethylphenylamino)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.023,uM,=,-1.6382721639824072,0,c1ccc(Nc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2124,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1ccccc1CSc1nc(Cc2ccccc2)cc(=O)[nH]1,6-Benzyl-2-(2-methyl-benzylthio)pyrimidin-4(3H)-one,47.72,uM,=,1.6787004349983043,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
2125,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CN(C)c1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Dimethylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.003,uM,=,-2.5228787452803374,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
2126,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3cccc(F)c3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(3-fluorobenzyl)-1H-indole-2-carboxamide",0.07,uM,=,-1.154901959985743,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2127,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1OC,"6-((3',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2128,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CC(=O)N1C(=O)C(O)(C(F)(F)F)c2cc(C)ccc21,1-Acetyl-3-hydroxy-5-methyl-2-oxo-3-trifluoromethylindole,8.37,uM,=,0.92272545799326,1,O=C1Cc2ccccc2N1
2129,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,Cc1ccc2[nH]c(C(=O)N3CCN(c4ncccc4NC(C)C)CC3)cc2c1,[4-(3-Isopropylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methyl-1H-indol-2-yl)-methanone,34.0,uM,=,1.5314789170422551,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
2130,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CSc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenylsulfanylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.01,uM,=,-2.0,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccccc3)cc21
2131,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(O)c(O)c2)cs1,"3-(2-(4-(3,4-dihydroxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one",3.2,uM,=,0.505149978319906,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2132,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccco3)nc21,"5-Ethyl-7-furan-2-yl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2ccc(-c3ccco3)nc2Nc2ncccc21
2133,939437,10.1021/jm301271j,,,,Inhibition of wild type HIV-1 reverse transcriptase p66/p51 NNRTI adjacent binding site after 30 mins by fluorescence assay,CCOC(=O)c1cnn2ccccc12,"ethyl pyrazolo[1,5-a]pyridine-3-carboxylate",350.0,uM,=,2.544068044350276,1,c1ccn2nccc2c1
2134,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCCc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-propyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.37,uM,=,-0.431798275933005,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2135,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,2-[4-Chloro-2-(3-chloro-5-cyano-benzoyl)-phenoxy]-N-(2-methyl-4-sulfamoyl-phenyl)-acetamide,0.00216,uM,=,-2.6655462488490693,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
2136,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.035,uM,=,-1.4559319556497243,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2137,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,CCOC(=O)c1c(O)c(=O)[nH]c2ccc([N+](=O)[O-])cc12,Ethyl 3-hydroxy-6-nitro-2-oxoquinoline-4-carboxylate,64.0,uM,=,1.806179973983887,1,O=c1ccc2ccccc2[nH]1
2138,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc([N+](=O)[O-])cc2c1=O,"1-(4-Fluorobenzyl)-6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",56.0,uM,=,1.7481880270062005,1,O=c1ccn(Cc2ccccc2)c2ccccc12
2139,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3cc(C#N)ccn3)c21,"2-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)isonicotinonitrile",1.36,uM,=,0.1335389083702175,1,O=c1[nH]c2cccc(Oc3ccccn3)c2[nH]1
2140,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,Oc1ccc(-c2csc(Nc3ccccn3)n2)cc1O,SID49641337,18.0,uM,=,1.255272505103306,1,c1ccc(-c2csc(Nc3ccccn3)n2)cc1
2141,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3cc(Cl)cc(C(N)=O)c3)CC2)n1,"3-chloro-5-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.028,uM,=,-1.5528419686577808,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2142,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(CCCCc3ccccc3)cc2-c2ccccc2)n[nH]1,3-(4-Phenyl-1-(4-phenylbutyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,63.0,uM,=,1.7993405494535817,1,c1ccc(CCCCn2cc(-c3ccccc3)c(-c3cc[nH]n3)c2)cc1
2143,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(F)c(CC/N=C(\S)Nc2ccc(Br)cn2)c1C#N,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-cyano-6-fluoro-3-methoxy-phenyl)-ethyl]-thiourea,0.001,uM,=,-3.0,0,C(=NCCc1ccccc1)Nc1ccccn1
2144,2026094,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 48 hrs by pico-green reagent based fluorescence analysis,N#Cc1cc2c(Oc3ccc(OS(=O)(=O)F)cc3OCCn3ccc(=O)[nH]c3=O)cc(F)cn2c1,"4-((2-Cyano-6-fluoroindolizin-8-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.429,uM,=,-0.3675427078152757,0,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
2145,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1c(C)nc(O)c(NCc2nc3ccccc3o2)c1C,"3-[(Benzooxazol-2-ylmethyl)-amino]-5-ethyl-4,6-dimethyl-1H-pyridin-2-one",0.6,uM,=,-0.2218487496163563,0,c1cncc(NCc2nc3ccccc3o2)c1
2146,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(O)c1cc(N2C(=O)c3ccc(Oc4ccc5c(c4)C(=O)N(c4ccc(O)c(C(=O)O)c4)C5=O)cc3C2=O)ccc1O,"5-{5-[2-(3-carboxy-4-hydroxyphenyl)-1,3-dioxo-2,3-dihydro-1H-5-isoindolyloxy]-1,3-dioxo-2,3,3a,7a-tetrahydro-1H-2-isoindolyl}-2-hydroxybenzoic acid",13.0,uM,=,1.1139433523068367,1,O=C1c2ccc(Oc3ccc4c(c3)C(=O)N(c3ccccc3)C4=O)cc2C(=O)N1c1ccccc1
2147,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,CC(C)C#CC1(C(C)C)NS(=O)(=O)Nc2ccc(Cl)cc21,"6-Chloro-4-isopropyl-4-(3-methyl-but-1-ynyl)-3,4-dihydro-1H-benzo[1,2,6]thiadiazine 2,2-dioxide",0.137,uM,=,-0.8632794328435932,0,O=S1(=O)NCc2ccccc2N1
2148,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@@H]1[C@H](O)c2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)O[C@H]2[C@@H]3C2(C)C)O[C@@H]1C,"4-hydroxy-2,3,10,10-tetramethyl-8-phenyl-(2R,3S,4S)-3,4,10,10a-tetrahydro-2H,6H,9aH-cyclopropa[4,5]furo[2,3-f]pyrano[2,3-h]chromen-6-one",70.0,uM,=,1.845098040014257,1,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)[C@H]1C[C@H]1O3
2149,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCOCC3)cc2)n1,"3,5-dimethyl-4-(2-(4-(morpholinomethyl)phenylamino)pyrimidin-4-yloxy)benzonitrile",0.042,uM,=,-1.3767507096020994,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCOCC4)cc3)n2)cc1
2150,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(-c2ccccc2Oc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",12.0,uM,=,1.0791812460476249,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2151,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,Cc1cccc(-c2nc(O)c(O)c(C(=O)O)n2)c1,"5,6-Dihydroxy-2-(m-tolyl)pyrimidine-4-carboxylic acid",49.0,uM,=,1.6901960800285136,1,c1ccc(-c2ncccn2)cc1
2152,856828,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.5 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,SID26752991,1.8,uM,=,0.255272505103306,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
2153,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccc4[nH]ccc4c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(1H-indol-5-yloxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.31,uM,=,-0.5086383061657274,0,O=C1Nc2cccnc2Nc2ncc(COc3ccc4[nH]ccc4c3)cc21
2154,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccccc2-c2ccc(Cl)cc2)cc(=O)n(O)c1=O,"6-((4'-Chloro-[1,1'-biphenyl]-2-yl)oxy)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",3.3,uM,=,0.5185139398778875,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2155,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2scc(-c3ccc(Cl)cc3)c2c(=O)n1O,"5-(4-Chlorophenyl)-3-hydroxythieno[2,3-d]pyrimidine-2,4(1H,3H)-dione",0.04,uM,=,-1.3979400086720375,0,O=c1[nH]c(=O)c2c(-c3ccccc3)csc2[nH]1
2156,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2ccn(S(=O)(=O)c3ccccc3)c12,"4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-5-(phenylsulfonyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.195,uM,=,-0.7099653886374819,0,O=S(=O)(c1ccccc1)n1ccc2nc(NC3CCN(Cc4ccccc4)CC3)nc(Oc3ccccc3)c21
2157,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CC(O)C(=O)O.CCOc1ccc2nc3cc(N)ccc3c(N)c2c1,TCMDC-123983,20.0,uM,=,1.3010299956639813,1,c1ccc2nc3ccccc3cc2c1
2158,722004,10.1128/aac.00800-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild-type Human immunodeficiency virus 1 subtype B reverse transcriptase by filter-based filtration assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.093,uM,=,-1.031517051446065,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2159,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCCC#CC1(C(F)(F)F)OC(=O)Nc2ccc([N+](=O)[O-])cc21,"6-Nitro-4-pent-1-ynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.304,uM,=,-0.5171264163912462,0,O=C1Nc2ccccc2CO1
2160,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cc(=O)[nH]c(=O)[nH]3)CC2)nc2c1CSCC2,"(E)-3-(4-(2-(1-((2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)piperidin-4-ylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)acrylonitrile",0.171,uM,=,-0.7670038896078462,0,O=c1cc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)[nH]c(=O)[nH]1
2161,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",4.7,uM,=,0.6720978579357175,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2162,1763343,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 reverse transcriptase RNase H,O=C(Oc1ccc2c(c1OC(=O)c1ccccc1)C(=O)c1ccccc1C2=O)c1ccccc1,"9,10-dioxo-9,10-dihydroanthracene-1,2-diyl dibenzoate",13.0,uM,=,1.1139433523068367,1,O=C(Oc1ccc2c(c1OC(=O)c1ccccc1)C(=O)c1ccccc1C2=O)c1ccccc1
2163,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(CCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)ccc1O,"N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3-methoxyphenyl)propanamide",0.0315,uM,=,-1.5016894462103996,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
2164,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(O)nc21,"8-Ethyl-3-methyl-7H,8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-one",3.2,uM,=,0.505149978319906,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2165,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,O=C(CC/N=C(\S)Nc1ccc(Br)cn1)c1c(F)cccc1F,"1-(5-Bromo-pyridin-2-yl)-3-[3-(2,6-difluoro-phenyl)-3-oxo-propyl]-thiourea",0.003,uM,=,-2.5228787452803374,0,O=C(CCN=CNc1ccccn1)c1ccccc1
2166,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,COC(=O)c1cc(NC(=O)c2cc3cc([N+](=O)[O-])c(O)c(O)c3oc2=O)ccc1O,"Methyl 5-(7,8-dihydroxy-6-nitro-2-oxo-2H-chromene-3-carboxamido)-2-hydroxy benzoate",12.3,uM,=,1.089905111439398,1,O=C(Nc1ccccc1)c1cc2ccccc2oc1=O
2167,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,N#Cc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"4'-(1-Hydroxy-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-[1,1'-biphenyl]-4-carbonitrile",0.024,uM,=,-1.619788758288394,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
2168,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,O=C1Nc2ccc(Cl)c3c2C(C(F)(F)F)(C=C(C2CC2)O3)N1,"7-Chloro-5-cyclopropyl-3a-trifluoromethyl-3,3a-dihydro-1H-6-oxa-1,3-diaza-phenalen-2-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccc3c2C(C=C(C2CC2)O3)N1
2169,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1cc(/C=N/NC(=O)c2ccccc2OC)ccc1O,N'-(4-hydroxy-3-methoxybenzylidene)-2-methoxybenzohydrazide,100.0,uM,=,2.0,1,O=C(N/N=C/c1ccccc1)c1ccccc1
2170,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,"4-[4-Amino-6-(2,6-dichloro-benzyl)-[1,3,5]triazin-2-ylamino]-benzonitrile",0.006,uM,=,-2.2218487496163566,0,c1ccc(Cc2ncnc(Nc3ccccc3)n2)cc1
2171,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,Cn1cc(C(=O)c2ccc(F)cc2)cc1/C=C/C(=O)/C=C(\O)C(=O)O,"6-(4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoic Acid",20.0,uM,=,1.3010299956639813,1,O=C(c1ccccc1)c1cc[nH]c1
2172,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCCCSc1nc(O)cc(Cc2c(Cl)cccc2Cl)n1,"2-Butylsulfanyl-6-(2,6-dichloro-benzyl)-3H-pyrimidin-4-one",0.5,uM,=,-0.3010299956639812,0,c1ccc(Cc2ccncn2)cc1
2173,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1cc(F)ccc1F)CC(=O)C(=O)O,"6-[1-(2,5-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",5.0,uM,=,0.6989700043360189,1,c1ccc(Cn2cccc2)cc1
2174,543620,10.1016/j.ejmech.2008.02.039,,,,Inhibition of HIV1 3B reverse transcriptase after 30 mins,Cc1cc(C)nc(N2C(=O)CS[C@@H]2C23CC4CC(CC(C4)C2)C3)c1,"(R)-(+)-2-adamantan-1-yl-3-(4,6-dimethyl-pyridin-2-yl)-thiazolidin-4-one",13.4,uM,=,1.1271047983648077,1,O=C1CS[C@H](C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
2175,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCCc1cc(CCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[2-(4,7-Dichloro-benzooxazol-2-yl)-ethyl]-6-methyl-5-propyl-1H-pyridin-2-one",0.034,uM,=,-1.4685210829577449,0,c1cncc(CCc2nc3ccccc3o2)c1
2176,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1ccc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c(C)c1,"6-Chloro-1-(2,4-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.63,uM,=,-0.2006594505464183,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
2177,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccc(C#N)cc3F)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(4-cyano-2-fluorophenyl)acetamide",0.174,uM,=,-0.7594507517174003,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
2178,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=C(Nc1ccc2c(=O)n(O)c(=O)[nH]c2c1)c1ccc(C(F)(F)F)cc1,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-4-(trifluoromethyl)benzamide",6.09,uM,=,0.7846172926328754,1,O=C(Nc1ccc2c(=O)[nH]c(=O)[nH]c2c1)c1ccccc1
2179,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1CSCC2,"(E)-4-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.203,uM,=,-0.6925039620867871,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
2180,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=C(Nc1ccc2c(=O)n(O)c(=O)[nH]c2c1)c1ccc(F)cc1,"4-Fluoro-N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)benzamide",3.73,uM,=,0.5717088318086876,1,O=C(Nc1ccc2c(=O)[nH]c(=O)[nH]c2c1)c1ccccc1
2181,195055,10.1021/jm00171a023,,,,Compound was evaluated for the 50% inhibitory concentration on human immunodeficiency virus associated reverse transcriptase,CC1CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COCP(=O)(O)OP(=O)(O)OP(=O)([O-])O)O2)C(=O)NC1=O.[Na+],5'-o-(triphosphomethyl)-3'-deoxy-3'-fluorothymidine with sodium salt,322.0,uM,=,2.507855871695831,1,O=C1CCN([C@H]2CCCO2)C(=O)N1
2182,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(OCCCN(C)C)ccc1NC(=O)Cc1ccc(Cl)cc1C(=O)c1ccccc1,2-(2-Benzoyl-4-chloro-phenyl)-N-[4-(3-dimethylamino-propoxy)-2-methyl-phenyl]-acetamide,0.7540070024999311,uM,=,-0.1226246207973904,0,O=C(Cc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
2183,494380,10.1021/jm801071m,,,,Inhibition of HIV1 LAI CRF01 A_E s93JP-NH1 reverse transcriptase RNase H activity by real time monitoring assay,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NC12CC3CC(CC(C3)C1)C2,5-nitro-furan-2-carboxylic acid adamantan-1-carbamoylmethyl ester,3.8,uM,=,0.5797835966168101,1,O=C(COC(=O)c1ccco1)NC12CC3CC(CC(C3)C1)C2
2184,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cnc[nH]3)nc21,"5-Ethyl-7-(3H-imidazol-4-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.7,uM,=,0.568201724066995,1,O=C1Nc2ccc(-c3cnc[nH]3)nc2Nc2ncccc21
2185,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2ccc(-c3ccc(O)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.45,uM,=,-0.3467874862246563,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2186,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,Oc1nc2ccc(Cl)cc2n1Cc1cccc2ccccc12,"6-Chloro-1-naphthalen-1-ylmethyl-1,3-dihydro-benzoimidazol-2-one",12.7,uM,=,1.1038037209559568,1,c1ccc2c(Cn3cnc4ccccc43)cccc2c1
2187,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1,2-Amino-6-(4-methoxy-benzenesulfonyl)-benzonitrile,13.0,uM,=,1.1139433523068367,1,O=S(=O)(c1ccccc1)c1ccccc1
2188,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccco3)nc21,"5-Ethyl-7-furan-2-yl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2ccc(-c3ccco3)nc2Nc2ncccc21
2189,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-6-methyl-5-propyl-1H-pyridin-2-one",0.05,uM,=,-1.3010299956639813,0,O=c1cc(Cc2ccccc2)cc[nH]1
2190,305627,10.1021/jm049252r,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase (IIIB),Cl.S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea hydrochloride,1.03,uM,=,0.0128372247051722,1,S=C(NCCc1ccccn1)Nc1ccccn1
2191,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),S=C(NCc1ccco1)Nc1nccs1,1-Furan-2-ylmethyl-3-thiazol-2-yl-thiourea,2.0,uM,=,0.3010299956639812,1,S=C(NCc1ccco1)Nc1nccs1
2192,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCCCc1csc(NC(=S)NCCc2ccccc2)n1,1-(4-Butyl-thiazol-2-yl)-3-phenethyl-thiourea,2.5,uM,=,0.3979400086720376,1,S=C(NCCc1ccccc1)Nc1nccs1
2193,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)Nc1ccc(S(C)(=O)=O)cc1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(4-(methylsulfonyl)phenyl)acetamide",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)Nc1ccccc1
2194,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCOCn1c(Sc2ccccc2)c(CC)c(=O)[nH]c1=O,"1-Ethoxymethyl-5-ethyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",0.032,uM,=,-1.494850021680094,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2195,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1nc([C@H](CN)NC(=O)c2ccc(-c3ccc(Cl)c(F)c3)[nH]2)sc1CO,(S)-N-(2-amino-1-(5-(hydroxymethyl)-4-methylthiazol-2-yl)ethyl)-5-(4-chloro-3-fluorophenyl)-1H-pyrrole-2-carboxamide,8.3,uM,=,0.919078092376074,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
2196,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3F)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-fluorobenzyl)-1H-indole-2-carboxamide",0.18,uM,=,-0.744727494896694,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2197,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCOc1ccc(F)c(C2CC2NC(=O)Nc2ccc(C#N)cn2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-cyano-pyridin-2-yl)-urea,0.0043,uM,=,-2.3665315444204134,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
2198,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)CCCN12,"9b-Phenyl-1,2,3,9b-tetrahydro-pyrrolo[2,1-a]isoindol-5-one",15.0,uM,=,1.1760912590556811,1,O=C1c2ccccc2C2(c3ccccc3)CCCN12
2199,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1CSCC2,"4-((4-(4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.151,uM,=,-0.8210230527068306,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
2200,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1O,"6-Benzyl-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.4,uM,=,0.1461280356782379,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
2201,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1cccc(Br)c1,2-Amino-6-(3-bromo-phenylsulfanyl)-benzonitrile,15.0,uM,=,1.1760912590556811,1,c1ccc(Sc2ccccc2)cc1
2202,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1[nH]c(Sc2ccc(Br)cc2)c(I)c(=O)n1O,"6-((4-Bromophenyl)thio)-3-hydroxy-5-iodopyrimidine-2,4(1H,3H)-dione",0.12,uM,=,-0.9208187539523752,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2203,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,Cc1cc(Cc2ccc(Cl)c(Oc3ccccc3)c2)n[nH]c1=O,6-(4-chloro-3-phenoxybenzyl)-4-methylpyridazin-3(2H)-one,0.36,uM,=,-0.4436974992327127,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
2204,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)n(O)c(=O)[nH]1,"6-([1,1'-Biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.022,uM,=,-1.6575773191777938,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
2205,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2[C@]2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",39.6,uM,=,1.5976951859255124,1,O=C1c2ccccc2[C@]2(c3ccccc3)SCCN12
2206,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(Cl)cc2)nc(SC(C)C)[nH]c1=O,"2-(4-chlorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",3.366,uM,=,0.527114111639805,1,O=c1cc(Cc2ccccc2)nc[nH]1
2207,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)-oxy)pyrimidine-2,4(1H,3H)-dione",9.5,uM,=,0.9777236052888478,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2208,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)[nH]2)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.51,uM,=,-0.2924298239020636,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2209,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,COc1ccc(-c2cccc(Cc3cc(=O)n(O)c(=O)[nH]3)c2)cc1F,"6-((3'-fluoro-4'-methoxy-[1,1'-biphenyl]-3-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.0077,uM,=,-2.113509274827518,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2210,666605,10.1128/aac.01795-09,,,,Inhibition of DNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by gel-based primer extension assay,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-[4-(2,4,6-Trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",0.131,uM,=,-0.8827287043442358,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
2211,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1ccnc(N2C(=O)CSC2c2c(F)cccc2Cl)c1,2-(2-Chloro-6-fluoro-phenyl)-3-(4-methyl-pyridin-2-yl)-thiazolidin-4-one,4.12,uM,=,0.6148972160331346,1,O=C1CSC(c2ccccc2)N1c1ccccn1
2212,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1CSCC2,"5-(4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)picolinonitrile",0.043,uM,=,-1.3665315444204136,0,c1ccc(Oc2nc(Nc3cccnc3)nc3c2CSCC3)cc1
2213,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(C[S+]([O-])c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzenesulfinylmethyl-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2cccnc2Nc2ncc(C[SH+]c3ccccc3)cc21
2214,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cc(F)nc(F)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4-(2,6-Difluoropyridin-4-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0456,uM,=,-1.341035157335565,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
2215,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(C3OCCCO3)cc(OC)nc21,"9-[1,3]Dioxan-2-yl-5-ethyl-7-methoxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.8,uM,=,-0.0969100130080563,0,O=C1Nc2c(C3OCCCO3)ccnc2Nc2ncccc21
2216,1770167,10.1016/j.bmcl.2018.03.012,,,,Inhibition of recombinant wild-type HIV1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1ccn2COC(=O)OC(C)C,"(4-(4-cyano-2,6-dimethylphenoxy)-2-(4-cyanophenylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl isopropyl carbonate",0.264,uM,=,-0.5783960731301689,0,c1ccc(Nc2nc(Oc3ccccc3)c3cc[nH]c3n2)cc1
2217,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
2218,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2cc(Cl)ccc2C2(c3ccccc3)SCCN12,"7-Chloro-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",24.0,uM,=,1.380211241711606,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2219,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2cccc3nc(O)n(c23)C[C@@H]1C,"8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",3155.0,uM,=,3.498999363580153,1,c1cc2c3c(c1)ncn3CCNC2
2220,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CN1C(=O)c2cccnc2N(C2CC2)c2ccc(Cl)nc21,"2-Chloro-5-cyclopropyl-11-methyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",1.0,uM,=,0.0,0,O=C1Nc2ncccc2N(C2CC2)c2ncccc21
2221,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,"6-(biphenyl-4-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.3,uM,=,-0.5228787452803376,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2222,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccccc2-c2ccc(C(F)(F)F)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.013,uM,=,-1.8860566476931635,0,O=c1cc(Sc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2223,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",6.7,uM,=,0.8260748027008264,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
2224,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Cc1ccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n2c1,"2-(2-Chlorophenyl)-N-cyclohexyl-6-methylimidazo[1,2-a]pyridin-3-amine",5.39,uM,=,0.7315887651867387,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
2225,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1c(F)cccc1F)CC(=O)C(=O)O,"6-[1-(2,6-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",50.0,uM,=,1.6989700043360187,1,c1ccc(Cn2cccc2)cc1
2226,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Oc4ccccc4)cc3)cc2c1=O,"6-((4-(Benzyloxy)benzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",7.48,uM,=,0.8739015978644614,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc(Oc4ccccc4)cc3)cc12
2227,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",3.4,uM,=,0.5314789170422551,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2228,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=C1C[C@@H](c2ccc(O)c(O)c2)Oc2c1c(O)cc(O)c2[C@H]1C(=O)c2c(O)cc(O)cc2O[C@@H]1c1ccc(O)cc1,"(2S,2'S,3R)-2'-(3,4-dihydroxyphenyl)-5,5',7,7'-tetrahydroxy-2-(4-hydroxyphenyl)-3,8'-bichroman-4,4'-dione",170.0,uM,=,2.230448921378274,1,O=C1C[C@@H](c2ccccc2)Oc2c1cccc2[C@H]1C(=O)c2ccccc2O[C@@H]1c1ccccc1
2229,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",2.2,uM,=,0.3424226808222063,1,O=C1Nc2cccnc2Nc2ncccc21
2230,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,COn1c(=O)c(C(C)C)c(Cc2ccccc2)n(COCc2ccc(F)cc2)c1=O,"6-Benzyl-1-((4-fluorobenzyloxy)methyl)-5-isopropyl-3-methoxypyrimidine-2,4(1H,3H)-dione",11.0,uM,=,1.0413926851582251,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2231,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccncc3)CC2)nc2c1CCCC2,"3,5-Dimethyl-4-((2-((1-(pyridin-4-ylmethyl)piperidin-4-yl)-amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)benzonitrile",0.072,uM,=,-1.1426675035687317,0,c1ccc(Oc2nc(NC3CCN(Cc4ccncc4)CC3)nc3c2CCCC3)cc1
2232,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nccn2-c2ccc(N3CCCC3)nc21,"8-Ethyl-6-pyrrolidin-1-yl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",3.9,uM,=,0.5910646070264992,1,c1cnc2c(c1)-c1nccn1-c1ccc(N3CCCC3)nc1N2
2233,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(F)c(CC/N=C(\S)Nc2ccc(C#N)cn2)c1C#N,1-[2-(2-Cyano-6-fluoro-3-methoxy-phenyl)-ethyl]-3-(5-cyano-pyridin-2-yl)-thiourea,0.003,uM,=,-2.5228787452803374,0,C(=NCCc1ccccc1)Nc1ccccn1
2234,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(=O)NCc3ccncn3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-oxo-2-((pyrimidin-4-ylmethyl)amino)ethyl)-1H-indole-2-carboxamide",0.202,uM,=,-0.6946486305533762,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncn1
2235,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc4nc(N)[nH]c4c3)[nH]c3ccc(Cl)cc23)c1,"N-((2-Amino-1H-benzo[d]imidazol-6-yl)methyl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.278,uM,=,-0.5559552040819237,0,O=C(NCc1ccc2nc[nH]c2c1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2236,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2cc(-c3ccccc3)sc2c(=O)n1O,"3-Hydroxy-6-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione",0.1,uM,=,-1.0,0,O=c1[nH]c(=O)c2sc(-c3ccccc3)cc2[nH]1
2237,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1nc2c(ncn2C2C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2)c(=O)[nH]1,9-[4-(Diphosphoryloxyphosphonylmethoxy)-cyclopent-2-enyl]guanine,0.3,uM,=,-0.5228787452803376,0,O=c1[nH]cnc2c1ncn2C1C=CCC1
2238,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3ccc(Cl)cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-N-(4-chlorophenethyl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.089,uM,=,-1.0506099933550872,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2239,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,COc1ccc(-c2csc(N/N=C3\C(=O)Nc4ccccc43)n2)cc1,(Z)-3-(2-(4-(4-methoxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one,4.7,uM,=,0.6720978579357175,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2240,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(Nc2ccccc2)c1Br,3-Bromo-6-phenethyl-4-(phenylamino)pyridin-2(1H)-one,11.35,uM,=,1.0549958615291417,1,O=c1cc(Nc2ccccc2)cc(CCc2ccccc2)[nH]1
2241,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)c1cc(C(=CCCCC=O)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-5-formyl-1-pentenyl]-2-methoxybenzoate,4.2,uM,=,0.6232492903979004,1,C=C(c1ccccc1)c1ccccc1
2242,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccc(F)c2)nc(SC(C)C)[nH]c1=O,"2-(3-fluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.8290000000000001,uM,=,-0.0814454694497264,0,O=c1cc(Cc2ccccc2)nc[nH]1
2243,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ccc(C(F)(F)F)cc3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(4-(trifluoromethyl)phenyl)acetamide,30.1,uM,=,1.4785664955938431,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccccc1
2244,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1ccn(Cc2ccc(F)cc2)c1,"Ethyl 6-(1-(4-Fluorobenzyl)-1H-pyrrol-3-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",55.0,uM,=,1.740362689494244,1,c1ccc(Cn2cccc2)cc1
2245,195669,10.1021/jm00048a021,,,,Tested against HIV-1 reverse transcriptase (HIV-1 RT) with poly(rA)/(dT)12-18 as template and [methyl-3H]-dTTP as competing substrate,Cc1cn([C@H]2CC(N=[N+]=[N-])C(COP(=S)(S)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"1-[4-azido-5'-O-(1,1-Dithiotriphosphate)-methyl-(2R,4R)-dihydro-2-furanyl]-5-methyl-1,2,3,4-tetrahydro-2,4-pyrimidinedione",0.94,uM,=,-0.0268721464003013,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2246,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(OC)c(CCNC(=S)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2-fluoro-3,6-dimethoxy-phenyl)-ethyl]-thiourea",0.001,uM,=,-3.0,0,S=C(NCCc1ccccc1)Nc1ccccn1
2247,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1[nH]c(SCCc2ccccc2)nc(Cc2ccccc2)c1Br,6-Benzyl-5-bromo-2-(phenethylthio)pyrimidin-4(3H)-one,13.95,uM,=,1.1445742076096164,1,O=c1cc(Cc2ccccc2)nc(SCCc2ccccc2)[nH]1
2248,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)cc1F,"N-(2,4-Difluorobenzyl)-1-(hydroxy)-4-(ethylamino)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.01,uM,=,-2.0,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
2249,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),CCc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccc(O)c(C(=O)O)c3)C2=O)cc1,5-(3-{5-[1-(4-Ethyl-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid,15.0,uM,=,1.1760912590556811,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
2250,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=C(Nc1ccc2c(=O)n(O)c(=O)[nH]c2c1)c1cccc(F)c1,"3-Fluoro-N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)benzamide",3.73,uM,=,0.5717088318086876,1,O=C(Nc1ccc2c(=O)[nH]c(=O)[nH]c2c1)c1ccccc1
2251,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CN(OC(=O)c1ccc([N+](=O)[O-])o1)C(=O)c1ccc([N+](=O)[O-])o1,N-methyl-5-nitro-N-(5-nitrofuran-2-carbonyloxy)furan-2-carboxamide,2.7,uM,=,0.4313637641589873,1,O=C(NOC(=O)c1ccco1)c1ccco1
2252,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,COc1c(Cl)ccc2c1C(C#Cc1cccnc1)(C(F)(F)F)NC(=O)N2,"6-Chloro-5-methoxy-4-pyridin-3-ylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.139,uM,=,-0.8569851997459049,0,O=C1Nc2ccccc2C(C#Cc2cccnc2)N1
2253,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1CCC2,"3,5-Dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)oxy)-benzonitrile",0.157,uM,=,-0.8041003475907662,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCC4)CC2)cc1
2254,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.012,uM,=,-1.9208187539523751,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2255,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,Nc1ccccc1CO[C@H]1C(=O)Nc2ccc(Cl)cc2[C@@]1(C#CC1CC1)C(F)(F)F,"(3R,4R)-3-(2-Amino-benzyloxy)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.019,uM,=,0.0081741840064263,1,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
2256,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2S(=O)(=O)n2cccc21,"6-Chloro-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",0.7,uM,=,-0.1549019599857432,0,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
2257,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCc2nnc(C)o2)c2cc(C)c3oc(=O)n(C)c3c2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]-oxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",90.0,uM,=,1.954242509439325,1,O=c1[nH]c2cc(/C(=C\CCc3nnco3)c3ccccc3)ccc2o1
2258,508734,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA PPT primed substrate by scintillation proximity assay,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.43,uM,=,-0.3665315444204134,0,c1cncc(NCc2nc3ccccc3o2)c1
2259,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.006,uM,=,-2.2218487496163566,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2260,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1ncnc2c1ncn2C1C=CC(OCP(=O)(O)OP(=O)(O)C(F)(F)P(=O)(O)O)C1,9-[4-(Difluoromethyldiphosphonyl)oxyphosphonylmethoxy)-cyclopent-2-enyl]adenine,25.0,uM,=,1.3979400086720375,1,C1=CC(n2cnc3cncnc32)CC1
2261,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ccn[nH]3)c2=O)c1,"2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(1H-1,2,4-triazol-5-yl)acetamide",19.4,uM,=,1.287801729930226,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccn[nH]1
2262,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CCNC(=S)Nc2ccc(Cl)cn2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-3-(5-chloro-pyridin-2-yl)-thiourea,0.006,uM,=,-2.2218487496163566,0,S=C(NCCc1ccccc1)Nc1ccccn1
2263,195841,10.1021/jm980510s,,,,The compound was tested for inhibitory activity against Recombinant HIV-1 reverse transcriptase,CCN(CC)CC.Nc1nc(=O)n([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2)cc1F,"cis-(+/-)-4-Amino-5-fluoro-1-[4-(triphosphonooxymethyl)-2-cyclopenten-1-yl]-2(1H)-pyrimidinone, Triethylammonium salt",0.27,uM,=,-0.5686362358410126,0,O=c1ncccn1[C@H]1C=CCC1
2264,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.125,uM,=,-0.9030899869919436,0,O=C1Nc2cccnc2Nc2ncccc21
2265,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1cc(C)cc(S(=O)(=O)n2c(=O)[nH]c3ccc(C)cc32)c1,"6-Methyl 1-(3,5-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.1,uM,=,-1.0,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
2266,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCc2ccc(N3CCOCC3)cc2)c2cccnc2n1O,"1-Hydroxy-4-({[4-(4-morpholinyl)phenyl]methyl}amino)pyrido[2,3-d]pyrimidin-2(1H)-one",0.1,uM,=,-1.0,0,O=c1nc(NCc2ccc(N3CCOCC3)cc2)c2cccnc2[nH]1
2267,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-[2-(4-Cyano-phenylamino)-pyrimidin-4-ylamino]-3,5-dimethyl-benzonitrile",0.0004,uM,=,-3.397940008672037,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
2268,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(OCc2nc3ccccc3o2)c(O)nc1C,3-(Benzooxazol-2-ylmethoxy)-5-ethyl-6-methyl-1H-pyridin-2-one,0.191,uM,=,-0.7189666327522725,0,c1cncc(OCc2nc3ccccc3o2)c1
2269,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-n2nncc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,"2-(3'-chloro-4'-(2-(1-(2-chloro-4-methylphenyl)-1H-1,2,3-triazol-5-ylthio)acetamido)biphenyl-4-yl)acetic acid",0.0024,uM,=,-2.619788758288394,0,O=C(CSc1cnnn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
2270,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",2.6,uM,=,0.414973347970818,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2271,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2cc(-c3ccccc3)ccc2c(=O)n1O,"3-Hydroxy-7-phenylquinazoline-2,4(1H,3H)-dione",0.2,uM,=,-0.6989700043360187,0,O=c1[nH]c(=O)c2ccc(-c3ccccc3)cc2[nH]1
2272,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2ccccc2S[C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)N12,"(5aS,6S,7S,8R,9S)-6,7,8-trihydroxy-9-(hydroxymethyl)-6,7,8,9-tetrahydro-5aH,11H-pyrido[2,1-b][1,3]benzothiazin-11-one",0.49,uM,=,-0.3098039199714864,0,O=C1c2ccccc2S[C@H]2CCCCN12
2273,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ccccc1C(OCCn1c([N+](=O)[O-])cnc1C)c1ccccc1,2-Methyl-5-nitro-1-[2-(phenyl-o-tolyl-methoxy)-ethyl]-1H-imidazole,0.2,uM,=,-0.6989700043360187,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
2274,1293405,10.1016/j.bmc.2014.01.054,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotinylated dUTP incorporation after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.18,uM,=,-0.744727494896694,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
2275,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,CC(=O)Nc1ccc(S(=O)(=O)N/N=C/c2c(O)ccc3ccccc23)cc1,N-(4-(2-((2-hydroxynaphthalen-1-yl)methylene)hydrazinylsulfonyl)phenyl)acetamide,64.0,uM,=,1.806179973983887,1,O=S(=O)(N/N=C/c1cccc2ccccc12)c1ccccc1
2276,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),COc1cccc(CSc2nc(N)cc(Cl)n2)c1,6-Chloro-2-(3-methoxy-benzylsulfanyl)-pyrimidin-4-ylamine,0.16,uM,=,-0.7958800173440752,0,c1ccc(CSc2ncccn2)cc1
2277,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(O)nc3)nc21,"5-Ethyl-7-(6-hydroxy-pyridin-3-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.1,uM,=,0.041392685158225,1,O=C1Nc2ccc(-c3cccnc3)nc2Nc2ncccc21
2278,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCCOc1cccc(CCNC(=S)Nc2nccs2)c1,1-[2-(3-Propoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccc1)Nc1nccs1
2279,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1ccc(Br)cc1CCNC(=S)Nc1nccs1,1-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.03,uM,=,-1.5228787452803376,0,S=C(NCCc1ccccc1)Nc1nccs1
2280,197449,10.1016/s0960-894x(98)00250-9,,,,Compound was evaluated for enzymatic inhibitory activity against recombinant HIV reverse transcriptase,CSCSc1nc(O)c(C(C)C)c(Cc2cc(C)cc(C)c2)n1,"6-(3,5-Dimethyl-benzyl)-5-isopropyl-2-methylsulfanylmethylsulfanyl-3H-pyrimidin-4-one",4.8,uM,=,0.6812412373755872,1,c1ccc(Cc2ccncn2)cc1
2281,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(C(F)(F)F)c2)[nH]c(=O)n1O,"3-Hydroxy-6-((3-(trifluoromethyl)phenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.013,uM,=,-1.8860566476931635,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2282,471467,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type LAI by heteropolymeric DNA polymerase assay,Nc1nc(=O)c2ncn([C@H]3C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C3)c2[nH]1,carbovir-triphosphate,0.68,uM,=,-0.1674910872937636,0,O=c1nc[nH]c2c1ncn2[C@H]1C=CCC1
2283,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1ccccc1[S+]([O-])c1cccc(N)c1C#N,2-Amino-6-(2-methoxy-benzenesulfinyl)-benzonitrile,12.0,uM,=,1.0791812460476249,1,c1ccc([SH+]c2ccccc2)cc1
2284,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(O)c1cc(-c2ccc(C=C3C(=O)c4ccccc4C3=O)o2)ccc1O,"5-[5-(1,3-Dioxo-indan-2-ylidenemethyl)-furan-2-yl]-2-hydroxy-benzoic acid",43.0,uM,=,1.6334684555795866,1,O=C1C(=Cc2ccc(-c3ccccc3)o2)C(=O)c2ccccc21
2285,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)c(F)c2[C@@](C#CC2CC2)(C(F)(F)F)N1,"6-Chloro-4-cyclopropylethynyl-5-fluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.102,uM,=,-0.9913998282380824,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
2286,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,Cc1ccc2oc(=O)c3c(O)cc(=O)oc3c2c1,"4-hydroxy-9-methylpyrano[3,2-c]chromene-2,5-dione",16.5,uM,=,1.2174839442139065,1,O=c1ccc2c(=O)oc3ccccc3c2o1
2287,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Fc1cc(F)cc(Cn2c(=S)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-(3,5-difluorobenzyl)-1,3-dihydro-2H-benzimidazol-2-thione",0.16,uM,=,-0.7958800173440752,0,S=c1[nH]c2ccccc2n1Cc1ccccc1
2288,508731,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization using RNA PPT primed-DNA hybrid substrate,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.15,uM,=,-0.8239087409443188,0,c1cncc(NCc2nc3ccccc3o2)c1
2289,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1ccn([C@@H]2O[C@H](CNCc3c(Cl)cccc3Cl)[C@@H](O)[C@H]2O)c(=O)[nH]1,"5'-(2,6-dichlorobenzylamino)methyl-uridine",4.72,uM,=,0.6739419986340878,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
2290,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NC(C)c2ccc3ccccc3c2)c(O)nc1C,5-Ethyl-6-methyl-3-(1-naphthalen-2-yl-ethylamino)-1H-pyridin-2-one,1.13,uM,=,0.0530784434834196,1,c1cncc(NCc2ccc3ccccc3c2)c1
2291,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,COC(=O)CSc1nc(O)c(C(C)C)c(Cc2cccc3ccccc23)n1,"(5-Isopropyl-4-naphthalen-1-ylmethyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-acetic acid methyl ester",4.49,uM,=,0.6522463410033232,1,c1ccc2c(Cc3ccncn3)cccc2c1
2292,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cc(F)cc(C#N)c4)cc3F)c2=O)n[nH]c1=O,"3',5-difluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",5.98,uM,=,0.7767011839884109,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2293,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.5,uM,=,0.1760912590556812,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2294,494378,10.1021/jm801071m,,,,Inhibition of HIV1 LAI clade B reverse transcriptase RNase H activity by real time monitoring assay,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NC12CC3CC(CC(C3)C1)C2,5-nitro-furan-2-carboxylic acid adamantan-1-carbamoylmethyl ester,29.6,uM,=,1.4712917110589383,1,O=C(COC(=O)c1ccco1)NC12CC3CC(CC(C3)C1)C2
2295,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(C(=CCCc2nnc(C)o2)c2cc(C)c(OC)c(C(=O)OC)c2)cc(C)c1OC,"methyl 2-methoxy-5-[1-(4-methoxy-3-methyl-5-methoxycarbonylphenyl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-1-enyl]-3-methylbenzoate",71.0,uM,=,1.8512583487190752,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
2296,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(Cl)cc2Cl)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(2,4-dichlorophenyl)acetamide",15.3,uM,=,1.1846914308175989,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
2297,508734,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA PPT primed substrate by scintillation proximity assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.017,uM,=,-1.769551078621726,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2298,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,COC(=O)c1ccc(C(=O)c2cc(=O)n(O)c(=O)[nH]2)cc1,"Methyl 4-(1-hydroxy-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)benzoate",0.031,uM,=,-1.5086383061657274,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
2299,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCCN(c1ncccc1CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethyl-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.13,uM,=,-0.8860566476931633,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2300,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3O)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-hydroxybenzyl)-1H-indole-2-carboxamide",0.083,uM,=,-1.080921907623926,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2301,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,CCC1(CCC/C=C(\c2cc(Cl)c(OC)c(C=O)c2)c2cc(Cl)c(OC)c(CO)c2)OCCO1,"3-Chloro-5-[1-(3-chloro-5-hydroxymethyl-4-methoxy-phenyl)-5-(2-ethyl-[1,3]dioxolan-2-yl)-pent-1-enyl]-2-methoxy-benzaldehyde",31.6,uM,=,1.499687082618404,1,C(CCCC1OCCO1)=C(c1ccccc1)c1ccccc1
2302,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2cc(F)c(F)c(F)c2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-5,6,7-trifluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.442,uM,=,-0.3545777306509081,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2303,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(N)ccc12,"7-(2-Amino-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",3.0,uM,=,0.4771212547196624,1,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
2304,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,COc1cc(-c2cc(F)cc(C#N)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"5-fluoro-3'-methoxy-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",27.8,uM,=,1.4440447959180762,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2305,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-({5-[(4-bromo-2-carboxyphenyl)amino]-5-oxopentanoyl}amino)benzoic acid,10.0,uM,=,1.0,1,O=C(CCCC(=O)Nc1ccccc1)Nc1ccccc1
2306,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccccc2)Oc2ccccc2-n2cccc2C1=O,5-Ethyl-5-phenyl-6-oxa-10b-aza-benzo[e]azulen-4-one,0.25,uM,=,-0.6020599913279624,0,O=C1c2cccn2-c2ccccc2OC1c1ccccc1
2307,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
2308,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCC#N)c1Cc1cccc(C)c1,"3-{[5-Ethyl-6-methyl-4-(3-methyl-benzyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-methyl-amino}-propionitrile",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccccc2)cc[nH]1
2309,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(N)C3)cc2)nc2ccsc12,"(E)-3-(4-(2((4-(3-aminopiperidin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile",1.582,uM,=,0.1992064791616577,1,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3ccsc23)cc1
2310,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.5,uM,=,-0.3010299956639812,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2311,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",2.0,uM,=,0.3010299956639812,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2312,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)ncc1Br,"4-(5-bromo-2-(1-(4-(methylsulfonyl)benzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.028,uM,=,-1.5528419686577808,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
2313,1454138,10.1016/j.bmc.2014.07.018,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 using dsDNA by microplate reader based assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.35,uM,=,0.1303337684950061,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2314,2104796,10.1016/j.bmc.2021.116239,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into cDNA measured after 1 hr by ELISA,Cc1cc(C#CC=C2CCNCC2)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-(2,6-dimethy1-4-(3-(piperidin-4-ylidene)prop-1-yn-1-yl)phenoxy)pyrimidin-2-yDamino)benzonitrile",0.13,uM,=,-0.8860566476931633,0,C(#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1)C=C1CCNCC1
2315,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)[nH]2)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.47,uM,=,-0.3279021420642826,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2316,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(F)cc2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(4-fluorophenyl)acetamide",1.84,uM,=,0.2648178230095365,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
2317,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,C/C(=C\CCC(=O)Nc1ccc(-c2ccc(OCC(=O)O)cc2)cc1Cl)c1ccc(C)cc1Cl,(E)-2-(3'-chloro-4'-(5-(2-chloro-4-methylphenyl)hex-4-enamido)biphenyl-4-yloxy)acetic acid,0.272,uM,=,-0.5654310959658013,0,O=C(CCC=Cc1ccccc1)Nc1ccc(-c2ccccc2)cc1
2318,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",0.8,uM,=,-0.0969100130080563,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2319,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,Cc1ccc(Sc2cc(=O)n(O)c(=O)[nH]2)cc1,"3-Hydroxy-6-(p-tolylthio)pyrimidine-2,4(1H,3H)-dione",0.033,uM,=,-1.4814860601221125,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2320,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1CCC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)-benzamide",0.073,uM,=,-1.136677139879544,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCC4)CC2)cc1
2321,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccccc2)n[nH]1,Ethyl 3-(1-(naphthalen-1-ylmethyl)-4-phenyl-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,9.4,uM,=,0.9731278535996988,1,c1ccc(-c2cn(Cc3cccc4ccccc34)cc2-c2cc[nH]n2)cc1
2322,197123,10.1021/jm970559i,,,,Antiviral activity against Human Immunodeficiency Virus by Reverse transcriptase assay in CEM-SS cells,Cc1cccc(Cn2c(Br)nc3cc(Cl)c(Cl)cc32)c1,"2-Bromo-5,6-dichloro-1-(3-methyl-benzyl)-1H-benzoimidazole",66.0,uM,=,1.8195439355418688,1,c1ccc(Cn2cnc3ccccc32)cc1
2323,2111169,10.1016/j.ejmech.2020.113063,,,,"Inhibition of HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into cDNA incubated for 1 hr with DIG-dUTP, biotin-dUTP and dTTP followed by transferring onto streptavidin-coated plate and measured after 1 hr by ELISA",C#CCNC(=O)/C=C/c1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"(E)-3-(4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)acrylamide",0.059,uM,=,-1.2291479883578558,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
2324,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccccc3)nc21,"5-Ethyl-10-methyl-7-phenyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.4,uM,=,0.1461280356782379,1,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
2325,629799,10.1016/j.bmc.2010.03.041,,,,Inhibition of HIV1 reverse transcriptase,Nc1ncnc2c1ncn2[C@@H]1O[C@H](OCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C=C1F,"((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yloxy)methylphosphonic diphosphoric anhydride",1.9,uM,=,0.2787536009528289,1,C1=C[C@H](n2cnc3cncnc32)OC1
2326,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",4.1,uM,=,0.6127838567197355,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2327,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",3.7,uM,=,0.568201724066995,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2328,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Br)cc3)ccc2C(=O)N1O,"6-(4-Bromobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
2329,195688,10.1021/jm00042a004,,,,The 50% inhibitory concentration was measured as inhibition of Ribonuclease H activity of reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Nc1c(OC(=O)CCCCCCCCCCCCCCC)cc(S(=O)(=O)O)c2ccccc12,Hexadecanoic acid 1-hexadecanoylamino-4-sulfo-naphthalen-2-yl ester,16.8,uM,=,1.2253092817258628,1,c1ccc2ccccc2c1
2330,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4ccc(-c5cn(C)cn5)nc4c32)CCO1,"Cis-4-(2-Ethyl-tetrahydro-pyran-4-yl)-6-(1-methyl-1H-imidazol-4-yl)-1-(1-methyl-1H-pyrazol-4-yl)-4H-9-oxa-2,4,5-triaza-fluoren-3-one",0.0058,uM,=,-2.2365720064370627,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4c[nH]cn4)nc3c2n1C1CCOCC1
2331,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",9.1e-05,uM,=,-4.040958607678906,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2332,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1ccccc1CNC(=O)COc1ccc(Cl)cc1C(=O)c1ccccc1,2-(2-Benzoyl-4-chloro-phenoxy)-N-(2-methyl-benzyl)-acetamide,6.359491829021653,uM,=,0.8034224136564092,1,O=C(COc1ccccc1C(=O)c1ccccc1)NCc1ccccc1
2333,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,CC(=O)Oc1cc(C)c2c(c(OC(C)=O)c1=O)CC[C@H](C(C)(O)CO)C2,"(2S)-2-(1,2-dihydroxypropan-2-yl)-9-methyl-6-oxo-2,3,4,6-tetrahydro-1H-benzo[7]annulene-5,7-diyl diacetate",1.9,uM,=,0.2787536009528289,1,O=c1cccc2c(c1)CCCC2
2334,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(C)c(Nc2cnc([N+](=O)[O-])c(Nc3ccc(C#N)cc3)c2)c(C)c1,4-((5-(mesitylamino)-2-nitropyridin-3-yl)amino)benzonitrile,0.65,uM,=,-0.1870866433571444,0,c1ccc(Nc2cncc(Nc3ccccc3)c2)cc1
2335,663847,10.1016/j.bmc.2010.08.031,,,,Inhibition of HIV1 DH012 reverse transcriptase by roche colorimetric assay,Cc1cc(=O)oc2c3c(ccc12)OC(C)(C)[C@H](OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C)[C@@H]3OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C,"(13R,14R)-6,12,12-trimethyl-4-oxo-13-{[(1R,4S)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptan-1-yl]carbonyloxy}-3,11-dioxatricyclo[8.4.0.0^{2,7}]tetradeca-1,5,7,9-tetraen-14-yl (1R,4S)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate",10.4,uM,=,1.0170333392987805,1,O=C1O[C@]2(C(=O)O[C@H]3COc4ccc5ccc(=O)oc5c4[C@H]3OC(=O)[C@@]34CCC(C3)C(=O)O4)CCC1C2
2336,1891830,10.1021/acs.jmedchem.8b00843,,,,Inhibition of HIV1 reverse transcriptase derived from HIV patient plasma by LC/MS/MS analysis,O=C1Nc2cccnc2Nc2ccccc21,"5,11-Dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one",6.0,uM,=,0.7781512503836436,1,O=C1Nc2cccnc2Nc2ccccc21
2337,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cccc(Cl)c32)c(Cl)c1,"S-2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl 8-chloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.002,uM,=,-2.6989700043360187,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
2338,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(Cl)cc2)[nH]c(=O)n1O,"6-((4-Chlorophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2339,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2ccc3ccccc3c2)c(O)nc1C,5-Ethyl-6-methyl-3-(2-naphthalen-2-yl-ethyl)-1H-pyridin-2-one,8.4,uM,=,0.9242792860618816,1,c1cncc(CCc2ccc3ccccc3c2)c1
2340,195341,10.1021/jm000255n,,,,Inhibition of HIV-1 reverse transcriptase at 37 degree Centigrade,CCN1c2ncccc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2cccnc2Nc2ncccc21
2341,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(OC)c2)C2CC2)cc1,"N-((2S,3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3-methoxyphenyl)propanamide",0.285,uM,=,-0.5451551399914898,0,O=C(CCc1ccccc1)N[C@H](CCN(C1CC1)S(=O)(=O)c1ccccc1)Cc1ccccc1
2342,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc([N+](=O)[O-])ccc2N(C)C(=O)c2cccnc21,"11-Ethyl-6-methyl-9-nitro-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.4,uM,=,-0.3979400086720376,0,O=C1Nc2ccccc2Nc2ncccc21
2343,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccc(O)cc2oc1=O)S(=O)(=O)c1ccc(N)cc1,"N-((2S,3R)-4-(((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-7-hydroxy-2-oxo-2H-chromene-3-carboxamide",0.5544,uM,=,-0.2561767783962496,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
2344,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCS(=O)(=O)CC3)cc2)n1,"4-((2-((4-((1,1-dioxidothiomorpholino)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.078,uM,=,-1.1079053973095196,0,O=S1(=O)CCN(Cc2ccc(Nc3nccc(Oc4ccccc4)n3)cc2)CC1
2345,197437,10.1016/S0960-894X(01)80472-8,,,,Compound concentration that causes 50 % inhibition of HIV-1 peptide-derived reverse transcriptase (RT) obtained from HIV-1-infected H9 cell cultures,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.022,uM,=,-1.6575773191777938,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2346,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(Cc1ccccc1)NC(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(2-methyl-1-phenylpropan-2-ylamino)-2-oxoethyl 5-nitrofuran-2-carboxylate,4.3,uM,=,0.6334684555795865,1,O=C(COC(=O)c1ccco1)NCCc1ccccc1
2347,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid carbamoylmethyl-amide",0.026,uM,=,-1.585026652029182,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
2348,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnc(C)o2)c2cc(C)c3onc(OC)c3c2)cc(C)c1OC,"(Z)-2-methoxy-5-[1-(3-methoxy-7-methyl-benzo[d]isoxazol-5-yl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-1-enyl]-3-methylbenzoic acid methyl ester",0.39,uM,=,-0.4089353929735008,0,C(\CCc1nnco1)=C(\c1ccccc1)c1ccc2oncc2c1
2349,195841,10.1021/jm980510s,,,,The compound was tested for inhibitory activity against Recombinant HIV-1 reverse transcriptase,CCN(CC)CC.Nc1ccn(C2C=CC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2)c(=O)n1,"cis-(+/-)-4-Amino-1-[4-(triphosphonooxymethyl)-2-cyclopenten-1-yl]-2(1H)-pyrimidinone, Triethylammonium salt",0.38,uM,=,-0.4202164033831898,0,O=c1ncccn1C1C=CCC1
2350,2201739,10.1016/j.ejmech.2022.114217,,,,Inhibition of wild-type HIV-1 reverse transcriptase by Picogreen assay,N#Cc1ccc2c(Oc3ccccc3OCCn3ccc(=O)[nH]c3=O)cc(F)cc2c1,"5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-7-fluoro-2-naphthonitrile",0.0048,uM,=,-2.318758762624413,0,O=c1ccn(CCOc2ccccc2Oc2cccc3ccccc23)c(=O)[nH]1
2351,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SC(C)C)nc1Cc1c(Cl)cccc1Cl,"6-(2,6-Dichloro-benzyl)-2-isopropylsulfanyl-5-methyl-3H-pyrimidin-4-one",1.15,uM,=,0.0606978403536116,1,c1ccc(Cc2ccncn2)cc1
2352,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCOC(=O)CN1c2ccccc2N(C)C(=O)c2cccnc21,"(6-Methyl-5-oxo-5,6-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-11-yl)-acetic acid ethyl ester",16.0,uM,=,1.2041199826559248,1,O=C1Nc2ccccc2Nc2ncccc21
2353,722004,10.1128/aac.00800-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild-type Human immunodeficiency virus 1 subtype B reverse transcriptase by filter-based filtration assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.175,uM,=,-0.7569619513137056,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
2354,1336117,10.1021/jm5001503,,,,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(CCCCl)CC3)ccc2c1=O,4-[1-[(4-Fluorophenyl)methyl]-7-[N-(3-chloroprop-1-yl)piperazin-1-yl]-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,5.7,uM,=,0.7558748556724915,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCNCC3)ccc12
2355,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CN1C(=O)c2cccn2S(=O)(=O)c2cc(Cl)ccc21,"6-Chloro-9-methyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",0.5,uM,=,-0.3010299956639812,0,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
2356,195689,10.1021/jm9800595,,,,The compound is evaluated for the inhibitory against HIV -1 reverse transcriptase with rAdT as the template primer.,COC(=O)c1cc(C(=CCCN=[N+]=[N-])c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"4-Azido-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene",9.9,uM,=,0.99563519459755,1,C=C(c1ccccc1)c1ccccc1
2357,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cccc(C#N)c4)c(F)c3F)c2=O)n[nH]c1=O,"2,3'-Difluoro-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-ypoxy)-[1,1'-bipheny1]-3-carbonitrile",1.31,uM,=,0.1172712956557642,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2358,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Oc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",2.1,uM,=,0.3222192947339193,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2359,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(/C=C\CO)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-hydroxy-propenyl)-5-methyl-1H-pyrimidine-2,4-dione",3.1,uM,=,0.4913616938342727,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
2360,1542247,10.1021/acsmedchemlett.5b00254,,,,Inhibition of wild-type HIV-1 reverse transcriptase by fluorescence assay,N#C/C=C/c1cc(F)cc(Oc2ccc(F)cc2OCCn2ccc(=O)[nH]c2=O)c1,"(E)-3-(3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)-4-fluorophenoxy)-5-fluorophenyl)acrylonitrile",0.0027,uM,=,-2.5686362358410126,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
2361,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3cccc3)ccc12,"7-(5-Methyl-2-pyrrol-1-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.08,uM,=,-1.0969100130080565,0,O=C(CCCCCCc1ncc2ccc(-n3cccc3)nn12)c1ccccc1
2362,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=S(=O)([O-])c1cc(O)c2c(O)cc(S(=O)(=O)[O-])cc2c1.[Na+].[Na+],"4,5-Dihydroxy-naphthalene-2,7-disulfonic acid; disodium salt",125.0,uM,=,2.096910013008056,1,c1ccc2ccccc2c1
2363,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(Cl)cc3)CC2)ncc1Br,"4-(5-bromo-2-(1-(4-chlorobenzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.152,uM,=,-0.8181564120552275,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
2364,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1N(C)c1nc(O)nc(NCc2ccc3occc3c2)n1,"4-(benzofuran-5-ylmethylamino)-6-(methyl(3-methylbiphenyl-2-yl)amino)-1,3,5-triazin-2-ol",5.1,uM,=,0.7075701760979364,1,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
2365,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-hydroxy-6-(4'-methylbiphenyl-3-ylamino)pyrimidine-2,4(1H,3H)-dione",3.1,uM,=,0.4913616938342727,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2366,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,CCSCC(C)(O)[C@H]1CCc2c(c(C)cc(O)c(=O)c2O)C1,"(2S)-2-(1-(ethylthio)-2-hydroxypropan-2-yl)-5,7-dihydroxy-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.38,uM,=,-0.4202164033831898,0,O=c1cccc2c(c1)CCCC2
2367,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",3.2,uM,=,0.505149978319906,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2368,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,Cc1ccc(Sc2cc(CCc3ccccc3)[nH]c(=O)c2I)cc1,3-Iodo-6-phenethyl-4-(p-tolylthio)pyridin-2(1H)-one,12.03,uM,=,1.0802656273398448,1,O=c1cc(Sc2ccccc2)cc(CCc2ccccc2)[nH]1
2369,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4)cc3)ccc2C(=O)N1O,"6-((4'-Fluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",5.4,uM,=,0.7323937598229685,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
2370,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccc(OC)cc2)c(O)nc1C,5-Ethyl-3-(4-methoxy-benzylamino)-6-methyl-1H-pyridin-2-one,7.5,uM,=,0.8750612633917001,1,c1ccc(CNc2cccnc2)cc1
2371,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2cccc([N+](=O)[O-])c2)cs1,SID507686,2.8,uM,=,0.4471580313422192,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2372,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,Cc1cc(/C=C2\SC(=N)NC2=O)c(C)n1-c1ccc(Cl)cc1,"5-((1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-iminothiazolidin-4-one",16.06,uM,=,1.205745540942662,1,N=C1NC(=O)/C(=C/c2ccn(-c3ccccc3)c2)S1
2373,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cc(Cl)cc(Cl)c3)SCCN12,"9b-(3,5-Dichloro-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.59,uM,=,-0.2291479883578558,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2374,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,CS(=O)(=O)c1ccc(NC(=O)COc2ccc(Cl)c(Oc3cc(Cl)cc(C#N)c3)c2)c(Cl)c1,2-(4-chloro-3-(3-chloro-5-cyanophenoxy)phenoxy)-N-(2-chloro-4-(methylsulfonyl)phenyl)acetamide,0.00099,uM,=,-3.0043648054024503,0,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ccccc1
2375,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCOCn1c(C(=O)c2cc(C)cc(C)c2)c(CC)c(=O)n(O)c1=O,"6-(3,5-Dimethylbenzoyl)-1-(ethoxymethyl)-5-ethyl-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.5,uM,=,-0.3010299956639812,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
2376,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(C)nc21,"5-Ethyl-7,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.17,uM,=,-0.7695510786217261,0,O=C1Nc2cccnc2Nc2ncccc21
2377,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(F)nc21,"5-Ethyl-7-fluoro-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.85,uM,=,-0.0705810742857072,0,O=C1Nc2cccnc2Nc2ncccc21
2378,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1CSCC2,"4-(2-(4-cyanophenylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.0409999999999999,uM,=,-1.3872161432802643,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CSCC3)cc1
2379,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(C[S+]([O-])c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzenesulfinylmethyl-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.42,uM,=,0.3838153659804312,1,O=C1Nc2cccnc2Nc2ncc(C[SH+]c3ccccc3)cc21
2380,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncccc21
2381,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccc(F)cc2)n(Cc2ccc(F)cc2)c(=O)n(O)c1=O,"1,6-Bis(4-fluorobenzyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",13.0,uM,=,1.1139433523068367,1,O=c1cc(Cc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
2382,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCOC(=O)NCCC=C(c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,"4-(N-Ethoxycarbonyl)amino-3',3''-dimethyl-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",0.016,uM,=,-1.7958800173440752,0,C=C(c1ccccc1)c1ccccc1
2383,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-amino)pyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2384,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CC[C@H]1C(=O)Nc2ccc(F)cc2N1C(=O)OC(C)C,"(S)-2-Ethyl-7-fluoro-3-oxo-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester",0.045,uM,=,-1.3467874862246565,0,O=C1CNc2ccccc2N1
2385,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,O=[N+]([O-])c1cc([N+](=O)[O-])c([O-])c([N+](=O)[O-])c1.c1c2c(cc3c1OCO3)-c1cc3ccc4c(c3c[n+]1CC2)OCO4,coptisine picrate,102.17457466111752,uM,=,2.0093428384784287,1,c1c2c(cc3c1OCO3)-c1cc3ccc4c(c3c[n+]1CC2)OCO4.c1ccccc1
2386,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cc(OC)cc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",4.0,uM,=,0.6020599913279624,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2387,195062,10.1021/jm990383f,,,,In vitro ability to inhibit wild type resistant (WT) reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.1,uM,=,0.4913616938342727,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2388,546494,10.1021/np50121a006,,,,Inhibition of HIV1 reverse transcriptase p66/p51,C=C1C(=O)O[C@@H](CCCCCCCCCCCCC)[C@@H]1C(=O)O,(+)-protolichesterinic acid,24.3,uM,=,1.385606273598312,1,C=C1CCOC1=O
2389,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,COc1ccccc1Nc1nc(-c2ccc(O)c(O)c2)cs1,"4-(2-(2-methoxyphenylamino)thiazol-4-yl)benzene-1,2-diol",28.0,uM,=,1.4471580313422192,1,c1ccc(Nc2nc(-c3ccccc3)cs2)cc1
2390,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1CCCC2,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile",0.119,uM,=,-0.9244530386074692,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
2391,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,CCC1(CCCC=C(c2cc(Cl)c(OC)c(CO)c2)c2cc(Cl)c(OC)c(CO)c2)OCCO1,"{3-Chloro-5-[1-(3-chloro-5-hydroxymethyl-4-methoxy-phenyl)-5-(2-ethyl-[1,3]dioxolan-2-yl)-pent-1-enyl]-2-methoxy-phenyl}-methanol",31.6,uM,=,1.499687082618404,1,C(CCCC1OCCO1)=C(c1ccccc1)c1ccccc1
2392,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nccn2-c2c(C)ccnc21,"8-Ethyl-4-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",1.62,uM,=,0.2095150145426309,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2393,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CSc3[nH]cnc4ncnc3-4)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(9H-purin-6-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncc(CSc3[nH]cnc4ncnc3-4)cc21
2394,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccccn3)nc21,"5-Ethyl-10-methyl-7-pyridin-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.6,uM,=,0.2041199826559248,1,O=C1Nc2ccc(-c3ccccn3)nc2Nc2ncccc21
2395,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(=O)O)c3)CC2)ncc1Br,"3-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzoic acid",0.016,uM,=,-1.7958800173440752,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2396,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3[N+](=O)[O-])[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-nitrobenzyl)-1H-indole-2-carboxamide",0.023,uM,=,-1.6382721639824072,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2397,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1ccccc1Cl,2-Amino-6-(2-chloro-phenylsulfanyl)-benzonitrile,7.2,uM,=,0.8573324964312685,1,c1ccc(Sc2ccccc2)cc1
2398,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cccc(OC)c2)c(O)nc1C,5-Ethyl-3-(3-methoxy-benzylamino)-6-methyl-1H-pyridin-2-one,1.25,uM,=,0.0969100130080564,1,c1ccc(CNc2cccnc2)cc1
2399,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,O=C(Cn1cncn1)Nc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,"2-(3-(4-(2-(1H-1,2,4-Triazol-1-yl)acetamido)phenyl)ureido)-5-(3,4-dichlorophenyl)thiophene-3-carboxylic Acid",0.8,uM,=,-0.0969100130080563,0,O=C(Cn1cncn1)Nc1ccc(NC(=O)Nc2ccc(-c3ccccc3)s2)cc1
2400,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4ccc(-c5cnn(C)c5)cc4c32)CCO1,"Cis-1-(2-Ethyl-tetrahydro-pyran-4-yl)-4,8-bis-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[4,5]furo[3,2-d]pyrimidin-2-one",0.0026,uM,=,-2.5850266520291822,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4cn[nH]c4)cc3c2n1C1CCOCC1
2401,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CCC#CC1(C(F)(F)F)OCC(=O)Nc2ccc(Cl)cc21,"5-But-1-ynyl-7-chloro-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.964,uM,=,-0.0159229660971692,0,O=C1COCc2ccccc2N1
2402,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1ccccc1,1-(2-Benzhydryloxy-ethyl)-2-methyl-5-nitro-1H-imidazole,0.05,uM,=,-1.3010299956639813,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
2403,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,Cc1ccc(CNc2ccnc(Nc3ccc(C#N)cc3)n2)cc1C,"4-(4-(3,4-dimethylbenzylamino)pyrimidin-2-ylamino)benzonitrile",0.009,uM,=,-2.0457574905606752,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2404,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3ccnc(C#N)c3)c21,"4-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)picolinonitrile",13.3,uM,=,1.1238516409670858,1,O=c1[nH]c2cccc(Oc3ccncc3)c2[nH]1
2405,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)ccnc21,"5-Ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2cccnc2Nc2ncccc21
2406,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1ccc2c(Oc3ccc(OS(=O)(=O)F)cc3OCCn3ccc(=O)[nH]c3=O)cc(Cl)cc2c1,"4-((3-chloro-6-cyanonaphthalen-1-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.0147,uM,=,-1.832682665251824,0,O=c1ccn(CCOc2ccccc2Oc2cccc3ccccc23)c(=O)[nH]1
2407,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3[N+](=O)[O-])nc3ccccc32)c1,"2-({1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)-N-2-nitrophenylacetamide",100.0,uM,=,2.0,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
2408,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N(C1CC1)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Cyclopropyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.23,uM,=,-0.6382721639824072,0,O=C(c1cc2ccccc2[nH]1)N1CCC(N(c2ccccn2)C2CC2)CC1
2409,508741,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.29,uM,=,-0.5376020021010439,0,c1cncc(NCc2nc3ccccc3o2)c1
2410,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(Br)cc2)cs1,SID507649,81.0,uM,=,1.9084850188786493,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2411,197428,10.1021/jm970559i,,,,Antiviral activity against Human Immunodeficiency Virus by Reverse transcriptase (RT) assay in CEM-SS cells,Nc1nc2cc(Cl)c(Cl)cc2n1Cc1ccc(Cl)cc1,"5,6-Dichloro-1-(4-chloro-benzyl)-1H-benzoimidazol-2-ylamine",10.0,uM,=,1.0,1,c1ccc(Cn2cnc3ccccc32)cc1
2412,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-pyridin-2-yl-benzyl)-hydrazinocarbonyl]-2-methyl-propyl}-carbamic acid methyl ester",0.029,uM,=,-1.537602002101044,0,c1ccc(CCCCNCc2ccc(-c3ccccn3)cc2)cc1
2413,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccccc2-c2ccccc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-2-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",47.0,uM,=,1.6720978579357175,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2414,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,CCOC(=O)c1c(O)c(O)nc2ccccc12,"3-Hydroxy-2-oxo-1,2-dihydro-quinoline-4-carboxylic acid ethyl ester",16.0,uM,=,1.2041199826559248,1,c1ccc2ncccc2c1
2415,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)c(F)c2)nc2c1CSCC2,"(E)-4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)-2-fluorobenzonitrile",0.008,uM,=,-2.096910013008056,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CSCC3)cc1
2416,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN(CC)CCOc1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2ccccc2)cc1,2-(2-Benzoyl-4-chloro-phenoxy)-N-[4-(2-diethylamino-ethoxy)-phenyl]-acetamide,0.9371454757423302,uM,=,-0.0281929871184764,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
2417,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(-c3cccc(F)c3)c2)[nH]c(=O)n1O,"6-((3'-fluoro-[1,1'-biphenyl]-3-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Sc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2418,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(Cl)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-chloro-5-methyl-benzenesulfonyl)-benzonitrile,0.005,uM,=,-2.3010299956639813,0,O=S(=O)(c1ccccc1)c1ccccc1
2419,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,CCc1ccccc1Sc1cc(=O)n(O)c(=O)[nH]1,"6-((2-Ethylphenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.01,uM,=,-2.0,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2420,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1ccccc1Nc1nc(-c2ccc(O)c(O)c2)cs1,"4-(2-(2-methoxyphenylamino)thiazol-4-yl)benzene-1,2-diol",21.0,uM,=,1.3222192947339193,1,c1ccc(Nc2nc(-c3ccccc3)cs2)cc1
2421,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3Cl)CC2)n1,"4-(2-(1-(2-chloro-4-(methylsulfonyl)benzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.022,uM,=,-1.6575773191777938,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
2422,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C(N)=O)c3)CC2)nc2c1COC2,"3-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro-[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.091,uM,=,-1.0409586076789064,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
2423,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=C(CCCCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c12)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c12.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],"8-[10-(6,8,11-trisulfo-1-naphthylcarbamoyl)decylcarboxamido]-1,3,7-naphthalenetrisulfonic acid: hexasodium salt",214.0,uM,=,2.330413773349191,1,O=C(CCCCCCCCCCC(=O)Nc1cccc2ccccc12)Nc1cccc2ccccc12
2424,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccccc2F)nc(SC(C)C)[nH]c1=O,"2-(2-fluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.099,uM,=,-1.00436480540245,0,O=c1cc(Cc2ccccc2)nc[nH]1
2425,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCCCN1c2ccccc2N(C)C(=O)c2cccnc21,"11-Butyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",1.0,uM,=,0.0,0,O=C1Nc2ccccc2Nc2ncccc21
2426,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2cccc(F)c2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((3'-fluoro-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.052,uM,=,-1.2839966563652008,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2427,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccccc2[N+](=O)[O-])c(C)c1,2-(1-mesityl-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.003,uM,=,-2.5228787452803374,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
2428,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2C#N)c(O)nc1C,"2-[(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-benzonitrile",0.79,uM,=,-0.1023729087095585,0,c1ccc(CNc2cccnc2)cc1
2429,553446,10.1128/aac.00212-07,,,,Inhibition of HIV1 recombinant reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.054,uM,=,-1.2676062401770316,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2430,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OC1COc2cc(O)ccc2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 7-hydroxy-chroman-3-yl ester",36.3,uM,=,1.5599066250361124,1,O=C(OC1COc2ccccc2C1)c1ccccc1
2431,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Cc1c2oc3c(C)c(N)cc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,"2,7-Diamino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxylic acid bis-[((5R,12S,17aS)-5,12-diisopropyl-9,13,16-trimethyl-4,7,11,14,17-pentaoxo-hexadecahydro-10-oxa-3a,6,13,16-tetraaza-cyclopentacyclohexadecen-8-yl)-amide]",93.0,uM,=,1.9684829485539352,1,O=C1CNC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@@H](NC(=O)c2cc(=O)cc3oc4cccc(C(=O)N[C@H]5COC(=O)CNC(=O)CNC(=O)[C@@H]6CCCN6C(=O)CNC5=O)c4nc2-3)COC(=O)CN1
2432,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cccnc2Oc2cc(C)cc(C#N)c21,"10-Ethyl-7-methyl-11-oxo-10,11-dihydro-5-oxa-4,10-diaza-dibenzo[a,d]cycloheptene-9-carbonitrile",0.019,uM,=,-1.7212463990471711,0,O=C1Nc2ccccc2Oc2ncccc21
2433,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3cncnc3)cc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-5-ethyl-9-methyl-2-(pyrimidin-5-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.026,uM,=,-1.585026652029182,0,O=C1Nc2cccnc2Nc2ncc(CSc3cncnc3)cc21
2434,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CCC#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(F)cc21,"4-But-1-ynyl-6-fluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.054,uM,=,-1.2676062401770316,0,O=C1NCc2ccccc2N1
2435,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(Cc2c(F)cccc2F)nc(SC(C)C)[nH]c1=O,"6-(2,6-Difluoro-benzyl)-2-isopropylsulfanyl-5-methyl-3H-pyrimidin-4-one",0.05,uM,=,-1.3010299956639813,0,O=c1cc(Cc2ccccc2)nc[nH]1
2436,732389,10.1128/aac.01455-09,,,,Inhibition of HIV1 reverse transcriptase activity by primer extension assay,CCc1nn(CCO)c(CC)c1Oc1cc(C#N)cc(C#N)c1,"5-(3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yloxy)isophthalonitrile",0.118,uM,=,-0.9281179926938746,0,c1ccc(Oc2cn[nH]c2)cc1
2437,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,Cc1ccc(-c2nc(O)c(O)c(C(=O)O)n2)cc1Cl,"2-(3-Chloro-4-methylphenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",1.6,uM,=,0.2041199826559248,1,c1ccc(-c2ncccn2)cc1
2438,140625,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 variant with Y181C plus K103N mutations in RT (reverse transcriptase),S=C(NCCc1cccs1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-thiophen-2-yl-ethyl)-thiourea,3.3,uM,=,0.5185139398778875,1,S=C(NCCc1cccs1)Nc1ccccn1
2439,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)c(F)c1,"6-[1-(3,4-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",3.0,uM,=,0.4771212547196624,1,c1ccc(Cn2cccc2)cc1
2440,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4cnccc34)c2F)c1,"3-[6-Bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",0.005,uM,=,-2.3010299956639813,0,c1ccc(Oc2cccc(Cc3n[nH]c4cnccc34)c2)cc1
2441,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.001,uM,=,-3.0,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2442,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(c1ccccc1)c1cc(Cl)ccc1OCC(=O)N1CCc2ccccc2C1,"2-(2-Benzoyl-4-chloro-phenoxy)-1-(3,4-dihydro-1H-isoquinolin-2-yl)-ethanone",0.0148106761933298,uM,=,-1.8294251129623864,0,O=C(c1ccccc1)c1ccccc1OCC(=O)N1CCc2ccccc2C1
2443,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,Cc1n[nH]c2ccc(Cl)c(Oc3cc(C#N)cc(C#N)c3)c12,5-(5-Chloro-3-methyl-1H-indazol-4-yloxy)-isophthalonitrile,0.399,uM,=,-0.3990271043132517,0,c1ccc(Oc2cccc3[nH]ncc23)cc1
2444,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccnc(C(F)(F)F)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-trifluoromethyl-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
2445,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2cc(F)nc(F)c2)cc1F,"4-((4-((4-(2,6-Difluoropyridin-4-yl)-2,6-difluorophenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.055,uM,=,-1.259637310505756,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
2446,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(Cl)ccc12,"7-(2-Chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one hydrochloride",0.84,uM,=,-0.0757207139381183,0,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
2447,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2cccc(Cl)c2[C@@](C#CC2CC2)(C(F)(F)F)N1,"5-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.072,uM,=,-1.1426675035687317,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
2448,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,"3-Dimethylamino-4-(3,5-dimethylbenzyl)-5-ethyl-6-methylpyridin-2(1H)-one",0.008,uM,=,-2.096910013008056,0,O=c1cc(Cc2ccccc2)cc[nH]1
2449,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",3.5,uM,=,0.5440680443502757,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2450,195055,10.1021/jm00171a023,,,,Compound was evaluated for the 50% inhibitory concentration on human immunodeficiency virus associated reverse transcriptase,C=C1C(=O)NC(=O)N([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COCP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)C1C,"beta,gama-methylene AzddTPP",7.9,uM,=,0.8976270912904415,1,C=C1CN([C@H]2CCCO2)C(=O)NC1=O
2451,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C#N)c3)CC2)ncc1Br,"4-(5-bromo-2-(1-(3-cyanophenyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.103,uM,=,-0.9871627752948278,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2452,195844,10.1021/jm00020a026,,,,antiviral activity in Human immunodeficiency virus-1 as reverse transcriptase activity in culture supernatant,NC(=S)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c2ncnc(N)c12,"4-Amino-7-(3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbothioic acid amide",0.07,uM,=,-1.154901959985743,0,c1ncc2ccn([C@H]3CCCO3)c2n1
2453,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(N(C)Cc2ccc3c(c2)OCO3)n1,"4-((benzo[d][1,3]dioxol-5-ylmethyl)(methyl)amino)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.09,uM,=,-1.0457574905606752,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4c(c3)OCO4)n2)cc1
2454,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2C)c(O)nc1C,5-Ethyl-6-methyl-3-(2-methyl-benzylamino)-1H-pyridin-2-one,2.2,uM,=,0.3424226808222063,1,c1ccc(CNc2cccnc2)cc1
2455,2114055,10.1016/j.bmc.2021.116195,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation in presence of template-primer incubated for 60 mins followed by transferring to streptavidin-coated plate and further incubation for 60 mins by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1-c1ccncc1,"4-(2-(4-cyanophenylamino)-5-(pyridin-4-yl)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.57,uM,=,-0.2441251443275086,0,c1ccc(Nc2ncc(-c3ccncc3)c(Oc3ccccc3)n2)cc1
2456,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
2457,1293405,10.1016/j.bmc.2014.01.054,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotinylated dUTP incorporation after 1 hr by ELISA,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)[nH]c(=O)c2)c(C)c1,"4-((4-(Mesityloxy)-6-oxo-1,6-dihydropyridin-2-yl)amino)benzonitrile",39.0,uM,=,1.591064607026499,1,O=c1cc(Oc2ccccc2)cc(Nc2ccccc2)[nH]1
2458,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),N#Cc1cccc(S(=O)(=O)Nc2cc(Cl)ccc2NC(=O)CCl)c1,2-chloro-N-(4-chloro-2-(3-cyanophenylsulfonamido)phenyl)acetamide,283.68,uM,=,2.4528287182568427,1,O=S(=O)(Nc1ccccc1)c1ccccc1
2459,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nccn2-c2ccc(N(C)C)nc21,"(8-Ethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-yl)-dimethyl-amine",3.9,uM,=,0.5910646070264992,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2460,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1cc(COCc2ccc(Cl)cc2)n(COCc2ccccc2)c(=O)[nH]1,"1-[(Benzyloxy)methyl]-6-{[(4-chlorobenzyl)oxy]-methyl}pyrimidine-2,4(1H,3H)-dione",1.2,uM,=,0.0791812460476248,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2461,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)Cc1cc(=O)oc2cc(N(C)C)ccc12)S(=O)(=O)c1ccc(N)cc1,"N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-2-(7-(dimethylamino)-2-oxo-2H-chromen-4-yl)acetamide",0.5722,uM,=,-0.2424521465307561,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
2462,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCc1nnc2n1-c1cccnc1N(CC)c1ncccc1-2,"3,8-Diethyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",20.2,uM,=,1.305351369446624,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
2463,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccccc2F)c2cc(Cl)ccc2c1=O,4-[7-Chloro-1-(2-fluorophenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,22.6,uM,=,1.354108439147401,1,O=c1ccn(Cc2ccccc2)c2ccccc12
2464,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2cc(N)ccc2Oc2cc(C)ccc21,"2-Amino-7-methyl-10-propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2ccccc2Oc2ccccc21
2465,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,CCOc1ccc(F)c(CCNC(=O)Nc2ccc(Br)cn2)c1Cl,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-urea,0.004,uM,=,-2.397940008672037,0,O=C(NCCc1ccccc1)Nc1ccccn1
2466,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Cc1cccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n12,"2-(2-Chlorophenyl)-N-cyclohexyl-5-methylimidazo[1,2-a]pyridin-3-amine",1.55,uM,=,0.1903316981702915,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
2467,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,COc1ccc2c(c1)[C@@](C#CC1CC1)(C(F)(F)F)NC(=O)N2,"4-Cyclopropylethynyl-6-methoxy-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.124,uM,=,-0.906578314837765,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
2468,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,"(8S,10S)-8-Acetyl-10-(4-amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione",139.0,uM,=,2.143014800254095,1,O=C1c2ccccc2C(=O)c2cc3c(cc21)CCC[C@@H]3O[C@H]1CCCCO1
2469,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,COc1ccc(C(C)=O)c(F)c1CCNC(=O)Nc1ccc(Cl)cn1,1-[2-(3-Acetyl-2-fluoro-6-methoxy-phenyl)-ethyl]-3-(5-chloro-pyridin-2-yl)-urea,0.1,uM,=,-1.0,0,O=C(NCCc1ccccc1)Nc1ccccn1
2470,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,C=CCN1C(=O)c2cccn2S(=O)(=O)c2ccccc21,"9-Allyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
2471,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=c1ccc(Cc2ccc(Cl)c(Oc3cccc(Cl)c3)c2)n[nH]1,6-(4-chloro-3-(3-chlorophenoxy)benzyl)pyridazin-3(2H)-one,0.1,uM,=,-1.0,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
2472,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(N(C)C)ccc12,"7-(2-Dimethylamino-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.27,uM,=,-0.5686362358410126,0,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
2473,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(F)cc2)c(=O)n(C)c1=O,"6-Benzyl-1-((4-fluorobenzyloxy)methyl)-5-isopropyl-3-methylpyrimidine-2,4(1H,3H)-dione",7.0,uM,=,0.8450980400142568,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2474,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1ccc(S(=O)(=O)n2c(=S)[nH]c3ccc(Cl)cc32)cc1C,"6-chloro-1-(3,5-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-thione",0.006,uM,=,-2.2218487496163566,0,O=S(=O)(c1ccccc1)n1c(=S)[nH]c2ccccc21
2475,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.097,uM,=,-1.0132282657337552,0,S=c1[nH]c2cccc3c2n1CCNC3
2476,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccccc2)C(=O)c2cccn2-c2ccccc2[S+]1[O-],"5-Ethyl-6-oxo-5-phenyl-5,6-dihydro-6lambda*4*-thia-10b-aza-benzo[e]azulen-4-one",500.0,uM,=,2.6989700043360187,1,O=C1c2cccn2-c2ccccc2[SH+]C1c1ccccc1
2477,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,COCc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Methoxymethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,6.8,uM,=,0.8325089127062363,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2478,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,COc1ccc(C(=O)N/N=C/c2cccc([N+](=O)[O-])c2)cc1,N'-(3-nitrobenzylidene)-4-methoxybenzohydrazide,70.0,uM,=,1.845098040014257,1,O=C(N/N=C/c1ccccc1)c1ccccc1
2479,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)-methanone,5.2,uM,=,0.7160033436347992,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
2480,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2c(C#N)ccc3nc(S)n(c23)C[C@@H]1C,"8-Methyl-7-(3-methyl-but-2-enyl)-1-thioxo-1,2,6,7,8,9-hexahydro-2,7,9a-triaza-benzo[cd]azulene-5-carbonitrile",56.3,uM,=,1.7505083948513462,1,c1cc2c3c(c1)ncn3CCNC2
2481,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NC(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-carboxylic acid (2-{4-[(3-isopropylamino-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.19,uM,=,-0.721246399047171,0,O=C(Nc1ccc2[nH]c(C(=O)N3CCC(Nc4ccccn4)CC3)cc2c1)N1CCNCC1
2482,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCC(=O)Cc2ccccc2)n2nc(Cl)ccc12,"7-(2-Chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-2-one",3.9,uM,=,0.5910646070264992,1,O=C(CCCCCc1ncc2cccnn12)Cc1ccccc1
2483,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-({6-[(4-bromo-2-carboxyphenyl)amino]-6-oxohexanoyl}amino)benzoic acid,3.1,uM,=,0.4913616938342727,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
2484,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCCN(c1ncccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-tert-Butylamino-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.48,uM,=,-0.3187587626244128,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2485,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.02,uM,=,-1.6989700043360187,0,c1cncc(NCc2nc3ccccc3o2)c1
2486,1567015,10.1021/acs.jmedchem.5b01979,,,,Inhibition of recombinant HIV1 His-tagged p66/p51 reverse transcriptase expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)-oligo(dT) (12 to 18 bp) as template/primer incubated for 20 mins by scintillation counting method,Cc1c(Cc2c(Cl)cccc2Cl)nc(N(C)Cc2ccc(N3CCOCC3)cc2)[nH]c1=O,"6-(2,6-dichlorobenzyl)-5-methyl-2-(methyl(4-morpholinobenzyl)amino)pyrimidin-4(3H)-one",0.09,uM,=,-1.0457574905606752,0,O=c1cc(Cc2ccccc2)nc(NCc2ccc(N3CCOCC3)cc2)[nH]1
2487,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),S=C(NCC12CC3CC(CC(C3)C1)C2)Nc1nccs1,1-Adamantan-1-ylmethyl-3-thiazol-2-yl-thiourea,0.6,uM,=,-0.2218487496163563,0,S=C(NCC12CC3CC(CC(C3)C1)C2)Nc1nccs1
2488,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1cc(OC)cc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"6-((3',5'-dimethoxy-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2489,195536,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at high (~1 pfu/cell) multiplicity of injection (moi),Nc1ncnc2c1ncn2/C=C1/CC1CO,{2-[1-(6-Amino-purin-9-yl)-meth-(Z)-ylidene]-cyclopropyl}-methanol,20.0,uM,=,1.3010299956639813,1,C(=C1CC1)n1cnc2cncnc21
2490,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,Cc1ccnc2c1-n1ccnc1-c1cccnc1N2C1CC1,"8-Cyclopropyl-4-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",2.05,uM,=,0.3117538610557542,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2C1CC1
2491,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.1,uM,=,0.041392685158225,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2492,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nc(SC(C)C)[nH]c1=O,"2-(3,5-bis(trifluoromethyl)phenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",55.122,uM,=,1.7413249667588953,1,O=c1cc(Cc2ccccc2)nc[nH]1
2493,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(C)cc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)c1,"2-(3,5-dimethylphenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.226,uM,=,-0.645891560852599,0,O=c1cc(Cc2ccccc2)nc[nH]1
2494,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-{4-[4-((E)-2-Cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile",0.022,uM,=,-1.6575773191777938,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
2495,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3C(=O)O)nc3ccccc32)c1,"2-[[2-[1-(3,5-Dimethylphenyl)sulfonylbenzimidazol-2-yl]oxyacetyl]amino]benzoic acid",21.34,uM,=,1.3291944150884512,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
2496,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CSc3[nH]cnc4nncc3-4)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(1H-pyrazolo[3,4-d]pyrimidin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(CSc3[nH]cnc4nncc3-4)cc21
2497,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cnc3ccccc3c2)c(O)nc1C,5-Ethyl-6-methyl-3-[(quinolin-3-ylmethyl)-amino]-1H-pyridin-2-one,0.335,uM,=,-0.4749551929631547,0,c1cncc(NCc2cnc3ccccc3c2)c1
2498,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccsc2)cc1F,"4-((4-((2,6-Difluoro-4-(thiophen-3-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.012,uM,=,-1.9208187539523751,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccsc4)cc3)n2)cc1
2499,439842,10.1021/jm070236e,,,,Inhibition of HIV1 recombinant reverse transcriptase,CO/N=C(\F)c1cc(/C(=C\CCCC(=O)OC)c2cc(C)c3oc(=O)n(C)c3c2)cc(C)c1OC,"(E)-methyl 6-(3,7-Dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-6-(3-(Z)-fluoro-(methoxyimino)methyl)-4-methoxy-5-methylphenyl)hex-5-enoate",0.55,uM,=,-0.2596373105057561,0,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
2500,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1cccc(N2C(=O)CSC2c2c(Cl)cccc2Cl)n1,"2-(2,6-Dichloro-phenyl)-3-(6-methyl-pyridin-2-yl)-thiazolidin-4-one",2.24,uM,=,0.3502480183341628,1,O=C1CSC(c2ccccc2)N1c1ccccn1
2501,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,Cn1c(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)n[nH]c1=O,"5-(3-(3-bromophenoxy)-4-chlorobenzyl)-4-methyl-2H-1,2,4-triazol-3(4H)-one",0.69,uM,=,-0.1611509092627447,0,O=c1[nH]nc(Cc2cccc(Oc3ccccc3)c2)[nH]1
2502,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(COc3cccc(Cl)c3)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-ethyl-6-[4-[(3-chlorophenyloxy)methyl]phenyl]pyrrolo[2,1-d][1,5]benzoxazepine-7(6H)-one",0.1,uM,=,-1.0,0,O=C1c2cccn2-c2ccccc2OC1c1ccc(COc2ccccc2)cc1
2503,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCOc1ccc(F)c(C2CC2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[2-(3-ethoxy-2,6-difluoro-phenyl)-cyclopropyl]-urea",0.0016,uM,=,-2.7958800173440754,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
2504,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2[N+](=O)[O-])c(O)nc1C,5-Ethyl-6-methyl-3-(2-nitro-benzylamino)-1H-pyridin-2-one,0.53,uM,=,-0.2757241303992109,0,c1ccc(CNc2cccnc2)cc1
2505,197440,10.1016/s0960-894x(99)00664-2,,,,Compound dose required to inhibit HIV-1 reverse transcriptase enzyme(rRT) activity,Cc1ccc(C(OCCn2c([N+](=O)[O-])cnc2C)c2ccccc2)cc1,2-Methyl-5-nitro-1-[2-(phenyl-p-tolyl-methoxy)-ethyl]-1H-imidazole,2.1,uM,=,0.3222192947339193,1,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
2506,494378,10.1021/jm801071m,,,,Inhibition of HIV1 LAI clade B reverse transcriptase RNase H activity by real time monitoring assay,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccc(Br)cc2)cs1)c1ccc([N+](=O)[O-])o1,5-nitro-furan-2-carboxylic acid [[4-(4-bromo-phenyl)-thiazol-2-yl]-(tetrahydro-furan-2-ylmethyl)-carbamoyl]-methyl ester,26.7,uM,=,1.4265112613645752,1,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccccc2)cs1)c1ccco1
2507,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1ccc(Cl)cc1C(=O)O,2-({5-[(2-carboxy-4-chlorophenyl)amino]-5-oxopentanoyl}amino)-5-chlorobenzoic acid,9.6,uM,=,0.9822712330395684,1,O=C(CCCC(=O)Nc1ccccc1)Nc1ccccc1
2508,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CC(=O)NCc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1F,"N-(3-{2-[3-(5-Bromo-pyridin-2-yl)-thioureido]-ethyl}-2,4-difluoro-benzyl)-acetamide",0.045,uM,=,-1.3467874862246565,0,S=C(NCCc1ccccc1)Nc1ccccn1
2509,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CC(C)C#CC1(C(F)(F)F)OC(=O)Nc2ccc(N)cc21,"6-Amino-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.896,uM,=,-0.0476919903378747,0,O=C1Nc2ccccc2CO1
2510,1299153,10.1039/C3MD00036B,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli BL21 (DE3) using [alpha-32P]dATP after 30 mins by liquid scintillation counting,Cc1ccc(Cn2c(=O)ccn(C3C=CC(OC(=O)c4ccccc4)C3)c2=O)cc1,"(+/-)-4-(3-(4-methylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopent-2-enyl benzoate",18.7,uM,=,1.271841606536499,1,O=C(OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1)c1ccccc1
2511,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(CCC(=O)O)cc2Cl)c(Cl)c1,3-(4-(2-(1-(4-tert-butyl-2-chlorophenyl)-1H-tetrazol-5-ylthio)acetamido)-3-chlorophenyl)propanoic acid,0.01,uM,=,-2.0,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
2512,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,C=CCNC(=O)CSc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"N-allyl-2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetamide",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
2513,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),CCC(/N=C(\S)Nc1nccs1)c1ccccc1,1-(1-Phenyl-propyl)-3-thiazol-2-yl-thiourea,2.1,uM,=,0.3222192947339193,1,C(=NCc1ccccc1)Nc1nccs1
2514,1364717,10.1016/j.ejmech.2014.06.061,,,,Inhibition of HIV1 reverse transcriptase strand transfer activity,O=C(O)c1ncc2cccnc2c1O,"8-hydroxy-1,6-naphthyridine-7-carboxylic acid",11.0,uM,=,1.0413926851582251,1,c1cnc2ccncc2c1
2515,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(F)c(F)c1CC/N=C(\S)Nc1ccc(Br)cn1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,3-difluoro-6-methoxy-phenyl)-ethyl]-thiourea",0.003,uM,=,-2.5228787452803374,0,C(=NCCc1ccccc1)Nc1ccccn1
2516,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NC1CCCc2ccccc21,"2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl 5-nitrofuran-2-carboxylate",4.3,uM,=,0.6334684555795865,1,O=C(COC(=O)c1ccco1)NC1CCCc2ccccc21
2517,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COc1noc2c(C)cc(/C(=C\CCN3CCOC3=O)c3cc(C)c4oc(=O)n(C)c4c3)cc12,"(E)-5-[1-(3-Methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(2-ox-oxazolidin-3-yl)-but-1-enyl]-3,7-dimethyl-3Hbenzoxazol-2-one",3.6,uM,=,0.5563025007672873,1,O=C1OCCN1CC/C=C(\c1ccc2oncc2c1)c1ccc2oc(=O)[nH]c2c1
2518,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)O)CC2,"(2S)-5,7-dihydroxy-2-(1-hydroxyethyl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.68,uM,=,-0.1674910872937636,0,O=c1cccc2c(c1)CCCC2
2519,471467,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type LAI by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2CO[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,1-(beta-D-dioxolane)thymine triphosphate,0.11,uM,=,-0.958607314841775,0,O=c1ccn([C@H]2COCO2)c(=O)[nH]1
2520,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cccc(C)c1Oc1cnc(N)c(Nc2ccc(C#N)cc2)c1,"4-((2-amino-5-(2,6-dimethylphenoxy)pyridin-3-yl)amino)benzonitrile",0.91,uM,=,-0.0409586076789063,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
2521,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CSc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(O)c2)cc1,"(E)-3-(3, 4-dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0215,uM,=,-1.6675615400843946,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
2522,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCOS(C)(=O)=O)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"3',3''-Dichloro-4-methanesulfonyloxy-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene",96.0,uM,=,1.9822712330395684,1,C=C(c1ccccc1)c1ccccc1
2523,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1O,"6-([1,1'-Biphenyl]-4-ylmethyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.9,uM,=,-0.0457574905606751,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
2524,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnn(C)n2)c2cccc(C#N)c2)cc(C)c1OC,(Z)-5-[1-(3-cyanophenyl)-4-(2-methyl-2H-tetrazol-5-yl)-but-1-enyl]-2-methoxy-3-methylbenzoic acid methyl ester,7.7,uM,=,0.8864907251724818,1,C(CCc1nn[nH]n1)=C(c1ccccc1)c1ccccc1
2525,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1c2ccccc2C(=O)N1CNc1cccnc1O,"2-[(2-Oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",1.66,uM,=,0.220108088040055,1,O=C1c2ccccc2C(=O)N1CNc1cccnc1
2526,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,Cc1nc(O)c(NCc2nc3ccccc3o2)cc1S(C)(=O)=O,3-[(Benzooxazol-2-ylmethyl)-amino]-5-methanesulfonyl-6-methyl-1H-pyridin-2-one,1.15,uM,=,0.0606978403536116,1,c1cncc(NCc2nc3ccccc3o2)c1
2527,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,FC(F)(F)C1(C#CC2CC2)NC(Nc2ccccc2Br)=Nc2ccc(Cl)cc21,"N-(2-bromophenyl)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2-amine",0.0034,uM,=,-2.468521082957745,0,C(#CC1NC(Nc2ccccc2)=Nc2ccccc21)C1CC1
2528,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=C(Cn1ccc(=O)n(Cc2cccc3ccccc23)c1=O)Nc1ccccc1Cl,"N-(2-Chlorophenyl)-2-(3-(naphthalen-1-ylmethyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",44.54,uM,=,1.6487502126980194,1,O=C(Cn1ccc(=O)n(Cc2cccc3ccccc23)c1=O)Nc1ccccc1
2529,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3c4ccccc4cc4ccccc34)SCCN12,"9b-Anthracen-9-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.9,uM,=,-0.0457574905606751,0,O=C1c2ccccc2C2(c3c4ccccc4cc4ccccc34)SCCN12
2530,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",3.0,uM,=,0.4771212547196624,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
2531,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCCCNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,(S)-1-(6-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-6-oxohexylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,156.0,uM,=,2.1931245983544616,1,O=C(CCCCCNC(=O)CCc1c[nH]c2ccccc12)NCCc1c[nH]c2ccccc12
2532,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(O)c(O)c2)cs1,"3-(2-(4-(3,4-dihydroxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one",1.4,uM,=,0.1461280356782379,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2533,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(F)c1F,"6-[1-(2,3-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",8.0,uM,=,0.9030899869919436,1,c1ccc(Cn2cccc2)cc1
2534,494380,10.1021/jm801071m,,,,Inhibition of HIV1 LAI CRF01 A_E s93JP-NH1 reverse transcriptase RNase H activity by real time monitoring assay,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccc(Br)cc2)cs1)c1ccc([N+](=O)[O-])o1,5-nitro-furan-2-carboxylic acid [[4-(4-bromo-phenyl)-thiazol-2-yl]-(tetrahydro-furan-2-ylmethyl)-carbamoyl]-methyl ester,2.6,uM,=,0.414973347970818,1,O=C(OCC(=O)N(CC1CCCO1)c1nc(-c2ccccc2)cs1)c1ccco1
2535,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CNc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenylaminomethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CNc3ccccc3)cc21
2536,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1ccc(Cl)cc1C(=O)O,2-({6-[(2-carboxy-4-chlorophenyl)amino]-6-oxohexanoyl}amino)-5-chlorobenzoic acid,1.8,uM,=,0.255272505103306,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
2537,195520,10.1021/jm00089a002,,,,Inhibitory activity against human immunodeficiency virus-1 reverse transcriptase(HIV-1 RT).,Cc1cn([C@H]2C[C@@H](O)[C@@H](OP(=O)(O)NP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"TMPNPPthymidine 5'-[alpha,beta-imido]triphosphate",10.0,uM,=,1.0,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2538,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,"3-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.019,uM,=,-1.7212463990471711,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2539,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3F)ccc2C(=O)N1O,"6-(2,4-Difluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.0,uM,=,0.0,0,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
2540,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cc(=O)[nH]c(=O)[nH]3)CC2)nc2ccsc12,"4-((2-((1-((2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.022,uM,=,-1.6575773191777938,0,O=c1cc(CN2CCC(Nc3nc(Oc4ccccc4)c4sccc4n3)CC2)[nH]c(=O)[nH]1
2541,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1ccccc1C(F)(F)F)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(2-(trifluoromethyl)benzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,9.0,uM,=,0.9542425094393248,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
2542,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",9.4,uM,=,0.9731278535996988,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2543,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(CSc3ccc(F)cc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-Ethyl-6-[4-[(2-chloro-4-fluorophenylthio)methyl]-phenyl]-6,7-dihydrobenzo[b]pyrrolo[1,2-d][1,4]oxazepin-7-one",0.61,uM,=,-0.2146701649892329,0,O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2)cc1
2544,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCCC1C(=O)N(O)C(=O)c2ccccc21,"2-Hydroxy-4-propylisoquinoline-1,3(2H,4H)-dione",46.8,uM,=,1.670245853074124,1,O=C1Cc2ccccc2C(=O)N1
2545,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,S=C(NCCn1nc2ccccc2n1)Nc1ccc(Br)cn1,1-(2-Benzotriazol-2-yl-ethyl)-3-(5-bromo-pyridin-2-yl)-thiourea,0.003,uM,=,-2.5228787452803374,0,S=C(NCCn1nc2ccccc2n1)Nc1ccccn1
2546,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),COc1ccc(C(C)=O)c(F)c1CCNC(=O)Nc1ccc(Cl)cn1,1-[2-(3-Acetyl-2-fluoro-6-methoxy-phenyl)-ethyl]-3-(5-chloro-pyridin-2-yl)-urea,1.1,uM,=,0.041392685158225,1,O=C(NCCc1ccccc1)Nc1ccccn1
2547,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1nc(=O)c(-c2ccccc2)c(C)n1-c1ccc(O)c(C(=O)O)c1,"5-(2,6-Dimethyl-4-oxo-5-phenyl-4H-pyrimidin-1-yl)-2-hydroxy-benzoic acid",96.0,uM,=,1.9822712330395684,1,O=c1ncn(-c2ccccc2)cc1-c1ccccc1
2548,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1cc(-c2ccc(C(F)(F)F)cn2)[nH]c1C(=O)N[C@H](CN)c1nc(CO)cs1,(R)-N-(2-Amino-1-(4-(hydroxymethyl)thiazol-2-yl)ethyl)-3-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1H-pyrrole-2-carboxamide,5.0,uM,=,0.6989700043360189,1,O=C(NCc1nccs1)c1ccc(-c2ccccn2)[nH]1
2549,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)nn(COP(=O)(O)O)c1=O,"(3-((3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)methyl dihydrogen phosphate",0.93,uM,=,-0.0315170514460648,0,O=c1[nH]nc(Cn2cccc(Oc3ccccc3)c2=O)[nH]1
2550,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCC(=O)N(C)C)c2cc(C)c(OC)c(C(=O)OC)c2)cc(C)c1OC,"N,N-Dimethyl-3',3''-Dimethyl-4',4''-dimethoxy-5',5''-bis(methoxy-carbonyl)-6,6-diphenylhexenamide",5.65,uM,=,0.7520484478194386,1,C=C(c1ccccc1)c1ccccc1
2551,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccc(Cl)c3)SCCN12,"9b-(3-Chloro-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.14,uM,=,-0.8538719643217619,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2552,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3cccc(Br)c3)n2)cc1,4-(4-(3-bromobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.024,uM,=,-1.619788758288394,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2553,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Fc1ccccc1CCNC(=S)Nc1nccs1,1-[2-(2-Fluoro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.06,uM,=,-1.2218487496163564,0,S=C(NCCc1ccccc1)Nc1nccs1
2554,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccn3)SCCN12,"9b-Pyridin-2-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",5.85,uM,=,0.7671558660821804,1,O=C1c2ccccc2C2(c3ccccn3)SCCN12
2555,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1ccc(Cl)cc1C(=O)O,2-({5-[(2-carboxy-4-chlorophenyl)amino]-5-oxopentanoyl}amino)-5-chlorobenzoic acid,8.7,uM,=,0.9395192526186184,1,O=C(CCCC(=O)Nc1ccccc1)Nc1ccccc1
2556,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(F)cc2F)c(=O)n(O)c1=O,"6-Benzyl-1-((2,4-difluorobenzyloxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",1.8,uM,=,0.255272505103306,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2557,306312,10.1016/j.bmcl.2005.06.036,,,,In vitro inhibitory concentration against HIV-1 recombinant integrase activity in strand transfer assay,O=C(O)c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,"2-[2-(3,4-Dihydroxy-phenyl)-vinyl]-8-hydroxy-quinoline-7-carboxylic acid",1.0,uM,=,0.0,0,C(=C/c1ccc2ccccc2n1)\c1ccccc1
2558,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1cc(CCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(SC)cc2)ccc1O,"3-(4-Hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0035,uM,=,-2.4559319556497243,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
2559,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,CCOc1ccc(/C=C2\NC(=O)NC2=O)c(Cl)c1OC,"5-(2-chloro-4-ethoxy-3-methoxybenzylidene)imidazolidine-2,4-dione",84.2,uM,=,1.925312091499649,1,O=C1NC(=O)/C(=C/c2ccccc2)N1
2560,734864,10.1016/j.bmc.2011.01.024,,,,Inhibition of HIV1 3B reverse transcriptase activity,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2561,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Oc2ccccc2-c2ccc(C(F)(F)F)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)-oxy)pyrimidine-2,4(1H,3H)-dione",5.1,uM,=,0.7075701760979364,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2562,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(N3CCCCC3)ccc12,"7-(5-Methyl-2-piperidin-1-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",6.7,uM,=,0.8260748027008264,1,O=C(CCCCCCc1ncc2ccc(N3CCCCC3)nn12)c1ccccc1
2563,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Oc1cc(Cc2c(Cl)cccc2Cl)nc(SC2CCCC2)n1,"2-Cyclopentylsulfanyl-6-(2,6-dichloro-benzyl)-3H-pyrimidin-4-one",0.4,uM,=,-0.3979400086720376,0,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
2564,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nccn2-c2ccc(N3CCCC3)nc21,"8-Ethyl-6-pyrrolidin-1-yl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",2.0,uM,=,0.3010299956639812,1,c1cnc2c(c1)-c1nccn1-c1ccc(N3CCCC3)nc1N2
2565,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1ccc(F)cc1)c1cc(=O)n(O)c(=O)[nH]1,"6-(4-Fluorobenzoyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.085,uM,=,-1.0705810742857071,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
2566,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,COc1ccc(OC)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,5-dimethoxy-phenyl)-ethyl]-thiourea",0.1,uM,=,-1.0,0,S=C(NCCc1ccccc1)Nc1ccccn1
2567,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(Nc1ccc(Br)cc1C(=O)O)c1ccnc(C(=O)Nc2ccc(Br)cc2C(=O)O)c1,5-bromo-2-[(2-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}isonicotinoyl)amino]benzoic acid,66.0,uM,=,1.8195439355418688,1,O=C(Nc1ccccc1)c1ccnc(C(=O)Nc2ccccc2)c1
2568,1336117,10.1021/jm5001503,,,,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCCC3)ccc2c1=O,4-[1-(4-Fluorophenyl)methyl-7-(pyrrolidin-1-yl)-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,5.1,uM,=,0.7075701760979364,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCCC3)ccc12
2569,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2C#N)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-2-carbonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2570,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,Nc1ccc(C(=O)Nc2ccc3c(O)cc(S(=O)(=O)O)cc3c2)cc1,SID89852628,98.0,uM,=,1.9912260756924949,1,O=C(Nc1ccc2ccccc2c1)c1ccccc1
2571,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1ccccc1Sc1cc(=O)n(O)c(=O)[nH]1,"3-Hydroxy-6-((2-methoxyphenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.017,uM,=,-1.769551078621726,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2572,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc(C(=O)O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"3-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzoic acid",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
2573,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1ccccc1CSc1nc(Cc2ccccc2)c(Br)c(=O)[nH]1,6-Benzyl-5-bromo-2-(2-methylbenzylthio)pyrimidin-4(3H)-one,24.94,uM,=,1.3968964491425238,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
2574,858890,10.1021/jm300477h,,,,Inhibition of wild type HIV1 reverse transcriptase RNA-dependent DNA polymerase activity using poly(rA)/oligo(dT)10:1 and [3H]-dTTP substrate,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccncc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(pyridin-4-ylmethyl)-1H-indole-2-carboxamide",0.021,uM,=,-1.6777807052660807,0,O=C(NCc1ccncc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2575,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,Cc1nnc2n1-c1cccnc1N(C1CC1)c1ncccc1-2,"8-Cyclopropyl-3-methyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",11.5,uM,=,1.0606978403536118,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2C1CC1
2576,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1ccccc1C(=O)c1cc(Cl)ccc1Oc1nc(Nc2ccc(C#N)cc2)ncc1C,4-{5-Methyl-4-[4-chloro-2-(2-methylbenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,5.23,uM,=,0.7185016888672743,1,O=C(c1ccccc1)c1ccccc1Oc1ccnc(Nc2ccccc2)n1
2577,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)[nH]2)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.7,uM,=,-0.1549019599857432,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2578,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2cccc(-c3cncnc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((3-(pyrimidin-5-yl)phenyl)amino)-pyrimidine-2,4(1H,3H)-dione",4.1,uM,=,0.6127838567197355,1,O=c1cc(Nc2cccc(-c3cncnc3)c2)[nH]c(=O)[nH]1
2579,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCC(=O)c2ccccc2)n2nc(Cl)ccc12,"6-(2-Chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-hexan-1-one hydrochloride",4.8,uM,=,0.6812412373755872,1,O=C(CCCCCc1ncc2cccnn12)c1ccccc1
2580,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2c(C)ccnc21,"5-Ethyl-9,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.9,uM,=,0.2787536009528289,1,O=C1Nc2cccnc2Nc2ncccc21
2581,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1cn(-c2ccc3c(C)nc(CCCCCCC(=O)c4ccccc4)n3n2)cn1,"7-[5-Methyl-2-(4-methyl-imidazol-1-yl)-imidazo[1,5-b]pyridazin-7-yl]-1-phenyl-heptan-1-one",0.55,uM,=,-0.2596373105057561,0,O=C(CCCCCCc1ncc2ccc(-n3ccnc3)nn12)c1ccccc1
2582,911152,10.1007/s00044-009-9192-x,,,,Inhibition of wild type Human immunodeficiency virus 1 reverse transcriptase after 30 min by fluorescence microplate reader analysis,O=C(OCCN1C(=O)c2ccccc2C1=O)c1ccc(Cl)c(Cl)c1,"2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl 3,4-dichlorobenzoate",0.002,uM,=,-2.6989700043360187,0,O=C(OCCN1C(=O)c2ccccc2C1=O)c1ccccc1
2583,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CC(=O)N1C(=O)C(O)(C(F)(F)F)c2cc(Cl)ccc21,1-Acetyl-5-chloro-3-hydroxy-2-oxo-3-trifluoromethylindole,3.41,uM,=,0.5327543789924978,1,O=C1Cc2ccccc2N1
2584,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Cn1cccc1CC/N=C(\S)Nc1nccs1,1-[2-(1-Methyl-1H-pyrrol-2-yl)-ethyl]-3-thiazol-2-yl-thiourea,1.9,uM,=,0.2787536009528289,1,C(=NCCc1ccc[nH]1)Nc1nccs1
2585,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,COc1cc(Oc2cc(N)nc(Nc3ccc(C#N)cc3)n2)ccc1-c1ccc(C#N)cc1,"4'-((6-amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-2'-methoxy-[1,1'-biphenyl]-4-carbonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2586,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccccc2-c2ccccc2O)cc(=O)n(O)c1=O,"3-Hydroxy-6-((2'-hydroxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",11.0,uM,=,1.0413926851582251,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2587,195502,10.1016/s0960-894x(99)00460-6,,,,Inhibitory activity against recombinant HIV-1 reverse transcriptase (rRT),S=C(NCCC1=CCCCC1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-cyclohex-1-enyl-ethyl)-thiourea,0.4,uM,=,-0.3979400086720376,0,S=C(NCCC1=CCCCC1)Nc1ccccn1
2588,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCOCc2ccccc2)n2nc(Cl)ccc12,"7-(5-Benzyloxy-pentyl)-2-chloro-5-methyl-imidazo[1,5-b]pyridazine hydrochloride",2.3,uM,=,0.3617278360175928,1,c1ccc(COCCCCCc2ncc3cccnn23)cc1
2589,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,CCCN(C(=O)c1cc2cc([N+](=O)[O-])c(O)c(O)c2oc1=O)[C@@H]1CCc2nc(N)sc2C1,"(R)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-7,8-dihydroxy-6-nitro-2-oxo-N-propyl-2H-chromene-3-carboxamide",45.1,uM,=,1.6541765418779606,1,O=C(N[C@@H]1CCc2ncsc2C1)c1cc2ccccc2oc1=O
2590,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2ccc(-c3ccccc3O)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((2'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.49,uM,=,-0.3098039199714864,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2591,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc4ccccc4c3)cc2c1=O,"Ethyl 1-(4-Fluorobenzyl)-6-(naphthalen-2-ylmethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylate",19.6,uM,=,1.292256071356476,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc4ccccc4c3)cc12
2592,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CC(C)N1c2ncccc2NC(=O)c2cccnc21,"5-Isopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.59,uM,=,-0.2291479883578558,0,O=C1Nc2cccnc2Nc2ncccc21
2593,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,CC(C)c1ccc2c(c1)C(C#CC1CC1)(C(F)(F)F)OC(=O)N2,"4-Cyclopropylethynyl-6-isopropyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",1.958,uM,=,0.291812687467119,1,O=C1Nc2ccccc2C(C#CC2CC2)O1
2594,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),Cc1nc(=O)c(-c2ccccc2)c(C)n1-c1ccc(O)c(C(=O)O)c1,"5-(2,6-Dimethyl-4-oxo-5-phenyl-4H-pyrimidin-1-yl)-2-hydroxy-benzoic acid",73.0,uM,=,1.863322860120456,1,O=c1ncn(-c2ccccc2)cc1-c1ccccc1
2595,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2c(F)cccc2Cl)nc(SC(C)C)[nH]c1=O,"2-(2-chloro-6-fluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.074,uM,=,-1.1307682802690238,0,O=c1cc(Cc2ccccc2)nc[nH]1
2596,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(OC)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[(1R,2R)-2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-cyclopropyl]-urea",0.24,uM,=,-0.619788758288394,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
2597,722004,10.1128/aac.00800-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild-type Human immunodeficiency virus 1 subtype B reverse transcriptase by filter-based filtration assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",11.0,uM,=,1.0413926851582251,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2598,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccnc(C23SCCN2C(=O)c2cccnc23)c1,"9b-(4-Methyl-pyridin-2-yl)-2,3-dihydro-9bH-thiazolo[3',2':1,2]pyrrolo[3,4-b]pyridin-5-one",4.6,uM,=,0.6627578316815741,1,O=C1c2cccnc2C2(c3ccccn3)SCCN12
2599,1792973,10.1016/j.bmcl.2018.10.010,,,,Inhibition of recombinant wild-type HIV1 GST-fused reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.004,uM,=,-2.397940008672037,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2600,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-(2-(4-cyanophenylamino)-5-methylpyrimidin-4-ylamino)-3',5'-difluorobiphenyl-4-carbonitrile",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
2601,471453,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Nc1nc(=O)c2ncn([C@H]3C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C3)c2[nH]1,carbovir-triphosphate,0.9,uM,=,-0.0457574905606751,0,O=c1nc[nH]c2c1ncn2[C@H]1C=CCC1
2602,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1cc(Oc2ccc(C(=O)c3ccc(O)cc3)cc2)nc(Nc2ccc(C#N)cc2)n1,4-{6-Methyl-4-[4-(4-hydroxybenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,16.9,uM,=,1.2278867046136734,1,O=C(c1ccccc1)c1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1
2603,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc(Cl)c3Cl)cc2c1=O,"Ethyl 6-((2,3-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",24.0,uM,=,1.380211241711606,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
2604,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(Br)cc2)cs1,SID507649,14.9,uM,=,1.173186268412274,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2605,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.6,uM,=,0.2041199826559248,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2606,1504947,10.1016/j.bmc.2015.06.048,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin deoxyuridine triphosphate (biotin-dUTP) incorporation using poly(rA)/oligo (dT)16 template and primer by spectrofluorometry,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.807,uM,=,-0.0931264652779295,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2607,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,CS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3cccc(Cl)c3)s2)cc1,"2-[[5-[2-(3-Chlorophenyl)-4-oxo-thiazolidin-3-yl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-methylsulfonylphenyl)acetamide",15.75,uM,=,1.1972805581256194,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
2608,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(NC)nc21,"5-Ethyl-10-methyl-7-methylamino-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.71,uM,=,-0.1487416512809247,0,O=C1Nc2cccnc2Nc2ncccc21
2609,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-Ethyl-6-[4-[(phenylthio)methyl]phenyl]-6,7-dihydrobenzo[b]pyrrolo[1,2-d][1,4]oxazepin-7-one",0.06,uM,=,-1.2218487496163564,0,O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2)cc1
2610,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c12.[Na+].[Na+].[Na+],"8-Hexadecanoylamino-naphthalene-1,3,6-trisulfonic acid; trisodium salt",55.0,uM,=,1.740362689494244,1,c1ccc2ccccc2c1
2611,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#C/C=C/c1cc(Cl)cc(Oc2ccc(OS(=O)(=O)F)cc2OCCn2ccc(=O)[nH]c2=O)c1,"(E)-4-(3-chloro-5-(2-cyanovinyl)phenoxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.119,uM,=,-0.9244530386074692,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
2612,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",5.0,uM,=,0.6989700043360189,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2613,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-[5-(4-bromo-2-carboxyphenylcarbamoyl)pentylcarboxamido]benzoic acid,4.7,uM,=,0.6720978579357175,1,O=C(CCCCCC(=O)Nc1ccccc1)Nc1ccccc1
2614,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,O=C(CSC(=O)N1CCCc2cc(Cl)cc(Cl)c21)Nc1ccc(C(=O)NCc2ccccc2)cc1Cl,"S-2-(4-(benzylcarbamoyl)-2-chlorophenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.002,uM,=,-2.6989700043360187,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccc(C(=O)NCc2ccccc2)cc1
2615,1924017,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using A5'-end 32P-labeled 24-mer primer/a48-mer template preincubated for 5 mins followed by 10 uM nucleotides addition measured after 5 mins by gel-based primer extension assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccccc2)C1,"1-benzyl-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",0.96,uM,=,-0.0177287669604316,0,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
2616,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](n3cc(CNCc4cc5ccccc5oc4=O)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,"1-((2R,4S,5S)-5-(hydroxymethyl)-4-(4-(((2-oxo-2H-chromen-3-yl)methylamino)methyl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",5.59,uM,=,0.7474118078864233,1,O=c1ccn([C@H]2C[C@H](n3cc(CNCc4cc5ccccc5oc4=O)nn3)CO2)c(=O)[nH]1
2617,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3cccc(F)c3o2)c(O)nc1C,5-Ethyl-3-[2-(7-fluoro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridin-2-one,0.037,uM,=,-1.431798275933005,0,c1cncc(CCc2nc3ccccc3o2)c1
2618,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cc[nH]c3)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2ccc(-c3cc[nH]c3)nc2Nc2ncccc21
2619,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(Br)cc(C)c1Sc1ccnc(Nc2ccc(C#N)cc2)n1,"4-[4-(4-Bromo-2,6-dimethyl-phenylsulfanyl)-pyrimidin-2-ylamino]-benzonitrile",0.0057,uM,=,-2.2441251443275085,0,c1ccc(Nc2nccc(Sc3ccccc3)n2)cc1
2620,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)C#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(F)c(Cl)c21,"5-Chloro-6-fluoro-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.078,uM,=,-1.1079053973095196,0,O=C1NCc2ccccc2N1
2621,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCC1CC1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(cyclopropylmethyl)acetamide",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCC1CC1
2622,196795,10.1021/jm00058a009,,,,In vitro for inhibitory activity against HIV-1 Reverse Transcriptase,O=C1c2ccccc2[C@@]23CC=CCC12c1ccccc1C3=O,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",8.7,uM,=,0.9395192526186184,1,O=C1c2ccccc2[C@@]23CC=CCC12c1ccccc1C3=O
2623,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC1C(C)n2c(S)nc3cccc(c32)CN1CC1CC1,"7-Cyclopropylmethyl-8,9-dimethyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",13.4,uM,=,1.1271047983648077,1,c1cc2c3c(c1)ncn3CCN(CC1CC1)C2
2624,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(NCCCO)nc21,"5-Ethyl-7-(3-hydroxy-propylamino)-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncccc21
2625,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc(NC(=O)c2ccc(Br)o2)c(C(N)=O)c1C,"5-bromo-N-(3-carbamoyl-4,5-dimethylthiophen-2-yl)furan-2-carboxamide",1.7,uM,=,0.2304489213782739,1,O=C(Nc1cccs1)c1ccco1
2626,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",4.54,uM,=,0.6570558528571039,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2627,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.34,uM,=,0.1271047983648076,1,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
2628,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CN1C(=O)/C(=C/c2ccccc2Cl)SC1=S)Nc1cc([N+](=O)[O-])ccc1O,2-{5-[1-(2-Chloro-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-N-(2-hydroxy-5-nitro-phenyl)-acetamide,18.0,uM,=,1.255272505103306,1,O=C(CN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
2629,663847,10.1016/j.bmc.2010.08.031,,,,Inhibition of HIV1 DH012 reverse transcriptase by roche colorimetric assay,Cc1cc(=O)oc2c3c(ccc12)O[C@@H](C)[C@H](OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C)[C@@H]3OC(=O)[C@]12CC[C@](C)(C(=O)O1)C2(C)C,"(2'S,3'S,4'R)-2',4-Dimethyl-3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone",6.7,uM,=,0.8260748027008264,1,O=C1O[C@]2(C(=O)O[C@H]3COc4ccc5ccc(=O)oc5c4[C@H]3OC(=O)[C@@]34CCC(C3)C(=O)O4)CCC1C2
2630,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCc1nc(O)c(NCN2C(=O)c3ccccc3C2=O)cc1C,"2-[(6-Ethyl-5-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",0.887,uM,=,-0.0520763801682736,0,O=C1c2ccccc2C(=O)N1CNc1cccnc1
2631,306023,10.1016/j.bmcl.2004.12.072,,,,Inhibitory concentration against human immunodeficiency virus type 1 reverse transcriptase,C#C[C@]1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1O,"[(2R,3S,5R)-2-ethynyl-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl tetrahydrogen triphosphate",3.28,uM,=,0.5158738437116791,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2632,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3)ccc2C(=O)N1O,"6-(4-Fluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
2633,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(Cl)cccc3o2)c(O)nc1C,3-[(4-Chloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.15,uM,=,-0.8239087409443188,0,c1cncc(NCc2nc3ccccc3o2)c1
2634,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,CS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3ccccc3)s2)cc1,"N-(4-Methylsulfonylphenyl)-2-[[5-(4-oxo-2-phenyl-thiazolidin-3-yl)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide",40.64,uM,=,1.6089536992758628,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
2635,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,"6-((4'-Fluoro-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2636,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1,"(E)-6-[1-(4-Fluoro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",13.0,uM,=,1.1139433523068367,1,c1ccc(Cn2cccc2)cc1
2637,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(/C=C/c1ccc2c(c1)c(=O)c(C(=O)O)cn2Cc1ccc(F)cc1)c1ccccc1,"(E)-1-(4-Fluorobenzyl)-4-oxo-6-(3-oxo-3-phenylprop-1-en-1-yl)-1,4-dihydroquinoline-3 carboxylic Acid",5.9,uM,=,0.7708520116421442,1,O=C(/C=C/c1ccc2c(c1)c(=O)ccn2Cc1ccccc1)c1ccccc1
2638,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.31,uM,=,-0.5086383061657274,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2639,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)cc2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.0289999999999999,uM,=,-1.537602002101044,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2640,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC(=O)c1c(C)nc2c(c(C#N)cn2Cc2ccccc2)c1-c1ccc([N+](=O)[O-])cc1,"5-acetyl-1-benzyl-6-methyl-4-(4-nitrophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile",6.3,uM,=,0.7993405494535817,1,c1ccc(Cn2ccc3c(-c4ccccc4)ccnc32)cc1
2641,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,Nc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazol-4-ylamine",0.28,uM,=,-0.5528419686577808,0,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
2642,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SC/C=C/c2ccccc2)n1,6-Chloro-2-((E)-3-phenyl-allylsulfanyl)-pyrimidin-4-ylamine,0.07,uM,=,-1.154901959985743,0,C(=C/c1ccccc1)\CSc1ncccn1
2643,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(C(=O)OC)cc2N(C)C(=O)c2cccnc21,"11-Ethyl-6-methyl-5-oxo-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepine-8-carboxylic acid methyl ester",1.1,uM,=,0.041392685158225,1,O=C1Nc2ccccc2Nc2ncccc21
2644,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(F)c(CCc3ccccc3)[nH]c(=O)c2Cl)c1,"3-Chloro-5-(3-chloro-5-fluoro-2-oxo-6-phenethyl-1,2-dihydropyridin-4-yloxy)benzonitrile",0.007,uM,=,-2.154901959985743,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccc2)[nH]1
2645,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccc(C(F)(F)F)c3)SCCN12,"9b-(3-Trifluoromethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",1.05,uM,=,0.021189299069938,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2646,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc(C)c1CCC#N,"2-(2-Chloro-6-fluorophenyl)-3-(5-propanenitrile-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",2.01,uM,=,0.3031960574204888,1,O=C1CSC(c2ccccc2)N1c1ncccn1
2647,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c(-c3ccccn3)c2Cl)c1,4-(2-((4-Chloro-5-(pyridin-2-yl)-1H-pyrazol-3-yl)methylamino)pyridin-4-yl)-3-methylbenzonitrile,0.003,uM,=,-2.5228787452803374,0,c1ccc(-c2ccnc(NCc3cc(-c4ccccn4)[nH]n3)c2)cc1
2648,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),S=C(NCCC1=CCCCC1)Nc1nccs1,1-(2-Cyclohex-1-enyl-ethyl)-3-thiazol-2-yl-thiourea,0.9,uM,=,-0.0457574905606751,0,S=C(NCCC1=CCCCC1)Nc1nccs1
2649,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCOC(=O)CCCC=C(c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,"Ethyl 3',3''-Dimethyl-4',4''-dimethoxy-5',5''-bis(methoxy-carbonyl)-6,6-diphenylhexenoate",0.181,uM,=,-0.7423214251308154,0,C=C(c1ccccc1)c1ccccc1
2650,543620,10.1016/j.ejmech.2008.02.039,,,,Inhibition of HIV1 3B reverse transcriptase after 30 mins,O=C1CSC(c2c(Cl)cccc2Cl)N1CC12CC3CC(CC(C3)C1)C2,"3-Adamantan-1-ylmethyl-2-(2,6-dichlorophenyl)-thiazolidin-4-one",42.9,uM,=,1.6324572921847242,1,O=C1CSC(c2ccccc2)N1CC12CC3CC(CC(C3)C1)C2
2651,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(/C=C/C(N)=O)nc21,"(E)-3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-7-yl)-acrylamide",2.4,uM,=,0.380211241711606,1,O=C1Nc2cccnc2Nc2ncccc21
2652,750572,10.1016/j.bmc.2009.05.049,,,,Antiviral activity against HIV1 Reverse transcriptase activity,C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,lupenone,4.948505892968383,uM,=,0.6944740917844396,1,O=C1CCC2[C@@H](CCC3C4CCC5CCC[C@@H]5[C@H]4CC[C@@H]32)C1
2653,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1F,"6-[1-(2,4-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",19.0,uM,=,1.2787536009528289,1,c1ccc(Cn2cccc2)cc1
2654,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CS(=O)(=O)c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzenesulfonylmethyl-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",11.0,uM,=,1.0413926851582251,1,O=C1Nc2cccnc2Nc2ncc(CS(=O)(=O)c3ccccc3)cc21
2655,196519,10.1021/jm9607921,,,,Inhibitory effect on Moloney Murine Leukemia virus (mo-MuLv) recombinant Reverse transcriptase,O=C([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+],trisodium phosphonoformate,17.6,uM,=,1.24551266781415,1,
2656,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccc(O)c3)nc21,"5-Ethyl-7-(3-hydroxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
2657,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2cc(-c3ccc(Cl)cc3)ccc2c(=O)n1O,"7-(4-Chlorophenyl)-3-hydroxyquinazoline-2,4(1H,3H)-dione",0.2,uM,=,-0.6989700043360187,0,O=c1[nH]c(=O)c2ccc(-c3ccccc3)cc2[nH]1
2658,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1nc(Nc2ccc(-c3cnc4ccccc4c3)cc2)c2cccnc2n1O,"1-Hydroxy-4-(4-quinolin-3-yl-phenylamino)-1H-pyrido[2,3-d]pyrimidin-2-one",0.85,uM,=,-0.0705810742857072,0,O=c1nc(Nc2ccc(-c3cnc4ccccc4c3)cc2)c2cccnc2[nH]1
2659,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nn2cccc12,"5-((4-(4-Cyano-2,6-dimethylphenoxy)pyrrolo[2,1-f][1,2,4]triazin-2-yl)amino)picolinonitrile",0.0139999999999999,uM,=,-1.853871964321762,0,c1ccc(Oc2nc(Nc3cccnc3)nn3cccc23)cc1
2660,1862051,10.1016/j.ejmech.2019.111619,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H]3CCN(S(C)(=O)=O)C3)[nH]c3ccc(Cl)cc23)c1,"(S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(methylsulfonyl)pyrrolidin-3-yl)-1H-indole-2-carboxamide",0.61,uM,=,-0.2146701649892329,0,O=C(N[C@H]1CCNC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2661,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(OCC(=O)Nc3ccccc3Br)nc3ccccc32)c1,"N-(2-Bromophenyl)-2-((1-((3,5-dimethylphenyl)sulfonyl)-1Hbenzo[d]imidazol-2-yl)oxy)acetamide",15.74,uM,=,1.1970047280230458,1,O=C(COc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
2662,195688,10.1021/jm00042a004,,,,The 50% inhibitory concentration was measured as inhibition of Ribonuclease H activity of reverse transcriptase,CC(C)CCCC(C)C1CCC2C3CC=C4CC(OC(=O)Nc5cc(S(=O)(=O)O)cc6cc(S(=O)(=O)O)cc(O)c56)CC[C@]4(C)C3CC[C@]12C,"4-[(10R,13R)-17-(1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonylamino]-5-hydroxy-naphthalene-2,7-disulfonic acid",21.8,uM,=,1.3384564936046048,1,O=C(Nc1cccc2ccccc12)OC1CCC2C(=CCC3C4CCCC4CCC23)C1
2663,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(OC)c2)cc1,"(E)-3-(4-hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.146,uM,=,-0.835647144215563,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
2664,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),CCOc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccc(O)c(C(=O)O)c3)C2=O)cc1,5-(3-{5-[1-(4-Ethoxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid,17.0,uM,=,1.230448921378274,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
2665,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Cc1ccc(NC(=S)NCCc2ccccn2)nc1,1-(5-Methyl-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,0.05,uM,=,-1.3010299956639813,0,S=C(NCCc1ccccn1)Nc1ccccn1
2666,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)NCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,"4-(N-Methoxycarbonyl)amino-3',3''-dibromo-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",2.39,uM,=,0.3783979009481377,1,C=C(c1ccccc1)c1ccccc1
2667,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccncc2)cc1F,"4-((4-((2,6-Difluoro-4-(pyridin-4-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.012,uM,=,-1.9208187539523751,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
2668,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,CCN(CC)c1ccc(CN(C[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)cc1,"((S)-1-{N'-(4-Diethylamino-benzyl)-N'-[(2S,3S)-2-hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-hydrazinocarbonyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.041,uM,=,-1.3872161432802643,0,c1ccc(CCCCNCc2ccccc2)cc1
2669,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCN=[N+]=[N-])c2cc(Br)c(OC)c(C(=O)OC)c2)cc(Br)c1OC,"4-Azido-3',3''-dibromo-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene",94.0,uM,=,1.9731278535996988,1,C=C(c1ccccc1)c1ccccc1
2670,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cccc(CS(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-[(3-methylbenzyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",0.79,uM,=,-0.1023729087095585,0,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
2671,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2ccccc2Oc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",22.0,uM,=,1.3424226808222062,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
2672,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2c(Cl)ccc3[nH]c(=S)n(c23)C[C@@H]1C,"5-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",4.3,uM,=,0.6334684555795865,1,S=c1[nH]c2cccc3c2n1CCNC3
2673,534522,10.1016/j.bmc.2007.12.046,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,1.03,uM,=,0.0128372247051722,1,S=C(NCCc1ccccn1)Nc1ccccn1
2674,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(/C=C/C#N)cc(C)c1Nc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,"(E)-4-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenylamino)thieno[3,2-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.16,uM,=,-0.7958800173440752,0,c1ccc(CN2CCC(Nc3nc(Nc4ccccc4)c4sccc4n3)CC2)cc1
2675,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,Cc1ccc(C(=O)Nc2ccc3c(=O)n(O)c(=O)[nH]c3c2)cc1,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-4-methylbenzamide",2.74,uM,=,0.437750562820388,1,O=C(Nc1ccc2c(=O)[nH]c(=O)[nH]c2c1)c1ccccc1
2676,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CCC1OC(/C=C/C2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-((E)-2-cyclopropyl-vinyl)-3-ethyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.185,uM,=,-0.7328282715969863,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
2677,197432,10.1021/jm990236h,,,,Antiviral activity was evaluated by Reverse transcriptase activity in cells acutely infected with HIV-1,CCCCCCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"Octanoic acid [1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-amide",0.1,uM,=,-1.0,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
2678,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCCc2nc3ccccc3o2)c(O)nc1C,3-(3-Benzooxazol-2-yl-propyl)-5-ethyl-6-methyl-1H-pyridin-2-one,16.0,uM,=,1.2041199826559248,1,c1cncc(CCCc2nc3ccccc3o2)c1
2679,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(COc3ccccc3)cc(-c3cccc(OC)c3)nc21,"5-Ethyl-7-(3-methoxy-phenyl)-9-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.49,uM,=,-0.3098039199714864,0,O=C1Nc2c(COc3ccccc3)cc(-c3ccccc3)nc2Nc2ncccc21
2680,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,CC1=C(Cc2cc(OS(=O)(=O)[O-])ccc2OS(=O)(=O)[O-])[C@]2(C)CCC[C@@](C)(CC[C@@]3(O)[C@H](C)CC[C@@H]4OC(C)(C)CCC[C@@]43C)[C@H]2CC1.[Na+].[Na+],shaagrockol C,3.3,uM,=,0.5185139398778875,1,C1=C(Cc2ccccc2)C2CCCC(CCC3CCC[C@@H]4OCCCCC34)[C@H]2CC1
2681,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(/C=C(\O)c1nc[nH]n1)c1cccn1Cc1ccc(F)cc1,"1-(1-(4-Fluorobenzyl)-1H-pyrrol-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3-yl)prop-2-en-1-one",26.0,uM,=,1.414973347970818,1,O=C(C=Cc1nc[nH]n1)c1cccn1Cc1ccccc1
2682,508734,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA PPT primed substrate by scintillation proximity assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.9,uM,=,-0.0457574905606751,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2683,195367,10.1021/jm9607921,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase,CCCOn1c(Sc2cc(C)cc(C)c2)c(C(C)C)c(=O)[nH]c1=O,"6-(3,5-Dimethyl-phenylsulfanyl)-5-isopropyl-1-propoxy-1H-pyrimidine-2,4-dione",12.3,uM,=,1.089905111439398,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2684,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=C(Nc1ccc2[nH]c(=O)n(O)c(=O)c2c1)c1ccccc1F,"2-Fluoro-N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzamide",4.29,uM,=,0.6324572921847242,1,O=C(Nc1ccc2[nH]c(=O)[nH]c(=O)c2c1)c1ccccc1
2685,2034655,10.1016/j.bmc.2020.115927,,,,Inhibition of recombinant HIV-1 BH10 reverse transcriptase using D38/[32P]25PGA as template-primer incubated for 5 mins in presence of DTT followed by dTTP addition and measured after 15 to 30 sec by nucleotide incorporation assay,NC(=O)c1[nH]c2ccc(Br)cc2c1S(=O)(=O)N1CCCC1,5-bromo-3-(pyrrolidine-1-sulfonyl)-1H-indole-2-carboxylic acid amide,0.48,uM,=,-0.3187587626244128,0,O=S(=O)(c1c[nH]c2ccccc12)N1CCCC1
2686,195513,10.1021/jm9508088,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN1c2ncccc2-c2nccn2-c2ccc(N3CC=CCC3)nc21,"6-(3,6-Dihydro-2H-pyridin-1-yl)-8-ethyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",3.9,uM,=,0.5910646070264992,1,C1=CCN(c2ccc3c(n2)Nc2ncccc2-c2nccn2-3)CC1
2687,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccccc1C12SCCN1C(=O)c1ccccc12,"9b-o-Tolyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",6.3,uM,=,0.7993405494535817,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2688,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,Cc1c(O)nc(SCC(=O)c2ccc(Cl)cc2)nc1Cc1cccc2ccccc12,2-[2-(4-Chloro-phenyl)-2-oxo-ethylsulfanyl]-5-methyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.55,uM,=,-0.2596373105057561,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
2689,195062,10.1021/jm990383f,,,,In vitro ability to inhibit wild type resistant (WT) reverse transcriptase,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.8,uM,=,-0.0969100130080563,0,c1cncc(NCc2nc3ccccc3o2)c1
2690,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccncc3)CC2)nc2c1COC2,"3,5-Dimethyl-4-((2-((1-(pyridin-4-ylmethyl)piperidin-4-yl)-amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl)oxy)benzonitrile",0.056,uM,=,-1.2518119729937995,0,c1ccc(Oc2nc(NC3CCN(Cc4ccncc4)CC3)nc3c2COC3)cc1
2691,1501272,10.1016/j.bmc.2015.03.037,,,,Inhibition of wild-type HIV1 Reverse transcriptase p66/p51 assessed as relative fluorescence signal after 40 mins,CCn1cc(C(=O)O)c(=O)c2ccc(Oc3ccnc(Nc4ccc(C#N)cc4)n3)cc21,"7-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)oxy)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",7.15,uM,=,0.8543060418010806,1,O=c1cc[nH]c2cc(Oc3ccnc(Nc4ccccc4)n3)ccc12
2692,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc2nc(-c3ccc([N+](=O)[O-])cc3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4(3H)-one",0.85,uM,=,-0.0705810742857072,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
2693,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CC(C)c1ccc(C23SCCN2C(=O)c2ccccc23)cc1,"9b-(4-Isopropyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",10.0,uM,=,1.0,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2694,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(/C=C/C(=O)OC)nc21,"(E)-3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-7-yl)-acrylic acid methyl ester",0.18,uM,=,-0.744727494896694,0,O=C1Nc2cccnc2Nc2ncccc21
2695,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc(NC(=O)c2ccco2)c(C(N)=O)c1C,"N-[3-(aminocarbonyl)-4,5-dimethyl-2-thienyl]-2-furancarboxamide",3.4,uM,=,0.5314789170422551,1,O=C(Nc1cccs1)c1ccco1
2696,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,(S)-1-(3-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-oxopropylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,227.0,uM,=,2.3560258571931225,1,O=C(CCNC(=O)CCc1c[nH]c2ccccc12)NCCc1c[nH]c2ccccc12
2697,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3ccc(F)cc3o2)c(O)nc1C,5-Ethyl-3-[(6-fluoro-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,1.25,uM,=,0.0969100130080564,1,c1cncc(NCc2nc3ccccc3o2)c1
2698,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(OC)c(CCNC(=S)Nc2ccc(Cl)cn2)c1F,1-(5-Chloro-pyridin-2-yl)-3-[2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-ethyl]-thiourea,0.005,uM,=,-2.3010299956639813,0,S=C(NCCc1ccccc1)Nc1ccccn1
2699,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,CC(C)c1nc(COC(N)=O)n(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1,"Carbamic acid 5-(3,5-dichloro-phenylsulfanyl)-4-isopropyl-1-pyridin-4-ylmethyl-1H-imidazol-2-ylmethyl ester",0.047,uM,=,-1.3279021420642825,0,c1ccc(Sc2cncn2Cc2ccncc2)cc1
2700,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccccc2Br)nc(SC(C)C)[nH]c1=O,"2-(2-bromophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.198,uM,=,-0.7033348097384688,0,O=c1cc(Cc2ccccc2)nc[nH]1
2701,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1cccc(F)c1F)CC(=O)C(=O)O,"6-[1-(2,3-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",6.0,uM,=,0.7781512503836436,1,c1ccc(Cn2cccc2)cc1
2702,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(C(N)=O)cc2Cl)c(C)c1,3-chloro-4-(2-(1-mesityl-1H-tetrazol-5-ylthio)acetamido)benzamide,0.003,uM,=,-2.5228787452803374,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
2703,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccccc2)n1,6-Benzyl-2-sec-butylsulfanyl-3H-pyrimidin-4-one,2.7,uM,=,0.4313637641589873,1,c1ccc(Cc2ccncn2)cc1
2704,305327,10.1021/jm049252r,,,,Inhibitory concentration against HIV-1 virion reverse transcriptase,O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccccc1,"Phenyl-thiocarbamic acid 2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl ester",0.6,uM,=,-0.2218487496163563,0,O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccccc1
2705,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1ncnc2c1ncn2C1C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)COC2C=CC(n3cnc4c(N)ncnc43)C2)C1,"P,P'-Bis {[4-(adenine-9-yl)cyclopent-2-enyl]oxy-methylphosphonyl}diphosphate",2.0,uM,=,0.3010299956639812,1,O=[PH](COC1C=CC(n2cnc3cncnc32)C1)O[PH](=O)O[PH](=O)O[PH](=O)COC1C=CC(n2cnc3cncnc32)C1
2706,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])c(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-methyl-1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
2707,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1ccc([N+](=O)[O-])cc1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(4-nitrobenzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,6.9,uM,=,0.8388490907372553,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
2708,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(COCc3ccncc3)c[nH]c(=O)c2Br)c1,"3-(3-Bromo-2-oxo-5-((pyridin-4-ylmethoxy)methyl)-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.021,uM,=,-1.6777807052660807,0,O=c1cc(Oc2ccccc2)c(COCc2ccncc2)c[nH]1
2709,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,O=[N+]([O-])c1ccccc1CCNC(=S)Nc1nccs1,1-[2-(2-Nitro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.15,uM,=,-0.8239087409443188,0,S=C(NCCc1ccccc1)Nc1nccs1
2710,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)c3ccccc3)[nH]c3ccc(Cl)cc23)c1,"(S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-phenylethyl)-1H-indole-2-carboxamide",0.05,uM,=,-1.3010299956639813,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2711,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1,3-(3-{4-Oxo-2-thioxo-5-[1-p-tolyl-meth-(Z)-ylidene]-thiazolidin-3-yl}-propionylamino)-benzoic acid,100.0,uM,=,2.0,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
2712,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,Cc1cc(NCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[(5,6-Dimethyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",0.218,uM,=,-0.6615435063953952,0,O=C1c2ccccc2C(=O)N1CNc1cccnc1
2713,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cn1c(Nc2cccc(-c3ccc(O)cc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",12.0,uM,=,1.0791812460476249,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2714,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCOC(C#CC1CC1)(c1cc(CC)c(C)nc1O)C(F)(F)F,3-(3-Cyclopropyl-1-ethoxy-1-trifluoromethyl-prop-2-ynyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.183,uM,=,-0.7375489102695706,0,C(#CC1CC1)Cc1cccnc1
2715,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2cc(Cl)c(N)nc21,"7-Amino-8-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.85,uM,=,-0.0705810742857072,0,O=C1Nc2cccnc2Nc2ncccc21
2716,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(NN1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S)c1ccccc1O,N-{5-[1-(4-Bromo-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-2-hydroxy-benzamide,27.0,uM,=,1.4313637641589874,1,O=C(NN1C(=O)/C(=C/c2ccccc2)SC1=S)c1ccccc1
2717,195504,10.1021/jm001095i,,,,Inhibitory activity against wild-type HIV-1 reverse transcriptase,Nc1nc2c(ncn2[C@H]2CC[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1,"2-Amino-9-(5-methyloxy-triphosphate-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one (ddGTP)",0.8553957012246944,uM,=,-0.0678329366126251,0,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
2718,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,NS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3ccccc3)s2)cc1,"2-[[5-(4-Oxo-2-phenyl-thiazolidin-3-yl)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-sulfamoylphenyl)acetamide",30.56,uM,=,1.4851533499036522,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
2719,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CCC1(OC)CC(n2c(=O)nc(-c3ccc(NC)nc3)c3oc4ncc(-c5cnn(C)c5)cc4c32)C1,"1-(3-Ethyl-3-methoxy-cyclobutyl)-4-(6-methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0055,uM,=,-2.2596373105057563,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1C1CCC1
2720,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",1.7,uM,=,0.2304489213782739,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2721,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",3.2,uM,=,0.505149978319906,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2722,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(CSc3c(Cl)cccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-Ethyl-6-[4-[(2,6-dichlorophenylthio)methyl]phenyl]-6,7-dihydrobenzo[b]pyrrolo[1,2-d][1,4]oxazepin-7-one",7.36,uM,=,0.8668778143374989,1,O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2)cc1
2723,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,Br.NC(=O)c1sc(N)nc1-c1cccc(C(=O)c2ccccc2)c1,2-amino-4-(3-benzoylphenyl)thiazole-5-carboxamide hydrobromide,44.1,uM,=,1.6444385894678386,1,O=C(c1ccccc1)c1cccc(-c2cscn2)c1
2724,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCC(N)=O)[nH]c3ccc([N+](=O)[O-])cc23)c1,"N-(3-Amino-3-oxopropyl)-3-[(3,5-dimethylphenyl)sulfonyl]-5-nitro-1H-indole-2-carboxamide",0.027,uM,=,-1.5686362358410126,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
2725,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(C#N)cc4)cc3Cl)c2=O)n[nH]c1=O,"3'-chloro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",6.73,uM,=,0.8280150642239769,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2726,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,"9-(5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one",5.37,uM,=,0.7299742856995556,1,O=c1[nH]cnc2c1ncn2[C@H]1CCCO1
2727,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1ccccc1Cl,1-{2-[(2-Chloro-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole,0.6,uM,=,-0.2218487496163563,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
2728,1763334,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 3B reverse transcriptase using polyC/oligo(dG12) as template/primer in presence of [3H]dGTP and calf thymus DNA after 30 mins,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCOP(=O)(O)C(=O)OCc2ccccc2)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[(3-[[[(benzyloxycarbonyl)hydroxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",3.7,uM,=,0.568201724066995,1,O=C(OCc1ccccc1)[PH](=O)OCCCn1c(=O)ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c1=O
2729,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Oc1cc(Cc2ccccc2)nc(SC2CCCCC2)n1,6-Benzyl-2-cyclohexylsulfanyl-3H-pyrimidin-4-one,3.0,uM,=,0.4771212547196624,1,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
2730,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),Cc1cc(Cl)nc2c1NC(=O)c1cccnc1N2C1CC1,"7-Chloro-5-cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.78,uM,=,-0.1079053973095195,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2731,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc(C)c1C,"2-(2-chloro-6-fluorophenyl)-3-(4,5,6-trimethylpyrimidin-2-yl)thiazolidin-4-one",0.38,uM,=,-0.4202164033831898,0,O=C1CSC(c2ccccc2)N1c1ncccn1
2732,1769209,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 RNase H preincubated for 10 mins followed by PBS-22dpol/radiolabeled PBS-14r8d addition measured after 5 mins,COc1ccc(-c2cc3c(NCc4nc(O)c(O)c(C(=O)O)n4)ncnc3nc2SC)cc1,"5,6-Dihydroxy-2-(((6-(4-methoxyphenyl)-7-(methylthio)pyrido[2,3-d]pyrimidin-4-yl)amino)methyl)pyrimidine-4-carboxylic acid",2.0,uM,=,0.3010299956639812,1,c1ccc(-c2cnc3ncnc(NCc4ncccn4)c3c2)cc1
2733,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3cc(C#N)cc(C#N)c3)c21,"5-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yloxy)isophthalonitrile",0.063,uM,=,-1.2006594505464183,0,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
2734,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CSc1nc(O)c(C)c(Cc2ccccc2)n1,6-Benzyl-5-methyl-2-methylsulfanyl-3H-pyrimidin-4-one,4.9,uM,=,0.6901960800285137,1,c1ccc(Cc2ccncn2)cc1
2735,718271,10.1021/jm101052g,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(C(F)(F)F)c1,2-[4-Chloro-2-(3-fluoro-5-trifluoromethyl-benzoyl)-phenoxy]-N-(2-methyl-4-sulfamoyl-phenyl)-acetamide,0.0014,uM,=,-2.853871964321762,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
2736,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3cccc(F)c3o2)c(S)nc1C,5-Ethyl-3-[2-(7-fluoro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridine-2-thione,0.043,uM,=,-1.3665315444204136,0,c1cncc(CCc2nc3ccccc3o2)c1
2737,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C=O)cc(C)c1Oc1nc(Nc2ccc(C#N)cn2)nc2c1CCCC2,"6-((4-(4-Formyl-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)nicotinonitrile",0.0579999999999999,uM,=,-1.2365720064370629,0,c1ccc(Oc2nc(Nc3ccccn3)nc3c2CCCC3)cc1
2738,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(S(C)(=O)=O)cc3)nc3ccccc32)c1,"2-{[1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl]sulfanyl}-N-[4-(methylsulfonyl)phenyl]acetamide",0.047,uM,=,-1.3279021420642825,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
2739,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,O=C1Cc2ccccc2C(=O)N1O,"2-Hydroxy-4H-isoquinoline-1,3-dione",0.86,uM,=,-0.0655015487564322,0,O=C1Cc2ccccc2C(=O)N1
2740,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccco1)Nc1nccs1,1-(2-Furan-2-yl-ethyl)-3-thiazol-2-yl-thiourea,0.65,uM,=,-0.1870866433571444,0,S=C(NCCc1ccco1)Nc1nccs1
2741,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CN(c1ncccc1CO)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Hydroxymethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,7.0,uM,=,0.8450980400142568,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2742,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,CCOCSc1nc(Cc2ccccc2)c(C)c(=O)[nH]1,6-Benzyl-2-(ethoxymethylthio)-5-methyl pyrimidin-4(3H)-one,51.66,uM,=,1.7131544018372984,1,O=c1cc(Cc2ccccc2)nc[nH]1
2743,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccn1)Nc1nccs1,1-(2-Pyridin-2-yl-ethyl)-3-thiazol-2-yl-thiourea,0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccn1)Nc1nccs1
2744,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCc1c(C(=O)c2ccccc2)n(COCc2ccccc2)c(=O)n(O)c1=O,"6-Benzoyl-1-(benzyloxymethyl)-5-ethyl-3-hydroxypyrimidine-2,4(1H,3H)-dione",14.0,uM,=,1.146128035678238,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1COCc1ccccc1
2745,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1CCS[C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)N12,"(6S,7R,8S,9S,9aS)-7,8,9-trihydroxy-6-(hydroxymethyl)hexahydro-4H,6H-pyrido[2,1-b][1,3]thiazin-4-one",12.88,uM,=,1.1099158630237933,1,O=C1CCS[C@H]2CCCCN12
2746,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1cc(Cl)cc(Oc2ccc(OS(=O)(=O)F)cc2Cl)c1,5-(3-Chloro-5-cyanophenoxy)-3-methoxyphenyl sulfurofluoridate,4.9,uM,=,0.6901960800285137,1,c1ccc(Oc2ccccc2)cc1
2747,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,Cc1sc(NC(=O)C2CCCO2)c(C(N)=O)c1C,SID14728143,27.3,uM,=,1.436162647040756,1,O=C(Nc1cccs1)C1CCCO1
2748,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,C=CCC1(c2ccccc2)Sc2ccccc2-n2cccc2C1=O,"6-allyl-6-phenylbenzo[b]pyrrolo[1,2-d][1,4]thiazepin-7(6H)-one",0.71,uM,=,-0.1487416512809247,0,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
2749,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCCc2nnc(C)o2)c2cc(C)c3oc(=O)n(C)c3c2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]-oxazol-5-yl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-2-methoxy-3-methylbenzothioate",36.0,uM,=,1.5563025007672873,1,O=c1[nH]c2cc(/C(=C\CCCc3nnco3)c3ccccc3)ccc2o1
2750,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccccc1C,"6-[1-(2-Methylphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",3.0,uM,=,0.4771212547196624,1,c1ccc(Cn2cccc2)cc1
2751,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ncc[nH]3)nc21,"5-Ethyl-7-(1H-imidazol-2-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2ccc(-c3ncc[nH]3)nc2Nc2ncccc21
2752,195839,10.1021/jm00023a007,,,,Inhibition of HIV-1 reverse transcriptase (RT),CCOC(=O)c1c(O)nc(C)c(CC)c1Sc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-phenylsulfanyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid ethyl ester",0.6,uM,=,-0.2218487496163563,0,c1ccc(Sc2ccncc2)cc1
2753,195502,10.1016/s0960-894x(99)00460-6,,,,Inhibitory activity against recombinant HIV-1 reverse transcriptase (rRT),S=C(NCCC1=CCCCC1)Nc1ccc(Cl)cn1,1-(5-Chloro-pyridin-2-yl)-3-cyclohex-1-enylmethyl-thiourea,0.5,uM,=,-0.3010299956639812,0,S=C(NCCC1=CCCCC1)Nc1ccccn1
2754,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCOC(=O)c1csc(NC(=S)NCCc2ccccc2)n1,2-(3-Phenethyl-thioureido)-thiazole-4-carboxylic acid ethyl ester,0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccc1)Nc1nccs1
2755,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCOCn1c(Cc2ccc(-c3ccc(Cl)c(F)c3)cc2)cc(=O)n(O)c1=O,"6-((4'-chloro-3'-fluoro-[1,1'-biphenyl]-4-yl)methyl)-1-(ethoxymethyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.43,uM,=,-0.3665315444204134,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2756,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",12.0,uM,=,1.0791812460476249,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2757,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1,SID507704,71.6,uM,=,1.854913022307856,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
2758,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2ccccc2)C(F)(F)F)c(O)nc1C,3-(1-Benzyloxy-3-cyclopropyl-1-trifluoromethyl-prop-2-ynyl)-5-ethyl-6-methyl-1H-pyridin-2-one,1.348,uM,=,0.129689892199301,1,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
2759,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(N)=O)[nH]c3ccc(Cl)cc23)c1,"(R)-N-(1-amino-1-oxopropan-2-yl)-5-chloro-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.017,uM,=,-1.769551078621726,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
2760,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCN(S(N)(=O)=O)CC3)cc2)nc2sccc12,"(E)-4-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[2,3-d]pyrimidin-2-yl)amino)phenyl)piperazine-1-sulfonamide",0.713,uM,=,-0.1469104701481344,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3sccc23)cc1
2761,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccccc3)nc21,"5-Ethyl-10-methyl-7-phenyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
2762,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc(O)c3ccccc3n2)c(O)nc1C,"2-[(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-3H-quinazolin-4-one",2.5,uM,=,0.3979400086720376,1,c1cncc(NCc2ncc3ccccc3n2)c1
2763,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-[5-(4-bromo-2-carboxyphenylcarbamoyl)pentylcarboxamido]benzoic acid,3.8,uM,=,0.5797835966168101,1,O=C(CCCCCC(=O)Nc1ccccc1)Nc1ccccc1
2764,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccccc1O,2-hydroxy-N'-((5-nitrothiophen-2-yl)methylene)benzohydrazide,84.0,uM,=,1.9242792860618816,1,O=C(N/N=C/c1cccs1)c1ccccc1
2765,195359,10.1016/0960-894X(94)00478-X,,,,Inhibitory activity against HIV-1 Reverse transcriptase (RT) was determined,CCN1c2cnccc2N(C)C(=O)c2cccnc21,"5-Ethyl-11-methyl-5,11-dihydro-3,5,6,11-tetraaza-dibenzo[a,d]cyclohepten-10-one",0.35,uM,=,-0.4559319556497244,0,O=C1Nc2ccncc2Nc2ncccc21
2766,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1,1beta-hydroxymaprounic acid,4.9,uM,=,0.6901960800285137,1,C1=C2C(CC[C@H]3C2CC[C@H]2CCCCC23)[C@@H]2CCCCC2C1
2767,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(F)cc1C(=O)c1ccccc1)Nc1ccccc1,2-(2-Benzoyl-4-fluoro-phenoxy)-N-phenyl-acetamide,0.0085932450629072,uM,=,-2.0658428027832523,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
2768,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cccc(-c2cc(C)c(Oc3cc(N)nc(Nc4ccc(C#N)cc4)n3)c(C)c2)c1,"4-((4-Amino-6-((3,3',5-trimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.152,uM,=,-0.8181564120552275,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2769,545152,10.1021/np50073a012,,,,Inhibition of HIV1 RT using poly A oligo(dT) template primer,COc1cc2c(ccc3c4cc(OC)c(OC)cc4c[n+](C)c23)cc1O.[Cl-],"2-Hydroxy-3,8,9-trimethoxy-5-methyl-benzo[c]phenanthridinium chloride",25.966736011856547,uM,=,1.4144173627549468,1,c1ccc2c(c1)c[nH+]c1c3ccccc3ccc21
2770,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(N)C3)cc2)nc2sccc12,"(E)-3-(4-((2-((4-(3-aminopiperidin-1-yl)phenyl)amino)thieno[2,3-d]pyrimidin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile",0.956,uM,=,-0.0195421077238999,0,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3sccc23)cc1
2771,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cn1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",3.3,uM,=,0.5185139398778875,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2772,508733,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA/DNAM duplex primed substrate by scintillation proximity assay,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.23,uM,=,-0.6382721639824072,0,c1cncc(NCc2nc3ccccc3o2)c1
2773,427350,10.1128/aac.00749-06,,,,Inhibition of reverse transcriptase activity in HIV1 NL4-3 infected MT4 cells after dialysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",12.0,uM,=,1.0791812460476249,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2774,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(Br)ccc21,"7-Bromo-5-cyclopropyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2775,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(OCC(=O)N(Cc1ccccc1)CC1CCCO1)c1ccc([N+](=O)[O-])o1,2-(benzyl((tetrahydrofuran-2-yl)methyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,7.7,uM,=,0.8864907251724818,1,O=C(OCC(=O)N(Cc1ccccc1)CC1CCCO1)c1ccco1
2776,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1nc(O)c(CCc2nc3ccccc3o2)cc1C(N)=O,"5-(2-Benzooxazol-2-yl-ethyl)-2-methyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid amide",41.5,uM,=,1.6180480967120927,1,c1cncc(CCc2nc3ccccc3o2)c1
2777,503078,10.1021/np960399y,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51,C[C@H]1[C@H](C)Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2[C@H]1O)OC(C)(C)C=C3,Soulattrolide,0.73,uM,=,-0.1366771398795441,0,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
2778,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)cc2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3',5'-dimethyl-[1,1'-biphenyl]-4-carbonitrile",0.037,uM,=,-1.431798275933005,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2779,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(-c2cccc(C#N)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"3'-methyl-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",4.73,uM,=,0.6748611407378116,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2780,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCOc1cccc(CCNC(=S)Nc2nccs2)c1,1-[2-(3-Ethoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.06,uM,=,-1.2218487496163564,0,S=C(NCCc1ccccc1)Nc1nccs1
2781,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-c2ncoc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(4-(2-chloro-4-methylphenyl)oxazol-5-ylthio)acetamido)biphenyl-4-yl)acetic acid,0.365,uM,=,-0.4377071355435253,0,O=C(CSc1ocnc1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
2782,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2F)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((2'-fluoro-3-methyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.045,uM,=,-1.3467874862246565,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2783,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1cccc(CSc2nc(Cc3ccccc3)c(I)c(=O)[nH]2)c1,6-Benzyl-5-iodo-2-(3-methylbenzylthio)pyrimidin-4(3H)-one,3.03,uM,=,0.481442628502305,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
2784,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc(C)ccc2OC)c(O)nc1C,5-Ethyl-3-(2-methoxy-5-methyl-benzylamino)-6-methyl-1H-pyridin-2-one,0.023,uM,=,-1.6382721639824072,0,c1ccc(CNc2cccnc2)cc1
2785,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccccc2N(C)C(=O)c2cccnc21,"11-Ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.35,uM,=,-0.4559319556497244,0,O=C1Nc2ccccc2Nc2ncccc21
2786,1565176,10.1016/j.bmcl.2016.02.049,,,,Inhibition of HIV1 reverse transcriptase using DIG-labeled dNTPs as substrate after 1 hr by ELISA,C[C@H]1C(=O)N2C[C@@H](O)[C@@H](O)[C@@H]2[C@H]2Sc3ccccc3C(=O)N21,"(1S,2R,6S,13aR,13bR)-1,2-dihydroxy-6-methyl-1,2,3,13b-tetrahydrobenzo[e]pyrrolo[2',1':3,4]pyrazino[2,1-b][1,3]thiazine-5,8(6H,13aH)-dione",4.21,uM,=,0.6242820958356683,1,O=C1CN2C(=O)c3ccccc3S[C@@H]2[C@H]2CCCN12
2787,196377,10.1021/jm0309856,,,,Inhibitory concentration required to inhibit the HIV-1 reverse transcriptase activity,CC(c1cc(=O)[nH]c(SC2CCCC2)n1)c1c(F)cccc1F,"2-Cyclopentylsulfanyl-6-[1-(2,6-difluoro-phenyl)-ethyl]-3H-pyrimidin-4-one",0.03,uM,=,-1.5228787452803376,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
2788,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OCCc1ccc(O)cc1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 2-(4-hydroxy-phenyl)-ethyl ester",4.5,uM,=,0.6532125137753437,1,O=C(OCCc1ccccc1)c1ccccc1
2789,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,COc1ccc(NC(=O)COc2ccnc(Nc3ccc(C#N)cc3)n2)cc1,2-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)oxy)-N-(4-methoxyphenyl)acetamide,24.63,uM,=,1.3914644118391033,1,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
2790,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccccn2)nc(SC(C)C)[nH]c1=O,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(pyridin-2-yl)acetonitrile",9.397,uM,=,0.9729892268553488,1,O=c1cc(Cc2ccccn2)nc[nH]1
2791,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4cccnc34)ccc2Cl)c1,"3-Chloro-5-[2-chloro-5-(1H-pyrazolo[4,3-b]pyridine-3-yl-methoxy)phenoxy]benzonitrile",0.0036,uM,=,-2.4436974992327127,0,c1ccc(Oc2cccc(OCc3n[nH]c4cccnc34)c2)cc1
2792,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccccc1-c1cccc(Oc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",13.0,uM,=,1.1139433523068367,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2793,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])c(C(F)(F)F)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(1-oxy-2-trifluoromethyl-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
2794,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,CCOC(=O)c1cccn1S(=O)(=O)c1cc(C)ccc1[N+](=O)[O-],1-(5-Methyl-2-nitro-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid ethyl ester,5.0,uM,=,0.6989700043360189,1,O=S(=O)(c1ccccc1)n1cccc1
2795,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccc3ccccc3n2)c(O)nc1C,5-Ethyl-6-methyl-3-[(quinolin-2-ylmethyl)-amino]-1H-pyridin-2-one,0.53,uM,=,-0.2757241303992109,0,c1cncc(NCc2ccc3ccccc3n2)c1
2796,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(C)ccc(C)c3o2)c(S)nc1C,"3-[2-(4,7-Dimethyl-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridine-2-thione",0.052,uM,=,-1.2839966563652008,0,c1cncc(CCc2nc3ccccc3o2)c1
2797,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,COc1ccc(CNC(=O)c2c(O)c(=O)[nH]c3c(F)cccc23)cc1,N-(4-Methoxybenzyl)-8-fluoro-3-hydroxy-2-oxoquinoline-4-carboxamide,74.0,uM,=,1.869231719730976,1,O=C(NCc1ccccc1)c1cc(=O)[nH]c2ccccc12
2798,442660,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rA.dT template,Cc1cc(C)nc(N2C(=O)CSC2C23CC4CC(CC(C4)C2)C3)c1,"2-adamantan-1-yl-3-(4,6-dimethyl-pyridin-2-yl)-thiazolidin-4-one",38.0,uM,=,1.57978359661681,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
2799,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,"6-(biphenyl-4-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",2.0,uM,=,0.3010299956639812,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2800,196377,10.1021/jm0309856,,,,Inhibitory concentration required to inhibit the HIV-1 reverse transcriptase activity,Cc1c(Cc2c(F)cccc2F)nc(NC2CCCC2)[nH]c1=O,"2-Cyclopentylamino-6-(2,6-difluoro-benzyl)-5-methyl-3H-pyrimidin-4-one",0.03,uM,=,-1.5228787452803376,0,O=c1cc(Cc2ccccc2)nc(NC2CCCC2)[nH]1
2801,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1O,"6-(4-Cyclopropylbenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.8,uM,=,-0.0969100130080563,0,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1
2802,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,COc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"5-Cyclopropyl-9-(4-methoxy-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.04,uM,=,0.0170333392987803,1,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
2803,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccccc2)c(O)nc1C,3-Benzylamino-5-ethyl-6-methyl-1H-pyridin-2-one,5.33,uM,=,0.7267272090265723,1,c1ccc(CNc2cccnc2)cc1
2804,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3cncn3)ccc12,"7-(5-Methyl-2-[1,2,4]triazol-1-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.1,uM,=,-1.0,0,O=C(CCCCCCc1ncc2ccc(-n3cncn3)nn12)c1ccccc1
2805,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1OC,"6-((3',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",0.5,uM,=,-0.3010299956639812,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2806,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),Cc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)C2=O)cc1,3-{4-Oxo-2-thioxo-5-[1-p-tolyl-meth-(Z)-ylidene]-thiazolidin-3-yl}-N-[4-(thiazol-2-ylsulfamoyl)-phenyl]-propionamide,44.0,uM,=,1.6434526764861874,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1
2807,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3ccccc3C)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-methylphenethyl)-1H-indole-2-carboxamide",0.288,uM,=,-0.5406075122407692,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
2808,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(Cl)cc2Cl)c2ccccc2c1=O,"4-[1-(2,4-Dichlorophenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid",44.7,uM,=,1.6503075231319366,1,O=c1ccn(Cc2ccccc2)c2ccccc12
2809,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.0013,uM,=,-2.886056647693163,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2810,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2cc3c(C#N)cn(Cc4ccccc4)c3nc2C1,"1-benzyl-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",12.0,uM,=,1.0791812460476249,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)cc21
2811,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2c(Cl)cccc2Cl)n1,"2-sec-Butylsulfanyl-6-(2,6-dichloro-benzyl)-5-methyl-3H-pyrimidin-4-one",0.06,uM,=,-1.2218487496163564,0,c1ccc(Cc2ccncn2)cc1
2812,2300485,10.1016/j.ejmech.2017.02.031,,,,Inhibition of HIV-1 reverse transcriptase,Cc1ccc(C)c(/C=C2\SC(=O)N(CCC(=O)Nc3ccccc3O)C2=O)c1,"3-(5-(2,5-dimethylbenzylidene)-2,4-dioxothiazolidin-3-yl)-N-(2-hydroxyphenyl)propanamide",1.31,uM,=,0.1172712956557642,1,O=C(CCN1C(=O)S/C(=C\c2ccccc2)C1=O)Nc1ccccc1
2813,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),COC(=O)c1cccc(CSc2nc(N)cc(Cl)n2)c1,3-(4-Amino-6-chloro-pyrimidin-2-ylsulfanylmethyl)-benzoic acid methyl ester,0.23,uM,=,-0.6382721639824072,0,c1ccc(CSc2ncccn2)cc1
2814,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cn1cc(-c2cnc3oc4c(-c5ccc(=O)[nH]c5)nc(=O)n(CCC5CCCO5)c4c3c2)cn1,"8-(1-Methyl-1H-pyrazol-4-yl)-4-(6-oxo-1,6-dihydro-pyridin-3-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.041,uM,=,-1.3872161432802643,0,O=c1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cn[nH]c4)cc23)c[nH]1
2815,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),S=C(NCCOc1ccccc1)Nc1nccs1,1-(2-Phenoxy-ethyl)-3-thiazol-2-yl-thiourea,4.4,uM,=,0.6434526764861874,1,S=C(NCCOc1ccccc1)Nc1nccs1
2816,439842,10.1021/jm070236e,,,,Inhibition of HIV1 recombinant reverse transcriptase,CO/N=C(\Br)CCC/C=C(\c1cc(C)c(OC)c(/C(Br)=N/OC)c1)c1cc(C)c2oc(=O)n(C)c2c1,"5-((1(E/Z),6Z)-6-bromo-1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-6-(methoxyimino)hex-1-enyl)-N,2-demethoxy-3-methylbenzimidoyl bromide",0.85,uM,=,-0.0705810742857072,0,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
2817,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cn2)[nH]1)c1nc(CO)cs1,(S)-N-(2-Amino-1-(4-(hydroxymethyl)thiazol-2-yl)ethyl)-5-(5-(trifluoromethyl)pyridin-2-yl)-1H-pyrrole-2-carboxamide,2.8,uM,=,0.4471580313422192,1,O=C(NCc1nccs1)c1ccc(-c2ccccn2)[nH]1
2818,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,C=CCOCc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"9-Allyloxymethyl-5-cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.41,uM,=,0.1492191126553798,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2819,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2cc(O)nc(SC3CCCC3)n2)c1,2-Cyclopentylsulfanyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,2.6,uM,=,0.414973347970818,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
2820,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(Cl)c1Oc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,3-(4-(4-(2-chloro-4-cyano-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.008,uM,=,-2.096910013008056,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2821,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc([N+](=O)[O-])cc2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(4-nitrophenyl)acetamide",0.053,uM,=,-1.275724130399211,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
2822,630077,10.1016/j.bmcl.2009.04.051,,,,Inhibition of biotin-dUTP labeled HIV-1 reverse transcriptase after 30 mins colorimetric streptavidin alkaline phosphatase reporter system,Nc1cc(Cc2ccccc2)nc(SCc2ccc3ccccc3c2)n1,6-benzyl-2-(naphthalen-2-ylmethylthio)pyrimidin-4-amine,17.14,uM,=,1.2340108175871791,1,c1ccc(Cc2ccnc(SCc3ccc4ccccc4c3)n2)cc1
2823,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCc3cccc4ccccc34)cc2)n[nH]1,Ethyl 3-(1-(4-fluorobenzyl)-4-(4-(naphthalen-1-ylmethoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,5.5,uM,=,0.7403626894942439,1,c1ccc(Cn2cc(-c3ccc(OCc4cccc5ccccc45)cc3)c(-c3cc[nH]n3)c2)cc1
2824,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CCCN1Cc2cccc3[nH]c(=S)n(c23)CC1C,"8-Methyl-7-propyl-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",1.67,uM,=,0.2227164711475832,1,S=c1[nH]c2cccc3c2n1CCNC3
2825,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.007,uM,=,-2.154901959985743,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2826,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CC(C)Sc1nc(Cc2c(F)cccc2F)cc(=O)[nH]1,"6-(2,6-Difluoro-benzyl)-2-isopropylsulfanyl-3H-pyrimidin-4-one",0.05,uM,=,-1.3010299956639813,0,O=c1cc(Cc2ccccc2)nc[nH]1
2827,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,O=c1cc(Nc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,"6-(4'-chlorobiphenyl-3-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.45,uM,=,-0.3467874862246563,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2828,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,2-Amino-6-(toluene-2-sulfonyl)-benzonitrile,4.5,uM,=,0.6532125137753437,1,O=S(=O)(c1ccccc1)c1ccccc1
2829,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc2[nH]cc(CC/N=C(\S)Nc3ccc(Br)cn3)c2c1,1-(5-Bromo-pyridin-2-yl)-3-[2-(5-methoxy-1H-indol-3-yl)-ethyl]-thiourea,0.32,uM,=,-0.494850021680094,0,C(=NCCc1c[nH]c2ccccc12)Nc1ccccn1
2830,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,O=C(O)c1cnc2ccccc2n1,Quinoxaline-2-carboxylic acid,320.0,uM,=,2.505149978319906,1,c1ccc2nccnc2c1
2831,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1ccc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)cc1,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(p-tolyl)acetonitrile",0.667,uM,=,-0.175874166083451,0,O=c1cc(Cc2ccccc2)nc[nH]1
2832,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,O=C(CSc1nnnn1-c1c(Cl)cccc1Cl)Nc1ccccc1[N+](=O)[O-],"2-(1-(2,6-dichlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide",0.004,uM,=,-2.397940008672037,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
2833,197423,10.1021/jm00001a001,,,,Ability to inhibit the HIV-1 reverse transcriptase in cord blood mononuclear cells.,Nc1ccn([C@@H]2CC[C@H](CO)S2)c(=O)n1,"4-Amino-1-((2S,5R)-5-hydroxymethyl-tetrahydro-thiophen-2-yl)-1H-pyrimidin-2-one",0.287,uM,=,-0.5421181032660077,0,O=c1ncccn1[C@@H]1CCCS1
2834,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc2c1=O,4-[1-(4-Nitrophenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,47.0,uM,=,1.6720978579357175,1,O=c1ccn(Cc2ccccc2)c2ccccc12
2835,471469,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 by heteropolymeric DNA polymerase assay,Nc1nc(=O)c2ncn([C@H]3C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C3)c2[nH]1,carbovir-triphosphate,1.2,uM,=,0.0791812460476248,1,O=c1nc[nH]c2c1ncn2[C@H]1C=CCC1
2836,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1[nH]c(=O)c(N(C)C)c(Cc2cc(C)cc(C)c2)c1C,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-6-ethyl-5-methyl-1H-pyridin-2-one",0.01,uM,=,-2.0,0,O=c1cc(Cc2ccccc2)cc[nH]1
2837,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(C#N)cc(-c4cc(F)cc(C#N)c4)c3)c2=O)n[nH]c1=O,"5-fluoro-5'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3,3'-dicarbonitrile",0.17,uM,=,-0.7695510786217261,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
2838,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,CCS(=O)(=O)N(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"N-(4'-cyano-3,5-difluorobiphenyl-4-yl)-N-(2-(4-cyanophenylamino)pyrimidin-4-yl)ethanesulfonamide",0.2,uM,=,-0.6989700043360187,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
2839,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,Cn1c(=O)ccn(CCOc2cc(S(=O)(=O)F)ccc2Oc2cc(Cl)cc(C#N)c2)c1=O,"4-(3-Chloro-5-cyanophenoxy)-3-(2-(3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)benzenesulfonyl fluoride",0.375,uM,=,-0.4259687322722811,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
2840,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,C[C@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-cyclopropylethynyl-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.249,uM,=,-0.6038006529042637,0,O=C1COC(C#CC2CC2)c2ccccc2N1
2841,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,Cn1ccc2c(Cc3ccc(Br)c(Oc4cc(Cl)cc(C#N)c4)c3F)n[nH]c2c1=O,"3-[6-Bromo-2-fluoro-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrazolo[3,4-c]pyridin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",0.008,uM,=,-2.096910013008056,0,O=c1[nH]ccc2c(Cc3cccc(Oc4ccccc4)c3)n[nH]c12
2842,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2cccc(-c3cccc(O)c3)c2)cc(=O)n(O)c1=O,"3-hydroxy-6-(3'-hydroxybiphenyl-3-yloxy)-1-methylpyrimidine-2,4(1H,3H)-dione",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2843,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C=O)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1CCCC2,"4-((4-(4-Formyl-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile",0.055,uM,=,-1.259637310505756,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
2844,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,N#Cc1csc(NC(=S)NCCc2ccccc2)n1,1-(4-Cyano-thiazol-2-yl)-3-phenethyl-thiourea,0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccc1)Nc1nccs1
2845,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3cncc3C)ccc12,"7-[5-Methyl-2-(5-methyl-imidazol-1-yl)-imidazo[1,5-b]pyridazin-7-yl]-1-phenyl-heptan-1-one",0.1,uM,=,-1.0,0,O=C(CCCCCCc1ncc2ccc(-n3ccnc3)nn12)c1ccccc1
2846,2026094,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 48 hrs by pico-green reagent based fluorescence analysis,N#Cc1cc(Cl)cc(Oc2ccc(OS(=O)(=O)F)cc2OCCn2ccc(=O)[nH]c2=O)c1,"4-(3-Chloro-5-cyanophenoxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.163,uM,=,-0.7878123955960422,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
2847,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),N#Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cycloheptene-9-carbonitrile",1.25,uM,=,0.0969100130080564,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2848,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1nc(Cl)ccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-tert-Butylamino-6-chloro-pyridin-2-yl)-ethyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,1.02,uM,=,0.0086001717619175,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
2849,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCc1c(C(=O)c2ccccc2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzoyl-5-ethyl-1-((4-fluorobenzyloxy)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",23.0,uM,=,1.3617278360175928,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1COCc1ccccc1
2850,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1cc(CCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[2-(4,7-Dichloro-benzooxazol-2-yl)-ethyl]-5,6-dimethyl-1H-pyridin-2-one",0.097,uM,=,-1.0132282657337552,0,c1cncc(CCc2nc3ccccc3o2)c1
2851,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,Cc1ccc(CNc2ccnc(Nc3ccc(C#N)cc3)n2)cc1,4-(4-(4-methylbenzylamino)pyrimidin-2-ylamino)benzonitrile,0.013,uM,=,-1.8860566476931635,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2852,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3Cl)CC2)ncc1Br,"4-((4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)methyl)-3-chlorobenzenesulfonamide",0.09,uM,=,-1.0457574905606752,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
2853,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CC(C)=CCN1Cc2cccc3nc(S)n(c23)C(Cl)[C@@H]1C,"(S)-9-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.2,uM,=,-0.6989700043360187,0,c1cc2c3c(c1)ncn3CCNC2
2854,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)c(C)c1,"N-(2-methyl-4-sulfamoyl-phenyl)-2-[1-(2,4,6-trimethyl-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide",0.054,uM,=,-1.2676062401770316,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
2855,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccccc3F)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(2-fluoro-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.17,uM,=,-0.7695510786217261,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
2856,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",5.52,uM,=,0.7419390777291989,1,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
2857,701790,10.1021/ml1002162,,,,Inhibition of HIV1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)n(N)c1=O,"3-Amino-6-benzyl-1-(benzyloxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",1.5,uM,=,0.1760912590556812,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2858,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)c1cc(C(=CCCCCBr)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 5-[6-bromo-1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-1-hexenyl]-3-chloro-2-methoxybenzoate,11.0,uM,=,1.0413926851582251,1,C=C(c1ccccc1)c1ccccc1
2859,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@@H]1[C@H](C(=O)c2ccc(Br)cc2)c2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)OC(C)(C)C=C3)O[C@@H]1C,"12-(4-Bromo-benzoyl)-6,6,10,11-tetramethyl-4-phenyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",46.0,uM,=,1.662757831681574,1,O=C(c1ccccc1)[C@H]1CCOc2c3c(c4c(-c5ccccc5)cc(=O)oc4c21)OCC=C3
2860,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,COc1cccc(CSc2nc(Cc3ccccc3)c(C)c(=O)[nH]2)c1,6-Benzyl-5-methyl-2-(3-methoxybenzylthio)pyrimidin-4(3H)-one,48.74,uM,=,1.6878855248487057,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
2861,1501272,10.1016/j.bmc.2015.03.037,,,,Inhibition of wild-type HIV1 Reverse transcriptase p66/p51 assessed as relative fluorescence signal after 40 mins,CCCn1cc(C(=O)O)c(=O)c2ccc(Oc3ccnc(Nc4ccc(C#N)cc4)n3)cc21,"7-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)oxy)-4-oxo-1-propyl-1,4-dihydroquinoline-3-carboxylic acid",9.12,uM,=,0.959994838328416,1,O=c1cc[nH]c2cc(Oc3ccnc(Nc4ccccc4)n3)ccc12
2862,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(N3CCCC3)nc21,"8-Ethyl-3-methyl-6-pyrrolidin-1-yl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",2.7,uM,=,0.4313637641589873,1,c1cnc2c(c1)-c1nccn1-c1ccc(N3CCCC3)nc1N2
2863,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)N[C@@H](CC(=O)O)C(=O)O)c1=O,"(S)-2-(2-{3-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetylamino)-succinic acid",11.9,uM,=,1.0755469613925308,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
2864,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,CC1=C(/N=N/c2ccccc2)N=C(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)NN1,"4-(4-Chlorophenyl)-5-(6-methyl-5-(phenyldiazenyl)-1,2-dihydro-1,2,4-triazin-3-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",4.5e-05,uM,=,-4.346787486224656,0,C1=C(/N=N/c2ccccc2)N=C(N2Nc3onc(-c4ccccc4)c3C2c2ccccc2)NN1
2865,196375,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1/138Lys reverse transcriptase (RT) using [3H]dGTP as a radioligand,O=C(O)P(=O)(O)O,Foscarnet,56.0,uM,=,1.7481880270062005,1,
2866,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cc(C)cc([C@]23SCCN2C(=O)c2ccccc23)c1,"9b-(3,5-Dimethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.016,uM,=,-1.7958800173440752,0,O=C1c2ccccc2[C@@]2(c3ccccc3)SCCN12
2867,1336117,10.1021/jm5001503,,,,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,O=C(O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCOCC3)ccc2c1=O,4-[1-[(4-Fluorophenyl)methyl]-7-(morpholin-4-yl)-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,6.8,uM,=,0.8325089127062363,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCOCC3)ccc12
2868,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(=S)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-(3,5-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazole-2-thione",1.76,uM,=,0.2455126678141498,1,O=S(=O)(c1ccccc1)n1c(=S)[nH]c2ccccc21
2869,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nccn2-c2c(C)ccnc21,"8-Ethyl-4-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.245,uM,=,-0.6108339156354675,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2870,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2ncc(C)n2-c2cccnc21,"8-Ethyl-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",1.22,uM,=,0.0863598306747482,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2871,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(OC1COc2cc(O)ccc2C1)c1ccc(O)c(O)c1O,"2,3,4-Trihydroxy-benzoic acid 7-hydroxy-chroman-3-yl ester",36.29,uM,=,1.5597869682005563,1,O=C(OC1COc2ccccc2C1)c1ccccc1
2872,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC(C)C#CC1(C(F)(F)F)OCC(=O)Nc2ccc(Cl)cc21,"7-Chloro-5-(3-methyl-but-1-ynyl)-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.423,uM,=,-0.3736596326249576,0,O=C1COCc2ccccc2N1
2873,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)ccc32)c(Cl)c1,"S-2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl 6-chloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.008,uM,=,-2.096910013008056,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
2874,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CSc1nc(O)cc(Cc2c(F)cccc2F)n1,"6-(2,6-Difluoro-benzyl)-2-methylsulfanyl-3H-pyrimidin-4-one",0.8,uM,=,-0.0969100130080563,0,c1ccc(Cc2ccncn2)cc1
2875,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1nc(O)c2ncn(C3C=CC(OCP(=O)(O)OP(=O)(O)C(F)(F)P(=O)(O)OP(=O)(O)COC4C=CC(n5cnc6c(O)nc(N)nc65)C4)C3)c2n1,"P,P'-Bis {[4-(guanine-9-yl)cyclopent-2-enyl]oxy-methylphosphonyl}difluorodiphosphonate",15.0,uM,=,1.1760912590556811,1,O=[PH](COC1C=CC(n2cnc3cncnc32)C1)O[PH](=O)C[PH](=O)O[PH](=O)COC1C=CC(n2cnc3cncnc32)C1
2876,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(F)ccc(Cl)c3o2)c(O)nc1C,3-[(7-Chloro-4-fluoro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.105,uM,=,-0.978810700930062,0,c1cncc(NCc2nc3ccccc3o2)c1
2877,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc([N+](=O)[O-])cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4-nitrophenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2878,666605,10.1128/aac.01795-09,,,,Inhibition of DNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by gel-based primer extension assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.057,uM,=,-1.2441251443275083,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
2879,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cccnc2OC)c(O)nc1C,5-Ethyl-3-[(2-methoxy-pyridin-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.68,uM,=,-0.1674910872937636,0,c1cncc(CNc2cccnc2)c1
2880,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)ccnc21,"5-Ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.035,uM,=,-1.4559319556497243,0,O=C1Nc2cccnc2Nc2ncccc21
2881,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,O=C(Nc1ccc(NS(=O)(=O)c2ccccc2)cc1)Nc1sc(-c2ccc(Cl)c(Cl)c2)cc1C(=O)O,"5-(3,4-Dichlorophenyl)-2-(3-(4-(phenylsulfonamido)phenyl)-ureido)thiophene-3-carboxylic Acid",0.9,uM,=,-0.0457574905606751,0,O=C(Nc1ccc(NS(=O)(=O)c2ccccc2)cc1)Nc1ccc(-c2ccccc2)s1
2882,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1N,"3-(4-(5-amino-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.019,uM,=,-1.7212463990471711,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2883,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,COc1ccc2c(c1)N(C(=O)OC(C)C)[C@@H](CSC)C(=O)N2,"(R)-isopropyl 7-methoxy-2-(methylthiomethyl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate",0.002,uM,=,-2.6989700043360187,0,O=C1CNc2ccccc2N1
2884,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NC(=O)C(F)(F)F)ccc3[nH]2)CC1,"2,2,2-Trifluoro-N-{2-[4-(3-isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-acetamide",27.0,uM,=,1.4313637641589874,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
2885,306312,10.1016/j.bmcl.2005.06.036,,,,In vitro inhibitory concentration against HIV-1 recombinant integrase activity in strand transfer assay,O=C(c1ccccc1[N+](=O)[O-])c1ccc2ccc(/C=C/c3ccc(O)c(O)c3)nc2c1O,"{2-[(E)-2-(3,4-Dihydroxy-phenyl)-vinyl]-8-hydroxy-quinolin-7-yl}-(2-nitro-phenyl)-methanone",70.0,uM,=,1.845098040014257,1,O=C(c1ccccc1)c1ccc2ccc(/C=C/c3ccccc3)nc2c1
2886,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cccc(C#N)c4)cc3F)c2=O)n[nH]c1=O,"3'-fluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",5.0,uM,=,0.6989700043360189,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2887,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cnc(Nc2ccc(C#N)cc2)nc1OCC(=O)Nc1ccc(C#N)cc1F,N-(4-Cyano-2-fluorophenyl)-2-((2-((4-cyanophenyl)amino)-5-methylpyrimidin-4-yl)oxy)acetamide,12.04,uM,=,1.0806264869218056,1,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
2888,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3cc(C)cc(C)c3)c21,"7-(3,5-dimethylphenoxy)-1-ethyl-1,3-dihydro-2H-benzo[d]imidazol-2-one",0.303,uM,=,-0.518557371497695,0,O=c1[nH]c2cccc(Oc3ccccc3)c2[nH]1
2889,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(O)c2)C2CC2)cc1,"N-((2S,3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(3,4-dihydroxyphenyl)propanamide",0.0455,uM,=,-1.3419886033428876,0,O=C(CCc1ccccc1)N[C@H](CCN(C1CC1)S(=O)(=O)c1ccccc1)Cc1ccccc1
2890,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCN(S(C)(=O)=O)CC3)cc2)nc2sccc12,"(E)-3-(3,5-dimethyl-4-((2-((4-((4-(methylsulfonyl)piperazin-1-yl)methyl)phenyl)amino)thieno[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.103,uM,=,-0.9871627752948278,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3sccc23)cc1
2891,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(CCc2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-ethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.022,uM,=,-1.6575773191777938,0,c1cncc(CCc2nc3ccccc3o2)c1
2892,195505,10.1016/s0960-894x(99)00235-8,,,,Inhibition of purified recombinant HIV-1 reverse transcriptase,S=C(NCCC1=CCCCC1)Nc1ccc(Cl)cn1,1-(5-Chloro-pyridin-2-yl)-3-cyclohex-1-enylmethyl-thiourea,3.7,uM,=,0.568201724066995,1,S=C(NCCC1=CCCCC1)Nc1ccccn1
2893,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(F)cc1,"(E)-6-[1-(4-Fluoro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",8.0,uM,=,0.9030899869919436,1,c1ccc(Cn2cccc2)cc1
2894,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,O=S1(=O)Nc2ccc(Cl)cc2C(C#CC2CC2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-cyclopropylethynyl-3,4-dihydro-1H-benzo[1,2,6]thiadiazine 2,2-dioxide",35.87,uM,=,1.5547313766759665,1,O=S1(=O)Nc2ccccc2C(C#CC2CC2)(C2CC2)N1
2895,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1cc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)ccn1,"4-(2-Methylamino-pyridin-4-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.021,uM,=,-1.6777807052660807,0,O=c1nc(-c2ccncc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
2896,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccc(Cl)c(Cl)c3)SCCN12,"9b-(3,4-Dichloro-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.0,uM,=,0.6020599913279624,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
2897,638659,10.1016/j.bmc.2010.05.004,,,,Inhibition of HIV 3B reverse transcriptase using [3H]TTP as a tracer by scintillation counting,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(Cc3cccc(C(=O)/C=C(\O)C(=O)O)c3)cc2)c(=O)[nH]c1=O,"(Z)-4-(3-(4-(((6-Benzyl-5-isopropyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl)methoxy)methyl)benzyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.16,uM,=,-0.7958800173440752,0,O=c1cc(Cc2ccccc2)n(COCc2ccc(Cc3ccccc3)cc2)c(=O)[nH]1
2898,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccncc3)CC2)nc2c1SCC2,"3,5-Dimethyl-4-((2-((1-(pyridin-4-ylmethyl)piperidin-4-yl)-amino)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl)oxy)-benzonitrile",0.112,uM,=,-0.9507819773298184,0,c1ccc(Oc2nc(NC3CCN(Cc4ccncc4)CC3)nc3c2SCC3)cc1
2899,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,CC1CCCCC1Nc1cc(CCc2ccccc2)[nH]c(=O)c1I,3-Iodo-4-((2-methylcyclohexyl)amino)-6-phenethylpyridin-2(1H)-one,0.42,uM,=,-0.3767507096020995,0,O=c1cc(NC2CCCCC2)cc(CCc2ccccc2)[nH]1
2900,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,O=C(CSc1nnnn1-c1cc(F)ccc1Cl)Nc1ccccc1[N+](=O)[O-],2-(1-(2-chloro-5-fluorophenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.01,uM,=,-2.0,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
2901,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,"8-[5-(5,7-Dihydroxy-4-oxo-4H-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",119.0,uM,=,2.0755469613925306,1,O=c1cc(-c2cccc(-c3cccc4c(=O)cc(-c5ccccc5)oc34)c2)oc2ccccc12
2902,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,COc1cc(-c2ccc(C#N)cc2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"3'-methoxy-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",24.57,uM,=,1.390405156480081,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
2903,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),C#CN1c2ccccc2N(C)C(=O)c2cccnc21,"11-Ethynyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.65,uM,=,-0.1870866433571444,0,O=C1Nc2ccccc2Nc2ncccc21
2904,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1cccc(N2C(=O)CSC2c2c(F)cccc2F)n1,"2-(2,6-Difluoro-phenyl)-3-(6-methyl-pyridin-2-yl)-thiazolidin-4-one",2.9,uM,=,0.4623979978989561,1,O=C1CSC(c2ccccc2)N1c1ccccn1
2905,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)CC(=O)c1cccc(I)c1,3-(3-iodophenyl)-3-oxopropanamide,29.6,uM,=,1.4712917110589383,1,c1ccccc1
2906,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCCc2nnc(C)o2)c2cc(C)c3onc(OC)c3c2)cc1C(=O)SC,"(E)-S-methyl 2-methoxy-5-(1-(3-methoxy-7-methylbenzo[d]-isoxazol-5-yl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-3-methylbenzothioate",5.2,uM,=,0.7160033436347992,1,C(\CCCc1nnco1)=C(/c1ccccc1)c1ccc2oncc2c1
2907,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(COc3ccccc3Cl)ccnc2N(C2CC2)c2ncccc21,"9-(2-Chloro-phenoxymethyl)-5-cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.05,uM,=,0.4842998393467858,1,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
2908,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(Cc2cc(C)cc(C)c2)n(COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c(=O)[nH]c1=O,"4-(4-(((6-(3,5-dimethylbenzyl)-5-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.02419,uM,=,-1.6163641316381203,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
2909,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccc(N)c3)nc21,"7-(3-Amino-phenyl)-5-ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.56,uM,=,-0.2518119729937995,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
2910,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=C(CCl)Nc1ccc(Cl)cc1NS(=O)(=O)c1c(F)cccc1F,"2-Chloro-N-[4-chloro-2-(2,6-difluoro-phenylsulfonamido)-phenyl]acetamide",30.36,uM,=,1.4823017672234426,1,O=S(=O)(Nc1ccccc1)c1ccccc1
2911,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",9.2,uM,=,0.9637878273455552,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2912,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],"9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium chloride",269.4746385807264,uM,=,2.430517898121161,1,c1ccc2c[n+]3c(cc2c1)-c1cc2c(cc1CC3)OCO2
2913,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2CC[C@@H](OCP(=O)(O)O)O2)c(=O)[nH]c1=O.O=P(O)(O)OP(=O)(O)O,"(2R,5R)-[5-(5-methyl-2,4-dioxo-3,4-dihydro-2Hpyrimidin-1-yl)-tetrahydro-furan-2-yloxymethyl]-phosphonic acid diphosphate",5.4,uM,=,0.7323937598229685,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
2914,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CC1(C)OC(=O)Nc2cccc(Oc3cc(Cl)cc(C#N)c3)c21,"3-chloro-5-(4,4-dimethyl-2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-5-yloxy)benzonitrile",0.021,uM,=,-1.6777807052660807,0,O=C1Nc2cccc(Oc3ccccc3)c2CO1
2915,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,CNC(=O)CCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"5-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-pentanoic acid methylamide",0.56,uM,=,-0.2518119729937995,0,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
2916,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,COc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1OC,"6-(3',4'-Dimethoxy-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.074,uM,=,-1.1307682802690238,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
2917,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,"Ethyl 6-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",13.4,uM,=,1.1271047983648077,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
2918,2201751,10.1016/j.ejmech.2022.114217,,,,Inhibition of HIV-1 LTR reverse transcriptase infected in human CEM cells using RNA template incubated for 1 hr by RT-PCR based cell-free assay,C=CCOCc1cn(C2CCON2C(=O)OCc2ccccc2)c(=O)[nH]c1=O,"Benzyl 3-(2,4-dioxo-5-((allyloxy)methyl)-3,4-dihydropyrimidin-1(2H)-yl)isoxazolidine-2-carboxylate",0.01,uM,=,-2.0,0,O=C(OCc1ccccc1)N1OCCC1n1ccc(=O)[nH]c1=O
2919,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCCCCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-((4-(4-fluorophenyl)butoxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",1.8,uM,=,0.255272505103306,1,O=c1cc(Cc2ccccc2)n(COCCCCc2ccccc2)c(=O)[nH]1
2920,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SC2CCCCC2)nc1Cc1c(Cl)cccc1Cl,"2-Cyclohexylsulfanyl-6-(2,6-dichloro-benzyl)-5-methyl-3H-pyrimidin-4-one",4.9,uM,=,0.6901960800285137,1,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
2921,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1O,"6-Benzyl-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
2922,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Fc1cccc(Cl)c1CCNC(=S)Nc1nccs1,1-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.006,uM,=,-2.2218487496163566,0,S=C(NCCc1ccccc1)Nc1nccs1
2923,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,O=C1Nc2c(Cc3ccccc3O)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-(2-hydroxy-benzyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.12,uM,=,0.0492180226701816,1,O=C1Nc2c(Cc3ccccc3)ccnc2N(C2CC2)c2ncccc21
2924,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCn1c(=O)[nH]c2cccc(Oc3cccc4ccccc34)c21,"1-ethyl-7-(naphthalen-1-yloxy)-1,3-dihydro-2H-benzo[d]imidazol-2-one",2.27,uM,=,0.3560258571931227,1,O=c1[nH]c2cccc(Oc3cccc4ccccc34)c2[nH]1
2925,2119941,10.1016/j.ejmech.2021.113681,,,,Inhibition of recombinant HIV1 reverse transcriptase by colorimetric assay,NC[C@H](NC(=O)c1ccc(-c2ccc(Cl)cc2)[nH]1)c1nccs1,(S)-N-(2-amino-1-(thiazol-2-yl)ethyl)-5-(4-chlorophenyl)-1H-pyrrole-2-carboxamide,18.9,uM,=,1.276461804173244,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
2926,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccccc2)Sc2cccc(Cl)c2-n2cccc2C1=O,10-Chloro-5-ethyl-5-phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,600.0,uM,=,2.778151250383644,1,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
2927,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2928,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2cc(O)nc(SC3CCCCC3)n2)c1,2-Cyclohexylsulfanyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,2.6,uM,=,0.414973347970818,1,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
2929,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NCC1NC(=O)C[C@@H](C(N)=O)NC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC1=O,"((20S)-20-carbamoyl-3,6,9,12,15,18,22-heptaoxo-5,17-bis((quinoxaline-2-carboxamido)methyl)-1,4,7,10,13,16,19-heptaazacyclodocosan-2-yl)methanaminium",6.5,uM,=,0.8129133566428556,1,O=C1CCNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CN1
2930,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,CC(=O)CC[C@@H]1[C@](C)(CC[C@@]2(O)[C@H](C)CC[C@@H]3OC(C)(C)CCC[C@@]32C)CCC[C@@]1(C)C(=O)Cc1cc(OS(=O)(=O)[O-])ccc1OS(=O)(=O)[O-].[Na+].[Na+],shaagrockol B,8.5,uM,=,0.9294189257142929,1,O=C(Cc1ccccc1)C1CCCC(CCC2CCC[C@@H]3OCCCCC23)C1
2931,2125951,10.1021/acs.jmedchem.1c00268,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.011,uM,=,-1.9586073148417749,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
2932,553446,10.1128/aac.00212-07,,,,Inhibition of HIV1 recombinant reverse transcriptase,Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione-5`-triphosphate (d4T-TP)",0.036,uM,=,-1.4436974992327127,0,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
2933,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCc2ccccc2)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-3-phenethyl-1H-pyrimidine-2,4-dione",3.0,uM,=,0.4771212547196624,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)n1CCc1ccccc1
2934,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(F)c(CC/N=C(\S)Nc2ccc(Cl)cn2)c1C#N,1-(5-Chloro-pyridin-2-yl)-3-[2-(2-cyano-6-fluoro-3-methoxy-phenyl)-ethyl]-thiourea,0.005,uM,=,-2.3010299956639813,0,C(=NCCc1ccccc1)Nc1ccccn1
2935,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,CCOC(=O)c1cccn1S(=O)(=O)c1cc(C)ccc1N,1-(2-Amino-5-methyl-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid ethyl ester,4.0,uM,=,0.6020599913279624,1,O=S(=O)(c1ccccc1)n1cccc1
2936,306090,10.1021/jm040071z,,,,Concentration required for 50% inhibition of human immunodeficiency virus type 1 reverse transcriptase Ile100,CCCc1c(O)nc2ccc(Cl)cc2c1[S+]([O-])C1CCCCC1,6-Chloro-4-cyclohexanesulfinyl-3-propyl-1H-quinolin-2-one,2.38,uM,=,0.3765769570565119,1,c1ccc2c([SH+]C3CCCCC3)ccnc2c1
2937,494379,10.1021/jm801071m,,,,Inhibition of HIV1 LAI clade C 93IN101 reverse transcriptase RNase H activity by real time monitoring assay,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NC12CC3CC(CC(C3)C1)C2,5-nitro-furan-2-carboxylic acid adamantan-1-carbamoylmethyl ester,26.5,uM,=,1.423245873936808,1,O=C(COC(=O)c1ccco1)NC12CC3CC(CC(C3)C1)C2
2938,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCc1c(C(=O)c2cc(C)cc(C)c2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-(3,5-Dimethylbenzoyl)-5-ethyl-1-((4-fluorobenzyloxy)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",7.6,uM,=,0.8808135922807914,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1COCc1ccccc1
2939,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccccc1-c1nc2cccc(Cl)n2c1NC1CCCCC1,"5-Chloro-2-(2-chlorophenyl)-N-cyclohexylimidazo[1,2-a]pyridin-3-amine",3.74,uM,=,0.5728716022004802,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
2940,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),COCc1cc(CCc2nc3ccccc3o2)c(O)nc1C,3-(2-Benzooxazol-2-yl-ethyl)-5-methoxymethyl-6-methyl-1H-pyridin-2-one,2.1,uM,=,0.3222192947339193,1,c1cncc(CCc2nc3ccccc3o2)c1
2941,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCc1c(C(=O)c2cc(C)cc(C)c2)n(COCCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-(3,5-dimethylbenzoyl)-5-ethyl-1-((4-fluorophenethoxy)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",10.0,uM,=,1.0,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1COCCc1ccccc1
2942,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4cnccc34)ccc2Cl)c1,"3-Chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-c]pyridine-3-ylmethoxy)-phenoxy]benzonitrile",0.0008,uM,=,-3.096910013008056,0,c1ccc(Oc2cccc(OCc3n[nH]c4cnccc34)c2)cc1
2943,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",1.0,uM,=,0.0,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2944,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),CN(C)C(=O)/C=C/CSc1nc(N)cc(Cl)n1,(E)-4-(4-Amino-6-chloro-pyrimidin-2-ylsulfanyl)-but-2-enoic acid dimethylamide,0.07,uM,=,-1.154901959985743,0,c1cncnc1
2945,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.778,uM,=,-0.109020403010311,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2946,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(NC3CCN(Cc4ccc(C(N)=O)cc4)CC3)c2)c(C)c1,4-((4-((6-chloro-4-(mesityloxy)pyridin-2-yl)amino)piperidin-1-yl)methyl)benzamide,0.098,uM,=,-1.0087739243075051,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
2947,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.27,uM,=,-0.5686362358410126,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
2948,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccccc2F)[nH]c(=O)n1O,"6-((2-Fluorophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.015,uM,=,-1.8239087409443189,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
2949,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,"6-([1,1'-biphenyl]-4-ylmethyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2950,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])c(C(F)(F)F)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(1-oxy-2-trifluoromethyl-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.27,uM,=,-0.5686362358410126,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
2951,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#Cc2ccccn2)(C2CC2)N1,"(S)-6-Chloro-4-cyclopropyl-4-pyridin-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.012,uM,=,-1.9208187539523751,0,O=C1Nc2ccccc2[C@@](C#Cc2ccccn2)(C2CC2)N1
2952,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccccn3)nc21,"5-Ethyl-10-methyl-7-pyridin-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.018,uM,=,-1.744727494896694,0,O=C1Nc2ccc(-c3ccccn3)nc2Nc2ncccc21
2953,2294755,10.1016/j.bmcl.2023.129216,,,,Inhibition of recombinant wildtype HIV-1 reverse transcriptase using r(A)350 as template and d(T)16 as primer preincubated with compound for 1 hrs followed by template/primer addition and measured after 30 mins by picogreen based plate reader analysis,N#Cc1ccc(Nc2ncc(Cc3c(F)cc(-c4ccc(C#N)cc4)cc3F)o2)cc1,"4'-((2-((4-cyanophenyl)amino)oxazol-5-yl)methyl)-3',5'-difluoro-[1,1'-biphenyl]-4-carbonitrile",0.011,uM,=,-1.958607314841775,0,c1ccc(Nc2ncc(Cc3ccc(-c4ccccc4)cc3)o2)cc1
2954,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccccc2)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-phenylacetamide",15.7,uM,=,1.1958996524092338,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
2955,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.039,uM,=,-1.408935392973501,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2956,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(Cl)cccc3o2)c(S)nc1C,3-[2-(4-Chloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridine-2-thione,0.03,uM,=,-1.5228787452803376,0,c1cncc(CCc2nc3ccccc3o2)c1
2957,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(C(=O)c2cc(Cl)ccc2Oc2nc(Nc3ccc(C#N)cc3)ncc2C)c1,"4-{5-Methyl-4-[4-chloro-2-(3,5-dimethylbenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile",3.06,uM,=,0.48572142648158,1,O=C(c1ccccc1)c1ccccc1Oc1ccnc(Nc2ccccc2)n1
2958,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O,"6-Benzyl-1-ethoxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.15,uM,=,-0.8239087409443188,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
2959,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CNc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenylaminomethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.37,uM,=,-0.431798275933005,0,O=C1Nc2cccnc2Nc2ncc(CNc3ccccc3)cc21
2960,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccccc3)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-phenylacetamide",0.199,uM,=,-0.7011469235902933,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
2961,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)c(F)c2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3-fluoro-3'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.039,uM,=,-1.408935392973501,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2962,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,COc1c(Cl)ccc2c1C(C#CC1CC1)(C(F)(F)F)NC(=O)N2,"6-Chloro-4-cyclopropylethynyl-5-methoxy-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
2963,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,FC(F)(F)C1(C#CC2CC2)NC(Nc2ccc(Cl)c(Cl)c2)=Nc2ccc(Cl)cc21,"6-chloro-4-(cyclopropylethynyl)-N-(3,4-dichlorophenyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2-amine",0.0037,uM,=,-2.431798275933005,0,C(#CC1NC(Nc2ccccc2)=Nc2ccccc21)C1CC1
2964,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCC(N)=O)[nH]c3ccc(Cl)c(F)c23)c1,"N-(3-Amino-3-oxopropyl)-5-chloro-3-[(3,5-dimethylphenyl)-sulfonyl]-4-fluoro-1H-indole-2-carboxamide",0.034,uM,=,-1.4685210829577449,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
2965,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3cccc(Cl)c3)n2)cc1,4-(4-(3-chlorobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.018,uM,=,-1.744727494896694,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2966,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(N4CCCC4)cc3)CC2)nc2ccsc12,"3,5-dimethyl-4-((2-((1-(4-(pyrrolidin-1-yl)benzyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)benzonitrile",0.221,uM,=,-0.6556077263148893,0,c1ccc(Oc2nc(NC3CCN(Cc4ccc(N5CCCC5)cc4)CC3)nc3ccsc23)cc1
2967,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,COc1ccccc1NC(=O)C1CCCCC1(C)C(=O)O,2-(2-methoxyphenylcarbamoyl)-1-methylcyclohexanecarboxylic acid,61.25,uM,=,1.78710609303657,1,O=C(Nc1ccccc1)C1CCCCC1
2968,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4)cc3)ccc2C(=O)N1O,"6-((4'-Fluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",5.0,uM,=,0.6989700043360189,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
2969,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2ccc(-c3ccccc3O)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((2'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.24,uM,=,-0.619788758288394,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
2970,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccccc3)n2)cc1,4-(4-(benzylamino)pyrimidin-2-ylamino)benzonitrile,0.02,uM,=,-1.6989700043360187,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
2971,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,8.32,uM,=,0.920123326290724,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
2972,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,COc1c(Cl)ccc2c1C(C#Cc1ccccc1)(C(F)(F)F)NC(=O)N2,"6-Chloro-5-methoxy-4-phenylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.144,uM,=,-0.8416375079047503,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)N1
2973,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CCCCC[C@]12C[C@@]1(C(=O)OCC)C(=O)Nc1ccc(Br)cc12,"(1aS,7bR)-ethyl 6-bromo-2-oxo-7b-pentyl-1a,2,3,7b-tetrahydro-1H-cyclopropa[c]quinoline-1a-carboxylate",0.001,uM,=,-3.0,0,O=C1Nc2ccccc2C2CC12
2974,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,O=c1cc(Nc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,"6-(4'-chlorobiphenyl-3-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.37,uM,=,-0.431798275933005,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
2975,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nnc(C)n2-c2cccnc21,"8-Ethyl-3-methyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",38.9,uM,=,1.5899496013257075,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
2976,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(S(C)(=O)=O)cc3Cl)nc3ccc(Cl)cc32)c1,"2-({6-Chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl]sulfanyl}-N-[2-chloro-4-(methylsulfonyl)phenyl]-acetamide",2.61,uM,=,0.4166405073382809,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
2977,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCN1C(=O)/C(=C\c2cccs2)SC1=S)Nc1ccc(C(=O)O)cc1,4-(3-{4-Oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-propionylamino)-benzoic acid,86.0,uM,=,1.934498451243568,1,O=C(CCN1C(=O)/C(=C\c2cccs2)SC1=S)Nc1ccccc1
2978,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,NCc1cccc(-c2cccc(-c3cc(=O)n(O)c4ncccc34)c2)c1,"4-(3'-(aminomethyl)biphenyl-3-yl)-1-hydroxy-1,8-naphthyridin-2(1H)-one",0.15,uM,=,-0.8239087409443188,0,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2[nH]1
2979,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Nc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,"3-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenylamino)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.019,uM,=,-1.7212463990471711,0,c1ccc(Nc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2980,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2cccc(Cl)c2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((3'-chloro-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.085,uM,=,-1.0705810742857071,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
2981,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,[N-]=[N+]=Nc1ccccc1CC/N=C(\S)Nc1nccs1,1-[2-(2-Azido-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.03,uM,=,-1.5228787452803376,0,C(=NCCc1ccccc1)Nc1nccs1
2982,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)NCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,"4-(N-Methoxycarbonyl)amino-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",4.43,uM,=,0.6464037262230695,1,C=C(c1ccccc1)c1ccccc1
2983,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCNCC3)cc2)nc2sccc12,"(E)-3-(3,5-dimethyl-4-((2-((4-(piperazin-1-yl)phenyl)amino)thieno[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.8490000000000001,uM,=,-0.0710923097560472,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3sccc23)cc1
2984,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nccn2-c2ccc(O)nc21,"8-Ethyl-7H,8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-one",23.9,uM,=,1.3783979009481375,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
2985,1872150,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of Triton-X-100 by scintillation counting method,NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](N)Cc1c[nH]c2ccccc12,(R)-1-(2-((R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-2-oxoethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,5.0,uM,=,0.6989700043360189,1,O=C(CCc1c[nH]c2ccccc12)NCC(=O)NCCc1c[nH]c2ccccc12
2986,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,Cc1cc(=O)c2c(=O)oc3c4ccccc4oc(=O)c3c2o1,"3-Methyl-1H-Pyrano[2',3':4,5]Pyrano[3,2-c]chromene-1,5,12-trione",16.8,uM,=,1.2253092817258628,1,O=c1ccoc2c1c(=O)oc1c3ccccc3oc(=O)c21
2987,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NC(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-carboxylic acid (2-{4-[ethyl-(3-isopropylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.14,uM,=,-0.8538719643217619,0,O=C(Nc1ccc2[nH]c(C(=O)N3CCC(Nc4ccccn4)CC3)cc2c1)N1CCNCC1
2988,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,O=C(Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12)c1ccccc1.[Na+].[Na+],"4-Benzoylamino-5-hydroxy-naphthalene-2,7-disulfonic acid; disodium salt",721.0,uM,=,2.857935264719429,1,O=C(Nc1cccc2ccccc12)c1ccccc1
2989,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(Cl)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Cl,3-(4-(5-chloro-4-(2-chloro-4-cyano-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.02,uM,=,-1.6989700043360187,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
2990,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2ccc(NS(=O)(=O)c3ccccc3)cc2c(=O)n1O,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide",1.19,uM,=,0.0755469613925307,1,O=c1[nH]c(=O)c2cc(NS(=O)(=O)c3ccccc3)ccc2[nH]1
2991,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CC(C)c1ccc(O)c(=O)c(O)c1,"(2E,4Z,6E)-2,7-dihydroxy-4-isopropylcyclohepta-2,4,6-trienone",0.19,uM,=,-0.721246399047171,0,O=c1cccccc1
2992,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2cccc(-c3ccc(OC)c(OC)c3)c2)c2nccnc2n(O)c1=O,"Methyl 8-((3',4'-dimethoxy-[1,1'-biphenyl]-3-yl)amino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",4.72,uM,=,0.6739419986340878,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)c2nccnc2[nH]1
2993,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
2994,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(C=O)cc(-c3cccc(OC)c3)nc21,"5-Ethyl-7-(3-methoxy-phenyl)-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cycloheptene-9-carbaldehyde",0.33,uM,=,-0.4814860601221125,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
2995,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,C=Cc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-6-methyl-5-vinyl-1H-pyridin-2-one",0.023,uM,=,-1.6382721639824072,0,c1cncc(NCc2nc3ccccc3o2)c1
2996,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(CO)cc(OC)nc21,"5-Ethyl-9-hydroxymethyl-7-methoxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncccc21
2997,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(=O)NCc3ccco3)[nH]c3ccc(Cl)cc23)c1,"(R)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-((furan-2-ylmethyl)amino)-1-oxopropan-2-yl)-1H-indole-2-carboxamide",0.145,uM,=,-0.8386319977650252,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccco1
2998,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(NCc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-Benzylamino-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.26,uM,=,-0.585026652029182,0,O=C1Nc2cccnc2Nc2ncc(NCc3ccccc3)cc21
2999,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,CSc1ccc(NC(=O)CCCCC(=O)Nc2ccc(SC)cc2C(=O)O)c(C(=O)O)c1,2-[4-(2-carboxy-4-methylsulfanylphenylcarbamoyl)butylcarboxamido]-5-methylsulfanylbenzoic acid,6.9,uM,=,0.8388490907372553,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3000,80271,10.1016/s0960-894x(98)00249-2,,,,Compound was tested for its inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),O=C(NCCc1c(F)cccc1F)Nc1ccc(Cl)cn1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2,6-difluoro-phenyl)-ethyl]-urea",0.48,uM,=,-0.3187587626244128,0,O=C(NCCc1ccccc1)Nc1ccccn1
3001,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCOC(=O)CCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,"Ethyl 3',3''-Dibromo-4',4''-dimethoxy-5',5''-bis(methoxy-carbonyl)-6,6-diphenyl5-hexenoate",0.359,uM,=,-0.4449055514216808,0,C=C(c1ccccc1)c1ccccc1
3002,196934,10.1021/jm00115a022,,,,Inhibition of HIV-1 reverse transcriptase from peripheral blood mononuclear cells,O=c1cc([Se]c2ccccc2)n(COCCO)c(=O)[nH]1,"1-(2-Hydroxy-ethoxymethyl)-6-phenylselanyl-1H-pyrimidine-2,4-dione",139.0,uM,=,2.143014800254095,1,O=c1cc([Se]c2ccccc2)[nH]c(=O)[nH]1
3003,197440,10.1016/s0960-894x(99)00664-2,,,,Compound dose required to inhibit HIV-1 reverse transcriptase enzyme(rRT) activity,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1ccc(C(C)(C)C)cc1,1-{2-[(4-tert-Butyl-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole,1.5,uM,=,0.1760912590556812,1,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
3004,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCc1cccs1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-thiophen-2-yl-ethyl)-thiourea,0.8,uM,=,-0.0969100130080563,0,S=C(NCCc1cccs1)Nc1ccccn1
3005,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CCc1cccc(C23SCCN2C(=O)c2ccccc23)c1,"9b-(3-Ethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",1.1,uM,=,0.041392685158225,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3006,1849529,10.1016/j.bmc.2019.06.044,,,,Inhibition of HIV1 reverse transcriptase RNase H using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate measured after 1 hr by FRET based assay,CC(C)Oc1ccc2cccnc2c1-c1cccc2ccccc12,7-Isopropoxy-8-(naphth-1-yl)quinoline,46.8,uM,=,1.670245853074124,1,c1ccc2c(-c3cccc4cccnc34)cccc2c1
3007,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(OC1COc2cc(O)cc(O)c2C1)c1ccc(O)c(O)c1O,"2,3,4-Trihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",3.83,uM,=,0.5831987739686227,1,O=C(OC1COc2ccccc2C1)c1ccccc1
3008,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,C=Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-vinyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3009,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N3CCCC3)nc21,"5-Ethyl-10-methyl-7-pyrrolidin-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.8,uM,=,0.5797835966168101,1,O=C1Nc2ccc(N3CCCC3)nc2Nc2ncccc21
3010,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(C)cc2C(=O)N(C)c2cccnc21,"11-Ethyl-5,8-dimethyl-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one",0.58,uM,=,-0.2365720064370627,0,O=C1Nc2cccnc2Nc2ccccc21
3011,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1nc(Nc2ccc(-c3cnc4ccccc4c3)cc2)c2cccnc2n1O,"1-Hydroxy-4-(4-quinolin-3-yl-phenylamino)-1H-pyrido[2,3-d]pyrimidin-2-one",0.7,uM,=,-0.1549019599857432,0,O=c1nc(Nc2ccc(-c3cnc4ccccc4c3)cc2)c2cccnc2[nH]1
3012,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,COc1ccc2c(c1)[C@@](C#Cc1ccccn1)(C(F)(F)F)NC(=O)N2,"6-Methoxy-4-pyridin-2-ylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.237,uM,=,-0.6252516539898961,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)N1
3013,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),COc1cc(S(=O)(=O)Nc2ccc(C(=O)O)c(O)c2)cc(/C=C/C(=O)O)c1OC,"4-[3-(2-Carboxy-vinyl)-4,5-dimethoxy-benzenesulfonylamino]-2-hydroxy-benzoic acid",75.0,uM,=,1.8750612633917,1,O=S(=O)(Nc1ccccc1)c1ccccc1
3014,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cccc(C)c2NC(=O)c2cccnc21,"11-Ethyl-7-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.038,uM,=,-1.42021640338319,0,O=C1Nc2ccccc2Nc2ncccc21
3015,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,O=c1[nH]nc(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)s1,"5-(3-(3-bromophenoxy)-4-chlorobenzyl)-1,3,4-thiadiazol-2(3H)-one",0.53,uM,=,-0.2757241303992109,0,O=c1[nH]nc(Cc2cccc(Oc3ccccc3)c2)s1
3016,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CNc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[(3-Amino-phenylamino)-methyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(CNc3ccccc3)cc21
3017,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,CNc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"[1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-1H-benzoimidazol-4-yl]-methyl-amine",4.94,uM,=,0.693726948923647,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
3018,1792973,10.1016/j.bmcl.2018.10.010,,,,Inhibition of recombinant wild-type HIV1 GST-fused reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.323,uM,=,-0.4907974776688971,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3019,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCc2ccc(-c3ccccc3)cc2)c2cccnc2n1O,"4-(([1,10-Biphenyl]-4-ylmethyl)amino)-1-hydroxypyrido[2,3-d]pyrimidin-2(1H)-one",0.01,uM,=,-2.0,0,O=c1nc(NCc2ccc(-c3ccccc3)cc2)c2cccnc2[nH]1
3020,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Cc1ccccc1CCNC(=S)Nc1nccs1,1-Thiazol-2-yl-3-(2-o-tolyl-ethyl)-thiourea,0.08,uM,=,-1.0969100130080565,0,S=C(NCCc1ccccc1)Nc1nccs1
3021,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(I)cc1C(=O)O)Nc1ccc(I)cc1C(=O)O,2-({6-[(2-carboxy-4-iodophenyl)amino]-6-oxohexanoyl}amino)-5-iodobenzoic acid,8.5,uM,=,0.9294189257142929,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3022,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](n3cc(CNCC(=O)N(Cc4ccccc4)Cc4cc5cc(Cl)ccc5oc4=O)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,"N-benzyl-N-((6-chloro-2-oxo-2H-chromen-3-yl)methyl)-2-((1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methylamino)acetamide",3.69,uM,=,0.5670263661590603,1,O=C(CNCc1cn([C@@H]2CO[C@@H](n3ccc(=O)[nH]c3=O)C2)nn1)N(Cc1ccccc1)Cc1cc2ccccc2oc1=O
3023,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccc(Br)cc3)n2)cc1,4-(4-(4-bromobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.029,uM,=,-1.537602002101044,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
3024,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1ccc(O)c(O)c1)S(=O)(=O)c1ccc(OC)cc1,"(E)-3-(3, 4-dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0535,uM,=,-1.2716462179787715,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3025,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1ccc(-c2cc(C)c(Oc3cc(N)nc(Nc4ccc(C#N)cc4)n3)c(C)c2)cc1,"4-((4-Amino-6-((3,4',5-trimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.069,uM,=,-1.1611509092627446,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3026,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(I)cc1C(=O)O)Nc1ccc(I)cc1C(=O)O,2-({6-[(2-carboxy-4-iodophenyl)amino]-6-oxohexanoyl}amino)-5-iodobenzoic acid,4.1,uM,=,0.6127838567197355,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3027,1795827,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CXCR4 tropic HIV1 UG070 reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(N)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-amino-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.0007850482427163,uM,=,-3.1051036542079453,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
3028,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,Cc1cc(-c2ccc(C#N)cc2F)ccc1Oc1nc(Nc2ccc(C#N)cc2)nc2ccsc12,"4'-(2-(4-cyanophenylamino)thieno[3,2-d]pyrimidin-4-yloxy)-2-fluoro-3'-methylbiphenyl-4-carbonitrile",0.062,uM,=,-1.207608310501746,0,c1ccc(Nc2nc(Oc3ccc(-c4ccccc4)cc3)c3sccc3n2)cc1
3029,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN(CC)CCOc1ccc(NC(=O)COc2ccccc2C(=O)c2ccccc2)cc1,2-(2-Benzoyl-phenoxy)-N-[4-(2-diethylamino-ethoxy)-phenyl]-acetamide,5.154401700350312,uM,=,0.7121782616047488,1,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
3030,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,Cc1cccc(Cn2c(C)c(/C=C3\SC(=N)NC3=O)c3ccccc32)c1,2-imino-5-((2-methyl-1-(3-methylbenzyl)-1H-indol-3-yl)methylene)thiazolidin-4-one,19.31,uM,=,1.2857822737793947,1,N=C1NC(=O)/C(=C/c2cn(Cc3ccccc3)c3ccccc23)S1
3031,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3ccccc3[nH]2)CC1.CS(=O)(=O)O,(1H-Indol-2-yl)-{4-[(3-isopropylamino-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-methanone; compound with methanesulfonic acid,0.23,uM,=,-0.6382721639824072,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3032,140625,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 variant with Y181C plus K103N mutations in RT (reverse transcriptase),CCC(/N=C(\S)Nc1nccs1)c1ccccc1,1-(1-Phenyl-propyl)-3-thiazol-2-yl-thiourea,1.5,uM,=,0.1760912590556812,1,C(=NCc1ccccc1)Nc1nccs1
3033,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,CCOc1ccc(/C=C2\SC(=O)NC2=O)cc1OCc1ccc(Cl)c(Cl)c1,"5-(3-(3,4-dichlorobenzyloxy)-4-ethoxybenzylidene)thiazolidine-2,4-dione",5.17,uM,=,0.7134905430939426,1,O=C1NC(=O)/C(=C/c2cccc(OCc3ccccc3)c2)S1
3034,447048,10.1016/j.bmcl.2007.01.025,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.18,uM,=,-0.744727494896694,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3035,541098,10.1016/j.bmc.2008.12.028,,,,Inhibition on HIV1 reverse transcriptase p66/p51,C=C[C@@]1(OCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C=C[C@H](n2cnc3c(N)ncnc32)C1,"((1S,4R)-4-(6-Amino-9H-purin-9-yl)-1-vinyl-cyclopent-2-enyloxy)methylphosphonic acid diphosphate",0.62,uM,=,-0.2076083105017461,0,C1=C[C@H](n2cnc3cncnc32)CC1
3036,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CC1(C)CCC[C@]2(C)OC3CC[C@](C)(C4CC[C@]5(C)C4CC[C@]4(C)c6c(OS(=O)(=O)[O-])ccc(OS(=O)(=O)[O-])c6CC54)[C@]3(C)CCC12.[Na+].[Na+],toxicol A,2.7,uM,=,0.4313637641589873,1,c1ccc2c(c1)CC1C2CCC2C1CCC2C1CCC2OC3CCCCC3CCC21
3037,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccccc2Cl)n1,2-sec-Butylsulfanyl-6-(2-chloro-benzyl)-3H-pyrimidin-4-one,1.6,uM,=,0.2041199826559248,1,c1ccc(Cc2ccncn2)cc1
3038,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1ccc(CCNC(=S)Nc2nccs2)cc1,1-[2-(4-Methoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.35,uM,=,-0.4559319556497244,0,S=C(NCCc1ccccc1)Nc1nccs1
3039,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(/C=C(\O)C(=O)O)/C=C/c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,"6-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoic Acid",23.0,uM,=,1.3617278360175928,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
3040,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2c(F)cccc2F)n1,"2-sec-Butylsulfanyl-6-(2,6-difluoro-benzyl)-3H-pyrimidin-4-one",0.05,uM,=,-1.3010299956639813,0,c1ccc(Cc2ccncn2)cc1
3041,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1CCCC2,"(E)-5-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)picolinonitrile",0.147,uM,=,-0.8326826652518239,0,c1ccc(Oc2nc(Nc3cccnc3)nc3c2CCCC3)cc1
3042,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2ccccc2S[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)CN12,"(5aR,6S,7S,8R)-6,7,8-trihydroxy-6,7,8,9-tetrahydro-5aH,11H-pyrido[2,1-b][1,3]benzothiazin-11-one",3.83,uM,=,0.5831987739686227,1,O=C1c2ccccc2S[C@@H]2CCCCN12
3043,427347,10.1128/aac.00749-06,,,,Inhibition of reverse transcriptase activity in HIV1 infected HeLa-MAGI cells at 37 deg C after 48 hrs,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3044,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(Oc3ccc(OCc4ccccc4)cc3)n2)cc1,4-{4-[4-Benzyloxyphenoxy]pyrimidin-2-ylamino}benzonitrile,30.96,uM,=,1.490800952010855,1,c1ccc(COc2ccc(Oc3ccnc(Nc4ccccc4)n3)cc2)cc1
3045,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,Cc1ccc(C(=O)c2cc(=O)n(O)c(=O)[nH]2)cc1,"3-Hydroxy-6-(4-methylbenzoyl)pyrimidine-2,4(1H,3H)-dione",0.093,uM,=,-1.031517051446065,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
3046,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)ccc2C(=O)N1O,"6-((2',4'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",5.6,uM,=,0.7481880270062004,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3047,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",3.6,uM,=,0.5563025007672873,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3048,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(OC)cc3)nc21,"5-Ethyl-7-(4-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.4,uM,=,0.1461280356782379,1,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
3049,196946,10.1016/S0960-894X(01)80437-6,,,,Compound was evaluated as inhibitor of recombinant HIV-l reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",2995.1693097382145,uM,=,3.476421377044781,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3050,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2ccn(COCc3ccccc3)c12,"4-((4-((5-((benzyloxy)methyl)-4-(4-cyano-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.158,uM,=,-0.8013429130455774,0,c1ccc(COCn2ccc3nc(NC4CCN(Cc5ccccc5)CC4)nc(Oc4ccccc4)c32)cc1
3051,2297017,10.1016/j.ejmech.2016.07.056,,,,Inhibition of HIV1 reverse transcriptase,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O,"(10R,11S,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",20.0,uM,=,1.3010299956639813,1,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
3052,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCSCC3)cc2)n1,"(E)-3-(3,5-dimethyl-4-((2-((4-(thiomorpholinomethyl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.062,uM,=,-1.207608310501746,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCSCC4)cc3)n2)cc1
3053,1293405,10.1016/j.bmc.2014.01.054,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotinylated dUTP incorporation after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)[nH]c(=O)c1,"4-((6-((4-Cyanophenyl)amino)-2-oxo-1,2-dihydropyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",5.2,uM,=,0.7160033436347992,1,O=c1cc(Oc2ccccc2)cc(Nc2ccccc2)[nH]1
3054,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.422,uM,=,-0.3746875490383261,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3055,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,"6-(biphenyl-4-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.25,uM,=,-0.6020599913279624,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3056,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1,2-Amino-6-(toluene-4-sulfonyl)-benzonitrile,7.3,uM,=,0.8633228601204559,1,O=S(=O)(c1ccccc1)c1ccccc1
3057,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,S=C(NCCc1ccccc1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-phenethyl-thiourea,1.3,uM,=,0.1139433523068367,1,S=C(NCCc1ccccc1)Nc1ccccn1
3058,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,N#Cc1ccc(NC2=Nc3ccc(Cl)cc3C(C#CC3CC3)(C(F)(F)F)N2)cc1,"4-((6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2-yl)amino)benzonitrile",0.01,uM,=,-2.0,0,C(#CC1NC(Nc2ccccc2)=Nc2ccccc21)C1CC1
3059,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(OCC(=O)Nc3ccccc3Cl)nc3ccccc32)c1,"N-(2-Chlorophenyl)-2-((1-((3,5-dimethylphenyl)sulfonyl)-1Hbenzo[d]imidazol-2-yl)oxy)acetamide",47.3,uM,=,1.6748611407378116,1,O=C(COc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3060,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccccc1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",8.9,uM,=,0.9493900066449128,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3061,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1cccc(C23SCCN2C(=O)c2ccccc23)c1C,"9b-(2,3-Dimethyl-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",1.65,uM,=,0.2174839442139062,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3062,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCN(S(C)(=O)=O)CC3)cc2)n1,"3,5-dimethyl-4-(2-(4-((4-(methylsulfonyl)piperazin-1-yl)methyl)phenylamino)pyrimidin-4-yloxy)benzonitrile",0.049,uM,=,-1.3098039199714864,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
3063,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)c(Cl)c2[C@@](C#Cc2ccccn2)(C(F)(F)F)N1,"5-Chloro-6-fluoro-4-pyridin-2-ylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)N1
3064,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cncs3)nc21,"5-Ethyl-10-methyl-7-thiazol-5-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.38,uM,=,-0.4202164033831898,0,O=C1Nc2ccc(-c3cncs3)nc2Nc2ncccc21
3065,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,Cc1cc(C)cc(C(=O)c2cc(=O)n(O)c(=O)[nH]2)c1,"6-(3,5-Dimethylbenzoyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.09,uM,=,-1.0457574905606752,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)[nH]1
3066,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1cc(Cl)cc(Oc2ccc(S(=O)(=O)F)cc2OCCn2ccc(=O)[nH]c2=O)c1,"4-(3-Chloro-5-cyanophenoxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)benzenesulfonyl fluoride",5.0,uM,=,0.6989700043360189,1,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
3067,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C(N)=O)c3)CC2)nc2c1CCCC2,"3-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)piperidin-1-yl)methyl)-benzamide",0.101,uM,=,-0.9956786262173574,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCCC4)CC2)cc1
3068,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1ccn2CO,"6-((4-(4-Cyano-2,6-dimethylphenozy)-7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)nicotinonitrile",0.047,uM,=,-1.3279021420642825,0,c1ccc(Oc2nc(Nc3cccnc3)nc3[nH]ccc23)cc1
3069,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C)c(Oc2nc(N)nc(Nc3ccc(CN4CCOCC4)cc3)n2)c(C)c1,"6-(mesityloxy)-N2-(4-(morpholinomethyl)phenyl)-1,3,5-triazine-2,4-diamine",0.442,uM,=,-0.3545777306509081,0,c1ccc(Oc2ncnc(Nc3ccc(CN4CCOCC4)cc3)n2)cc1
3070,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCCc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-propyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.45,uM,=,-0.3467874862246563,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3071,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1cc(Cc2ccccc2)nc(SCCCc2ccccc2)[nH]1,6-Benzyl-2-(3-phenylpropylthio)pyrimidin-4(3H)-one,8.17,uM,=,0.9122220565324156,1,O=c1cc(Cc2ccccc2)nc(SCCCc2ccccc2)[nH]1
3072,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),N#Cc1cccc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"3-(6-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-ylsulfonyl)benzonitrile",0.36,uM,=,-0.4436974992327127,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
3073,195358,10.1021/jm00012a014,,,,Inhibitory activity against HIV-1 Reverse transcriptase,CCOCCOCn1c2c(c(=O)[nH]c1=O)CNc1ccccc1S2,"4-(2-Ethoxy-ethoxymethyl)-10,11-dihydro-4H-5-thia-2,4,10-triaza-dibenzo[a,d]cycloheptene-1,3-dione",0.64,uM,=,-0.1938200260161128,0,O=c1[nH]c2c(c(=O)[nH]1)CNc1ccccc1S2
3074,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(Cl)cc2)cs1,(Z)-3-(2-(4-(4-chlorophenyl)thiazol-2-yl)hydrazono)indolin-2-one,10.6,uM,=,1.0253058652647702,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
3075,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)Sc3ccccc3CN12,"4b-Phenyl-4bH,10H-5-thia-10a-aza-benzo[b]fluoren-11-one",40.0,uM,=,1.6020599913279625,1,O=C1c2ccccc2C2(c3ccccc3)Sc3ccccc3CN12
3076,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2ccn(S(=O)(=O)c3ccccc3)c12,"3,5-dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-5-(phenylsulfonyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy)benzonitrile",0.38,uM,=,-0.4202164033831898,0,O=S(=O)(c1ccccc1)n1ccc2nc(NC3CCN(Cc4ccccc4)CC3)nc(Oc3ccccc3)c21
3077,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,"6-[4-(5,7-Dihydroxy-4-oxo-4H-chromen-2-yl)-phenoxy]-5,7-dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",62.0,uM,=,1.792391689498254,1,O=c1cc(-c2ccc(Oc3ccc4oc(-c5ccccc5)cc(=O)c4c3)cc2)oc2ccccc12
3078,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc([N+](=O)[O-])ccc2N(C)C(=O)c2cc(Br)cnc21,"3-Bromo-11-ethyl-6-methyl-9-nitro-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.89,uM,=,-0.0506099933550872,0,O=C1Nc2ccccc2Nc2ncccc21
3079,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2cccc(Cl)c2C2(c3ccccc3)SCCN12,"9-Chloro-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.29,uM,=,-0.5376020021010439,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3080,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),COc1ccc2c(c1)C1(c3ccccc3)SCCN1C2=O,"8-Methoxy-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",3.6,uM,=,0.5563025007672873,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3081,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2c(=O)n1O,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)naphthalene-2-sulfonamide",0.41,uM,=,-0.3872161432802645,0,O=c1[nH]c(=O)c2cc(NS(=O)(=O)c3ccc4ccccc4c3)ccc2[nH]1
3082,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.26,uM,=,-0.585026652029182,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3083,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1CSCC2,"(E)-5-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)picolinonitrile",0.032,uM,=,-1.494850021680094,0,c1ccc(Oc2nc(Nc3cccnc3)nc3c2CSCC3)cc1
3084,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cc1noc(C)c1-c1ccccc1Nc1cc(=O)n(O)c(=O)n1C,"6-((2-(3,5-Dimethylisoxazol-4-yl)phenyl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Nc2ccccc2-c2cnoc2)[nH]c(=O)[nH]1
3085,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cc1noc(C)c1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,"6-((4-(3,5-Dimethylisoxazol-4-yl)phenyl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",4.4,uM,=,0.6434526764861874,1,O=c1cc(Nc2ccc(-c3cnoc3)cc2)[nH]c(=O)[nH]1
3086,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)CNC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"6,8-dichloro-N-(2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl)-3,4-dihydroquinoline-1(2H)-carboxamide",0.336,uM,=,-0.4736607226101559,0,O=C(CNC(=O)N1CCCc2ccccc21)Nc1ccccc1
3087,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccc(-c3ccc(O)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",11.0,uM,=,1.0413926851582251,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3088,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCc3cccc4ccccc34)cc2)n[nH]1,3-(1-(4-Fluorobenzyl)-4-(4-(naphthalen-1-ylmethoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,4.5,uM,=,0.6532125137753437,1,c1ccc(Cn2cc(-c3ccc(OCc4cccc5ccccc45)cc3)c(-c3cc[nH]n3)c2)cc1
3089,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,Cc1nnc2n1-c1cccnc1N(C1CC1)c1ncccc1-2,"8-Cyclopropyl-3-methyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",7.82,uM,=,0.893206753059848,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2C1CC1
3090,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CCC(C)(C)NC(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-oxo-2-(tert-pentylamino)ethyl 5-nitrofuran-2-carboxylate,5.8,uM,=,0.7634279935629373,1,c1ccoc1
3091,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(=S)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-(3,5-dimethylbenzyl)-1,3-dihydro-2H-benzimidazol-2-thione",0.046,uM,=,-1.337242168318426,0,S=c1[nH]c2ccccc2n1Cc1ccccc1
3092,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cn2)nc2c1ccn2COCC[Si](C)(C)C,"6-((4-(4-Cyano-2,6-dimethylphenoxy)-7-((2-(trimethylsilyl)-ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-nicotinonitrile",31.0,uM,=,1.4913616938342726,1,c1ccc(Oc2nc(Nc3ccccn3)nc3[nH]ccc23)cc1
3093,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,C#CC1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)CC(n2cc(C)c(=O)[nH]c2=O)CC1O,"rac-(1-ethynyl-2-hydroxy-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopentyl)methyltriphosphoric acid",0.114,uM,=,-0.9430951486635274,0,O=c1ccn(C2CCCC2)c(=O)[nH]1
3094,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,Cc1cc(C)cc(C(=O)OC2C=CC(n3ccc(=O)n(Cc4ccccc4)c3=O)C2)c1,"1-[4-(3,5-Dimethylbenzoyloxy)-2-cyclopenten-1-yl]-3-benzyluracil",8.2,uM,=,0.9138138523837168,1,O=C(OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1)c1ccccc1
3095,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c(O)c12,"5,7,5',7'-Tetrahydroxy-2,2'-bis-(4-hydroxy-phenyl)-[6,8']bichromenyl-4,4'-dione",100.0,uM,=,2.0,1,O=c1cc(-c2ccccc2)oc2ccc(-c3cccc4c(=O)cc(-c5ccccc5)oc34)cc12
3096,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,CCN(CC)CC(C)(O)[C@H]1CCc2c(c(C)cc(O)c(=O)c2O)C1,"(2S)-2-(1-(diethylamino)-2-hydroxypropan-2-yl)-5,7-dihydroxy-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.5,uM,=,-0.3010299956639812,0,O=c1cccc2c(c1)CCCC2
3097,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COc1noc2c(C)cc(/C(=C\CCN3CCOC3=O)c3cccc(C#N)c3)cc12,(Z)-3-[1-(3-Methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(2-ox-oxazolidin-3-yl)-but-1-enyl]-benzonitrile,39.2,uM,=,1.5932860670204574,1,O=C1OCCN1CC/C=C(/c1ccccc1)c1ccc2oncc2c1
3098,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2ccc(-c3cccc(O)c3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.79,uM,=,-0.1023729087095585,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3099,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,Cc1cc(SCc2cnc3c(c2)C(=O)Nc2c(C)cc(Cl)nc2N3C2CC2)cc(C)n1,"7-Chloro-5-cyclopropyl-2-(2,6-dimethyl-pyridin-4-ylsulfanylmethyl)-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.012,uM,=,-1.9208187539523751,0,O=C1Nc2cccnc2N(C2CC2)c2ncc(CSc3ccncc3)cc21
3100,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)OCCCN12,"4a-Phenyl-2,3-dihydro-1H,4aH-4-oxa-9a-aza-fluoren-9-one",51.0,uM,=,1.7075701760979365,1,O=C1c2ccccc2C2(c3ccccc3)OCCCN12
3101,600528,10.1021/jm801176e,,,,Inhibition of HIV1 wild type reverse transcriptase-mediated viral DNA synthesis in human HOS-313 cells expressing HSV thymidine kinase assessed as luciferase activity treated 3 hrs before infection measured after 48 hrs by luminescence assay,Cc1cccc2c1OP(=O)(OC[C@H]1C[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]1O)OC2,"1-{(3S,1R,4R)-3-hydroxy-4-[(8-methyl-2-oxo(4H-benzo[d]1,3,2-dioxaphosphan-2-yloxy))methylcyclopentyl}-5-methyl-1,3-dihydropyrimidine-2,4(1H,3H)-dione",0.12,uM,=,-0.9208187539523752,0,O=c1ccn([C@H]2CC[C@@H](COP3(=O)OCc4ccccc4O3)C2)c(=O)[nH]1
3102,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,CN(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(methyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.015,uM,=,-1.8239087409443189,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
3103,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1ccc(-c2ccc(C(=O)N[C@H](CN)c3ncc(CO)s3)[nH]2)cc1F,(R)-N-(2-amino-1-(5-(hydroxymethyl)thiazol-2-yl)ethyl)-5-(3-fluoro-4-methylphenyl)-1H-pyrrole-2-carboxamide,7.2,uM,=,0.8573324964312685,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
3104,2226592,10.1016/j.ejmech.2022.114471,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction of biotin-dUTP incorporation into protein using ABTS as substrate incubated for 1 hrs by ELISA analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.48,uM,=,-0.3187587626244128,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3105,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CC(C)C1C(=O)N(O)C(=O)c2ccccc21,"2-Hydroxy-4-isopropylisoquinoline-1,3(2H,4H)-dione",18.5,uM,=,1.2671717284030135,1,O=C1Cc2ccccc2C(=O)N1
3106,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,Fc1ccoc1CC/N=C(\S)Nc1ccc(Cl)cn1,1-(5-Chloro-pyridin-2-yl)-3-[2-(3-fluoro-furan-2-yl)-ethyl]-thiourea,0.004,uM,=,-2.397940008672037,0,C(=NCCc1ccco1)Nc1ccccn1
3107,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCCCC=C(c1cc(I)c(OC)c(C(=O)OC)c1)c1cc(I)c(OC)c(C(=O)OC)c1,"3',3''-Diiodo-4',4''-Dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-heptene",11.0,uM,=,1.0413926851582251,1,C=C(c1ccccc1)c1ccccc1
3108,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,C=CCCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,"methyl 3-bromo-5-[1-(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-1,6-heptadienyl]-2-methoxybenzoate",99.0,uM,=,1.99563519459755,1,C=C(c1ccccc1)c1ccccc1
3109,195844,10.1021/jm00020a026,,,,antiviral activity in Human immunodeficiency virus-1 as reverse transcriptase activity in culture supernatant,N#Cc1c(Br)n([C@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c2ncnc(N)c12,"4-Amino-6-bromo-7-(3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile",32.0,uM,=,1.505149978319906,1,c1ncc2ccn([C@@H]3CCCO3)c2n1
3110,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccccc2Br)[nH]c(=O)n1O,"6-((2-Bromophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.008,uM,=,-2.096910013008056,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
3111,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,Cn1c(Cc2cccc(Oc3ccccc3)c2)n[nH]c1=O,"5-(3-phenoxybenzyl)-4-methyl-2H-1,2,4-triazol-3(4H)-one",18.0,uM,=,1.255272505103306,1,O=c1[nH]nc(Cc2cccc(Oc3ccccc3)c2)[nH]1
3112,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=[N+]([O-])c1ccc(O)c(/C=N/NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)c1,"N'-(2-hydroxy-5-nitrobenzylidene)-2,4,5-trichlorobenzenesulfonohydrazide",22.0,uM,=,1.3424226808222062,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
3113,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1,2-(2-Benzoyl-4-chloro-phenoxy)-N-phenyl-acetamide,0.0273911163301112,uM,=,-1.5623902676318449,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
3114,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(O)c2)cn1,"(E)-3-(3, 4-dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0355,uM,=,-1.449771646944906,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1cccnc1)Cc1ccccc1
3115,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,COC(=O)CSc1nc(O)c(C)c(Cc2cccc3ccccc23)n1,"(5-Methyl-4-naphthalen-1-ylmethyl-6-oxo-1,6-dihydro-pyrimidin-2-ylsulfanyl)-acetic acid methyl ester",6.99,uM,=,0.8444771757456815,1,c1ccc2c(Cc3ccncn3)cccc2c1
3116,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cccc(-c2ccc(Oc3c(C(F)(F)F)ccn(Cc4n[nH]c(=O)n4C)c3=O)cc2C)c1,"3-(2,3'-Dimethyl-[1,1'-biphenyl]-4-yl)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",6.54,uM,=,0.8155777483242672,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3117,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCc1cc(CCCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[3-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-propyl]-isoindole-1,3-dione",210.0,uM,=,2.322219294733919,1,O=C1c2ccccc2C(=O)N1CCCc1cccnc1
3118,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",1.0,uM,=,0.0,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3119,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CC(C)=CCN1C(C)C(=O)Nc2ccc(Cl)cc2S1(=O)=O,"8-chloro-3-methyl-2-(3-methylbut-2-enyl)-1,1-dioxo-3,5-dihydro-1'6,2,5-benzothiadiazepin-4-one",0.8,uM,=,-0.0969100130080563,0,O=C1CNS(=O)(=O)c2ccccc2N1
3120,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),COC(=O)/C=C/CSc1nc(N)cc(Cl)n1,(E)-4-(4-Amino-6-chloro-pyrimidin-2-ylsulfanyl)-but-2-enoic acid methyl ester,0.93,uM,=,-0.0315170514460648,0,c1cncnc1
3121,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CN(C)c1cc(F)c(CC/N=C(\S)Nc2ccc(Cl)cn2)c(F)c1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(4-dimethylamino-2,6-difluoro-phenyl)-ethyl]-thiourea",0.02,uM,=,-1.6989700043360187,0,C(=NCCc1ccccc1)Nc1ccccn1
3122,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3ccc(C)cc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(6-methyl-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,1.65,uM,=,0.2174839442139062,1,c1cncc(NCc2nc3ccccc3o2)c1
3123,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.54,uM,=,-0.2676062401770315,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3124,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(Br)cc(C)c1Oc1cnc(N)c(Nc2ccc(C#N)cc2)c1,"4-((2-amino-5-(4-bromo-2,6-dimethylphenoxy)pyridin-3-yl)amino)benzonitrile",0.26,uM,=,-0.585026652029182,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
3125,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)Cc2cc(=O)oc3cc(N(C)C)ccc23)cc1,"2-(7-(Dimethylamino)-2-oxo-2H-chromen-4-yl-N-((25,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acetamide",0.3551,uM,=,-0.4496493276983845,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3126,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,"6-([1,1'-biphenyl]-4-ylthio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.09,uM,=,-1.0457574905606752,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3127,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,Cc1ccc(S(=O)(=O)NNC(=O)c2nc3ccccc3c(=O)[nH]2)cc1,"4-methyl-N'-(4-oxo-3,4-dihydroquinazoline-2-carbonyl)benzenesulfonohydrazide",73.0,uM,=,1.863322860120456,1,O=C(NNS(=O)(=O)c1ccccc1)c1nc2ccccc2c(=O)[nH]1
3128,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(Cc2ccc3c(c2)CC(=O)N(O)C3=O)cc1,"2-Hydroxy-6-(4-methylbenzyl)isoquinoline-1,3(2H,4H)-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3129,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Cc1cccc(CSc2nc(N)cc(Cl)n2)c1,6-Chloro-2-(3-methyl-benzylsulfanyl)-pyrimidin-4-ylamine,0.28,uM,=,-0.5528419686577808,0,c1ccc(CSc2ncccn2)cc1
3130,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
3131,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3cccc(S(N)(=O)=O)c3)CC2)n1,"3-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzenesulfonamide",0.015,uM,=,-1.8239087409443189,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
3132,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1cccc(F)c1CCNC(=S)Nc1nccs1,1-[2-(2-Fluoro-6-methoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.01,uM,=,-2.0,0,S=C(NCCc1ccccc1)Nc1nccs1
3133,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(Nc2ccc(C#N)cc2)c1,"4-((2-Chloro-6-((4-cyanophenyl)amino)pyridine-4-yl)oxy)-3,5-dimethylbenzonitrile",0.773,uM,=,-0.111820506081675,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
3134,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(3-ethoxy-2,6-difluoro-phenyl)-cyclopropyl]-urea",0.0015,uM,=,-2.8239087409443187,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
3135,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1,"8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid (suramin)",9.4,uM,=,0.9731278535996988,1,O=C(Nc1cccc(C(=O)Nc2cccc(C(=O)Nc3cccc4ccccc34)c2)c1)Nc1cccc(C(=O)Nc2cccc(C(=O)Nc3cccc4ccccc34)c2)c1
3136,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccccc3OC)nc21,"5-Ethyl-7-(2-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.5,uM,=,0.3979400086720376,1,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
3137,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1Cl,"1-[(1R,2R)-2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea",0.008,uM,=,-2.096910013008056,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
3138,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CC(C)Cc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isobutyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3139,195370,10.1021/jm9607921,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+],trisodium phosphonoformate,2.03,uM,=,0.3074960379132129,1,
3140,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3ccc(OCCOCCOCCO)cc3[nH]2)CC1,(6-{2-[2-(2-Hydroxy-ethoxy)-ethoxy]-ethoxy}-1H-indol-2-yl)-{4-[(3-isopropylamino-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-methanone,0.3,uM,=,-0.5228787452803376,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3141,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3cccnc3)ccc21,"5-Cyclopropyl-10-methyl-7-pyridin-3-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.44,uM,=,-0.3565473235138126,0,O=C1Nc2ccc(-c3cccnc3)nc2N(C2CC2)c2ncccc21
3142,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)nc3ccc(Cl)cc32)c1,"2-({6-Chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl}sulfanyl)-N-(2-chloro-4-sulfamoylphenyl)-acetamide",3.04,uM,=,0.4828735836087537,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3143,1875049,10.1016/j.ejmech.2019.111637,,,,Inhibition of HIV-1 reverse transcriptase,Oc1ccc(/C=C/c2cc(O)c3c(-c4cc(O)cc(O)c4)c(-c4ccc(O)cc4)oc3c2)cc1,"(5-[4-hydroxy-2-(4-hydroxyphenyl)-6-{(1E)-2-(4-hydroxyphenyl)ethenyl}-3-benzofuranyl]-1,3-benzenediol)",8.0,uM,=,0.9030899869919436,1,C(=C/c1ccc2c(-c3ccccc3)c(-c3ccccc3)oc2c1)\c1ccccc1
3144,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CC(C)c1c(O)nc(SCC(=O)c2ccccc2)nc1Cc1cccc2ccccc12,5-Isopropyl-6-naphthalen-1-ylmethyl-2-(2-oxo-2-phenyl-ethylsulfanyl)-3H-pyrimidin-4-one,0.046,uM,=,-1.337242168318426,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
3145,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1cc(C)c(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c(C)c1,"6-Chloro-1-(2,4,6-trimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.0012,uM,=,-2.920818753952376,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
3146,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc4ccccc34)cc2c1=O,"1-(4-Fluorobenzyl)-6-(naphthalen-1-ylmethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",11.4,uM,=,1.0569048513364727,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3cccc4ccccc34)cc12
3147,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.7,uM,=,-0.1549019599857432,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3148,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cccc(C)c2N(C)C(=O)c2cccnc21,"11-Ethyl-6,7-dimethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.24,uM,=,-0.619788758288394,0,O=C1Nc2ccccc2Nc2ncccc21
3149,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3ccnn3)ccc12,"7-(5-Methyl-2-[1,2,3]triazol-1-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.64,uM,=,-0.1938200260161128,0,O=C(CCCCCCc1ncc2ccc(-n3ccnn3)nn12)c1ccccc1
3150,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,N#Cc1ccc2nc(-c3ccccc3Cl)c(NC3CCCCC3)n2c1,"2-(2-Chlorophenyl)-3-(cyclohexylamino)imidazo[1,2-a]pyridine-6-carbonitrile",6.6,uM,=,0.8195439355418687,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
3151,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),CC(C)c1nc(CCCCCCC(=O)c2ccccc2)n2nc(Cl)ccc12,"7-(2-Chloro-5-isopropyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",110.0,uM,=,2.041392685158225,1,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
3152,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CCC(C)C)NC(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(3-methyl-butyl)-hydrazinocarbonyl]-2-methyl-propyl}-carbamic acid methyl ester",0.016,uM,=,-1.7958800173440752,0,c1ccccc1
3153,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2c(Cl)cccc2Cl)C(F)(F)F)c(O)nc1C,"3-[3-Cyclopropyl-1-(2,6-dichloro-benzyloxy)-1-trifluoromethyl-prop-2-ynyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.041102,uM,=,-1.3861370450866817,0,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
3154,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CN1C(=O)c2cccnc2N(CCF)c2ncccc21,"5-(2-Fluoro-ethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.9,uM,=,0.4623979978989561,1,O=C1Nc2cccnc2Nc2ncccc21
3155,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cccc(NC(=O)CS(=O)(=O)c2nccc(Oc3c(C)cc(C#N)cc3C)n2)c1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(m-tolyl)acetamide",133.0,uM,=,2.123851640967086,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
3156,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccccc2oc1=O)S(=O)(=O)c1ccc(N)cc1,"N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-2-oxo-2H-chromene-3-carboxamide",0.0752999999999999,uM,=,-1.1232050237992994,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
3157,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nc(C)cn2-c2cccnc21,"8-Ethyl-2-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",11.2,uM,=,1.0492180226701815,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
3158,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1O,"4-(4-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)phenyl)pyridin-1-ium 4-methylbenzenesulfonate",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1.c1ccccc1
3159,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2ncccc12,"7-(5-Methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.56,uM,=,-0.2518119729937995,0,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
3160,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CN(c1ncccc1NCC1CC1)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-[2-(4-{[3-(Cyclopropylmethyl-amino)-pyridin-2-yl]-methyl-amino}-piperidine-1-carbonyl)-1H-indol-5-yl]-methanesulfonamide,0.52,uM,=,-0.2839966563652008,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ncccc2NCC2CC2)CC1
3161,195844,10.1021/jm00020a026,,,,antiviral activity in Human immunodeficiency virus-1 as reverse transcriptase activity in culture supernatant,N#Cc1c(Br)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c2ncnc(N)c12,"4-Amino-6-bromo-7-(3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile",12.0,uM,=,1.0791812460476249,1,c1ncc2ccn([C@H]3CCCO3)c2n1
3162,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1c2ccccc2C(=O)N1CNc1cc2c(nc1O)CCCC2,"2-[(2-Oxo-1,2,5,6,7,8-hexahydro-quinolin-3-ylamino)-methyl]-isoindole-1,3-dione",3.7,uM,=,0.568201724066995,1,O=C1c2ccccc2C(=O)N1CNc1cnc2c(c1)CCCC2
3163,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1Nc2ccc(Cl)cc2[C@@](/C=C/C2CC2)(C(F)(F)F)N1,"(S)-6-Chloro-4-((E)-2-cyclopropyl-vinyl)-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.023,uM,=,-1.6382721639824072,0,O=C1Nc2ccccc2C(/C=C/C2CC2)N1
3164,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCNC(=S)NNc1c(Cc2cccc(C)c2)c(CC)c(C)[nH]c1=O,"3-ethyl-1-({5-ethyl-6-methyl-4-[(3-methylphenyl)methyl]-2-oxo-1,2-dihydropyridin-3-yl}amino)thiourea",25.119,uM,=,1.400002345927956,1,O=c1cc(Cc2ccccc2)cc[nH]1
3165,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,COc1ccc(OC)c(CCNC(=S)Nc2nccs2)c1,"1-[2-(2,5-Dimethoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea",0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccc1)Nc1nccs1
3166,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1nc2ccccc2s1,1-Benzothiazol-2-yl-3-phenethyl-thiourea,0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccc1)Nc1nc2ccccc2s1
3167,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1nc(O)c2ncn(C3C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)COC4C=CC(n5cnc6c(O)nc(N)nc65)C4)C3)c2n1,"P,P'-Bis {[4-(guanine-9-yl)cyclopent-2-enyl]oxy-methylphosphonyl}phosphate",8.0,uM,=,0.9030899869919436,1,O=[PH](COC1C=CC(n2cnc3cncnc32)C1)O[PH](=O)O[PH](=O)COC1C=CC(n2cnc3cncnc32)C1
3168,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,CCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-3-propyl-1H-pyrimidine-2,4-dione",4.3,uM,=,0.6334684555795865,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3169,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,Cc1cc(/C=C2\NC(=O)NC2=O)cc(C)c1OCc1cccc([N+](=O)[O-])c1,"5-(3,5-dimethyl-4-(3-nitrobenzyloxy)benzylidene)imidazolidine-2,4-dione",17.78,uM,=,1.249931756634195,1,O=C1NC(=O)/C(=C/c2ccc(OCc3ccccc3)cc2)N1
3170,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(C=O)cc(OC)nc21,"5-Ethyl-7-methoxy-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cycloheptene-9-carbaldehyde",0.24,uM,=,-0.619788758288394,0,O=C1Nc2cccnc2Nc2ncccc21
3171,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,CC(=O)N1CCN(c2ccc3c(=O)c(C(=O)/C=C(\O)C(=O)O)cn(Cc4ccc(F)cc4)c3c2)CC1,4-[1-[(4-Fluorophenyl)methyl]-7-(N-acetylpiperazin-1-yl)-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid,3.3,uM,=,0.5185139398778875,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCNCC3)ccc12
3172,1454137,10.1016/j.bmc.2014.07.018,,,,Inhibition of HIV reverse transcriptase,CCN1c2ncc(CCOc3cc[n+]([O-])c4ccccc34)cc2C(=O)N(C)c2cccnc21,"11-ethyl-5,11-dihydro-5-methyl-8-[2-(1-oxido-4-quinolinyl)oxy]ethyl)-6H-dipyrido[3,2-b:2',3'-e][1,4]dizepin-6-one",0.017,uM,=,-1.769551078621726,0,O=C1Nc2cccnc2Nc2ncc(CCOc3cc[nH+]c4ccccc34)cc21
3173,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cccc(C#N)c4)cc3)c2=O)n[nH]c1=O,"4'-((1-((4-Methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)[1,1'-bipheny1]-3-carbonitrile",14.36,uM,=,1.1571544399062814,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3174,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3175,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCCN1CCN(C(=O)OC(C)(C)C)CC1,"Tert-butyl 4-(2-(2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetamido)ethyl)piperazine-1-carboxylate",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCCN1CCNCC1
3176,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,CCc1n[nH]c2cccc(Oc3cc(C#N)cc(C#N)c3)c12,5-(3-ethyl-1H-indazol-4-yloxy)isophthalonitrile,0.112,uM,=,-0.9507819773298184,0,c1ccc(Oc2cccc3[nH]ncc23)cc1
3177,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-oxy)pyrimidine-2,4(1H,3H)-dione",6.2,uM,=,0.7923916894982539,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3178,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC[C@H]1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O,"5-Cyclopropylethynyl-3-ethyl-7-fluoro-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",1.14,uM,=,0.0569048513364725,1,O=C1COC(C#CC2CC2)c2ccccc2N1
3179,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc([N+](=O)[O-])cc2)cs1,SID507693,2.9,uM,=,0.4623979978989561,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
3180,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OC1COc2cc(O)ccc2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 7-hydroxy-chroman-3-yl ester",7.6,uM,=,0.8808135922807914,1,O=C(OC1COc2ccccc2C1)c1ccccc1
3181,442660,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rA.dT template,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",23.0,uM,=,1.3617278360175928,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3182,471469,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.13,uM,=,-0.8860566476931633,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3183,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1CSCC2,"3,5-dimethyl-4-(2-(1-(4-nitrobenzyl)piperidin-4-ylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)benzonitrile",0.23,uM,=,-0.6382721639824072,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
3184,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Cc1cc2cc3cc(C)c(N)cc3nc2cc1N.Cl,SID540666,32.0,uM,=,1.505149978319906,1,c1ccc2nc3ccccc3cc2c1
3185,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3ccnc3)ccc12,"7-(2-Imidazol-1-yl-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.0006,uM,=,-3.2218487496163566,0,O=C(CCCCCCc1ncc2ccc(-n3ccnc3)nn12)c1ccccc1
3186,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC1OC(/C=C/C2CC2)(C(F)(F)F)c2c(ccc(F)c2F)NC1=O,"5-((E)-2-Cyclopropyl-vinyl)-6,7-difluoro-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.173,uM,=,-0.7619538968712046,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
3187,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(OS(C)(=O)=O)cc3[nH]2)CC1,Methanesulfonic acid 2-[4-(3-isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-6-yl ester,2.2,uM,=,0.3424226808222063,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3188,503078,10.1021/np960399y,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@@H](C)[C@H](C)[C@@H]3O,"(10S,11R,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",1.4,uM,=,0.1461280356782379,1,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
3189,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(C#N)cn2)c1Cl,"1-[(1R,2R)-2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-cyano-pyridin-2-yl)-urea",0.08,uM,=,-1.0969100130080565,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
3190,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,O=C(CSc1nnnn1-c1cccc2ccccc12)Nc1ccccc1[N+](=O)[O-],2-(1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.0095,uM,=,-2.0222763947111524,0,O=C(CSc1nnnn1-c1cccc2ccccc12)Nc1ccccc1
3191,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2cc(N)ccc2Oc2ccc(C)c(C)c21,"2-Amino-8,9-dimethyl-10-propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.67,uM,=,-0.1739251972991735,0,O=C1Nc2ccccc2Oc2ccccc21
3192,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccccc1-c1nc2ccccn2c1NC1CCCCC1,"2-(2-Chlorophenyl)-N-cyclohexylimidazo[1,2-a]pyridin-3-amine",4.39,uM,=,0.6424645202421213,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
3193,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccc(Cl)cc1Cl)CC(=O)C(=O)O,"6-[1-(2,4-Dichlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",7.0,uM,=,0.8450980400142568,1,c1ccc(Cn2cccc2)cc1
3194,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.58,uM,=,0.4116197059632301,1,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
3195,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccccc2F)n1,2-sec-Butylsulfanyl-6-(2-fluoro-benzyl)-3H-pyrimidin-4-one,0.3,uM,=,-0.5228787452803376,0,c1ccc(Cc2ccncn2)cc1
3196,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,Br.NC(=O)c1sc(N)nc1-c1ccccc1,2-amino-4-phenylthiazole-5-carboxamide hydrobromide,80.7,uM,=,1.9068735347220704,1,c1ccc(-c2cscn2)cc1
3197,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccc(F)cc3)n2)cc1,4-(4-(4-fluorobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.382,uM,=,-0.4179366370882912,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
3198,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.019,uM,=,-1.7212463990471711,0,c1cncc(NCc2nc3ccccc3o2)c1
3199,427347,10.1128/aac.00749-06,,,,Inhibition of reverse transcriptase activity in HIV1 infected HeLa-MAGI cells at 37 deg C after 48 hrs,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.01,uM,=,-2.0,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3200,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(Cl)cc2)cs1,(Z)-3-(2-(4-(4-chlorophenyl)thiazol-2-yl)hydrazono)indolin-2-one,20.0,uM,=,1.3010299956639813,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
3201,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(O)cc3[nH]2)CC1,(6-Hydroxy-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,1.2,uM,=,0.0791812460476248,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3202,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCCC#CC1(C(F)(F)F)OC(=O)Nc2ccc(N)cc21,"6-Amino-4-pent-1-ynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",1.506,uM,=,0.1778249718646817,1,O=C1Nc2ccccc2CO1
3203,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1ccc(O)c(O)c1)S(=O)(=O)c1ccc(N)cc1,"(E)-N-((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(3,4-dihydroxyphenyl)acrylamide",0.0075,uM,=,-2.1249387366083,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3204,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",5.3,uM,=,0.724275869600789,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3205,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2sccc2c(=O)n1O,"3-Hydroxy-4a,7a-dihydro-1H-thieno[2,3-d]pyrimidine-2,4-dione",0.2,uM,=,-0.6989700043360187,0,O=c1[nH]c(=O)c2ccsc2[nH]1
3206,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CC1(C)CCC[C@]2(C)OC3CC[C@](C)(C4CC[C@]5(C)C4CC[C@]4(C)c6c(O)ccc(O)c6CC54)[C@]3(C)CCC12,toxicol B,8.2,uM,=,0.9138138523837168,1,c1ccc2c(c1)CC1C2CCC2C1CCC2C1CCC2OC3CCCCC3CCC21
3207,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,CC1CCCCC1Nc1cc(CCc2ccccc2)[nH]c(=O)c1Br,3-Bromo-4-((2-methylcyclohexyl)amino)-6-phenethylpyridin-2(1H)-one,0.68,uM,=,-0.1674910872937636,0,O=c1cc(NC2CCCCC2)cc(CCc2ccccc2)[nH]1
3208,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(-c2cccc(Cl)c2)nc(O)c1O,"2-(3-Chlorophenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",18.0,uM,=,1.255272505103306,1,c1ccc(-c2ncccn2)cc1
3209,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccccc2C(=O)N(C)c2cccnc21,"11-Ethyl-5-methyl-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one",0.5,uM,=,-0.3010299956639812,0,O=C1Nc2cccnc2Nc2ccccc21
3210,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)nc3ccccc32)c1,"2-({1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)-N-(2-chloro-4-sulfamoylphenyl)-acetamide",18.51,uM,=,1.2674064187529042,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3211,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4nccnc34)c2F)c1,"3-[6-Bromo-2-fluoro-3-(1H-pyrazolo[3,4-b]pyrazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",0.003,uM,=,-2.5228787452803374,0,c1ccc(Oc2cccc(Cc3n[nH]c4nccnc34)c2)cc1
3212,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-pyridin-2-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester",0.02,uM,=,-1.6989700043360187,0,c1ccc(CCCCNCc2ccc(-c3ccccn3)cc2)cc1
3213,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,COc1ccc2[nH]c(=S)n3c2c1CN(CC=C(C)C)[C@@H](C)C3,"(S)-5-Methoxy-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",33.9,uM,=,1.530199698203082,1,S=c1[nH]c2cccc3c2n1CCNC3
3214,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Nc1ccc2c(c1)C1(c3ccccc3)SCCN1C2=O,"8-Amino-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.5,uM,=,0.6532125137753437,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3215,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cc(F)cc(C#N)c4)cc3)c2=O)n[nH]c1=O,"5-Fluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-y1)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)[1,1'-bipheny1]-3-carbonitrile",8.1,uM,=,0.9084850188786496,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3216,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1cc(C)cc(S(=O)(=O)n2c(=O)[nH]c3cc(F)c(Cl)cc32)c1,"6-Chloro-5-fluoro-1-(3,5-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.158,uM,=,-0.8013429130455774,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
3217,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCOc1ccc(Cl)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-[(1R,2R)-2-(6-Chloro-3-ethoxy-2-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea",0.0015,uM,=,-2.8239087409443187,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
3218,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1.CS(=O)(=O)O,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)-methanone; compound with methanesulfonic acid,2.3,uM,=,0.3617278360175928,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3219,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(C)c(Oc2cnc(N)c(Nc3ccc(C#N)cc3)c2)c(C)c1,4-((2-amino-5-(mesityloxy)pyridin-3-yl)amino)benzonitrile,0.09,uM,=,-1.0457574905606752,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
3220,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cn1c(Oc2ccccc2-c2ccc(Cl)cc2)cc(=O)n(O)c1=O,"6-((4'-Chloro-[1,1'-biphenyl]-2-yl)oxy)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",14.0,uM,=,1.146128035678238,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
3221,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",1.0,uM,=,0.0,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3222,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",6.7,uM,=,0.8260748027008264,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3223,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)c(F)c1,"N-(3,4-Difluorobenzyl)-1-(hydroxy)-4-(ethylamino)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.026,uM,=,-1.585026652029182,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
3224,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-n2nccc2OCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(1-(2-chloro-4-methylphenyl)-1H-pyrazol-5-yloxy)acetamido)biphenyl-4-yl)acetic acid,0.018,uM,=,-1.744727494896694,0,O=C(COc1ccnn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
3225,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(C)c1,"6-[1-(3-Methylphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",9.6,uM,=,0.9822712330395684,1,c1ccc(Cn2cccc2)cc1
3226,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2c(c(=O)n1O)C1CCCC1S2,"3-Hydroxy-1,5,6,7-tetrahydro-2H-cyclopenta[4,5]thieno[2,3-d]pyrimidine-2,4(3H)-dione",0.1,uM,=,-1.0,0,O=c1[nH]c2c(c(=O)[nH]1)C1CCCC1S2
3227,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1ncc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)cn1,"4-((4-((2,6-Dimethyl-4-(2-methylpyrimidin-5-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0467,uM,=,-1.3306831194338875,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
3228,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCCCOC(C#CC1CC1)(c1cc(CC)c(C)nc1O)C(F)(F)F,3-(1-Butoxy-3-cyclopropyl-1-trifluoromethyl-prop-2-ynyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.129,uM,=,-0.889410289700751,0,C(#CC1CC1)Cc1cccnc1
3229,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccc(Cl)c2)nc(SC(C)C)[nH]c1=O,"2-(3-chlorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.713,uM,=,-0.1469104701481344,0,O=c1cc(Cc2ccccc2)nc[nH]1
3230,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])c(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-methyl-1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.31,uM,=,0.6344772701607315,1,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
3231,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",1.1,uM,=,0.041392685158225,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3232,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCC(NS(C)(=O)=O)CC3)cc2)n1,"N-(1-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)benzyl)piperidin-4-yl)methanesulfonamide",0.079,uM,=,-1.1023729087095586,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCCCC4)cc3)n2)cc1
3233,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCc2nnc(C)o2)c2cccc(C#N)c2)cc1C(=O)SC,"(E)-S-methyl 5-(1-(3-cyanophenyl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",55.0,uM,=,1.740362689494244,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
3234,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1[nH]c(=O)n([C@@H]2O[C@H](CNCc3c(Cl)cccc3Cl)[C@@H](O)[C@H]2O)cc1F,"5'-(2, 6-dichlorobenzylamino)methyl-5-fluorouridine",4.84,uM,=,0.6848453616444125,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
3235,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),CCOc1cc(/C=C2\SC(=S)N(NC(=O)c3ccccc3O)C2=O)ccc1O,N-{5-[1-(3-Ethoxy-4-hydroxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-2-hydroxy-benzamide,70.0,uM,=,1.845098040014257,1,O=C(NN1C(=O)/C(=C/c2ccccc2)SC1=S)c1ccccc1
3236,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1cccc(C(F)(F)F)c1,"6-Chloro-1-(3-trifluoromethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",1.72,uM,=,0.2355284469075489,1,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
3237,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccccc2I)c(C)c1,N-(2-iodophenyl)-2-(1-mesityl-1H-tetrazol-5-ylthio)acetamide,0.031,uM,=,-1.5086383061657274,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
3238,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(C(N)=O)cc3)CC2)ncc1Br,"4-(4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.024,uM,=,-1.619788758288394,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
3239,1862051,10.1016/j.ejmech.2019.111619,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.59,uM,=,-0.2291479883578558,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3240,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2n1O,"4-(biphenyl-3-yl)-1-hydroxy-1,8-naphthyridin-2(1H)-one",0.64,uM,=,-0.1938200260161128,0,O=c1cc(-c2cccc(-c3ccccc3)c2)c2cccnc2[nH]1
3241,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(O)c1ccc(S(=O)(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)c(C(=O)O)c2)C3=O)cc1,"5-[5-(4-Carboxy-benzenesulfonyl)-1,3-dioxo-1,3-dihydro-isoindol-2-yl]-2-hydroxy-benzoic acid",66.0,uM,=,1.8195439355418688,1,O=C1c2ccc(S(=O)(=O)c3ccccc3)cc2C(=O)N1c1ccccc1
3242,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1cc(Cl)ccc1Cl,"2-Amino-6-(2,5-dichloro-benzenesulfonyl)-benzonitrile",0.3,uM,=,-0.5228787452803376,0,O=S(=O)(c1ccccc1)c1ccccc1
3243,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1CCCC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)piperidin-1-yl)methyl)-benzenesulfonamide",0.084,uM,=,-1.0757207139381184,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCCC4)CC2)cc1
3244,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1Br,"4-[5-Bromo-2-(4-cyano-phenylamino)-pyrimidin-4-ylamino]-3,5-dimethyl-benzonitrile",0.0004,uM,=,-3.397940008672037,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
3245,195372,10.1021/jm9800806,,,,Inhibitory activity against HIV-1 reverse transcriptase (wild type),CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.17,uM,=,-0.7695510786217261,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3246,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cc(Cl)cc(C(F)(F)F)c2)nc(SC(C)C)[nH]c1=O,"2-(3-chloro-5-(trifluoromethyl)phenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",3.519,uM,=,0.5464192668351916,1,O=c1cc(Cc2ccccc2)nc[nH]1
3247,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCCCOc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-butoxy-5-methyl-benzenesulfonyl)-benzonitrile,0.4,uM,=,-0.3979400086720376,0,O=S(=O)(c1ccccc1)c1ccccc1
3248,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cn2)nc2c1CSCC2,"(E)-6-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)nicotinonitrile",0.059,uM,=,-1.2291479883578558,0,c1ccc(Oc2nc(Nc3ccccn3)nc3c2CSCC3)cc1
3249,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,CC(C)c1ccc(-c2nc(O)c(O)c(C(=O)O)n2)cc1,"5,6-Dihydroxy-2-(4-isopropylphenyl)pyrimidine-4-carboxylic acid",22.0,uM,=,1.3424226808222062,1,c1ccc(-c2ncccn2)cc1
3250,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(F)cc2)nc(SC(C)C)[nH]c1=O,"2-(4-fluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",14.265999999999998,uM,=,1.1543022196846644,1,O=c1cc(Cc2ccccc2)nc[nH]1
3251,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](N)Cc1c[nH]c2ccccc12,(R)-1-(2-((R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-2-oxoethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,6.1,uM,=,0.785329835010767,1,O=C(CCc1c[nH]c2ccccc12)NCC(=O)NCCc1c[nH]c2ccccc12
3252,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,O=P(O)(O)C(Nc1ncnc2nc(-c3cccs3)ccc12)P(=O)(O)O,"(((7-(Thiophen-2-yl)pyrido[2,3-d]pyrimidin-4-yl)amino)-methylene)diphosphonic Acid",10.4,uM,=,1.0170333392987805,1,c1csc(-c2ccc3cncnc3n2)c1
3253,195512,10.1021/jm960056x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"6-Benzyl-1-benzyloxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3254,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccnc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(2-Amino-pyridin-4-yl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
3255,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCc2nnc(C)o2)c2ccc(C#N)cc2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(4-cyanophenyl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",6.3,uM,=,0.7993405494535817,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
3256,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cnccc2OC)c(O)nc1C,5-Ethyl-3-[(4-methoxy-pyridin-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,10.0,uM,=,1.0,1,c1cncc(CNc2cccnc2)c1
3257,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@]3(C)Cl,"(7S,8R,9S,13S,14S,17R)-7-Chloro-17-ethynyl-17-hydroxy-7,13-dimethyl-1,2,4,6,7,8,9,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one",0.2,uM,=,-0.6989700043360187,0,O=C1CCC2=C(CC[C@@H]3[C@@H]2CCC2CCC[C@H]23)C1
3258,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,CN1C(=O)Nc2ccc(Cl)cc2C1(C#Cc1ccccn1)C1CC1,"6-Chloro-4-cyclopropyl-3-methyl-4-pyridin-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.0196,uM,=,-1.707743928643524,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)(C2CC2)N1
3259,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccc([N+](=O)[O-])cc2)C1,"1-benzyl-7,7-dimethyl-4-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",1.4,uM,=,0.1461280356782379,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
3260,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2cncs2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-5-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester",0.041,uM,=,-1.3872161432802643,0,c1ccc(CCCCNCc2ccc(-c3cncs3)cc2)cc1
3261,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,N#Cc1ccc(Nc2nc(Oc3ccc(-c4ccc(C#N)cc4F)cc3)c3sccc3n2)cc1,"4'-(2-(4-cyanophenylamino)thieno[3,2-d]pyrimidin-4-yloxy)-2-fluorobiphenyl-4-carbonitrile",0.065,uM,=,-1.1870866433571443,0,c1ccc(Nc2nc(Oc3ccc(-c4ccccc4)cc3)c3sccc3n2)cc1
3262,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccc(OC)c3)nc21,"5-Ethyl-7-(3-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
3263,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=S(=O)(N/N=C/c1cc(Cl)ccc1O)c1cc(Cl)c(Cl)cc1Cl,"N'-(5-chloro-2-hydroxybenzylidene)-2,4,5-trichlorobenzenesulfonohydrazide",25.0,uM,=,1.3979400086720375,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
3264,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CNc2nc3ccccc3o2)c(O)nc1C,3-(Benzooxazol-2-ylaminomethyl)-5-ethyl-6-methyl-1H-pyridin-2-one,1.25,uM,=,0.0969100130080564,1,c1cncc(CNc2nc3ccccc3o2)c1
3265,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,N#Cc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,"6-[1-(2-Cyanophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",6.0,uM,=,0.7781512503836436,1,c1ccc(Cn2cccc2)cc1
3266,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(C#CC1CC1)(OCc1ccccn1)C(F)(F)F,3-[3-Cyclopropyl-1-(pyridin-2-ylmethoxy)-1-trifluoromethyl-prop-2-ynyl]-1H-pyridin-2-one,0.0259989999999999,uM,=,-1.585043355984333,0,C(#CC(OCc1ccccn1)c1cccnc1)C1CC1
3267,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,O=C(Cc1ccccc1)OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1,1-[4-(Phenylacetoxy)-2-cyclopenten-1-yl]-3-benzyluracil,52.0,uM,=,1.7160033436347992,1,O=C(Cc1ccccc1)OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1
3268,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3cccc(Cl)c3o2)c(S)nc1C,3-[2-(7-Chloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridine-2-thione,0.029,uM,=,-1.537602002101044,0,c1cncc(CCc2nc3ccccc3o2)c1
3269,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),Cc1cc(C)c2c(n1)N(C1CC1)c1ncccc1C(=O)N2,"5-Cyclopropyl-7,9-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3270,80130,10.1016/S0960-894X(01)80437-6,,,,The compound was evaluated as inhibitor of recombinant HIV-l reverse transcriptase,Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)C(F)F)O2)c(=O)[nH]c1=O,"Difluoromethyl-phosphonic acid mono-[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester",55.10871192445703,uM,=,1.7412202602245614,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
3271,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,Cc1[nH]c(=O)c(Br)c(Oc2cc(Cl)cc(C#N)c2)c1Cc1ccccc1,"3-(5-Benzyl-3-bromo-6-methyl-2-oxo-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.01,uM,=,-2.0,0,O=c1cc(Oc2ccccc2)c(Cc2ccccc2)c[nH]1
3272,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(O)c1cc(NCc2cccc(C#Cc3ccccc3)c2)ccc1O,2-Hydroxy-5-(3-phenylethynyl-benzylamino)-benzoic acid,32.0,uM,=,1.505149978319906,1,C(#Cc1cccc(CNc2ccccc2)c1)c1ccccc1
3273,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OC1COc2cc(O)cc(O)c2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",6.2,uM,=,0.7923916894982539,1,O=C(OC1COc2ccccc2C1)c1ccccc1
3274,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccccc3O)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(2-hydroxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.35,uM,=,-0.4559319556497244,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3275,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SC2CCCCC2)nc1Cc1c(F)cccc1F,"2-Cyclohexylsulfanyl-6-(2,6-difluoro-benzyl)-5-methyl-3H-pyrimidin-4-one",0.07,uM,=,-1.154901959985743,0,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
3276,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,CS(=O)(=O)c1ccc2c(c1)CCN2C(=O)COc1ccc(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1,3-chloro-5-(2-chloro-5-(2-(5-(methylsulfonyl)indolin-1-yl)-2-oxoethoxy)phenoxy)benzonitrile,0.00086,uM,=,-3.065501548756432,0,O=C(COc1cccc(Oc2ccccc2)c1)N1CCc2ccccc21
3277,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCCN1C(=O)/C(=C\c2cccs2)SC1=S)Nc1ccc(O)c(C(=O)O)c1,2-Hydroxy-5-(4-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-butyrylamino)-benzoic acid,44.0,uM,=,1.6434526764861874,1,O=C(CCCN1C(=O)/C(=C\c2cccs2)SC1=S)Nc1ccccc1
3278,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,O=C(Oc1cccc(Cn2ccc(=O)n(Cc3ccccc3)c2=O)c1)c1ccccc1,1-[3-(Benzoyloxy)benzyl]-3-benzyluracil,32.3,uM,=,1.509202522331103,1,O=C(Oc1cccc(Cn2ccc(=O)n(Cc3ccccc3)c2=O)c1)c1ccccc1
3279,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1ccc(CNc2cc(CC)c(C)nc2O)c(OC)c1,5-Ethyl-3-(4-ethyl-2-methoxy-benzylamino)-6-methyl-1H-pyridin-2-one,0.51,uM,=,-0.2924298239020636,0,c1ccc(CNc2cccnc2)cc1
3280,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(Nc2ccc(N3CCOCC3)cc2)c2cccnc2n1O,"1-Hydroxy-4-{[4-(4-morpholinyl)phenyl]amino}pyrido[2,3-d]pyrimidin-2(1H)-one",0.05,uM,=,-1.3010299956639813,0,O=c1nc(Nc2ccc(N3CCOCC3)cc2)c2cccnc2[nH]1
3281,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(Oc2ccccc2)c1I,3-Iodo-6-phenethyl-4-phenoxypyridin-2(1H)-one,0.29,uM,=,-0.5376020021010439,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccc2)[nH]1
3282,541098,10.1016/j.bmc.2008.12.028,,,,Inhibition on HIV1 reverse transcriptase p66/p51,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1,{4-[2-Amino-6-((R)-cyclopropylamino)-purin-9-yl]-cyclopent-2-enyl}-methanol,0.13,uM,=,-0.8860566476931633,0,C1=C[C@H](n2cnc3c(NC4CC4)ncnc32)CC1
3283,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CC(=O)c1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"5-Acetyl-3-[(4,7-dichloro-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",0.3,uM,=,-0.5228787452803376,0,c1cncc(NCc2nc3ccccc3o2)c1
3284,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,COc1cc2c(cc1O)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2.[I-],"2-Hydroxy-3-methoxy-9,10-dimethoxyprotoberberineIodide",124.71946020710936,uM,=,2.095934222533727,1,c1ccc2c(c1)CC[n+]1cc3ccccc3cc1-2
3285,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,O=C(Nc1ccccc1)Nc1sc(-c2ccc(Cl)c(Cl)c2)cc1C(=O)O,"5-(3,4-Dichlorophenyl)-2-(3-phenylureido)thiophene-3-carboxylic Acid",1.2,uM,=,0.0791812460476248,1,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
3286,196512,10.1021/jm9801049,,,,Inhibitory activity against wild type HIV-1 reverse transcriptase (WT-RT),C[C@@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,"6-Chloro-2-((R)-1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine",0.085,uM,=,-1.0705810742857071,0,c1cnc(SCc2cc3ccoc3cn2)nc1
3287,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-c2c(SCC(=O)Nc3ccc(-c4ccc(CC(=O)O)cc4)cc3Cl)cnn2C)c(Cl)c1,2-(3'-chloro-4'-(2-(5-(2-chloro-4-methylphenyl)-1-methyl-1H-pyrazol-4-ylthio)acetamido)biphenyl-4-yl)acetic acid,0.0019,uM,=,-2.721246399047171,0,O=C(CSc1cn[nH]c1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
3288,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(OC)c2)C2CC2)cc1,"(E)-N-((2S, 3R)-4-((N-cyclopropyl-4-methoxyphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide",0.0435,uM,=,-1.3615107430453628,0,O=C(/C=C/c1ccccc1)N[C@H](CCN(C1CC1)S(=O)(=O)c1ccccc1)Cc1ccccc1
3289,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cc(OC)cc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",2.8,uM,=,0.4471580313422192,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3290,1899209,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase polymerase using deoxynucleotide triphosphates and 18 nucleotide DNA primer annealed to 100 nucleotide DNA template after 30 mins,COc1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1OC,"6-(3',4'-Dimethoxy-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",9.6,uM,=,0.9822712330395684,1,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
3291,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](n2nncc2C(N)=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@]12OS(=O)(=O)C=C2N,"3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3H-[1,2,3]triazole-4-carboxylic acid amide",10.1,uM,=,1.0043213737826426,1,O=S1(=O)C=C[C@]2(CO[C@@H](n3ccnn3)C2)O1
3292,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2ccc(-c3cncnc3)cc2)c2nccnc2n(O)c1=O,"Methyl 5-hydroxy-6-oxo-8-((4-(pyrimidin-5-yl)phenyl)amino)-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",3.24,uM,=,0.5105450102066121,1,O=c1cc(Nc2ccc(-c3cncnc3)cc2)c2nccnc2[nH]1
3293,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(O)cc1C(=O)O)Nc1ccc(O)cc1C(=O)O,2-({6-[(2-carboxy-4-hydroxyphenyl)amino]-6-oxohexanoyl}amino)-5-hydroxybenzoic acid,120.0,uM,=,2.0791812460476247,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3294,471455,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,C[C@@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,tenofovir diphosphate,4.0,uM,=,0.6020599913279624,1,c1ncc2nc[nH]c2n1
3295,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c3nc(N)ccc23)c1,"4-(2-((6-Amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methylamino)pyridin-4-yl)-3-methylbenzonitrile",0.0059,uM,=,-2.229147988357856,0,c1ccc(-c2ccnc(NCc3n[nH]c4ncccc34)c2)cc1
3296,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1CSCC2,"4-((4-(4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzamide",0.143,uM,=,-0.8446639625349381,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
3297,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(NNC(N)=S)c1Cc1cccc(C)c1,"({5-ethyl-6-methyl-4-[(3-methylphenyl)methyl]-2-oxo-1,2-dihydropyridin-3-yl}amino)thiourea",0.316,uM,=,-0.5003129173815962,0,O=c1cc(Cc2ccccc2)cc[nH]1
3298,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,NC(=O)[C@H](CCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1)NC(=O)CCCNC(=O)[C@@H](N)CCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1,"N-[(5S)-5-amino-6-[[4-[[(1S)-1-carbamoyl-5-[[4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzoyl]amino]pentyl]amino]-4-oxo-butyl]amino]-6-oxo-hexyl]-4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzamide",0.0105,uM,=,-1.978810700930062,0,O=C(CCCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1)NCCCC(=O)NCCCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
3299,195839,10.1021/jm00023a007,,,,Inhibition of HIV-1 reverse transcriptase (RT),CCc1c(C)nc(O)c([N+](=O)[O-])c1Sc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-phenylsulfanyl)-5-ethyl-6-methyl-3-nitro-pyridin-2-ol",0.03,uM,=,-1.5228787452803376,0,c1ccc(Sc2ccncc2)cc1
3300,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(C(=O)O)cc3)nc3ccccc32)c1,"4-[[2-[1-(3,5-Dimethylphenyl)sulfonylbenzimidazol-2-yl]oxyacetyl]amino]benzoic acid",0.13,uM,=,-0.8860566476931633,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3301,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,CN(C)c1c(Sc2ccccc2)cc(CCc2ccccc2)[nH]c1=O,3-(Dimethylamino)-6-phenethyl-4-(phenylthio)pyridin-2(1H)-one,15.21,uM,=,1.1821292140529984,1,O=c1cc(Sc2ccccc2)cc(CCc2ccccc2)[nH]1
3302,196935,10.1021/jm00104a010,,,,Inhibition of purified HIV-2 reverse transcriptase,Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)[O-])cc(O)c2c1O.[Na+],"3-Amino-4,5-dihydroxy-naphthalene-2,7-disulfonic acid sodium",452.0,uM,=,2.655138434811382,1,c1ccc2ccccc2c1
3303,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2ccc(-c3ccccc3)cc2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-4-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",5.1,uM,=,0.7075701760979364,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3304,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CN(C)c1ccc(F)c(CCNC(=S)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[2-(3-dimethylamino-2,6-difluoro-phenyl)-ethyl]-thiourea",0.008,uM,=,-2.096910013008056,0,S=C(NCCc1ccccc1)Nc1ccccn1
3305,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N3CCOCC3)nc21,"5-Ethyl-10-methyl-7-morpholin-4-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.4,uM,=,-0.3979400086720376,0,O=C1Nc2ccc(N3CCOCC3)nc2Nc2ncccc21
3306,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,O=Cc1ccc(-c2cc(-c3cccc(C=O)c3)c(O)c(O)c(=O)c2O)cc1,"3-[3-(4-formylphenyl)-4,6,7-trihydroxy-5-oxocyclohepta-1,3,6-trien-1-yl]benzaldehyde",1.2,uM,=,0.0791812460476248,1,O=c1ccc(-c2ccccc2)cc(-c2ccccc2)c1
3307,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCCOC(C#CC1CC1)(c1cc(CC)c(C)nc1O)C(F)(F)F,3-(3-Cyclopropyl-1-propoxy-1-trifluoromethyl-prop-2-ynyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.105,uM,=,-0.978810700930062,0,C(#CC1CC1)Cc1cccnc1
3308,543748,10.1128/aac.00145-07,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 expressed in Escherichia coli using calf thymus DNA substrate,C[C@@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,tenofovir diphosphate,22.0,uM,=,1.3424226808222062,1,c1ncc2nc[nH]c2n1
3309,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccc(C(=O)OC)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzoic acid methyl ester",0.8,uM,=,-0.0969100130080563,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3310,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,O=c1cc(O)c2c(=O)oc3c4ccccc4ccc3c2o1,"1-hydroxybenzo[h]pyrano[3,2-c]chromene-3,12-dione",24.7,uM,=,1.3926969532596658,1,O=c1ccc2c(=O)oc3c4ccccc4ccc3c2o1
3311,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc([N+](=O)[O-])c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(3-nitro-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.35,uM,=,-0.4559319556497244,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3312,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3ccccc3Cl)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-N-(2-chlorophenethyl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.131,uM,=,-0.8827287043442358,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
3313,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCNc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"5-Cyclopropyl-9-(4-ethylamino-phenoxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
3314,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cccc(C)c2OC)c(O)nc1C,5-Ethyl-3-(2-methoxy-3-methyl-benzylamino)-6-methyl-1H-pyridin-2-one,3.8,uM,=,0.5797835966168101,1,c1ccc(CNc2cccnc2)cc1
3315,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=c1ccc(Cc2ccc(Cl)c(Oc3ccccc3)c2F)n[nH]1,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,0.1,uM,=,-1.0,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
3316,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,N#Cc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"4-(5-Cyclopropyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-9-ylmethoxy)-benzonitrile",0.41,uM,=,-0.3872161432802645,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
3317,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3ccnc3C)ccc12,"7-[5-Methyl-2-(2-methyl-imidazol-1-yl)-imidazo[1,5-b]pyridazin-7-yl]-1-phenyl-heptan-1-one",2.5,uM,=,0.3979400086720376,1,O=C(CCCCCCc1ncc2ccc(-n3ccnc3)nn12)c1ccccc1
3318,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1SCC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)-methyl)benzamide",0.066,uM,=,-1.1804560644581312,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)SCC4)CC2)cc1
3319,2119941,10.1016/j.ejmech.2021.113681,,,,Inhibition of recombinant HIV1 reverse transcriptase by colorimetric assay,NC[C@@H](NC(=O)c1ccc(-c2ccc(Cl)cc2)[nH]1)c1nccs1,(R)-N-(2-amino-1-(thiazol-2-yl)ethyl)-5-(4-chlorophenyl)-1H-pyrrole-2-carboxamide,31.0,uM,=,1.4913616938342726,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
3320,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccc(F)cc2)n(Cc2ccccc2)c(=O)n(O)c1=O,"1-Benzyl-6-(4-fluorobenzyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",10.0,uM,=,1.0,1,O=c1cc(Cc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
3321,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2cncs2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-5-yl-benzyl)-hydrazinocarbonyl]-2-methyl-propyl}-carbamic acid methyl ester",0.032,uM,=,-1.494850021680094,0,c1ccc(CCCCNCc2ccc(-c3cncs3)cc2)cc1
3322,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1C(=O)c2ccccc2N(CC)c2ncccc21,"5,11-Diethyl-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one",0.69,uM,=,-0.1611509092627447,0,O=C1Nc2cccnc2Nc2ccccc21
3323,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccccc2)n[nH]1,Ethyl 3-(1-(4-fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,14.3,uM,=,1.155336037465062,1,c1ccc(Cn2cc(-c3ccccc3)c(-c3cc[nH]n3)c2)cc1
3324,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCN)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-amino-propyl)-5-methyl-1H-pyrimidine-2,4-dione",8.1,uM,=,0.9084850188786496,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3325,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CC(=O)CC(=O)c1c(O)c2c(=O)oc3ccccc3c2oc1=O,"4-hydroxy-3-(3-oxobutanoyl)pyrano[3,2-c]chromene-2,5-dione",85.8,uM,=,1.9334872878487053,1,O=c1ccc2c(=O)oc3ccccc3c2o1
3326,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCC#CC1(C(F)(F)F)OC(=O)Nc2ccc(N)cc21,"6-Amino-4-but-1-ynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",1.894,uM,=,0.2773799746672546,1,O=C1Nc2ccccc2CO1
3327,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ccc(Br)cc3)c2=O)c1,N-(4-bromophenyl)-2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)acetamide,92.5,uM,=,1.9661417327390327,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccccc1
3328,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(N3CCCC3)ccc12,"7-(5-Methyl-2-pyrrolidin-1-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",0.05,uM,=,-1.3010299956639813,0,O=C(CCCCCCc1ncc2ccc(N3CCCC3)nn12)c1ccccc1
3329,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(Nc1ccc(Br)cc1C(=O)O)c1cccc(C(=O)Nc2ccc(Br)cc2C(=O)O)c1,5-bromo-2-[(3-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}benzoyl)amino]benzoic acid,19.0,uM,=,1.2787536009528289,1,O=C(Nc1ccccc1)c1cccc(C(=O)Nc2ccccc2)c1
3330,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2cccc3nc(O)n(c23)CC1C,"8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",3.32,uM,=,0.5211380837040362,1,c1cc2c3c(c1)ncn3CCNC2
3331,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ncco3)nc21,"5-Ethyl-10-methyl-7-oxazol-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.82,uM,=,-0.0861861476162833,0,O=C1Nc2ccc(-c3ncco3)nc2Nc2ncccc21
3332,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccccc2)Oc2cc3ccccc3cc2-n2cccc2C1=O,"5-Ethyl-5-phenyl-6-oxa-12b-aza-naphtho[2,3-e]azulen-4-one",150.0,uM,=,2.1760912590556813,1,O=C1c2cccn2-c2cc3ccccc3cc2OC1c1ccccc1
3333,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1nc(O)c(CCc2nc3ccccc3o2)cc1N(C)C,3-(2-Benzooxazol-2-yl-ethyl)-5-dimethylamino-6-methyl-1H-pyridin-2-one,1.85,uM,=,0.2671717284030138,1,c1cncc(CCc2nc3ccccc3o2)c1
3334,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)c1[nH]cnc1-c1ccc(Cl)c(Br)c1,4-(3-bromo-4-chlorophenyl)-1H-imidazole-5-carboxamide,9.9,uM,=,0.99563519459755,1,c1ccc(-c2c[nH]cn2)cc1
3335,526428,10.1021/np050510c,,,,Inhibition of HIV1 RT at 200 uM,CCC[C@@H](O)C1=C(Br)C(=C(Br)Br)OC1=O,(R)-4-bromo-5-(dibromomethylene)-3-(1-hydroxybutyl)furan-2(5H)-one,700.0,uM,=,2.845098040014257,1,C=C1C=CC(=O)O1
3336,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1nncs1,"1-Phenethyl-3-[1,3,4]thiadiazol-2-yl-thiourea",1.9,uM,=,0.2787536009528289,1,S=C(NCCc1ccccc1)Nc1nncs1
3337,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,Cc1nc(O)c(NCc2nc3c(Cl)ccc(Cl)c3o2)c2c1C2,"5-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-2-methyl-3-aza-bicyclo[4.1.0]hepta-1,5-dien-4-one",0.113,uM,=,-0.9469215565165804,0,c1ccc2oc(CNc3cncc4c3C4)nc2c1
3338,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,COC(=O)c1ccc(NC(=O)COc2nc3ccccc3n2S(=O)(=O)c2cc(C)cc(C)c2)c(Cl)c1,"Methyl 3-chloro-4-[[2-[1-(3,5-dimethylphenyl)sulfonylbenzimidazol-2-yl]oxyacetyl]amino]benzoate",5.45,uM,=,0.7363965022766424,1,O=C(COc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3339,442659,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rC.dG template,Cc1ccnc(N2C(=O)CSC2C23CC4CC(CC(C4)C2)C3)c1,2-adamantan-1-yl-3-(4-methyl-pyridin-2-yl)-thiazolidin-4-one,40.0,uM,=,1.6020599913279625,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
3340,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,O=C(Nc1ccc(F)cc1)Nc1sc(-c2ccc(Cl)c(Cl)c2)cc1C(=O)O,"5-(3,4-Dichlorophenyl)-2-(3-(4-fluorophenyl)ureido)-thiophene-3-carboxylic Acid",0.7,uM,=,-0.1549019599857432,0,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
3341,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)CSc1ccccc1)CC2,"(2S)-5,7-dihydroxy-2-(2-hydroxy-1-(phenylthio)propan-2-yl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.93,uM,=,-0.0315170514460648,0,O=c1cccc2c(c1)CC[C@H](CCSc1ccccc1)C2
3342,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(COCc3ccccc3)cc(O)nc21,"9-Benzyloxymethyl-5-ethyl-7-hydroxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2c(COCc3ccccc3)ccnc2Nc2ncccc21
3343,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCCC(=O)c2ccccc2)n2nc(-n3cccn3)ccc12,"7-(5-Methyl-2-pyrazol-1-yl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",3.4,uM,=,0.5314789170422551,1,O=C(CCCCCCc1ncc2ccc(-n3cccn3)nn12)c1ccccc1
3344,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C(F)(F)F)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(trifluoromethyl)benzyl)isoquinoline-1,3(2H,4H)-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3345,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CC(C)=CCN1Cc2cccc3nc(S)n(c23)C(Cl)[C@@H]1C,"(S)-9-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",31.0,uM,=,1.4913616938342726,1,c1cc2c3c(c1)ncn3CCNC2
3346,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2nnc(C(C)C)n2-c2cccnc21,"8-Ethyl-3-isopropyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",62.6,uM,=,1.7965743332104298,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
3347,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cc(N)ccc2Oc2ccc(C)cc21,"2-Amino-10-ethyl-8-methyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.24,uM,=,-0.619788758288394,0,O=C1Nc2ccccc2Oc2ccccc21
3348,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,CNCc1cc(-c2ccc3c(c2)OCO3)[nH]c1C(=O)NCc1nc(S)c(CO)s1,"5-(benzo[d][1,3]dioxol-5-yl)-N-((5-(hydroxymethyl)-4-mercaptothiazol-2-yl)methyl)-3-((methylamino)methyl)-1H-pyrrole-2-carboxamide",28.1,uM,=,1.44870631990508,1,O=C(NCc1nccs1)c1ccc(-c2ccc3c(c2)OCO3)[nH]1
3349,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione (TASO-m3T)",5.7,uM,=,0.7558748556724915,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3350,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4cccc(C#N)c4)c(F)c3)c2=O)n[nH]c1=O,"2'-Fluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-y1)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-bipheny1]-3-carbonitrile",0.45,uM,=,-0.3467874862246563,0,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3351,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3352,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1N,"4-[5-Amino-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.001,uM,=,-3.0,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
3353,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,C[C@@H]1CC=C2[C@@H](CCC[C@@]2(C)CC[C@@]2(C)C3=CCCC(C)(C)[C@H]3CC[C@@H]2C)[C@]1(C)Cc1cc(OS(=O)(=O)[O-])ccc1OS(=O)(=O)[O-].[Na+].[Na+],toxiusol,1.5,uM,=,0.1760912590556812,1,C1=C2C(CCC3CCC[C@@H]4C3=CCCC4Cc3ccccc3)CCC[C@@H]2CCC1
3354,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,O=C(NC1CCN(Cc2ccc(Cl)cc2)CC1)c1cc2cc([N+](=O)[O-])c(O)c(O)c2oc1=O,"N-(1-(4-chlorobenzyl)piperidin-4-yl)-7,8-dihydroxy-6-nitro-2-oxo-2H-chromene-3-carboxamide",8.4,uM,=,0.9242792860618816,1,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc2ccccc2oc1=O
3355,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCc1c[nH]c2ccccc12)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[2-(1H-indol-3-yl)-ethyl]-thiourea,0.9,uM,=,-0.0457574905606751,0,S=C(NCCc1c[nH]c2ccccc12)Nc1ccccn1
3356,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,COc1cccc(OC)c1Oc1cnc(N)c(Nc2ccc(C#N)cc2)c1,"4-((2-amino-5-(2,6-dimethoxyphenoxy)pyridin-3-yl)amino)benzonitrile",145.9,uM,=,2.1640552918934515,1,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
3357,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,"3,3-dimethyl-2-oxobutyl 5-nitrofuran-2-carboxylate",21.9,uM,=,1.3404441148401185,1,c1ccoc1
3358,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccc([N+](=O)[O-])cc2C2(c3ccccc3)SCCN12,"8-Nitro-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",10.0,uM,=,1.0,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3359,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,C#CCCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,methyl 3-bromo-5-[1-(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-1-hepten-6-ynyl]-2-methoxybenzoate,6.0,uM,=,0.7781512503836436,1,C=C(c1ccccc1)c1ccccc1
3360,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,COc1ccc(O)c(Cc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)c1,"5-Cyclopropyl-9-(2-hydroxy-5-methoxy-benzyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.85,uM,=,-0.0705810742857072,0,O=C1Nc2c(Cc3ccccc3)ccnc2N(C2CC2)c2ncccc21
3361,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",0.03,uM,=,-1.5228787452803376,0,O=C1c2ccccc2C(=O)N1CNc1cccnc1
3362,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1c(Cl)cccc1Cl,"6-[1-(2,6-Dichlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",22.0,uM,=,1.3424226808222062,1,c1ccc(Cn2cccc2)cc1
3363,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1ccccc1[S+]([O-])c1cccc(N)c1C#N,2-Amino-6-(2-cyano-benzenesulfinyl)-benzonitrile,9.9,uM,=,0.99563519459755,1,c1ccc([SH+]c2ccccc2)cc1
3364,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CCOC(=O)[C@@H]1C[C@@]12C(=O)Nc1ccc(Cl)cc12,"(1R,2R)-ethyl 5'-chloro-2'-oxospiro[cyclopropane-1,3'-indoline]-2-carboxylate",0.059,uM,=,-1.2291479883578558,0,O=C1Nc2ccccc2C12CC2
3365,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Oc1ccc(C(=O)c2ccc(O)cc2)cc1,4-{5-Methyl-4-[4-(4-hydroxybenzoyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,5.21,uM,=,0.7168377232995244,1,O=C(c1ccccc1)c1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1
3366,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,O=C1Nc2ccccc2C1(O)C(F)(F)F,"3-Hydroxy-3-trifluoromethyl-1,3-dihydro-indol-2-one",6.07,uM,=,0.7831886910752576,1,O=C1Cc2ccccc2N1
3367,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),CC(=O)n1c(=O)n(Cc2cc(F)cc(F)c2)c2cc(Cl)ccc21,"3-Acetyl-6-chloro-1-(3,5-difluorolbenzyl)-1,3-dihydro-2H-benzimidazol-2-one",38.5,uM,=,1.5854607295085006,1,O=c1[nH]c2ccccc2n1Cc1ccccc1
3368,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(OC)c2)C(C)C)cc1,"3-(4-Hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.0405,uM,=,-1.3925449767853315,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3369,858890,10.1021/jm300477h,,,,Inhibition of wild type HIV1 reverse transcriptase RNA-dependent DNA polymerase activity using poly(rA)/oligo(dT)10:1 and [3H]-dTTP substrate,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)Nc3cccc(C#N)c3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-N-(3-cyanophenyl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.506,uM,=,-0.2958494831602009,0,O=C(Nc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
3370,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-(3-Amino-phenoxymethyl)-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3371,2231068,10.1016/j.bmc.2021.116531,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation,Cc1cc(C)cc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid amide",0.0048,uM,=,-2.318758762624413,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3372,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCc1ccco1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-furan-2-yl-ethyl)-thiourea,1.2,uM,=,0.0791812460476248,1,S=C(NCCc1ccco1)Nc1ccccn1
3373,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)c2nccnc2n(O)c1=O,"Methyl 8-((4'-cyano-[1,1'-biphenyl]-4-yl)amino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",1.77,uM,=,0.2479732663618066,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)c2nccnc2[nH]1
3374,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCS(N)(=O)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-sulfamoylethyl)-1H-indole-2-carboxamide",0.0004,uM,=,-3.397940008672037,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3375,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1ccccc1C(=O)N/N=C/c1c(O)ccc2ccccc12,N'-((2-hydroxynaphthalen-1-yl)methylene)-2-methoxybenzohydrazide,21.0,uM,=,1.3222192947339193,1,O=C(N/N=C/c1cccc2ccccc12)c1ccccc1
3376,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,C=C(C)[C@H]1CCc2c(c(C)cc(O)c(=O)c2O)C1,"(S)-5,7-dihydroxy-9-methyl-2-(prop-1-en-2-yl)-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",0.6,uM,=,-0.2218487496163563,0,O=c1cccc2c(c1)CCCC2
3377,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(OC)c(CCNC(=O)Nc2ccc(Cl)cn2)c1F,1-(5-Chloro-pyridin-2-yl)-3-[2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-ethyl]-urea,2.5,uM,=,0.3979400086720376,1,O=C(NCCc1ccccc1)Nc1ccccn1
3378,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CC(C)C(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"N-[1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-isobutyramide",8.0,uM,=,0.9030899869919436,1,C1=NNc2ncnc3c2c1cn3C1CCCO1
3379,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,N#Cc1ccc(Nc2cc(N)nc(Cc3c(Cl)cccc3Cl)n2)cc1,"4-[6-Amino-2-(2,6-dichloro-benzyl)-pyrimidin-4-ylamino]-benzonitrile",0.452,uM,=,-0.3448615651886179,0,c1ccc(Cc2nccc(Nc3ccccc3)n2)cc1
3380,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),COc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3cccc(O)c3)C2=O)cc1OC,"3-{5-[1-(3,4-Dimethoxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-N-(3-hydroxy-phenyl)-propionamide",90.0,uM,=,1.954242509439325,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
3381,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccccc3C(F)(F)F)n2)cc1,4-(4-(2-(trifluoromethyl)benzylamino)pyrimidin-2-ylamino)benzonitrile,1.541,uM,=,0.1878026387184193,1,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
3382,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,CNC(=O)Cn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"2-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-N-methyl-acetamide",3.1,uM,=,0.4913616938342727,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3383,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccccc2)n1,6-Benzyl-2-sec-butylsulfanyl-5-methyl-3H-pyrimidin-4-one,0.5,uM,=,-0.3010299956639812,0,c1ccc(Cc2ccncn2)cc1
3384,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.006,uM,=,-2.2218487496163566,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3385,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.2,uM,=,0.0791812460476248,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3386,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCc2nnc(C)o2)c2cc(C)c3onc(OC)c3c2)cc1C(=O)SC,"(E)-S-methyl 2-methoxy-5-(1-(3-methoxy-7-methylbenzo[d]-isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-3-methylbenzothioate",33.0,uM,=,1.5185139398778875,1,C(\CCc1nnco1)=C(/c1ccccc1)c1ccc2oncc2c1
3387,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1nc(O)c2ncn(C3C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)COC4C=CC(n5cnc6c(O)nc(N)nc65)C4)C3)c2n1,"P,P'-Bis {[4-(guanine-9-yl)cyclopent-2-enyl]oxy-methylphosphonyl}diphosphate",0.7,uM,=,-0.1549019599857432,0,O=[PH](COC1C=CC(n2cnc3cncnc32)C1)O[PH](=O)O[PH](=O)O[PH](=O)COC1C=CC(n2cnc3cncnc32)C1
3388,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.43,uM,=,-0.3665315444204134,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3389,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCCCCc1c(C)nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc1C,"2-(2,6-Dichlorophenyl)-3-(5-pentyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",74.39,uM,=,1.871514558708382,1,O=C1CSC(c2ccccc2)N1c1ncccn1
3390,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,NC(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carboxamide",2.1,uM,=,0.3222192947339193,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3391,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1O,"6-([1,1'-Biphenyl]-4-ylmethyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.5,uM,=,-0.3010299956639812,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3392,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)N(Cc1cccc(C(F)(F)F)c1)C(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-(tert-butyl(3-(trifluoromethyl)benzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,8.5,uM,=,0.9294189257142929,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
3393,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccc(F)cc1)CC(=O)C(=O)O,"(E)-6-[1-(4-Fluoro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid",2.5,uM,=,0.3979400086720376,1,c1ccc(Cn2cccc2)cc1
3394,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.91,uM,=,-0.0409586076789063,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3395,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-amino)pyrimidine-2,4(1H,3H)-dione",2.2,uM,=,0.3424226808222063,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3396,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(Cl)cc(OCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)c2)c1,2-[3-chloro-5-(3-chloro-5-cyano-phenoxy)-phenoxy]-N-(2-chloro-4-sulfamoyl-phenyl)-acetamide,0.00211,uM,=,-2.6757175447023074,0,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ccccc1
3397,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1nc(O)c(CCc2nc3ccccc3o2)cc1-c1ccccc1,3-(2-Benzooxazol-2-yl-ethyl)-6-methyl-5-phenyl-1H-pyridin-2-one,1.1,uM,=,0.041392685158225,1,c1ccc(-c2cncc(CCc3nc4ccccc4o3)c2)cc1
3398,1364717,10.1016/j.ejmech.2014.06.061,,,,Inhibition of HIV1 reverse transcriptase strand transfer activity,O=C(NCc1ccc(Cl)cc1)c1ncc2cccnc2c1O,"N-(4-chlorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide",0.135,uM,=,-0.8696662315049939,0,O=C(NCc1ccccc1)c1cc2ncccc2cn1
3399,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc([N+](=O)[O-])cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-nitrobenzyl)-1H-indole-2-carboxamide",0.05,uM,=,-1.3010299956639813,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
3400,195668,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,CCN(c1ncccc1CC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-isobutyl-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.88,uM,=,-0.0555173278498313,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3401,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)N1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.032,uM,=,-1.494850021680094,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
3402,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccc(O)cc3oc2=O)cc1,"7-Hydroxy-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)-2-oxo-2H-chromene-3-carboxamide",0.4206999999999999,uM,=,-0.3760274879830036,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
3403,2294755,10.1016/j.bmcl.2023.129216,,,,Inhibition of recombinant wildtype HIV-1 reverse transcriptase using r(A)350 as template and d(T)16 as primer preincubated with compound for 1 hrs followed by template/primer addition and measured after 30 mins by picogreen based plate reader analysis,N#Cc1ccc(Nc2ncc(Cc3c(F)cc(-c4ccc(OS(=O)(=O)F)cc4)cc3F)o2)cc1Cl,"4'-((2-((3-chloro-4-cyanophenyl)amino)oxazol-5-yl)methyl)-3',5'-difluoro-[1,1'-biphenyl]-4-yl sulfofluoridate",3.0,uM,=,0.4771212547196624,1,c1ccc(Nc2ncc(Cc3ccc(-c4ccccc4)cc3)o2)cc1
3404,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((3-methyl-[1,1'-biphenyl]-4-yl)oxy)pyrimidin-2-yl)amino)benzonitrile",0.039,uM,=,-1.408935392973501,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3405,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3cccc(C(F)(F)F)c3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.008,uM,=,-2.096910013008056,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3406,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,COc1cc(Oc2c(C)cc(C#N)cc2C)cc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)n1,"4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-6-methoxypyridin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.132,uM,=,-0.8794260687941501,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
3407,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CC(=O)c1c(O)c2c(=O)oc3ccccc3c2oc1=O,"3-acetyl-4-hydroxypyrano[3,2-c]chromene-2,5-dione",26.31,uM,=,1.420120848085703,1,O=c1ccc2c(=O)oc3ccccc3c2o1
3408,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),COc1ccc(/C=C2/SC(=S)N(CCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC,"4-(3-{5-[1-(3,4-Dimethoxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid",61.0,uM,=,1.7853298350107671,1,O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
3409,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc(C(=O)O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"3-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzoic acid",0.55,uM,=,-0.2596373105057561,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3410,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=C1CN(S(=O)(=O)c2c(Cl)cccc2Cl)c2cc(Cl)ccc2N1,"6-chloro-4-(2,6-dichlorophenylsulfonyl)-3,4-dihydroquinoxalin-2(1H)-one",1.67,uM,=,0.2227164711475832,1,O=C1CN(S(=O)(=O)c2ccccc2)c2ccccc2N1
3411,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CC(C)Sc1nc(O)cc(Cc2c(Cl)cccc2Cl)n1,"6-(2,6-Dichloro-benzyl)-2-isopropylsulfanyl-3H-pyrimidin-4-one",1.5,uM,=,0.1760912590556812,1,c1ccc(Cc2ccncn2)cc1
3412,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1CCCC2,"3,5-Dimethyl-4-((2-((1-(4-nitrobenzyl)piperidin-4-yl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)benzonitrile",0.094,uM,=,-1.0268721464003014,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCCC4)CC2)cc1
3413,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCC2CC2)C(F)(F)F)c(O)nc1C,3-(3-Cyclopropyl-1-cyclopropylmethoxy-1-trifluoromethyl-prop-2-ynyl)-5-ethyl-6-methyl-1H-pyridin-2-one,0.188,uM,=,-0.7258421507363202,0,C(#CC(OCC1CC1)c1cccnc1)C1CC1
3414,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,"6-((4'-fluoro-[1,1'-biphenyl]-3-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Sc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3415,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(C(F)(F)F)cc2c1=O,"Ethyl 1-(4-Fluorobenzyl)-4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate",59.0,uM,=,1.7708520116421442,1,O=c1ccn(Cc2ccccc2)c2ccccc12
3416,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,O=C(O)P(=O)(O)O,Foscarnet,2.5,uM,=,0.3979400086720376,1,
3417,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,"2-Amino-6-(3,5-dimethyl-benzenesulfonyl)-benzonitrile",0.007,uM,=,-2.154901959985743,0,O=S(=O)(c1ccccc1)c1ccccc1
3418,854340,10.1016/j.ejmech.2012.03.032,,,,Inhibition of wild type HIV1 reverse transcriptase activity using poly (rA)/oligo (dT)15 homopolymer template after 1 hr by ELISA,Cc1ccc(C(=O)Nc2cc(Cl)ccc2OCC(=O)Nc2ccc(S(N)(=O)=O)cc2C)cc1C,"N-[4-(Aminosulfonyl)-2-methylphenyl]-2-[4-chloro-2-(3,4-dimethylbenzoyl)aminophenoxy]acetamide",0.00114,uM,=,-2.943095148663528,0,O=C(COc1ccccc1NC(=O)c1ccccc1)Nc1ccccc1
3419,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(Cl)c(F)c1,"N-(4-Chloro-3-fluorobenzyl)-1-(hydroxy)-4-(ethylamino)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.022,uM,=,-1.6575773191777938,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
3420,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)CC(N)=O)[nH]c3ccc(Cl)cc23)c1,"(S)-N-(4-amino-4-oxobutan-2-yl)-5-chloro-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.315,uM,=,-0.5016894462103995,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3421,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCCN1c2ccccc2N(C)C(=O)c2cccnc21,"6-Methyl-11-propyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2ccccc2Nc2ncccc21
3422,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCCN1C(=O)c2cc(N)ccc2Oc2c(C)cc(C)cc21,"2-Amino-6,8-dimethyl-10-propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.9,uM,=,-0.0457574905606751,0,O=C1Nc2ccccc2Oc2ccccc21
3423,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@H]1[C@H](O)c2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)OC(C)(C)C=C3)O[C@@H]1C,"(10R,11S,12S)-12-hydroxy-6,6,10,11-tetramethyl-4-phenyl-6,10,11,12-tetrahydro-2H-1,5,9-trioxatriphenylen-2-one",0.038,uM,=,-1.42021640338319,0,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
3424,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(=O)NCc3ccncc3)[nH]c3ccc(Cl)cc23)c1,"(R)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide",13.01,uM,=,1.1142772965615864,1,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncc1
3425,600528,10.1021/jm801176e,,,,Inhibition of HIV1 wild type reverse transcriptase-mediated viral DNA synthesis in human HOS-313 cells expressing HSV thymidine kinase assessed as luciferase activity treated 3 hrs before infection measured after 48 hrs by luminescence assay,Cc1cn([C@@H]2C[C@H](CO)[C@@H](O)C2)c(=O)[nH]c1=O,"1-(3-Hydroxy-4-hydroxymethyl-cyclopentyl)-5-methyl-1H-pyrimidine-2,4-dione",0.83,uM,=,-0.0809219076239261,0,O=c1ccn(C2CCCC2)c(=O)[nH]1
3426,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccoc2)cc1F,"4-((4-((2,6-Difluoro-4-(furan-3-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.0084,uM,=,-2.0757207139381184,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccoc4)cc3)n2)cc1
3427,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2ccccn2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-pyridin-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.0232,uM,=,-1.6345120151091004,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)(C2CC2)N1
3428,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.0014,uM,=,-2.853871964321762,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
3429,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(NC3CCN(Cc4ccc(S(C)(=O)=O)cc4)CC3)c2)c(C)c1,6-Chloro-4-(mesityloxy)-N-(1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)pyridin-2-amine,0.16,uM,=,-0.7958800173440752,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
3430,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),C=CCN1C(=O)c2cccnc2Nc2ccccc21,"6-Allyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",1.4,uM,=,0.1461280356782379,1,O=C1Nc2ccccc2Nc2ncccc21
3431,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CCOCC3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-pyran-4-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0039,uM,=,-2.408935392973501,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCOCC1
3432,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3ccncc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-(4-(pyridin-4-yl)phenoxy)pyrimidine-2,4-(1H,3H)-dione",3.7,uM,=,0.568201724066995,1,O=c1cc(Oc2ccc(-c3ccncc3)cc2)[nH]c(=O)[nH]1
3433,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(N(C)Cc2ccc3occc3c2)n1,"4-((benzofuran-5-ylmethyl)(methyl)amino)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.083,uM,=,-1.080921907623926,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4occc4c3)n2)cc1
3434,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2cccc([N+](=O)[O-])c2)n1,2-sec-Butylsulfanyl-5-methyl-6-(3-nitro-benzyl)-3H-pyrimidin-4-one,0.4,uM,=,-0.3979400086720376,0,c1ccc(Cc2ccncn2)cc1
3435,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCCC#CC1(C(F)(F)F)OC(=O)Nc2cccc(F)c21,"5-Fluoro-4-pent-1-ynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.156,uM,=,-0.8068754016455384,0,O=C1Nc2ccccc2CO1
3436,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)Cc1cc(=O)oc2cc(O)ccc12)S(=O)(=O)c1ccc([N+](=O)[O-])cc1,"2-(7-Hydroxy-2-oxo-2H-chromen-4-yl)-N((2S,3R)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl)acetamide",0.367,uM,=,-0.4353339357479107,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3437,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cccc(Sc2cccc(N)c2C#N)c1,2-Amino-6-m-tolylsulfanyl-benzonitrile,0.96,uM,=,-0.0177287669604316,0,c1ccc(Sc2ccccc2)cc1
3438,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(C)cc2N(C)C(=O)c2cccnc21,"11-Ethyl-6,8-dimethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2ccccc2Nc2ncccc21
3439,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(C#N)cn2)c1O,1-(5-Cyano-pyridin-2-yl)-3-[2-(6-fluoro-2-hydroxy-3-propionyl-phenyl)-cyclopropyl]-urea,0.0068,uM,=,-2.167491087293764,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
3440,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCOc1ccc(F)c(C2CC2NC(=O)Nc2cc(Cl)cnn2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridazin-3-yl)-urea,0.016,uM,=,-1.7958800173440752,0,O=C(Nc1cccnn1)NC1CC1c1ccccc1
3441,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccc3ccccc3c2C2(c3ccccc3)SCCN12,"10a-Phenyl-8,9-dihydro-10aH-10-thia-7a-aza-pentaleno[1,2-a]naphthalen-7-one",26.0,uM,=,1.414973347970818,1,O=C1c2ccc3ccccc3c2C2(c3ccccc3)SCCN12
3442,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc3c(nc2OC)CCCC3)c(O)nc1C,"5-Ethyl-3-[(2-methoxy-5,6,7,8-tetrahydro-quinolin-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one",0.035,uM,=,-1.4559319556497243,0,c1cncc(NCc2cnc3c(c2)CCCC3)c1
3443,2215045,10.1016/j.ejmech.2022.114199,,,,Inhibition of HIV-1 reverse transcriptase using rC.dG as primer/template,CCc1cc(NCc2nc3ccccc3o2)c(O)nc1C,3-[(Benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.0002099999999999,uM,=,-3.677780705266081,0,c1cncc(NCc2nc3ccccc3o2)c1
3444,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=O)[nH]c3cccc(c32)C1C,"6-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",12.1,uM,=,1.08278537031645,1,O=c1[nH]c2cccc3c2n1CCNC3
3445,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=C(Cn1ccc(=O)n(Cc2cc(Cl)cc(Cl)c2)c1=O)Nc1ccccc1Cl,"N-(2-Chlorophenyl)-2-(3-(3,5-dichlorobenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",12.67,uM,=,1.1027766148834413,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
3446,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",2.1,uM,=,0.3222192947339193,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3447,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCC1=C(C)NC(OC)C(CN2C(=O)c3ccccc3C2=O)=C1,"2-(5-Ethyl-2-methoxy-6-methyl-1,2-dihydro-pyridin-3-ylmethyl)-isoindole-1,3-dione",16.0,uM,=,1.2041199826559248,1,O=C1c2ccccc2C(=O)N1CC1=CC=CNC1
3448,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cccc(-c2ccc(Oc3c(C(F)(F)F)ccn(Cc4n[nH]c(=O)n4C)c3=O)cc2F)c1,"3-(2,-fluoro-3'-methyl-[1,1'-biphenyl]-4-yl)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",17.86,uM,=,1.2518814545525276,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3449,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(F)cccc3o2)c(O)nc1C,5-Ethyl-3-[(4-fluoro-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.11,uM,=,-0.958607314841775,0,c1cncc(NCc2nc3ccccc3o2)c1
3450,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2c(F)cccc2F)n1,"2-sec-Butylsulfanyl-6-(2,6-difluoro-benzyl)-5-methyl-3H-pyrimidin-4-one",0.05,uM,=,-1.3010299956639813,0,c1ccc(Cc2ccncn2)cc1
3451,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,Cc1cccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)c1,"5-Cyclopropyl-9-m-tolyloxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.43,uM,=,0.3856062735983122,1,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
3452,195513,10.1021/jm9508088,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCc1nc2n(c1C)-c1cccnc1N(CC)c1ncccc1-2,"2,8-Diethyl-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",5.63,uM,=,0.7505083948513462,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
3453,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,O=C1Nc2ccc(Cl)c3c2C(C(F)(F)F)(C=C(c2ccccc2)O3)N1,"7-Chloro-5-phenyl-3a-trifluoromethyl-3,3a-dihydro-1H-6-oxa-1,3-diaza-phenalen-2-one",0.244,uM,=,-0.6126101736612706,0,O=C1Nc2cccc3c2C(C=C(c2ccccc2)O3)N1
3454,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Cl)cc3)ccc2C(=O)N1O,"6-(4-Chlorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",3.7,uM,=,0.568201724066995,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3455,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(CC)CC)c1Cc1cc(C)cc(C)c1,"3-Diethylamino-4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccccc2)cc[nH]1
3456,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2Cl)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((2'-chloro-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.1,uM,=,-1.0,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3457,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)SCCCN12,"4a-Phenyl-2,3-dihydro-1H,4aH-4-thia-9a-aza-fluoren-9-one",2.2,uM,=,0.3424226808222063,1,O=C1c2ccccc2C2(c3ccccc3)SCCCN12
3458,468352,10.1016/j.bmcl.2007.11.125,,,,Inhibition of wild type HIV 3B reverse transcriptase in MT2 cells,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.05,uM,=,-1.3010299956639813,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3459,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccc(Cl)cc3)SCCN12,"9b-(4-Chloro-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.0,uM,=,0.6020599913279624,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3460,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc(Cl)cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-N-(4-chlorobenzyl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.057,uM,=,-1.2441251443275083,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
3461,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,CS(=O)(=O)c1ccc(NC(=O)CSC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"S-2-(2-chloro-4-(methylsulfonyl)phenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carbothioate",0.004,uM,=,-2.397940008672037,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
3462,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccncc2C2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[3',2':1,2]pyrrolo[3,4-c]pyridin-5-one",17.0,uM,=,1.230448921378274,1,O=C1c2ccncc2C2(c3ccccc3)SCCN12
3463,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(=O)Oc1ccccc1CN(C(=O)COC(=O)c1ccc([N+](=O)[O-])o1)C(C)(C)C,2-((2-acetoxybenzyl)(tert-butyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,12.8,uM,=,1.1072099696478683,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
3464,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc(Cl)c3Cl)cc2c1=O,"6-((2,3-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",5.6,uM,=,0.7481880270062004,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
3465,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(SCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-(4,7-Dichloro-benzooxazol-2-ylmethylsulfanyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.011,uM,=,-1.958607314841775,0,c1cncc(SCc2nc3ccccc3o2)c1
3466,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(C#N)cc(-c4cccc(F)c4)c3)c2=O)n[nH]c1=O,"3'-fluoro-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",0.0559999999999999,uM,=,-1.2518119729937995,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
3467,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CN1C(=O)c2cccnc2N(C2CC2)c2ncc(Cl)cc21,"8-Chloro-5-cyclopropyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.29,uM,=,-0.5376020021010439,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3468,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCC(=O)OC(C)C)c2cc(C)c(OC)c(C(=O)OC)c2)cc(C)c1OC,"isopropyl 6,6-di(4-methoxy-3-methyl-5-methyloxycarbonylphenyl)-5-hexenoate",60.4,uM,=,1.7810369386211318,1,C=C(c1ccccc1)c1ccccc1
3469,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,COc1cc(Oc2c(C)cc(C#N)cc2C)cc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)n1,"4-((2-Methoxy-6-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)pyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.175,uM,=,-0.7569619513137056,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
3470,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(=S)[nH]c3ccccc32)c1,"1-(3,5-Dimethylbenzyl)-1,3-dihydro-2H-benzimidazole-2-thione",27.24,uM,=,1.4352071032407476,1,S=c1[nH]c2ccccc2n1Cc1ccccc1
3471,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CN(C)c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-[(methyl-phenyl-amino)-methyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.59,uM,=,-0.2291479883578558,0,O=C1Nc2cccnc2Nc2ncc(CNc3ccccc3)cc21
3472,197453,10.1016/s0960-894x(98)00214-5,,,,Compound was evaluated for inhibition of HIV-1 reverse transcriptase using rC.dG and [3H]dGTP as substrates at 100 ug/mL,O=C(CCCCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1C(=O)O,5-bromo-2-[6-(4-bromo-2-carboxyphenylcarbamoyl)hexylcarboxamido]benzoic acid,18.0,uM,=,1.255272505103306,1,O=C(CCCCCCC(=O)Nc1ccccc1)Nc1ccccc1
3473,1872150,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of Triton-X-100 by scintillation counting method,NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,Trp-NH2,15700.0,uM,=,4.195899652409234,1,c1ccc2[nH]ccc2c1
3474,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C#N)c3)CC2)ncc1Br,"4-(5-bromo-2-(1-(3-cyanobenzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.023,uM,=,-1.6382721639824072,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
3475,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,COc1ccc(S(=O)(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)cc1,N'-(2-hydroxy-5-nitrobenzylidene)-4-methoxybenzenesulfonohydrazide,100.0,uM,=,2.0,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
3476,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,COc1ccc(CSc2nc(C(C#N)c3c(F)cccc3Cl)c(C)c(=O)[nH]2)cc1,"2-(2-(4-methoxybenzylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(2-chloro-6-fluorophenyl)acetonitrile",0.17,uM,=,-0.7695510786217261,0,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
3477,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(-c2ccc(Cl)cc2)nc(O)c1O,"2-(4-Chloro-phenyl)-5,6-dihydroxy-pyrimidine-4-carboxylic acid",4.5,uM,=,0.6532125137753437,1,c1ccc(-c2ncccn2)cc1
3478,1454138,10.1016/j.bmc.2014.07.018,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 using dsDNA by microplate reader based assay,CCN1c2ncccc2NC(=O)c2cc(N3CCN(c4cc5c(cc4N)c(=O)c(C(=O)O)cn5C)CC3)cnc21,"6-Amino-7-[4-(11-ethyl-6-oxo-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-8-yl)piperazin-1-yl]-1-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",14.8,uM,=,1.1702617153949575,1,O=C1Nc2cccnc2Nc2ncc(N3CCN(c4ccc5c(=O)cc[nH]c5c4)CC3)cc21
3479,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2c(Cl)cccc2Cl)nc(SC(C)C)[nH]c1=O,"2-(2,6-dichlorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.466,uM,=,-0.3316140833099998,0,O=c1cc(Cc2ccccc2)nc[nH]1
3480,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1CSCC2,"(E)-4-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzamide",0.179,uM,=,-0.7471469690201069,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
3481,630077,10.1016/j.bmcl.2009.04.051,,,,Inhibition of biotin-dUTP labeled HIV-1 reverse transcriptase after 30 mins colorimetric streptavidin alkaline phosphatase reporter system,Cc1cccc(CSc2nc(Cl)cc(Cc3ccccc3)n2)c1,4-benzyl-6-chloro-2-(3-methylbenzylthio)pyrimidine,90.77,uM,=,1.9579423354454049,1,c1ccc(CSc2nccc(Cc3ccccc3)n2)cc1
3482,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccccc1C(=O)O)Nc1ccccc1C(=O)O,2-({6-[(2-carboxyphenyl)amino]-6-oxohexanoyl}amino)benzoic acid,9.0,uM,=,0.9542425094393248,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3483,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-yl ester",0.73,uM,=,-0.1366771398795441,0,O=C(O[C@@H]1Cc2ccccc2O[C@@H]1c1ccccc1)c1ccccc1
3484,195837,10.1016/s0960-894x(99)00672-1,,,,The compound was evaluated for the inhibition of HIV-1 reverse transcriptase,Oc1ncc2c(F)c(F)ccc2n1,"5,6-Difluoro-1H-quinazolin-2-one",0.018,uM,=,-1.744727494896694,0,c1ccc2ncncc2c1
3485,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cc(Cl)cc(Cl)c2)nc(SC(C)C)[nH]c1=O,"2-(3,5-dichlorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.479,uM,=,-0.3196644865854368,0,O=c1cc(Cc2ccccc2)nc[nH]1
3486,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,N=C(Nc1ccc(Br)cn1)N[C@@H]1C[C@@H]1c1ccccc1,N-((R)-5-Bromo-pyridin-2-yl)-N'-((R)-2-phenyl-cyclopropyl)-guanidine,0.18,uM,=,-0.744727494896694,0,N=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
3487,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,Cc1ccc(S(=O)(=O)NNC(=O)c2nc3ccccc3c(=O)[nH]2)cc1,"4-methyl-N'-(4-oxo-3,4-dihydroquinazoline-2-carbonyl)benzenesulfonohydrazide",76.0,uM,=,1.880813592280792,1,O=C(NNS(=O)(=O)c1ccccc1)c1nc2ccccc2c(=O)[nH]1
3488,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1c(Cc2ccccc2)nc(SCCc2ccccc2)[nH]c1=O,6-Benzyl-2-(benzylthio)-5-methylpyrimidin-4(3H)-one,59.61,uM,=,1.7753191218294777,1,O=c1cc(Cc2ccccc2)nc(SCCc2ccccc2)[nH]1
3489,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3ccc(O)cc3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.004,uM,=,-2.397940008672037,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3490,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2cccc(-c3cncnc3)c2)c2nccnc2n(O)c1=O,"Methyl 5-hydroxy-6-oxo-8-((3-(pyrimidin-5-yl)phenyl)amino)-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",1.85,uM,=,0.2671717284030138,1,O=c1cc(Nc2cccc(-c3cncnc3)c2)c2nccnc2[nH]1
3491,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1F,"6-((3'-Fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.2,uM,=,0.3424226808222063,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3492,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ncco3)nc21,"5-Ethyl-10-methyl-7-oxazol-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.22,uM,=,-0.6575773191777937,0,O=C1Nc2ccc(-c3ncco3)nc2Nc2ncccc21
3493,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CCN1C(=O)c2cccn2S(=O)(=O)c2ccc(Cl)cc21,"7-Chloro-9-ethyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
3494,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.024,uM,=,-1.619788758288394,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3495,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=[N+]([O-])c1ccc(O)c(/C=N/NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl)c1,"N'-(2-hydroxy-5-nitrobenzylidene)-2,4,5-trichlorobenzenesulfonohydrazide",16.0,uM,=,1.2041199826559248,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
3496,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccsc3)nc21,"5-Ethyl-10-methyl-7-thiophen-3-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.3,uM,=,-0.5228787452803376,0,O=C1Nc2ccc(-c3ccsc3)nc2Nc2ncccc21
3497,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,Cc1ccc(Cn2cc(C(=O)/C=C(\O)C(=O)O)c(=O)c3ccccc32)c(C)c1,"4-[1-(2,4-Dimethylphenyl)methyl-4(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid",19.6,uM,=,1.292256071356476,1,O=c1ccn(Cc2ccccc2)c2ccccc12
3498,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,CS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3ccccc3Cl)s2)cc1,"2-[[5-[2-(2-Chlorophenyl)-4-oxo-thiazolidin-3-yl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-methylsulfonylphenyl)acetamide",11.83,uM,=,1.0729847446279304,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
3499,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCN(S(N)(=O)=O)CC3)cc2)nc2ccsc12,"(E)-4-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)benzyl)piperazine-1-sulfonamide",0.961,uM,=,-0.0172766123314546,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3ccsc23)cc1
3500,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,NS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3ccc(Cl)cc3)s2)cc1,"2-[[5-[2-(4-Chlorophenyl)-4-oxo-thiazolidin-3-yl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-sulfamoylphenyl)acetamide",71.95,uM,=,1.857030798272624,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
3501,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)[C@H]1OCc1ccccc1,"(3R,4R)-3-Benzyloxy-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.44,uM,=,-0.3565473235138126,0,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
3502,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,COc1ccccc1C(=O)CC/N=C(\S)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[3-(2-methoxy-phenyl)-3-oxo-propyl]-thiourea,0.003,uM,=,-2.5228787452803374,0,O=C(CCN=CNc1ccccn1)c1ccccc1
3503,1770167,10.1016/j.bmcl.2018.03.012,,,,Inhibition of recombinant wild-type HIV1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2[nH]ccc12,"4-(2-(4-cyanophenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.016,uM,=,-1.7958800173440752,0,c1ccc(Nc2nc(Oc3ccccc3)c3cc[nH]c3n2)cc1
3504,2104796,10.1016/j.bmc.2021.116239,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into cDNA measured after 1 hr by ELISA,Cc1cc(C#CC=C2CCN(S(C)(=O)=O)CC2)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-(2,6-dimethy1-4-(3-(1-(methylsulfonyl)piperidin-4-ylidene)prop-1-yn-1-yl)phenoxy)pyrimidin-2-yl)amino)benzonitrile",1.98,uM,=,0.2966651902615311,1,C(#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1)C=C1CCNCC1
3505,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nnc(C)n2-c2c(C)ccnc21,"8-Ethyl-3,4-dimethyl-8H-1,2,3a,7,8,9-hexaaza-dibenzo[e,h]azulene",198.0,uM,=,2.296665190261531,1,c1cnc2c(c1)-c1nncn1-c1cccnc1N2
3506,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1ccc2[nH]c(=O)n(S(=O)(=O)c3cc(F)cc(F)c3)c2c1,"6-Methyl 1-(3,5-difluorophenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.2,uM,=,-0.6989700043360187,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
3507,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2ccc(-c3ccccc3)cc2)c2nccnc2n(O)c1=O,"Methyl 8-([1,1'-biphenyl]-4-ylamino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",5.25,uM,=,0.7201593034059569,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)c2nccnc2[nH]1
3508,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(C)cc(Sc2cccc(N)c2C#N)c1,"2-Amino-6-(3,5-dimethyl-phenylsulfanyl)-benzonitrile",1.1,uM,=,0.041392685158225,1,c1ccc(Sc2ccccc2)cc1
3509,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,Oc1nc2ccc(Cl)cc2n1CC1CCCCC1,"6-Chloro-1-cyclohexylmethyl-1,3-dihydro-benzoimidazol-2-one",50.0,uM,=,1.6989700043360187,1,c1ccc2c(c1)ncn2CC1CCCCC1
3510,195841,10.1021/jm980510s,,,,The compound was tested for inhibitory activity against Recombinant HIV-1 reverse transcriptase,CCN(CC)CC.Nc1nc(=O)n(C2C=CC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2)cc1F,"cis-(+/-)-4-Amino-5-fluoro-1-[4-(triphosphonooxymethyl)-2-cyclopenten-1-yl]-2(1H)-pyrimidinone, Triethylammonium salt",0.4,uM,=,-0.3979400086720376,0,O=c1ncccn1C1C=CCC1
3511,2231068,10.1016/j.bmc.2021.116531,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.6948,uM,=,-0.158140190224939,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
3512,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc(C(=O)OC)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"3-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzoic acid methyl ester",0.7,uM,=,-0.1549019599857432,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3513,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(N)c2c(c1)Oc1ncccc1C(=O)N2C,"9-Amino-7,10-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",1.0,uM,=,0.0,0,O=C1Nc2ccccc2Oc2ncccc21
3514,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cc(F)cc(Cl)c2)nc(SC(C)C)[nH]c1=O,"2-(3-chloro-5-fluorophenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",0.716,uM,=,-0.1450869776921444,0,O=c1cc(Cc2ccccc2)nc[nH]1
3515,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2cccc(C#N)c2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3',5'-dimethyl-[1,1'-biphenyl]-3-carbonitrile",0.042,uM,=,-1.3767507096020994,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3516,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,CS(=O)(=O)c1ccc(NC(=O)Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)cc1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(4-(methylsulfonyl)phenyl)acetamide,1.0,uM,=,0.0,0,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccccc1
3517,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2cccc(Cl)c2)C1,"1-benzyl-4-(3-chlorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",58.0,uM,=,1.7634279935629371,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
3518,471453,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2CO[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,1-(beta-D-dioxolane)thymine triphosphate,0.19,uM,=,-0.721246399047171,0,O=c1ccn([C@H]2COCO2)c(=O)[nH]1
3519,442659,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rC.dG template,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.5,uM,=,0.3979400086720376,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3520,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccccc3O)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(2-hydroxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3521,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(F)nc21,"5-Ethyl-7-fluoro-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncccc21
3522,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,Oc1ccc2ccccc2c1/C=N/NC(=S)N[C@@H]1CN2CCC1CC2,(S)-2-((2-hydroxynaphthalen-1-yl)methylene)-N-(quinuclidin-3-yl)hydrazinecarbothioamide,61.0,uM,=,1.7853298350107671,1,S=C(N/N=C/c1cccc2ccccc12)N[C@@H]1CN2CCC1CC2
3523,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3524,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,O=C(COC(=O)c1ccc([N+](=O)[O-])o1)NC1CCc2ccccc21,"2-(2,3-dihydro-1H-inden-1-ylamino)-2-oxoethyl 5-nitrofuran-2-carboxylate",6.1,uM,=,0.785329835010767,1,O=C(COC(=O)c1ccco1)NC1CCc2ccccc21
3525,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CCCC(=O)NC1=NN(C)c2ncnc3c2c1cn3C1O[C@H](CO)[C@@H](O)[C@H]1O,"N-[1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1,5-dihydro-1,4,5,6,8-pentaaza-acenaphthylen-3-yl]-butyramide",0.5,uM,=,-0.3010299956639812,0,C1=NNc2ncnc3c2c1cn3C1CCCO1
3526,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Br)cc3)ccc2C(=O)N1O,"6-(4-Bromobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.1,uM,=,0.041392685158225,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3527,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C(N)=O)c3)CC2)nc2c1CSCC2,"(E)-3-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzamide",0.184,uM,=,-0.7351821769904636,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
3528,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CC(C)n2c(S)nc3cccc(c32)C1C,"6,9-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",25.8,uM,=,1.4116197059632305,1,c1cc2c3c(c1)ncn3CCNC2
3529,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",0.2,uM,=,-0.6989700043360187,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3530,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1COC(C#Cc2ccoc2)(C(F)(F)F)c2cc(Cl)ccc2N1,"7-Chloro-5-furan-3-ylethynyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",2.51,uM,=,0.3996737214810381,1,O=C1COC(C#Cc2ccoc2)c2ccccc2N1
3531,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",3.6,uM,=,0.5563025007672873,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3532,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,Cc1nc(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)sc1/N=N/c1ccc(Br)cc1,"5-(5-((4-Bromophenyl)diazenyl)-4-methylthiazol-2-yl)-4-(4-chlorophenyl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",1.6e-05,uM,=,-4.795880017344075,0,c1ccc(/N=N/c2cnc(N3Nc4onc(-c5ccccc5)c4C3c3ccccc3)s2)cc1
3533,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(Cl)c2)[nH]c(=O)n1O,"6-((3-Chlorophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
3534,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),CCOc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccc(O)c(C(=O)O)c3)C2=O)cc1,5-(3-{5-[1-(4-Ethoxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid,11.0,uM,=,1.0413926851582251,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
3535,1338882,10.1016/j.bmc.2014.02.029,,,,Inhibition of recombinant HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation in to poly [A] x oligo[dT]15 by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.55,uM,=,-0.2596373105057561,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3536,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,COc1ccc(-c2ccc(Cc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1F,"6-((3'-fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.0076,uM,=,-2.1191864077192086,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3537,80573,10.1016/0960-894X(95)00311-G,,,,Inhibitory activity was evaluated in vitro against HIV- I reverse transcriptase (RT),CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1.CS(=O)(=O)O,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)-methanone; compound with methanesulfonic acid,5.2,uM,=,0.7160033436347992,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3538,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CCC(C)(C)N(Cc1ccc([N+](=O)[O-])cc1)C(=O)COC(=O)c1ccc([N+](=O)[O-])s1,2-((4-nitrobenzyl)(tert-pentyl)amino)-2-oxoethyl 5-nitrothiophene-2-carboxylate,33.5,uM,=,1.5250448070368452,1,O=C(COC(=O)c1cccs1)NCc1ccccc1
3539,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,CC(C)=CCN1Cc2cccc3nc(S)n(c23)C[C@H]1C,"(R)-8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.07,uM,=,-1.154901959985743,0,c1cc2c3c(c1)ncn3CCNC2
3540,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),Cc1ccnc(C23SCCN2C(=O)c2ccccc23)c1,"9b-(4-Methyl-pyridin-2-yl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",1.0,uM,=,0.0,0,O=C1c2ccccc2C2(c3ccccn3)SCCN12
3541,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2ccc(C(F)(F)F)cc2n1Cc1c(F)cccc1F,"6-Trifluoromethyl-1-(2,6-difluorobenzyl)-1,3-dihydro-2H-benzimidazol-2-one",0.017,uM,=,-1.769551078621726,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
3542,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,Cc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-((4'-methyl-[1,1'-biphenyl]-4-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3543,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,C=CCN1C(=O)c2cccn2S(=O)(=O)c2cc(Cl)ccc21,"9-Allyl-6-chloro-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",2.9,uM,=,0.4623979978989561,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
3544,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.073,uM,=,-1.136677139879544,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3545,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(C(N)=O)cc2N(C)C(=O)c2cccnc21,"11-Ethyl-6-methyl-5-oxo-6,11-dihydro-5H-benzo[b]pyrido[2,3-e][1,4]diazepine-8-carboxylic acid amide",27.0,uM,=,1.4313637641589874,1,O=C1Nc2ccccc2Nc2ncccc21
3546,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(C#N)cn2)c1Cl,"1-[(1R,2R)-2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-cyano-pyridin-2-yl)-urea",0.004,uM,=,-2.397940008672037,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
3547,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+],SID11112047,6700.0,uM,=,3.8260748027008256,1,c1ccc2ccccc2c1
3548,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(Cl)cccc3o2)c(O)nc1C,3-[2-(4-Chloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one,0.062,uM,=,-1.207608310501746,0,c1cncc(CCc2nc3ccccc3o2)c1
3549,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CC)c1Cc1cccc(/C=C/C#N)c1,"3-{3-[5-Ethyl-3-(ethyl-methyl-amino)-6-methyl-2-oxo-1,2-dihydro-pyridin-4-ylmethyl]-phenyl}-acrylonitrile",0.001,uM,=,-3.0,0,O=c1cc(Cc2ccccc2)cc[nH]1
3550,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)/C=C/c1cccn1Cc1ccc(F)c(F)c1,"ethyl 6-(1-(3,4-difluorobenzyl)-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoate",3.0,uM,=,0.4771212547196624,1,c1ccc(Cn2cccc2)cc1
3551,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,Br.NC(=O)c1sc(N)nc1-c1cccc(Cl)c1,2-amino-4-(3-chlorophenyl)thiazole-5-carboxamide hydrobromide,54.4,uM,=,1.73559889969818,1,c1ccc(-c2cscn2)cc1
3552,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SCc2ccc3ccccc3c2)n1,6-Chloro-2-(naphthalen-2-ylmethylsulfanyl)-pyrimidin-4-ylamine,0.15,uM,=,-0.8239087409443188,0,c1cnc(SCc2ccc3ccccc3c2)nc1
3553,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CCc1cc(OC)c(O)cc1OC)S(=O)(=O)c1ccc(OC)cc1,"3-(4-hydroxy-2,5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-(4-methoxy-N-propylphenylsulfonamido)-1-phenylbutan-2-yl)propanamide",0.0065,uM,=,-2.1870866433571443,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3554,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)cc2)[nH]c(=O)n1O,"6-((2',4'-bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.085,uM,=,-1.0705810742857071,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3555,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1[S+]([O-])c1cc(Cl)ccc1Cl,"2-Amino-6-(2,5-dichloro-benzenesulfinyl)-benzonitrile",6.2,uM,=,0.7923916894982539,1,c1ccc([SH+]c2ccccc2)cc1
3556,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1cc(C)cc(Cn2c(=O)[nH]c3ccc(C)cc32)c1,"6-Methyl-1-(3,5-dimethylbenzyl)-1,3-dihydro-2H-benzimidazol-2-one",76.92,uM,=,1.8860392755664424,1,O=c1[nH]c2ccccc2n1Cc1ccccc1
3557,732389,10.1128/aac.01455-09,,,,Inhibition of HIV1 reverse transcriptase activity by primer extension assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.0072,uM,=,-2.1426675035687315,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3558,437168,10.1016/j.bmc.2007.05.047,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.06,uM,=,-1.2218487496163564,0,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
3559,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,Cn1c(Cc2ccc(Br)c(Oc3cc(Cl)cc(C#N)c3)c2F)n[nH]c1=O,"3-(6-bromo-2-fluoro-3-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)phenoxy)-5-chlorobenzonitrile",0.005,uM,=,-2.3010299956639813,0,O=c1[nH]nc(Cc2cccc(Oc3ccccc3)c2)[nH]1
3560,1567954,10.1016/j.bmc.2016.04.018,,,,Inhibition of HIV1 reverse transcriptase using 234-nt long RNA/18-mer DNA oligonucleotide as template/primer preincubated for 15 mins followed by incubation with template/primer for 40 mins by liquid scintillation counting in presence of alpha[P33]-dCTP,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.92,uM,=,-0.0362121726544447,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3561,539250,10.1021/jm800856c,,,,Inhibition of wild type HIV1 RT polymerase by SPA,N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4ccccc34)ccc2Cl)c1,3-(5-((1H-indazol-3-yl)methoxy)-2-chlorophenoxy)-5-chlorobenzonitrile,0.0014,uM,=,-2.853871964321762,0,c1ccc(Oc2cccc(OCc3n[nH]c4ccccc34)c2)cc1
3562,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cc4ccccc4cc3o2)c(O)nc1C,"5-Ethyl-6-methyl-3-[(naphtho[2,3-d]oxazol-2-ylmethyl)-amino]-1H-pyridin-2-one",10.0,uM,=,1.0,1,c1cncc(NCc2nc3cc4ccccc4cc3o2)c1
3563,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(NCc2ccc3ccccc3c2)c(O)nc1C,5-Ethyl-6-methyl-3-[(naphthalen-2-ylmethyl)-amino]-1H-pyridin-2-one,0.44,uM,=,-0.3565473235138126,0,c1cncc(NCc2ccc3ccccc3c2)c1
3564,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1ccccc1CS(=O)(=O)n1c(=O)[nH]c2ccc(Cl)cc21,"6-Chloro-1-[(2-methylbenzyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",21.0,uM,=,1.3222192947339193,1,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
3565,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2ccccc2S[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N12,"(5aR,6S,7S,8R,9R)-6,7,8-trihydroxy-9-(hydroxymethyl)-6,7,8,9-tetrahydrobenzo[e]pyrido[2,1-b][1,3]thiazin-11(5aH)-one",19.72,uM,=,1.2949069106051925,1,O=C1c2ccccc2S[C@@H]2CCCCN12
3566,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)C(=O)COC(=O)c1ccc([N+](=O)[O-])s1,"3,3-dimethyl-2-oxobutyl 5-nitrothiophene-2-carboxylate",5.7,uM,=,0.7558748556724915,1,c1ccsc1
3567,822365,10.1016/j.ejmech.2012.04.004,,,,Inhibition of HIV1 wildtype reverse transcriptase using poly(rA)/oligo(dT)15 as template by colometric streptavidin alkaline phosphate reporter assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.98,uM,=,-0.0087739243075051,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
3568,195520,10.1021/jm00089a002,,,,Inhibitory activity against human immunodeficiency virus-1 reverse transcriptase(HIV-1 RT).,Cc1cn([C@H]2C[C@@H](N=[N+]=[N-])[C@@H](OP(=O)(O)OP(=O)(O)NP(=O)(O)O)O2)c(=O)[nH]c1=O,"AZTMPPNP3'-azidothymidine 5'-[alpha,beta-imido]triphosphate",0.1,uM,=,-1.0,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3569,195667,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (Wild Type) with poly(rA)600:oligo(dT)10 template primer,CCc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethyl-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.061,uM,=,-1.214670164989233,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3570,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",1.6,uM,=,0.2041199826559248,1,c1cncc(NCc2nc3ccccc3o2)c1
3571,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,CCOc1ccc(NC(=O)c2c(NC(=O)c3ccco3)sc3c2CCCCC3)cc1,"N-(3-(4-ethoxyphenylcarbamoyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)furan-2-carboxamide",4.2,uM,=,0.6232492903979004,1,O=C(Nc1sc2c(c1C(=O)Nc1ccccc1)CCCCC2)c1ccco1
3572,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CC#N)cc2)nc2c1CCCC2,"(E)-3-(4-((2-((4-(Cyanomethyl)phenyl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile",0.049,uM,=,-1.3098039199714864,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
3573,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1,2-Amino-6-benzenesulfonyl-benzonitrile,6.9,uM,=,0.8388490907372553,1,O=S(=O)(c1ccccc1)c1ccccc1
3574,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#C/C=C/c1cc(F)cc(Oc2ccc(OS(=O)(=O)F)cc2OCCn2ccc(=O)[nH]c2=O)c1,"(E)-4-(3-(2-cyanovinyl)-5-fluorophenoxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.15,uM,=,-0.8239087409443188,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
3575,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCC1=C(C)NC(N)C(CCc2nc3ccccc3o2)=C1,"3-(2-Benzooxazol-2-yl-ethyl)-5-ethyl-6-methyl-1,2-dihydro-pyridin-2-ylamine",100.0,uM,=,2.0,1,C1=CNCC(CCc2nc3ccccc3o2)=C1
3576,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1OC,"6-((3',4'-dimethoxy-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.004,uM,=,-2.397940008672037,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3577,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(C=O)cc(-c3cccc(OC)c3)nc21,"5-Ethyl-7-(3-methoxy-phenyl)-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cycloheptene-9-carbaldehyde",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
3578,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(N(C)Cc2cc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzofuran-2-ylmethyl)-methyl-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",1.05,uM,=,0.021189299069938,1,c1cncc(NCc2cc3ccccc3o2)c1
3579,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1ccc(Cl)nc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(6-Chloro-3-isopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.36,uM,=,-0.4436974992327127,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3580,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CC(=O)CC(=O)c1c(O)c2c(=O)oc3c4ccccc4ccc3c2oc1=O,"1-hydroxy-2-(3-oxobutanoyl)benzo[h]pyrano[3,2-c]chromene-3,12-dione",51.2,uM,=,1.7092699609758308,1,O=c1ccc2c(=O)oc3c4ccccc4ccc3c2o1
3581,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)OC(=O)COC(=O)c1ccc([N+](=O)[O-])o1,2-isopropoxy-2-oxoethyl 5-nitrofuran-2-carboxylate,13.2,uM,=,1.1205739312058498,1,c1ccoc1
3582,195674,10.1021/jm0009437,,,,Tested for inhibitory concentration on HIV-1 Reverse transcriptase in the presence of poly(c)-oligo-(dG),Cc1c(Sc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"1-Benzyloxymethyl-5-methyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",0.3,uM,=,-0.5228787452803376,0,O=c1cc(Sc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3583,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OCCc1ccccc1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid phenethyl ester",6.9,uM,=,0.8388490907372553,1,O=C(OCCc1ccccc1)c1ccccc1
3584,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.3,uM,=,-0.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
3585,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CC1=C(Cc2cc(O)ccc2O)[C@]2(C)CCC[C@@](C)(CC[C@@]3(O)[C@H](C)CC[C@@H]4OC(C)(C)CCC[C@@]43C)[C@H]2CC1,"2-(((4aR,5S,8aR)-5-(2-((5aS,6R,7R,9aS)-6-hydroxy-2,2,5a,7-tetramethyldecahydrobenzo[b]oxepin-6-yl)ethyl)-2,5,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methyl)benzene-1,4-diol",1.4,uM,=,0.1461280356782379,1,C1=C(Cc2ccccc2)C2CCCC(CCC3CCC[C@@H]4OCCCCC34)[C@H]2CC1
3586,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[2-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-ethyl]-isoindole-1,3-dione",3.7,uM,=,0.568201724066995,1,O=C1c2ccccc2C(=O)N1CCc1cccnc1
3587,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccccc1F)CC(=O)C(=O)O,"6-[1-(2-Fluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",6.4,uM,=,0.8061799739838872,1,c1ccc(Cn2cccc2)cc1
3588,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),NC(=O)[C@H]1CSC2(c3ccccc3)c3ccccc3C(=O)N12,"5-Oxo-9b-phenyl-2,3,5,9b-tetrahydro-thiazolo[2,3-a]isoindole-3-carboxylic acid amide",59.0,uM,=,1.7708520116421442,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3589,705547,10.1128/aac.01559-08,,,,Inhibition of HIV1 isolate R8 reverse transcriptase after 90 mins,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.0004199999999999,uM,=,-3.3767507096021,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3590,2281181,10.1016/j.ejmech.2021.113220,,,,Inhibition of HIV-1 reverse transcriptase incubated for 90 mins by liquid scintillation counting analysis,CC(C)[C@H]1C(=O)OC[C@@H](NC(=O)c2nc3ccccc3cc2O)C(=O)N2CCCC[C@H]2C(=O)NCC(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)OC[C@@H](NC(=O)c2nc3ccccc3cc2O)C(=O)N2CCCC[C@H]2C(=O)NCC(=O)N(C)CC(=O)N1C,"7,26-di(3-hydroxy-2-quinolylcarboxamido)-11,30-diisopropyl-12,15,31,34-tetramethyl-6,10,13,16,19,25,29,32,35,38-decaoxoperhydrodipyrido[2,1-l:2,1-b1][1,17,4,7,10,13,20,23,26,29]dioxaoctaazacyclodotriacontine",0.00013,uM,=,-3.886056647693163,0,O=C1CNC(=O)CNC(=O)[C@@H]2CCCCN2C(=O)[C@H](NC(=O)c2ccc3ccccc3n2)COC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCCN2C(=O)[C@H](NC(=O)c2ccc3ccccc3n2)COC(=O)CN1
3591,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1ccc(NC(=O)CS(=O)(=O)c2nccc(Oc3c(C)cc(C#N)cc3C)n2)cc1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(p-tolyl)acetamide",0.766,uM,=,-0.115771230367396,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
3592,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(3-Amino-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
3593,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1cc(Cl)cc(Oc2ccc(OS(=O)(=O)F)cc2OCCn2ccc(=O)[nH]c2=O)c1,"4-(3-Chloro-5-cyanophenoxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.103,uM,=,-0.9871627752948278,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
3594,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(F)cc(F)c1,"6-[1-(3,5-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",5.0,uM,=,0.6989700043360189,1,c1ccc(Cn2cccc2)cc1
3595,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(-c2cccc(Br)c2)nc(O)c1O,"2-(3-Bromophenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",14.0,uM,=,1.146128035678238,1,c1ccc(-c2ncccn2)cc1
3596,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",0.4,uM,=,-0.3979400086720376,0,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3597,195513,10.1021/jm9508088,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(N3CC=CCC3)nc21,"6-(3,6-Dihydro-2H-pyridin-1-yl)-8-ethyl-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",2.7,uM,=,0.4313637641589873,1,C1=CCN(c2ccc3c(n2)Nc2ncccc2-c2nccn2-3)CC1
3598,196375,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1/138Lys reverse transcriptase (RT) using [3H]dGTP as a radioligand,CCOC(=O)P(=O)(O)OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[(3-[[[(ethyloxycarbonyl)hydroxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",293.0,uM,=,2.4668676203541096,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3599,939435,10.1021/jm301271j,,,,Inhibition of wild type HIV-1 reverse transcriptase incoming nucleotide binding site after 30 mins by fluorescence assay,CN1CCN(c2ccc(C(=O)O)cc2)CC1,4-(4-methylpiperazino)-benzoic acid,200.0,uM,=,2.3010299956639813,1,c1ccc(N2CCNCC2)cc1
3600,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(C)ccc(C)c3o2)c(O)nc1C,"3-[(4,7-Dimethyl-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.02,uM,=,-1.6989700043360187,0,c1cncc(NCc2nc3ccccc3o2)c1
3601,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCc1cc(NCCCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[3-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-propyl]-isoindole-1,3-dione",190.0,uM,=,2.278753600952829,1,O=C1c2ccccc2C(=O)N1CCCNc1cccnc1
3602,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=c1ccc(Cc2cccc(Oc3cccc(Cl)c3)c2)n[nH]1,6-(3-(3-chlorophenoxy)benzyl)pyridazin-3(2H)-one,21.0,uM,=,1.3222192947339193,1,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
3603,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(COCCc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-phenethyloxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2c(COCCc3ccccc3)ccnc2N(C2CC2)c2ncccc21
3604,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Cc1ccc(NC(=S)NCCc2c(F)cccc2F)nc1,"1-[2-(2,6-Difluoro-phenyl)-ethyl]-3-(5-methyl-pyridin-2-yl)-thiourea",0.003,uM,=,-2.5228787452803374,0,S=C(NCCc1ccccc1)Nc1ccccn1
3605,1984595,10.1016/j.bmc.2020.115431,,,,Inhibition of wild type recombinant HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by picogreen dye-based spectrofluorometric method,NS(=O)(=O)c1ccc(NC(=O)CSc2nnc(N3C(=O)CSC3c3ccccc3Cl)s2)cc1,"2-[[5-[2-(2-Chlorophenyl)-4-oxo-thiazolidin-3-yl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(4-sulfamoylphenyl)acetamide",21.84,uM,=,1.3392526340326996,1,O=C(CSc1nnc(N2C(=O)CSC2c2ccccc2)s1)Nc1ccccc1
3606,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3607,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(C#N)cc2F)n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(4-cyano-2-fluorophenyl)acetamide",0.296,uM,=,-0.5287082889410615,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
3608,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)cc2[C@@](C#CC2CC2)(C(F)(F)F)N1,"4-Cyclopropylethynyl-6-fluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
3609,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",6.6,uM,=,0.8195439355418687,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3610,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(-c3ccc(C(F)(F)F)cc3)c2)[nH]c(=O)n1O,"3-Hydroxy-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.007,uM,=,-2.154901959985743,0,O=c1cc(Sc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3611,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,COc1ccc(OCCOCCOCCOCCOCC#Cc2cn([C@H]3C=C[C@@H](CO)O3)c(=O)[nH]c2=O)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"5-{15-[2-(2-(5-Bromo-2-pyridinylamino thiocarbonylamino)ethyl)-4-methoxyphenoxy]pentadeca-4,7,10,13-tetraoxa-1-ynyl}-2',3'-didehydro-2',3'-dideoxyuridine",1.4,uM,=,0.1461280356782379,1,O=c1[nH]c(=O)n([C@H]2C=CCO2)cc1C#CCOCCOCCOCCOCCOc1ccccc1CCNC(=S)Nc1ccccn1
3612,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2ccc(-c3ccc(Cl)cc3)cc2)[nH]c(=O)n1O,"6-((4'-Chloro-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.47,uM,=,-0.3279021420642826,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3613,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1Cl,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-thiourea,0.012,uM,=,-1.9208187539523751,0,S=C(NCCc1ccccc1)Nc1ccccn1
3614,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1COC(C#Cc2ccccc2)(C(F)(F)F)c2cc(Cl)ccc2N1,"7-Chloro-5-phenylethynyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",3.3,uM,=,0.5185139398778875,1,O=C1COC(C#Cc2ccccc2)c2ccccc2N1
3615,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CC(C)N1c2ccccc2N(C)C(=O)c2cccnc21,"11-Isopropyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.2,uM,=,-0.6989700043360187,0,O=C1Nc2ccccc2Nc2ncccc21
3616,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,COc1ccc(C(=O)CSc2nc(Cc3cccc4ccccc34)c(C(C)C)c(=O)[nH]2)cc1,5-Isopropyl-2-[2-(4-methoxy-phenyl)-2-oxo-ethylsulfanyl]-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.03,uM,=,-1.5228787452803376,0,O=C(CSc1nc(Cc2cccc3ccccc23)cc(=O)[nH]1)c1ccccc1
3617,306454,10.1016/j.bmcl.2004.07.050,,,,Inhibitory activity against strand transfer in wild-type HIV-1 integrase was determined using 21-mer oligonucleotide substrate,Nc1ncnc2c1ncn2[C@@H]1CO[C@H](COP(=O)(O)O[C@H]2C[C@H](n3cnc4c(N)ncnc43)O[C@@H]2COP(=O)(O)O)[C@H]1O,Phosphoric acid 4-(6-amino-purin-9-yl)-3-hydroxy-tetrahydro-furan-2-ylmethyl ester 5-(6-amino-purin-9-yl)-2-phosphonooxymethyl-tetrahydro-furan-3-yl ester,41.0,uM,=,1.6127838567197357,1,O=[PH](OC[C@@H]1C[C@H](n2cnc3cncnc32)CO1)O[C@@H]1CO[C@@H](n2cnc3cncnc32)C1
3618,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3ccc(F)cc3F)cc2)[nH]c(=O)n1O,"6-((2',4'-difluoro-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.015,uM,=,-1.8239087409443189,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3619,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(O)c(C(=O)O)c1,"5-(3-{5-[1-Benzo[1,3]dioxol-5-yl-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid",17.0,uM,=,1.230448921378274,1,O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccccc1
3620,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,COc1ccc2c(c1)N(C(=O)OC(C)C)C(CSC)C(S)=N2,"7-Methoxy-2-methylsulfanylmethyl-3-thioxo-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester",0.17,uM,=,-0.7695510786217261,0,C1=Nc2ccccc2NC1
3621,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,C=CCC[C@]12C[C@@]1(C(=O)OCC)C(=O)Nc1ccc(Br)cc12,"(1aS,7bR)-ethyl 6-bromo-7b-(but-3-enyl)-2-oxo-1a,2,3,7b-tetrahydro-1H-cyclopropa[c]quinoline-1a-carboxylate",0.001,uM,=,-3.0,0,O=C1Nc2ccccc2C2CC12
3622,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"rac-4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.005,uM,=,-2.3010299956639813,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
3623,195228,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(ra)-oligo(dt) as the template primer.,COC(=O)CCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-5-methyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,1.9,uM,=,0.2787536009528289,1,C=C(c1ccccc1)c1ccccc1
3624,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,CCOc1cc(/C=C2\SC(=S)N(c3ccccc3)C2=O)cc([N+](=O)[O-])c1O,5-(3-ethoxy-4-hydroxy-5-nitrobenzylidene)-3-phenyl-2-thioxothiazolidin-4-one,12.82,uM,=,1.1078880251827987,1,O=C1/C(=C/c2ccccc2)SC(=S)N1c1ccccc1
3625,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(C(=CCCCc2nnc(C)o2)c2cc(C)c(OC)c(C(=O)SC)c2)cc1C(=O)SC,"S,S'-dimethyl 5,5'-(5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-ene-1,1-diyl)bis(2-methoxy-3-methylbenzothioate)",6.7,uM,=,0.8260748027008264,1,C(CCCc1nnco1)=C(c1ccccc1)c1ccccc1
3626,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3ccncc3)ccc21,"5-Cyclopropyl-10-methyl-7-pyridin-4-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2ccc(-c3ccncc3)nc2N(C2CC2)c2ncccc21
3627,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2cccnc2N(C)C(=O)c2cccnc21,"5-Ethyl-11-methyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",1.3,uM,=,0.1139433523068367,1,O=C1Nc2ncccc2Nc2ncccc21
3628,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1[nH]c(=O)n(COCc2ccccc2)c(COCc2ccccc2)c1Br,"1,6-Bis[(benzyloxy)methyl]-5-bromopyrimidine-2,4(1H,3H)-dione",7.9,uM,=,0.8976270912904415,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3629,195513,10.1021/jm9508088,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN1c2ncccc2-c2ncc(C)n2-c2c(C)cc(O)nc21,"8-Ethyl-3,4-dimethyl-7H,8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-one",12.2,uM,=,1.0863598306747482,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
3630,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C#Cc1ccc(NC(=O)CSc2nnnn2-c2ccc(C3CC3)cc2Cl)c(Cl)c1)C(=O)O,"4-(3-chloro-4-(2-(1-(2-chloro-4-cyclopropylphenyl)-1H-tetrazol-5-ylthio)acetamido)phenyl)-2,2-dimethylbut-3-ynoic acid",0.0037,uM,=,-2.431798275933005,0,O=C(CSc1nnnn1-c1ccc(C2CC2)cc1)Nc1ccccc1
3631,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCNC(=O)OCC(C)C)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"4-(N-Isobutyloxycarbonyl)amino-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylbutene",65.4,uM,=,1.8155777483242672,1,C=C(c1ccccc1)c1ccccc1
3632,2125951,10.1021/acs.jmedchem.1c00268,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)ncc1-c1ccoc1,"4-((4-(4-(4-cyano-2,6-dimethylphenoxy)-5-(furan-3-yl)pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.092,uM,=,-1.0362121726544449,0,c1ccc(CN2CCC(Nc3ncc(-c4ccoc4)c(Oc4ccccc4)n3)CC2)cc1
3633,195341,10.1021/jm000255n,,,,Inhibition of HIV-1 reverse transcriptase at 37 degree Centigrade,CCc1ccnc2c1N(C)C(=O)c1cccnc1N2CC,"5,9-Diethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2Nc2ncccc21
3634,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(-c3ccc(F)cc3)cc2)[nH]c(=O)n1O,"6-((4'-fluoro-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3635,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3ccncc3)ccc21,"5-Cyclopropyl-10-methyl-7-pyridin-4-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.32,uM,=,-0.494850021680094,0,O=C1Nc2ccc(-c3ccncc3)nc2N(C2CC2)c2ncccc21
3636,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",6.44,uM,=,0.8088858673598122,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3637,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",44.0,uM,=,1.6434526764861874,1,S=c1[nH]c2cccc3c2n1CCNC3
3638,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2ccc([N+](=O)[O-])cc2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-6-nitro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.209,uM,=,-0.679853713888946,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3639,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,COc1cccc(CSc2nc(Cc3ccccc3)cc(=O)[nH]2)c1,6-Benzyl-2-(3-methoxybenzylthio)pyrimidin-4(3H)-one,90.85,uM,=,1.9583249316440527,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
3640,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Oc4ccccc4)cc3)cc2c1=O,"6-((4-(Benzyloxy)benzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",2.2,uM,=,0.3424226808222063,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc(Oc4ccccc4)cc3)cc12
3641,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(C#CC1CC1)(OCc1ccccc1)C(F)(F)F,3-(1-Benzyloxy-3-cyclopropyl-1-trifluoromethyl-prop-2-ynyl)-1H-pyridin-2-one,0.011824,uM,=,-1.9272355789492488,0,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
3642,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid amide",0.0003,uM,=,-3.522878745280338,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3643,1763341,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 reverse transcriptase polymerase p51/p66 after 10 to 20 mins in presence of [3H]-TTP by liquid scintillation counting method,COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(Oc2ccccc2)cc1,N'-((2-methoxynaphthalen-1-yl)methylene)-4-phenoxybenzohydrazide,0.4,uM,=,-0.3979400086720376,0,O=C(N/N=C/c1cccc2ccccc12)c1ccc(Oc2ccccc2)cc1
3644,817161,10.1016/j.bmc.2012.02.037,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by colorimetry,CC1=N/C(=C/c2ccccc2O)C(=O)N1Cc1ccncc1,4-(2-Hydroxybenzylidene)-2-methyl-1-(pyridin-4-ylmethyl)-1H-imidazol-5(4H)-one,3.5,uM,=,0.5440680443502757,1,O=C1/C(=C\c2ccccc2)N=CN1Cc1ccncc1
3645,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,COc1cc(OC)c2c(c1)OCC(OC(=O)c1cc(O)c(O)c(O)c1)C2,"3,4,5-Trihydroxy-benzoic acid 5,7-dimethoxy-chroman-3-yl ester",0.9,uM,=,-0.0457574905606751,0,O=C(OC1COc2ccccc2C1)c1ccccc1
3646,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(F)c(CCc3cccc(Cl)c3)[nH]c(=O)c2Br)c1,"3-(3-bromo-6-(3-chlorophenethyl)-5-fluoro-2-oxo-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.017,uM,=,-1.769551078621726,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccc2)[nH]1
3647,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(-c2ccc(C#N)cc2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"3'-methyl-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",4.8,uM,=,0.6812412373755872,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3648,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(OC)cc2N(C)C(=O)c2cccnc21,"11-Ethyl-8-methoxy-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",2.1,uM,=,0.3222192947339193,1,O=C1Nc2ccccc2Nc2ncccc21
3649,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccs3)nc21,"5-Ethyl-10-methyl-7-thiophen-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2ccc(-c3cccs3)nc2Nc2ncccc21
3650,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(Cl)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,3-(4-(5-bromo-4-(2-chloro-4-cyano-6-methylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.028,uM,=,-1.5528419686577808,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
3651,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,Nc1cccc(CO[C@H]2C(=O)Nc3ccc(Cl)cc3[C@@]2(C#CC2CC2)C(F)(F)F)c1,"(3R,4R)-3-(3-Amino-benzyloxy)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",1.455,uM,=,0.1628629933219261,1,O=C1Nc2ccccc2C(C#CC2CC2)[C@H]1OCc1ccccc1
3652,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCC(N)=O)[nH]c3ccc(Cl)c(F)c23)c1,"N-(2-Amino-2-oxoethyl)-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-1H-indole-2-carboxamide",0.025,uM,=,-1.6020599913279625,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3653,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,COc1cccc2cc(CNCc3cn([C@H]4C[C@H](n5cc(C)c(=O)[nH]c5=O)O[C@@H]4CO)nn3)c(=O)oc12,"1-((2R,4S,5S)-5-(hydroxymethyl)-4-(4-(((8-methoxy-2-oxo-2H-chromen-3-yl)methylamino)methyl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",106.4,uM,=,2.026941627959029,1,O=c1ccn([C@H]2C[C@H](n3cc(CNCc4cc5ccccc5oc4=O)nn3)CO2)c(=O)[nH]1
3654,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NC1CC1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-cyclopropylacetamide",0.021,uM,=,-1.6777807052660807,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NC1CC1
3655,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,Cc1ccc(-c2ccccc2OCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,2-(3'-chloro-4'-(2-(2'-chloro-4'-methylbiphenyl-2-yloxy)acetamido)biphenyl-4-yl)acetic acid,0.177,uM,=,-0.7520267336381934,0,O=C(COc1ccccc1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
3656,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccccc1-c1cccc(Oc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",2.5,uM,=,0.3979400086720376,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3657,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(N)=O)[nH]c3ccc(Cl)cc23)c1,"(S)-N-(1-amino-1-oxopropan-2-yl)-5-chloro-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.026,uM,=,-1.585026652029182,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3658,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccccc2)n1,6-Benzyl-2-sec-butylsulfanyl-3H-pyrimidin-4-one,1.0,uM,=,0.0,0,c1ccc(Cc2ccncn2)cc1
3659,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCOCn1c(Cc2ccc(-c3ccccc3)cc2)c(C)c(=O)n(O)c1=O,"6-([1,1'-biphenyl]-4-ylmethyl)-1-(ethoxymethyl)-3-hydroxy-5-methylpyrimidine-2,4(1H,3H)-dione",6.2,uM,=,0.7923916894982539,1,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3660,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1ccccc1CNc1cc(CC)c(C)nc1O,5-Ethyl-3-(2-ethyl-benzylamino)-6-methyl-1H-pyridin-2-one,6.9,uM,=,0.8388490907372553,1,c1ccc(CNc2cccnc2)cc1
3661,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2ncccn2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-pyrimidin-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2ccccc2C(C#Cc2ncccn2)(C2CC2)N1
3662,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CCc1c(O)nc(SCC(=O)c2ccc(OC)cc2)nc1Cc1cccc2ccccc12,5-Ethyl-2-[2-(4-methoxy-phenyl)-2-oxo-ethylsulfanyl]-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.045,uM,=,-1.3467874862246565,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
3663,2134368,10.1016/j.ejmech.2021.113769,,,,Inhibition of wild type HIV1 Reverse transcriptase RNase H expressed in Escherichia coli using 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGU-3' oligonucleotide as substrate and DNA21P as primer in presence of [gamma32P]-ATP by PAGE analysis,Cc1c(O)c([N+](=O)[O-])cc2cc(C(=O)NC3CCN(Cc4cccc(F)c4)CC3)c(=O)oc12,N-(1-(3-fluorobenzyl)piperidin-4-yl)-7-hydroxy-8-methyl-6-nitro-2-oxo-2H-chromene-3-carboxamide,45.2,uM,=,1.6551384348113822,1,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc2ccccc2oc1=O
3664,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1ccc(Cl)cc1)CC(=O)C(=O)O,"(E)-6-[1-(4-Chloro-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid",5.0,uM,=,0.6989700043360189,1,c1ccc(Cn2cccc2)cc1
3665,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CC1(c2ccccc2)Sc2ccccc2-n2cccc2C1=O,5-Methyl-5-phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,5.0,uM,=,0.6989700043360189,1,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
3666,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)-methanone,0.14,uM,=,-0.8538719643217619,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3667,630077,10.1016/j.bmcl.2009.04.051,,,,Inhibition of biotin-dUTP labeled HIV-1 reverse transcriptase after 30 mins colorimetric streptavidin alkaline phosphatase reporter system,Cc1cccc(CSc2nc(N)cc(Cc3ccccc3)n2)c1,6-benzyl-2-(3-methylbenzylthio)pyrimidin-4-amine,18.03,uM,=,1.255995726722402,1,c1ccc(CSc2nccc(Cc3ccccc3)n2)cc1
3668,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c(-c3ccccc3)c2Cl)c1,4-(2-((4-Chloro-5-phenyl-1H-pyrazol-3-yl)methylamino)pyridin-4-yl)-3-methylbenzonitrile,0.0050999999999999,uM,=,-2.292429823902064,0,c1ccc(-c2ccnc(NCc3cc(-c4ccccc4)[nH]n3)c2)cc1
3669,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CCC(C)(C)NC(=O)COC(=O)c1ccc([N+](=O)[O-])s1,2-oxo-2-(tert-pentylamino)ethyl 5-nitrothiophene-2-carboxylate,5.8,uM,=,0.7634279935629373,1,c1ccsc1
3670,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCCCCC1C(=O)N(O)C(=O)c2ccccc21,"2-Hydroxy-4-pentylisoquinoline-1,3(2H,4H)-dion",33.6,uM,=,1.526339277389844,1,O=C1Cc2ccccc2C(=O)N1
3671,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,Cc1nc(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)sc1/N=N/c1ccc(Cl)cc1,"4-(4-Chlorophenyl)-5-(5-((4-chlorophenyl)diazenyl)-4-methylthiazol-2-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",3.5000000000000004e-05,uM,=,-4.455931955649724,0,c1ccc(/N=N/c2cnc(N3Nc4onc(-c5ccccc5)c4C3c3ccccc3)s2)cc1
3672,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Oc1cc(Cc2ccccc2)nc(SC2CCCC2)n1,6-Benzyl-2-cyclopentylsulfanyl-3H-pyrimidin-4-one,2.8,uM,=,0.4471580313422192,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
3673,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cccc([S+]([O-])c2cccc(N)c2C#N)c1,2-Amino-6-(toluene-3-sulfinyl)-benzonitrile,10.0,uM,=,1.0,1,c1ccc([SH+]c2ccccc2)cc1
3674,600527,10.1021/jm801176e,,,,Inhibition of HIV1 wild type reverse transcriptase-mediated viral DNA synthesis in human HOS cells assessed as luciferase activity treated 3 hrs before infection measured after 48 hrs by luminescence assay,Cc1cn([C@@H]2C[C@H](CO)[C@@H](O)C2)c(=O)[nH]c1=O,"1-(3-Hydroxy-4-hydroxymethyl-cyclopentyl)-5-methyl-1H-pyrimidine-2,4-dione",3.2,uM,=,0.505149978319906,1,O=c1ccn(C2CCCC2)c(=O)[nH]1
3675,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)n1O,"6-(biphenyl-4-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.15,uM,=,-0.8239087409443188,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3676,306286,10.1021/jm0496077,,,,Concentration required to inhibit catalytic activity of human immuno deficiency virus type 1 integrase,O=C(/C=C(\O)c1c[nH]c2ccc(Cl)cc12)c1nn[nH]n1,(Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-propenone,2.3,uM,=,0.3617278360175928,1,O=C(C=Cc1c[nH]c2ccccc12)c1nn[nH]n1
3677,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cnc(C(F)(F)F)nc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2,6-Dimethyl-4-(2-(trifluoromethyl)pyrimidin-5-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.064,uM,=,-1.193820026016113,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
3678,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),CSc1ccc2c(C)nc(CCCCCCC(=O)c3ccccc3)n2n1.Cl,"7-(5-Methyl-2-methylsulfanyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one hydrochloride",0.08,uM,=,-1.0969100130080565,0,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
3679,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)Cc2cc(=O)oc3cc(OC)ccc23)cc1,"N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl-2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetamide",0.2418,uM,=,-0.6165437034752469,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3680,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",0.5,uM,=,-0.3010299956639812,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3681,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCCc1c(C)nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc1C,"2-(2-Chloro-6-fluorophenyl)-3-(5-propyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",0.85,uM,=,-0.0705810742857072,0,O=C1CSC(c2ccccc2)N1c1ncccn1
3682,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cccc(-n2nnnc2SCC(=O)Nc2ccccc2[N+](=O)[O-])c1C,"2-(1-(2,3-dimethylphenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide",0.018,uM,=,-1.744727494896694,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
3683,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,COCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(2-methoxy-ethyl)-5-methyl-1H-pyrimidine-2,4-dione",2.9,uM,=,0.4623979978989561,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3684,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,Cc1cnc(Nc2ccc(C#N)cc2)nc1OCC(=O)Nc1cccc(Cl)c1,N-(3-Chlorophenyl)-2-((2-((4-cyanophenyl)amino)-5-methylpyrimidin-4-yl)oxy)acetamide,0.16,uM,=,-0.7958800173440752,0,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
3685,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc([N+](=O)[O-])cc2c1=O,"Ethyl 1-(4-Fluorobenzyl)-6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate",47.8,uM,=,1.6794278966121188,1,O=c1ccn(Cc2ccccc2)c2ccccc12
3686,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cc(F)ccc3o2)c(O)nc1C,5-Ethyl-3-[(5-fluoro-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.47,uM,=,-0.3279021420642826,0,c1cncc(NCc2nc3ccccc3o2)c1
3687,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.001,uM,=,-3.0,0,c1cncc(NCc2nc3ccccc3o2)c1
3688,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2cc(O)nc(SC(C)C)n2)c1,2-Isopropylsulfanyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,2.9,uM,=,0.4623979978989561,1,c1ccc(Cc2ccncn2)cc1
3689,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.014,uM,=,-1.853871964321762,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3690,950904,10.1016/j.bmc.2012.12.049,,,,Inhibition of HIV 1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly rA.dT by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.2,uM,=,0.0791812460476248,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3691,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CC(C)C#CC1(C(F)(F)F)OC(=O)Nc2cccc(F)c21,"5-Fluoro-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.102,uM,=,-0.9913998282380824,0,O=C1Nc2ccccc2CO1
3692,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(O)nc21,"5-Ethyl-7-hydroxy-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.47,uM,=,-0.3279021420642826,0,O=C1Nc2cccnc2Nc2ncccc21
3693,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1F,"6-((3'-Fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3694,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,O=c1[nH]c(CCc2ccccc2)cc(NC2CCCC2)c1Br,3-Bromo-4-(cyclopentylamino)-6-phenethylpyridin-2(1H)-one,43.34,uM,=,1.6368889069837993,1,O=c1cc(NC2CCCC2)cc(CCc2ccccc2)[nH]1
3695,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,COC(=O)Nc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,"5-(3,4-Dichlorophenyl)-2-(3-(4-((methoxycarbonyl)amino)-phenyl)ureido)thiophene-3-carboxylic Acid",0.3,uM,=,-0.5228787452803376,0,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
3696,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)CCc1ccccc1,"6-Chloro-1-[(2-phenylethyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",76.0,uM,=,1.880813592280792,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
3697,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(Oc2c(C(F)(F)F)ccn(Cc3n[nH]c(=O)n3C)c2=O)ccc1-c1ccc(C#N)cc1,"2'-methyl-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-y1)oxy)-[1,1'-biphenyl]-4-carbonitrile",4.2,uM,=,0.6232492903979004,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3698,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(c1ccccc1)c1cc(Cl)ccc1OCc1nc2ccccc2[nH]1,[2-(1H-Benzoimidazol-2-ylmethoxy)-5-chloro-phenyl]-phenyl-methanone,1.4085199228075622,uM,=,0.1487629942427693,1,O=C(c1ccccc1)c1ccccc1OCc1nc2ccccc2[nH]1
3699,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc4[nH]ccc34)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(1H-indol-4-yloxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.33,uM,=,-0.4814860601221125,0,O=C1Nc2cccnc2Nc2ncc(COc3cccc4[nH]ccc34)cc21
3700,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3ccncc3)cc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-5-ethyl-9-methyl-2-(pyridin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.0022,uM,=,-2.657577319177794,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
3701,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CSc3[nH]cnc4ncnc3-4)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(9H-purin-6-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(CSc3[nH]cnc4ncnc3-4)cc21
3702,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2cccc(-c3ccc(O)cc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",3.8,uM,=,0.5797835966168101,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3703,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(O)cccc3o2)c(O)nc1C,5-Ethyl-3-[(4-hydroxy-benzooxazol-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.44,uM,=,-0.3565473235138126,0,c1cncc(NCc2nc3ccccc3o2)c1
3704,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Cc1ccc(Cl)c(-c2nc3ccccn3c2NC2CCCCC2)c1F,"DG 402-49648::US8501787, 74",90.0,uM,=,1.954242509439325,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
3705,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2sc(-c3ccccc3)cc2c(=O)n1O,"3-Hydroxy-6-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione",0.084,uM,=,-1.0757207139381184,0,O=c1[nH]c(=O)c2cc(-c3ccccc3)sc2[nH]1
3706,2294755,10.1016/j.bmcl.2023.129216,,,,Inhibition of recombinant wildtype HIV-1 reverse transcriptase using r(A)350 as template and d(T)16 as primer preincubated with compound for 1 hrs followed by template/primer addition and measured after 30 mins by picogreen based plate reader analysis,N#Cc1ccc(Nc2ncc(Cc3c(F)cc(-c4ccc(O)cc4)cc3F)o2)cc1Cl,"2-chloro-4-((5-((3,5-difluoro-4'-hydroxy-[1,1'-biphenyl]-4-yl)methyl)oxazol-2-yl)amino)benzonitrile",0.28,uM,=,-0.5528419686577808,0,c1ccc(Nc2ncc(Cc3ccc(-c4ccccc4)cc3)o2)cc1
3707,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1O,"6-([1,1'-Biphenyl]-4-ylmethyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.8,uM,=,-0.0969100130080563,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3708,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3c(F)cc(-c4cc(F)cc(C#N)c4)cc3F)c2=O)n[nH]c1=O,"3',5,5'-trifluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",3.25,uM,=,0.5118833609788744,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3709,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,COC(=O)c1ccc(-c2ccc(C(=O)c3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"Methyl 4'-(1-hydroxy-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-[1,1'-biphenyl]-4-carboxylate",0.015,uM,=,-1.8239087409443189,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
3710,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Fc1cccc(F)c1CC/N=C(\S)Nc1ccc(Br)cn1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,6-difluoro-phenyl)-ethyl]-thiourea",0.001,uM,=,-3.0,0,C(=NCCc1ccccc1)Nc1ccccn1
3711,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(COc1ccc(-c2cn(Cc3ccc(F)cc3)cc2-c2cc(C(=O)O)[nH]n2)cc1)Nc1ccccc1,3-(1-(4-Fluorobenzyl)-4-(4-(2-oxo-2-(phenylamino)ethoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,23.0,uM,=,1.3617278360175928,1,O=C(COc1ccc(-c2cn(Cc3ccccc3)cc2-c2cc[nH]n2)cc1)Nc1ccccc1
3712,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CC(=O)N1c2ncccc2C(=O)N(C)c2cccnc21,"5-Acetyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",15.3,uM,=,1.1846914308175989,1,O=C1Nc2cccnc2Nc2ncccc21
3713,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1,SID507704,100.0,uM,=,2.0,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
3714,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"3-Hydroxy-6-(3'-methoxybiphenyl-4-ylamino)-1H-pyrimidine-2,4-dione",0.2,uM,=,-0.6989700043360187,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3715,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,Cc1ccccc1Cn1cccc1/C=C/C(=O)CC(=O)C(=O)O,"6-[1-(2-Methylphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",26.0,uM,=,1.414973347970818,1,c1ccc(Cn2cccc2)cc1
3716,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1ccn([C@@H]2O[C@H](CNCc3c(F)cccc3Cl)[C@@H](O)[C@H]2O)c(=O)[nH]1,5'-(2-chloro-6-fluorobenzylamino)methyl-uridine,4.99,uM,=,0.69810054562339,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
3717,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,"6-(4'-chlorobiphenyl-3-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.86,uM,=,-0.0655015487564322,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3718,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccccc2)n[nH]1,3-(1-(Naphthalen-1-ylmethyl)-4-phenyl-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,25.3,uM,=,1.403120521175818,1,c1ccc(-c2cn(Cc3cccc4ccccc34)cc2-c2cc[nH]n2)cc1
3719,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(N(C)S(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-N-methyl-methanesulfonamide,5.6,uM,=,0.7481880270062004,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3720,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Cl)nc(Nc3ccc(C#N)cc3)c2)c(C)c1,4-((6-Chloro-4-(mesityloxy)pyridin-2-yl)amino)benzonitrile,0.248,uM,=,-0.6055483191737837,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
3721,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",15.0,uM,=,1.1760912590556811,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3722,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCOc1ccc(Cl)c(C2CC2NC(=O)Nc2ccc(C#N)cn2)c1F,1-[2-(6-Chloro-3-ethoxy-2-fluoro-phenyl)-cyclopropyl]-3-(5-cyano-pyridin-2-yl)-urea,0.0027,uM,=,-2.5686362358410126,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
3723,756682,10.1016/j.bmcl.2011.05.020,,,,Inhibition of HIV1 wild type reverse transcriptase,CCC1(c2ccc(CSc3ccc(F)cc3)cc2)Oc2ccccc2-n2cccc2C1=O,"(+/-)-6-Ethyl-6-[4-[(4-fluorophenylthio)methyl]phenyl]-6,7-dihydrobenzo[b]pyrrolo[1,2-d][1,4]oxazepin-7-one",0.25,uM,=,-0.6020599913279624,0,O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2)cc1
3724,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccccc2C#N)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3',5'-dimethyl-[1,1'-biphenyl]-2-carbonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3725,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(NC=O)c1Cc1cc(C)cc(C)c1,"N-[4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl]-formamide",0.079,uM,=,-1.1023729087095586,0,O=c1cc(Cc2ccccc2)cc[nH]1
3726,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccccc3Br)n2)cc1,4-(4-(2-bromobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.071,uM,=,-1.1487416512809248,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
3727,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,18.0,uM,=,1.255272505103306,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3728,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,O=C(CSc1nnnn1-c1cc(Cl)ccc1Cl)Nc1ccccc1[N+](=O)[O-],"2-(1-(2,5-dichlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide",0.004,uM,=,-2.397940008672037,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
3729,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2c(C)ccc3nc(O)n(c23)C[C@@H]1C,"5,8-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",989.0,uM,=,2.99519629159718,1,c1cc2c3c(c1)ncn3CCNC2
3730,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccc(O)c3)SCCN12,"9b-(3-Hydroxy-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",12.7,uM,=,1.1038037209559568,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3731,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-propylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.13,uM,=,-0.8860566476931633,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3732,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,Trp-NH2,9900.0,uM,=,3.99563519459755,1,c1ccc2[nH]ccc2c1
3733,1542247,10.1021/acsmedchemlett.5b00254,,,,Inhibition of wild-type HIV-1 reverse transcriptase by fluorescence assay,N#Cc1cc2c(Oc3ccccc3OCCn3ccc(=O)[nH]c3=O)cccn2c1,"8-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)indolizine-2-carbonitrile",0.00106,uM,=,-2.9746941347352296,0,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
3734,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2cccc(-c3cccc(O)c3)c2)cc(=O)n(O)c1=O,"3-hydroxy-6-(3'-hydroxybiphenyl-3-yloxy)-1-methylpyrimidine-2,4(1H,3H)-dione",4.3,uM,=,0.6334684555795865,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3735,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Clc1ccc(-c2nc3ccccn3c2NC2CCCCC2)c(Cl)c1,"N-Cyclohexyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-3-amine",21.76,uM,=,1.3376588910261424,1,c1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1
3736,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1,5-Bromo-2-[5-(4-bromo-phenylcarbamoyl)-pentanoylamino]-benzoic acid,32.0,uM,=,1.505149978319906,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3737,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),Oc1ccc(CC/N=C(\S)Nc2ccc(Br)cn2)cc1,1-(5-Bromo-pyridin-2-yl)-3-[2-(4-hydroxy-phenyl)-ethyl]-thiourea,0.07,uM,=,-1.154901959985743,0,C(=NCCc1ccccc1)Nc1ccccn1
3738,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2ncc(-c3ccccc3)o2)c(O)nc1C,5-Ethyl-6-methyl-3-[2-(5-phenyl-oxazol-2-yl)-ethyl]-1H-pyridin-2-one,0.385,uM,=,-0.4145392704914993,0,c1ccc(-c2cnc(CCc3cccnc3)o2)cc1
3739,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,COC(=O)c1ccccc1NC(=O)CSc1nc2ccccc2n1S(=O)(=O)c1cc(C)cc(C)c1,"Methyl 2-[[2-[1-(3,5-dimethylphenyl)sulfonylbenzimidazol-2-yl]sulfanylacetyl]amino]benzoate",15.67,uM,=,1.19506899646859,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3740,2226592,10.1016/j.ejmech.2022.114471,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction of biotin-dUTP incorporation into protein using ABTS as substrate incubated for 1 hrs by ELISA analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid amide",0.015,uM,=,-1.8239087409443189,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3741,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2ccccc2C(=O)N1O,"2-Hydroxy-4H-isoquinoline-1,3-dione",0.5,uM,=,-0.3010299956639812,0,O=C1Cc2ccccc2C(=O)N1
3742,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",6.3,uM,=,0.7993405494535817,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3743,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,Cc1cc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)ccc1F,"6-((4'-fluoro-3'-methyl-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3744,195660,10.1021/jm030116g,,,,Inhibitory concentration required against Reverse transcriptase (RT),Cc1cn([C@H]2C=C[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+],"1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; triphosphate",0.08,uM,=,-1.0969100130080565,0,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
3745,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,Cc1n[nH]c2cccc(Oc3cc(C#N)cc(C#N)c3)c12,5-(3-Methyl-1H-indazol-4-yloxy)-isophthalonitrile,0.332,uM,=,-0.4788619162959637,0,c1ccc(Oc2cccc3[nH]ncc23)cc1
3746,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,CS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3747,701790,10.1021/ml1002162,,,,Inhibition of HIV1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)n(O)c1=O,"6-Benzyl-1-(benzyloxymethyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",6.2,uM,=,0.7923916894982539,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3748,947897,10.1021/np3006887,,,,Inhibition of HIV-1 reverse transcriptase assessed as decrease in incorporation of [3H]TTP into polyA template,C=C(C(=O)O)[C@@H]1CC[C@@H]2[C@]3(CC[C@]4(C)[C@@H]([C@H](C)CC(=O)C=C(C)C)CC[C@@]24C)C[C@]13CCC(=O)O,Dikamaliartane D,68.7,uM,=,1.8369567370595503,1,C1CC2CC[C@@]34CC3CCC[C@H]4C2C1
3749,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CC(N)=O)[nH]c3ccc(Cl)cc23)c1,"N-(4-Amino-4-oxobutan-3-yl)-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.12,uM,=,-0.9208187539523752,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3750,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OC1COc2cc(O)cc(O)c2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",3.8,uM,=,0.5797835966168101,1,O=C(OC1COc2ccccc2C1)c1ccccc1
3751,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2cc3ccccc3cc2C2(c3ccccc3)SCCN12,"3a-Phenyl-1,2-dihydro-3aH-3-thia-10a-aza-pentaleno[1,2-b]naphthalen-10-one",10.0,uM,=,1.0,1,O=C1c2cc3ccccc3cc2C2(c3ccccc3)SCCN12
3752,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CSc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenylsulfanylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccccc3)cc21
3753,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(O)cc3)nc21,"5-Ethyl-7-(4-hydroxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.27,uM,=,-0.5686362358410126,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
3754,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,Cc1cc(Oc2ccc(OCc3ccccc3)cc2)nc(Nc2ccc(C#N)cc2)n1,4-{6-Methyl-4-[(4-benzyloxy)phenoxy]pyrimidin-2-ylamino}benzonitrile,17.43,uM,=,1.2412973871099933,1,c1ccc(COc2ccc(Oc3ccnc(Nc4ccccc4)n3)cc2)cc1
3755,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-phenethyl-thiourea,0.015,uM,=,-1.8239087409443189,0,S=C(NCCc1ccccc1)Nc1ccccn1
3756,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,Cc1ccc(CNC(=O)C2C(=O)N(O)C(=O)c3ccccc32)cc1,"N-(4-Methylbenzyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",14.0,uM,=,1.146128035678238,1,O=C1NC(=O)C(C(=O)NCc2ccccc2)c2ccccc21
3757,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cnc(C#N)nc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"5-(4-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylphenyl)pyrimidine-2-carbonitrile",0.0395,uM,=,-1.40340290437354,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
3758,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCCCc1c(C)nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc1C,"2-(2,6-Dichlorophenyl)-3-(5-butyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",4.29,uM,=,0.6324572921847242,1,O=C1CSC(c2ccccc2)N1c1ncccn1
3759,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cccc(Cl)c1,"6-[1-(3-Chlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",19.0,uM,=,1.2787536009528289,1,c1ccc(Cn2cccc2)cc1
3760,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1ccc(F)cc1,"N-(4-Fluorobenzyl)-1-(hydroxy)-4-(ethylamino)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.011,uM,=,-1.958607314841775,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
3761,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)[nH]1)c1nc(CO)cs1,(S)-N-(2-Amino-1-(4-(hydroxymethyl)thiazol-2-yl)ethyl)-5-(4-(trifluoromethyl)phenyl)-1H-pyrrole-2-carboxamide,1.5,uM,=,0.1760912590556812,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
3762,197436,10.1016/S0960-894X(01)80472-8,,,,Compound concentration that causes 50 % inhibition of HIV-1 peptide-derived reverse transcriptase (RT),Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)OP(=O)(O)CP(=O)(O)O)O2)c(=O)[nH]c1=O,Azidothymidine difluoromethylenephosphonate derivative,6.95,uM,=,0.8419848045901139,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
3763,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CC(N)=O)[nH]c3ccc(Cl)c(F)c23)c1,"N-(4-Amino-4-oxobutan-2-yl)-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-1H-indole-2-carboxamide",0.359,uM,=,-0.4449055514216808,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3764,539716,10.1021/jm800473d,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CCCOCCCNC(=S)Nc1cc(OC)c(Cl)cc1OC,"1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea",0.51,uM,=,-0.2924298239020636,0,c1ccccc1
3765,1982637,10.1021/acsmedchemlett.9b00623,,,,Inhibition of recombinant HIV-1 BH10 reverse transcriptase p51/p66 expressed in Escherichia coli preincubated for 10 mins followed by D38/25PGA template-primer addition and measured after 10 to 30 secs by denaturing PAGE based single nucleotide incorporation assay,CC[C@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,"(4R,7S,10S,13S,16S,19R)-19-amino-10,13-bis(2-amino-2-oxo-ethyl)-7-(2-carboxyethyl)-16-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxylic acid",109.4,uM,=,2.039017321997412,1,O=C1CCSSCCNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
3766,969194,10.1016/j.ejmech.2013.04.052,,,,Inhibition of recombinant wild type HIV1 RT using poly(rA)/oligo(dT)16 as template after 40 mins by spectrofluorometric analysis,COCCc1ccc(Oc2ccnc(Nc3ccc(C#N)cc3)n2)cc1,4-{4-[4-(2-Methoxylethyl)phenoxy]pyrimidin-2-ylamino}benzonitrile,2.69,uM,=,0.4297522800024079,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
3767,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid (1-carbamoyl-ethyl)-amide",0.02,uM,=,-1.6989700043360187,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3768,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1ccc2ccccc2c1,2-Amino-6-(naphthalene-2-sulfonyl)-benzonitrile,0.03,uM,=,-1.5228787452803376,0,O=S(=O)(c1ccccc1)c1ccc2ccccc2c1
3769,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCOCc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-ethoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.3,uM,=,0.1139433523068367,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3770,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1[nH]c(=O)n(COCc2ccccc2)c(COCc2ccccc2)c1I,"1,6-Bis[(benzyloxy)methyl]-5-iodopyrimidine-2,4(1H,3H)-dione",3.7,uM,=,0.568201724066995,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3771,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCCC1(c2ccccc2)Oc2ccccc2-n2cccc2C1=O,5-Phenyl-5-propyl-6-oxa-10b-aza-benzo[e]azulen-4-one,500.0,uM,=,2.6989700043360187,1,O=C1c2cccn2-c2ccccc2OC1c1ccccc1
3772,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3[N+](=O)[O-])nc3ccc(Cl)cc32)c1,"2-({6-Chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl}sulfanyl)-N-2-nitrophenylacetamide",37.04,uM,=,1.5686709780098966,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3773,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(Cl)cc2Cl)cs1,"(Z)-3-(2-(4-(2,4-dichlorophenyl)thiazol-2-yl)hydrazono)indolin-2-one",3.9,uM,=,0.5910646070264992,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
3774,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Cl)cc3)ccc2C(=O)N1O,"6-(4-Chlorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.9,uM,=,0.4623979978989561,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3775,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(Cl)cc(C)c1Oc1cnc(N)c(Nc2ccc(C#N)cc2)c1,"4-((2-amino-5-(4-chloro-2,6-dimethylphenoxy)pyridin-3-yl)amino)benzonitrile",0.31,uM,=,-0.5086383061657274,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
3776,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COC(=O)c1cc(/C(=C/CCN2CCOC2=O)c2cc(C)c3onc(OC)c3c2)cc(Cl)c1OC,(E)-3-Chloro-2-methoxy-5-[1-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(2-ox-oxazolidin-3-yl)-but-1-enyl]-benzoic acid methyl ester,5.88,uM,=,0.7693773260761385,1,O=C1OCCN1CC/C=C(/c1ccccc1)c1ccc2oncc2c1
3777,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1nc2ccccc2cc1C(C#CC1CC1)(OCc1ccccc1)C(F)(F)F,3-(1-Benzyloxy-3-cyclopropyl-1-trifluoromethyl-prop-2-ynyl)-1H-quinolin-2-one,0.036008,uM,=,-1.4436010000695774,0,C(#CC(OCc1ccccc1)c1cnc2ccccc2c1)C1CC1
3778,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2cccc(F)c2)ccc1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((3'-fluoro-3-methyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.1009999999999999,uM,=,-0.9956786262173576,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3779,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1ccccc1-c1ccccc1Oc1cc(=O)n(O)c(=O)n1C,"3-(Benzyloxy)-6-((2'-methoxy-[1,1'-biphenyl]-2-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",8.1,uM,=,0.9084850188786496,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
3780,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cccc(C(N)=O)c3)CC2)nc2c1SCC2,"3-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)-methyl)benzamide",0.094,uM,=,-1.0268721464003014,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)SCC4)CC2)cc1
3781,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,"((S)-1-{N'-Biphenyl-4-ylmethyl-N'-[(2S,3S)-2-hydroxy-3-((S)-2-methoxycarbonylamino-3,3-dimethyl-butyrylamino)-4-phenyl-butyl]-hydrazinocarbonyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.058,uM,=,-1.2365720064370629,0,c1ccc(CCCCNCc2ccc(-c3ccccc3)cc2)cc1
3782,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1cccc(C(F)(F)F)c1,2-Amino-6-(3-trifluoromethyl-benzenesulfonyl)-benzonitrile,5.3,uM,=,0.724275869600789,1,O=S(=O)(c1ccccc1)c1ccccc1
3783,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cc(N)cnc2Oc2cc(C)c(C)cc21,"2-Amino-10-ethyl-7,8-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.071,uM,=,-1.1487416512809248,0,O=C1Nc2ccccc2Oc2ncccc21
3784,195536,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at high (~1 pfu/cell) multiplicity of injection (moi),Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.017,uM,=,-1.769551078621726,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3785,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,CC(C)c1c(Sc2ccccc2)cc(CCc2ccccc2)[nH]c1=O,3-Isopropyl-6-phenethyl-4-(phenylthio)pyridin-2(1H)-one,0.093,uM,=,-1.031517051446065,0,O=c1cc(Sc2ccccc2)cc(CCc2ccccc2)[nH]1
3786,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C#N)cc3Cl)CC2)ncc1Br,"4-(5-bromo-2-(1-(2-chloro-4-cyanobenzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.146,uM,=,-0.835647144215563,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
3787,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCNc1ccc2c(n1)N(CC)c1ncccc1C(=O)N2C,"5-Ethyl-7-ethylamino-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.3,uM,=,0.1139433523068367,1,O=C1Nc2cccnc2Nc2ncccc21
3788,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc3c(cc2OC)CCC3)c(O)nc1C,5-Ethyl-3-[(6-methoxy-indan-5-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.04,uM,=,-1.3979400086720375,0,c1cncc(NCc2ccc3c(c2)CCC3)c1
3789,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(CCCCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-(4-(4-fluorophenyl)butyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Cc2ccccc2)n(CCCCc2ccccc2)c(=O)[nH]1
3790,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(=O)(=O)CC)ccc3[nH]2)CC1,Ethanesulfonic acid (2-{4-[ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.4,uM,=,-0.3979400086720376,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
3791,1499865,10.1021/acs.jmedchem.5b00159,,,,Inhibition of RNase H function of HIV1 reverse transcriptase using DNA/RNA hybrid as substrate by fluorescence spectrometer analysis,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,"(S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",91.0,uM,=,1.9590413923210936,1,O=c1cc[nH]c2ccc(Cc3ccccc3)cc12
3792,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,COc1ccc(NC(=O)CCCCC(=O)Nc2ccc(OC)cc2C(=O)O)c(C(=O)O)c1,2-[4-(2-carboxy-4-methoxyphenylcarbamoyl)butylcarboxamido]-5-methoxybenzoic acid,4.3,uM,=,0.6334684555795865,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3793,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.026,uM,=,-1.585026652029182,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
3794,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)c1cn(Cc2ccc(F)cc2)c2cc(N3CCN(CC)CC3)ccc2c1=O,4-[1-[(4-Fluorophenyl)methyl]-7-(N-ethylpiperazin-1-yl)-4-(1H)-quinolinon-3-yl]-2-hydroxy-4-oxo-2-butenoic Acid Ethyl Ester,26.2,uM,=,1.4183012913197457,1,O=c1ccn(Cc2ccccc2)c2cc(N3CCNCC3)ccc12
3795,1462916,10.1016/j.bmc.2014.11.032,,,,Inhibition of wild type HIV1 p66/p51 reverse transcriptase by spectrofluorometry,N#Cc1ccc(Nc2nccc(OCC(=O)Nc3ccc(Cl)cc3)n2)cc1,N-(4-Chlorophenyl)-2-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)acetamide,26.88,uM,=,1.4294292643817876,1,O=C(COc1ccnc(Nc2ccccc2)n1)Nc1ccccc1
3796,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)[nH]3)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",0.3,uM,=,-0.5228787452803376,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3797,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,"6-((4'-chloro-[1,1'-biphenyl]-3-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Sc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3798,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3cccc(OC)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(3-methoxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3799,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(F)c1CCNC(=S)Nc1ccc(Br)cn1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(6-ethoxy-2,3-difluoro-phenyl)-ethyl]-thiourea",0.005,uM,=,-2.3010299956639813,0,S=C(NCCc1ccccc1)Nc1ccccn1
3800,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzofuran-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.057,uM,=,-1.2441251443275083,0,c1cncc(NCc2cc3ccccc3o2)c1
3801,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1COC(/C=C/C2CC2)(C(F)(F)F)c2cc(Cl)ccc2N1,"7-Chloro-5-((E)-2-cyclopropyl-vinyl)-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.108,uM,=,-0.9665762445130504,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
3802,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1[nH]c(=O)n([C@@H]2O[C@H](CNCc3ccc(Cl)cc3)[C@@H](O)[C@H]2O)cc1F,5'-(4-chlorobenzylamino)methyl-5-fluorouridine,3.75,uM,=,0.5740312677277188,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
3803,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc(C)c1Br,"2-(2,6-Dichlorophenyl)-3-(5-bromo-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",9.82,uM,=,0.9921114877869496,1,O=C1CSC(c2ccccc2)N1c1ncccn1
3804,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,CC1=Cc2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)OC(C)(C)C=C3)O[C@@H]1C,"6,6,10,11-Tetramethyl-4-phenyl-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",9.0,uM,=,0.9542425094393248,1,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)C=CCO4)C=CCO3
3805,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(Br)ccc21,"7-Bromo-5-cyclopropyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.1,uM,=,0.3222192947339193,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3806,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(C)ccc(C)c3o2)c(O)nc1C,"3-[2-(4,7-Dimethyl-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.028,uM,=,-1.5528419686577808,0,c1cncc(CCc2nc3ccccc3o2)c1
3807,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(Br)cn2)c1O,1-[2-(3-Acetyl-6-fluoro-2-hydroxy-phenyl)-cyclopropyl]-3-(5-bromo-pyridin-2-yl)-urea,0.0035,uM,=,-2.4559319556497243,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
3808,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),Cc1nc(CCCCCOC(=O)C2CCCC2)n2nc(Cl)ccc12,"Cyclopentanecarboxylic acid 5-(2-chloro-5-methyl-imidazo[1,5-b]pyridazin-7-yl)-pentyl ester hydrochloride",22.0,uM,=,1.3424226808222062,1,O=C(OCCCCCc1ncc2cccnn12)C1CCCC1
3809,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C(F)(F)F)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(trifluoromethyl)benzyl)isoquinoline-1,3(2H,4H)-dione",1.1,uM,=,0.041392685158225,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3810,582812,10.1021/jm900597q,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 heterodimer in presence of Mg2+,O=C(O)c1nc(Cc2c(Br)sc3ccc(Cl)cc23)nc(O)c1O,"2-(2-Bromo-5-chloro-benzo[b]thiophen-3-ylmethyl)-5,6-dihydroxy-pyrimidine-4-carboxylic acid",48.0,uM,=,1.6812412373755872,1,c1cnc(Cc2csc3ccccc23)nc1
3811,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.003,uM,=,-2.5228787452803374,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
3812,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Cl)c(Cl)c3)cc2c1=O,"Ethyl 6-((3,4-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",24.1,uM,=,1.3820170425748683,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
3813,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,Nc1ccc(C(=O)Nc2ccc3c(O)cc(S(=O)(=O)O)cc3c2)cc1,SID89852628,16.0,uM,=,1.2041199826559248,1,O=C(Nc1ccc2ccccc2c1)c1ccccc1
3814,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1ncnc2c1ncn2C1C=CC(OCP(=O)(O)OP(=O)(O)OP(=O)(O)COC2C=CC(n3cnc4c(N)ncnc43)C2)C1,"P,P'-Bis {[4-(adenine-9-yl)cyclopent-2-enyl]oxy-methylphosphonyl}phosphate",10.0,uM,=,1.0,1,O=[PH](COC1C=CC(n2cnc3cncnc32)C1)O[PH](=O)O[PH](=O)COC1C=CC(n2cnc3cncnc32)C1
3815,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1ccc(Cl)cc1-n1nnnc1SCC(=O)Nc1ccccc1[N+](=O)[O-],2-(1-(5-chloro-2-methylphenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.023,uM,=,-1.6382721639824072,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
3816,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.8,uM,=,0.255272505103306,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3817,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=C(c1ccc(Cl)cc1)c1cc(Cc2ccc(=O)[nH]n2)cc2ccoc12,6-((7-(4-chlorobenzoyl)benzofuran-5-yl)methyl)pyridazin-3(2H)-one,0.4,uM,=,-0.3979400086720376,0,O=C(c1ccccc1)c1cc(Cc2ccc(=O)[nH]n2)cc2ccoc12
3818,768443,10.1016/j.ejmech.2011.06.034,,,,Inhibition of wild-type HIV1 subtype B reverse transcriptase assessed as incorporation of [3H]dTTP,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],tetrasodium {[({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphinato phosphonato]oxy}phosphonate,11.3,uM,=,1.0530784434834195,1,c1ncc2nc[nH]c2n1
3819,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(Cl)nc(SC/C=C/c2ccccc2)n1,6-Chloro-2-((E)-3-phenyl-allylsulfanyl)-pyrimidin-4-ylamine,0.19,uM,=,-0.721246399047171,0,C(=C/c1ccccc1)\CSc1ncccn1
3820,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,Fc1cccc(F)c1C1SCc2nc3ccccc3n21,"1-(2,6-Difluoro-phenyl)-3H-benzo[4,5]imidazo[1,2-c]thiazole",24.57,uM,=,1.390405156480081,1,c1ccc(C2SCc3nc4ccccc4n32)cc1
3821,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccccc3Br)nc3ccccc32)c1,"2-({1-[(3,5-Dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)-N-2-bromophenylacetamide",0.18,uM,=,-0.744727494896694,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
3822,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-methoxy-5-methyl-benzenesulfonyl)-benzonitrile,0.01,uM,=,-2.0,0,O=S(=O)(c1ccccc1)c1ccccc1
3823,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3824,195050,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of Y181C HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(COCc3ccccc3)cc(O)nc21,"9-Benzyloxymethyl-5-ethyl-7-hydroxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.07,uM,=,0.0293837776852096,1,O=C1Nc2c(COCc3ccccc3)ccnc2Nc2ncccc21
3825,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(Cn2c(=O)ccn(CC(=O)Nc3ccccc3C)c2=O)c1,"2-(3-(3,5-Dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(o-tolyl)acetamide",68.77,uM,=,1.8373990243420224,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
3826,1879993,10.1021/acs.jmedchem.9b01769,,,,Inhibition of recombinant HIV-1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation in to cDNA chain incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)c(F)c2)nc2sccc12,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)thieno[2,3-d]pyrimidin-2-yl)amino)-2-fluorobenzonitrile",0.0566,uM,=,-1.2471835688117283,0,c1ccc(Nc2nc(Oc3ccccc3)c3ccsc3n2)cc1
3827,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(-c3cccc(C(F)(F)F)c3)c2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)methyl)pyrimidine-2,4(1H,3H)-dione",0.037,uM,=,-1.431798275933005,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3828,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Br)cc3)ccc2C(=O)N1O,"6-(4-Bromobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.4,uM,=,0.1461280356782379,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3829,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",18.22,uM,=,1.2605483726369795,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3830,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2cc(NS(=O)(=O)c3ccc(-c4ccc(S(=O)(=O)Nc5ccc6cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c6c5)cc4)cc3)ccc2c1.[Na+].[Na+].[Na+].[Na+],"7-{4-[4-(6,8-disulfo-2-naphthylsulfamoyl)phenyl]phenylsulfonamido}-1,3-naphthalenedisulfonic acidTetrasodium salt",125.0,uM,=,2.096910013008056,1,O=S(=O)(Nc1ccc2ccccc2c1)c1ccc(-c2ccc(S(=O)(=O)Nc3ccc4ccccc4c3)cc2)cc1
3831,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccnc3)SCCN12,"9b-Pyridin-3-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",28.0,uM,=,1.4471580313422192,1,O=C1c2ccccc2C2(c3cccnc3)SCCN12
3832,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)nc(OCCCN3CCOCC3)c2)c(C)c1,4-((4-(mesityloxy)-6-(3-morpholinopropoxy)pyridin-2-yl)amino)benzonitrile,4.06,uM,=,0.608526033577194,1,c1ccc(Nc2cc(Oc3ccccc3)cc(OCCCN3CCOCC3)n2)cc1
3833,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Cl)cc3)ccc2C(=O)N1O,"6-(4-Chlorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",3.9,uM,=,0.5910646070264992,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
3834,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1ccc(Cl)cc1,2-Amino-6-(4-chloro-phenylsulfanyl)-benzonitrile,12.0,uM,=,1.0791812460476249,1,c1ccc(Sc2ccccc2)cc1
3835,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc(Cl)c(Cl)c3)cc2c1=O,"6-((3,4-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",29.5,uM,=,1.469822015978163,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
3836,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCc1c(Cc2ccccc2)c(=O)n(O)c(=O)n1COCc1ccc(F)cc1,"5-Benzyl-6-ethyl-1-((4-fluorobenzyloxy)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",15.0,uM,=,1.1760912590556811,1,O=c1[nH]c(=O)n(COCc2ccccc2)cc1Cc1ccccc1
3837,305018,10.1016/j.bmcl.2004.12.030,,,,Inhibitory concentration against HIV-Reverse transcriptase,O=C(O)C1(C(=O)O)[C@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c(c2c2c4c4c6c6c8c%10c8c%12c%10c%14c(c%15%19)c%12c%20c2c2c4c6c8c%10c%122)[C@@H]%18[C@H]2c4c6c8c%10c(c4-%17)[C@@H]%16[C@H]%13[C@@]%114C(C(=O)O)(C(=O)O)[C@]%104C=9[C@H]8[C@@H]7C5=C6[C@@]213,Fullerene Derivative,1.2,uM,=,0.0791812460476248,1,C1[C@]23c4c5c6c7c8c9c%10c%11c%12c%13c%14c%15c%16c%17c%18c%19c%20c(c2c2c4c4c6c6c8c%10c8c%12c%10c%14c(c%15%19)c%12c%20c2c2c4c6c8c%10c%122)[C@@H]%18[C@H]2c4c6c8c%10c(c4-%17)[C@@H]%16[C@H]%13[C@@]%114C[C@]%104C=9[C@H]8[C@@H]7C5=C6[C@]123
3838,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)c1,"4-((2-Chloro-6-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)pyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.08,uM,=,-1.0969100130080565,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
3839,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(CCCCc3ccccc3)cc2-c2ccccc2)n[nH]1,Ethyl 3-(4-phenyl-1-(4-phenylbutyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,97.0,uM,=,1.9867717342662448,1,c1ccc(CCCCn2cc(-c3ccccc3)c(-c3cc[nH]n3)c2)cc1
3840,1769209,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 RNase H preincubated for 10 mins followed by PBS-22dpol/radiolabeled PBS-14r8d addition measured after 5 mins,Cc1ccc(-c2nc(O)c(O)c(C(=O)O)n2)cc1Br,"2-(3-Bromo-4-methylphenyl)-5,6-dihydroxypyrimidine-4-carboxylic acid",23.0,uM,=,1.3617278360175928,1,c1ccc(-c2ncccn2)cc1
3841,1473730,10.1021/jm501132s,,,,Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4F)cc3)ccc2C(=O)N1O,"6-((2',4'-Difluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",0.7,uM,=,-0.1549019599857432,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3842,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](n3cc(CNCC(=O)N(Cc4ccccc4)Cc4cc5ccccc5oc4=O)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,"N-benzyl-2-((1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methylamino)-N-((2-oxo-2H-chromen-3-yl)methyl)acetamide",3.4,uM,=,0.5314789170422551,1,O=C(CNCc1cn([C@@H]2CO[C@@H](n3ccc(=O)[nH]c3=O)C2)nn1)N(Cc1ccccc1)Cc1cc2ccccc2oc1=O
3843,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2cccc(F)c2)n1,2-sec-Butylsulfanyl-6-(3-fluoro-benzyl)-5-methyl-3H-pyrimidin-4-one,1.5,uM,=,0.1760912590556812,1,c1ccc(Cc2ccncn2)cc1
3844,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(N)=C/C(=O)c1cn(Cc2ccc(F)cc2)cc1-c1ccccc1,Ethyl 2-Amino-4-(1-(4-fluorobenzyl)-4-phenyl-1H-pyrrol-3-yl)-4-oxobut-2-enoate,72.0,uM,=,1.8573324964312683,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
3845,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCC2CCCc3ccccc32)c(O)nc1C,"5-Ethyl-6-methyl-3-[(1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-amino]-1H-pyridin-2-one",9.5,uM,=,0.9777236052888478,1,c1cncc(NCC2CCCc3ccccc32)c1
3846,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",1.2,uM,=,0.0791812460476248,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3847,2104796,10.1016/j.bmc.2021.116239,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into cDNA measured after 1 hr by ELISA,CCC(=O)N1CCC(=CC#Cc2cc(C)c(Oc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)CC1,"4-((4-(2,6-dimethy1-4-(3-(1-propionylpiperidin-4-ylidene)prop-1-yn-1-yl)phenoxy)pyrimidin-2-yl)amino)benzonitrile",2.98,uM,=,0.4742162640762553,1,C(#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1)C=C1CCNCC1
3848,1504947,10.1016/j.bmc.2015.06.048,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin deoxyuridine triphosphate (biotin-dUTP) incorporation using poly(rA)/oligo (dT)16 template and primer by spectrofluorometry,Cc1cc(C#N)cc(C)c1Oc1ccnc(SCC(=O)Nc2ccccc2Cl)n1,"N-(2-Chlorophenyl)-2-((4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)thio)acetamide",0.473,uM,=,-0.3251388592621884,0,O=C(CSc1nccc(Oc2ccccc2)n1)Nc1ccccc1
3849,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,COc1cc(NC(C)CCCN)c2ncccc2c1.O=P(O)(O)O.O=P(O)(O)O,"N*4*-(6-Methoxy-quinolin-8-yl)-pentane-1,4-diamine; Diphosphate (Primaquine diphosphate)",100.0,uM,=,2.0,1,c1ccc2ncccc2c1
3850,1795827,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CXCR4 tropic HIV1 UG070 reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(Cl)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-chloro-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.0011219364154496,uM,=,-2.950031755559213,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
3851,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,O=C(CCCCCCCCC(=O)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12)Nc1cc(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(O)c12.[Na+].[Na+].[Na+].[Na+],"4-Decanoylamino-5-hydroxy-naphthalene-2,7-disulfonic acid; compound with 4-formylamino-5-hydroxy-naphthalene-2,7-disulfonic acid Tetrasodium salt",52.0,uM,=,1.7160033436347992,1,O=C(CCCCCCCCC(=O)Nc1cccc2ccccc12)Nc1cccc2ccccc12
3852,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCCCCCc1c(O)n(O)c(=O)c2ccccc12,"4-hexyl-2,3-dihydroxyisoquinolin-1(2H)-one",7.8,uM,=,0.8920946026904804,1,O=c1[nH]ccc2ccccc12
3853,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2COC)c(O)nc1C,5-Ethyl-3-(2-methoxymethyl-benzylamino)-6-methyl-1H-pyridin-2-one,35.5,uM,=,1.5502283530550942,1,c1ccc(CNc2cccnc2)cc1
3854,195371,10.1021/jm9800806,,,,Inhibitory activity against HIV-1 reverse transcriptase (P236L),CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,6.66,uM,=,0.8234742291703011,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3855,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1[C@H](C)Cn2c(=S)[nH]c3cccc(c32)[C@H]1C,"(6R,8R)-6,8-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.042,uM,=,-1.3767507096020994,0,S=c1[nH]c2cccc3c2n1CCNC3
3856,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@@H]1[C@@H](C)Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2[C@@H]1O)OC(C)(C)C=C3,"(10R,11S,12R)-12-hydroxy-6,6,10,11-tetramethyl-4-phenyl-6,10,11,12-tetrahydro-2H-1,5,9-trioxatriphenylen-2-one",0.13,uM,=,-0.8860566476931633,0,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
3857,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2ccnc(F)c2)cc1F,"4-((4-((2,6-Difluoro-4-(2-fluoropyridin-4-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.036,uM,=,-1.4436974992327127,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
3858,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CN(C)CCCOc1ccc(NC(=O)Cc2ccc(Cl)cc2C(=O)c2ccccc2)cc1,2-(2-Benzoyl-4-chloro-phenyl)-N-[4-(3-dimethylamino-propoxy)-phenyl]-acetamide,0.444275599572164,uM,=,-0.3523475383507618,0,O=C(Cc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
3859,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CC(C)c1c(O)nc(SCC(=O)c2ccc(F)cc2)nc1Cc1cccc2ccccc12,2-[2-(4-Fluoro-phenyl)-2-oxo-ethylsulfanyl]-5-isopropyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,0.078,uM,=,-1.1079053973095196,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
3860,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",4.2,uM,=,0.6232492903979004,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3861,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1[nH]c(SCc2ccc3ccccc3c2)nc(Cc2ccccc2)c1Br,6-Benzyl-5-bromo-2-(naphthalen-2-ylmethylthio)pyrimidin4(3H)-one,12.26,uM,=,1.0884904701823963,1,O=c1cc(Cc2ccccc2)nc(SCc2ccc3ccccc3c2)[nH]1
3862,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,O=c1cc(Nc2ccc(-c3cccc(O)c3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.4,uM,=,-0.3979400086720376,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3863,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#Cc2ccccn2)(C(F)(F)F)N1,"6-Chloro-4-pyridin-2-ylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.129,uM,=,-0.889410289700751,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)N1
3864,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,CCCOC(=O)c1cccn1S(=O)(=O)c1cc(Cl)ccc1N,1-(2-Amino-5-chloro-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid propyl ester,0.4,uM,=,-0.3979400086720376,0,O=S(=O)(c1ccccc1)n1cccc1
3865,195074,10.1016/s0960-894x(98)00369-2,,,,Compound was tested for inhibitory activity against HIV-1 wild type reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3866,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),C[C@H]1COC2(c3ccccc3)c3ccccc3C(=O)N12,"3-Methyl-9b-phenyl-2,3-dihydro-9bH-oxazolo[2,3-a]isoindol-5-one",73.0,uM,=,1.863322860120456,1,O=C1c2ccccc2C2(c3ccccc3)OCCN12
3867,600527,10.1021/jm801176e,,,,Inhibition of HIV1 wild type reverse transcriptase-mediated viral DNA synthesis in human HOS cells assessed as luciferase activity treated 3 hrs before infection measured after 48 hrs by luminescence assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",1.4,uM,=,0.1461280356782379,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3868,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2nc(SC3CCCCC3)nc(O)c2C)c1,2-Cyclohexylsulfanyl-5-methyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,1.3,uM,=,0.1139433523068367,1,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
3869,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,COc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-methoxy-6-methyl-1H-pyridin-2-one",0.115,uM,=,-0.9393021596463884,0,c1cncc(NCc2nc3ccccc3o2)c1
3870,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1cccc([N+](=O)[O-])c1,2-Methyl-5-nitro-1-{2-[(3-nitro-phenyl)-phenyl-methoxy]-ethyl}-1H-imidazole,0.3,uM,=,-0.5228787452803376,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
3871,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)CCc1cccc(Cl)c1,"6-Chloro-1-{[2-(3-chlorophenyl)ethyl]sulfonyl}-1,3-dihydro-2H-benzimidazol-2-one",131.0,uM,=,2.1172712956557644,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
3872,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1onc(-c2ccccc2Cl)c1C(=O)c1ccc(O)c(C(=O)O)c1,5-[3-(2-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-2-hydroxy-benzoic acid,100.0,uM,=,2.0,1,O=C(c1ccccc1)c1conc1-c1ccccc1
3873,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(-c3cccc(F)c3)c2)[nH]c(=O)n1O,"6-((3'-fluoro-[1,1'-biphenyl]-3-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.018,uM,=,-1.744727494896694,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3874,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,NC[C@H](NC(=O)c1ccc(-c2cc(F)c(Cl)c(F)c2)[nH]1)c1ncc(CO)s1,"(S)-N-(2-amino-1-(5-(hydroxymethyl)thiazol-2-yl)ethyl)-5-(4-chloro-3,5-difluorophenyl)-1H-pyrrole-2-carboxamide",8.4,uM,=,0.9242792860618816,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
3875,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1ccccc1CSc1nc(Cc2ccccc2)c(I)c(=O)[nH]1,6-Benzyl-2-(2-methylbenzylthio)-5-iodo pyrimidin-4(3H)-one,4.16,uM,=,0.6190933306267428,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
3876,1924019,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using A5'-end 32P-labeled 24-mer primer/a48-mer template preincubated for 5 mins followed by 1 uM nucleotides addition measured after 10 mins by gel-based primer extension assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccccc2)C1,"1-benzyl-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",8.9,uM,=,0.9493900066449128,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
3877,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,CSc1ccc(NC(=O)CCCCC(=O)Nc2ccc(SC)cc2C(=O)O)c(C(=O)O)c1,2-[4-(2-carboxy-4-methylsulfanylphenylcarbamoyl)butylcarboxamido]-5-methylsulfanylbenzoic acid,19.0,uM,=,1.2787536009528289,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
3878,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CCCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1ccc(O)c(OC)c1)S(=O)(=O)c1ccc(OC)cc1,"(E)-3-(4-hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((4-methoxy-N-propylphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.106,uM,=,-0.9746941347352298,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3879,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)pyrimidine-2,4(1H,3H)-dione",0.025,uM,=,-1.6020599913279625,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3880,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(Br)cn2)c1O,1-(5-Bromo-pyridin-2-yl)-3-[2-(6-fluoro-2-hydroxy-3-propionyl-phenyl)-cyclopropyl]-urea,0.0048,uM,=,-2.318758762624413,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
3881,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cccc3cc[nH]c23)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4-(1H-Indol-7-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0605,uM,=,-1.2182446253475312,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccc5cc[nH]c45)cc3)n2)cc1
3882,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(N)=O)c1=O,"2-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetamide",7.0,uM,=,0.8450980400142568,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
3883,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Cc1ccccc1,1-(2-Benzoyl-4-chloro-phenoxy)-3-phenyl-propan-2-one,32.959189577779725,uM,=,1.5179765244381431,1,O=C(COc1ccccc1C(=O)c1ccccc1)Cc1ccccc1
3884,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,C[C@@H]1C(=O)c2c(c3c(c4c(-c5ccccc5)cc(=O)oc24)OC(C)(C)C=C3)O[C@@H]1C,"6,6,10,11-Tetramethyl-4-phenyl-10,11-dihydro-6H-dipyrano[2,3-f,2',3'-h]chromene-2,12-dione",100.0,uM,=,2.0,1,O=C1CCOc2c3c(c4c(-c5ccccc5)cc(=O)oc4c21)OCC=C3
3885,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,CN(C)S(=O)(=O)Nc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,"5-(3,4-Dichlorophenyl)-2-(3-(4-((N,N-dimethylsulfamoyl)-amino)phenyl)ureido)thiophene-3-carboxylic Acid",0.6,uM,=,-0.2218487496163563,0,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
3886,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)n(O)c1=O,"6-Benzyl-1-(ethoxymethyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",6.8,uM,=,0.8325089127062363,1,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
3887,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3cccc(C(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"3-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-ylmethoxy)-benzamide",0.34,uM,=,-0.4685210829577448,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3888,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"3-Hydroxy-6-(3'-methoxybiphenyl-4-ylamino)-1H-pyrimidine-2,4-dione",7.3,uM,=,0.8633228601204559,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3889,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,CCOC(=O)/C(O)=C/C(=O)c1cc(-c2ccccc2)cn1Cc1ccc(F)cc1,Ethyl 4-(1-(4-Fluorobenzyl)-4-phenyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxobut-2-enoate,6.0,uM,=,0.7781512503836436,1,c1ccc(Cn2ccc(-c3ccccc3)c2)cc1
3890,884996,10.1016/j.bmcl.2012.09.062,,,,Inhibition of HIV1 reverse transcriptase assessed as biotin-dUTP incorporation into enzyme using poly(rC)-oligo(dG) as template primer by colorimetric analysis,Cc1ccc(NC(=O)CSc2nncnc2-c2ccccc2Cl)c([N+](=O)[O-])c1,"2-(5-(2-chlorophenyl)-1,2,4-triazin-6-ylthio)-N-(4-methyl-2-nitrophenyl)acetamide",18.0,uM,=,1.255272505103306,1,O=C(CSc1nncnc1-c1ccccc1)Nc1ccccc1
3891,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(Cl)cc(Sc2cccc(N)c2C#N)c1,2-Amino-6-(3-chloro-5-methyl-phenylsulfanyl)-benzonitrile,1.7,uM,=,0.2304489213782739,1,c1ccc(Sc2ccccc2)cc1
3892,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,N#Cc1ccc2c(Oc3ccc(OS(=O)(=O)F)cc3OCCn3ccc(=O)[nH]c3=O)cccc2c1,"4-((6-Cyanonaphthalen-1-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.0823,uM,=,-1.08460016478773,0,O=c1ccn(CCOc2ccccc2Oc2cccc3ccccc23)c(=O)[nH]1
3893,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,COc1cc(N2CCCC2)c(OC)cc1/C=C1/NC(=O)NC1=O,"5-(2,5-dimethoxy-4-(pyrrolidin-1-yl)benzylidene)imidazolidine-2,4-dione",9.35,uM,=,0.9708116108725178,1,O=C1NC(=O)/C(=C\c2ccc(N3CCCC3)cc2)N1
3894,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2nc(CC)c(C)cc2OC)c(O)nc1C,5-Ethyl-3-[(6-ethyl-3-methoxy-5-methyl-pyridin-2-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,0.07,uM,=,-1.154901959985743,0,c1ccc(CNc2cccnc2)nc1
3895,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2cccc(-c3cccc(C#N)c3)c2)c2nccnc2n(O)c1=O,"Methyl 8-((3'-cyano-[1,1'-biphenyl]-3-yl)amino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",4.02,uM,=,0.60422605308447,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)c2nccnc2[nH]1
3896,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccnc(C(F)(F)F)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-trifluoromethyl-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
3897,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(Cn2c(=O)ccn(CC(=O)Nc3ccccc3)c2=O)c1,"2-(3-(3,5-Dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-phenylacetamide",79.28,uM,=,1.899163641477219,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
3898,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1nc([C@@H](CN)NC(=O)c2ccc(-c3ccc(F)c(F)c3)[nH]2)sc1CO,"(R)-N-(2-amino-1-(5-(hydroxymethyl)-4-methylthiazol-2-yl)ethyl)-5-(3,4-difluorophenyl)-1H-pyrrole-2-carboxamide",45.9,uM,=,1.6618126855372612,1,O=C(NCc1nccs1)c1ccc(-c2ccccc2)[nH]1
3899,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,"6-((4'-Fluoro-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.2,uM,=,-0.6989700043360187,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
3900,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(NC2CCN(Cc3ccncc3)CC2)c1,"4-((2-Chloro-6-((1-(pyridin-4-ylmethyl)piperidin-4-yl)amino)pyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Oc2ccnc(NC3CCN(Cc4ccncc4)CC3)c2)cc1
3901,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(C(C)C)cc2)nc(SC(C)C)[nH]c1=O,"2-(4-isopropylphenyl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",2.149,uM,=,0.3322364154914433,1,O=c1cc(Cc2ccccc2)nc[nH]1
3902,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),C[C@@H]1COC2(c3ccccc3)c3ccccc3C(=O)N12,"3-Methyl-9b-phenyl-2,3-dihydro-9bH-oxazolo[2,3-a]isoindol-5-one",40.0,uM,=,1.6020599913279625,1,O=C1c2ccccc2C2(c3ccccc3)OCCN12
3903,953196,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dTTP incorporation after 15 mins by PAGE,Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione-5`-triphosphate (d4T-TP)",13.0,uM,=,1.1139433523068367,1,O=c1ccn([C@H]2C=CCO2)c(=O)[nH]1
3904,197423,10.1021/jm00001a001,,,,Ability to inhibit the HIV-1 reverse transcriptase in cord blood mononuclear cells.,Nc1ccn([C@H]2CS[C@@H](CO)C2)c(=O)n1,"4-Amino-1-((3R,5R)-5-hydroxymethyl-tetrahydro-thiophen-3-yl)-1H-pyrimidin-2-one",0.355,uM,=,-0.4497716469449059,0,O=c1ncccn1[C@@H]1CCSC1
3905,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,Cn1c(=O)ccn(CCOc2cc(OS(=O)(=O)F)ccc2Oc2cccn3cc(C#N)cc23)c1=O,"4-((2-Cyanoindolizin-8-yl)oxy)-3-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.164,uM,=,-0.7851561519523022,0,O=c1ccn(CCOc2ccccc2Oc2cccn3cccc23)c(=O)[nH]1
3906,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.019,uM,=,-1.7212463990471711,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3907,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",16.0,uM,=,1.2041199826559248,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3908,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,N#Cc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carbonitrile",0.9,uM,=,-0.0457574905606751,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
3909,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2cc(C)c(C)nc2N(C)C(=O)c2cc(N)cnc21,"5-Ethyl-2,3,11-trimethyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2ncccc2Nc2ncccc21
3910,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CC/N=C(\S)Nc2ccc(Br)cn2)c1C#N,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-cyano-3-ethoxy-6-fluoro-phenyl)-ethyl]-thiourea,0.002,uM,=,-2.6989700043360187,0,C(=NCCc1ccccc1)Nc1ccccn1
3911,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1ccccc1S(=O)(=O)n1c(=O)[nH]c2ccc(Cl)cc21,"6-Chloro-1-(2-methylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.269,uM,=,-0.570247719997592,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
3912,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(OC)c2)C(C)C)cc1,"(E)-3-(4-hydroxy-3-methoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0875,uM,=,-1.0579919469776868,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3913,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2cc(OC)c(O)cc2OC)cn1,"3-(4-Hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-6-methoxypyridine)-3-sulfonamido)-1-phenylbutan-2-yl)propanamide",0.00297,uM,=,-2.527243550682788,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1cccnc1)Cc1ccccc1
3914,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCC#CC1(C(F)(F)F)OC(=O)Nc2cccc(F)c21,"4-But-1-ynyl-5-fluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.127,uM,=,-0.8961962790440431,0,O=C1Nc2ccccc2CO1
3915,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,O=C(CSc1nnnn1-c1ccc(C2CC2)cc1Cl)Nc1ccc(C(=O)O)cc1Cl,3-chloro-4-(2-(1-(2-chloro-4-cyclopropylphenyl)-1H-tetrazol-5-ylthio)acetamido)benzoic acid,0.016,uM,=,-1.7958800173440752,0,O=C(CSc1nnnn1-c1ccc(C2CC2)cc1)Nc1ccccc1
3916,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(COCn2c(COCc3ccccc3)cc(=O)[nH]c2=O)c1,"6-[(Benzyloxy)methyl]-1-{[(3,5-dimethylbenzyl)oxy]methyl}pyrimidine-2,4(1H,3H)-dione",0.82,uM,=,-0.0861861476162833,0,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3917,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2c(=O)n1O,"4-Fluoro-N-(3-hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide",2.25,uM,=,0.3521825181113625,1,O=c1[nH]c(=O)c2cc(NS(=O)(=O)c3ccccc3)ccc2[nH]1
3918,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccccc2Br)c(C)c1,N-(2-bromophenyl)-2-(1-mesityl-1H-tetrazol-5-ylthio)acetamide,0.007,uM,=,-2.154901959985743,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
3919,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),S=C(NCCc1cccs1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-thiophen-2-yl-ethyl)-thiourea,0.048,uM,=,-1.3187587626244128,0,S=C(NCCc1cccs1)Nc1ccccn1
3920,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)n1,"3,5-dimethyl-4-(2-(1-(4-(methylsulfonyl)benzyl)piperidin-4-ylamino)pyrimidin-4-yloxy)benzonitrile",0.034,uM,=,-1.4685210829577449,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
3921,370933,10.1016/j.bmcl.2006.04.012,,,,Inhibition of HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.8,uM,=,-0.0969100130080563,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3922,705547,10.1128/aac.01559-08,,,,Inhibition of HIV1 isolate R8 reverse transcriptase after 90 mins,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.137,uM,=,-0.8632794328435932,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
3923,508733,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA synthesis initiation using RNA/DNAM duplex primed substrate by scintillation proximity assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.36,uM,=,-0.4436974992327127,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3924,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccn(S(=O)(=O)c3ccccc3)c12,"4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-5-(phenylsulfonyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.193,uM,=,-0.7144426909922262,0,O=S(=O)(c1ccccc1)n1ccc2nc(NC3CCN(Cc4ccccc4)CC3)nc(Oc3ccccc3)c21
3925,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(N)cc3)nc21,"7-(4-Amino-phenyl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
3926,701790,10.1021/ml1002162,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)n(O)c1=O,"6-Benzyl-1-(benzyloxymethyl)-5-ethyl-3-hydroxypyrimidine-2,4(1H,3H)-dione",9.4,uM,=,0.9731278535996988,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3927,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)CS(N)(=O)=O)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(1-sulfamoylpropan-3-yl)-1H-indole-2-carboxamide",0.003,uM,=,-2.5228787452803374,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
3928,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3ccc(Cl)cc3Cl)cc2)[nH]c(=O)n1O,"6-((2',4'-dichloro-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.0092,uM,=,-2.036212172654445,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3929,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(thiophen-2-yl)benzyl)isoquinoline-1,3(2H,4H)-dione",2.0,uM,=,0.3010299956639812,1,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1
3930,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(NCc2cccc(N3CCOCC3)c2)c2cccnc2n1O,"1-Hydroxy-4-({[3-(4-morpholinyl)phenyl]methyl}amino)pyrido[2,3-d]pyrimidin-2(1H)-one",0.2,uM,=,-0.6989700043360187,0,O=c1nc(NCc2cccc(N3CCOCC3)c2)c2cccnc2[nH]1
3931,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)Cc1ccccc1,"1-(Benzylsulfonyl)-6-chloro-1,3-dihydro-2H-benzimidazol-2-one",17.0,uM,=,1.230448921378274,1,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
3932,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1CSC2,"3,5-Dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl)oxy)-benzonitrile",0.091,uM,=,-1.0409586076789064,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSC4)CC2)cc1
3933,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,CC(C)c1ccc(Cn2c(O)nc3ccc(Cl)cc32)cc1,"6-Chloro-1-(4-isopropyl-benzyl)-1,3-dihydro-benzoimidazol-2-one",16.2,uM,=,1.209515014542631,1,c1ccc(Cn2cnc3ccccc32)cc1
3934,2249496,10.1021/acs.jmedchem.2c00203,,,,Inhibition of recombinant p66/p51 HIV-1 RNase H using 6-FAM-labeld DNA substrate preincubated for 2 mins by fluorescence based assay,O=C(O)c1nc(Cc2ccccc2)nc(O)c1O,"2-benzyl-5,6-dihydroxypyrimidine-4-carboxylic acid",2.5,uM,=,0.3979400086720376,1,c1ccc(Cc2ncccn2)cc1
3935,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(CO)cc3[nH]2)CC1,(6-Hydroxymethyl-1H-indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,0.76,uM,=,-0.1191864077192086,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3936,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(OC1COc2cc(O)cc(O)c2C1)c1cccc(O)c1O,"2,3-Dihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",37.24,uM,=,1.571009672309305,1,O=C(OC1COc2ccccc2C1)c1ccccc1
3937,442659,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rC.dG template,Cc1cc(C)nc(N2C(=O)CS[C@@H]2C23CC4CC(CC(C4)C2)C3)c1,"(R)-(+)-2-adamantan-1-yl-3-(4,6-dimethyl-pyridin-2-yl)-thiazolidin-4-one",19.0,uM,=,1.2787536009528289,1,O=C1CS[C@H](C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
3938,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccccc2-c2ccc(C(F)(F)F)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)-oxy)pyrimidine-2,4(1H,3H)-dione",3.9,uM,=,0.5910646070264992,1,O=c1cc(Oc2ccccc2-c2ccccc2)[nH]c(=O)[nH]1
3939,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccccc3)cc2c1=O,"6-(Benzyloxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",38.5,uM,=,1.5854607295085006,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
3940,471467,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type LAI by heteropolymeric DNA polymerase assay,C[C@@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,tenofovir diphosphate,0.55,uM,=,-0.2596373105057561,0,c1ncc2nc[nH]c2n1
3941,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,Cc1cn([C@H]2C[C@H](n3cc(CNCc4cc5cc(Br)ccc5oc4=O)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,"1-((2R,4S,5S)-4-(4-(((6-bromo-2-oxo-2H-chromen-3-yl)methylamino)methyl)-1H-1,2,3-triazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",6.1,uM,=,0.785329835010767,1,O=c1ccn([C@H]2C[C@H](n3cc(CNCc4cc5ccccc5oc4=O)nn3)CO2)c(=O)[nH]1
3942,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2ccc(O)c(O)c2)C(C)C)cc1,"(E)-3-(3, 4-dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isopropyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.0535,uM,=,-1.2716462179787715,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
3943,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,CC(C)(C)NC(=O)COC(=O)c1ccc([N+](=O)[O-])s1,2-(tert-butylamino)-2-oxoethyl 5-nitrothiophene-2-carboxylate,2.8,uM,=,0.4471580313422192,1,c1ccsc1
3944,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccoc2)c(O)nc1C,5-Ethyl-3-[(furan-3-ylmethyl)-amino]-6-methyl-1H-pyridin-2-one,145.0,uM,=,2.161368002234975,1,c1cncc(NCc2ccoc2)c1
3945,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,CCOC(=O)N[C@H](C(=O)NN(Cc1ccc(-c2ccccn2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C,"{(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-pyridin-2-yl-benzyl)-hydrazinocarbonyl]-2-methyl-propyl}-carbamic acid ethyl ester",0.034,uM,=,-1.4685210829577449,0,c1ccc(CCCCNCc2ccc(-c3ccccn3)cc2)cc1
3946,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2cncnc2)cc1F,"4-((4-((2,6-Difluoro-4-(pyrimidin-5-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.28,uM,=,-0.5528419686577808,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
3947,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2c3c([nH]c(=O)c2N(C)C)CCCC3)c1,"4-(3,5-dimethylbenzyl)-3-(dimethylamino)-5,6,7,8-tetrahydroquinolin-2(1H)-one",0.01,uM,=,-2.0,0,O=c1cc(Cc2ccccc2)c2c([nH]1)CCCC2
3948,499472,10.1016/j.ejmech.2008.09.013,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) (rCdG) homopolymer template primer,COc1noc2c(C)cc(C(=CCCN3CCOC3=O)c3cc(C)c4onc(OC)c4c3)cc12,"3-[4,4-Bis-(3-methoxy-7-methyl-benzo[d]isoxazol-5-yl)-but-3-enyl]-oxazolidin-2-one",0.93,uM,=,-0.0315170514460648,0,O=C1OCCN1CCC=C(c1ccc2oncc2c1)c1ccc2oncc2c1
3949,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(/C=C/C(=O)OC)nc21,"(E)-3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-7-yl)-acrylic acid methyl ester",0.67,uM,=,-0.1739251972991735,0,O=C1Nc2cccnc2Nc2ncccc21
3950,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCCN1C(=O)/C(=C/c2cccs2)SC1=S)Nc1ccc(C(=O)O)c(O)c1,2-Hydroxy-4-(4-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-butyrylamino)-benzoic acid,32.0,uM,=,1.505149978319906,1,O=C(CCCN1C(=O)/C(=C/c2cccs2)SC1=S)Nc1ccccc1
3951,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,O=c1oc2ccc(Cl)cc2n1Cc1c(F)cccc1F,"5-Chloro-3-(2,6-difluoro-benzyl)-3H-benzooxazol-2-one",20.0,uM,=,1.3010299956639813,1,O=c1oc2ccccc2n1Cc1ccccc1
3952,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2nc(SC3CCCCC3)nc(O)c2C)c1,2-Cyclohexylsulfanyl-5-methyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,0.9,uM,=,-0.0457574905606751,0,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
3953,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,COc1ccc(CC/N=C(\S)Nc2ccc(Br)cn2)cc1,1-(5-Bromo-pyridin-2-yl)-3-[2-(4-methoxy-phenyl)-ethyl]-thiourea,0.9,uM,=,-0.0457574905606751,0,C(=NCCc1ccccc1)Nc1ccccn1
3954,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1c(Cl)cccc1-n1nnnc1SCC(=O)Nc1ccccc1[N+](=O)[O-],2-(1-(3-chloro-2-methylphenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide,0.003,uM,=,-2.5228787452803374,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
3955,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,COc1ccc(CNC(=O)c2[nH]c3ccc(Cl)cc3c2S(=O)(=O)c2cc(C)cc(C)c2)cc1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-methoxybenzyl)-1H-indole-2-carboxamide",0.0037,uM,=,-2.431798275933005,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
3956,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(OC1COc2cccc(O)c2C1)c1ccc(O)c(O)c1O,"2,3,4-Trihydroxy-benzoic acid 5-hydroxy-chroman-3-yl ester",45.5,uM,=,1.6580113966571124,1,O=C(OC1COc2ccccc2C1)c1ccccc1
3957,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCC1C(Cc2cccc(C)c2)=C(N(C)CCO)C(=O)NC1C,"5-ethyl-3-[(2-hydroxy-ethyl)-methyl-amino]-6-methyl-4-(3-methyl-benzyl)-5,6-dihydro-1H-pyridin-2-one",0.005,uM,=,-2.3010299956639813,0,O=C1C=C(Cc2ccccc2)CCN1
3958,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[3-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-4-hydroxy-tetrahydro-furan-2-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",6.6,uM,=,0.8195439355418687,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
3959,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,COC(=O)Nc1ccc2[nH]c(C(=O)N3CCN(c4ncccc4NC(C)C)CC3)cc2c1,{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-carbamic acid methyl ester,2.5,uM,=,0.3979400086720376,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
3960,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,O=C(Nc1ccc(Br)cc1C(=O)O)c1ccnc(C(=O)Nc2ccc(Br)cc2C(=O)O)c1,5-bromo-2-[(2-{[(4-bromo-2-carboxyphenyl)amino]carbonyl}isonicotinoyl)amino]benzoic acid,17.0,uM,=,1.230448921378274,1,O=C(Nc1ccccc1)c1ccnc(C(=O)Nc2ccccc2)c1
3961,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4ncccc34)c2F)c1,"3-[6-Bromo-2-fluoro-3-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",0.008,uM,=,-2.096910013008056,0,c1ccc(Oc2cccc(Cc3n[nH]c4ncccc34)c2)cc1
3962,817161,10.1016/j.bmc.2012.02.037,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by colorimetry,O=C1/C(=C\c2ccc(Cl)cc2Cl)N=C(c2ccccc2)N1Cc1ccncc1,"4-(2,4-Dichlorobenzylidene)-2-phenyl-1-(pyridin-4-ylmethyl)-1H-imidazol-5(4H)-one",3.8,uM,=,0.5797835966168101,1,O=C1/C(=C\c2ccccc2)N=C(c2ccccc2)N1Cc1ccncc1
3963,445160,10.1021/jm060103d,,,,Inhibition of HIV1 NL4-3 reverse transcriptase,Cc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-4-methyl-1H-benzoimidazole",0.2,uM,=,-0.6989700043360187,0,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
3964,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CN(C)c1cnc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(5-Dimethylamino-pyrazin-2-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0094,uM,=,-2.026872146400301,0,O=c1nc(-c2cnccn2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
3965,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCc2ccc(Cl)cc2Cl)C(F)(F)F)c(O)nc1C,"3-[3-Cyclopropyl-1-(2,4-dichloro-benzyloxy)-1-trifluoromethyl-prop-2-ynyl]-5-ethyl-6-methyl-1H-pyridin-2-one",2.696,uM,=,0.4307198878632822,1,C(#CC(OCc1ccccc1)c1cccnc1)C1CC1
3966,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2c(C)cccc2OC)c(O)nc1C,5-Ethyl-3-(2-methoxy-6-methyl-benzylamino)-6-methyl-1H-pyridin-2-one,1.3,uM,=,0.1139433523068367,1,c1ccc(CNc2cccnc2)cc1
3967,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(Oc2cc(N)nc(Nc3ccc(C#N)cc3)n2)ccc1-c1ccc(C#N)cc1,"4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-2'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.026,uM,=,-1.585026652029182,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3968,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,"2-Amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxylic acid bis-[(5,12-diisopropyl-9,13,16-trimethyl-4,7,11,14,17-pentaoxo-hexadecahydro-10-oxa-3a,6,13,16-tetraaza-cyclopentacyclohexadecen-8-yl)-amide] .2H2O",270.0,uM,=,2.431363764158988,1,O=C1CNC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@@H](NC(=O)c2cc(=O)cc3oc4cccc(C(=O)N[C@H]5COC(=O)CNC(=O)CNC(=O)[C@@H]6CCCN6C(=O)CNC5=O)c4nc2-3)COC(=O)CN1
3969,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3cc(C)nc(C)c3)cc2C(=O)Nc2c(C)ccnc21,"2-(2,6-Dimethyl-pyridin-4-ylsulfanylmethyl)-5-ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.0042,uM,=,-2.3767507096021,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
3970,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(-c2ccc(F)cc2)cc(C)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"4-((4-Amino-6-((4'-fluoro-3,5-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.061,uM,=,-1.214670164989233,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
3971,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(-c2cccc(F)c2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"3-((3'-fluoro-3-methyl-[1,1'-biphenyl]-4-yl)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",5.44,uM,=,0.7355988996981799,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
3972,1932801,10.1021/acs.jmedchem.6b00040,,,,Inhibition of RNase H activity of full length HIV1 reverse transcriptase using RNA-DNA duplex HTS-1 substrate,CCNc1[nH]c(=O)n(O)c(=O)c1C(=O)NCc1cccc(Cl)c1F,"N-(3-Chloro-2-fluorobenzyl)-1-(hydroxy)-4-(ethylamino)-1,2,3,6-tetrahydro-2,6-dioxopyrimidine-5-carboxamide",0.029,uM,=,-1.537602002101044,0,O=C(NCc1ccccc1)c1c[nH]c(=O)[nH]c1=O
3973,503280,10.1021/np9700275,,,,Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)cc2)[C@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)c(O)c3)oc12,Morelloflavone,116.0,uM,=,2.0644579892269186,1,O=C1c2ccccc2O[C@H](c2ccccc2)[C@H]1c1cccc2c(=O)cc(-c3ccccc3)oc12
3974,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Cc1ccc(NC(=S)NCCc2ccccc2)nc1,1-(5-Methyl-pyridin-2-yl)-3-phenethyl-thiourea,0.03,uM,=,-1.5228787452803376,0,S=C(NCCc1ccccc1)Nc1ccccn1
3975,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OCCc1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 2-(3,4-dihydroxy-phenyl)-ethyl ester",10.7,uM,=,1.0293837776852095,1,O=C(OCCc1ccccc1)c1ccccc1
3976,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)c(Cl)c2[C@@](C#CC2CC2)(C(F)(F)F)N1,"5,6-Dichloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.166,uM,=,-0.7798919119599449,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
3977,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4c(N)cccc34)c2F)c1,3-[3-(7-Amino-1H-indazol-3-ylmethyl)-6-bromo-2-fluorophenoxy]-5-chlorobenzonitrile,0.024,uM,=,-1.619788758288394,0,c1ccc(Oc2cccc(Cc3n[nH]c4ccccc34)c2)cc1
3978,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.000166,uM,=,-3.779891911959945,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
3979,195505,10.1016/s0960-894x(99)00235-8,,,,Inhibition of purified recombinant HIV-1 reverse transcriptase,S=C(NCN1CCCCC1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-piperidin-1-ylmethyl-thiourea,5.8,uM,=,0.7634279935629373,1,S=C(NCN1CCCCC1)Nc1ccccn1
3980,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2ccc(-c3cccc(C#N)c3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",3.3,uM,=,0.5185139398778875,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3981,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",2.7,uM,=,0.4313637641589873,1,c1cncc(NCc2nc3ccccc3o2)c1
3982,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(Cl)cc2Cl)cs1,"(Z)-3-(2-(4-(2,4-dichlorophenyl)thiazol-2-yl)hydrazono)indolin-2-one",19.5,uM,=,1.290034611362518,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
3983,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(C)c(C)cc2N(C)C(=O)c2cccnc21,"11-Ethyl-6,8,9-trimethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2ccccc2Nc2ncccc21
3984,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),N#Cc1cccc(C23SCCN2C(=O)c2ccccc23)c1,"3-(5-Oxo-2,3-dihydro-5H-thiazolo[2,3-a]isoindol-9b-yl)-benzonitrile",1.81,uM,=,0.2576785748691845,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
3985,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=C(c1cccc(Cl)c1)c1cc(Cc2ccc(=O)[nH]n2)cc2ccoc12,6-((7-(3-chlorobenzoyl)benzofuran-5-yl)methyl)pyridazin-3(2H)-one,8.2,uM,=,0.9138138523837168,1,O=C(c1ccccc1)c1cc(Cc2ccc(=O)[nH]n2)cc2ccoc12
3986,1276829,10.1021/jm401232v,,,,Inhibition of HIV1 reverse transcriptase-mediated [H3]TTP incorporation into poly(rA)-oligo(dT)16 DNA preincubated for 5 mins prior to primer/template and substrate addition by liquid scintillation spectrometric analysis,Cc1cn([C@H]2C[C@H](n3nncc3-c3cccc4ccccc34)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+],"Trisodium Mono(((2S,3S,5R)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-(5-(naphthalen-1-yl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)methyl triphosphate)",3.7,uM,=,0.568201724066995,1,O=c1ccn([C@H]2C[C@H](n3nncc3-c3cccc4ccccc34)CO2)c(=O)[nH]1
3987,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3cccc(O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(3-hydroxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.78,uM,=,-0.1079053973095195,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
3988,1467609,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated DNA polymerase-independent RNase H activity after 1 hr,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(-c3ccccc3)cc2)cs1,(Z)-3-(2-(4-(biphenyl-4-yl)thiazol-2-yl)hydrazono)indolin-2-one,2.5,uM,=,0.3979400086720376,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(-c3ccccc3)cc2)cs1
3989,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)C2CC2C(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"cis-N-(2-chloro-4-sulfamoylphenyl)-2-(6,8-dichloro-1,2,3,4-tetrahydroquinoline-1-carbonyl)cyclopropanecarboxamide",0.018,uM,=,-1.744727494896694,0,O=C(Nc1ccccc1)C1CC1C(=O)N1CCCc2ccccc21
3990,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2cc[nH]c12,"4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.075,uM,=,-1.1249387366083,0,c1ccc(CN2CCC(Nc3nc(Oc4ccccc4)c4[nH]ccc4n3)CC2)cc1
3991,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CC(C/N=C(\S)Nc1nccs1)c1ccccc1,1-(2-Phenyl-propyl)-3-thiazol-2-yl-thiourea,0.45,uM,=,-0.3467874862246563,0,C(=NCCc1ccccc1)Nc1nccs1
3992,197440,10.1016/s0960-894x(99)00664-2,,,,Compound dose required to inhibit HIV-1 reverse transcriptase enzyme(rRT) activity,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1ccc(F)cc1,1-{2-[(4-Fluoro-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole,2.3,uM,=,0.3617278360175928,1,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
3993,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccc(C)cc3Cl)nc3ccccc32)c1,"2-{[1-(3,5-Dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-2-chloro-4-methylphenylacetamide",178.93,uM,=,2.2526831619321976,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
3994,197431,10.1021/jm990236h,,,,Antiviral activity was evaluated by RT (reverse transcriptase) activity in cells acutely infected with HIV-1,CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23,"Phosphoric acid mono-[5-(3-amino-5-methyl-5H-1,4,5,6,8-pentaaza-acenaphthylen-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester",0.04,uM,=,-1.3979400086720375,0,C1=NNc2ncnc3c2c1cn3[C@H]1CCCO1
3995,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"6-Benzyl-1-benzyloxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
3996,195504,10.1021/jm001095i,,,,Inhibitory activity against wild-type HIV-1 reverse transcriptase,CC(C)=CCOc1cc(NC(=S)c2ccoc2C)ccc1Cl,2-Methyl-furan-3-carbothioic acid [4-chloro-3-(3-methyl-but-2-enyloxy)-phenyl]-amide,0.0238752747888431,uM,=,-1.622051621269179,0,S=C(Nc1ccccc1)c1ccoc1
3997,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1cc(C)cc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)nc32)c1,"6-chloro-1-(3,5-dimethylphenylsulfonyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one",0.02,uM,=,-1.6989700043360187,0,O=c1[nH]c2cccnc2n1S(=O)(=O)c1ccccc1
3998,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",7.2,uM,=,0.8573324964312685,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
3999,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-n3cccc3)nc21,"5-Ethyl-10-methyl-7-pyrrol-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2ccc(-n3cccc3)nc2Nc2ncccc21
4000,2226592,10.1016/j.ejmech.2022.114471,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction of biotin-dUTP incorporation into protein using ABTS as substrate incubated for 1 hrs by ELISA analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC3CC4(C3)CN(S(C)(=O)=O)C4)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-(methylsulfonyl)-2-azaspiro [3.3]heptan-6-yl)-1H-indole-2-carboxamide",0.12,uM,=,-0.9208187539523752,0,O=C(NC1CC2(CNC2)C1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4001,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CC1(c2ccccc2)Oc2ccccc2-n2cccc2C1=O,5-Methyl-5-phenyl-6-oxa-10b-aza-benzo[e]azulen-4-one,10.0,uM,=,1.0,1,O=C1c2cccn2-c2ccccc2OC1c1ccccc1
4002,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(N3CCCC3)nc21,"8-Ethyl-3-methyl-6-pyrrolidin-1-yl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",1.77,uM,=,0.2479732663618066,1,c1cnc2c(c1)-c1nccn1-c1ccc(N3CCCC3)nc1N2
4003,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCC(NC(=O)OC(C)(C)C)CC3)cc2)n1,"tert-butyl 1-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)benzyl)piperidin-4-ylcarbamate",0.413,uM,=,-0.384049948343599,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCCCC4)cc3)n2)cc1
4004,725041,10.1128/aac.00434-10,,,,Inhibition of RNase H activity of HIV-1 HXB2 reverse transcriptase p66/p51 after 10 mins by fluorescence spectrophotometry,NC(=O)c1c(N)sc2c1CCCC2,"2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide",14.0,uM,=,1.146128035678238,1,c1cc2c(s1)CCCC2
4005,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)NC1CCCCC1,2-(2-Benzoyl-4-chloro-phenoxy)-N-cyclohexyl-acetamide,39.06999179259893,uM,=,1.5918433199929092,1,O=C(COc1ccccc1C(=O)c1ccccc1)NC1CCCCC1
4006,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,CCc1cc(C(C#CC2CC2)(OCC#N)C(F)(F)F)c(O)nc1C,"[3-Cyclopropyl-1-(5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-1-trifluoromethyl-prop-2-ynyloxy]-acetonitrile",1.842,uM,=,0.2652896258608301,1,C(#CC1CC1)Cc1cccnc1
4007,1906077,10.1016/j.ejmech.2019.111603,,,,Inhibition of recombinant HIV-1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye based spectrofluorometric assay,Cc1cc(C#N)ccc1-c1ccc(Oc2nc(Nc3ccc(C#N)cc3)nc3ccsc23)cc1C,"4-[4-[2-(4-cyanoanilino)thieno[3,2-d]pyrimidin-4-yl]oxy-2-methyl-phenyl]-3-methyl-benzonitrile",0.027,uM,=,-1.5686362358410126,0,c1ccc(Nc2nc(Oc3ccc(-c4ccccc4)cc3)c3sccc3n2)cc1
4008,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCN(C)C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-dimethylamino-propyl)-5-methyl-1H-pyrimidine-2,4-dione",6.6,uM,=,0.8195439355418687,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4009,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cn1cc(-c2cnc3oc4c(-c5cnn(C)c5)nc(=O)n(CCC5CCCO5)c4c3c2)cn1,"4,8-Bis-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0029,uM,=,-2.537602002101044,0,O=c1nc(-c2cn[nH]c2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
4010,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CCOc1cccc(F)c1CCNC(=S)Nc1nccs1,1-[2-(2-Ethoxy-6-fluoro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,0.01,uM,=,-2.0,0,S=C(NCCc1ccccc1)Nc1nccs1
4011,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,O=c1cc(Nc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,"6-(4'-chlorobiphenyl-3-ylamino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.22,uM,=,-0.6575773191777937,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4012,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,Cn1cccc1CC/N=C(\S)Nc1ccc(C#N)cn1,1-(5-Cyano-pyridin-2-yl)-3-[2-(1-methyl-1H-pyrrol-2-yl)-ethyl]-thiourea,0.07,uM,=,-1.154901959985743,0,C(=NCCc1ccc[nH]1)Nc1ccccn1
4013,1501272,10.1016/j.bmc.2015.03.037,,,,Inhibition of wild-type HIV1 Reverse transcriptase p66/p51 assessed as relative fluorescence signal after 40 mins,N#Cc1ccc(Nc2nccc(Oc3ccc4c(=O)c(C(=O)O)cn(C5CCCC5)c4c3)n2)cc1,"7-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)oxy)-1-cyclopentyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",6.08,uM,=,0.7839035792727349,1,O=c1ccn(C2CCCC2)c2cc(Oc3ccnc(Nc4ccccc4)n3)ccc12
4014,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2cc(Cl)c(Cl)cc2C2(c3ccccc3)SCCN12,"7,8-Dichloro-9b-phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",4.48,uM,=,0.651278013998144,1,O=C1c2ccccc2C2(c3ccccc3)SCCN12
4015,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(C(F)(F)F)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(trifluoromethyl)benzyl)isoquinoline-1,3(2H,4H)-dione",1.5,uM,=,0.1760912590556812,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
4016,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ccccn2)c(O)nc1C,5-Ethyl-6-methyl-3-[(pyridin-2-ylmethyl)-amino]-1H-pyridin-2-one,15.0,uM,=,1.1760912590556811,1,c1ccc(CNc2cccnc2)nc1
4017,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(C)cc([S+]([O-])c2cccc(N)c2C#N)c1,"2-Amino-6-(3,5-dimethyl-benzenesulfinyl)-benzonitrile",0.5,uM,=,-0.3010299956639812,0,c1ccc([SH+]c2ccccc2)cc1
4018,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1c(O)nc(SCC(C)C)nc1Cc1ccccc1,6-Benzyl-2-isobutylsulfanyl-5-methyl-3H-pyrimidin-4-one,2.2,uM,=,0.3424226808222063,1,c1ccc(Cc2ccncn2)cc1
4019,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NNC(C)C)[nH]c3ccc(Cl)cc23)c1,"N'-isopropyl-3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carboxyhydrazide",0.01,uM,=,-2.0,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
4020,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,NC(=O)C(CNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1)NC(=O)CCCCCNC(=O)[C@@H](N)CCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1,"N-[(5S)-5-amino-6-[[6-[[2-amino-1-[[[4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzoyl]amino]methyl]-2-oxo-ethyl]amino]-6-oxo-hexyl]amino]-6-oxo-hexyl]-4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzamide",0.0306999999999999,uM,=,-1.5128616245228137,0,O=C(CCCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1)NCCCCCC(=O)NCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
4021,750572,10.1016/j.bmc.2009.05.049,,,,Antiviral activity against HIV1 Reverse transcriptase activity,C=C(C)[C@@H]1CC[C@]2(COC(C)=O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,"Acetic acid (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-acetoxymethyl-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysen-9-yl ester",2.6595633013144284,uM,=,0.4248103315937616,1,C1CC[C@@H]2CCC3C4CCC5CCC[C@@H]5[C@H]4CC[C@@H]3C2C1
4022,1338882,10.1016/j.bmc.2014.02.029,,,,Inhibition of recombinant HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation in to poly [A] x oligo[dT]15 by ELISA,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)nc3ccnn23)c(C)c1,"4-(7-(Mesityloxy)pyrazolo[1,5-a]pyrimidin-5-ylamino)benzonitrile",2.26,uM,=,0.3541084391474008,1,c1ccc(Nc2cc(Oc3ccccc3)n3nccc3n2)cc1
4023,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccc(OC)cc3oc2=O)cc1,"N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfanamido)-7-phenylbutan-2-yl)-7-methoxy-2-oxo-2H-chromene-3-carbuxamide",0.3703999999999999,uM,=,-0.4313290219901033,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1cc2ccccc2oc1=O
4024,989557,10.1016/j.bmc.2013.08.040,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 (1:1.2) as template/primer after 40 mins by spectrofluorometric analysis,CCc1c(C(=O)c2cccc(F)c2)nc(SCc2ccc(OC)cc2)[nH]c1=O,2-(4-Methoxybenzylthio)-5-ethyl-6-(3-fluorobenzoyl)pyrimidin-4(3H)-one,0.19,uM,=,-0.721246399047171,0,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
4025,442660,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rA.dT template,CCN(CC)CCN1C(=O)CSC1C12CC3CC(CC(C3)C1)C2,2-adamantan-1-yl-3-(2-diethylamino-ethyl)-thiazolidin-4-one,481.0,uM,=,2.682145076373832,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1
4026,195840,10.1021/jm00099a006,,,,Inhibition of HIV-1 reverse transcriptase.,CCCCc1cc(NCN2C(=O)c3ccccc3C2=O)c(O)nc1C,"2-[(5-Butyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylamino)-methyl]-isoindole-1,3-dione",0.128,uM,=,-0.8927900303521317,0,O=C1c2ccccc2C(=O)N1CNc1cccnc1
4027,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCCc2nnc(C)o2)c2cccc(C#N)c2)cc1C(=O)SC,"(E)-S-methyl 5-(1-(3-cyanophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-2-methoxy-3-methylbenzothioate",7.7,uM,=,0.8864907251724818,1,C(CCCc1nnco1)=C(c1ccccc1)c1ccccc1
4028,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)C(C)COC)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-3-[(2-methoxy-1-methyl-ethyl)-methyl-amino]-6-methyl-1H-pyridin-2-one",0.006,uM,=,-2.2218487496163566,0,O=c1cc(Cc2ccccc2)cc[nH]1
4029,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCCC#N)c1Cc1cccc(C)c1,"4-{[5-Ethyl-6-methyl-4-(3-methyl-benzyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-methyl-amino}-butyronitrile",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Cc2ccccc2)cc[nH]1
4030,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,O=C(CSc1nnnn1-c1cccc(Cl)c1Cl)Nc1ccccc1[N+](=O)[O-],"2-(1-(2,3-dichlorophenyl)-1H-tetrazol-5-ylthio)-N-(2-nitrophenyl)acetamide",0.012,uM,=,-1.9208187539523751,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4031,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(OCC(=O)Nc3ccc(S(C)(=O)=O)cc3Cl)nc3ccccc32)c1,"N-(2-Chloro-5-(methylsulfonyl)phenyl)-2-((1-((3,5-dimethylphenyl)sulfonyl)-1H-benzo[d]imidazol-2-yl)oxy)acetamide",0.76,uM,=,-0.1191864077192086,0,O=C(COc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
4032,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CC(=O)c1c(O)c2c(=O)oc3c(C)cccc3c2oc1=O,"3-acetyl-4-hydroxy-7-methylpyrano[3,2-c]chromene-2,5-dione",25.5,uM,=,1.4065401804339552,1,O=c1ccc2c(=O)oc3ccccc3c2o1
4033,195059,10.1016/s0960-894x(99)00581-8,,,,Inhibition of recombinant HIV-1 reverse transcriptase,Fc1ccc(CC/N=C(\S)Nc2ccc(Br)cn2)cc1,1-(5-Bromo-pyridin-2-yl)-3-[2-(4-fluoro-phenyl)-ethyl]-thiourea,6.4,uM,=,0.8061799739838872,1,C(=NCCc1ccccc1)Nc1ccccn1
4034,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2cccc(Cl)c2)n1,"N-(3-Chlorophenyl)-2-((4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)acetamide",0.978,uM,=,-0.0096611452123985,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
4035,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-((4-fluorobenzyloxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",2.1,uM,=,0.3222192947339193,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
4036,543620,10.1016/j.ejmech.2008.02.039,,,,Inhibition of HIV1 3B reverse transcriptase after 30 mins,O=C1CSC(c2c(F)cccc2F)N1CCC12CC3CC(CC(C3)C1)C2,"3-(2-Adamantan-1-ylethyl)-2-(2,6-difluorophenyl)-thiazolidin-4-one",31.7,uM,=,1.5010592622177514,1,O=C1CSC(c2ccccc2)N1CCC12CC3CC(CC(C3)C1)C2
4037,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(Cl)cc([S+]([O-])c2cccc(N)c2C#N)c1,2-Amino-6-(3-chloro-5-methyl-benzenesulfinyl)-benzonitrile,0.52,uM,=,-0.2839966563652008,0,c1ccc([SH+]c2ccccc2)cc1
4038,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1ccccc1-c1cccc(Oc2cc(=O)n(O)c(=O)n2C)c1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",4.4,uM,=,0.6434526764861874,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4039,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(NC2CCN(Cc3ccccc3)CC2)c1,"4-((2-((1-benzylpiperidin-4-yl)amino)-6-chloropyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.168,uM,=,-0.7746907182741372,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
4040,2297017,10.1016/j.ejmech.2016.07.056,,,,Inhibition of HIV1 reverse transcriptase,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@H](C)[C@@H]3O,"(10R,11R,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",30.0,uM,=,1.4771212547196624,1,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
4041,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,C=CCN(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-(allyl(2-(4-cyanophenylamino)pyrimidin-4-yl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.064,uM,=,-1.193820026016113,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4042,750572,10.1016/j.bmc.2009.05.049,,,,Antiviral activity against HIV1 Reverse transcriptase activity,CC1(C)[C@H](O)CC[C@]2(C)C3=CC[C@@]4(C)[C@@H]5C[C@](C)(COC(=O)c6ccccc6)CC[C@]5(C)CC[C@]4(C)C3=CC[C@@H]12,karounidiol 29-benzoate,4.041208233242461,uM,=,0.6065112291157928,1,O=C(OCC1CCC2CCC3C4=CC[C@H]5CCCCC5C4=CCC3[C@@H]2C1)c1ccccc1
4043,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3cc(=O)[nH]c(=O)[nH]3)CC2)nc2c1CSCC2,"4-(2-(1-((2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)piperidin-4-ylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.089,uM,=,-1.0506099933550872,0,O=c1cc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)[nH]c(=O)[nH]1
4044,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccc(OC)c3)nc21,"5-Ethyl-7-(3-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
4045,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2cccc(C)c2)n1,2-sec-Butylsulfanyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,1.2,uM,=,0.0791812460476248,1,c1ccc(Cc2ccncn2)cc1
4046,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1ccc(NC(=O)CN2CCC(Nc3nccc(Oc4c(C)cc(C#N)cc4C)n3)CC2)cc1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(p-tolyl)acetamide",0.181,uM,=,-0.7423214251308154,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
4047,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(F)cc2)cs1,(Z)-3-(2-(4-(4-fluorophenyl)thiazol-2-yl)hydrazono)indolin-2-one,23.9,uM,=,1.3783979009481375,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
4048,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2cccc([N+](=O)[O-])c2)c(C)c1,2-(1-mesityl-1H-tetrazol-5-ylthio)-N-(3-nitrophenyl)acetamide,0.2,uM,=,-0.6989700043360187,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4049,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),COc1cc(/C=C2\SC(=S)N(CC(=O)Nc3cc(Cl)ccc3O)C2=O)cc(OC)c1OC,"N-(5-Chloro-2-hydroxy-phenyl)-2-{4-oxo-2-thioxo-5-[1-(3,4,5-trimethoxy-phenyl)-meth-(Z)-ylidene]-thiazolidin-3-yl}-acetamide",32.0,uM,=,1.505149978319906,1,O=C(CN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
4050,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCC2=NC3CCCCC3O2)c(O)nc1C,"5-Ethyl-3-[2-(3a,4,5,6,7,7a-hexahydro-benzooxazol-2-yl)-ethyl]-6-methyl-1H-pyridin-2-one",0.058,uM,=,-1.2365720064370629,0,c1cncc(CCC2=NC3CCCCC3O2)c1
4051,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=C(N/N=C/c1ccc(O)c(O)c1)c1ccccc1,"N'-(3,4-dihydroxybenzylidene)benzohydrazide",50.0,uM,=,1.6989700043360187,1,O=C(N/N=C/c1ccccc1)c1ccccc1
4052,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCc1c(C)nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc1C,"2-(2-Chloro-6-fluorophenyl)-3-(5-ethyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",0.23,uM,=,-0.6382721639824072,0,O=C1CSC(c2ccccc2)N1c1ncccn1
4053,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(N)cccc3o2)c(O)nc1C,3-[(4-Amino-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,67.0,uM,=,1.8260748027008264,1,c1cncc(NCc2nc3ccccc3o2)c1
4054,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2cccnc2)c(O)nc1C,5-Ethyl-6-methyl-3-[(pyridin-3-ylmethyl)-amino]-1H-pyridin-2-one,300.0,uM,=,2.4771212547196626,1,c1cncc(CNc2cccnc2)c1
4055,734864,10.1016/j.bmc.2011.01.024,,,,Inhibition of HIV1 3B reverse transcriptase activity,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC(=O)[C@]3(C)[C@H](CC[C@@]4(C)[C@@H](c5ccoc5)OC(=O)[C@H]5O[C@]543)[C@@]12C,nomilin,3.42,uM,=,0.534026106056135,1,O=C1CCC2[C@H](CO1)CC(=O)C1[C@@H]2CCC2[C@@H](c3ccoc3)OC(=O)[C@H]3O[C@@]123
4056,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3cccc(NC(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"{3-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-phenyl}-urea",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4057,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N3CC=CC3)nc21,"7-(2,5-Dihydro-pyrrol-1-yl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2ccc(N3CC=CC3)nc2Nc2ncccc21
4058,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,O=C(O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccccc3)cc2c1=O,"6-(Benzyloxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",34.0,uM,=,1.5314789170422551,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
4059,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(SCC(=O)Nc3ccc(C)cc3Cl)nc3ccc(Cl)cc32)c1,"2-({6-Chloro-1-[(3,5-dimethylphenyl)sulfonyl]-1Hbenzimidazol-2-yl}sulfanyl)-N-2-chloro-4-methylphenylacetamide",46.41,uM,=,1.66661156841903,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
4060,1795829,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CCR5 tropic HIV1 VB59 reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(Cl)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-chloro-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.0004986384068665,uM,=,-3.302214273670576,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
4061,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3nc(C)cc(C)n3)cc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-2-(4,6-dimethyl-pyrimidin-2-ylsulfanylmethyl)-5-ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.006,uM,=,-2.2218487496163566,0,O=C1Nc2cccnc2Nc2ncc(CSc3ncccn3)cc21
4062,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)CNc1ccccc1)CC2,"(2S)-5,7-dihydroxy-2-(2-hydroxy-1-(phenylamino)propan-2-yl)-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",1.2,uM,=,0.0791812460476248,1,O=c1cccc2c(c1)CC[C@H](CCNc1ccccc1)C2
4063,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,Cn1c(=O)ccn(CCOc2cc(OS(=O)(=O)F)ccc2Oc2cc(Cl)cc(C#N)c2)c1=O,"4-(3-Chloro-5-cyanophenoxy)-3-(2-(3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenyl sulfurofluoridate",0.246,uM,=,-0.6090648928966209,0,O=c1ccn(CCOc2ccccc2Oc2ccccc2)c(=O)[nH]1
4064,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3cc(C)ccc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(5-methyl-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,1.25,uM,=,0.0969100130080564,1,c1cncc(NCc2nc3ccccc3o2)c1
4065,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",0.7,uM,=,-0.1549019599857432,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4066,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2cccc(-c3ccc(C#N)cc3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",3.4,uM,=,0.5314789170422551,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4067,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)CCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-5-methyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,0.3,uM,=,-0.5228787452803376,0,C=C(c1ccccc1)c1ccccc1
4068,1567015,10.1021/acs.jmedchem.5b01979,,,,Inhibition of recombinant HIV1 His-tagged p66/p51 reverse transcriptase expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)-oligo(dT) (12 to 18 bp) as template/primer incubated for 20 mins by scintillation counting method,COc1ccc(CN(C)c2nc(C(C)c3c(Cl)cccc3Cl)c(C)c(=O)[nH]2)cc1,"6-(1-(2,6-Dichlorophenyl)ethyl)-2-((4-methoxybenzyl)-(methyl)amino)-5-methylpyrimidin-4(3H)-one",0.017,uM,=,-1.769551078621726,0,O=c1cc(Cc2ccccc2)nc(NCc2ccccc2)[nH]1
4069,442659,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rC.dG template,Cc1cc(C)nc(N2C(=O)CSC2C23CC4CC(CC(C4)C2)C3)c1,"2-adamantan-1-yl-3-(4,6-dimethyl-pyridin-2-yl)-thiazolidin-4-one",29.0,uM,=,1.462397997898956,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
4070,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1C(F)(F)F,"3-(4-(4-(4-cyano-2,6-dimethylphenoxy)-5-(trifluoromethyl)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.086,uM,=,-1.0655015487564323,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4071,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCOc1ccc(OC)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[(1R,2R)-2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-cyclopropyl]-urea",0.007,uM,=,-2.154901959985743,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
4072,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.9,uM,=,0.2787536009528289,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4073,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3cccnc3)ccc21,"5-Cyclopropyl-10-methyl-7-pyridin-3-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.18,uM,=,-0.744727494896694,0,O=C1Nc2ccc(-c3cccnc3)nc2N(C2CC2)c2ncccc21
4074,1869493,10.1021/acs.jmedchem.8b01729,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer measured after 40 mins by pico-green based spectrofluorometric analysis,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCC(NS(C)(=O)=O)CC3)cc2)n1,"(E)-N-(1-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-ylamino)benzyl)piperidin-4-yl)methanesulfonamide",0.076,uM,=,-1.1191864077192086,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCCCC4)cc3)n2)cc1
4075,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2cccc(Cl)c2)n1,2-sec-Butylsulfanyl-6-(3-chloro-benzyl)-5-methyl-3H-pyrimidin-4-one,0.9,uM,=,-0.0457574905606751,0,c1ccc(Cc2ccncn2)cc1
4076,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccccc3Cl)nc3ccccc32)c1,"2-{[1-(3,5-Dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-2-chlorophenylacetamide",42.13,uM,=,1.6245914591268478,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
4077,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C/C=C/CO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(4-hydroxy-but-2-enyl)-5-methyl-1H-pyrimidine-2,4-dione",4.5,uM,=,0.6532125137753437,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4078,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,Cc1cc(C)c(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)n1,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-4,6-dimethyl-1H-pyridin-2-one",2.85,uM,=,0.4548448600085102,1,c1cncc(NCc2nc3ccccc3o2)c1
4079,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,CC1OC(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)=NNC1=O,"2-(3-(3-bromophenoxy)-4-chlorobenzyl)-6-methyl-4H-1,3,4-oxadiazin-5(6H)-one",0.05,uM,=,-1.3010299956639813,0,O=C1COC(Cc2cccc(Oc3ccccc3)c2)=NN1
4080,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,CC1=C(/N=N/c2ccc(C)cc2)N=C(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)NN1,"4-(4-Chlorophenyl)-5-(6-methyl-5-(p-tolyldiazenyl)-1,2-dihydro-1,2,4-triazin-3-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",1.9e-05,uM,=,-4.721246399047171,0,C1=C(/N=N/c2ccccc2)N=C(N2Nc3onc(-c4ccccc4)c3C2c2ccccc2)NN1
4081,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3)ccc2C(=O)N1O,"6-(4-Fluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
4082,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,Cn1cc(-c2cnc3oc4c(-c5cccnc5)nc(=O)n(CCC5CCCO5)c4c3c2)cn1,"8-(1-Methyl-1H-pyrazol-4-yl)-4-pyridin-3-yl-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.012,uM,=,-1.9208187539523751,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
4083,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)n1,"3-(4-(4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.007,uM,=,-2.154901959985743,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4084,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C/CCc2nnc(C)o2)c2ccc(C#N)cc2)cc1C(=O)SC,"(E)-S-methyl 5-(1-(4-cyanophenyl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",48.0,uM,=,1.6812412373755872,1,C(CCc1nnco1)=C(c1ccccc1)c1ccccc1
4085,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCCN(C)c1c(Cc2cc(C)cc(C)c2)c(CC)c(C)[nH]c1=O,"4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-3-(methyl-propyl-amino)-1H-pyridin-2-one",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Cc2ccccc2)cc[nH]1
4086,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,C[C@H]1NC(Cc2ccc(Cl)c(Oc3cc(Cl)cc(C#N)c3)c2F)=NNC1=O,"(R)-3-chloro-5-(6-chloro-2-fluoro-3-((5-methyl-6-oxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl)methyl)phenoxy)benzonitrile",0.011,uM,=,-1.958607314841775,0,O=C1CNC(Cc2cccc(Oc3ccccc3)c2)=NN1
4087,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3ccccc3s2)c(O)nc1C,3-[(Benzothiazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.35,uM,=,-0.4559319556497244,0,c1cncc(NCc2nc3ccccc3s2)c1
4088,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N3CCCC3)nc21,"5-Ethyl-10-methyl-7-pyrrolidin-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2ccc(N3CCCC3)nc2Nc2ncccc21
4089,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(Cc2c(F)cccc2F)nc(SC2CCCC2)[nH]c1=O,"2-Cyclopentylsulfanyl-6-(2,6-difluoro-benzyl)-5-methyl-3H-pyrimidin-4-one",0.08,uM,=,-1.0969100130080565,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
4090,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2cc(CCc3cccnc3)[nH]c(=O)c2Cl)c1,"3-chloro-5-(3-chloro-2-oxo-6-(2-(pyridin-3-yl)ethyl)-1,2-dihydropyridin-4-yloxy)benzonitrile",0.022,uM,=,-1.6575773191777938,0,O=c1cc(Oc2ccccc2)cc(CCc2cccnc2)[nH]1
4091,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(F)cc2F)cs1,"(Z)-3-(2-(4-(2,4-difluorophenyl)thiazol-2-yl)hydrazono)indolin-2-one",18.5,uM,=,1.2671717284030135,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
4092,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc(F)cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-fluorobenzyl)-1H-indole-2-carboxamide",0.026,uM,=,-1.585026652029182,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4093,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccccc2N(C)C(=O)c2ccc(F)nc21,"11-Ethyl-2-fluoro-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",2.9,uM,=,0.4623979978989561,1,O=C1Nc2ccccc2Nc2ncccc21
4094,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC1OC(/C=C/C2CC2)(C(F)(F)F)c2cc(F)ccc2NC1=O,"5-((E)-2-Cyclopropyl-vinyl)-7-fluoro-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.129,uM,=,-0.889410289700751,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
4095,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)CCCC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,methyl 3-bromo-5-[1-(3-bromo-4-methoxy-5-methyloxycarbonylphenyl)-5-methyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,0.3,uM,=,-0.5228787452803376,0,C=C(c1ccccc1)c1ccccc1
4096,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3cc(C)nc(C)c3)cc2C(=O)Nc2c(C)cc(F)nc21,"2-(2,6-Dimethyl-pyridin-4-ylsulfanylmethyl)-5-ethyl-7-fluoro-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.0069,uM,=,-2.161150909262745,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
4097,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,NC(=O)c1[nH]cnc1-c1cccc(Cl)c1,4-(3-chlorophenyl)-1H-imidazole-5-carboxamide,79.8,uM,=,1.9020028913507288,1,c1ccc(-c2c[nH]cn2)cc1
4098,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),O=C1Nc2cccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.45,uM,=,-0.3467874862246563,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4099,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3cccc(Cl)c3o2)c(O)nc1C,3-[2-(7-Chloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one,0.039,uM,=,-1.408935392973501,0,c1cncc(CCc2nc3ccccc3o2)c1
4100,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(=O)NCc3ccncn3)[nH]c3ccc(Cl)cc23)c1,"(R)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyrimidin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide",1.8,uM,=,0.255272505103306,1,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncn1
4101,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1ccc(CCNC(=O)c2[nH]c3ccc(Cl)cc3c2S(=O)(=O)c2cc(C)cc(C)c2)cc1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-methylphenethyl)-1H-indole-2-carboxamide",2.0,uM,=,0.3010299956639812,1,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4102,2231068,10.1016/j.bmc.2021.116531,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc(B4OC(C)(C)C(C)(C)O4)cc3)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-1H-indole-2-carboxamide",0.1191,uM,=,-0.9240882385172224,0,O=C(NCc1ccc(B2OCCO2)cc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4103,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCCN(c1ncccc1NC(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isopropylamino-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.24,uM,=,-0.619788758288394,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4104,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1[nH]c(=O)n([C@@H]2O[C@H](CNCc3c(F)cccc3Cl)[C@@H](O)[C@H]2O)cc1F,5'-(2-fluoro-6-chlorobenzylamino)methyl-5-fluorouridine,3.9,uM,=,0.5910646070264992,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
4105,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(=O)NCc3ccncn3)[nH]c3ccc(Cl)cc23)c1,"(S)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyrimidin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide",0.47,uM,=,-0.3279021420642826,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncn1
4106,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(OC)nc21,"5-Ethyl-7-methoxy-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.6,uM,=,-0.2218487496163563,0,O=C1Nc2cccnc2Nc2ncccc21
4107,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCN(S(C)(=O)=O)CC3)cc2)nc2ccsc12,"(E)-3-(3,5-dimethyl-4((2-((4-((4-(methylsulfonyl)piperazin-1-yl)methyl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.139,uM,=,-0.8569851997459049,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3ccsc23)cc1
4108,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Oc2ccc(-c3ccc(O)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",2.2,uM,=,0.3424226808222063,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4109,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",21.43,uM,=,1.3310221710418286,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4110,195674,10.1021/jm0009437,,,,Tested for inhibitory concentration on HIV-1 Reverse transcriptase in the presence of poly(c)-oligo-(dG),CCc1c(C)[nH]c(=O)c(N(C)C)c1Cc1cc(C)cc(C)c1,"3-Dimethylamino-4-(3,5-dimethylbenzyl)-5-ethyl-6-methylpyridin-2(1H)-one",0.02,uM,=,-1.6989700043360187,0,O=c1cc(Cc2ccccc2)cc[nH]1
4111,581398,10.1016/j.bmc.2009.06.068,,,,Inhibition of HIV1 recombinant RNA-dependent DNA polymerase activity of reverse transcriptase assessed as incorporation of radioactive dTTP into poly(rA)/oligo(dT),O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1cccc(F)c1,6-chloro-1-(3-fluorophenylsulfonyl)-1H-benzo[d]imidazol-2(3H)-one,0.132,uM,=,-0.8794260687941501,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
4112,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,NC(=S)N1Nc2onc(-c3ccccc3)c2C1c1ccc(Cl)cc1,"4-(4-chlorophenyl)-3-phenyl-4H-pyrazolo[4,3-d]isoxazole-5(6H)-carbothioamide",3.7e-05,uM,=,-4.431798275933005,0,c1ccc(-c2noc3c2C(c2ccccc2)NN3)cc1
4113,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCCN(S(=O)(=O)C4CC4)CC3)cc2)n1,"4-((2-((4-((4-(cyclopropylsulfonyl)-1,4-diazepan-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.2,uM,=,-0.6989700043360187,0,O=S(=O)(C1CC1)N1CCCN(Cc2ccc(Nc3nccc(Oc4ccccc4)n3)cc2)CC1
4114,884996,10.1016/j.bmcl.2012.09.062,,,,Inhibition of HIV1 reverse transcriptase assessed as biotin-dUTP incorporation into enzyme using poly(rC)-oligo(dG) as template primer by colorimetric analysis,O=C(CSc1nncnc1-c1ccccc1Cl)Nc1ccccc1[N+](=O)[O-],"2-(5-(2-chlorophenyl)-1,2,4-triazin-6-ylthio)-N-(2-nitrophenyl)acetamide",6.5,uM,=,0.8129133566428556,1,O=C(CSc1nncnc1-c1ccccc1)Nc1ccccc1
4115,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(Cl)c1Nc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Br,3-(4-(5-bromo-4-(2-chloro-4-cyano-6-methylphenylamino)pyrimidin-2-ylamino)piperidin-1-yl)benzamide,0.015,uM,=,-1.8239087409443189,0,c1ccc(Nc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4116,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",CSc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCc2ccc(O)c(O)c2)cc1,"3-(3, 4-Dihydroxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-(methylthio)phenyl)sulfonamido)-1-phenylbutan-2-yl)propanamide",0.00043,uM,=,-3.3665315444204134,0,O=C(CCc1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
4117,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)Cc1cc2ccc(O)cc2oc1=O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1,"N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl)-2-(7-hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetamide",0.3753999999999999,uM,=,-0.4255057317146725,0,O=C(Cc1cc2ccccc2oc1=O)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
4118,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2cccc([N+](=O)[O-])c2)cs1,SID507686,13.0,uM,=,1.1139433523068367,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
4119,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)c(F)c2[C@@](C#Cc2ccccn2)(C(F)(F)F)N1,"5,6-Difluoro-4-pyridin-2-ylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.068,uM,=,-1.1674910872937636,0,O=C1Nc2ccccc2C(C#Cc2ccccn2)N1
4120,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1ccc(CCS(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)cc1,"6-Chloro-1-{[2-(4-methylphenyl)ethyl]sulfonyl}-1,3-dihydro-2H-benzimidazol-2-one",218.0,uM,=,2.338456493604605,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
4121,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),Cc1ccc(/C=C2\SC(=S)N(CCC(=O)Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)C2=O)cc1,3-{4-Oxo-2-thioxo-5-[1-p-tolyl-meth-(Z)-ylidene]-thiazolidin-3-yl}-N-[4-(thiazol-2-ylsulfamoyl)-phenyl]-propionamide,83.0,uM,=,1.919078092376074,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1
4122,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,Cc1cc(C#N)cc(C)c1Oc1ccnc(S(=O)(=O)CC(=O)Nc2ccc(Br)cc2)n1,"N-(4-Bromophenyl)-2-((4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)acetamide",0.728,uM,=,-0.1378686206869628,0,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
4123,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,O=C1Nc2ccccc2/C1=N\NC(=O)c1ccc(O)cc1O,"2,4-dihydroxy-N'-(2-oxoindolin-3-ylidene)benzohydrazide",36.43,uM,=,1.561459171241916,1,O=C1Nc2ccccc2/C1=N\NC(=O)c1ccccc1
4124,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,CCCN(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"4'-((2-(4-cyanophenylamino)pyrimidin-4-yl)(propyl)amino)-3',5'-difluorobiphenyl-4-carbonitrile",0.041,uM,=,-1.3872161432802643,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4125,734861,10.1016/j.bmc.2011.01.024,,,,Inhibition of HIV1 3B reverse transcriptase activity infected in human H9 cells assessed as level of p24 antigen,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4126,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CN1C(=O)c2cccnc2N(C2CC2)c2cc(Cl)cnc21,"3-Chloro-5-cyclopropyl-11-methyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",0.76,uM,=,-0.1191864077192086,0,O=C1Nc2ncccc2N(C2CC2)c2ncccc21
4127,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,CC(C)c1ccc(O)c(=O)c(O)c1,"(2E,4Z,6E)-2,7-dihydroxy-4-isopropylcyclohepta-2,4,6-trienone",0.21,uM,=,-0.6777807052660807,0,O=c1cccccc1
4128,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,Cc1cc(C#N)cc(C)c1Oc1cc(Cl)nc(Nc2ccc(CN3CCOCC3)cc2)c1,"4-((2-Chloro-6-((4-((tetrahydro-2H-pyran-4-yl)methyl)phenyl)amino)pyridin-4-yl)oxy)-3,5-dimethylbenzonitrile",1.32,uM,=,0.1205739312058498,1,c1ccc(Oc2ccnc(Nc3ccc(CN4CCOCC4)cc3)c2)cc1
4129,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(F)cc3F)ccc2C(=O)N1O,"6-(2,4-Difluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.6,uM,=,0.2041199826559248,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
4130,197442,10.1021/jm010904a,,,,Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50%,Cc1ncc([N+](=O)[O-])n1CCOC(c1ccccc1)c1cccc(F)c1,1-{2-[(3-Fluoro-phenyl)-phenyl-methoxy]-ethyl}-2-methyl-5-nitro-1H-imidazole,0.5,uM,=,-0.3010299956639812,0,c1ccc(C(OCCn2ccnc2)c2ccccc2)cc1
4131,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1CCS[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)N12,"(6S,7R,8S,9S,9aR)-7,8,9-trihydroxy-6-(hydroxymethyl)hexahydro-4H,6H-pyrido[2,1-b][1,3]thiazin-4-one",6.02,uM,=,0.7795964912578245,1,O=C1CCS[C@@H]2CCCCN12
4132,947897,10.1021/np3006887,,,,Inhibition of HIV-1 reverse transcriptase assessed as decrease in incorporation of [3H]TTP into polyA template,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",7.5,uM,=,0.8750612633917001,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4133,502868,10.1021/np960322+,,,,Inhibition of HIV1 reverse transcriptase,COCc1cc2cc(OC)c(OC)cc2c(-c2ccc3c(c2)OCO3)c1C=O,Phyllamyricin B,3.5,uM,=,0.5440680443502757,1,c1ccc2c(-c3ccc4c(c3)OCO4)cccc2c1
4134,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,Oc1nc2ccc(Cl)cc2n1Cc1c(Cl)cccc1Cl,"6-Chloro-1-(2,6-dichloro-benzyl)-1,3-dihydro-benzoimidazol-2-one",7.5,uM,=,0.8750612633917001,1,c1ccc(Cn2cnc3ccccc32)cc1
4135,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CSc3ncccn3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyrimidin-2-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CSc3ncccn3)cc21
4136,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(N)ccc2N(C)C(=O)c2cccnc21,"9-Amino-11-ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",4.5,uM,=,0.6532125137753437,1,O=C1Nc2ccccc2Nc2ncccc21
4137,195666,10.1021/jm990051a,,,,Inhibition of Reverse transcriptase (P236L) using poly(rA)600:oligo(dT)10 as template primer.,CCCN(c1ncccc1CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethyl-pyridin-2-yl)-propyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.54,uM,=,-0.2676062401770315,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4138,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Nc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-amino)pyrimidine-2,4(1H,3H)-dione",8.9,uM,=,0.9493900066449128,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4139,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2ccc(C3=CCC=N3)nc21,"5-Ethyl-10-methyl-2-phenethyl-7-(4H-pyrrol-2-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.28,uM,=,0.1072099696478683,1,O=C1Nc2ccc(C3=CCC=N3)nc2Nc2ncc(CCc3ccccc3)cc21
4140,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1cc(C)cc(S(=O)(=O)n2c(OCC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)nc3ccccc32)c1,"N-(2-Chloro-5-sulfamoylphenyl)-2-((1-((3,5-dimethylphenyl)sulfonyl)-1H-benzo[d]imidazol-2-yl)oxy)acetamide",5.84,uM,=,0.7664128471123994,1,O=C(COc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
4141,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,COc1ccc(-c2ccc(Sc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1F,"6-((3'-fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.004,uM,=,-2.397940008672037,0,O=c1cc(Sc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4142,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.105,uM,=,-0.978810700930062,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4143,471453,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Nc1nc2c(ncn2[C@H]2CO[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1,beta-D-dioxolane-guanine-triphosphate,0.2,uM,=,-0.6989700043360187,0,O=c1[nH]cnc2c1ncn2[C@H]1COCO1
4144,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",6.5,uM,=,0.8129133566428556,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4145,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2cccc3ccccc23)n1,2-sec-Butylsulfanyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,8.1,uM,=,0.9084850188786496,1,c1ccc2c(Cc3ccncn3)cccc2c1
4146,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1cc(CCc2nc3ccccc3o2)c(O)nc1C,"3-(2-Benzooxazol-2-yl-ethyl)-5,6-dimethyl-1H-pyridin-2-one",0.17,uM,=,-0.7695510786217261,0,c1cncc(CCc2nc3ccccc3o2)c1
4147,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cc(Br)cc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-bromo-5-methyl-benzenesulfonyl)-benzonitrile,0.003,uM,=,-2.5228787452803374,0,O=S(=O)(c1ccccc1)c1ccccc1
4148,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,CCCc1cc2c(cc1/C=C1\NC(=O)NC1=O)OCO2,"5-((6-propylbenzo[d][1,3]dioxol-5-yl)methylene)imidazolidine-2,4-dione",91.57,uM,=,1.9617532141867824,1,O=C1NC(=O)/C(=C/c2ccc3c(c2)OCO3)N1
4149,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",11.0,uM,=,1.0413926851582251,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4150,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCc1ccccc1)Nc1nccs1,1-Benzyl-3-thiazol-2-yl-thiourea,1.2,uM,=,0.0791812460476248,1,S=C(NCc1ccccc1)Nc1nccs1
4151,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1c(Cc2ccccc2)nc(SCOCc2ccccc2)[nH]c1=O,6-Benzyl-2-(benzyloxymethylthio)-5-methyl-pyrimidin-4(3H)-one,19.01,uM,=,1.2789821168654432,1,O=c1cc(Cc2ccccc2)nc(SCOCc2ccccc2)[nH]1
4152,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,COc1ccc2c(CC(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc(N)cc3)cc(=O)oc2c1,"N-((25,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetamide",0.4106,uM,=,-0.3865810549654269,0,O=C(Cc1cc(=O)oc2ccccc12)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
4153,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1F,"3-(4-(4-(4-cyano-2,6-dimethylphenoxy)-5-fluoropyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.014,uM,=,-1.853871964321762,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4154,1522234,10.1016/j.ejmech.2015.08.007,,,,Inhibition of HIV1 reverse transcriptase p66/p51 assessed as inhibition of biotin-dUTP incorporation using poly (rA)/oligo(dT)16 as template/primer incubated for 40 mins,COc1ccc(NC(=O)CS(=O)(=O)c2nccc(Oc3c(C)cc(C#N)cc3C)n2)cc1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)sulfonyl)-N-(4-methoxyphenyl)acetamide",4.66,uM,=,0.6683859166900001,1,O=C(CS(=O)(=O)c1nccc(Oc2ccccc2)n1)Nc1ccccc1
4155,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc(C)c1Br,"2-(2-Chloro-6-fluorophenyl)-3-(5-bromo-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",1.52,uM,=,0.1818435879447725,1,O=C1CSC(c2ccccc2)N1c1ncccn1
4156,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1CCCC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl)amino)piperidin-1-yl)methyl)-benzamide",0.051,uM,=,-1.2924298239020635,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CCCC4)CC2)cc1
4157,2123991,10.1021/acs.jmedchem.1c00987,,,,"Inhibition of wild type HIV1 p66/p51 reverse transcriptase using poly(rA) as template, oligo(dT)16 as primer and RNA/DNA as substrate measured after 40 mins by PICOGreen-dye based spectrofluorimetry analysis",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(OC(F)(F)F)cc2)nc2c1CCCC2,"3,5-Dimethyl-4-((2-((4-(trifluoromethoxy)phenyl)amino)-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)benzonitrile",61.0,uM,=,1.7853298350107671,1,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CCCC3)cc1
4158,439842,10.1021/jm070236e,,,,Inhibition of HIV1 recombinant reverse transcriptase,CO/N=C(\F)c1cc(/C(=C\CCCc2nc(C)no2)c2cc(C)c3oc(=O)n(C)c3c2)cc(C)c1OC,"(Z)-5-((E)-1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)pent-1-enyl)-N,2-dimethoxy-3-methylbenzimidoyl fluoride",0.67,uM,=,-0.1739251972991735,0,O=c1[nH]c2cc(/C(=C/CCCc3ncno3)c3ccccc3)ccc2o1
4159,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C(I)=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-iodo-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",3.5,uM,=,0.5440680443502757,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4160,442660,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rA.dT template,Cc1cc(C)nc(N2C(=O)CS[C@@H]2C23CC4CC(CC(C4)C2)C3)c1,"(R)-(+)-2-adamantan-1-yl-3-(4,6-dimethyl-pyridin-2-yl)-thiazolidin-4-one",20.0,uM,=,1.3010299956639813,1,O=C1CS[C@H](C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
4161,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)C(=O)NCc3ccco3)[nH]c3ccc(Cl)cc23)c1,"(S)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-((furan-2-ylmethyl)amino)-1-oxopropan-2-yl)-1H-indole-2-carboxamide",0.113,uM,=,-0.9469215565165804,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccco1
4162,1752560,10.1016/j.bmc.2017.12.033,,,,Inhibition of recombinant wild-type HIV-1 3B reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,COC(=O)c1ccc(NC(=O)CSc2nc3ccccc3n2S(=O)(=O)c2cc(C)cc(C)c2)cc1,"Methyl 4-[[2-[1-(3,5-dimethylphenyl)sulfonylbenzimidazol-2-yl]sulfanylacetyl]amino]benzoate",0.088,uM,=,-1.055517327849831,0,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
4163,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)CC(N)=O)[nH]c3ccc(Cl)cc23)c1,"(R)-N-(4-amino-4-oxobutan-2-yl)-5-chloro-3-(3,5-dimethylphenylsulfonyl)-1H-indole-2-carboxamide",0.147,uM,=,-0.8326826652518239,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
4164,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1nc(O)c(CCc2nc3ccccc3o2)cc1CO,3-(2-Benzooxazol-2-yl-ethyl)-5-hydroxymethyl-6-methyl-1H-pyridin-2-one,3.4,uM,=,0.5314789170422551,1,c1cncc(CCc2nc3ccccc3o2)c1
4165,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1cccc(C(C#N)c2nc(SC(C)C)[nH]c(=O)c2C)c1,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(3-methoxyphenyl)acetonitrile",1.056,uM,=,0.0236639181977934,1,O=c1cc(Cc2ccccc2)nc[nH]1
4166,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1ccccc1S(=O)(=O)c1cccc(N)c1C#N,2-Amino-6-(2-cyano-benzenesulfonyl)-benzonitrile,6.0,uM,=,0.7781512503836436,1,O=S(=O)(c1ccccc1)c1ccccc1
4167,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(Cc2ccc3c(c2)CC(=O)N(O)C3=O)cc1,"2-Hydroxy-6-(4-methylbenzyl)isoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
4168,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(Cl)ccnc21,"9-Chloro-5-ethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.095,uM,=,-1.0222763947111522,0,O=C1Nc2cccnc2Nc2ncccc21
4169,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,C=CCc1c(C)nc(N2C(=O)CSC2c2c(Cl)cccc2Cl)nc1C,"2-(2,6-Dichlorophenyl)-3-(5-allyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",1.22,uM,=,0.0863598306747482,1,O=C1CSC(c2ccccc2)N1c1ncccn1
4170,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCCO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(4-hydroxy-butyl)-5-methyl-1H-pyrimidine-2,4-dione",13.0,uM,=,1.1139433523068367,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4171,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3n[nH]c(=O)n3C)CC2)nc2ccsc12,"3,5-dimethyl-4-((2-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)benzonitrile",0.055,uM,=,-1.259637310505756,0,O=c1[nH]nc(CN2CCC(Nc3nc(Oc4ccccc4)c4sccc4n3)CC2)[nH]1
4172,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,Cc1cccc2c1N(C(=O)SCC(=O)Nc1ccc(S(N)(=O)=O)cc1Cl)CCC2,"S-2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl 8-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",0.006,uM,=,-2.2218487496163566,0,O=C(CSC(=O)N1CCCc2ccccc21)Nc1ccccc1
4173,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2cc(C)c(C)cc2OC)c(O)nc1C,"5-Ethyl-3-(2-methoxy-4,5-dimethyl-benzylamino)-6-methyl-1H-pyridin-2-one",0.008,uM,=,-2.096910013008056,0,c1ccc(CNc2cccnc2)cc1
4174,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc3ccccc3c2)n[nH]1,Ethyl 3-(1-(4-fluorobenzyl)-4-(naphthalen-2-yl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,9.4,uM,=,0.9731278535996988,1,c1ccc(Cn2cc(-c3ccc4ccccc4c3)c(-c3cc[nH]n3)c2)cc1
4175,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CSc3[nH]cnc4ncnc3-4)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(9H-purin-6-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncc(CSc3[nH]cnc4ncnc3-4)cc21
4176,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,COc1ccc(OC)c(CCNC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2-fluoro-3,6-dimethoxy-phenyl)-ethyl]-urea",0.003,uM,=,-2.5228787452803374,0,O=C(NCCc1ccccc1)Nc1ccccn1
4177,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,N#Cc1cccc(Cn2cccc2/C=C/C(=O)CC(=O)C(=O)O)c1,"6-[1-(3-Cyanophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",5.0,uM,=,0.6989700043360189,1,c1ccc(Cn2cccc2)cc1
4178,540654,10.1016/j.bmcl.2008.12.074,,,,Inhibition of wild type HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)c(Cl)c1,(4'-{2-[1-(4-tert-butyl-2-chloro-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetylamino}-3'-chloro-biphenyl-4-yl)-acetic acid,0.0077,uM,=,-2.113509274827518,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
4179,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(C=O)cc3[nH]2)CC1,2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indole-6-carbaldehyde,1.4,uM,=,0.1461280356782379,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4180,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,C#CC1(C2CC2)c2cc(Cl)ccc2NC(=O)N1C,"6-chloro-4-cyclopropyl-4-ethynyl-3-methyl-3,4-dihydroquinazolin-2(1H)-one",0.006,uM,=,-2.2218487496163566,0,O=C1Nc2ccccc2C(C2CC2)N1
4181,306023,10.1016/j.bmcl.2004.12.072,,,,Inhibitory concentration against human immunodeficiency virus type 1 reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",2.1,uM,=,0.3222192947339193,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4182,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CCCN1C(=O)/C(=C/c2cccs2)SC1=S)Nc1ccc(C(=O)O)c(O)c1,2-Hydroxy-4-(4-{4-oxo-5-[1-thiophen-2-yl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-butyrylamino)-benzoic acid,25.0,uM,=,1.3979400086720375,1,O=C(CCCN1C(=O)/C(=C/c2cccs2)SC1=S)Nc1ccccc1
4183,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,CC=C(c1cc(Br)c(OC)c(C(=O)OC)c1)c1cc(Br)c(OC)c(C(=O)OC)c1,"3',3''-Dibromo-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenylpropene",26.0,uM,=,1.414973347970818,1,C=C(c1ccccc1)c1ccccc1
4184,656649,10.1128/aac.00986-09,,,,Inhibition of HIV1 Reverse transcriptase by primer extension-based scintillation assay,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-{4-[4-((E)-2-Cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile",0.042,uM,=,-1.3767507096020994,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
4185,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,O=c1cc(Nc2ccc(-c3ccccc3O)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((2'-hydroxy-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.83,uM,=,-0.0809219076239261,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4186,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CN1C(=O)c2cc(N)ccc2Oc2ccccc21,"2-Amino-10-methyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.18,uM,=,-0.744727494896694,0,O=C1Nc2ccccc2Oc2ccccc21
4187,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3cccc(O)c3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(3-hydroxybenzyl)-1H-indole-2-carboxamide",0.068,uM,=,-1.1674910872937636,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4188,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Cc1c(O)nc(SC2CCCC2)nc1Cc1c(Cl)cccc1Cl,"2-Cyclopentylsulfanyl-6-(2,6-dichloro-benzyl)-5-methyl-3H-pyrimidin-4-one",1.7,uM,=,0.2304489213782739,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
4189,197123,10.1021/jm970559i,,,,Antiviral activity against Human Immunodeficiency Virus by Reverse transcriptase assay in CEM-SS cells,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.0031,uM,=,-2.508638306165728,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4190,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=C1C=Cc2ccccc2/C1=C/NNS(=O)(=O)c1cc(Cl)c(Cl)cc1Cl,"2,4,5-trichloro-N'-((2-oxonaphthalen-1(2H)-ylidene)methyl)benzenesulfonohydrazide",10.0,uM,=,1.0,1,O=C1C=Cc2ccccc2/C1=C/NNS(=O)(=O)c1ccccc1
4191,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(CNc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-phenylaminomethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2c(CNc3ccccc3)ccnc2N(C2CC2)c2ncccc21
4192,1350089,10.1016/j.ejmech.2014.04.027,,,,Inhibition of HIV1 wild-type reverse transcriptase using [3H]dTTP by scintillation counting,Cc1ccc(CNC(=O)c2[nH]c3ccc(Cl)cc3c2S(=O)(=O)c2cc(C)cc(C)c2)cc1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-methylbenzyl)-1H-indole-2-carboxamide",0.05,uM,=,-1.3010299956639813,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4193,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1O,"4-(4-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)phenyl)pyridin-1-ium 4-methylbenzenesulfonate",0.5,uM,=,-0.3010299956639812,0,O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1.c1ccccc1
4194,195068,10.1021/jm00008a019,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCN1c2cccnc2N(C)C(=O)c2cc(N)cnc21,"8-Amino-5-ethyl-11-methyl-5,11-dihydro-1,6,11-triaza-dibenzo[a,d]cyclohepten-10-one",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2ncccc2Nc2ncccc21
4195,989557,10.1016/j.bmc.2013.08.040,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 (1:1.2) as template/primer after 40 mins by spectrofluorometric analysis,COc1ccc(CSc2nc(C(=O)c3cccc(F)c3)c(C(C)C)c(=O)[nH]2)cc1,2-(4-Methoxybenzylthio)-6-(3-fluorobenzoyl)-5-isopropylpyrimidin-4(3H)-one,0.04,uM,=,-1.3979400086720375,0,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
4196,195503,10.1016/s0960-894x(99)00624-1,,,,Inhibition of recombinant reverse transcriptase (RT) in cell-free Quan-T-RT assay system,S=C(NCCN1CCCCC1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-piperidin-1-yl-ethyl)-thiourea,0.6,uM,=,-0.2218487496163563,0,S=C(NCCN1CCCCC1)Nc1ccccn1
4197,196375,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1/138Lys reverse transcriptase (RT) using [3H]dGTP as a radioligand,COC(=O)P(=O)([O-])OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O.[Na+],"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-[[[(methoxycarbonyl)hydroxyphosphonyl]oxy]-propyl]thymine]-3''-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide); Sodium ion",394.0,uM,=,2.595496221825574,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4198,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cccs3)nc21,"5-Ethyl-10-methyl-7-thiophen-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2ccc(-c3cccs3)nc2Nc2ncccc21
4199,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1[N+](=O)[O-],"4-[2-(4-Cyano-phenylamino)-5-nitro-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.018,uM,=,-1.744727494896694,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4200,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCc2cccc(Cl)c2F)c(=O)n(O)c1=O,"6-Benzyl-1-((3-chloro-2-fluorobenzyloxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
4201,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(Cl)cc2[C@@](C#Cc2ccccc2)(C(F)(F)F)N1,"6-Chloro-4-phenylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.277,uM,=,-0.5575202309355514,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)N1
4202,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)ccn1,"4-((4-((2,6-Dimethyl-4-(2-methylpyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0357,uM,=,-1.4473317838878068,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
4203,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),NS(=O)(=O)c1ccc(NC(=O)CCN2C(=O)/C(=C/c3ccc(F)cc3)SC2=S)cc1,3-{5-[1-(4-Fluoro-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-N-(4-sulfamoyl-phenyl)-propionamide,84.0,uM,=,1.9242792860618816,1,O=C(CCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccccc1
4204,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccc1)Nc1nccs1,1-Phenethyl-3-thiazol-2-yl-thiourea,0.9,uM,=,-0.0457574905606751,0,S=C(NCCc1ccccc1)Nc1nccs1
4205,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,Cc1cccc(S(=O)(=O)Nc2ccc3c(=O)n(O)c(=O)[nH]c3c2)c1,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-3-methylbenzenesulfonamide",4.1,uM,=,0.6127838567197355,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2[nH]1
4206,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2cc(F)c(Cl)cc2n1Cc1cc(F)cc(F)c1,"6-Chloro,5-fluoro-(3,5-difluorobenzyl)-1,3-dihydro-2Hbenzimidazol-2-one",0.003,uM,=,-2.5228787452803374,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
4207,195688,10.1021/jm00042a004,,,,The 50% inhibitory concentration was measured as inhibition of Ribonuclease H activity of reverse transcriptase,CCCCCCCCCCCCCCCC(=O)Nc1c(O)cc(S(=O)(=O)O)c2ccccc12,4-Hexadecanoylamino-3-hydroxy-naphthalene-1-sulfonic acid,47.6,uM,=,1.677606952720493,1,c1ccc2ccccc2c1
4208,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[2-(4,7-Dichloro-benzooxazol-2-yl)-ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one",0.014,uM,=,-1.853871964321762,0,c1cncc(CCc2nc3ccccc3o2)c1
4209,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)NCCCN1CCOCC1,"2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)-N-(3-morpholinopropyl)acetamide",0.084,uM,=,-1.0757207139381184,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)NCCCN1CCOCC1
4210,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)CNCc1ccccc1F)CC2,"(2S)-2-(1-(2-fluorobenzylamino)-2-hydroxypropan-2-yl)-5,7-dihydroxy-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",1.2,uM,=,0.0791812460476248,1,O=c1cccc2c(c1)CC[C@H](CCNCc1ccccc1)C2
4211,471453,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,C[C@@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,tenofovir diphosphate,1.3,uM,=,0.1139433523068367,1,c1ncc2nc[nH]c2n1
4212,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,Cc1cc(/C=C2\SC(N)=NC2=O)c(C)n1-c1ccc(F)cc1,SID24797253,12.3,uM,=,1.089905111439398,1,O=C1N=CS/C1=C\c1ccn(-c2ccccc2)c1
4213,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,COc1ccc(CNC(=O)c2c(O)c(=O)[nH]c3ccc(F)cc23)cc1,N-(4-Methoxybenzyl)-6-fluoro-3-hydroxy-2-oxoquinoline-4-carboxamide,19.0,uM,=,1.2787536009528289,1,O=C(NCc1ccccc1)c1cc(=O)[nH]c2ccccc12
4214,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2cccc(F)c2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-5-fluoro-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.078,uM,=,-1.1079053973095196,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4215,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,CC1=CC(=O)/C(=C/Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)C(=O)O1,"6-methyl-3-((4-(3-nitrophenyl)thiazol-2-ylamino)methylene)-3H-pyran-2,4-dione",18.0,uM,=,1.255272505103306,1,O=C1C=COC(=O)/C1=C\Nc1nc(-c2ccccc2)cs1
4216,304786,10.1021/jm0494669,,,,Inhibitory concentration required to inhibit HIV-RT is determined,O=C(O)c1nc(-c2ccc(Cl)cc2)nc(O)c1O,"2-(4-Chloro-phenyl)-5,6-dihydroxy-pyrimidine-4-carboxylic acid",23.0,uM,=,1.3617278360175928,1,c1ccc(-c2ncccn2)cc1
4217,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,CCOC(=O)c1c(O)c2cccnc2n(O)c1=O,"ethyl 1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate",0.11,uM,=,-0.958607314841775,0,O=c1ccc2cccnc2[nH]1
4218,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Oc1nc(NCc2ccc3cc[nH]c3c2)nc(Nc2ccccc2-c2ccccc2)n1,"4-((1H-indol-6-yl)methylamino)-6-(biphenyl-2-ylamino)-1,3,5-triazin-2-ol",3.5,uM,=,0.5440680443502757,1,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4cc[nH]c4c3)n2)cc1
4219,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)N1CCN(C(=O)OC(C)(C)C)CC1,"Tert-butyl 4-(2-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)acetyl)piperazine-1-carboxylate",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)N1CCNCC1
4220,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),C=CCN1c2ncccc2C(=O)N(C)c2cccnc21,"5-Allyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.85,uM,=,-0.0705810742857072,0,O=C1Nc2cccnc2Nc2ncccc21
4221,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1COC2,"4-((4-((4-(4-Cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro-[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.109,uM,=,-0.9625735020593764,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
4222,2125951,10.1021/acs.jmedchem.1c00268,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into template,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)ncc1-c1ccncc1,"4-((4-(4-(4-cyano-2,6-dimethylphenoxy)-5-(pyridin-4-yl)pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzamide",0.113,uM,=,-0.9469215565165804,0,c1ccc(CN2CCC(Nc3ncc(-c4ccncc4)c(Oc4ccccc4)n3)CC2)cc1
4223,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-ylamino)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",0.85,uM,=,-0.0705810742857072,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4224,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)Cc1ccc(Cl)cc1,"6-Chloro-1-[(4-chlorobenzyl)sulfonyl]-1,3-dihydro-2H-benzimidazol-2-one",18.0,uM,=,1.255272505103306,1,O=c1[nH]c2ccccc2n1S(=O)(=O)Cc1ccccc1
4225,195843,10.1021/jm970096g,,,,The quantity of compound required to reduce WT Reverse transcriptase activity by 50%,Cc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1c(F)cccc1F,"1-(2,6-Difluoro-benzyl)-2-(2,6-difluoro-phenyl)-4-methyl-1H-benzoimidazole",200.0,uM,=,2.3010299956639813,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
4226,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,Cc1cc2nn(CC/N=C(\S)Nc3ccc(Br)cn3)nc2cc1C,"1-(5-Bromo-pyridin-2-yl)-3-[2-(5,6-dimethyl-benzotriazol-2-yl)-ethyl]-thiourea",0.15,uM,=,-0.8239087409443188,0,C(=NCCn1nc2ccccc2n1)Nc1ccccn1
4227,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=[N+]([O-])c1ccc(-c2csc(Nc3ccccc3O)n2)o1,2-(4-(5-nitrofuran-2-yl)thiazol-2-ylamino)phenol,66.0,uM,=,1.8195439355418688,1,c1ccc(Nc2nc(-c3ccco3)cs2)cc1
4228,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1ccccc1-c1cc(C)c(Oc2cc(N)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-((4-Amino-6-((2',3,5-trimethyl-[1,1'-biphenyl]-4-yl)oxy)-pyrimidin-2-yl)amino)benzonitrile",0.121,uM,=,-0.91721462968355,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
4229,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,Oc1cc(Cc2c(F)cccc2F)nc(SC2CCCCC2)n1,"2-Cyclohexylsulfanyl-6-(2,6-difluoro-benzyl)-3H-pyrimidin-4-one",0.09,uM,=,-1.0457574905606752,0,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
4230,1924015,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,Cc1cccc(C)c1-c1c2c(nc3c1c(C#N)cn3Cc1ccccc1)CC(C)(C)CC2=O,"1-benzyl-4-(2,6-dimethylphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",26.0,uM,=,1.414973347970818,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
4231,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(-c3cccc(C(F)(F)F)c3)c2)[nH]c(=O)n1O,"3-Hydroxy-6-((3'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)thio)pyrimidine-2,4(1H,3H)-dione",0.007,uM,=,-2.154901959985743,0,O=c1cc(Sc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4232,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,CCOCn1c(C(C#N)c2cc(C)cc(C)c2)cc(=O)n(O)c1=O,"2-(3,5-Dimethylphenyl)-2-(3-(ethoxymethyl)-1-hydroxy-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)acetonitrile",3.7,uM,=,0.568201724066995,1,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
4233,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-5-ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.01,uM,=,-2.0,0,O=C1Nc2cccnc2Nc2ncccc21
4234,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2ccco2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-furan-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",0.0092,uM,=,-2.036212172654445,0,O=C1Nc2ccccc2C(C#Cc2ccco2)(C2CC2)N1
4235,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2C(=O)Nc2c(C)ccnc21,"5-Ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",10.3,uM,=,1.0128372247051722,1,O=C1Nc2cccnc2Nc2ncccc21
4236,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,Cc1nc(N2Nc3onc(-c4ccccc4)c3C2c2ccc(Cl)cc2)sc1/N=N/c1ccc([N+](=O)[O-])cc1,"4-(4-Chlorophenyl)-5-(4-methyl-5-((4-nitrophenyl)diazenyl)thiazol-2-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",2.7e-05,uM,=,-4.568636235841013,0,c1ccc(/N=N/c2cnc(N3Nc4onc(-c5ccccc5)c4C3c3ccccc3)s2)cc1
4237,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,COc1cccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",5.1,uM,=,0.7075701760979364,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4238,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1CSCC2,"(E)-4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-ylamino)benzonitrile",0.081,uM,=,-1.0915149811213505,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CSCC3)cc1
4239,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",5.5,uM,=,0.7403626894942439,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4240,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1ccc(C)c(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1,"6-Chloro-1-(2,5-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.049,uM,=,-1.3098039199714864,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
4241,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1ccc(Sc2cccc(N)c2C#N)cc1,2-Amino-6-p-tolylsulfanyl-benzonitrile,5.7,uM,=,0.7558748556724915,1,c1ccc(Sc2ccccc2)cc1
4242,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,CCN1c2ncccc2C(=O)Nc2c(COc3ccccc3)cc(OC)nc21,"5-Ethyl-7-methoxy-9-phenoxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2c(COc3ccccc3)ccnc2Nc2ncccc21
4243,195663,10.1021/jm00132a002,,,,Inhibitory effect on HIV-1 reverse transcriptase activity using poly(rA)-oligo(dT) template primer,Cc1c(Sc2ccccc2)n(COCCOP(=O)(O)P(=O)(O)P(=O)(O)O)c(=O)[nH]c1=O,"5-methyl-6-(phenylthio)-1-({2-[(1,2,3,3-tetrahydroxy-1,2,3-trioxidotriphosphanyl)oxy]ethoxy}methyl)pyrimidine-2,4(1H,3H)-dione",280.0,uM,=,2.4471580313422194,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
4244,1443743,10.1016/j.bmc.2014.11.012,,,,Inhibition of HIV-1 recombinant reverse transcriptase after 1 hr by streptavidinalkaline phosphatase reporter system,CC(C)c1c(Oc2ccccc2)cc(CCc2ccccc2)[nH]c1=O,3-Isopropyl-6-phenethyl-4-phenoxypyridin-2(1H)-one,0.089,uM,=,-1.0506099933550872,0,O=c1cc(Oc2ccccc2)cc(CCc2ccccc2)[nH]1
4245,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=C1OC(c2ccc(Cl)cc2)=N/C1=C/c1c(O)ccc2ccccc12,2-(4-chlorophenyl)-4-((2-hydroxynaphthalen-1-yl)methylene)oxazol-5(4H)-one,37.0,uM,=,1.568201724066995,1,O=C1OC(c2ccccc2)=N/C1=C/c1cccc2ccccc12
4246,701790,10.1021/ml1002162,,,,Inhibition of HIV1 reverse transcriptase,CC(C)c1c(Cc2ccccc2)n(COCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-((4-fluorobenzyloxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.17,uM,=,-0.7695510786217261,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
4247,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1[C@H](C)Cn2c(O)nc3cc(Cl)cc(c32)[C@@H]1C,"(6S,8R)-4-Chloro-6,8-dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",0.23,uM,=,-0.6382721639824072,0,c1cc2c3c(c1)ncn3CCNC2
4248,1278689,10.1016/j.bmc.2013.09.051,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin dUTP incorporation by primer extension assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.7,uM,=,0.2304489213782739,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4249,471455,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 in presence of 5 mM ATP by heteropolymeric DNA polymerase assay,Nc1nc(=O)c2ncn([C@H]3C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C3)c2[nH]1,carbovir-triphosphate,1.8,uM,=,0.255272505103306,1,O=c1nc[nH]c2c1ncn2[C@H]1C=CCC1
4250,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),COc1ccc2c(n1)N(C1CC1)c1ncccc1C(=O)N2C,"5-Cyclopropyl-7-methoxy-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4251,490919,10.1016/j.bmcl.2008.06.080,,,,Inhibition of wild type HIV1 reverse transcriptase polymerase activity by scintillation counting assay,CN(C)c1cc(Cc2ccc(Cl)c(Oc3cccc(Br)c3)c2)n[nH]c1=O,6-(3-(3-bromophenoxy)-4-chlorobenzyl)-4-(dimethylamino)pyridazin-3(2H)-one,0.23,uM,=,-0.6382721639824072,0,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
4252,953196,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dTTP incorporation after 15 mins by PAGE,C#CCOCCOCCOCCOCCOCC#Cc1cc(C)c(Oc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-(4-(2,6-dimethyl-4-(4,7,10,13,16-pentaoxanonadeca-1,18-diynyl)phenoxy)pyrimidin-2-ylamino)benzonitrile",0.122,uM,=,-0.9136401693252518,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4253,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cncnc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2,6-Dimethyl-4-(pyrimidin-5-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.343,uM,=,-0.4647058799572294,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
4254,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2[C@](C#Cc2ccccn2)(C2CC2)N1,"(R)-6-Chloro-4-cyclopropyl-4-pyridin-2-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",9.3,uM,=,0.9684829485539352,1,O=C1Nc2ccccc2[C@](C#Cc2ccccn2)(C2CC2)N1
4255,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),COc1ccc2c(n1)N(C1CC1)c1ncccc1C(=O)N2C,"5-Cyclopropyl-7-methoxy-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.1,uM,=,0.041392685158225,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4256,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(Cl)cc3)ccc2C(=O)N1O,"6-(4-Chlorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",4.0,uM,=,0.6020599913279624,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
4257,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,Cc1[nH]c(=O)c(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1CCCc1ccncc1,"3-Chloro-5-(3-chloro-6-methyl-2-oxo-5-(3-(pyridin-4-yl)propyl)-1,2-dihydropyridin-4-yloxy)benzonitrile",0.004,uM,=,-2.397940008672037,0,O=c1cc(Oc2ccccc2)c(CCCc2ccncc2)c[nH]1
4258,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(/C=C/c1ccccc1)(OCc1ccccc1)C(F)(F)F,3-((E)-1-Benzyloxy-3-phenyl-1-trifluoromethyl-allyl)-1H-pyridin-2-one,0.04389,uM,=,-1.3576344191550267,0,C(=C/C(OCc1ccccc1)c1cccnc1)\c1ccccc1
4259,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1cc(C)c(C)c(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)c1C,"6-Chloro-1-(2,3,5,6-tetramethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.04,uM,=,-1.3979400086720375,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
4260,1504947,10.1016/j.bmc.2015.06.048,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin deoxyuridine triphosphate (biotin-dUTP) incorporation using poly(rA)/oligo (dT)16 template and primer by spectrofluorometry,Cc1cc(C#N)cc(C)c1Oc1ccnc(SCC(=O)Nc2ccccc2[N+](=O)[O-])n1,"2-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)thio)-N-(2-nitrophenyl)acetamide",1.169,uM,=,0.0678145111618401,1,O=C(CSc1nccc(Oc2ccccc2)n1)Nc1ccccc1
4261,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc2c(c([N+](=O)[O-])c1)N(C)C(=O)c1cccnc1O2,"7,10-Dimethyl-9-nitro-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.023,uM,=,-1.6382721639824072,0,O=C1Nc2ccccc2Oc2ncccc21
4262,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3ccccc3)CCCCN12,"10b-Phenyl-1,3,4,10b-tetrahydro-2H-pyrido[2,1-a]isoindol-6-one",75.5,uM,=,1.877946951629188,1,O=C1c2ccccc2C2(c3ccccc3)CCCCN12
4263,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,CC(C)CCOCn1c(COCc2ccccc2)cc(=O)[nH]c1=O,"6-[(Benzyloxy)methyl]-1-[(3-methylbutoxy)methyl]pyrimidine-2,4(1H,3H)-dione",30.0,uM,=,1.4771212547196624,1,O=c1cc(COCc2ccccc2)[nH]c(=O)[nH]1
4264,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2cccc(-c3ccc(O)cc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",0.75,uM,=,-0.1249387366082999,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4265,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)NN(Cc1ccc(-c2ccccn2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"((S)-1-{(1S,2S)-1-Benzyl-2-hydroxy-3-[N'-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-N-(4-pyridin-2-yl-benzyl)-hydrazino]-propylcarbamoyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.031,uM,=,-1.5086383061657274,0,c1ccc(CCCCNCc2ccc(-c3ccccn3)cc2)cc1
4266,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCC(N)=O)[nH]c3ccc(Cl)cc23)c1,"N-(3-Amino-3-oxopropyl)-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.027,uM,=,-1.5686362358410126,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
4267,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)ncc1SCC(=O)N1CCSCC1,"4-((2-((4-cyanophenyl)amino)-5-((2-oxo-2-thiomorpholinoethyl)thio)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.013,uM,=,-1.8860566476931635,0,O=C(CSc1cnc(Nc2ccccc2)nc1Oc1ccccc1)N1CCSCC1
4268,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(O)/C(O)=C/C(=O)c1cccn1Cc1ccc(F)cc1,4-(1-(4-fluorobenzyl)-1H-pyrrol-2-yl)-2-hydroxy-4-oxobut-2-enoic acid,54.0,uM,=,1.7323937598229686,1,c1ccc(Cn2cccc2)cc1
4269,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Cc1cccc2nc(-c3ccccc3Cl)c(NC3CCCC3)n12,"SM36::US8501787, 171",1.43,uM,=,0.1553360374650617,1,c1ccc(-c2nc3ccccn3c2NC2CCCC2)cc1
4270,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCCCC=C(c1cc(F)c(OC)c(C(=O)OC)c1)c1cc(F)c(OC)c(C(=O)OC)c1,"3',3''-Difluoro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-heptene",10.0,uM,=,1.0,1,C=C(c1ccccc1)c1ccccc1
4271,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2cccnc2C2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[3',2':1,2]pyrrolo[3,4-b]pyridin-5-one",3.45,uM,=,0.5378190950732742,1,O=C1c2cccnc2C2(c3ccccc3)SCCN12
4272,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",0.4,uM,=,-0.3979400086720376,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4273,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCN(S(=O)(=O)C(C)C)CC3)cc2)n1,"4-((2-((4-((4-(isopropylsulfonyl)piperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.073,uM,=,-1.136677139879544,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CCNCC4)cc3)n2)cc1
4274,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2cccnc2Cl)nc(SC(C)C)[nH]c1=O,"2-(2-chloropyridin-3-yl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",13.078,uM,=,1.1165413330267453,1,O=c1cc(Cc2cccnc2)nc[nH]1
4275,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2cc3ccccc3cc2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-naphtho[2,3-d][1,3]oxazin-2-one",1.909,uM,=,0.2808059283936668,1,O=C1Nc2cc3ccccc3cc2C(C#CC2CC2)O1
4276,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(C(F)(F)F)cc2)nc(SC(C)C)[nH]c1=O,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(4-(trifluoromethyl)phenyl)acetonitrile",13.265999999999998,uM,=,1.1227399929623576,1,O=c1cc(Cc2ccccc2)nc[nH]1
4277,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,Cc1cc(C)nc(N2C(=O)CSC2c2c(F)cccc2F)c1,"2-(2,6-Difluoro-phenyl)-3-(4,6-dimethyl-pyridin-2-yl)-thiazolidin-4-one",4.12,uM,=,0.6148972160331346,1,O=C1CSC(c2ccccc2)N1c1ccccn1
4278,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,O=C1Nc2ccc(Cl)c(O)c2C(C#Cc2ccccc2)(C(F)(F)F)N1,"6-Chloro-5-hydroxy-4-phenylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.174,uM,=,-0.7594507517174003,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)N1
4279,1566184,10.1016/j.ejmech.2016.02.068,,,,Inhibition of wild type HIV1 Reverse transcriptase assessed as reduction of biotin deoxyuridine triphosphate incorporation into the wild type HIV1 reverse transcriptase after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)nc(Nc2ccc(C#N)cc2)n1,"4,4'-((6-(4-Cyano-2,6-dimethylphenoxy)pyrimidine-2,4-diyl)bis(azanediyl))dibenzonitrile",0.0727,uM,=,-1.138465589140962,0,c1ccc(Nc2cc(Oc3ccccc3)nc(Nc3ccccc3)n2)cc1
4280,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,O=C(Nc1ccc2c(O)c(/N=N/c3ccc(C(=O)O)cc3)c(S(=O)(=O)O)cc2c1)Nc1ccc2c(O)c(/N=N/c3ccc(C(=O)O)cc3)c(S(=O)(=O)O)cc2c1,3-[(E)-2-(4-carboxyphenyl)diazen-1-yl]-7-[({6-[(E)-2-(4-carboxyphenyl)diazen-1-yl]-5-hydroxy-7-sulfonatonaphthalen-2-yl}carbamoyl)amino]-4-hydroxynaphthalene-2-sulfonate,0.39,uM,=,-0.4089353929735008,0,O=C(Nc1ccc2cc(/N=N/c3ccccc3)ccc2c1)Nc1ccc2cc(/N=N/c3ccccc3)ccc2c1
4281,484391,10.1021/np50102a014,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity,CC1=C(Cc2cc(OS(=O)(=O)[O-])ccc2OS(=O)(=O)[O-])[C@]2(C)CCC[C@@](C)(CC[C@@]3(O)[C@H](C)CC[C@@H]4OC(C)(C)CCC[C@@]43C)[C@H]2CC1.[Na+].[Na+],shaagrockol C,0.8,uM,=,-0.0969100130080563,0,C1=C(Cc2ccccc2)C2CCCC(CCC3CCC[C@@H]4OCCCCC34)[C@H]2CC1
4282,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCNCC3)cc2)nc2ccsc12,"(E)-3-(3,5-dimethyl-4-((2-((4-(piperazin-1-ylmethyl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.7070000000000001,uM,=,-0.1505805862031005,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3ccsc23)cc1
4283,471467,10.1128/aac.00119-07,,,,Inhibition of HIV1 LAI reverse transcriptase wild type LAI by heteropolymeric DNA polymerase assay,Nc1nc2c(ncn2[C@H]2CO[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1,beta-D-dioxolane-guanine-triphosphate,0.18,uM,=,-0.744727494896694,0,O=c1[nH]cnc2c1ncn2[C@H]1COCO1
4284,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1CSCC2,"(E)-3-(3,5-dimethyl-4-(2-(1-(4-nitrobenzyl)piperidin-4-ylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.2319999999999999,uM,=,-0.6345120151091004,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
4285,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1c(F)cccc1F,"6-[1-(2,6-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",19.0,uM,=,1.2787536009528289,1,c1ccc(Cn2cccc2)cc1
4286,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2cc(-c3ccc(F)cc3)sc2c(=O)n1O,"6-(4-Fluorophenyl)-3-hydroxythieno[3,2-d]pyrimidine-2,4(1H,3H)-dione",0.2,uM,=,-0.6989700043360187,0,O=c1[nH]c(=O)c2sc(-c3ccccc3)cc2[nH]1
4287,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCNCCNCCC[n+]1c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc31)c1cc(N)ccc21.[Cl-].[Cl-],Ethidium homodimer-1,0.0108,uM,=,-1.9665762445130504,0,c1ccc(-c2c3ccccc3c3ccccc3[n+]2CCCNCCNCCC[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
4288,1763341,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 reverse transcriptase polymerase p51/p66 after 10 to 20 mins in presence of [3H]-TTP by liquid scintillation counting method,COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(-c2ccccc2)cc1,N'-((2-methoxynaphthalen-1-yl)methylene)biphenyl-4-carbohydrazide,0.5,uM,=,-0.3010299956639812,0,O=C(N/N=C/c1cccc2ccccc12)c1ccc(-c2ccccc2)cc1
4289,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(Br)cc1C(=O)O)Nc1ccc(Br)cc1,5-Bromo-2-[5-(4-bromo-phenylcarbamoyl)-pentanoylamino]-benzoic acid,15.0,uM,=,1.1760912590556811,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
4290,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(SC)c1ccccc1,rac-Ethyl 5-chloro-3-((methylthio)(phenyl)methyl)-1H-indole-2-carboxylate,0.039,uM,=,-1.408935392973501,0,c1ccc(Cc2c[nH]c3ccccc23)cc1
4291,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),Cc1ccc2[nH]c(/C(C#N)=C/c3ccc(-c4ccc(O)c(C(=O)O)c4)o3)nc2c1,5-{5-[(E)-2-Cyano-2-(5-methyl-1H-benzoimidazol-2-yl)-vinyl]-furan-2-yl}-2-hydroxy-benzoic acid,8.0,uM,=,0.9030899869919436,1,C(=C/c1ccc(-c2ccccc2)o1)\c1nc2ccccc2[nH]1
4292,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(CNc2cc(CC)c(C)nc2O)c(OC)cc1C,5-Ethyl-3-(5-ethyl-2-methoxy-4-methyl-benzylamino)-6-methyl-1H-pyridin-2-one,0.033,uM,=,-1.4814860601221125,0,c1ccc(CNc2cccnc2)cc1
4293,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(C#N)cc(-c4cccc(C#N)c4)c3)c2=O)n[nH]c1=O,"5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3,3'-dicarbonitrile",0.21,uM,=,-0.6777807052660807,0,O=c1[nH]nc(Cn2cccc(Oc3cccc(-c4ccccc4)c3)c2=O)[nH]1
4294,2117264,10.1016/j.ejmech.2021.113498,,,,"Inhibition of wild type HIV-1 NL4-3 reverse transcriptase using random mRNA as template and GADPH as primer measured at 42 degreeC for 5 mins, 95 degreeC for 10sec and 60 degreeC for 60 sec by qRT-PCR analysis",COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)cc1,"(E)-3-(4-hydroxy-3, 5-dimethoxyphenyl)-N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)acrylamide",0.125,uM,=,-0.9030899869919436,0,O=C(/C=C/c1ccccc1)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
4295,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCCCO)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"3',3''-Dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-hexen-6-ol",3.6,uM,=,0.5563025007672873,1,C=C(c1ccccc1)c1ccccc1
4296,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cccc(S(=O)(=O)c2cccc(N)c2C#N)c1,2-Amino-6-(3-methoxy-benzenesulfonyl)-benzonitrile,0.6,uM,=,-0.2218487496163563,0,O=S(=O)(c1ccccc1)c1ccccc1
4297,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCNCC3)cc2)nc2sccc12,"(E)-3-(3,5-dimethyl-4((2-((4-(piperazin-1-ylmethyl)phenyl)amino)thieno[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.151,uM,=,-0.8210230527068306,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3sccc23)cc1
4298,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,Cc1ccc(C(=O)CSc2nc(O)c(C(C)C)c(Cc3cccc4ccccc34)n2)c(C)c1,"2-[2-(2,4-Dimethyl-phenyl)-2-oxo-ethylsulfanyl]-5-isopropyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one",0.24,uM,=,-0.619788758288394,0,O=C(CSc1nccc(Cc2cccc3ccccc23)n1)c1ccccc1
4299,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1cccc(OC)c1-c1cccc(Nc2cc(=O)n(O)c(=O)n2C)c1,"6-((2',6'-Dimethoxy-[1,1'-biphenyl]-3-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",4.5,uM,=,0.6532125137753437,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4300,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CCn1cc(-c2nc(=O)n(CCC3CCCO3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(1-Ethyl-1H-pyrazol-4-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.011,uM,=,-1.958607314841775,0,O=c1nc(-c2cn[nH]c2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
4301,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Nc2cccc(-c3cncnc3)c2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((3-(pyrimidin-5-yl)phenyl)amino)-pyrimidine-2,4(1H,3H)-dione",0.9,uM,=,-0.0457574905606751,0,O=c1cc(Nc2cccc(-c3cncnc3)c2)[nH]c(=O)[nH]1
4302,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2ccc(-c3ccc(OC)c(OC)c3)cc2)c2nccnc2n(O)c1=O,"Methyl 8-((3',4'-dimethoxy-[1,1'-biphenyl]-4-yl)amino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",5.9,uM,=,0.7708520116421442,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)c2nccnc2[nH]1
4303,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccccc2C(F)(F)F)[nH]c(=O)n1O,"3-Hydroxy-6-((2-(trifluoromethyl)phenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
4304,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1Nc2ccc(F)c(F)c2[C@@](C#CC2CC2)(C(F)(F)F)N1,"4-Cyclopropylethynyl-5,6-difluoro-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one (DPC 963)",0.074,uM,=,-1.1307682802690238,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
4305,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,CCC(=O)CCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-6-oxo-1-octenyl]-2-methoxybenzoate,1.0,uM,=,0.0,0,C=C(c1ccccc1)c1ccccc1
4306,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,Br.O=c1[nH]c2c(c(=O)n1O)C1CCNCC1S2,"3-Hydroxy-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione hydrobromide",0.3,uM,=,-0.5228787452803376,0,O=c1[nH]c2c(c(=O)[nH]1)C1CCNCC1S2
4307,502585,10.1021/np960149h,,,,Inhibition of HIV1 reverse transcriptase,C=C(C)[C@@H]1CC[C@@H]2[C@]3(CC[C@]4(C)[C@@H]([C@H](C)CC/C=C(/C)C(=O)O)CC[C@@]24C)C[C@]13CCC(=O)O,nigranoic acid,159.4,uM,=,2.202488317060093,1,C1CC2CC[C@@]34CC3CCC[C@H]4C2C1
4308,1548831,10.1016/j.ejmech.2015.11.025,,,,Inhibition of HIV1 reverse transcriptase,CN1C(=O)C(O)(C(F)(F)F)c2cc(Br)ccc21,5-Bromo-3-hydroxy-1-methyl-2-oxo-3-trifluoromethylindole,3.61,uM,=,0.557507201905658,1,O=C1Cc2ccccc2N1
4309,465754,10.1016/j.bmcl.2007.11.114,,,,Inhibition of HIV1 reverse transcriptase,COc1noc2c(C)cc(/C(=C\CCc3nnc(C)o3)c3cccc(C#N)c3)cc12,"3-(1-(3-methoxy-7-methylbenzo[d]isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)benzonitrile",93.0,uM,=,1.9684829485539352,1,C(\CCc1nnco1)=C(/c1ccccc1)c1ccc2oncc2c1
4310,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,COc1cccc(-c2cc(C)c(Oc3cc(N)nc(Nc4ccc(C#N)cc4)n3)c(C)c2)c1,"4-((4-Amino-6-((3'-methoxy-3,5-dimethyl-[1,1'-biphenyl]-4-yl)-oxy)pyrimidin-2-yl)amino)benzonitrile",0.073,uM,=,-1.136677139879544,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
4311,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnn(C)n2)c2cc(C)c(OC)c(C(=O)SC)c2)cc(C)c1OC,(Z)-methyl 2-methoxy-5-[1-(4-methoxy-3-methyl-5-methylsulfanylcarbonyl-phenyl)-4-(2-methyl-2H-tetrazol-5-yl)-but-1-enyl]-3-methylbenzoate,95.0,uM,=,1.977723605288848,1,C(CCc1nn[nH]n1)=C(c1ccccc1)c1ccccc1
4312,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CC1(c2ccccc2)Sc2ccccc2-n2cccc2C1=O,5-Methyl-5-phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,0.35,uM,=,-0.4559319556497244,0,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
4313,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,COC(=O)c1ccc(NC(=O)CSc2nc3ccccc3n2S(=O)(=O)c2cc(C)cc(C)c2)c(Cl)c1,"Methyl-3-chloro-4-{[({1-[(3,5-dimethylphenyl)sulfonyl]-1H-benzimidazol-2-yl}sulfanyl)acetyl]amino}benzoate",162.17,uM,=,2.2099705167093435,1,O=C(CSc1nc2ccccc2n1S(=O)(=O)c1ccccc1)Nc1ccccc1
4314,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2c(CC(C)C)c(C)[nH]c(=O)c2N(C)C)c1,"3-Dimethylamino-4-(3,5-dimethyl-benzyl)-5-isobutyl-6-methyl-1H-pyridin-2-one",0.05,uM,=,-1.3010299956639813,0,O=c1cc(Cc2ccccc2)cc[nH]1
4315,750572,10.1016/j.bmc.2009.05.049,,,,Antiviral activity against HIV1 Reverse transcriptase activity,C=C(CC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](OC(=O)/C=C/c5ccc(O)c(OC)c5)CC[C@@]45C[C@@]35CC[C@]12C)C(C)C,24-methylenecycloartanol ferulate,3.082168201457413,uM,=,0.4888563355412376,1,O=C(/C=C/c1ccccc1)O[C@H]1CC[C@]23C[C@]24CCC2CCCC2[C@@H]4CC[C@H]3C1
4316,195083,10.1021/jm011011l,,,,Inhibition of DNA synthesis by HIV reverse transcriptase,Nc1nc2c(ncn2C2C=CC(OCP(=O)(O)OP(=O)(O)C(F)(F)P(=O)(O)O)C2)c(=O)[nH]1,9-[4-(Difluoromethyldiphosphonyl)oxyphosphonylmethoxy)-cyclopent-2-enyl]guanine,25.0,uM,=,1.3979400086720375,1,O=c1[nH]cnc2c1ncn2C1C=CCC1
4317,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2ccc(C(F)(F)F)cc2)[nH]c(=O)n1O,"3-Hydroxy-6-((4-(trifluoromethyl)phenyl)thio)pyrimidine-2,4(1H,3H)-dione",0.031,uM,=,-1.5086383061657274,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
4318,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(Cl)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-[(1R,2R)-2-(6-Chloro-3-ethoxy-2-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea",0.05,uM,=,-1.3010299956639813,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
4319,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCN(c1ncccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(=O)(=O)N4CCN(C)CC4)ccc3[nH]2)CC1,4-Methyl-piperazine-1-sulfonic acid (2-{4-[(3-tert-butylamino-pyridin-2-yl)-ethyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.79,uM,=,-0.1023729087095585,0,O=C(c1cc2cc(NS(=O)(=O)N3CCNCC3)ccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4320,532312,10.1021/jm701218j,,,,Inhibition of HIV1 reverse transcriptase in human LAI cells,CCc1c(C)[nH]c(=O)c(NC(=S)Nc2ccccc2)c1Cc1cccc(C)c1,"1-[5-Ethyl-6-methyl-4-(3-methyl-benzyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-3-phenyl-thiourea",3.162,uM,=,0.4999618655961902,1,O=c1[nH]ccc(Cc2ccccc2)c1NC(=S)Nc1ccccc1
4321,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccc(-c3ccc(Cl)cc3)cc2)cc(=O)n(O)c1=O,"6-((4'-Chloro-[1,1'-biphenyl]-4-yl)oxy)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",11.0,uM,=,1.0413926851582251,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4322,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),CNc1ccc2c(C)nc(CCCCCCC(=O)c3ccccc3)n2n1,"7-(5-Methyl-2-methylamino-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one",3.4,uM,=,0.5314789170422551,1,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
4323,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1Cl,"1-[(1R,2R)-2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea",0.08,uM,=,-1.0969100130080565,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
4324,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(OC)c1cc(C)cc(C)c1,"ethyl 5-chloro-3-((3,5-dimethylphenyl)(methoxy)methyl)-1H-indole-2-carboxylate",0.034,uM,=,-1.4685210829577449,0,c1ccc(Cc2c[nH]c3ccccc23)cc1
4325,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c(OC)c1,"6-((2',4'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",5.3,uM,=,0.724275869600789,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4326,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(=O)(=O)C(C)C)ccc3[nH]2)CC1,Propane-2-sulfonic acid (2-{4-[ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-amide,0.45,uM,=,-0.3467874862246563,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4327,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,CC(C)CSc1nc(O)cc(Cc2ccccc2)n1,6-Benzyl-2-isobutylsulfanyl-3H-pyrimidin-4-one,9.4,uM,=,0.9731278535996988,1,c1ccc(Cc2ccncn2)cc1
4328,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)cc(C)n1,"4-((4-((4-(2,6-Dimethylpyridin-4-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0667,uM,=,-1.175874166083451,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
4329,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),Cc1nc(O)c(CCc2nc3ccccc3o2)cc1C#N,"5-(2-Benzooxazol-2-yl-ethyl)-2-methyl-6-oxo-1,6-dihydro-pyridine-3-carbonitrile",0.31,uM,=,-0.5086383061657274,0,c1cncc(CCc2nc3ccccc3o2)c1
4330,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(c3cccc(S(C)(=O)=O)c3)CC2)n1,"3,5-dimethyl-4-(2-(1-(3-(methylsulfonyl)phenyl)piperidin-4-ylamino)pyrimidin-4-yloxy)benzonitrile",0.011,uM,=,-1.958607314841775,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4331,80619,10.1016/s0960-894x(01)00577-7,,,,Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP,O=C(OCCC1COc2cc(O)c(O)cc2C1)c1ccc(O)c(O)c1O,"2,3,4-Trihydroxy-benzoic acid 2-(6,7-dihydroxy-chroman-3-yl)-ethyl ester",10.74,uM,=,1.0310042813635367,1,O=C(OCCC1COc2ccccc2C1)c1ccccc1
4332,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(CCOc3cccnc3)c[nH]c(=O)c2Br)c1,"3-(3-bromo-2-oxo-5-(2-(pyridin-3-yloxy)ethyl)-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.011,uM,=,-1.958607314841775,0,O=c1cc(Oc2ccccc2)c(CCOc2cccnc2)c[nH]1
4333,699570,10.1016/j.bmcl.2010.10.054,,,,Inhibition of HIV1 reverse transcriptase activity after 1 hr by ELISA,O=c1ccn([C@@H]2O[C@H](CNCc3ccc(Cl)cc3)[C@@H](O)[C@H]2O)c(=O)[nH]1,5'-(4-chlorobenzylamino)methyl-uridine,2.82,uM,=,0.450249108319361,1,O=c1ccn([C@H]2CC[C@@H](CNCc3ccccc3)O2)c(=O)[nH]1
4334,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC1OC(C#CC2CC2)(C(F)(F)F)c2c(ccc(F)c2F)NC1=O,"5-Cyclopropylethynyl-6,7-difluoro-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.193,uM,=,-0.7144426909922262,0,O=C1COC(C#CC2CC2)c2ccccc2N1
4335,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(NCc2nc3ccccc3[nH]2)c(O)nc1C,3-[(1H-Benzoimidazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,6.4,uM,=,0.8061799739838872,1,c1cncc(NCc2nc3ccccc3[nH]2)c1
4336,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc2c(c1)OCO2,"N-Benzo[1,3]dioxol-5-yl-3-{5-[1-benzo[1,3]dioxol-5-yl-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionamide",97.0,uM,=,1.9867717342662448,1,O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc2c(c1)OCO2
4337,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(NCc2nc3c(C)cccc3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(4-methyl-benzooxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,0.125,uM,=,-0.9030899869919436,0,c1cncc(NCc2nc3ccccc3o2)c1
4338,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,O=C(O)c1c(O)c(=O)[nH]c2ccc([N+](=O)[O-])cc12,3-Hydroxy-6-nitro-2-oxoquinoline-4-carboxylic acid,97.0,uM,=,1.9867717342662448,1,O=c1ccc2ccccc2[nH]1
4339,195058,10.1021/jm9804174,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)=CCN1Cc2c(F)ccc3nc(S)n(c23)C[C@@H]1C,"5-Fluoro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",5.8,uM,=,0.7634279935629373,1,c1cc2c3c(c1)ncn3CCNC2
4340,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,O=C(O)c1c(O)c(O)nc2ccccc12,"3-Hydroxy-2-oxo-1,2-dihydro-quinoline-4-carboxylic acid",59.0,uM,=,1.7708520116421442,1,c1ccc2ncccc2c1
4341,543748,10.1128/aac.00145-07,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 expressed in Escherichia coli using calf thymus DNA substrate,Nc1ncnc2c1ncn2CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O,adefovir diphosphate,8.3,uM,=,0.919078092376074,1,c1ncc2nc[nH]c2n1
4342,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCC(=O)Nc2ccccc2O)c(O)nc1C,"3-(5-Ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-N-(2-hydroxy-phenyl)-propionamide",5.4,uM,=,0.7323937598229685,1,O=C(CCc1cccnc1)Nc1ccccc1
4343,196364,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-2 reverse transcriptase,Cc1ccc(NC(=O)CCCCC(=O)Nc2ccc(C)cc2C(=O)O)c(C(=O)O)c1,2-[4-(2-carboxy-4-methylphenylcarbamoyl)butylcarboxamido]-5-methylbenzoic acid,9.2,uM,=,0.9637878273455552,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
4344,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(-c3ccc(F)c(Cl)c3)c2)[nH]c(=O)n1O,"6-((3'-chloro-4'-fluoro-[1,1'-biphenyl]-3-yl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Sc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4345,140627,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),Cc1ccc(CC/N=C(\S)Nc2nccs2)cc1,1-Thiazol-2-yl-3-(2-p-tolyl-ethyl)-thiourea,3.9,uM,=,0.5910646070264992,1,C(=NCCc1ccccc1)Nc1nccs1
4346,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,NCc1ccc(-c2ccc(Cc3cc(=O)n(O)c4ncccc34)cc2)cc1,"4-((4'-(aminomethyl)biphenyl-4-yl)methyl)-1-hydroxy-1,8-naphthyridin-2(1H)-one",0.045,uM,=,-1.3467874862246565,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)c2cccnc2[nH]1
4347,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(1-oxy-pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2cccnc2Nc2ncc(COc3cc[nH+]cc3)cc21
4348,1565176,10.1016/j.bmcl.2016.02.049,,,,Inhibition of HIV1 reverse transcriptase using DIG-labeled dNTPs as substrate after 1 hr by ELISA,O=C1CN2C(=O)c3ccccc3S[C@H]2[C@H]2[C@H](O)[C@H](O)CN12,"(1S,2R,13aS,13bR)-1,2-dihydroxy-1,2,3,13b-tetrahydrobenzo[e]pyrrolo[2',1':3,4]pyrazino[2,1-b][1,3]thiazine-5,8(6H,13aH)-dione",8.21,uM,=,0.9143431571194408,1,O=C1CN2C(=O)c3ccccc3S[C@H]2[C@H]2CCCN12
4349,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccncc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(pyridin-4-yloxymethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2cccnc2Nc2ncc(COc3ccncc3)cc21
4350,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cn1c(Nc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-1-methyl-6-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-amino)pyrimidine-2,4(1H,3H)-dione",3.6,uM,=,0.5563025007672873,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4351,495114,10.1021/jm801322h,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase,COCc1n[nH]c2cccc(Oc3cc(C#N)cc(C#N)c3)c12,5-(3-(methoxymethyl)-1H-indazol-4-yloxy)isophthalonitrile,1.67,uM,=,0.2227164711475832,1,c1ccc(Oc2cccc3[nH]ncc23)cc1
4352,196377,10.1021/jm0309856,,,,Inhibitory concentration required to inhibit the HIV-1 reverse transcriptase activity,O=c1cc(Cc2c(F)cccc2F)nc(NC2CCCC2)[nH]1,"2-Cyclopentylamino-6-(2,6-difluoro-benzyl)-3H-pyrimidin-4-one",0.07,uM,=,-1.154901959985743,0,O=c1cc(Cc2ccccc2)nc(NC2CCCC2)[nH]1
4353,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.6,uM,=,-0.2218487496163563,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4354,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)Cc1cc2ccc(O)cc2oc1=O)S(=O)(=O)c1ccc(N)cc1,"N-((25,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-2-(7-hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetamide",0.4508,uM,=,-0.346016092625931,0,O=C(Cc1cc2ccccc2oc1=O)N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1
4355,196375,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1/138Lys reverse transcriptase (RT) using [3H]dGTP as a radioligand,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCOP(=O)(O)C(=O)O)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-[[[(hydroxycarbonyl)hydroxyphosphonyl]oxy]-propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",437.0,uM,=,2.640481436970422,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4356,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4ccc(-c5cn(C)cn5)cc4c32)CCO1,"Cis-1-(2-Ethyl-tetrahydro-pyran-4-yl)-8-(1-methyl-1H-imidazol-4-yl)-4-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[4,5]furo[3,2-d]pyrimidin-2-one",0.0081999999999999,uM,=,-2.086186147616284,0,O=c1nc(-c2cn[nH]c2)c2oc3ccc(-c4c[nH]cn4)cc3c2n1C1CCOCC1
4357,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1C(=O)c2cccnc2N(CC)c2cccc(C)c21,"6,11-Diethyl-7-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",8.0,uM,=,0.9030899869919436,1,O=C1Nc2ccccc2Nc2ncccc21
4358,743750,10.1021/jm101536x,,,,Inhibition of wild type HIV-1 reverse transcriptase-mediated polymerization reaction after 30 mins,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",1.2,uM,=,0.0791812460476248,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4359,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4nnccc34)c2F)c1,"3-[6-Bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",0.003,uM,=,-2.5228787452803374,0,c1ccc(Oc2cccc(Cc3n[nH]c4nnccc34)c2)cc1
4360,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(-c2ccc(F)cc2)ccc1Oc1c(C(F)(F)F)ccn(Cc2n[nH]c(=O)n2C)c1=O,"3-((4'-fluoro-3-methyl-[1,1'-biphenyl]-4-yl)oxy)-1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-4-(trifluoromethyl)pyridin-2(1H)-one",5.4,uM,=,0.7323937598229685,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
4361,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,"N-(4-Fluorobenzyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",0.36,uM,=,-0.4436974992327127,0,O=C1NC(=O)C(C(=O)NCc2ccccc2)c2ccccc21
4362,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(Cn2c(=O)ccn(CC(=O)Nc3cccc(Cl)c3)c2=O)c1,"N-(3-Chlorophenyl)-2-(3-(3,5-dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",114.15,uM,=,2.057475915826254,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
4363,2081890,10.1016/j.ejmech.2021.113204,,,,Inhibition of HIV-1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation into wild type RT measured after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCNCC3)cc2)nc2ccsc12,"(E)-3-(3,5-dimethyl-4-(2-(4-(piperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.945,uM,=,-0.024568191490737,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3ccsc23)cc1
4364,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cnc(NC2CCN(c3cccc(C(N)=O)c3)CC2)nc1Oc1c(C)cc(C#N)cc1C,"3-(4-(4-(4-cyano-2,6-dimethylphenoxy)-5-methylpyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.012,uM,=,-1.9208187539523751,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4365,1704111,10.1016/j.bmc.2017.05.040,,,,Inhibition of recombinant wild-type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 assessed as reduction in dTTP incorporation using poly(rA)/oligo(dT)16 as template/primer after 40 mins by PicoGreen dye based spectrofluorometric analysis,Cc1ccccc1CCS(=O)(=O)n1c(=O)[nH]c2ccc(Cl)cc21,"6-Chloro-1-{[2-(2-methylphenyl)ethyl]sulfonyl}-1,3-dihydro-2H-benzimidazol-2-one",29.0,uM,=,1.462397997898956,1,O=c1[nH]c2ccccc2n1S(=O)(=O)CCc1ccccc1
4366,947897,10.1021/np3006887,,,,Inhibition of HIV-1 reverse transcriptase assessed as decrease in incorporation of [3H]TTP into polyA template,COc1cc2c(ccc3c4cc(OC)c(OC)cc4c[n+](C)c23)cc1O.[Cl-],"2-Hydroxy-3,8,9-trimethoxy-5-methyl-benzo[c]phenanthridinium chloride",26.5,uM,=,1.423245873936808,1,c1ccc2c(c1)c[nH+]c1c3ccccc3ccc21
4367,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,CC1(C)CCC[C@]2(C)OC3CC[C@](C)(C4CC[C@]5(C)C4CC[C@]4(C)c6c(O)ccc(O)c6CC54)[C@]3(C)CCC12,toxicol B,3.7,uM,=,0.568201724066995,1,c1ccc2c(c1)CC1C2CCC2C1CCC2C1CCC2OC3CCCCC3CCC21
4368,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,Cn1c(Oc2cccc(-c3ccccc3)c2)cc(=O)n(O)c1=O,"6-([1,1'-Biphenyl]-3-yloxy)-3-hydroxy-1-methylpyrimidine-2,4-(1H,3H)-dione",3.9,uM,=,0.5910646070264992,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4369,1982636,10.1021/acsmedchemlett.9b00623,,,,Inhibition of HIV-1 reverse transcriptase His-tagged p51 heterodimerization with HIV-1 reverse transcriptase p66 incubated for 16 hrs by ELISA,CC[C@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,"(4R,7S,10S,13S,16S,19R)-19-amino-10,13-bis(2-amino-2-oxo-ethyl)-7-(2-carboxyethyl)-16-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxylic acid",37.0,uM,=,1.568201724066995,1,O=C1CCSSCCNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
4370,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(Cc2ccccc2)c(=O)n(O)c1=O,"1,6-Bibenzyl-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",15.0,uM,=,1.1760912590556811,1,O=c1cc(Cc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
4371,196377,10.1021/jm0309856,,,,Inhibitory concentration required to inhibit the HIV-1 reverse transcriptase activity,Cc1c(C(C)c2c(F)cccc2F)nc(NC2CCCC2)[nH]c1=O,"2-Cyclopentylamino-6-[1-(2,6-difluoro-phenyl)-ethyl]-5-methyl-3H-pyrimidin-4-one",0.035,uM,=,-1.4559319556497243,0,O=c1cc(Cc2ccccc2)nc(NC2CCCC2)[nH]1
4372,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.5,uM,=,-0.3010299956639812,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4373,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,COc1ccc2ccccc2c1/C=N\NC(=O)c1ccc(C(C)(C)C)cc1,(Z)-4-(tert-butyl)-N'-((2-methoxynaphthalen-1-yl)methylene)benzohydrazide,8.3,uM,=,0.919078092376074,1,O=C(N/N=C\c1cccc2ccccc12)c1ccccc1
4374,2100870,10.1021/acs.jmedchem.1c00128,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,CC(=O)N(c1ccnc(Nc2ccc(C#N)cc2)n1)c1c(F)cc(-c2ccc(C#N)cc2)cc1F,"N-(4'-cyano-3,5-difluorobiphenyl-4-yl)-N-(2-(4-cyanophenylamino)pyrimidin-4-yl)acetamide",0.04,uM,=,-1.3979400086720375,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4375,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)cc(Cc2ccc3ccccc3c2)n1,2-sec-Butylsulfanyl-6-naphthalen-2-ylmethyl-3H-pyrimidin-4-one,7.4,uM,=,0.8692317197309762,1,c1ccc2cc(Cc3ccncn3)ccc2c1
4376,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(Cl)cn2)c1O,1-(5-Chloro-pyridin-2-yl)-3-[2-(6-fluoro-2-hydroxy-3-propionyl-phenyl)-cyclopropyl]-urea,0.0027,uM,=,-2.5686362358410126,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
4377,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(OC)nc21,"5-Ethyl-7-methoxy-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2cccnc2Nc2ncccc21
4378,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,Nc1ccc(OCc2ccnc3c2NC(=O)c2cccnc2N3C2CC2)cc1,"9-(4-Amino-phenoxymethyl)-5-cyclopropyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
4379,471469,10.1128/aac.00119-07,,,,Inhibition of HIV1 pNL4-3 reverse transcriptase wild type pNL4-3 by heteropolymeric DNA polymerase assay,Cc1cn([C@H]2CO[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,1-(beta-D-dioxolane)thymine triphosphate,0.1,uM,=,-1.0,0,O=c1ccn([C@H]2COCO2)c(=O)[nH]1
4380,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,O=c1ccc(Cc2cc(Oc3cccc(Cl)c3)c3occc3c2)n[nH]1,6-((7-(3-chlorophenoxy)benzofuran-5-yl)methyl)pyridazin-3(2H)-one,1.0,uM,=,0.0,0,O=c1ccc(Cc2cc(Oc3ccccc3)c3occc3c2)n[nH]1
4381,195510,10.1021/jm950568w,,,,Inhibitory activity against HIV rRT activity in wild type IIIB strain,COC(=O)c1cccn1S(=O)(=O)c1cc(Cl)ccc1N,1-(2-Amino-5-chloro-benzenesulfonyl)-1H-pyrrole-2-carboxylic acid methyl ester,0.45,uM,=,-0.3467874862246563,0,O=S(=O)(c1ccccc1)n1cccc1
4382,542167,10.1016/j.ejmech.2008.02.047,,,,Inhibition of polymerase activity of HIV1 recombinant reverse transcriptase expressed in Escherichia coli,Cc1c(C(=O)O[C@@H]2[C@H]3OC(C)(C)O[C@H]3O[C@@H]2[C@H]2COC(C)(C)O2)nnn1Cc1ccccc1,"1-Benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-(1,2:5,6-di-O-isopropylidene)-alpha-D-glucofuranose",5.0,uM,=,0.6989700043360189,1,O=C(O[C@@H]1[C@H]2OCO[C@H]2O[C@@H]1[C@H]1COCO1)c1cn(Cc2ccccc2)nn1
4383,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CN(C)c1ccc(F)c(CCNC(=O)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[2-(3-dimethylamino-2,6-difluoro-phenyl)-ethyl]-urea",0.025,uM,=,-1.6020599913279625,0,O=C(NCCc1ccccc1)Nc1ccccn1
4384,197421,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rN.dN template primer,CCN1c2ncccc2-c2ncc(C)n2-c2cccnc21,"8-Ethyl-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.425,uM,=,-0.3716110699496884,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
4385,442660,10.1016/j.ejmech.2007.01.003,,,,Inhibition of HIV1 reverse transcriptase using Poly rA.dT template,Cc1cccc(N2C(=O)CSC2C23CC4CC(CC(C4)C2)C3)n1,2-adamantan-1-yl-3-(6-methyl-pyridin-2-yl)-thiazolidin-4-one,43.0,uM,=,1.6334684555795866,1,O=C1CSC(C23CC4CC(CC(C4)C2)C3)N1c1ccccn1
4386,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCc2nnc(C)o2)c2ccc3oncc3c2)cc1C(=O)SC,"(Z)-S-methyl 5-(1-(benzo[d]isoxazol-5-yl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)but-1-enyl)-2-methoxy-3-methylbenzothioate",7.7,uM,=,0.8864907251724818,1,C(\CCc1nnco1)=C(\c1ccccc1)c1ccc2oncc2c1
4387,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccco3)CC2)nc2ccsc12,"4-((2-((1-(furan-2-ylmethyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile",0.082,uM,=,-1.0861861476162833,0,c1ccc(Oc2nc(NC3CCN(Cc4ccco4)CC3)nc3ccsc23)cc1
4388,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3ccccc3F)n2)cc1,4-(4-(2-fluorobenzylamino)pyrimidin-2-ylamino)benzonitrile,0.016,uM,=,-1.7958800173440752,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
4389,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cc1cc(Oc2c(C(F)(F)F)ccn(Cc3n[nH]c(=O)n3C)c2=O)ccc1-c1cc(F)cc(C#N)c1,"5-Fluoro-2'-methyl-4'-((1-((4-methy1-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-y1)oxy)-[1,1'-biphenyl]-3-carbonitrile",3.67,uM,=,0.5646660642520893,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
4390,1290640,10.1016/j.bmc.2013.12.045,,,,Inhibition of GST-tagged recombinant wild type HIV-1 reverse transcriptase p66/p51 RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using dTTP as substrate after 40 mins by spectrofluorometric analysis,Cc1cc(C)cc(Cn2c(SCC(=O)Nc3ccccc3Br)nc3ccccc32)c1,"2-{[1-(3,5-Dimethylbenzyl)-1H-benzimidazol-2-yl]sulfanyl}-N-2-bromophenylacetamide",15.02,uM,=,1.1766699326681496,1,O=C(CSc1nc2ccccc2n1Cc1ccccc1)Nc1ccccc1
4391,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2cccc3ccccc23)n1,2-sec-Butylsulfanyl-5-methyl-6-naphthalen-1-ylmethyl-3H-pyrimidin-4-one,22.5,uM,=,1.3521825181113625,1,c1ccc2c(Cc3ccncn3)cccc2c1
4392,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2ncc(C)n2-c2ccc(N(C)C)nc21,"(8-Ethyl-3-methyl-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulen-6-yl)-dimethyl-amine",2.4,uM,=,0.380211241711606,1,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
4393,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-5-ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.8,uM,=,-0.0969100130080563,0,O=C1Nc2cccnc2Nc2ncccc21
4394,306341,10.1021/jm049279a,,,,Concentration required to inhibit in vitro RNA-dependent DNA polymerase activity of reverse transcriptase,O=c1[nH]c2ccc(Cl)cc2n1Cc1c(F)cccc1F,"6-Chloro-1-(2,6-difluoro-benzyl)-1,3-dihydro-benzoimidazol-2-one",2.86,uM,=,0.456366033129043,1,O=c1[nH]c2ccccc2n1Cc1ccccc1
4395,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),COc1ccc(/C=C2/SC(=S)N(CCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC,"4-(3-{5-[1-(3,4-Dimethoxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-2-hydroxy-benzoic acid",17.0,uM,=,1.230448921378274,1,O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccccc1
4396,484392,10.1021/np50102a014,,,,Inhibition of RNA dependent DNA polymerase activity of HIV1 BH10 recombinant reverse transcriptase p66/p51 assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP,CC1(C)CCC[C@]2(C)OC3CC[C@](C)(C4CC[C@]5(C)C4CC[C@]4(C)c6c(OS(=O)(=O)[O-])ccc(OS(=O)(=O)[O-])c6CC54)[C@]3(C)CCC12.[Na+].[Na+],toxicol A,3.1,uM,=,0.4913616938342727,1,c1ccc2c(c1)CC1C2CCC2C1CCC2C1CCC2OC3CCCCC3CCC21
4397,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,CCOC(=O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCCCCc3ccccc3)cc2)n[nH]1,Ethyl 3-(4-(4-(3-phenylbutoxy)phenyl)-1-(4-fluorobenzyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylate,17.8,uM,=,1.250420002308894,1,c1ccc(CCCCOc2ccc(-c3cn(Cc4ccccc4)cc3-c3cc[nH]n3)cc2)cc1
4398,675614,10.1016/j.bmcl.2010.08.135,,,,Inhibition of wild type HIV1 reverse transcriptase RNasH activity,O=c1ccc2cccnc2n1O,"1-hydroxy-1,8-naphthyridin-2(1H)-one",1.4,uM,=,0.1461280356782379,1,O=c1ccc2cccnc2[nH]1
4399,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2ccccn2)c(O)nc1C,5-Ethyl-6-methyl-3-(2-pyridin-2-yl-ethyl)-1H-pyridin-2-one,260.0,uM,=,2.414973347970818,1,c1ccc(CCc2cccnc2)nc1
4400,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",2.0,uM,=,0.3010299956639812,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4401,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,NS(=O)(=O)c1ccc(NC(=O)COC(=O)N2CCCc3cc(Cl)cc(Cl)c32)c(Cl)c1,"2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl 6,8-dichloro-3,4-dihydroquinoline-1(2H)-carboxylate",0.019,uM,=,-1.7212463990471711,0,O=C(COC(=O)N1CCCc2ccccc21)Nc1ccccc1
4402,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,CNc1ccccc1C(=O)N/N=C/c1c(O)ccc2ccccc12,N'-((2-hydroxynaphthalen-1-yl)methylene)-2-(methylamino)benzohydrazide,100.0,uM,=,2.0,1,O=C(N/N=C/c1cccc2ccccc12)c1ccccc1
4403,2028543,10.1016/j.ejmech.2019.111900,,,,Inhibition of HIV-1BH10 reverse transcriptase expressed in Escherichia coli assessed as polymerization by real time FRET assay,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc2oc(=O)ccc2c1)S(=O)(=O)c1ccc(N)cc1,"N4(25,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-2-oxo-2H-chromene-6-carboxamide",0.398,uM,=,-0.4001169279263121,0,O=C(N[C@H](CCNS(=O)(=O)c1ccccc1)Cc1ccccc1)c1ccc2oc(=O)ccc2c1
4404,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CC(C)Nc1ccnnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(4-Isopropylamino-pyridazin-3-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.74,uM,=,-0.1307682802690238,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2cccnn2)CC1
4405,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(=O)(=O)C(F)(F)F)ccc3[nH]2)CC1,"C,C,C-Trifluoro-N-{2-[4-(3-isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide",8.3,uM,=,0.919078092376074,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4406,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O,"6-((4'-chloro-[1,1'-biphenyl]-3-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Cc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4407,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,Cc1cccc2c1oc(=O)c1c(O)cc(=O)oc12,"4-hydroxy-7-methylpyrano[3,2-c]chromene-2,5-dione",29.8,uM,=,1.4742162640762553,1,O=c1ccc2c(=O)oc3ccccc3c2o1
4408,195056,10.1021/jm990580e,,,,Inhibition of HIV-1 reverse transcriptase.,CC(C)C#C[C@]1(C(F)(F)F)NC(=O)Nc2ccc(F)cc21,"6-Fluoro-4-(3-methyl-but-1-ynyl)-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.039,uM,=,-1.408935392973501,0,O=C1NCc2ccccc2N1
4409,306221,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (Strand Transfer),O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc2c(c1)OCO2,"N-Benzo[1,3]dioxol-5-yl-3-{5-[1-benzo[1,3]dioxol-5-yl-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionamide",93.0,uM,=,1.9684829485539352,1,O=C(CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc2c(c1)OCO2
4410,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3nccs3)nc21,"5-Ethyl-10-methyl-7-thiazol-2-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.24,uM,=,-0.619788758288394,0,O=C1Nc2ccc(-c3nccs3)nc2Nc2ncccc21
4411,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1Cc2cccc3nc(O)n(c23)C(C)C1C,"8,9-Dimethyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",56.7,uM,=,1.7535830588929069,1,c1cc2c3c(c1)ncn3CCNC2
4412,195839,10.1021/jm00023a007,,,,Inhibition of HIV-1 reverse transcriptase (RT),CCc1c(C)nc(O)c(N)c1Sc1cc(C)cc(C)c1,"3-Amino-4-(3,5-dimethyl-phenylsulfanyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.015,uM,=,-1.8239087409443189,0,c1ccc(Sc2ccncc2)cc1
4413,196373,10.1016/j.bmcl.2003.11.049,,,,Inhibitory activity against wild type reverse transcriptase (WT RT) of HIV-1,CCN1c2ncc(CSc3cc(C)nc(C)c3)cc2C(=O)Nc2c(C)cc(Cl)nc21,"7-Chloro-2-(2,6-dimethyl-pyridin-4-ylsulfanylmethyl)-5-ethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.007,uM,=,-2.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
4414,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,COC(=O)c1cc(C(=CCCN2CCOC2=O)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,"Methyl 5-{1-[3-Chloro-4-methoxy-5-(methoxycarbonyl)phenyl]-4-(2-oxo(1,3-oxazolindin-3-yl))but-1-enyl}-3-chloro-2-methoxybenzoate",9.47,uM,=,0.9763499790032736,1,O=C1OCCN1CCC=C(c1ccccc1)c1ccccc1
4415,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)C(=O)NCc3cccc(O)c3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-((3-hydroxybenzyl)amino)-1-oxopropan-2-yl)-1H-indole-2-carboxamide",0.208,uM,=,-0.6819366650372385,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccccc1
4416,195681,10.1016/s0960-894x(01)00827-7,,,,Tested for its ability to inhibit HIV-1 reverse transcriptase strand transfer using wild type HIV-1-RT enzyme,O=C(OCCc1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 2-(3,4-dihydroxy-phenyl)-ethyl ester",0.6,uM,=,-0.2218487496163563,0,O=C(OCCc1ccccc1)c1ccccc1
4417,195842,10.1021/jm970873c,,,,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,COC(=O)N[C@H](C(=O)NN(Cc1ccc(-c2cncs2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)C,"((S)-1-{(1S,2S)-1-Benzyl-2-hydroxy-3-[N'-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-N-(4-thiazol-5-yl-benzyl)-hydrazino]-propylcarbamoyl}-2,2-dimethyl-propyl)-carbamic acid methyl ester",0.014,uM,=,-1.853871964321762,0,c1ccc(CCCCNCc2ccc(-c3cncs3)cc2)cc1
4418,1862183,10.1016/j.ejmech.2019.111617,,,,Inhibition of His6-tagged HIV-1 reverse transcriptase RNase H using 5'-GTTTTCTTTTCCCCCCTGAC-3'-Fluorescein-labeled RNA/5'-CAAAAGAAAAGGGGGGACUG-3'-Dabcyl-labeled DNA as susbtrate incubated for 1 hr by fluorescence based assay,CC(=O)c1c(O)c2c(=O)oc3ccc(C)cc3c2oc1=O,"3-acetyl-4-hydroxy-9-methylpyrano[3,2-c]chromene-2,5-dione",6.75,uM,=,0.829303772831025,1,O=c1ccc2c(=O)oc3ccccc3c2o1
4419,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,"1-(2-Hydroxy-ethoxymethyl)-5-methyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",5.06,uM,=,0.7041505168397991,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
4420,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1c(C(C#N)c2ccc(Cl)nc2)nc(SC(C)C)[nH]c1=O,"2-(6-chloropyridin-3-yl)-2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)acetonitrile",203.36,uM,=,2.308265533209933,1,O=c1cc(Cc2cccnc2)nc[nH]1
4421,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2cccnc2C2(c3ccccn3)SCCN12,"9b-Pyridin-2-yl-2,3-dihydro-9bH-thiazolo[3',2':1,2]pyrrolo[3,4-b]pyridin-5-one",23.0,uM,=,1.3617278360175928,1,O=C1c2cccnc2C2(c3ccccn3)SCCN12
4422,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc([N+](=O)[O-])cc2C)c(C)c1,2-(1-mesityl-1H-tetrazol-5-ylthio)-N-(2-methyl-4-nitrophenyl)acetamide,0.165,uM,=,-0.7825160557860937,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4423,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(F)ccc1F,"6-[1-(2,5-Difluorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid Ethyl Ester",9.0,uM,=,0.9542425094393248,1,c1ccc(Cn2cccc2)cc1
4424,545205,10.1016/j.ejmech.2008.10.032,,,,Inhibition of wild-type HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.0013,uM,=,-2.886056647693163,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4425,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(NCc3cccc(C(F)(F)F)c3)n2)cc1,4-(4-(3-(trifluoromethyl)benzylamino)pyrimidin-2-ylamino)benzonitrile,0.122,uM,=,-0.9136401693252518,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
4426,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(C#N)cc4)cc3F)c2=O)n[nH]c1=O,"3'-fluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",6.35,uM,=,0.8027737252919757,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
4427,1527769,,,,,Enzyme Inhibition Assay: The assay is based on a sandwich-ELISA protocol employing the ROCHE colorimetric reverse transcriptase kit (cat # 1468120910).,Cc1cccn2c(NC3CCCC3)c(-c3ccccc3Cl)nc12,"SM35::US8501787, 170",15.89,uM,=,1.2011238972073797,1,c1ccc(-c2nc3ccccn3c2NC2CCCC2)cc1
4428,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,O=C(Oc1cccc(Cn2ccc(=O)[nH]c2=O)c1)c1cc(Cl)cc(Cl)c1,"1-[3-(3,5-Dichlorobenzoyloxy)benzyl]uracil",42.0,uM,=,1.6232492903979006,1,O=C(Oc1cccc(Cn2ccc(=O)[nH]c2=O)c1)c1ccccc1
4429,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",6.2,uM,=,0.7923916894982539,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4430,972305,10.1021/ml400009t,,,,Inhibition of HIV1 recombinant reverse transcriptase RNase H activity after 10 mins,O=C(NCc1ccc(O)cc1O)C1C(=O)N(O)C(=O)c2ccccc21,"N-(2,4-Dihydroxybenzyl)-2-hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",0.52,uM,=,-0.2839966563652008,0,O=C1NC(=O)C(C(=O)NCc2ccccc2)c2ccccc21
4431,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1cc(C)c2c(c1)Oc1ccc(N)cc1C(=O)N2C,"2-Amino-7,9,10-trimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2ccccc2Oc2ccccc21
4432,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,O=c1[nH]c2ccc(Cl)cc2n1S(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,"6-Chloro-1-(3,5-bistrifluoromethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.31,uM,=,-0.5086383061657274,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
4433,1473728,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1F,"6-((3'-Fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.8,uM,=,0.255272505103306,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4434,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2cccc3ccccc23)c2nccnc2n(O)c1=O,"Methyl 5-hydroxy-8-(naphthalen-1-ylamino)-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",4.3,uM,=,0.6334684555795865,1,O=c1cc(Nc2cccc3ccccc23)c2nccnc2[nH]1
4435,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccc4c(c3)OCO4)cc2c1=O,"Ethyl 6-(Benzo[d][1,3]dioxol-5-ylmethoxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",55.3,uM,=,1.7427251313046983,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccc4c(c3)OCO4)cc12
4436,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.34,uM,=,-0.4685210829577448,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4437,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccncc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2,6-Dimethyl-4-(pyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0306,uM,=,-1.51427857351842,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
4438,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cn1c(Oc2ccc(-c3ccc(O)cc3)cc2)cc(=O)n(O)c1=O,"3-Hydroxy-6-((4'-hydroxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",15.0,uM,=,1.1760912590556811,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4439,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccc(C#N)cc3[nH]2)CC1,2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indole-6-carbonitrile,3.9,uM,=,0.5910646070264992,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4440,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,CS(=O)(=O)Nc1ccc(NC(=O)Nc2sc(-c3ccc(Cl)c(Cl)c3)cc2C(=O)O)cc1,"5-(3,4-Dichlorophenyl)-2-(3-(4-(methylsulfonamido)phenyl)-ureido)thiophene-3-carboxylic Acid",0.1,uM,=,-1.0,0,O=C(Nc1ccccc1)Nc1ccc(-c2ccccc2)s1
4441,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(Cl)nc(SCC2=CCCc3ccccc32)n1,"6-Chloro-2-(3,4-dihydro-naphthalen-1-ylmethylsulfanyl)-pyrimidin-4-ylamine",16.0,uM,=,1.2041199826559248,1,C1=C(CSc2ncccn2)c2ccccc2CC1
4442,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(=O)N[C@@H](C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-(3,5-dimethylphenylsulfonyl)-N-((R)-1-oxo-1-((S)-1-(pyridin-4-yl)ethylamino)propan-2-yl)-1H-indole-2-carboxamide",1.19,uM,=,0.0755469613925307,1,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncc1
4443,856669,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[I-].[I-],"3-(3,8-diamino-6-phenyl-5-phenanthridiniumyl)propyl(diethyl)methylammonium",3.0,uM,=,0.4771212547196624,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
4444,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1CSCC2,"3,5-dimethyl-4-(2-(1-(4-(methylsulfonyl)benzyl)piperidin-4-ylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)benzonitrile",0.134,uM,=,-0.8728952016351924,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)CSCC4)CC2)cc1
4445,1476517,10.1016/j.ejmech.2015.04.050,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 assessed as reduction in biotin-labeled dUTP incorporation into DNA using polyr(A) x oligo(dT)16 template/primer hybrid,Cc1cc(C#N)cc(C)c1Oc1ccnc(NC2CCN(CC(=O)Nc3ccc([N+](=O)[O-])cc3)CC2)n1,"2-(4-((4-(4-Cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)piperidin-1-yl)-N-(4-nitrophenyl)acetamide",0.136,uM,=,-0.8664610916297825,0,O=C(CN1CCC(Nc2nccc(Oc3ccccc3)n2)CC1)Nc1ccccc1
4446,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(CC3=CCNC3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-(2,5-dihydro-1H-pyrrol-3-ylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.64,uM,=,-0.1938200260161128,0,O=C1Nc2c(CC3=CCNC3)ccnc2N(C2CC2)c2ncccc21
4447,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,N#Cc1ccc(Nc2cc(Cc3c(Cl)cccc3Cl)nc(N)n2)cc1,"4-[2-Amino-6-(2,6-dichloro-benzyl)-pyrimidin-4-ylamino]-benzonitrile",0.01,uM,=,-2.0,0,c1ccc(Cc2cc(Nc3ccccc3)ncn2)cc1
4448,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,N#Cc1ccccc1C#CC1(C2CC2)NC(=O)Nc2ccc(Cl)cc21,"2-(6-Chloro-4-cyclopropyl-2-oxo-1,2,3,4-tetrahydro-quinazolin-4-ylethynyl)-benzonitrile",0.0108,uM,=,-1.9665762445130504,0,O=C1Nc2ccccc2C(C#Cc2ccccc2)(C2CC2)N1
4449,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(Cl)nc(SCc2ccccc2)n1,2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine,6.66,uM,=,0.8234742291703011,1,c1ccc(CSc2ncccn2)cc1
4450,953196,10.1021/jm400160s,,,,Competitive inhibition of C-Terminal histidine-tagged wild type heterodimeric HIV-1 reverse transcriptase p66/p51 assessed as inhibition of dTTP incorporation after 15 mins by PAGE,Cc1cc(C#CCOCCOCCOCCOCCOCC#Cc2cn([C@H]3C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)c(=O)[nH]c2=O)cc(C)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"((2S,5R)-5-(5-(19-(4-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethylphenyl)-4,7,10,13,16-pentaoxanonadeca-1,18-diynyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl tetrahydrogen triphosphate",0.003,uM,=,-2.5228787452803374,0,O=c1[nH]c(=O)n([C@H]2C=CCO2)cc1C#CCOCCOCCOCCOCCOCC#Cc1ccc(Oc2ccnc(Nc3ccccc3)n2)cc1
4451,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,NS(=O)(=O)c1ccc(NC(=O)CSc2nnnn2-c2cc(Cl)ccc2Cl)c(Cl)c1,"N-(2-chloro-4-sulfamoyl-phenyl)-2-[1-(2,5-dichloro-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide",0.003,uM,=,-2.5228787452803374,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4452,195844,10.1021/jm00020a026,,,,antiviral activity in Human immunodeficiency virus-1 as reverse transcriptase activity in culture supernatant,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.011,uM,=,-1.958607314841775,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4453,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)Nc2c(C)cc(N3CCSCC3)nc21,"5-Ethyl-9-methyl-7-thiomorpholin-4-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2ccc(N3CCSCC3)nc2Nc2ncccc21
4454,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCC(N)=O)[nH]c3ccc(Br)cc23)c1,"N-(3-Amino-3-oxopropyl)-5-bromo-3-[(3,5-dimethylphenyl)-sulfonyl]-1H-indole-2-carboxamide",0.086,uM,=,-1.0655015487564323,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
4455,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccccc2Cl)c(C)c1,N-(2-chlorophenyl)-2-(1-mesityl-1H-tetrazol-5-ylthio)acetamide,0.005,uM,=,-2.3010299956639813,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4456,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)c1nc(-c2cccs2)nc(O)c1O,"5,6-Dihydroxy-2-thiophen-2-yl-pyrimidine-4-carboxylic acid",46.0,uM,=,1.662757831681574,1,c1cnc(-c2cccs2)nc1
4457,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccccc1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,"3-Hydroxy-6-((2'-methoxy-[1,1'-biphenyl]-4-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",9.3,uM,=,0.9684829485539352,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4458,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2ncc(-c3ccccc3)o2)c(O)nc1C,5-Ethyl-6-methyl-3-[(5-phenyl-oxazol-2-ylmethyl)-amino]-1H-pyridin-2-one,2.35,uM,=,0.3710678622717362,1,c1ccc(-c2cnc(CNc3cccnc3)o2)cc1
4459,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CSc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(pyridin-4-ylsulfanylmethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(CSc3ccncc3)cc21
4460,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CC(=O)N1c2cc(C)c(C)cc2N(C)C(=O)c2cccnc21,"11-Acetyl-6,8,9-trimethyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.42,uM,=,-0.3767507096020995,0,O=C1Nc2ccccc2Nc2ncccc21
4461,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CNc1ccc(-c2nc(=O)n(CCC3CCC(C)O3)c3c2oc2ncc(-c4cnn(C)c4)cc23)cn1,"4-(6-Methylamino-pyridin-3-yl)-8-(1-methyl-1H-pyrazol-4-yl)-1-[2-(5-methyl-tetrahydro-furan-2-yl)-ethyl]-1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-one",0.0048,uM,=,-2.318758762624413,0,O=c1nc(-c2cccnc2)c2oc3ncc(-c4cn[nH]c4)cc3c2n1CCC1CCCO1
4462,1832380,10.1016/j.bmc.2018.12.039,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1cc(Cl)cc(Oc2c(C(F)(F)F)ccn(CC(=O)Nc3ccc(F)cc3)c2=O)c1,2-(3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-N-(4-fluorophenyl)acetamide,72.0,uM,=,1.8573324964312683,1,O=C(Cn1cccc(Oc2ccccc2)c1=O)Nc1ccccc1
4463,197420,10.1016/S0960-894X(00)80468-0,,,,Ability to inhibit HIV-1 IIIB reverse transcriptase catalyzed incorporation of tritiated thymidine triphosphate onto a biotinylated rA.dT template primer,CCN1c2ncccc2-c2nccn2-c2ccc(OC)nc21,"8-Ethyl-6-methoxy-8H-1,3a,7,8,9-pentaaza-dibenzo[e,h]azulene",0.598,uM,=,-0.2232988160115891,0,c1cnc2c(c1)-c1nccn1-c1cccnc1N2
4464,195365,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(=O)OC)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid methyl ester",6.0,uM,=,0.7781512503836436,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4465,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,COc1ccc(OCCOCC#Cc2cn([C@H]3C=C[C@@H](CO)O3)c(=O)[nH]c2=O)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"5-{6-[2-(2-(5-Bromo-2-pyridinylaminothiocarbonylamino)-ethyl)-4-methoxyphenoxy]hexa-4-oxa-1-ynyl}-2',3'-didehydro-2',3'-dideoxyuridine",0.575,uM,=,-0.2403321553103695,0,O=c1[nH]c(=O)n([C@H]2C=CCO2)cc1C#CCOCCOc1ccccc1CCNC(=S)Nc1ccccn1
4466,196512,10.1021/jm9801049,,,,Inhibitory activity against wild type HIV-1 reverse transcriptase (WT-RT),C[C@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1,"6-Chloro-2-((S)-1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine",0.02,uM,=,-1.6989700043360187,0,c1cnc(SCc2cc3ccoc3cn2)nc1
4467,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)CCC/C=C(\c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c2oc(=O)n(C)c2c1,"methyl 5-[(1E)-1-(3,7-dimethyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)-6-methoxy-6-oxohex-1-en-1-yl]-2-methoxy-3-methylbenzoate",0.02,uM,=,-1.6989700043360187,0,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
4468,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(F)cc(-c2cncc(C(F)(F)F)c2)cc1F,"4-((4-((2,6-Difluoro-4-(5-(trifluoromethyl)pyridin-3-yl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)benzonitrile",0.857,uM,=,-0.0670191780768018,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccnc4)cc3)n2)cc1
4469,2201751,10.1016/j.ejmech.2022.114217,,,,Inhibition of HIV-1 LTR reverse transcriptase infected in human CEM cells using RNA template incubated for 1 hr by RT-PCR based cell-free assay,C#CCOCc1cn(C2CCON2C(=O)OCc2ccccc2)c(=O)[nH]c1=O,"Benzyl 3-(2,4-dioxo-5-((prop-2-yn-1-yloxy)methyl)-3,4-dihydropyrimidin-1(2H)-yl)isoxazolidine-2-carboxylate",0.05,uM,=,-1.3010299956639813,0,O=C(OCc1ccccc1)N1OCCC1n1ccc(=O)[nH]c1=O
4470,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,O=C1Nc2c(CSc3ccccc3)ccnc2N(C2CC2)c2ncccc21,"5-Cyclopropyl-9-phenylsulfanylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.03,uM,=,0.0128372247051722,1,O=C1Nc2c(CSc3ccccc3)ccnc2N(C2CC2)c2ncccc21
4471,2055317,10.1016/j.ejmech.2020.112696,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type recombinant HIV-1 His-tagged p66/p51 reverse transcriptase assessed as inhibition of [3H]dTTP incorporation using poly(rA)/oligo(dT) as templates incubated for 15 mins by MicroBeta scintillation counting method,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccc(CO)cc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(4-(hydroxymethyl)benzyl)-1H-indole-2-carboxamide",0.038,uM,=,-1.42021640338319,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4472,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,CS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",1.4,uM,=,0.1461280356782379,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4473,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(=O)O)cc3Cl)CC2)ncc1Br,"4-((4-(5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)methyl)-3-chlorobenzoic acid",0.032,uM,=,-1.494850021680094,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
4474,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(N(C)C(=O)c3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"N-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-N-methyl-benzamide",0.21,uM,=,-0.6777807052660807,0,O=C(Nc1cnc2c(c1)C(=O)Nc1cccnc1N2)c1ccccc1
4475,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#Cc2ccncc2)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,"4-((4-((4-(2,6-dimethyl-4-(pyridin-4-ylethynyl)phenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.86,uM,=,-0.0655015487564322,0,C(#Cc1ccc(Oc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccsc23)cc1)c1ccncc1
4476,1769204,10.1016/j.bmc.2018.02.017,,,,Inhibition of HIV1 reverse transcriptase p66/p51 polymerase using PPT57 DNA/Cy5-labeled PPT24 as template/primer preincubated for 10 mins followed by dNTP addition measured after 5 mins by bromophenol blue staining based phosphor imaging analysis,O=C(O)P(=O)(O)O,Foscarnet,0.8,uM,=,-0.0969100130080563,0,
4477,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,O=C1Nc2ccc(Cl)c(O)c2C(C#CC2CC2)(C(F)(F)F)N1,"6-Chloro-4-cyclopropylethynyl-5-hydroxy-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.054,uM,=,-1.2676062401770316,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
4478,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=C(N/N=C/c1cccc([N+](=O)[O-])c1)c1ccc(O)cc1,N'-(3-nitrobenzylidene)-4-hydroxybenzohydrazide,21.0,uM,=,1.3222192947339193,1,O=C(N/N=C/c1ccccc1)c1ccccc1
4479,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1Oc2ccccc2-n2cccc2C1=O,5-Ethyl-6-oxa-10b-aza-benzo[e]azulen-4-one,100.0,uM,=,2.0,1,O=C1COc2ccccc2-n2cccc21
4480,195526,10.1021/jm00078a001,,,,Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay,CC(C)=CCN1Cc2cc(Cl)cc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.7,uM,=,-0.1549019599857432,0,S=c1[nH]c2cccc3c2n1CCNC3
4481,195218,10.1021/jm960158n,,,,In vitro inhibition of recombinant reverse transcriptase (WT) of HIV-1 IIIB,CCNc1cccnc1N(CC)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[Ethyl-(3-ethylamino-pyridin-2-yl)-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,0.46,uM,=,-0.3372421683184259,0,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4482,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=S)[nH]c3cccc(c32)C1C,"6-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.078,uM,=,-1.1079053973095196,0,S=c1[nH]c2cccc3c2n1CCNC3
4483,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cnc(O)c(CCc2nc3ccccc3o2)c1,3-(2-Benzooxazol-2-yl-ethyl)-5-ethyl-1H-pyridin-2-one,0.177,uM,=,-0.7520267336381934,0,c1cncc(CCc2nc3ccccc3o2)c1
4484,545941,10.1016/j.bmc.2009.04.024,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,CCCCc1c(C)nc(N2C(=O)CSC2c2c(F)cccc2Cl)nc1C,"2-(2-Chloro-6-fluorophenyl)-3-(5-butyl-4,6-dimethylpyrimidin-2-yl)thiazolidin-4-one",15.96,uM,=,1.203032887014711,1,O=C1CSC(c2ccccc2)N1c1ncccn1
4485,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,COc1ccccc1CNc1ccnc(Nc2ccc(C#N)cc2)n1,4-(4-(2-methoxybenzylamino)pyrimidin-2-ylamino)benzonitrile,0.936,uM,=,-0.0287241512618947,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
4486,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1cc(/C(=C\CCc2nnc(C)o2)c2cc(C)c3on(C)c(=O)c3c2)cc(C)c1OC,"(Z)-5-[1-(2,7-dimethyl-3-oxo-2,3-dihydrobenzo[d]isoxazol-5-yl)-4-(5-methyl-[1,3,4]oxadiazol-2-yl)-but-1-enyl]-2-methoxy-3-methylbenzoic acid methyl ester",7.4,uM,=,0.8692317197309762,1,O=c1[nH]oc2ccc(/C(=C/CCc3nnco3)c3ccccc3)cc12
4487,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,O=C1Nc2ccccc2C(C#CC2CC2)(C(F)(F)F)O1,"4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.478,uM,=,-0.3205721033878811,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4488,543748,10.1128/aac.00145-07,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 expressed in Escherichia coli using calf thymus DNA substrate,BP(=O)(COCCn1cnc2c(N)ncnc21)OP(=O)(O)OP(=O)(O)O,9-[2-(Boranophosphonomethoxy)ethyl]adenine diphosphate,17.0,uM,=,1.230448921378274,1,c1ncc2nc[nH]c2n1
4489,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),O=C(Nc1ccc(Cl)cn1)N[C@@H]1C[C@@H]1c1c(F)cccc1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(2,6-difluoro-phenyl)-cyclopropyl]-urea",0.03,uM,=,-1.5228787452803376,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
4490,195373,10.1016/s0960-894x(99)00486-2,,,,Inhibitory activity against HIV-1 reverse transcriptase enzyme,COc1ccc2c(c1)C(C#CC1CC1)(C(F)(F)F)OC(=O)N2,"4-Cyclopropylethynyl-6-methoxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.131,uM,=,-0.8827287043442358,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4491,479604,10.1016/j.bmcl.2008.03.064,,,,Inhibition of HIV1 reverse transcriptase by SPA assay,N#Cc1cc(Cl)cc(Oc2cc(OCc3nc4cccc(Cl)c4[nH]3)ccc2Cl)c1,3-chloro-5-(2-chloro-5-((7-chloro-1H-benzo[d]imidazol-2-yl)methoxy)phenoxy)benzonitrile,0.0032,uM,=,-2.494850021680094,0,c1ccc(Oc2cccc(OCc3nc4ccccc4[nH]3)c2)cc1
4492,545151,10.1021/np50073a012,,,,Inhibition of HIV1 RT,C/C=C/C=C1\C=Cc2c(C(=O)OC)coc(=O)c21,Fulvoplumierin,184.37064715016675,uM,=,2.2656917800830323,1,C=C1C=Cc2ccoc(=O)c21
4493,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(N(C)CCCCCO)c1Cc1cccc(C)c1,5-Ethyl-3-[(5-hydroxy-pentyl)-methyl-amino]-6-methyl-4-(3-methyl-benzyl)-1H-pyridin-2-one,0.01,uM,=,-2.0,0,O=c1cc(Cc2ccccc2)cc[nH]1
4494,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(OC)cc3)nc21,"5-Ethyl-7-(4-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.2,uM,=,0.505149978319906,1,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
4495,195223,10.1021/jm00076a005,,,,In vitro inhibitory concentration against reverse transcriptase of HIV-1 (RT),CCc1nc(CCCCCCC(=O)c2ccccc2)n2nc(Cl)ccc12,"7-(2-Chloro-5-ethyl-imidazo[1,5-b]pyridazin-7-yl)-1-phenyl-heptan-1-one hydrochloride",2.0,uM,=,0.3010299956639812,1,O=C(CCCCCCc1ncc2cccnn12)c1ccccc1
4496,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=[N+]([O-])c1cccc(/C=N/NS(=O)(=O)c2ccc(Cl)cc2)c1O,4-chloro-N'-(2-hydroxy-3-nitrobenzylidene)benzenesulfonohydrazide,59.0,uM,=,1.7708520116421442,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
4497,1294279,10.1016/j.ejmech.2014.02.047,,,,Inhibition of wild type HIV-1 reverse transcriptase using poly (rC)/oligo (dG) as template/primer assessed as inhibition of biotin-dUTP incorporation after 1 hr by microtiter plate ELISA reader analysis,Cc1cc(Br)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2[N+](=O)[O-])c(Br)c1,"4-(4-(2,6-Dibromo-4-methylphenoxy)-5-nitropyridin-2-ylamino)benzonitrile",10.4,uM,=,1.0170333392987805,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4498,1933122,10.1021/acs.jmedchem.6b00730,,,,Inhibition of HIV1 reverse transcriptase using T19-Cy5 labeled 23-mer DNA/T2-TAMRA labeled 63-mer DNA as primer/template assessed as inhibition of dNTP incorporation into primer/template,CCN(Cc1ccccc1)C(=O)Nc1sc(-c2ccc(Cl)c(Cl)c2)cc1C(=O)O,"2-(3-benzyl-3-ethylureido)-5-(3,4-dichlorophenyl)thiophene-3-carboxylic acid",0.9,uM,=,-0.0457574905606751,0,O=C(NCc1ccccc1)Nc1ccc(-c2ccccc2)s1
4499,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)ccc2C(=O)N1O,"6-((2',4'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",5.1,uM,=,0.7075701760979364,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4500,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4cnc(-c5cnn(C)c5)cc4c32)CCO1,"cis-4-(2-Ethyl-tetrahydro-pyran-4-yl)-1,6-bis-(1-methyl-1H-pyrazol-4-yl)-4H-9-oxa-2,4,7-triaza-fluoren-3-one",0.0077,uM,=,-2.113509274827518,0,O=c1nc(-c2cn[nH]c2)c2oc3cnc(-c4cn[nH]c4)cc3c2n1C1CCOCC1
4501,195839,10.1021/jm00023a007,,,,Inhibition of HIV-1 reverse transcriptase (RT),Cc1cc(C)cc(Sc2c(C)cnc(O)c2N)c1,"3-Amino-4-(3,5-dimethyl-phenylsulfanyl)-5-methyl-1H-pyridin-2-one",0.1,uM,=,-1.0,0,c1ccc(Sc2ccncc2)cc1
4502,197422,10.1021/jm00001a001,,,,Ability to inhibit the HIV-1 reverse transcriptase in cord blood mononuclear cells.,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.03,uM,=,-1.5228787452803376,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4503,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,O=C1CSC(c2c(F)cccc2F)N1c1ccc(Br)cn1,"3-(5-Bromo-pyridin-2-yl)-2-(2,6-difluoro-phenyl)-thiazolidin-4-one",61.4,uM,=,1.7881683711411678,1,O=C1CSC(c2ccccc2)N1c1ccccn1
4504,750572,10.1016/j.bmc.2009.05.049,,,,Antiviral activity against HIV1 Reverse transcriptase activity,COc1cc(/C=C/C(=O)O[C@H]2CC[C@]34C[C@]35CC[C@]3(C)[C@@H]([C@H](C)CCC=C(C)C)CC[C@@]3(C)[C@@H]5CC[C@H]4C2(C)C)ccc1O,cycloartenol ferulate,3.6518552873544112,uM,=,0.5625135593472925,1,O=C(/C=C/c1ccccc1)O[C@H]1CC[C@]23C[C@]24CCC2CCCC2[C@@H]4CC[C@H]3C1
4505,1454138,10.1016/j.bmc.2014.07.018,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 using dsDNA by microplate reader based assay,CCN1c2ncccc2NC(=O)c2cc(NCCNc3cc4c(cc3N)c(=O)c(C(=O)O)cn4C)cnc21,"6-Amino-7-({2-[(11-ethyl-6-oxo-5,11-dihydro-6Hdipyrido[3,2-b:2',3'-e][1,4]diazepin-8-yl)amino]ethyl}amino)-1-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",73.4,uM,=,1.8656960599160703,1,O=C1Nc2cccnc2Nc2ncc(NCCNc3ccc4c(=O)cc[nH]c4c3)cc21
4506,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCOC(=O)CCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-5-propyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,8.3,uM,=,0.919078092376074,1,C=C(c1ccccc1)c1ccccc1
4507,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2ccc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)cc2c(=O)n1O,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)-3-(trifluoromethyl)benzenesulfonamide",2.0,uM,=,0.3010299956639812,1,O=c1[nH]c(=O)c2cc(NS(=O)(=O)c3ccccc3)ccc2[nH]1
4508,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-{4-[4-((E)-2-Cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile",0.015,uM,=,-1.8239087409443189,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
4509,1925210,10.1021/acs.jmedchem.5b01879,,,,Inhibition of re-constituted HIV1 reverse transcriptase RNase H domain fragment,O=c1cc(Nc2cccc(-c3ccc(F)cc3)c2)[nH]c(=O)n1O,"6-((4'-Fluoro-[1,1'-biphenyl]-3-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.15,uM,=,-0.8239087409443188,0,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4510,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccoc2)c1Nc1nc(O)nc(N(C)Cc2ccc3occc3c2)n1,"4-((benzofuran-5-ylmethyl)(methyl)amino)-6-(2-(furan-3-yl)-6-methylphenylamino)-1,3,5-triazin-2-ol",0.08,uM,=,-1.0969100130080565,0,c1ccc(-c2ccoc2)c(Nc2ncnc(NCc3ccc4occc4c3)n2)c1
4511,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cc[nH]c3)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2ccc(-c3cc[nH]c3)nc2Nc2ncccc21
4512,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.19,uM,=,-0.721246399047171,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4513,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc(OC)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(3-methoxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
4514,546494,10.1021/np50121a006,,,,Inhibition of HIV1 reverse transcriptase p66/p51,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1CC1=NCCc2cc(OC)c(OC)cc21.O.O=S(=O)(O)O,O-methylpsychotrine sulfate heptahydrate,14.0,uM,=,1.146128035678238,1,c1ccc2c(c1)CCN=C2C[C@@H]1CCN2CCc3ccccc3[C@@H]2C1
4515,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,COc1cccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)c1,"3-Hydroxy-6-((3'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",1.0,uM,=,0.0,0,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4516,640765,10.1016/j.bmcl.2010.05.040,,,,Inhibition of wild type HIV1 reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccccc3)CC2)ncc1Br,"4-(2-(1-benzylpiperidin-4-ylamino)-5-bromopyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.019,uM,=,-1.7212463990471711,0,c1ccc(CN2CCC(Nc3nccc(Oc4ccccc4)n3)CC2)cc1
4517,195366,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y188L reverse transcriptase.,CCN1c2ncc(COc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-(3-Amino-phenoxymethyl)-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.37,uM,=,-0.431798275933005,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
4518,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,S=C(NCCC1=NC2C=CC=CC2N1)Nc1ccc(Br)cn1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(3a,7a-dihydro-1H-benzoimidazol-2-yl)-ethyl]-thiourea",0.021,uM,=,-1.6777807052660807,0,S=C(NCCC1=NC2C=CC=CC2N1)Nc1ccccn1
4519,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(C#CC1CC1)(Oc1cccc(Oc2ccccc2)c1)C(F)(F)F,3-[3-Cyclopropyl-1-(3-phenoxy-phenoxy)-1-trifluoromethyl-prop-2-ynyl]-1H-pyridin-2-one,0.024338,uM,=,-1.613715113232142,0,C(#CC(Oc1cccc(Oc2ccccc2)c1)c1cccnc1)C1CC1
4520,820058,10.1016/j.bmcl.2012.04.096,,,,Inhibition of HIV1 reverse transcriptase RNase H activity,O=C(NCc1ccc(F)cc1)c1c(O)c(=O)[nH]c2ccc(F)cc12,N-(4-Fluorobenzyl)-6-fluoro-3-hydroxy-2-oxoquinoline-4-carboxamide,22.0,uM,=,1.3424226808222062,1,O=C(NCc1ccccc1)c1cc(=O)[nH]c2ccccc12
4521,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Oc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",4.7,uM,=,0.6720978579357175,1,O=c1cc(Oc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4522,850446,10.1021/ml300146q,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type N-terminal His6x-tagged HIV 1 reverse transcriptase p66/p51 expressed in Escherichia coli (DE3) rosetta cells preincubated for 30 mins by SPA assay,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c3nc(F)ccc23)c1,"4-(2-((6-Fluoro-1H-pyrazolo[3,4-b]pyridin-3-yl)methylamino)pyridin-4-yl)-3-methylbenzonitrile",0.0019,uM,=,-2.721246399047171,0,c1ccc(-c2ccnc(NCc3n[nH]c4ncccc34)c2)cc1
4523,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CSCCN1C(=O)c2ccccc2Oc2nc(Cl)ccc21,"3-Chloro-11-(2-methylsulfanyl-ethyl)-11H-5-oxa-4,11-diaza-dibenzo[a,d]cyclohepten-10-one",0.072,uM,=,-1.1426675035687317,0,O=C1Nc2cccnc2Oc2ccccc21
4524,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1,"1,6-Bis[(benzyloxy)methyl]pyrimidine-2,4(1H,3H)-dione",0.74,uM,=,-0.1307682802690238,0,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
4525,195199,10.1021/jm980260f,,,,Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccccc2Cl)n1,2-sec-Butylsulfanyl-6-(2-chloro-benzyl)-5-methyl-3H-pyrimidin-4-one,0.4,uM,=,-0.3979400086720376,0,c1ccc(Cc2ccncn2)cc1
4526,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN(CC)CCOc1ccc(NC(=O)COc2ccccc2C(=O)c2ccc(OC)cc2)cc1,N-[4-(2-Diethylamino-ethoxy)-phenyl]-2-[2-(4-methoxy-benzoyl)-phenoxy]-acetamide,14.278781213776767,uM,=,1.1546911391823942,1,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
4527,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1ccc2c(c1)Oc1ccc(O)cc1C(=O)N2C,"2-Hydroxy-7,10-dimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.64,uM,=,-0.1938200260161128,0,O=C1Nc2ccccc2Oc2ccccc21
4528,195208,10.1021/jm990095j,,,,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CCC(=O)c1ccc(F)c(C2CC2NC(=O)Nc2ccc(Cl)cn2)c1O,1-(5-Chloro-pyridin-2-yl)-3-[2-(6-fluoro-2-hydroxy-3-propionyl-phenyl)-cyclopropyl]-urea,0.0032,uM,=,-2.494850021680094,0,O=C(Nc1ccccn1)NC1CC1c1ccccc1
4529,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC(C)C1OC(C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-cyclopropylethynyl-3-isopropyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.597,uM,=,-0.2240256688706309,0,O=C1COC(C#CC2CC2)c2ccccc2N1
4530,675251,10.1016/j.bmcl.2010.09.034,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cccc(-c2ccccc2)c1Nc1nc(O)nc(N(C)Cc2ccc3c(c2)CCO3)n1,"4-(((2,3-dihydrobenzofuran-5-yl)methyl)(methyl)amino)-6-(3-methylbiphenyl-2-ylamino)-1,3,5-triazin-2-ol",0.055,uM,=,-1.259637310505756,0,c1ccc(-c2ccccc2Nc2ncnc(NCc3ccc4c(c3)CCO4)n2)cc1
4531,195843,10.1021/jm970096g,,,,The quantity of compound required to reduce WT Reverse transcriptase activity by 50%,Cc1cccc2c1nc(-c1c(F)cccc1F)n2Cc1ccccc1,"1-Benzyl-2-(2,6-difluoro-phenyl)-4-methyl-1H-benzoimidazole",1.6,uM,=,0.2041199826559248,1,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1
4532,609013,10.1016/j.bmc.2009.12.059,,,,Inhibition of RNA-dependent DNA polymerase activity of HIV1 reverse transcriptase using poly(rA)/pligo(dT) template,Cc1ccc(S(=O)(=O)n2c(=O)[nH]c3ccc(Cl)cc32)cc1C,"6-Chloro-1-(3,4-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",0.004,uM,=,-2.397940008672037,0,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
4533,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(O)c(O)c2)cs1,"3-(2-(4-(3,4-dihydroxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one",2.0,uM,=,0.3010299956639812,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
4534,1795803,10.1016/j.ejmech.2018.09.013,,,,Inhibition of HIV1 LAI reverse transcriptase infected in human MT4 cells assessed as protection against virus-induced cytopathic effect by MTT assay,Cc1cnc(Nc2ccc(C#N)cc2)nc1Nc1c(C)cc(C#N)cc1C,"4-[2-(4-Cyano-phenylamino)-5-methyl-pyrimidin-4-ylamino]-3,5-dimethyl-benzonitrile",0.0008,uM,=,-3.096910013008056,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
4535,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1COC2,"3,5-Dimethyl-4-((2-((1-(4-nitrobenzyl)piperidin-4-yl)amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl)oxy)benzonitrile",0.092,uM,=,-1.0362121726544449,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
4536,195515,10.1021/jm00113a036,,,,Inhibitory activity against HIV-1 reverse transcriptase (RT),CCc1cc(NCc2cc3ccccc3o2)c(O)nc1C,3-[(Benzofuran-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.235,uM,=,-0.6289321377282637,0,c1cncc(NCc2cc3ccccc3o2)c1
4537,195362,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(COc3ccccc3F)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(2-fluoro-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.57,uM,=,-0.2441251443275086,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
4538,619113,10.1016/j.bmcl.2009.07.031,,,,Inhibition of HIV1 reverse transcriptase expressed in human MT4 cells after 72 hrs by spread assay,Cc1cc(C)c(N(C)C(=O)SCC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)c(C)c1,S-2-(2-chloro-4-sulfamoylphenylamino)-2-oxoethyl mesityl(methyl)carbamothioate,0.008,uM,=,-2.096910013008056,0,O=C(CSC(=O)Nc1ccccc1)Nc1ccccc1
4539,532747,10.1021/jm7012198,,,,Inhibition of HIV1 reverse transcriptase,CCc1c(C)[nH]c(=O)c(NC)c1Cc1cc(C)cc(C)c1,"4-(3,5-Dimethyl-benzyl)-5-ethyl-6-methyl-3-methylamino-1H-pyridin-2-one",0.01,uM,=,-2.0,0,O=c1cc(Cc2ccccc2)cc[nH]1
4540,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1cccc(Oc2ccccc2)c1)Nc1nccs1,1-[2-(3-Phenoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,1.1,uM,=,0.041392685158225,1,S=C(NCCc1cccc(Oc2ccccc2)c1)Nc1nccs1
4541,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1cc(Cc2ccccc2)nc(SCOCc2ccccc2)[nH]1,6-Benzyl-2-(benzyloxymethylthio)pyrimidin-4(3H)-one,12.12,uM,=,1.0835026198302673,1,O=c1cc(Cc2ccccc2)nc(SCOCc2ccccc2)[nH]1
4542,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,C=C(C)CN1Cc2cccc3[nH]c(=O)n(c23)CC1C,"8-Methyl-7-(2-methyl-allyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulen-1-one",34.7,uM,=,1.5403294747908738,1,O=c1[nH]c2cccc3c2n1CCNC3
4543,1885886,10.1016/j.bmc.2019.07.011,,,,Inhibition of HIV1 reverse transcriptase RNase H activity expressed in Escherichia coli using 32P-labeled template 31Trna RNA and DNA oligonucleotide 21P,O=c1[nH]c2cc(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)ccc2c(=O)n1O,"N-(3-Hydroxy-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-[1,1'-biphenyl]-4-sulfonamide",11.7,uM,=,1.0681858617461617,1,O=c1[nH]c(=O)c2ccc(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)cc2[nH]1
4544,806932,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 reverse transcriptase,O=C1/C(=C\c2cccc(O)c2O)SC(=S)N1Cc1ccco1,"5-(2,3-dihydroxybenzylidene)-3-(furan-2-ylmethyl)-2-thioxothiazolidin-4-one",1.0,uM,=,0.0,0,O=C1/C(=C\c2ccccc2)SC(=S)N1Cc1ccco1
4545,2231068,10.1016/j.bmc.2021.116531,,,,Inhibition of HIV1 reverse transcriptase assessed as inhibition of biotin-dUTP incorporation,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3cccc(B(O)O)c3)[nH]c3ccc(Cl)cc23)c1,"(3-((5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamido)methyl)phenyl)boronic acid",0.1235,uM,=,-0.9083330424043154,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4546,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,O=C1c2ccccc2C(CCCc2ccccc2)C(=O)N1O,"2-Hydroxy-4-(3-phenyl)propylisoquinoline-1,3(2H,4H)-dione",66.8,uM,=,1.8247764624755456,1,O=C1NC(=O)C(CCCc2ccccc2)c2ccccc21
4547,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,COc1cc([S+]([O-])c2cccc(N)c2C#N)cc(C(F)(F)F)c1,2-Amino-6-(3-methoxy-5-trifluoromethyl-benzenesulfinyl)-benzonitrile,0.9,uM,=,-0.0457574905606751,0,c1ccc([SH+]c2ccccc2)cc1
4548,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,O=C(NCCC(=O)c1ccccc1F)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[3-(2-fluoro-phenyl)-3-oxo-propyl]-urea,0.054,uM,=,-1.2676062401770316,0,O=C(NCCC(=O)c1ccccc1)Nc1ccccn1
4549,514577,10.1016/j.bmcl.2008.06.072,,,,Inhibition of HIV1 wild-type reverse transcriptase by scintillation counting assay,Cc1cc(Cl)cc(Oc2cccc(Cc3ccc(=O)[nH]n3)c2)c1,6-(3-(3-chloro-5-methylphenoxy)benzyl)pyridazin-3(2H)-one,14.0,uM,=,1.146128035678238,1,O=c1ccc(Cc2cccc(Oc3ccccc3)c2)n[nH]1
4550,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(C(=O)NCCCN(C)C)cc2Cl)c(C)c1,3-chloro-N-(3-(dimethylamino)propyl)-4-(2-(1-mesityl-1H-tetrazol-5-ylthio)acetamido)benzamide,0.005,uM,=,-2.3010299956639813,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4551,755992,10.1021/jm2000757,,,,Inhibition of RNase H activity of his6-tagged HIV1 HXB2 reverse transcriptase p66/p51 expressed in Escherichia coli assessed as substrate cleavage at polypurine tract by PAGE-based fluorescent imaging method,Cc1cc(O)c(=O)c(O)c2c1C[C@@H](C(C)(O)CSCc1ccccc1)CC2,"(2S)-2-(1-(benzylthio)-2-hydroxypropan-2-yl)-5,7-dihydroxy-9-methyl-3,4-dihydro-1H-benzo[7]annulen-6(2H)-one",1.3,uM,=,0.1139433523068367,1,O=c1cccc2c(c1)CC[C@H](CCSCc1ccccc1)C2
4552,1925209,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in RNA 5'-end directed cleavage using HTS3 substrate,Cn1c(Nc2ccc(-c3ccc(C#N)cc3)cc2)cc(=O)n(O)c1=O,"4'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-4-carbonitrile",3.7,uM,=,0.568201724066995,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4553,1390483,10.1039/C0MD00009D,,,,Inhibition of polymerase activity of wild type HIV-1 LAI reverse transcriptase,N#Cc1cc(Cl)cc(Oc2c(F)c(CCc3ccncc3)[nH]c(=O)c2Br)c1,"3-(3-bromo-5-fluoro-2-oxo-6-(2-(pyridin-4-yl)ethyl)-1,2-dihydropyridin-4-yloxy)-5-chlorobenzonitrile",0.002,uM,=,-2.6989700043360187,0,O=c1cc(Oc2ccccc2)cc(CCc2ccncc2)[nH]1
4554,666605,10.1128/aac.01795-09,,,,Inhibition of DNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by gel-based primer extension assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.2,uM,=,0.505149978319906,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4555,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,COc1cccc(-c2cc3c(NCC(P(=O)(O)O)P(=O)(O)O)ncnc3nc2SC)c1,"(2-((6-(3-Methoxyphenyl)-7-(methylthio)pyrido[2,3-d]-pyrimidin-4-yl)amino)ethane-1,1-diyl)diphosphonic Acid",2.4,uM,=,0.380211241711606,1,c1ccc(-c2cnc3ncncc3c2)cc1
4556,1473759,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2ccccc2C(=O)N1O,"2-Hydroxy-4H-isoquinoline-1,3-dione",1.2,uM,=,0.0791812460476248,1,O=C1Cc2ccccc2C(=O)N1
4557,1294279,10.1016/j.ejmech.2014.02.047,,,,Inhibition of wild type HIV-1 reverse transcriptase using poly (rC)/oligo (dG) as template/primer assessed as inhibition of biotin-dUTP incorporation after 1 hr by microtiter plate ELISA reader analysis,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2[N+](=O)[O-])c(C)c1,4-(4-(Mesityloxy)-5-nitropyridin-2-ylamino)benzonitrile,6.9,uM,=,0.8388490907372553,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4558,2219398,10.1021/acs.jmedchem.1c01104,,,,Inhibition of recombinant HIV-1 reverse transcriptase incubated for 2 hrs by colorimetric assay,Cc1nc([C@H](CNC2CCC2)NC(=O)c2ccc(-c3ccc(Cl)cc3)[nH]2)sc1CO,(R)-5-(4-chlorophenyl)-N-(2-(cyclobutylamino)-1-(5-(hydroxymethyl)-4-methylthiazol-2-yl)ethyl)-1H-pyrrole-2-carboxamide,43.44,uM,=,1.6378898165807905,1,O=C(N[C@@H](CNC1CCC1)c1nccs1)c1ccc(-c2ccccc2)[nH]1
4559,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CC[S+]([O-])CC3)cc2)n1,"(E)-3-(3,5-dimethyl-4-((2-((4-((1-oxidothiomorpholino)methyl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)acrylonitrile",0.051,uM,=,-1.2924298239020635,0,c1ccc(Oc2ccnc(Nc3ccc(CN4CC[SH+]CC4)cc3)n2)cc1
4560,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1cc(Cl)ccc1Cl,"2-Amino-6-(2,5-dichloro-phenylsulfanyl)-benzonitrile",3.5,uM,=,0.5440680443502757,1,c1ccc(Sc2ccccc2)cc1
4561,1767095,10.1021/acs.jmedchem.8b00141,,,,Inhibition of full-length wild-type HIV1 reverse transcriptase expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before addition of template/primer substrate and measured after 90 mins,C#C[C@]1(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O,4'-ethynyl-2-fluoro-2'-deoxyadenosine triphosphate,0.263,uM,=,-0.5800442515102421,0,c1ncc2ncn([C@H]3CCCO3)c2n1
4562,195535,10.1021/jm950589q,,,,Inhibitory concentration against HIV-1 replication by interfering with virus reverse transcriptase,CC(C)=CCN1CCn2c(=S)[nH]c3ccc(Cl)c(c32)C1,"5-Chloro-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.046,uM,=,-1.337242168318426,0,S=c1[nH]c2cccc3c2n1CCNC3
4563,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,0.015,uM,=,-1.8239087409443189,0,S=C(NCCc1ccccn1)Nc1ccccn1
4564,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3ccccc3)cc2c1=O,"Ethyl 6-(Benzyloxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",8.0,uM,=,0.9030899869919436,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
4565,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1ccc(C)cc1,"(E)-6-[1-(4-Methyl-benzyl)-1H-pyrrol-2-yl]-2,4-dioxo-hex-5-enoic acid ethyl ester",7.3,uM,=,0.8633228601204559,1,c1ccc(Cn2cccc2)cc1
4566,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"3-Hydroxy-6-(3'-methoxybiphenyl-4-ylamino)-1H-pyrimidine-2,4-dione",0.25,uM,=,-0.6020599913279624,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4567,195504,10.1021/jm001095i,,,,Inhibitory activity against wild-type HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.6576144434588318,uM,=,-0.1820286567733822,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4568,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,CCOc1cccc2cc(CNCc3cn([C@H]4C[C@H](n5cc(C)c(=O)[nH]c5=O)O[C@@H]4CO)nn3)c(=O)oc12,"1-((2R,4S,5S)-4-(4-(((8-ethoxy-2-oxo-2H-chromen-3-yl)methylamino)methyl)-1H-1,2,3-triazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",114.0,uM,=,2.0569048513364727,1,O=c1ccn([C@H]2C[C@H](n3cc(CNCc4cc5ccccc5oc4=O)nn3)CO2)c(=O)[nH]1
4569,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,COc1cc2c(ccc3c4cc(OC)c(OC)cc4c[n+](C)c23)cc1O.[Cl-],"2-Hydroxy-3,8,9-trimethoxy-5-methyl-benzo[c]phenanthridinium chloride",13.0,uM,=,1.1139433523068367,1,c1ccc2c(c1)c[nH+]c1c3ccccc3ccc21
4570,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cccs2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2,6-Dimethyl-4-(thiophen-2-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.029,uM,=,-1.537602002101044,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccs4)cc3)n2)cc1
4571,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(O)cc3)nc21,"5-Ethyl-7-(4-hydroxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2ccc(-c3ccccc3)nc2Nc2ncccc21
4572,1784874,10.1021/acsmedchemlett.7b00524,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase assessed as decrease in biotin-dUTP incorporation using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides after 1 hr by ELISA,COC(=O)CCSc1cnc(Nc2ccc(C#N)cc2)nc1Oc1c(C)cc(C#N)cc1C,"Methyl 3-((4-(4-cyano-2,6-dimethylphenoxy)-2-((4-cyanophenyl)amino)pyrimidin-5-yl)thio)propanoate",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4573,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3ccccc3o2)c(O)nc1C,3-[(Benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one,0.21,uM,=,-0.6777807052660807,0,c1cncc(NCc2nc3ccccc3o2)c1
4574,950883,10.1016/j.bmc.2013.01.025,,,,Inhibition of HIV1 reverse transcriptase,COc1cccc2cc(CN(Cc3ccccc3)C(=O)CNCc3cn([C@H]4C[C@H](n5cc(C)c(=O)[nH]c5=O)O[C@@H]4CO)nn3)c(=O)oc12,"N-benzyl-2-((1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methylamino)-N-((8-methoxy-2-oxo-2H-chromen-3-yl)methyl)acetamide",2.88,uM,=,0.4593924877592308,1,O=C(CNCc1cn([C@@H]2CO[C@@H](n3ccc(=O)[nH]c3=O)C2)nn1)N(Cc1ccccc1)Cc1cc2ccccc2oc1=O
4575,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3cccc(O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(3-hydroxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
4576,195049,10.1021/jm00024a011,,,,Compound was evaluated for inhibition of WT HIV type I reverse transcriptase.,Cc1ccccc1OCc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-o-tolyloxymethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.29,uM,=,-0.5376020021010439,0,O=C1Nc2c(COc3ccccc3)ccnc2N(C2CC2)c2ncccc21
4577,195053,10.1021/jm00041a023,,,,Ability to inhibit HIV-1 Reverse Transcriptase (RT) using an rC-dG template/primer,O=C1Nc2ccc(Cl)cc2C(C#Cc2cncnc2)(C2CC2)N1,"6-Chloro-4-cyclopropyl-4-pyrimidin-5-ylethynyl-3,4-dihydro-1H-quinazolin-2-one",1.5,uM,=,0.1760912590556812,1,O=C1Nc2ccccc2C(C#Cc2cncnc2)(C2CC2)N1
4578,1364719,10.1016/j.ejmech.2014.06.061,,,,"Inhibition of HIV1 reverse transcriptase RNase-H activity using dATP, dCTP, dTTP, [8-3H(N)]-dGTP, oligo1, oligo 2, oligo 3 as substrate preincubated for 30 mins followed by substrate addition measured after 90 mins",O=c1nc(Nc2ccc(-c3ccncc3)cc2)c2cccnc2n1O,"1-Hydroxy-4-((4-(pyridin-4-yl)phenyl)amino)pyrido[2,3-d]pyrimidin-2(1H)-one",0.079,uM,=,-1.1023729087095586,0,O=c1nc(Nc2ccc(-c3ccncc3)cc2)c2cccnc2[nH]1
4579,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(-c3ccc(OC)nc3)nc21,"5-Ethyl-7-(6-methoxy-pyridin-3-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.0,uM,=,0.4771212547196624,1,O=C1Nc2ccc(-c3cccnc3)nc2Nc2ncccc21
4580,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),Cc1ccc2[nH]c(=O)n(S(=O)(=O)c3c(F)cccc3F)c2c1,"6-Methyl 1-(2,6-difluorophenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one",1.3,uM,=,0.1139433523068367,1,O=c1[nH]c2ccccc2n1S(=O)(=O)c1ccccc1
4581,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N3CC=CC3)nc21,"7-(2,5-Dihydro-pyrrol-1-yl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.64,uM,=,-0.1938200260161128,0,O=C1Nc2ccc(N3CC=CC3)nc2Nc2ncccc21
4582,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.0081,uM,=,-2.0915149811213505,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4583,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN(CC)CCOc1ccc(NC(=O)COc2ccccc2C(=O)c2ccc(F)cc2)cc1,N-[4-(2-Diethylamino-ethoxy)-phenyl]-2-[2-(4-fluoro-benzoyl)-phenoxy]-acetamide,21.54192183794056,uM,=,1.3332844457762945,1,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
4584,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1CCS[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N12,"(6R,7R,8S,9S,9aR)-7,8,9-trihydroxy-6-(hydroxymethyl)hexahydropyrido[2,1-b][1,3]thiazin-4(6H)-one",1.41,uM,=,0.1492191126553798,1,O=C1CCS[C@@H]2CCCCN12
4585,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,O=C1COC(C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2N1,"7-Chloro-5-cyclopropylethynyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.432,uM,=,-0.3645162531850879,0,O=C1COC(C#CC2CC2)c2ccccc2N1
4586,1473729,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(thiophen-2-yl)benzyl)isoquinoline-1,3(2H,4H)-dione",2.7,uM,=,0.4313637641589873,1,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1
4587,378454,10.1021/jm0604575,,,,Inhibition of FLAG-p66/HIS-p51-mediated HIV1 reverse transcriptase dimerization,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2-hydroxy-2-oxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-hydroxy-propyl)-5-methyl-1H-pyrimidine-2,4-dione",1.6,uM,=,0.2041199826559248,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4588,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2cccnc2S[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)N12,"(7S,8R,9S,10S,10aR)-8,9,10-trihydroxy-7-(hydroxymethyl)-8,9,10,10a-tetrahydro-5H,7H-dipyrido[2,1-b:3',2'-e][1,3]thiazin-5-one",26.82,uM,=,1.42845877351558,1,O=C1c2cccnc2S[C@@H]2CCCCN12
4589,80141,10.1016/s0960-894x(99)00565-x,,,,Inhibitory activity against HIV-1 reverse transcriptase,Nc1ccc2c(c1)C(C#CC1CC1)(C(F)(F)F)OC(=O)N2,"6-Amino-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.802,uM,=,-0.0958256317158364,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4590,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1cccc(CSc2nc(Cc3ccccc3)cc(=O)[nH]2)c1,6-Benzyl-2-(3-methyl-benzylthio)pyrimidin-4(3H)-one,91.14,uM,=,1.95970902424643,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
4591,195081,10.1021/jm00062a027,,,,In vitro inhibition of HIV-1 reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,(1H-Indol-2-yl)-[4-(3-isopropylamino-pyridin-2-yl)-piperazin-1-yl]-methanone,1.2,uM,=,0.0791812460476248,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4592,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),O=C1c2ccccc2C2(c3cccs3)SCCN12,"9b-Thiophen-2-yl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",2.65,uM,=,0.4232458739368078,1,O=C1c2ccccc2C2(c3cccs3)SCCN12
4593,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1c(Cc2ccccc2)nc(SCCCc2ccccc2)[nH]c1=O,6-Benzyl-5-methyl-2-(3-phenylpropylthio)pyrimidin-4(3H)-one,2.93,uM,=,0.4668676203541094,1,O=c1cc(Cc2ccccc2)nc(SCCCc2ccccc2)[nH]1
4594,989557,10.1016/j.bmc.2013.08.040,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 (1:1.2) as template/primer after 40 mins by spectrofluorometric analysis,COc1ccc(CSc2nc(C(=O)c3ccccc3F)c(C(C)C)c(=O)[nH]2)cc1,2-(4-Methoxybenzylthio)-6-(2-fluorobenzoyl)-5-isopropylpyrimidin-4(3H)-one,0.072,uM,=,-1.1426675035687317,0,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
4595,2079300,10.1016/j.ejmech.2020.113051,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into template incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1ccnc(Nc2ccc(CN3CCS(=O)(=O)CC3)cc2)n1,"(E)-3-(4-((2-((4-((1,1-dioxidothiomorpholino)methyl)phenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile",0.034,uM,=,-1.4685210829577449,0,O=S1(=O)CCN(Cc2ccc(Nc3nccc(Oc4ccccc4)n3)cc2)CC1
4596,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1ccc2c(c1)Oc1ncc(N)cc1C(=O)N2C,"2-Amino-7,10-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2ccccc2Oc2ncccc21
4597,1463313,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 pre-incubated with compound before enzyme addition using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1cc(C)cc(Cn2c(=O)ccn(CC(=O)Nc3ccc(Cl)cc3)c2=O)c1,"N-(4-Chlorophenyl)-2-(3-(3,5-dimethylbenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",62.9,uM,=,1.7986506454452689,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
4598,717874,10.1016/j.ejmech.2010.11.033,,,,Inhibition of recombinant HIV-1 reverse transcriptase RNase H domain after 10 mins,CCCCC1C(=O)N(O)C(=O)c2ccccc21,"2-Hydroxy-4-butylisoquinoline-1,3(2H,4H)-dione",13.2,uM,=,1.1205739312058498,1,O=C1Cc2ccccc2C(=O)N1
4599,306401,10.1021/jm0408464,,,,Concentration required to inhibit strand transfer of HIV-1 integrase using Mn2+ as a divalent cation source.,O=C(O)C(=O)/C=C(\O)c1ccccc1,2-Hydroxy-4-oxo-4-phenyl-but-2-enoic acid,25.0,uM,=,1.3979400086720375,1,c1ccccc1
4600,1688928,10.1021/acs.jmedchem.6b01906,,,,Inhibition of HIV1 NL4-3 reverse transcriptase His-tagged p66/p51 associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer by scintillation counting analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)C(=O)N[C@H](C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-(3,5-dimethylphenylsulfonyl)-N-((R)-1-oxo-1-((R)-1-(pyridin-4-yl)ethylamino)propan-2-yl)-1H-indole-2-carboxamide",0.41,uM,=,-0.3872161432802645,0,O=C(CNC(=O)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1)NCc1ccncc1
4601,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)cc1,"3-Hydroxy-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)pyrimidine-2,4(1H,3H)-dione",5.7,uM,=,0.7558748556724915,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4602,197435,10.1021/jm960802y,,,,Compound concentration required to inhibit the HIV-1 recombinant Reverse transcriptase (rRT) activity by 50%.,CCC(C)Sc1nc(O)c(C)c(Cc2ccc3ccccc3c2)n1,2-sec-Butylsulfanyl-5-methyl-6-naphthalen-2-ylmethyl-3H-pyrimidin-4-one,29.7,uM,=,1.4727564493172125,1,c1ccc2cc(Cc3ccncn3)ccc2c1
4603,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,N#Cc1csc(NC(=S)NCCc2c(F)cccc2F)n1,"1-(4-Cyano-thiazol-2-yl)-3-[2-(2,6-difluoro-phenyl)-ethyl]-thiourea",0.006,uM,=,-2.2218487496163566,0,S=C(NCCc1ccccc1)Nc1nccs1
4604,195502,10.1016/s0960-894x(99)00460-6,,,,Inhibitory activity against recombinant HIV-1 reverse transcriptase (rRT),CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,1.5,uM,=,0.1760912590556812,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4605,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCN1c2ncccc2C(=O)N(C)c2ccc(N3CCCCC3)nc21,"5-Ethyl-10-methyl-7-piperidin-1-yl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.3,uM,=,-0.5228787452803376,0,O=C1Nc2ccc(N3CCCCC3)nc2Nc2ncccc21
4606,1893723,10.1016/j.ejmech.2019.05.011,,,,Inhibition of recombinant wild-type HIV1 3B reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)/oligo(dT)16 as template primer incubated for 1 hr followed by the addition of (DIG)-dUTP and biotin-labeled dNTPs by ELISA,COc1cccc(NC2=Nc3ccc(Cl)cc3C(C#CC3CC3)(C(F)(F)F)N2)c1,"6-Chloro-4-(cyclopropylethynyl)-N-(3-methoxyphenyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2-amine",0.0011,uM,=,-2.958607314841775,0,C(#CC1NC(Nc2ccccc2)=Nc2ccccc21)C1CC1
4607,196516,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Leu 100 to Ile 100 (clone 118),S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,0.7,uM,=,-0.1549019599857432,0,S=C(NCCc1ccccn1)Nc1ccccn1
4608,195360,10.1021/jm00024a010,,,,Inhibitory activity against HIV-1 Y181C Reverse transcriptase (RT),Cc1cc(C)c2c(n1)N(C1CC1)c1ncccc1C(=O)N2,"5-Cyclopropyl-7,9-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.2,uM,=,0.0791812460476248,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4609,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(C#CC1CC1)(OCc1cccnc1)C(F)(F)F,3-[3-Cyclopropyl-1-(pyridin-3-ylmethoxy)-1-trifluoromethyl-prop-2-ynyl]-1H-pyridin-2-one,0.025564,uM,=,-1.592371191123482,0,C(#CC(OCc1cccnc1)c1cccnc1)C1CC1
4610,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,CC(C)N1C(=O)c2cccn2S(=O)(=O)c2ccccc21,"9-Isopropyl-4,4-dioxo-4,9-dihydro-4lambda*6*-thia-3a,9-diaza-benzo[f]azulen-10-one",4.0,uM,=,0.6020599913279624,1,O=C1Nc2ccccc2S(=O)(=O)n2cccc21
4611,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2cccc(Oc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione",4.0,uM,=,0.6020599913279624,1,O=c1cc(Oc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4612,1575430,10.1016/j.bmc.2016.04.010,,,,Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry,Cc1ccc(COCc2c(Br)c(=O)[nH]c(=O)n2COCc2ccccc2)cc1,"1-[(Benzyloxy)methyl]-5-bromo-6-{[(4-methylbenzyl)oxy]methyl}pyrimidine-2,4(1H,3H)-dione",13.0,uM,=,1.1139433523068367,1,O=c1cc(COCc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
4613,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc(OCCCCCc3ccccc3)cc2)n[nH]1,3-(1-(4-Fluorobenzyl)-4-(4-((5-phenylpentiloxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,9.2,uM,=,0.9637878273455552,1,c1ccc(CCCCCOc2ccc(-c3cn(Cc4ccccc4)cc3-c3cc[nH]n3)cc2)cc1
4614,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1S(=O)(=O)c1cccc2ccccc12,2-Amino-6-(naphthalene-1-sulfonyl)-benzonitrile,1.0,uM,=,0.0,0,O=S(=O)(c1ccccc1)c1cccc2ccccc12
4615,1872148,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)[C@H](N)Cc1c[nH]c2ccccc12,(R)-1-(3-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-oxopropylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium,188.0,uM,=,2.27415784926368,1,O=C(CCNC(=O)CCc1c[nH]c2ccccc12)NCCc1c[nH]c2ccccc12
4616,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CN(C)CCCOc1ccc(NC(=O)COc2ccc(Cl)cc2C(=O)c2ccccc2)cc1,2-(2-Benzoyl-4-chloro-phenoxy)-N-[4-(3-dimethylamino-propoxy)-phenyl]-acetamide,0.2080804123857872,uM,=,-0.6817688001014266,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
4617,630077,10.1016/j.bmcl.2009.04.051,,,,Inhibition of biotin-dUTP labeled HIV-1 reverse transcriptase after 30 mins colorimetric streptavidin alkaline phosphatase reporter system,CC(Sc1nc(N)cc(Cc2ccccc2)n1)c1ccccc1,6-benzyl-2-(1-phenylethylthio)pyrimidin-4-amine,63.9,uM,=,1.8055008581584,1,c1ccc(CSc2nccc(Cc3ccccc3)n2)cc1
4618,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,CC(C)(C)c1ccc(-n2nnnc2SCC(=O)Nc2ccc(-c3ccc(C(C)(C)C(=O)O)cc3)cc2Cl)c(Cl)c1,2-(4'-{2-[1-(4-tert-butyl-2-chloro-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetylamino}-3'-chloro-biphenyl-4-yl)-2-methyl-propionic acid,0.01,uM,=,-2.0,0,O=C(CSc1nnnn1-c1ccccc1)Nc1ccc(-c2ccccc2)cc1
4619,196932,10.1021/jm00104a010,,,,Inhibition of purified HIV-1 reverse transcriptase,Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)[O-])cc(O)c2c1O.[Na+],"3-Amino-4,5-dihydroxy-naphthalene-2,7-disulfonic acid sodium",162.0,uM,=,2.2095150145426308,1,c1ccc2ccccc2c1
4620,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,FC(F)(F)c1csc(NC(=S)NCCc2ccccc2)n1,1-Phenethyl-3-(4-trifluoromethyl-thiazol-2-yl)-thiourea,0.55,uM,=,-0.2596373105057561,0,S=C(NCCc1ccccc1)Nc1nccs1
4621,480449,10.1021/np50105a017,,,,Inhibition of HIV1 reverse transcriptase,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1CC1=NCCc2cc(OC)c(OC)cc21,O-Methylpsychotrine,14.0,uM,=,1.146128035678238,1,c1ccc2c(c1)CCN=C2C[C@@H]1CCN2CCc3ccccc3[C@@H]2C1
4622,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1cc(OC)cc(-c2ccc(Nc3cc(=O)n(O)c(=O)[nH]3)cc2)c1,"6-((3',5'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.32,uM,=,-0.494850021680094,0,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4623,195204,10.1021/jm020977+,,,,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,c1ccc2[nH]c(-c3cscn3)nc2c1,2-Thiazol-4-yl-1H-benzoimidazole (Thiabendazole),14.6,uM,=,1.1643528557844371,1,c1ccc2[nH]c(-c3cscn3)nc2c1
4624,1328132,10.1039/C3MD00225J,,,,Inhibition of wild-type HIV1 Reverse transcriptase p51/p66 after 30 mins using alpha-[32P]dATP by liquid scintillation counting,O=C(OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1)c1cc(Cl)cc(Cl)c1,"1-[4-(3,5-Dichlorobenzoyloxy)-2-cyclopenten-1-yl]-3-benzyluracil",5.1,uM,=,0.7075701760979364,1,O=C(OC1C=CC(n2ccc(=O)n(Cc3ccccc3)c2=O)C1)c1ccccc1
4625,1784955,10.1021/acsmedchemlett.8b00054,,,,Inhibition of wild-type HIV1 reverse transcriptase infected in human MT4 cells assessed as reduction in biotin-dUTP incorporation,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2cc[nH]c12,"3,5-dimethyl-4-((2-((1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)amino)-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy)benzonitrile",0.098,uM,=,-1.0087739243075051,0,c1ccc(CN2CCC(Nc3nc(Oc4ccccc4)c4[nH]ccc4n3)CC2)cc1
4626,699967,10.1016/j.bmc.2010.12.011,,,,Inhibition RNase H activity of HIV1 reverse transcriptase expressed in Escherichia coli stain BL21(DE3)pLysS,COc1ccc(CN(C(=O)COC(=O)c2ccc([N+](=O)[O-])o2)C(C)(C)C)cc1,2-(tert-butyl(4-methoxybenzyl)amino)-2-oxoethyl 5-nitrofuran-2-carboxylate,7.5,uM,=,0.8750612633917001,1,O=C(COC(=O)c1ccco1)NCc1ccccc1
4627,1982637,10.1021/acsmedchemlett.9b00623,,,,Inhibition of recombinant HIV-1 BH10 reverse transcriptase p51/p66 expressed in Escherichia coli preincubated for 10 mins followed by D38/25PGA template-primer addition and measured after 10 to 30 secs by denaturing PAGE based single nucleotide incorporation assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.57,uM,=,-0.2441251443275086,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4628,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1ccc2c(c1)Oc1ccc(N)cc1C(=O)N2C,"2-Amino-7,10-dimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2ccccc2Oc2ccccc21
4629,195845,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (P236L),Nc1cc(Cl)nc(SCC2=CCCc3ccccc32)n1,"6-Chloro-2-(3,4-dihydro-naphthalen-1-ylmethylsulfanyl)-pyrimidin-4-ylamine",0.6,uM,=,-0.2218487496163563,0,C1=C(CSc2ncccn2)c2ccccc2CC1
4630,1451901,10.1016/j.bmcl.2014.05.079,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA plate reader analysis,O=C1c2cccnc2S[C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)N12,"(7S,8R,9S,10S,10aS)-8,9,10-trihydroxy-7-(hydroxymethyl)-8,9,10,10a-tetrahydro-5H,7H-dipyrido[2,1-b:3',2'-e][1,3]thiazin-5-one",31.37,uM,=,1.496514518697745,1,O=C1c2cccnc2S[C@H]2CCCCN12
4631,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2ccc(Cl)cc2N(C)C(=O)c2cccnc21,"8-Chloro-11-ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.17,uM,=,-0.7695510786217261,0,O=C1Nc2ccccc2Nc2ncccc21
4632,2226592,10.1016/j.ejmech.2022.114471,,,,Inhibition of wild type HIV-1 reverse transcriptase assessed as reduction of biotin-dUTP incorporation into protein using ABTS as substrate incubated for 1 hrs by ELISA analysis,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC3CC4(C3)CN(Cc3n[nH]c(=O)n3C)C4)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-azaspiro [3.3]heptan-6-yl)-1H-indole-2-carboxamide",0.17,uM,=,-0.7695510786217261,0,O=C(NC1CC2(C1)CN(Cc1n[nH]c(=O)[nH]1)C2)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4633,854340,10.1016/j.ejmech.2012.03.032,,,,Inhibition of wild type HIV1 reverse transcriptase activity using poly (rA)/oligo (dT)15 homopolymer template after 1 hr by ELISA,Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1,2-[4-Chloro-2-(3-chloro-5-cyano-benzoyl)-phenoxy]-N-(2-methyl-4-sulfamoyl-phenyl)-acetamide,0.00269,uM,=,-2.570247719997592,0,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
4634,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,Cc1sc2[nH]c(=O)n(O)c(=O)c2c1C,"3-Hydroxy-5,6-dimethylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione",0.1,uM,=,-1.0,0,O=c1[nH]c(=O)c2ccsc2[nH]1
4635,1617976,10.1016/j.ejmech.2016.05.054,,,,Inhibition of recombinant wild type HIV1 p66/p51 using poly(rA) template/oligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method,COc1cc(Oc2c(C)cc(C#N)cc2C)cc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)n1,"4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-6-methoxypyridin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.113,uM,=,-0.9469215565165804,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)ccn3)CC2)cc1
4636,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),S=C1c2ccccc2C2(c3ccccc3)SCCN12,"9b-Phenyl-2,3-dihydro-9bH-thiazolo[2,3-a]isoindole-5-thione",3.5,uM,=,0.5440680443502757,1,S=C1c2ccccc2C2(c3ccccc3)SCCN12
4637,1473838,10.1021/jm501799k,,,,Inhibition of HIV-1 recombinant RT-associted RNase H activity expressed in Escherichia coli M15 using poly(dC)-[3H]poly(rG) hybrid as substrate,O=C(/C=C(\O)C(=O)O)/C=C/c1cc(C(=O)c2ccc(F)cc2)cn1-c1ccccc1,"6-(4-(4-Fluorobenzoyl)-1-phenyl-1H-pyrrol-2-yl)-2-hydroxy-4-oxohexa-2,5-dienoic Acid",100.0,uM,=,2.0,1,O=C(c1ccccc1)c1ccn(-c2ccccc2)c1
4638,600527,10.1021/jm801176e,,,,Inhibition of HIV1 wild type reverse transcriptase-mediated viral DNA synthesis in human HOS cells assessed as luciferase activity treated 3 hrs before infection measured after 48 hrs by luminescence assay,Cc1cccc2c1OP(=O)(OC[C@H]1C[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]1O)OC2,"1-{(3S,1R,4R)-3-hydroxy-4-[(8-methyl-2-oxo(4H-benzo[d]1,3,2-dioxaphosphan-2-yloxy))methylcyclopentyl}-5-methyl-1,3-dihydropyrimidine-2,4(1H,3H)-dione",0.38,uM,=,-0.4202164033831898,0,O=c1ccn([C@H]2CC[C@@H](COP3(=O)OCc4ccccc4O3)C2)c(=O)[nH]1
4639,195074,10.1016/s0960-894x(98)00369-2,,,,Compound was tested for inhibitory activity against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C=Cc2cccnc21,"5-Ethyl-5H-4,5,6-triaza-dibenzo[a,d]cycloheptene",0.04,uM,=,-1.3979400086720375,0,C1=Cc2cccnc2Nc2ncccc21
4640,1454138,10.1016/j.bmc.2014.07.018,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase p66/p51 using dsDNA by microplate reader based assay,CCN1c2ncccc2NC(=O)c2ccc(N3CCN(c4cc5c(cc4N)c(=O)c(C(=O)O)cn5C)CC3)nc21,"6-Amino-7-[4-(11-ethyl-6-oxo-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-9-yl)piperazin-1-yl]-1-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",8.4,uM,=,0.9242792860618816,1,O=C1Nc2cccnc2Nc2nc(N3CCN(c4ccc5c(=O)cc[nH]c5c4)CC3)ccc21
4641,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,O=C(CSc1nnnn1-c1ccc(C2CC2)cc1Cl)Nc1ccc(C#CCCO)cc1Cl,N-(2-chloro-4-(4-hydroxybut-1-ynyl)phenyl)-2-(1-(2-chloro-4-cyclopropylphenyl)-1H-tetrazol-5-ylthio)acetamide,0.002,uM,=,-2.6989700043360187,0,O=C(CSc1nnnn1-c1ccc(C2CC2)cc1)Nc1ccccc1
4642,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCSc1cc(NCc2nc3ccccc3o2)c(O)nc1C,3-[(Benzooxazol-2-ylmethyl)-amino]-5-ethylsulfanyl-6-methyl-1H-pyridin-2-one,0.43,uM,=,-0.3665315444204134,0,c1cncc(NCc2nc3ccccc3o2)c1
4643,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,COc1ccc(OC)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,5-dimethoxy-phenyl)-ethyl]-thiourea",0.038,uM,=,-1.42021640338319,0,S=C(NCCc1ccccc1)Nc1ccccn1
4644,306024,10.1021/jm0402014,,,,Inhibitory concentration against human immunodeficiency virus type 1 reverse transcriptase,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,"2-(3-Amino-5-methyl-5H-1,4,5,6,8-pentaaza-acenaphthylen-1-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol",0.02,uM,=,-1.6989700043360187,0,C1=NNc2ncnc3c2c1cn3[C@H]1CCCO1
4645,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,O=C(/C=C/c1cccn1Cc1cc(Cl)cc(Cl)c1)CC(=O)C(=O)O,"6-[1-(3,5-Dichlorophenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoicAcid",30.0,uM,=,1.4771212547196624,1,c1ccc(Cn2cccc2)cc1
4646,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,COC(=O)[C@H](C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C#CCOCCOCCOCCOCCOc3ccc(OC)cc3CCNC(=S)Nc3ccc(Br)cn3)c(=O)[nH]c2=O)O1)Oc1ccc(C)cc1,"5-{15-[2-(2-(5-Bromo-2-pyridinylaminothiocarbonylamino)-ethyl)-4-methoxyphenoxy]pentadeca-4,7,10,13-tetraoxa-1-ynyl}-2',3-didehydro-2',3'-dideoxy-5-iodouridine-5'-5'-(p-methylphenylmethoxyalaninyl phosphate)-2',3'-didehydro-2',3'-dideoxyuridine",2.3,uM,=,0.3617278360175928,1,O=c1[nH]c(=O)n([C@H]2C=C[C@@H](CO[PH](=O)Oc3ccccc3)O2)cc1C#CCOCCOCCOCCOCCOc1ccccc1CCNC(=S)Nc1ccccn1
4647,1924020,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT using A5'-end 32P-labeled 24-mer primer/a48-mer template preincubated for 5 mins followed by 0.5 uM nucleotides addition measured after 15 mins by gel-based primer extension assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccccc2)C1,"1-benzyl-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",10.0,uM,=,1.0,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
4648,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,Cc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-3-yl)amino)-pyrimidine-2,4(1H,3H)-dione",7.2,uM,=,0.8573324964312685,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4649,632040,10.1016/j.bmc.2010.03.025,,,,Inhibition of HIV1 reverse transcriptase by ELISA,O=c1[nH]c(SCCCc2ccccc2)nc(Cc2ccccc2)c1I,6-Benzyl-5-iodo-2-(3-phenylpropylthio)pyrimidin-4(3H)-one,0.18,uM,=,-0.744727494896694,0,O=c1cc(Cc2ccccc2)nc(SCCCc2ccccc2)[nH]1
4650,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2F)nc2c1CSCC2,"4-(2-(4-cyano-2-fluorophenylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.065,uM,=,-1.1870866433571443,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CSCC3)cc1
4651,1899208,10.1016/j.ejmech.2019.01.081,,,,Inhibition of HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS-1,O=C(c1ccc(-c2ccc(F)cc2)cc1)c1cc(=O)n(O)c(=O)[nH]1,"6-(4'-Fluoro-[1,1'-biphenyl]-4-carbonyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.027,uM,=,-1.5686362358410126,0,O=C(c1ccc(-c2ccccc2)cc1)c1cc(=O)[nH]c(=O)[nH]1
4652,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),COc1cccc(C23SCCN2C(=O)c2ccccc23)c1,"9b-(3-Methoxy-phenyl)-2,3-dihydro-9bH-thiazolo[2,3-a]isoindol-5-one",0.97,uM,=,-0.0132282657337551,0,O=C1c2ccccc2C2(c3ccccc3)SCCN12
4653,1519673,10.1039/C4MD00282B,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of [32P]GTP into poly(rC).oligo(dG) template primer,Cc1ccc(/N=N/c2sc(N3Nc4onc(-c5ccccc5)c4C3c3ccc(Cl)cc3)nc2C)cc1,"4-(4-Chlorophenyl)-5-(4-methyl-5-(p-tolyldiazenyl)thiazol-2-yl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole",2.7e-05,uM,=,-4.568636235841013,0,c1ccc(/N=N/c2cnc(N3Nc4onc(-c5ccccc5)c4C3c3ccccc3)s2)cc1
4654,1801099,10.1016/j.ejmech.2018.07.039,,,,Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate,O=c1cc(Sc2cccc(Br)c2)[nH]c(=O)n1O,"6-((3-Bromophenyl)thio)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
4655,1501272,10.1016/j.bmc.2015.03.037,,,,Inhibition of wild-type HIV1 Reverse transcriptase p66/p51 assessed as relative fluorescence signal after 40 mins,CCn1cc(C(=O)O)c(=O)c2ccc(Nc3ccnc(Nc4ccc(C#N)cc4)n3)cc21,"7-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",7.07,uM,=,0.8494194137968994,1,O=c1cc[nH]c2cc(Nc3ccnc(Nc4ccccc4)n3)ccc12
4656,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3c(F)cc(-c4cccc(F)c4)cc3F)c2=O)n[nH]c1=O,"1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-3-((3,3',5-trifluoro-[1,1'-biphenyl]-4-yl)oxy)-4-(trifluoromethyl)pyridin-2(1H)-one",26.28,uM,=,1.4196253608877432,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
4657,2123611,10.1021/acs.jmedchem.1c01015,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation into protein incubated for 1 hrs by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)c(F)c2)nc2c1CSCC2,"4-(2-(4-cyano-3-fluorophenylamino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",0.053,uM,=,-1.275724130399211,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)CSCC3)cc1
4658,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CCNC(=S)Nc2ccc(C#N)cn2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-3-(5-cyano-pyridin-2-yl)-thiourea,0.005,uM,=,-2.3010299956639813,0,S=C(NCCc1ccccc1)Nc1ccccn1
4659,1300518,10.1039/C3MD00247K,,,,Inhibition of HIV-1 wild type recombinant reverse transcriptase p66/p51 assessed as RNA-DNA heteroduplex formation using poly(rA) template/oligo(dT)16 primer incubated prior to enzyme addition by spectrofluorometer analysis,COc1ccc(CSc2nc(C(C#N)c3ccccc3Br)c(C)c(=O)[nH]2)cc1,"2-(2-(4-methoxybenzylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(2-bromophenyl)acetonitrile",1.55,uM,=,0.1903316981702915,1,O=c1cc(Cc2ccccc2)nc(SCc2ccccc2)[nH]1
4660,435025,10.1021/jm0613121,,,,Inhibition of DNA polymerase activity of HIV1 reverse transcriptase,N#CCC(=O)Cc1cccc(I)c1,4-(3-iodophenyl)-3-oxobutanenitrile,3.5,uM,=,0.5440680443502757,1,c1ccccc1
4661,195673,10.1016/s0960-894x(00)00624-7,,,,Tested for inhibitory concentration against HIV-1 non-nucleoside reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)N1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinazolin-2-one",0.031,uM,=,-1.5086383061657274,0,O=C1Nc2ccccc2C(C#CC2CC2)N1
4662,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CCc1cc(C)c2c(n1)N(CC)c1ncccc1C(=O)N2,"5,7-Diethyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncccc21
4663,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,CCN1C(=O)c2cc(N)ccc2Oc2cc(C)cc(C)c21,"2-Amino-10-ethyl-7,9-dimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.043,uM,=,-1.3665315444204136,0,O=C1Nc2ccccc2Oc2ccccc21
4664,447797,10.1016/j.bmcl.2007.06.012,,,,Inhibition of HIV1 reverse transcriptase by scintillation proximity assay,NS(=O)(=O)c1ccc(NC(=O)CSc2nnnn2-c2ccc(C3CC3)cc2Cl)c(Cl)c1,2-[1-(2-chloro-4-cyclopropyl-phenyl)-1H-tetrazol-5-ylsulfanyl]-N-(2-chloro-4-sulfamoyl-phenyl)-acetamide,0.005,uM,=,-2.3010299956639813,0,O=C(CSc1nnnn1-c1ccc(C2CC2)cc1)Nc1ccccc1
4665,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)cc1,"3-Hydroxy-1-methyl-6-((4'-methyl-[1,1'-biphenyl]-4-yl)amino)-pyrimidine-2,4(1H,3H)-dione",2.7,uM,=,0.4313637641589873,1,O=c1cc(Nc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4666,1477014,10.1021/np5006696,,,,"Inhibition of human immunodeficiency virus-1 reverse transcriptase associated RNase H activity using using 18-nucleotide 3,-fluorescein-labeled RNA substrate by fluorescence resonance energy transfer assay",C=C(C)[C@@H]1CCc2cc(O[C@@H]3O[C@H](COC(=O)CC(C)(O)CC(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c(=O)cc(C)c2C1,"2-isopropenyl-9-methyl-1,2,3,4-tetrahydrobenzocyclohepten-7-one-6-O-[6'-(3''-hydroxy-3''-methylglutaryl)]-beta-D-glucopyranoside",34.0,uM,=,1.5314789170422551,1,O=c1ccc2c(cc1O[C@H]1CCCCO1)CCCC2
4667,2222731,10.1021/acs.jmedchem.2c00468,,,,Inhibition of HIV-1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorometric analysis,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4668,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),CCN1c2cc(Cl)c(Cl)cc2N(C)C(=O)c2cccnc21,"8,9-Dichloro-11-ethyl-6-methyl-6,11-dihydro-benzo[b]pyrido[2,3-e][1,4]diazepin-5-one",0.062,uM,=,-1.207608310501746,0,O=C1Nc2ccccc2Nc2ncccc21
4669,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,C=CCCCC=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,"methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-1,6-heptadienyl]-2-methoxybenzoate",258.0,uM,=,2.41161970596323,1,C=C(c1ccccc1)c1ccccc1
4670,1759388,10.1016/j.ejmech.2017.07.012,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 assessed as reduction in biotin-dUTP incorporation incubated for 40 mins using poly(rA) template and oligo(dT)16 primer by picogreen dye based spectrofluorometry,Cc1cc(C#N)cc(C)c1Oc1cnc(N)c(Nc2ccc(C#N)cc2)c1,"4-((6-amino-5-((4-cyanophenyl)amino)pyridin-3-yl)oxy)-3,5-dimethylbenzonitrile",0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2cncc(Oc3ccccc3)c2)cc1
4671,197436,10.1016/S0960-894X(01)80472-8,,,,Compound concentration that causes 50 % inhibition of HIV-1 peptide-derived reverse transcriptase (RT),Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)OP(=O)(O)C(F)(F)P(=O)(O)O)O2)c(=O)[nH]c1=O,Azidothymidine difluoromethylenephosphonate derivative,0.62,uM,=,-0.2076083105017461,0,O=c1ccn(C2CCCO2)c(=O)[nH]1
4672,195369,10.1021/jm00010a010,,,,Inhibitory activity against HIV-1 reverse transcriptase,CCN(CC)CCOc1ccc(NC(=O)COc2cc(OC)ccc2C(=O)c2ccccc2)cc1,2-(2-Benzoyl-5-methoxy-phenoxy)-N-[4-(2-diethylamino-ethoxy)-phenyl]-acetamide,13.228870830410829,uM,=,1.1215227759297397,1,O=C(COc1ccccc1C(=O)c1ccccc1)Nc1ccccc1
4673,642255,10.1016/j.bmc.2010.05.025,,,,Inhibition of HIV1 reverse transcriptase-mediated thymidine incorporation into D23/D36 primer-template preincubated for 15 mins by polyacrylamide gel-electrophoresis,COc1ccc(OCCC#Cc2cn([C@H]3C=C[C@@H](CO)O3)c(=O)[nH]c2=O)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"5-{4-[2-(2-(5-Bromo-2-pyridinylaminothiocarbonylamino)-ethyl)-4-methoxyphenoxy]but-1-ynyl}-2',3'-didehydro-2',3'-dideoxyuridine",0.061,uM,=,-1.214670164989233,0,O=c1[nH]c(=O)n([C@H]2C=CCO2)cc1C#CCCOc1ccccc1CCNC(=S)Nc1ccccn1
4674,321370,10.1021/jm050437n,,,,Inhibitory concentration required to inhibit recombinant HIV-1 reverse transcriptase ,CNC(=O)CCCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"6-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-hexanoic acid methylamide",2.4,uM,=,0.380211241711606,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4675,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)CCCCC(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,methyl 3-chloro-5-[1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-5-methyloxycarbonylpentyl]-2-methoxybenzoate,100.0,uM,=,2.0,1,c1ccc(Cc2ccccc2)cc1
4676,968173,10.1016/j.bmcl.2013.04.043,,,,Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay,CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4cnc(-c5cn(C)cn5)cc4c32)CCO1,"Cis-4-(2-Ethyl-tetrahydro-pyran-4-yl)-6-(1-methyl-1H-imidazol-4-yl)-1-(1-methyl-1H-pyrazol-4-yl)-4H-9-oxa-2,4,7-triaza-fluoren-3-one",0.0059,uM,=,-2.229147988357856,0,O=c1nc(-c2cn[nH]c2)c2oc3cnc(-c4c[nH]cn4)cc3c2n1C1CCOCC1
4677,195222,10.1021/jm00054a009,,,,In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG template primer,CCc1cc(NCc2ccccc2F)c(O)nc1C,5-Ethyl-3-(2-fluoro-benzylamino)-6-methyl-1H-pyridin-2-one,1.4,uM,=,0.1461280356782379,1,c1ccc(CNc2cccnc2)cc1
4678,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccc(C(=O)O)cc3)C2=O)SC1=S)Nc1ccc(C(=O)O)cc1,"4-{5-[3-(4-carboxyphenylcarbamoylmethyl)-4-oxo-2-thioxo-1,3-thiazolan-5-yliden]-4-oxo-2-thioxo-1,3-thiazolan-3-ylmethylcarboxamido}benzoic acid",59.0,uM,=,1.7708520116421442,1,O=C(CN1C(=O)/C(=C2\SC(=S)N(CC(=O)Nc3ccccc3)C2=O)SC1=S)Nc1ccccc1
4679,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,O=c1cc(Cc2ccc(-c3ccc(Cl)c(F)c3)cc2)[nH]c(=O)n1O,"6-((4'-chloro-3'-fluoro-[1,1'-biphenyl]-4-yl)methyl)-3-hydroxypyrimidine-2,4(1H,3H)-dione",0.0094,uM,=,-2.026872146400301,0,O=c1cc(Cc2ccc(-c3ccccc3)cc2)[nH]c(=O)[nH]1
4680,195670,10.1021/jm00069a011,,,,Inhibitory activity against HIV-1 reverse transcriptase (HIV-RT),CC(C)=CCN1Cc2cccc3[nH]c(=S)n(c23)C[C@@H]1C,"(S)-8-Methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",0.16,uM,=,-0.7958800173440752,0,S=c1[nH]c2cccc3c2n1CCNC3
4681,196959,10.1021/jm00088a027,,,,In vitro inhibitory activity against HIV-1 reverse transcriptase.,Cc1ccc2c(c1)Oc1ccccc1C(=O)N2C,"7,10-Dimethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one",0.6,uM,=,-0.2218487496163563,0,O=C1Nc2ccccc2Oc2ccccc21
4682,495635,10.1021/jm800527x,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 reverse transcriptase by SPA,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4c(C#N)cccc34)c2F)c1,3-[4-Bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorobenzyl]-1H-indazole-7-carbonitrile,0.024,uM,=,-1.619788758288394,0,c1ccc(Oc2cccc(Cc3n[nH]c4ccccc34)c2)cc1
4683,195847,10.1021/jm9800806,,,,Inhibition of HIV-1 reverse transcriptase (wild type),Nc1cc(Cl)nc(SCc2ccc3ccccc3c2)n1,6-Chloro-2-(naphthalen-2-ylmethylsulfanyl)-pyrimidin-4-ylamine,0.46,uM,=,-0.3372421683184259,0,c1cnc(SCc2ccc3ccccc3c2)nc1
4684,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,CCOc1ccc(F)c(CC/N=C(\S)N[n+]2ccc(Cl)cn2)c1Cl,1-[2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-3-(4-chloro-pyridazin-1-yl)-thiourea,0.005,uM,=,-2.3010299956639813,0,C(=NCCc1ccccc1)N[n+]1ccccn1
4685,440584,10.1021/jm070512p,,,,Inhibition of HIV1 reverse transcriptase,Cc1cc(C)cc(Cc2c(C(C)C)c(=O)[nH]c(=O)n2COCc2ccc(C(=O)/C=C(\O)C(=O)O)cc2)c1,"4-(4-(((6-(3,5-dimethylbenzyl)-5-isopropyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)methyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid",0.0092,uM,=,-2.036212172654445,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
4686,1740441,10.1016/j.ejmech.2018.06.036,,,,Inhibition of HIV-1 BH10 reverse transcriptase RNase H activity expressed in Escherichia coli using [32P]-labeled template primer 31Trna/21P as substrate pretreated for 5 mins followed by substrate addition by polyacrylamide gel electrophoresis method,COC(=O)c1c(Nc2cccc(-c3ccc(C#N)cc3)c2)c2nccnc2n(O)c1=O,"Methyl 8-((4'-cyano-[1,1'-biphenyl]-3-yl)amino)-5-hydroxy-6-oxo-5,6-dihydropyrido[2,3-b]pyrazine-7-carboxylate",5.56,uM,=,0.7450747915820575,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)c2nccnc2[nH]1
4687,2204934,10.1016/j.ejmech.2022.114581,,,,Inhibition of wild type HIV-1 Reverse transcriptase,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3ccc(-c4ccc(F)c(C#N)c4)cc3Cl)c2=O)n[nH]c1=O,"3'-chloro-4-fluoro-4'-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile",10.26,uM,=,1.0111473607757977,1,O=c1[nH]nc(Cn2cccc(Oc3ccc(-c4ccccc4)cc3)c2=O)[nH]1
4688,195514,10.1021/jm0004906,,,,Inhibitory activity against HIV-1 reverse transcriptase,N#Cc1c(N)cccc1Sc1ccccc1,2-Amino-6-phenylsulfanyl-benzonitrile,8.7,uM,=,0.9395192526186184,1,c1ccc(Sc2ccccc2)cc1
4689,1834345,10.1021/acsmedchemlett.8b00549,,,,Inhibition of wild-type HIV1 reverse transcriptase in HIV1 infected HEK293T cells harboring luciferase gene assessed as reduction in viral infection after 48 hrs by Bright-Glo luciferase assay,CCOC(=O)c1[nH]c2ccc(Cl)cc2c1C(OC)c1ccccc1,ethyl 5-chloro-3-(methoxy(phenyl)methyl)-1H-indole-2-carboxylate,0.016,uM,=,-1.7958800173440752,0,c1ccc(Cc2c[nH]c3ccccc23)cc1
4690,446085,10.1021/jm070382k,,,,Inhibition of HIV1 reverse transcriptase,COc1c(C)cc(/C(=C\CCCc2nnc(C)o2)c2cc(C)c3onc(OC)c3c2)cc1C(=O)SC,"(Z)-S-methyl 2-methoxy-5-(1-(3-methoxy-7-methylbenzo[d]-isoxazol-5-yl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl)-3-methylbenzothioate",0.47,uM,=,-0.3279021420642826,0,C(\CCCc1nnco1)=C(\c1ccccc1)c1ccc2oncc2c1
4691,195075,10.1016/s0960-894x(99)00675-7,,,,Inhibition of wild-type HIV-1 Reverse transcriptase.,O=C(CC/N=C(\S)Nc1ccc(Cl)cn1)c1c(F)cccc1F,"1-(5-Chloro-pyridin-2-yl)-3-[3-(2,6-difluoro-phenyl)-3-oxo-propyl]-thiourea",0.006,uM,=,-2.2218487496163566,0,O=C(CCN=CNc1ccccn1)c1ccccc1
4692,197451,10.1016/s0960-894x(98)00214-5,,,,Evaluated for inhibition of HIV-1 reverse transcriptase,O=C(CCCCC(=O)Nc1ccc(C(F)(F)F)cc1C(=O)O)Nc1ccc(C(F)(F)F)cc1C(=O)O,2-[4-(2-carboxy-4-trifluoromethylphenylcarbamoyl)butylcarboxamido]-5-trifluoromethylbenzoic acid,12.0,uM,=,1.0791812460476249,1,O=C(CCCCC(=O)Nc1ccccc1)Nc1ccccc1
4693,564789,10.1021/jm801470b,,,,Inhibition of HIV1 reverse transcriptase p66/p51,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCS(N)(=O)=O)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-(2-sulfamoylethyl)-1H-indole-2-carboxamide",0.061,uM,=,-1.214670164989233,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
4694,306176,10.1021/jm0496077,,,,Inhibitory concentration against human immuno deficiency virus type 1 integrase (3'-processing),CC(/C=C1\SC(=S)N(CCC(=O)Nc2ccc(O)c(C(=O)O)c2)C1=O)=C\c1ccccc1,2-Hydroxy-5-(3-{5-[(E)-2-methyl-3-phenyl-prop-2-en-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionylamino)-benzoic acid,36.0,uM,=,1.5563025007672873,1,O=C(CCN1C(=O)/C(=C/C=C/c2ccccc2)SC1=S)Nc1ccccc1
4695,195521,10.1021/jm00024a010,,,,Inhibitory concentration against HIV-1 wild type Reverse transcriptase (RT),CN1C(=O)c2cccnc2N(C2CC2)c2nc(-c3cc[nH]c3)ccc21,"5-Cyclopropyl-10-methyl-7-(1H-pyrrol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2ccc(-c3cc[nH]c3)nc2N(C2CC2)c2ncccc21
4696,1448873,10.1016/j.ejmech.2014.07.104,,,,Inhibition of purified recombinant HIV-1 reverse transcriptase after 1 hr using biotin-labeled dUTP by digoxigenin-peroxidase assay,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)nc2ncnn12,"4-((5-((4-Cyanophenyl)amino)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)oxy)-3,5-dimethylbenzonitrile",0.39,uM,=,-0.4089353929735008,0,c1ccc(Nc2cc(Oc3ccccc3)n3ncnc3n2)cc1
4697,1801106,10.1016/j.ejmech.2018.07.035,,,,Inhibition of recombinant HIV1 reverse transcriptase RNase H expressed in Escherichia coli JM109 using RNA/DNA duplex substrate HTS1 as substrate,CC(C)c1c(Cc2ccccc2)n(COCCc2ccc(F)cc2)c(=O)n(O)c1=O,"6-Benzyl-1-((4-fluorophenethoxy)methyl)-3-hydroxy-5-isopropylpyrimidine-2,4(1H,3H)-dione",2.8,uM,=,0.4471580313422192,1,O=c1cc(Cc2ccccc2)n(COCCc2ccccc2)c(=O)[nH]1
4698,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,O=C1c2cccn2-c2ccccc2SC1c1ccccc1,5-Phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,100.0,uM,=,2.0,1,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
4699,856671,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 0.05 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,NC(=O)[C@H](CCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1)NC(=O)CCNC(=O)C(N)CNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc32)cc1,"N-[(4S)-5-amino-4-[3-[[2-amino-3-[[4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzoyl]amino]propanoyl]amino]propanoylamino]-5-oxo-pentyl]-4-[(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)methyl]benzamide",0.0092,uM,=,-2.036212172654445,0,O=C(CCNC(=O)CCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1)NCCCCNC(=O)c1ccc(C[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
4700,740785,10.1016/j.bmcl.2011.02.069,,,,Inhibition of HIV-1 reverse transcriptase,CCc1c(C(=O)c2cc(C)cc(C)c2)n(COCc2ccccc2)c(=O)n(O)c1=O,"1-(Benzyloxymethyl)-6-(3,5-dimethylbenzoyl)-5-ethyl-3-hydroxypyrimidine-2,4(1H,3H)-dione",1.0,uM,=,0.0,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1COCc1ccccc1
4701,195381,10.1021/jm9800595,,,,Inhibitory activity against human immunodeficiency virus (HIV) - 1 reverse transcriptase with rCdG as the template primer,COC(=O)C=C(c1cc(Cl)c(OC)c(C(=O)OC)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,"Methyl 3',3''-Dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-3,3-diphenylpropenoate",16.0,uM,=,1.2041199826559248,1,C=C(c1ccccc1)c1ccccc1
4702,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COCc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,6-difluoro-3-methoxymethyl-phenyl)-ethyl]-thiourea",0.004,uM,=,-2.397940008672037,0,S=C(NCCc1ccccc1)Nc1ccccn1
4703,195685,10.1021/jm950639r,,,,Tested for the inhibition of wild type HIV-1 (IIIB) RT,COc1ccc(OC)c(CCNC(=S)Nc2ccc(Cl)cn2)c1,"1-(5-Chloro-pyridin-2-yl)-3-[2-(2,5-dimethoxy-phenyl)-ethyl]-thiourea",0.005,uM,=,-2.3010299956639813,0,S=C(NCCc1ccccc1)Nc1ccccn1
4704,1276474,10.1021/jm401040b,,,,Inhibition of RNase H activity of recombinant HIV1 reverse transcriptase using poly(dC)-[3H]poly(rG) as substrate,CCOC(=O)C(=O)CC(=O)/C=C/c1cccn1Cc1cc(C)cc(C)c1,"6-[1-(3,5-Dimethylphenyl)methyl-1H-pyrrol-2-yl]-2,4-dioxo-5-hexenoic Acid Ethyl Ester",6.0,uM,=,0.7781512503836436,1,c1ccc(Cn2cccc2)cc1
4705,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OC1COc2cccc(O)c2C1)c1cc(O)c(O)c(O)c1,"3,4,5-Trihydroxy-benzoic acid 5-hydroxy-chroman-3-yl ester",45.5,uM,=,1.6580113966571124,1,O=C(OC1COc2ccccc2C1)c1ccccc1
4706,195220,10.1021/jm00111a045,,,,In vitro inhibitory activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT),O=C1Nc2cccnc2N(C2CCC2)c2ncccc21,"5-Cyclobutyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.43,uM,=,-0.3665315444204134,0,O=C1Nc2cccnc2N(C2CCC2)c2ncccc21
4707,197427,10.1016/s0960-894x(01)00331-6,,,,Inhibition of HIV-1 reverse transcriptase.,O=C1C[C@](C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2N1,"(R)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-1H-quinolin-2-one",0.13,uM,=,-0.8860566476931633,0,O=C1CC(C#CC2CC2)c2ccccc2N1
4708,195688,10.1021/jm00042a004,,,,The 50% inhibitory concentration was measured as inhibition of Ribonuclease H activity of reverse transcriptase,O=C(Oc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)ccc12)c1ccc(-c2ccc(C(=O)Oc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)ccc34)cc2)cc1,"Biphenyl-4,4'-dicarboxylic acid bis-(3,6-disulfo-naphthalen-1-yl) ester",14.4,uM,=,1.1583624920952498,1,O=C(Oc1cccc2ccccc12)c1ccc(-c2ccc(C(=O)Oc3cccc4ccccc34)cc2)cc1
4709,195357,10.1021/jm010212m,,,,Inhibitory activity against HIV-1 Reverse Transcriptase with rCdG as the template primer,CCCCCC=C(c1ccc(OC)c(C(=O)OC)c1)c1ccc(OC)c(C(=O)OC)c1,"4',4''-Dimethoxy-3',3''-bis(methoxycarbonyl)-1,1-diphenyl-1-heptene",3.2,uM,=,0.505149978319906,1,C=C(c1ccccc1)c1ccccc1
4710,195375,10.1021/jm9707030,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(COc3ccc(O)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-(4-hydroxy-phenoxymethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2cccnc2Nc2ncc(COc3ccccc3)cc21
4711,1513506,10.1016/j.bmc.2015.06.016,,,,Inhibition of HIV1 reverse transcriptase,O=C(NNc1nc2ccccc2n2cccc12)c1cnccn1,"Pyrazine-2-carboxylic acid N'-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazide",19.0,uM,=,1.2787536009528289,1,O=C(NNc1nc2ccccc2n2cccc12)c1cnccn1
4712,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,S=C(NCCCc1ccccc1)Nc1nccs1,1-(3-Phenyl-propyl)-3-thiazol-2-yl-thiourea,4.5,uM,=,0.6532125137753437,1,S=C(NCCCc1ccccc1)Nc1nccs1
4713,195664,10.1021/jm00132a002,,,,Inhibitory effect on HIV-1 reverse transcriptase activity using poly(rC)-oligo(dG) template primer,Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O,"1-(2-Hydroxy-ethoxymethyl)-5-methyl-6-phenylsulfanyl-1H-pyrimidine-2,4-dione",150.0,uM,=,2.1760912590556813,1,O=c1cc(Sc2ccccc2)[nH]c(=O)[nH]1
4714,989557,10.1016/j.bmc.2013.08.040,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 (1:1.2) as template/primer after 40 mins by spectrofluorometric analysis,CCc1c(C(=O)c2cc(F)cc(F)c2)nc(SCc2ccc(OC)cc2)[nH]c1=O,"2-(4-Methoxybenzylthio)-6-(3,5-difluorobenzoyl)-5-ethylpyrimidin-4(3H)-one",0.16,uM,=,-0.7958800173440752,0,O=C(c1ccccc1)c1cc(=O)[nH]c(SCc2ccccc2)n1
4715,1720242,10.1016/j.ejmech.2017.09.054,,,,Inhibition of RNH activity of recombinant HIV1 reverse transcriptase RNase H assessed as reduction in internal cleavage of RNA strand using RNA/DNA duplex substrate HTS-1,O=c1[nH]c2cc(-c3ccc(Cl)cc3)sc2c(=O)n1O,"6-(4-Chlorophenyl)-3-hydroxythieno[3,2-d]pyrimidine-2,4(1H,3H)-dione",0.07,uM,=,-1.154901959985743,0,O=c1[nH]c(=O)c2sc(-c3ccccc3)cc2[nH]1
4716,1450642,10.1021/jm501010f,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as inhibition of DNA primer extension using [8-3H(N)]-dATP by scintillation proximity assay,COc1cccc(-c2cnc3ncnc(NCC(P(=O)(O)O)P(=O)(O)O)c3c2)c1,"(2-((6-(3-Methoxyphenyl)pyrido[2,3-d]pyrimidin-4-yl)-amino)ethane-1,1-diyl)diphosphonic Acid",20.0,uM,=,1.3010299956639813,1,c1ccc(-c2cnc3ncncc3c2)cc1
4717,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CN(C)CCCOc1ccc2c(c1)c(=O)c(C(=O)O)cn2Cc1ccc(F)cc1,"6-(3-(Dimethylamino)propoxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid",15.4,uM,=,1.187520720836463,1,O=c1ccn(Cc2ccccc2)c2ccccc12
4718,195678,10.1016/s0960-894x(01)00827-7,,,,Inhibition of HIV-1 reverse transcriptase polymerization using wild type HIV-1-RT enzyme,O=C(OC1COc2cc(O)cc(O)c2C1)c1ccc(O)c(O)c1,"3,4-Dihydroxy-benzoic acid 5,7-dihydroxy-chroman-3-yl ester",37.2,uM,=,1.5705429398818975,1,O=C(OC1COc2ccccc2C1)c1ccccc1
4719,355438,10.1016/j.bmcl.2006.02.024,,,,Inhibition of HIV1 wild type Reverse Transcriptase,Cc1cc(C)c(-n2nnnc2SCC(=O)Nc2ccc(S(N)(=O)=O)cc2)c(C)c1,"N-(4-sulfamoyl-phenyl)-2-[1-(2,4,6-trimethyl-phenyl)-1H-tetrazol-5-ylsulfanyl]-acetamide",1.252,uM,=,0.0976043288744108,1,O=C(CSc1nnnn1-c1ccccc1)Nc1ccccc1
4720,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2ccc(Cl)cc2n1Cc1cc(F)cc(F)c1,"6-Chloro-1-(3,5-difluorobenzyl)-1,3-dihydro-2H-benzimidazol-2-one",0.1,uM,=,-1.0,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
4721,2026091,10.1021/acsmedchemlett.0c00612,,,,Covalent inhibition of recombinant wild type HIV-1 reverse transcriptase using poly(rA)350/oligo(dT)16 as template/primer preincubated followed by substrate addition measured after 1 hr by pico-green reagent based fluorescence analysis,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-{4-[4-((E)-2-Cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile",0.038,uM,=,-1.42021640338319,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
4722,1791424,10.1039/C7MD00600D,,,,Inhibition of HIV1 reverse transcriptase RNase H activity using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabsyl-labeled DNA hybrid as substrate after 1 hr by fluorescence assay,Cc1cc(/C=C2\NC(=O)NC2=O)c(C)n1-c1ccc(OCc2ccc(Cl)cc2Cl)cc1,"5-((1-(4-(2,4-dichlorobenzyloxy)phenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)imidazolidine-2,4-dione",8.73,uM,=,0.9410142437055696,1,O=C1NC(=O)/C(=C/c2ccn(-c3ccc(OCc4ccccc4)cc3)c2)N1
4723,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,CC(C)c1csc(NC(=S)NCCc2ccccc2)n1,1-(4-Isopropyl-thiazol-2-yl)-3-phenethyl-thiourea,0.2,uM,=,-0.6989700043360187,0,S=C(NCCc1ccccc1)Nc1nccs1
4724,1467610,10.1016/j.ejmech.2015.02.032,,,,Inhibition of HIV1 reverse transcriptase-associated RNA-dependent DNA polymerase activity after 30 mins,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc([N+](=O)[O-])cc2)cs1,SID507693,34.0,uM,=,1.5314789170422551,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
4725,1925208,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in DNA 3'-end cleavage using HTS2 substrate,COc1ccc(-c2cccc(Nc3cc(=O)n(O)c(=O)n3C)c2)cc1,"3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-3-yl)amino)-1-methylpyrimidine-2,4(1H,3H)-dione",2.6,uM,=,0.414973347970818,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4726,2185969,10.1021/acs.jmedchem.1c00535,,,,Inhibition of HIV-1 reverse transcriptase associated RNA-dependent DNA polymerase activity using poly(A)-oligo(dT) as template/primer incubated for 30 mins by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(OCc3cccc(Cl)c3Cl)cc2c1=O,"Ethyl 6-((2,3-Dichlorobenzyl)oxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate",1.88,uM,=,0.2741578492636798,1,O=c1ccn(Cc2ccccc2)c2ccc(OCc3ccccc3)cc12
4727,101642,10.1016/j.bmcl.2004.04.008,,,,Concentration required to protect the cell against HIV-1 strain IIIB viral cytopathogenicity by 50% in MT-4 cells,CC(=O)CSc1nc(O)c(C)c(Cc2cccc3ccccc23)n1,5-Methyl-6-naphthalen-1-ylmethyl-2-(2-oxo-propylsulfanyl)-3H-pyrimidin-4-one,1.12,uM,=,0.0492180226701816,1,c1ccc2c(Cc3ccncn3)cccc2c1
4728,665357,10.1016/j.bmcl.2010.08.068,,,,Inhibition of HIV1 recombinant wild type reverse transcriptase by SPA heteropolymeric assay,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(c3cccc(C(N)=O)c3)CC2)ncc1Cl,"3-(4-(5-chloro-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-ylamino)piperidin-1-yl)benzamide",0.024,uM,=,-1.619788758288394,0,c1ccc(Oc2ccnc(NC3CCN(c4ccccc4)CC3)n2)cc1
4729,195077,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on wild type HIV- 1 reverse transcriptase using rCdG as template and dGTP as substrate.,CCOc1ccc(OC)c(CCNC(=O)Nc2ccc(Cl)cn2)c1F,1-(5-Chloro-pyridin-2-yl)-3-[2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-ethyl]-urea,0.008,uM,=,-2.096910013008056,0,O=C(NCCc1ccccc1)Nc1ccccn1
4730,2185968,10.1021/acs.jmedchem.1c00535,,,,Inhibition of recombinant His-tagged wild-type HIV-1 group M subtype B BH10 reverse transcriptase-associated RNase H activity harboring p66/p51 hetrodimer expressed in Escherichia coli M15 using GTTTTCTTTTCCCCCCTGAC-30 fluorescein/50-CAAAAGAAAAGGGGGGACUG-30 Dabcyl RNA/DNA template-primer as substrate incubated for 1 hr by multilabel counter plate reader analysis,CCOC(=O)c1cn(Cc2ccc(F)cc2)c2ccc(Oc3ccccc3)cc2c1=O,"Ethyl 1-(4-Fluorobenzyl)-4-oxo-6-phenoxy-1,4-dihydroquinoline-3-carboxylate",45.5,uM,=,1.6580113966571124,1,O=c1ccn(Cc2ccccc2)c2ccc(Oc3ccccc3)cc12
4731,195066,10.1021/jm950702c,,,,Compound was tested for Inhibition of HIV-1 RT activity.,CCC1(c2ccccc2)Sc2c(Cl)cccc2-n2cccc2C1=O,7-Chloro-5-ethyl-5-phenyl-6-thia-10b-aza-benzo[e]azulen-4-one,500.0,uM,=,2.6989700043360187,1,O=C1c2cccn2-c2ccccc2SC1c1ccccc1
4732,490747,10.1016/j.bmc.2008.06.012,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity assessed as incorporation of radioactive dTTP into poly(rA)/oligo(DT),O=c1[nH]c2cc(F)c(Cl)cc2n1Cc1c(F)cccc1F,"6-Chloro,5-fluoro-(2,6-difluorobenzyl)-1,3-dihydro-2Hbenzimidazol-2-one",0.14,uM,=,-0.8538719643217619,0,O=c1[nH]c2ccccc2n1Cc1ccccc1
4733,195069,10.1021/jm00025a010,,,,Inhibition of HIV-1 reverse transcriptase using rCdG as template and dGTP as substrate,Fc1ccc(CCNC(=S)Nc2nccs2)cc1,1-[2-(4-Fluoro-phenyl)-ethyl]-3-thiazol-2-yl-thiourea,1.0,uM,=,0.0,0,S=C(NCCc1ccccc1)Nc1nccs1
4734,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3cccc4ccccc34)cc2-c2ccc(OCCCCc3ccccc3)cc2)n[nH]1,3-(1-(Naphthalen-1-ylmethyl)-4-(3-(4-phenylbutoxy)phenyl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,2.38,uM,=,0.3765769570565119,1,c1ccc(CCCCOc2ccc(-c3cn(Cc4cccc5ccccc45)cc3-c3cc[nH]n3)cc2)cc1
4735,197438,10.1021/jm00017a010,,,,Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity by 50%.,Cc1cccc(Cc2cc(O)nc(SCC(C)C)n2)c1,2-Isobutylsulfanyl-6-(3-methyl-benzyl)-3H-pyrimidin-4-one,8.4,uM,=,0.9242792860618816,1,c1ccc(Cc2ccncn2)cc1
4736,2226856,10.1016/j.ejmech.2022.114512,,,,Inhibition of recombinant wild-type p66/p51 HIV-1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1ccccc1C(C#N)c1nc(SC(C)C)[nH]c(=O)c1C,"2-(2-(isopropylthio)-5-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-(o-tolyl)acetonitrile",0.68,uM,=,-0.1674910872937636,0,O=c1cc(Cc2ccccc2)nc[nH]1
4737,1925207,10.1021/acs.jmedchem.5b01879,,,,Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage using HTS1 substrate,Cc1noc(C)c1-c1ccc(Nc2cc(=O)n(O)c(=O)n2C)cc1,"6-((4-(3,5-Dimethylisoxazol-4-yl)phenyl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione",1.6,uM,=,0.2041199826559248,1,O=c1cc(Nc2ccc(-c3cnoc3)cc2)[nH]c(=O)[nH]1
4738,195078,10.1021/jm00099a007,,,,In vitro HIV-1 RT inhibitory activity using rC.dG as template-primer,CCc1cc(NCc2nc3c(F)ccc(F)c3o2)c(O)nc1C,"3-[(4,7-Difluoro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.07,uM,=,-1.154901959985743,0,c1cncc(NCc2nc3ccccc3o2)c1
4739,806931,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of HIV1 reverse transcriptase using as poly(dC)-[3H]poly(rG) as substrate,O=S(=O)(N/N=C/c1cc(Cl)ccc1O)c1cc(Cl)c(Cl)cc1Cl,"N'-(5-chloro-2-hydroxybenzylidene)-2,4,5-trichlorobenzenesulfonohydrazide",15.0,uM,=,1.1760912590556811,1,O=S(=O)(N/N=C/c1ccccc1)c1ccccc1
4740,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(S(=O)(=O)Cc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-(4,7-Dichloro-benzooxazol-2-ylmethanesulfonyl)-5-ethyl-6-methyl-1H-pyridin-2-one",0.205,uM,=,-0.6882461389442457,0,O=S(=O)(Cc1nc2ccccc2o1)c1cccnc1
4741,195505,10.1016/s0960-894x(99)00235-8,,,,Inhibition of purified recombinant HIV-1 reverse transcriptase,CSCSc1cc(Cc2ccccc2)c(C(C)C)c(O)n1,4-Benzyl-3-isopropyl-6-methylsulfanylmethylsulfanyl-1H-pyridin-2-one,5.6,uM,=,0.7481880270062004,1,c1ccc(Cc2ccncc2)cc1
4742,1925211,10.1021/acs.jmedchem.5b01879,,,,Inhibition of polymerase activity of HIV1 reverse transcriptase using poly(rA)-oligo(dT)16 and [3H]-TTP incubated for 20 mins by liquid scintillation spectrometry,Cn1c(Nc2cccc(-c3cccc(C#N)c3)c2)cc(=O)n(O)c1=O,"3'-((1-Hydroxy-3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)-[1,1'-biphenyl]-3-carbonitrile",5.0,uM,=,0.6989700043360189,1,O=c1cc(Nc2cccc(-c3ccccc3)c2)[nH]c(=O)[nH]1
4743,1869038,10.1021/acs.jmedchem.8b01656,,,,Inhibition of recombinant HIV1 reverse transcriptase using (DIG)-dUTP and biotin-labeled dNTPs as substrate after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccncc3)CC2)nc2c1CCC2,"3,5-Dimethyl-4-((2-((1-(pyridin-4-ylmethyl)piperidin-4-yl)-amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)oxy)-benzonitrile",0.073,uM,=,-1.136677139879544,0,c1ccc(Oc2nc(NC3CCN(Cc4ccncc4)CC3)nc3c2CCC3)cc1
4744,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(CCc2nc3cccc(C)c3o2)c(O)nc1C,5-Ethyl-6-methyl-3-[2-(7-methyl-benzooxazol-2-yl)-ethyl]-1H-pyridin-2-one,0.04,uM,=,-1.3979400086720375,0,c1cncc(CCc2nc3ccccc3o2)c1
4745,195231,10.1021/jm990343b,,,,Inhibition of HIV-1 Reverse transcriptase using poly-(rc)-oligo(dg) as the template primer.,COC(=O)c1cc(C(=CCCCCCl)c2cc(Cl)c(OC)c(C(=O)OC)c2)cc(Cl)c1OC,methyl 3-chloro-5-[6-chloro-1-(3-chloro-4-methoxy-5-methyloxycarbonylphenyl)-1-hexenyl]-2-methoxybenzoate,70.0,uM,=,1.845098040014257,1,C=C(c1ccccc1)c1ccccc1
4746,2160236,10.1021/acs.jmedchem.1c01676,,,,Inhibition of recombinant wild type p66/p51 HIV1 reverse transcriptase incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2cc3ccccc3s2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4-(Benzo[b]thiophen-2-yl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0615,uM,=,-1.2111248842245832,0,c1ccc(Nc2nccc(Nc3ccc(-c4cc5ccccc5s4)cc3)n2)cc1
4747,195051,10.1016/s0960-894x(01)00239-6,,,,Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in an in vitro enzyme assay,CC1OC(/C=C/C2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"7-Chloro-5-((E)-2-cyclopropyl-vinyl)-3-methyl-5-trifluoromethyl-1,5-dihydro-benzo[e][1,4]oxazepin-2-one",0.046,uM,=,-1.337242168318426,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
4748,195671,10.1021/jm00060a002,,,,Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template),CCc1cc(Cc2nc3ccccc3o2)c(O)nc1C,3-Benzooxazol-2-ylmethyl-5-ethyl-6-methyl-1H-pyridin-2-one,45.0,uM,=,1.6532125137753435,1,c1cncc(Cc2nc3ccccc3o2)c1
4749,140633,10.1016/s0960-894x(00)00662-4,,,,Inhibition of the NNRTI HIV-1 enzyme by 50% using enzyme assay.,Oc1ncccc1C(/C=C/C1CC1)(OCc1ccccc1)C(F)(F)F,3-((E)-1-Benzyloxy-3-cyclopropyl-1-trifluoromethyl-allyl)-1H-pyridin-2-one,0.016676,uM,=,-1.7779081135457402,0,C(=C/C(OCc1ccccc1)c1cccnc1)\C1CC1
4750,1518191,10.1016/j.bmc.2015.09.020,,,,Inhibition of recombinant HIV1 Reverse transcriptase p66/p51 using poly (rA)-oligo (dT) as template primer after 40 mins by spectrofluorometric analysis,COc1cccc(CNc2ccnc(Nc3ccc(C#N)cc3)n2)c1,4-(4-(3-methoxybenzylamino)pyrimidin-2-ylamino)benzonitrile,0.018,uM,=,-1.744727494896694,0,c1ccc(CNc2ccnc(Nc3ccccc3)n2)cc1
4751,1982604,10.1021/acsmedchemlett.9b00617,,,,Inhibition of RNase H activity of recombinant His-tagged HIV-1 group M subtype B reverse transcriptase p66/p51 expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA/5'-dabcyl-labeled DNA hybrid as substrate incubated for 1 hr,O=C(O)c1cc(-c2cn(Cc3ccc(F)cc3)cc2-c2ccc3ccccc3c2)n[nH]1,3-(1-(4-Fluorobenzyl)-4-(naphthalen-2-yl)-1H-pyrrol-3-yl)-1H-pyrazole-5-carboxylic acid,13.7,uM,=,1.136720567156407,1,c1ccc(Cn2cc(-c3ccc4ccccc4c3)c(-c3cc[nH]n3)c2)cc1
4752,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO[C@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC.[Na+],"sodium ((2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((S)-3-(oleoyloxy)-2-(palmitoyloxy)propoxy)tetrahydro-2H-pyran-2-yl)methanesulfonate",0.024,uM,=,-1.619788758288394,0,C1CCOCC1
4753,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCCCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(cyclohexylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.44,uM,=,-0.3565473235138126,0,c1ccc(Nc2nc(NC3CCCCC3)cc(Oc3ccc4ccccc4c3)n2)cc1
4754,484679,10.1021/np50109a004,,,,Inhibition of HIV1 reverse transcriptase,C=C(Cc1ccc2c(c1)OCO2)C(=C)Cc1ccc(O)cc1O,"2-(2',4'-dihydroxybenzyl)-3-(3'',4''-methylenedioxybenzyl)-1,3-butadiene",194.7629977258076,uM,=,2.2895064504382296,1,C=C(Cc1ccccc1)C(=C)Cc1ccc2c(c1)OCO2
4755,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)C2=CN3C=CC=CC3N=C2)c(O)c(OC)c2occc12,"(6-hydroxy-4,7-dimethoxybenzofuran-5-yl)(9aH-pyrido[1,2-a]pyrimidin-3-yl)methanone",16.3,uM,=,1.212187604403958,1,O=C(C1=CN2C=CC=CC2N=C1)c1ccc2occc2c1
4756,715432,10.1016/j.ejmech.2010.10.020,,,,Inhibition of HIV1 reverse transcriptase,CONC(=S)N/N=C1\C(=O)N(CN2CCN(c3ccc(Cl)cc3)CC2)c2ccc(Cl)cc21,2-(5-chloro-1-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)-N-methoxyhydrazinecarbothioamide,0.25,uM,=,-0.6020599913279624,0,N=C1C(=O)N(CN2CCN(c3ccccc3)CC2)c2ccccc21
4757,427351,10.1128/aac.00749-06,,,,Inhibition of reverse transcriptase activity in HIV1 NL4-3 infected MT4 cells before dialysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.042,uM,=,-1.3767507096020994,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4758,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)=CCc1c(O)c(C(=O)C(C)C)c(O)c2c(-c3ccccc3)cc(=O)oc12,"5,7-Dihydroxy-6-isobutyryl-8-(3-methyl-but-2-enyl)-4-phenyl-chromen-2-one",2.5,uM,=,0.3979400086720376,1,O=c1cc(-c2ccccc2)c2ccccc2o1
4759,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3C)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-benzoic acid",0.01,uM,=,-2.0,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
4760,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(=O)OC)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid methyl ester",0.48,uM,=,-0.3187587626244128,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4761,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)C2=CN3C(=CN=C2)Nc2ccccc23)c(O)c(OC)c2occc12,"(11H-Benzo[4,5]imidazo[1,2-a][1,4]diazepin-4-yl)(6-hydroxy-4,7-dimethoxy-benzofuran-5-yl)methanone",9.44,uM,=,0.974971994298069,1,O=C(C1=CN2C(=CN=C1)Nc1ccccc12)c1ccc2occc2c1
4762,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(Cc2ccccc2)c(=O)[nH]c1=O,"1-benzyl-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",15.6,uM,=,1.1931245983544616,1,O=c1cc(Sc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
4763,197448,10.1021/jm9704210,,,,Compound was evaluated for 50% inhibition of HIV-RT (HIV reverse transcriptase),Cc1cn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,(beta-D) FTTPTriphosphoric acid-[3-hydroxy-5-(4-hydroxy-5-methyl-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester 4M triethyl amine,100.0,uM,=,2.0,1,O=c1ccn([C@@H]2CCCO2)c(=O)[nH]1
4764,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCN2CCOCC2)nc(Nc2ccc(C#N)cc2)c1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-morpholinoethyl)amino)pyridin-2-yl)amino)benzonitrile",0.74,uM,=,-0.1307682802690238,0,c1ccc(Nc2cc(Oc3ccccc3)cc(NCCN3CCOCC3)n2)cc1
4765,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCN2CCNCC2)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-(piperidin-4-ylamino)pyrimidin-2-yl)amino)benzonitrile",0.44,uM,=,-0.3565473235138126,0,c1ccc(Nc2nc(NCCN3CCNCC3)cc(Oc3ccccc3)n2)cc1
4766,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cc4ccccc4[nH]3)[nH]c(=O)c2c1C,"2-(1H-indol-2-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",0.48,uM,=,-0.3187587626244128,0,O=c1[nH]c(-c2cc3ccccc3[nH]2)nc2sccc12
4767,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C)c(Oc2nc(Nc3ccc(C#N)cc3)cn3ccnc23)c(C)c1,"4-((8-(mesityloxy)imidazo[1,2-a]pyrazin-6-yl)amino)benzonitrile",0.4,uM,=,-0.3979400086720376,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
4768,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCCc3ccccc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(3-phenyl-propyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(CCCc3ccccc3)cc21
4769,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),CC(=O)NC1=CC(=O)c2ccc(-c3[nH]c(C(=O)OCCOP(=O)(O)O)cc4c5ccccc5nc3-4)nc2C1=O,"1-(7-Acetylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-9H-beta-carboline-3-carboxylic acid 2-phosphonooxy-ethyl ester",3.0,uM,=,0.4771212547196624,1,O=C1C=CC(=O)c2nc(-c3[nH]ccc4c5ccccc5nc3-4)ccc21
4770,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(thiophen-2-yl)benzyl)isoquinoline-1,3(2H,4H)-dione",1.5,uM,=,0.1760912590556812,1,O=C1Cc2cc(Cc3ccc(-c4cccs4)cc3)ccc2C(=O)N1
4771,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(C#N)nc21,"5-Ethyl-10-methyl-11-oxo-2-(2-pyridin-4-yl-ethyl)-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cycloheptene-7-carbonitrile",0.29,uM,=,-0.5376020021010439,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4772,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CSc1nc(O)cc(C(C)c2c(F)cccc2F)n1,"6-[1-(2,6-Difluoro-phenyl)-ethyl]-2-methylsulfanyl-3H-pyrimidin-4-one",0.2,uM,=,-0.6989700043360187,0,c1ccc(Cc2ccncn2)cc1
4773,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2Cc2ccccc2)c1,"1-benzyl-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1Cc1ccccc1
4774,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,COCCNc1cc(Oc2c(C)cc(/C=C/C#N)cc2C)cc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-methoxyethyl)amino)pyridin-2-yl)amino)benzonitrile",0.92,uM,=,-0.0362121726544447,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4775,806933,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type Human immunodeficiency virus 1 reverse transcriptase,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(O)c(O)c2)cs1,"3-(2-(4-(3,4-dihydroxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one",1.0,uM,=,0.0,0,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
4776,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,COc1cc2nc(Nc3ccc(C#N)cc3)nc(Nc3c(C)cc(/C=C/C#N)cc3C)c2cc1OC,"(E)-4-{4-[4-(2-cyanovinyl)-2,6-dimethylphenylamino]-6,7-dimethoxyquinazolin-2-yl}aminobenzonitrile",0.55,uM,=,-0.2596373105057561,0,c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1
4777,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCOCC1C(=O)NC(=O)C(CC)=C1Sc1cc(C)cc(C)c1,"4-(3,5-dimethylphenylthio)-3-(ethoxymethyl)-5-ethylpyridine-2,6(1H,3H)-dione",0.21,uM,=,-0.6777807052660807,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
4778,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1C(=O)NC1CC1,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-cyclopropylnicotinamide",3.37,uM,=,0.5276299008713387,1,O=C(NC1CC1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
4779,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,COC(=O)P(=O)(OC)OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-[[[(methoxycarbonyl)methoxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",11.0,uM,=,1.0413926851582251,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4780,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,COC(=O)C(=O)NC1=CS(=O)(=O)O[C@@]12[C@@H](COCc1ccccc1)O[C@@H](n1cc(C)c(=O)n(C)c1=O)[C@@H]2O[Si](C)(C)C(C)(C)C,"N-[(5R,6R,8R,9R)-6-benzyloxymethyl-9-(tert-butyl-dimethyl-silanyloxy)-8-(3,5-dimethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-4-yl]-oxalamic acid methyl ester",5.4,uM,=,0.7323937598229685,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)[C@@H](COCc3ccccc3)O2)c(=O)[nH]1
4781,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(Cc2ccccc2)c(=O)[nH]c1=O,"1-benzyl-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.095,uM,=,-1.0222763947111522,0,O=c1cc(Oc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
4782,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3c[nH]c4ccc(OC)cc34)nc21,"5-Ethyl-7-(5-methoxy-1H-indol-3-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.2,uM,=,-0.6989700043360187,0,O=C1Nc2ccc(-c3c[nH]c4ccccc34)nc2Nc2ncccc21
4783,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCN(CC(=O)O)CC(=O)O)c1=O,"[(3-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-propyl)-carboxymethyl-amino]-acetic acid",10.6,uM,=,1.0253058652647702,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4784,642450,10.1016/j.bmc.2010.05.036,,,,Inhibition of HIV1 reverse transcriptase,COc1c(Oc2ccnc(Nc3ccc(C#N)cc3)n2)ccc2cc(C#N)ccc12,6-(2-(4-Cyanophenylamino)pyrimidin-4-yloxy)-5-methoxy-2-naphthonitrile,2.289362295312146,uM,=,0.3597145259224005,1,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
4785,552634,10.1016/j.bmc.2008.05.010,,,,Inhibition of HIV1 virion-associated reverse transcriptase,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,1.06,uM,=,0.0253058652647702,1,S=C(NCCc1ccccn1)Nc1ccccn1
4786,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC[C@H]1CCCN1C1=C(C(=O)OC)C2(C(=O)OC)Sc3ccccc3C12,"(R,R/S,S)2-((R)-2-methoxymethyl-pyrrolidin-1-yl)-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",48.0,uM,=,1.6812412373755872,1,C1=C(N2CCCC2)C2c3ccccc3SC12
4787,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(C#N)cn2)c1Cl,"1-[(1R,2R)-2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-cyano-pyridin-2-yl)-urea",0.07,uM,=,-1.154901959985743,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
4788,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,COC(CNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C)cc1C)OC,"6-((4-Cyanophenyl)amino)-N-(2,2-dimethoxyethyl)-4-(mesityloxy)nicotinamide",1.89,uM,=,0.2764618041732441,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4789,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C)c(=O)[nH]c(=O)n2CC2CC=CC2)c1,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylbenzoyl)-5-methylpyrimidine-2,4(1H,3H)-dione",12.68,uM,=,1.103119253545714,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC=CC1
4790,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCOP(=O)(O)C(=O)OCc2ccccc2)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[(3-[[[(benzyloxycarbonyl)hydroxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",3.8,uM,=,0.5797835966168101,1,O=C(OCc1ccccc1)[PH](=O)OCCCn1c(=O)ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c1=O
4791,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.26,uM,=,-0.585026652029182,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4792,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),CC(=O)NC1=CC(=O)c2ccc(-c3[nH]c(C(=O)O)cc4c5ccccc5nc3-4)nc2C1=O,"1-(7-Acetylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-9H-beta-carboline-3-carboxylic acid",13.3,uM,=,1.1238516409670858,1,O=C1C=CC(=O)c2nc(-c3[nH]ccc4c5ccccc5nc3-4)ccc21
4793,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,Cc1c(C(C)c2c(F)cccc2F)nc(SC2CCCC2)[nH]c1=O,"[-]-2-Cyclopentylsulfanyl-6-[1-(2,6-difluoro-phenyl)-ethyl]-5-methyl-3H-pyrimidin-4-one",1.0,uM,=,0.0,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
4794,805873,10.1016/j.ejmech.2012.02.019,,,,Inhibition of HIV1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rA)-oligo(dT),Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.74,uM,=,0.437750562820388,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4795,2278448,10.1021/acs.jmedchem.2c00576,,,,Inhibition of wild type recombinant HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate assessed as inhibition of biotin-labelled UTP incorporation incubated for 1 hr by ELISA,N#C/C=C/c1cc(F)c(Oc2nc(Nc3ccc(C#N)nc3)nc3ccsc23)c(F)c1,"(E)-5-((4-(4-(2-cyanovinyl)-2,6-difluorophenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)picolinonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Oc2nc(Nc3cccnc3)nc3ccsc23)cc1
4796,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCC2)c1,"1-(cyclobutylmethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.12,uM,=,-0.9208187539523752,0,O=c1cc(Oc2ccccc2)n(CC2CCC2)c(=O)[nH]1
4797,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2c1COC2,"(E)-4-((4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)piperidin-1-yl)methyl)benzenesulfonamide",0.14,uM,=,-0.8538719643217619,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
4798,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCOCC1C(=S)NC(=O)C(CC)=C1Sc1cc(C)cc(C)c1,"4-(3,5-dimethylphenylthio)-5-(ethoxymethyl)-3-ethyl-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.3,uM,=,-0.5228787452803376,0,O=C1C=C(Sc2ccccc2)CC(=S)N1
4799,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CCC2C=CCC2)c(=O)[nH]c1=O,"1-(2-(cyclopent-2-enyl)ethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.075,uM,=,-1.1249387366083,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1C=CCC1
4800,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)=C(O)Cc1c(O)c(C(=O)CC(C)C)c(O)c2c(-c3ccccc3)cc(=O)oc12,"5,7-Dihydroxy-8-(2-hydroxy-3-methyl-but-2-enyl)-6-(3-methyl-butyryl)-4-phenyl-chromen-2-one",0.5,uM,=,-0.3010299956639812,0,O=c1cc(-c2ccccc2)c2ccccc2o1
4801,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(/C=C\c3ccccc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-((Z)-styryl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.58,uM,=,-0.2365720064370627,0,O=C1Nc2cccnc2Nc2ncc(/C=C\c3ccccc3)cc21
4802,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,COc1ccc(-c2nc3sc(C)c(C)c3c(=O)[nH]2)cc1,"2-(4-methoxyphenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",9.1,uM,=,0.9590413923210936,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
4803,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccoc4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(furan-3-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.01,uM,=,-2.0,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccoc4)cc3)n2)cc1
4804,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)c4ccccc34)cc2C(=O)N(C)c2cccnc21,"4-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-naphthalene-1-carboxylic acid",0.027,uM,=,-1.5686362358410126,0,O=C1Nc2cccnc2Nc2ncc(CCOc3cccc4ccccc34)cc21
4805,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccc(C(F)(F)F)cc3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(4-(trifluoromethyl)phenyl)thieno[2,3-d]pyrimidin-4(3H)-one",1.3,uM,=,0.1139433523068367,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
4806,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCC1=C(Sc2ccccc2)C(COCCc2ccccc2)C(=S)NC1=O,"3-ethyl-5-(phenethoxymethyl)-4-(phenylthio)-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.473,uM,=,-0.3251388592621884,0,O=C1C=C(Sc2ccccc2)C(COCCc2ccccc2)C(=S)N1
4807,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(S(N)(=O)=O)cc3)CC2)nc2c1COC2,"(E)-4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)piperidin-1-yl)benzenesulfonamide",0.06,uM,=,-1.2218487496163564,0,c1ccc(Oc2nc(NC3CCN(c4ccccc4)CC3)nc3c2COC3)cc1
4808,856670,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 25 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCNCCNCCC[n+]1c(-c3ccccc3)c3cc(N)ccc3c3ccc(N)cc31)c1cc(N)ccc21.[Cl-].[Cl-],Ethidium homodimer-1,2.3,uM,=,0.3617278360175928,1,c1ccc(-c2c3ccccc3c3ccccc3[n+]2CCCNCCNCCC[n+]2c(-c3ccccc3)c3ccccc3c3ccccc32)cc1
4809,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(I)nc21,"5-Ethyl-7-iodo-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4810,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(/c1ccc(C#N)cc1)c1cc(C)c2onc(OC)c2c1,(Z)-5-[1-(4-cyanophenyl)-5-methoxycarbonylpent-1-enyl]-2-methoxy-3-methylbenzoic acid methyl ester,0.7,uM,=,-0.1549019599857432,0,C=C(c1ccccc1)c1ccc2oncc2c1
4811,886109,10.1016/j.bmc.2012.09.058,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rC)-oligo(dG) by colorimetric analysis,O=C(CSc1nccnc1-c1ccccc1Cl)Nc1ccccc1[N+](=O)[O-],2-(3-(2-Chlorophenyl)pyrazin-2-ylthio)-N-(2-nitrophenyl)acetamide,50.0,uM,=,1.6989700043360187,1,O=C(CSc1nccnc1-c1ccccc1)Nc1ccccc1
4812,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccnc(Cl)c4)cc3F)n2)cc1,"4-((4-((4-(2-chloropyridin-4-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.014,uM,=,-1.853871964321762,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
4813,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCn2ccnc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.0805,uM,=,-1.0942041196321317,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](SCCn2ccnc2)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
4814,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccc(C(=O)O)cc3)[nH]c(=O)c2c1C,"4-(5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)benzoic acid",1.6,uM,=,0.2041199826559248,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
4815,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,COCCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C#N)cc1C,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-(2-methoxyethyl)nicotinamide",11.27,uM,=,1.0519239160461065,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4816,195064,10.1021/jm990383f,,,,In vitroir ability to inhibit wild type resistant (WT) reverse transcriptase,CCc1c(C)nn(-c2ccccc2)c1-c1ccccc1,"4-Ethyl-3-methyl-1,5-diphenyl-1H-pyrazole",14.5,uM,=,1.1613680022349748,1,c1ccc(-c2ccnn2-c2ccccc2)cc1
4817,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.179,uM,=,-0.7471469690201069,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC=CC1
4818,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,CCC(=O)N1CC(=O)Nc2ccccc21,"4-Propanoyl-3,4-dihydroquinoxalin-2(1H)-one",0.63,uM,=,-0.2006594505464183,0,O=C1CNc2ccccc2N1
4819,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC=CC2)c1,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.256,uM,=,-0.5917600346881504,0,O=c1cc(Oc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
4820,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4csc5ccccc45)cc3F)n2)cc1,"4-((4-((4-(benzo[b]thiophen-3-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.059,uM,=,-1.2291479883578558,0,c1ccc(Nc2nccc(Nc3ccc(-c4csc5ccccc45)cc3)n2)cc1
4821,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C)c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-[2-(2-methyl-pyridin-4-yl)-ethyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4822,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccncc4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(pyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0074,uM,=,-2.130768280269024,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
4823,196376,10.1021/jm030255y,,,,Inhibitory concentration against wild-type reverse transcriptase of HIV-1,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.021,uM,=,-1.6777807052660807,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
4824,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,C[C@@H](/N=C(\S)Nc1nccs1)C1CCCCC1,1-((R)-1-Cyclohexyl-ethyl)-3-thiazol-2-yl-thiourea,13.0,uM,=,1.1139433523068367,1,C(=NCC1CCCCC1)Nc1nccs1
4825,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid amide",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4826,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCCCC2)C2c3ccccc3SC12C(=O)OC,"(R,R/S,S)-2-piperidin-1-yl-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",8.9,uM,=,0.9493900066449128,1,C1=C(N2CCCCC2)C2c3ccccc3SC12
4827,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCCCC2)c1,"1-(cyclohexylmethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.143,uM,=,-0.8446639625349383,0,O=c1cc(Oc2ccccc2)n(CC2CCCCC2)c(=O)[nH]1
4828,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccnc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-pyridin-3-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncc(CCc3cccnc3)cc21
4829,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CCC2=CCCC2)c1,"1-(2-cyclopentenylethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.223,uM,=,-0.6516951369518393,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1=CCCC1
4830,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",160.0,uM,=,2.204119982655925,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4831,770448,10.1016/j.bmc.2011.08.060,,,,Inhibition of wild type HIV1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",1.52,uM,=,0.1818435879447725,1,O=C1Nc2ccccc2C(C#CC2CC2)O1
4832,197430,10.1021/jm970559i,,,,Antiviral activity against Human Immunodeficiency Virus by Reverse transcriptase assay in CEM-SS cells,Nc1nc2cc(Cl)c(Cl)cc2n1Cc1ccc(C(F)(F)F)cc1,"5,6-Dichloro-1-(4-trifluoromethyl-benzyl)-1H-benzoimidazol-2-ylamine",20.0,uM,=,1.3010299956639813,1,c1ccc(Cn2cnc3ccccc32)cc1
4833,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)c1cc(/C(=C\CCN2CCOC2=O)c2cc(F)cc(C(F)(F)F)c2)cc(C)c1OC,5-[(E)-1-(3-Fluoro-5-trifluoromethyl-phenyl)-4-(2-oxo-oxazolidin-3-yl)-but-1-enyl]-2-methoxy-3-methyl-benzoic acid methyl ester,15.7,uM,=,1.1958996524092338,1,O=C1OCCN1CCC=C(c1ccccc1)c1ccccc1
4834,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.176,uM,=,-0.7544873321858502,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
4835,1891828,10.1021/acs.jmedchem.8b00843,,,,Inhibition of HIV1 reverse transcriptase,CC1O[C@](/C=C/C2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"(5S)-7-chloro-5-((E)-2-cyclopropylvinyl)-3-methyl-5-(trifluoromethyl)-3,5-dihydrobenzo[e][1,4]oxazepin-2(1H)-one",0.046,uM,=,-1.337242168318426,0,O=C1COC(/C=C/C2CC2)c2ccccc2N1
4836,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-m-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.46,uM,=,-0.3372421683184259,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4837,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCCC3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-(2-(pyrrolidin-1-yl)ethyl)-1H-indole-2-carboxamide",0.28,uM,=,-0.5528419686577808,0,O=C(NCCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4838,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C(I)=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-iodo-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",8.0,uM,=,0.9030899869919436,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4839,910150,10.1007/s00044-007-9004-0,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 recombinant reverse transcriptase expressed in Escherichia coli using poly(rA)oligo(dT) template primer after 30 min,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4840,1763340,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 reverse transcriptase RNase H using RNA-DNA hybrid duplex after 30 mins by FRET-based microplate fluorescence assay,COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(Oc2ccccc2)cc1,N'-((2-methoxynaphthalen-1-yl)methylene)-4-phenoxybenzohydrazide,7.0,uM,=,0.8450980400142568,1,O=C(N/N=C/c1cccc2ccccc12)c1ccc(Oc2ccccc2)cc1
4841,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)CC2C(=O)Nc2ccccc2)cc1,"1-((4-aminophenyl)sulfonyl)-N-phenyl-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.56,uM,=,-0.2518119729937995,0,O=C(Nc1ccccc1)C1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccccc1
4842,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4843,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,Cc1cc(C)cc(Cc2c(Br)c(N)nc(=O)n2COCc2ccccc2)c1,"4-Amino-1-benzyloxymethyl-6-(3,5-dimethylbenzyl)-5-bromouracil",16.338,uM,=,1.2131988917236085,1,O=c1nccc(Cc2ccccc2)n1COCc1ccccc1
4844,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)C[C@H](O)[C@@H](O)[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,"(4aS,6bR,8aS,11S,12S,12aS,12bS,14aS,14bR)-11,12-dihydroxy-2,2,6b,9,9,12a,14a-heptamethyl-1,2,3,4,4a,5,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-icosahydropicene-4a-carboxylic acid",3.4,uM,=,0.5314789170422551,1,C1=C2C(CC[C@H]3C2CC[C@H]2CCCCC23)[C@H]2CCCCC2C1
4845,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-[2-(2-methyl-pyridin-4-yl)-ethyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4846,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccc(C#N)cc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3',5'-dimethyl-(1,1'-biphenyl)-4-carbonitrile",0.014,uM,=,-1.853871964321762,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4847,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1O,"4-(4-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)phenyl)pyridin-1-ium 4-methylbenzenesulfonate",0.9,uM,=,-0.0457574905606751,0,O=C1Cc2cc(Cc3ccc(-c4ccncc4)cc3)ccc2C(=O)N1.c1ccccc1
4848,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,COc1ccc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)cc1,"4-((4-((4'-methoxy-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.027,uM,=,-1.5686362358410126,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4849,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1C(=O)NCC1CC1,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-(cyclopropylmethyl)nicotinamide",4.25,uM,=,0.6283889300503115,1,O=C(NCC1CC1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
4850,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(cyclopentylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.21,uM,=,-0.6777807052660807,0,c1ccc(Nc2nc(NC3CCCC3)cc(Oc3ccc4ccccc4c3)n2)cc1
4851,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc4ccccc4c3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(2-naphthalen-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccc4ccccc4c3)cc21
4852,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,Cc1c(O)nc(SC(C)C)nc1C(C)c1c(F)cccc1F,"6-[1-(2,6-Difluoro-phenyl)-ethyl]-2-isopropylsulfanyl-5-methyl-3H-pyrimidin-4-one",0.019,uM,=,-1.7212463990471711,0,c1ccc(Cc2ccncn2)cc1
4853,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCOc1cccnc1N(C)C1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,{4-[(3-Ethoxy-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-(1H-indol-2-yl)-methanone,3.2,uM,=,0.505149978319906,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4854,805873,10.1016/j.ejmech.2012.02.019,,,,Inhibition of HIV1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rA)-oligo(dT),Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.55,uM,=,-0.2596373105057561,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4855,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3ccccc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-phenethyl-1H-indole-2-carboxamide",0.077,uM,=,-1.1135092748275182,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4856,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(C)c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-m-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4857,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CCC2CCCC2)c(=O)[nH]c1=O,"1-(2-cyclopentylethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",2.19,uM,=,0.3404441148401183,1,O=c1cc(Sc2ccccc2)n(CCC2CCCC2)c(=O)[nH]1
4858,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1c(CN(C)c2ccccc2)c(=O)[nH]c(=O)n1COCc1ccccc1,1-(benzyloxymethyl)-5-[(methyl-phenylamino)-methyl]-6-methyluracil,3.49,uM,=,0.5428254269591799,1,O=c1[nH]c(=O)n(COCc2ccccc2)cc1CNc1ccccc1
4859,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,NC(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carboxamide",2.6,uM,=,0.414973347970818,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4860,1339445,10.1016/j.bmc.2014.02.030,,,,Inhibition of wild-type HIV1 reverse transcriptase p66/p51 after 40 mins by spectrophotometry,Cc1ccc(C(C)(O)c2ccnc(Nc3ccc(C#N)cc3)n2)cc1,4-((4-(1-Hydroxy-1-(p-tolyl)ethyl)pyrimidin-2-yl)amino)benzonitrile,0.16,uM,=,-0.7958800173440752,0,c1ccc(Cc2ccnc(Nc3ccccc3)n2)cc1
4861,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3C)cc2C(=O)N(C)c2cccnc21,"4-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-benzoic acid",0.017,uM,=,-1.769551078621726,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
4862,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccnc(-c5ccnc(Cl)c5)c4)cc3F)n2)cc1,"4-((4-((4-(2'-chloro-[2,4'-bipyridin]-4-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.11,uM,=,-0.958607314841775,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccnc(-c5ccncc5)c4)cc3)n2)cc1
4863,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)Oc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isopropoxy-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,1.4,uM,=,0.1461280356782379,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4864,715432,10.1016/j.ejmech.2010.10.020,,,,Inhibition of HIV1 reverse transcriptase,CONC(=S)N/N=C1\C(=O)N(CN2CCN(c3ccc(Cl)cc3)CC2)c2ccc(C)cc21,"2-(1-{[4-(4-Chlorophenyl)tetrahydropyrazin-1(2H)-yl]methyl}-5-methyl-2-oxo-1,2-dihydro-3H-indol-3-yliden)-N-(methyloxy)hydrazine-1-carbothioamide",11.5,uM,=,1.0606978403536118,1,N=C1C(=O)N(CN2CCN(c3ccccc3)CC2)c2ccccc21
4865,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CC2CC2)c(=O)[nH]c1=O,"1-(cyclopropylmethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.178,uM,=,-0.7495799976911061,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC1
4866,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C)c(Oc2nc(Nc3ccc(CC#N)cc3)cn3ccnc23)c(C)c1,"2-(4-((8-(mesityloxy)imidazo[1,2-a]pyrazin-6-yl)amino)phenyl)acetonitrile",0.36,uM,=,-0.4436974992327127,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
4867,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,CN(C(=O)C1CN(C(=O)c2cc(O)c(O)c(O)c2)CCN1S(=O)(=O)c1ccc(N)cc1)c1ccccc1,"1-((4-aminophenyl)sulfonyl)-N-methyl-N-phenyl-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",1.78,uM,=,0.250420002308894,1,O=C(Nc1ccccc1)C1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccccc1
4868,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)N[C@@H](CC(=O)O)C(=O)O)c1=O,"(S)-2-(2-{3-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetylamino)-succinic acid",9.1,uM,=,0.9590413923210936,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4869,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)CC2)cc1,"(4-(4-aminophenylsulfonyl)piperazin-1-yl)(3,4,5-trihydroxyphenyl)methanone",0.72,uM,=,-0.1426675035687315,0,O=C(c1ccccc1)N1CCN(S(=O)(=O)c2ccccc2)CC1
4870,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CC2CCCC2)c(=O)[nH]c1=O,"1-(cyclopentylmethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.137,uM,=,-0.8632794328435932,0,O=c1cc(Oc2ccccc2)n(CC2CCCC2)c(=O)[nH]1
4871,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccc(F)cc2N(CC2CC2)C1(C#CC1CC1)C(F)(F)F,"3-Cyclopropylethynyl-4-cyclopropylmethyl-6-fluoro-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.263,uM,=,-0.5800442515102421,0,O=C1Nc2ccccc2N(CC2CC2)C1C#CC1CC1
4872,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(F)c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-[2-(3-fluoro-phenyl)-ethyl]-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.37,uM,=,-0.431798275933005,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4873,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccccc3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-phenylthieno[2,3-d]pyrimidin-4(3H)-one",11.3,uM,=,1.0530784434834195,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
4874,195658,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at low (~0.1 pfu/cell) multiplicity of injection (moi),Nc1nc(O)c2ncn(/C=C3\CC3CO)c2n1,"2-Amino-9-[2-hydroxymethyl-cycloprop-(E)-ylidenemethyl]-1,9-dihydro-purin-6-one",1.9,uM,=,0.2787536009528289,1,C(=C1CC1)n1cnc2cncnc21
4875,195658,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at low (~0.1 pfu/cell) multiplicity of injection (moi),Nc1nc(O)c2ncn(/C=C3/CC3CO)c2n1,"2-Amino-9-[2-hydroxymethyl-cycloprop-(Z)-ylidenemethyl]-1,9-dihydro-purin-6-one",1.1,uM,=,0.041392685158225,1,C(=C1CC1)n1cnc2cncnc21
4876,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(/C=C\c3ccccc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-((Z)-styryl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncc(/C=C\c3ccccc3)cc21
4877,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](C[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.293,uM,=,-0.5331323796458906,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
4878,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4coc5ccccc45)cc3F)n2)cc1,"4-((4-((4-(benzofuran-3-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.028,uM,=,-1.5528419686577808,0,c1ccc(Nc2nccc(Nc3ccc(-c4coc5ccccc45)cc3)n2)cc1
4879,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccccc2N(CCC2CC2)C1(C#CC1CC1)C(F)(F)F,"4-(2-Cyclopropyl-ethyl)-3-cyclopropylethynyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.34,uM,=,-0.4685210829577448,0,O=C1Nc2ccccc2N(CCC2CC2)C1C#CC1CC1
4880,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2N(CC2CC2)C1(C#CC1CC1)C(F)(F)F,"6-Chloro-3-cyclopropylethynyl-4-cyclopropylmethyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.329,uM,=,-0.4828041020500256,0,O=C1Nc2ccccc2N(CC2CC2)C1C#CC1CC1
4881,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-phenethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4882,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",15.0,uM,=,1.1760912590556811,1,c1cncc(NCc2nc3ccccc3o2)c1
4883,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,CN(C)C(=O)c1cnnn1[C@@H]1O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]2(OS(=O)(=O)C=C2N)[C@H]1O[Si](C)(C)C(C)(C)C,"3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3H-[1,2,3]triazole-4-carboxylic acid dimethylamide",6.4,uM,=,0.8061799739838872,1,O=S1(=O)C=C[C@]2(CO[C@@H](n3ccnn3)C2)O1
4884,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(OC2CCCCC2C)cc(CCc2ccccc2)[nH]c1=O,3-Isopropyl-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one,0.01,uM,=,-2.0,0,O=c1cc(OC2CCCCC2)cc(CCc2ccccc2)[nH]1
4885,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccccc2Cl)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2'-chloro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4886,195658,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at low (~0.1 pfu/cell) multiplicity of injection (moi),Nc1ncnc2c1ncn2/C=C1/CC1CO,{2-[1-(6-Amino-purin-9-yl)-meth-(Z)-ylidene]-cyclopropyl}-methanol,0.8,uM,=,-0.0969100130080563,0,C(=C1CC1)n1cnc2cncnc21
4887,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CCOC(=O)c1c(OC2CCC(C)CC2)cc(Cc2ccccc2)[nH]c1=O,"Ethyl 6-Benzyl-4-(4-methylcyclohexyloxy)-2-oxo-1,2-dihydropyridine-3-carboxylate",32.88,uM,=,1.5169318088680128,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
4888,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,CC(C)(C)c1ccc(S(=O)(=O)n2ccc(C(O)c3ccc(Cl)cc3Cl)c2)cc1,"[1-(4-tert-Butyl-benzenesulfonyl)-1H-pyrrol-3-yl]-(2,4-dichloro-phenyl)-methanol",6.4,uM,=,0.8061799739838872,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
4889,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2c(C)cccc2C)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2',3,5,6'-tetramethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.037,uM,=,-1.431798275933005,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4890,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,3.2,uM,=,0.505149978319906,1,S=C(NCCc1ccccn1)Nc1ccccn1
4891,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC(C)CN1c2cc(Cl)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"6-Chloro-3-cyclopropylethynyl-4-isobutyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.404,uM,=,-0.393618634889395,0,O=C1Nc2ccccc2NC1C#CC1CC1
4892,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4cc(Cl)nc(Cl)c4)cc3F)n2)cc1,"4-((4-((4-(2,6-dichloropyridin-4-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.096,uM,=,-1.0177287669604316,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
4893,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccccc2N(CC2CC2)C1(C#CC1CC1)C(F)(F)F,"3-Cyclopropylethynyl-4-cyclopropylmethyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.253,uM,=,-0.5968794788241821,0,O=C1Nc2ccccc2N(CC2CC2)C1C#CC1CC1
4894,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CCOC(=O)N1c2cc(F)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-7-fluoro-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid ethyl ester",0.121,uM,=,-0.91721462968355,0,O=C1Nc2ccccc2NC1C#CC1CC1
4895,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC=CC2)c1,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.241,uM,=,-0.6179829574251317,0,O=c1cc(Sc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
4896,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCC(=O)OC)cc2C(=O)N(C)c2cccnc21,"3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-propionic acid methyl ester",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncccc21
4897,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(4-(4-(methylsulfonyl)piperazin-1-yl)phenylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.18,uM,=,-0.744727494896694,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3c2COC3)cc1
4898,1924024,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT E138K using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC1(C)CC(=O)c2c(nc3c(c(C#N)cn3Cc3ccccc3)c2-c2ccccc2)C1,"1-benzyl-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-b]quinoline-3-carbonitrile",69.0,uM,=,1.8388490907372552,1,O=C1CCCc2nc3c(ccn3Cc3ccccc3)c(-c3ccccc3)c21
4899,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCC[C@H]2C)[C@H]2c3ccccc3S[C@@]12C(=O)OC,"(2aR,7aR)-2-((R)-2-methyl-pyrrolidin-1-yl)-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",0.5,uM,=,-0.3010299956639812,0,C1=C(N2CCCC2)[C@H]2c3ccccc3SC12
4900,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1O,"6-(4-Cyclopropylbenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.3,uM,=,0.1139433523068367,1,O=C1Cc2cc(Cc3ccc(C4CC4)cc3)ccc2C(=O)N1
4901,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,"30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone",0.455,uM,=,-0.3419886033428876,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
4902,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,COc1ccc(-c2nc3sc(C)c(C)c3c(=O)[nH]2)cc1OC,"2-(3,4-dimethoxyphenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",12.6,uM,=,1.100370545117563,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
4903,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CC2CCCCC2)c(=O)[nH]c1=O,"1-(cyclohexylmethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.173,uM,=,-0.7619538968712046,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CCCCC1
4904,195511,10.1016/s0960-894x(01)00012-9,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2C(C#CC2(O)CC2)(C(F)(F)F)O1,"6-Chloro-4-(1-hydroxy-cyclopropylethynyl)-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",1.983,uM,=,0.2973227142053027,1,O=C1Nc2ccccc2C(C#CC2CC2)O1
4905,1763340,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 reverse transcriptase RNase H using RNA-DNA hybrid duplex after 30 mins by FRET-based microplate fluorescence assay,COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(-c2ccccc2)cc1,N'-((2-methoxynaphthalen-1-yl)methylene)biphenyl-4-carbohydrazide,5.0,uM,=,0.6989700043360189,1,O=C(N/N=C/c1cccc2ccccc12)c1ccc(-c2ccccc2)cc1
4906,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(C(F)(F)F)cc3)ccc2C(=O)N1O,"2-Hydroxy-6-(4-(trifluoromethyl)benzyl)isoquinoline-1,3(2H,4H)-dione",3.3,uM,=,0.5185139398778875,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
4907,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCOCC3)[nH]c3ccc(Cl)c(F)c23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide",0.711,uM,=,-0.1481303992702337,0,O=C(NCCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4908,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(NS(N)(=O)=O)C3)cc2)nc2c1COC2,"(E)-N-(1-(4-((4-(4-(2-Cyanoyinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)phenyl)piperidin-3-yl)-methanesulfonamide",0.78,uM,=,-0.1079053973095195,0,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3c2COC3)cc1
4909,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cc[nH]c3)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrol-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.033,uM,=,-1.4814860601221125,0,O=C1Nc2ccc(-c3cc[nH]c3)nc2Nc2ncccc21
4910,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCC[C@@H]2C)[C@H]2c3ccccc3S[C@@]12C(=O)OC,"(2aR,7aR)-2-((S)-2-Methyl-pyrrolidin-1-yl)-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",2.3,uM,=,0.3617278360175928,1,C1=C(N2CCCC2)[C@H]2c3ccccc3SC12
4911,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCOCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.3,uM,=,-0.5228787452803376,0,c1ccc(Nc2nc(NC3CCOCC3)cc(Oc3ccc4ccccc4c3)n2)cc1
4912,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NC2CC2)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-(cyclopropylamino)pyrimidin-2-yl)amino)benzonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Nc2nc(NC3CC3)cc(Oc3ccccc3)n2)cc1
4913,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1C[S+]([O-])[C@@H]2[C@H](O)[C@H](O)[C@H](O)CN12,"(6R,7R,8R,8aR)-6,7,8-Trihydroxy-1-oxo-hexahydro-1lambda*4*-thiazolo[3,2-a]pyridin-3-one",2.45,uM,=,0.3891660843645325,1,O=C1C[SH+][C@@H]2CCCCN12
4914,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",20.52,uM,=,1.3121773564397787,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4915,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCOP(=O)(O)C(=O)O)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-[[[(hydroxycarbonyl)hydroxyphosphonyl]oxy]-propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",3.7,uM,=,0.568201724066995,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4916,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCCC3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-(piperidin-1-ylmethyl)-1H-indole-2-carboxamide",0.013,uM,=,-1.8860566476931635,0,O=C(NCN1CCCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4917,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[C@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC.[Na+],"sodium ((2S,3S,4S,5R,6S)-6-((S)-2,3-bis(palmitoyloxy)propoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methanesulfonate",0.112,uM,=,-0.9507819773298184,0,C1CCOCC1
4918,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cc(O)cc(O)c3)[nH]c(=O)c2c1C,"2-(3,5-dihydroxyphenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",5.2,uM,=,0.7160033436347992,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
4919,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccnc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-pyridin-3-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.32,uM,=,-0.494850021680094,0,O=C1Nc2cccnc2Nc2ncc(CCc3cccnc3)cc21
4920,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(/c1cc(C)c2on(C)c(=O)c2c1)c1cc(Cl)ccc1OC,"(Z)-6-(5-Chloro-2-methoxy-phenyl)-6-(2,7-dimethyl-3-oxo-2,3-dihydro-benzo[d]isoxazol-5-yl)-hex-5-enoic acid methyl ester",8.2,uM,=,0.9138138523837168,1,C=C(c1ccccc1)c1ccc2o[nH]c(=O)c2c1
4921,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.13,uM,=,-0.8860566476931633,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4922,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cc(Cl)cc(Cl)c2)C(COCCO)C(=O)NC1=O,"4-(3,5-dichlorophenylthio)-3-((2-hydroxyethoxy)methyl)-5-methylpyridine-2,6(1H,3H)-dione",0.027,uM,=,-1.5686362358410126,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
4923,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CC(C)c1c(Sc2ccccc2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-5-isopropyl-6-(phenylthio)pyrimidine-2,4(1H,3H)-dione",0.244,uM,=,-0.6126101736612706,0,O=c1cc(Sc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
4924,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,Cc1ccc(S(=O)(=O)n2ccc(C(O)c3ccc(Cl)cc3Cl)c2)cc1,"(2,4-Dichloro-phenyl)-[1-(toluene-4-sulfonyl)-1H-pyrrol-3-yl]-methanol",18.0,uM,=,1.255272505103306,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
4925,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,CN(C(=O)C1CN(S(=O)(=O)c2ccc(C#N)cc2)CCN1C(=O)c1cc(O)c(O)c(O)c1)c1ccccc1,"4-((4-cyanophenyl)sulfonyl)-N-methyl-N-phenyl-1-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.31,uM,=,-0.5086383061657274,0,O=C(Nc1ccccc1)C1CN(S(=O)(=O)c2ccccc2)CCN1C(=O)c1ccccc1
4926,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCn3c([N+](=O)[O-])cnc3C)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)-1H-indole-2-carboxamide",0.044,uM,=,-1.3565473235138126,0,O=C(NCCn1ccnc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4927,1795828,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CCR5 tropic HIV1 ADA5 reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(Cl)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-chloro-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.0002742511237765,uM,=,-3.561851584176332,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
4928,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",6.7,uM,=,0.8260748027008264,1,O=c1ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4929,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4)cc3)ccc2C(=O)N1O,"6-((4'-Fluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",3.7,uM,=,0.568201724066995,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4930,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC(C)OC(=O)N1c2cc(Cl)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"7-Chloro-2-cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2ccccc2NC1C#CC1CC1
4931,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCN(C)C)nc(Nc2ccc(C#N)cc2)c1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-(dimethylamino)ethyl)amino)pyridin-2-yl)amino)benzonitrile",0.83,uM,=,-0.0809219076239261,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4932,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3cccs3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(thiophen-2-ylmethyl)-1H-indole-2-carboxamide",0.03,uM,=,-1.5228787452803376,0,O=C(NCc1cccs1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4933,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)/C=C/Nc2ccncc2)c(O)c(OC)c2occc12,"E-1-(6-hydroxy-4,7-dimethoxybenzofuran-5-yl)-3-(pyridin-4-ylamino)prop-2-en-1-one",4.8,uM,=,0.6812412373755872,1,O=C(/C=C/Nc1ccncc1)c1ccc2occc2c1
4934,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCOCC3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-N-(morpholinomethyl)-5-nitro-1H-indole-2-carboxamide",0.15,uM,=,-0.8239087409443188,0,O=C(NCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4935,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCOc3ccccc3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-phenoxyethyl)-1H-indole-2-carboxamide",2.395,uM,=,0.379305517750582,1,O=C(NCCOc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4936,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCC3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(pyrrolidin-1-ylmethyl)-1H-indole-2-carboxamide",0.008,uM,=,-2.096910013008056,0,O=C(NCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4937,80143,10.1016/0960-894X(95)00401-E,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.043,uM,=,-1.3665315444204136,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
4938,306158,10.1021/jm040071z,,,,Concentration required for 50% inhibition of wild type human immunodeficiency virus type 1 reverse transcriptase,CC(C)c1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6-Chloro-4-cyclohexyloxy-3-isopropyl-1H-quinolin-2-one,0.63,uM,=,-0.2006594505464183,0,O=c1cc(OC2CCCCC2)c2ccccc2[nH]1
4939,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCN(S(N)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)benzyl)piperazine-1-sulfonamide",0.28,uM,=,-0.5528419686577808,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3c2COC3)cc1
4940,642450,10.1016/j.bmc.2010.05.036,,,,Inhibition of HIV1 reverse transcriptase,N#Cc1ccc(Nc2nccc(Oc3ccc4cc(C#N)ccc4c3Br)n2)cc1,5-bromo-6-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-2-naphthonitrile,3.015719001503431,uM,=,0.4793908724159583,1,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
4941,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,C[C@@H](/N=C(\S)Nc1ccc(Br)cn1)c1ccccc1,1-(5-Bromo-pyridin-2-yl)-3-((R)-1-phenyl-ethyl)-thiourea,1.6,uM,=,0.2041199826559248,1,C(=NCc1ccccc1)Nc1ccccn1
4942,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,COc1cc2nc(Nc3ccc(C#N)cc3)nc(Nc3c(Cl)cc(/C=C/C#N)cc3Cl)c2cc1OC,"(E)-4-{4-[2,6-dichloro-4-(2-cyanovinyl)phenylamino]-6,7-dimethoxyquinazolin-2-yl}aminobenzonitrile",0.046,uM,=,-1.337242168318426,0,c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1
4943,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3cccs3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(2-(thiophen-2-yl)-ethyl)-1H-indole-2-carboxamide",0.07,uM,=,-1.154901959985743,0,O=C(NCCc1cccs1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4944,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,CS(=O)(=O)c1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",1.8,uM,=,0.255272505103306,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4945,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CN(c1ncccc1NC(C)(C)C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-tert-Butylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,3.1,uM,=,0.4913616938342727,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4946,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccco3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(furan-2-ylmethyl)-1H-indole-2-carboxamide",0.003,uM,=,-2.5228787452803374,0,O=C(NCc1ccco1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4947,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(N=[N+]=[N-])c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(3-Azido-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4948,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3c[nH]c4ccc(F)cc34)nc21,"5-Ethyl-7-(5-fluoro-1H-indol-3-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.706,uM,=,-0.1511952989481962,0,O=C1Nc2ccc(-c3c[nH]c4ccccc34)nc2Nc2ncccc21
4949,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(Cl)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-chloro-6-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)benzonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4950,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1C(N)=O,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)nicotinamide",0.08,uM,=,-1.0969100130080565,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
4951,1339445,10.1016/j.bmc.2014.02.030,,,,Inhibition of wild-type HIV1 reverse transcriptase p66/p51 after 40 mins by spectrophotometry,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.016,uM,=,-1.7958800173440752,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4952,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",3.2,uM,=,0.505149978319906,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
4953,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(CCC(=O)O)cc3C)cc2C(=O)N(C)c2cccnc21,"3-{4-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-phenyl}-propionic acid",0.022,uM,=,-1.6575773191777938,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
4954,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc4c(C(=O)O)cccc4c3)cc2C(=O)N(C)c2cccnc21,"6-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-naphthalene-1-carboxylic acid",0.063,uM,=,-1.2006594505464183,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccc4ccccc4c3)cc21
4955,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,CC(C)Cc1nc2ccccc2[nH]c1=O,3-(2-Methylpropyl)quinoxalin-2(1H)-one,23.0,uM,=,1.3617278360175928,1,O=c1cnc2ccccc2[nH]1
4956,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1ccccc1-c1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-((4-((2',3,5-trimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.018,uM,=,-1.744727494896694,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4957,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),CCCCCCCCOC(=O)c1cc2c([nH]c3ccccc32)c(-c2ccc3c(n2)C(=O)C(NC=O)=CC3=O)n1,"1-(7-Formylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-9H-beta-carboline-3-carboxylic acid octyl ester",7.1,uM,=,0.8512583487190752,1,O=C1C=CC(=O)c2nc(-c3nccc4c3[nH]c3ccccc34)ccc21
4958,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC1CCCCC1Oc1cc(Cc2ccccc2)[nH]c(=O)c1,6-Benzyl-4-(2-methylcyclohexyloxy)pyridin-2(1H)-one,59.3,uM,=,1.7730546933642626,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
4959,197448,10.1021/jm9704210,,,,Compound was evaluated for 50% inhibition of HIV-RT (HIV reverse transcriptase),Cc1cn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,(beta-D) FTTPTriphosphoric acid-[3-hydroxy-5-(4-hydroxy-5-methyl-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester 4M triethyl amine,0.05,uM,=,-1.3010299956639813,0,O=c1ccn([C@@H]2CCCO2)c(=O)[nH]1
4960,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc(Cl)c2)C(COCCO)C(=O)NC1=O,"4-(3-chlorophenylthio)-3-((2-hydroxyethoxy)methyl)-5-methylpyridine-2,6(1H,3H)-dione",0.0022,uM,=,-2.657577319177794,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
4961,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CO)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-hydroxymethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.74,uM,=,-0.1307682802690238,0,O=C1Nc2cccnc2Nc2ncccc21
4962,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3nccs3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-thiazol-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.44,uM,=,-0.3565473235138126,0,O=C1Nc2cccnc2Nc2ncc(CCc3nccs3)cc21
4963,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3c[nH]c4ccncc34)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrolo[3,2-c]pyridin-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2ccc(-c3c[nH]c4ccncc34)nc2Nc2ncccc21
4964,805873,10.1016/j.ejmech.2012.02.019,,,,Inhibition of HIV1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rA)-oligo(dT),CNc1nc(Nc2c(C)cc(C)cc2C)nc(NC2CCN(Cc3cccc(C#N)c3)CC2)n1,"3-((4-(4-(mesitylamino)-6-(methylamino)-1,3,5-triazin-2-ylamino)piperidin-1-yl)methyl)benzonitrile",1.97,uM,=,0.2944662261615929,1,c1ccc(CN2CCC(Nc3ncnc(Nc4ccccc4)n3)CC2)cc1
4965,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC2CCOCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(((tetrahydro-2H-pyran-4-yl)methyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.2,uM,=,-0.6989700043360187,0,c1ccc(Nc2nc(NCC3CCOCC3)cc(Oc3ccc4ccccc4c3)n2)cc1
4966,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(=O)O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid",1.5,uM,=,0.1760912590556812,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4967,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cc(C)cc(C)c2)C(COCCO)C(=O)NC1=O,"4-(3,5-dimethylphenylthio)-3-((2-hydroxyethoxy)methyl)-5-methylpyridine-2,6(1H,3H)-dione",0.024,uM,=,-1.619788758288394,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
4968,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc(N)cc3)cc2C(=O)N(C)c2cccnc21,"2-[2-(4-Amino-phenyl)-ethyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4969,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CCOC(=O)c1c(OC2C(C)CCCC2C)cc(Cc2ccccc2)[nH]c1=O,"Ethyl 6-Benzyl-4-(2,6-dimethylcyclohexyloxy)-2-oxo-1,2-dihydropyridine-3-carboxylate",37.07,uM,=,1.5690225860295637,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
4970,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,O=C(O)c1cn(CC2(c3ccccc3)CCCC2)cc(O)c1=O,"5-Hydroxy-4-oxo-1-((1-phenylcyclopentyl)methyl)-1,4-dihydropyridine-3-carboxylic Acid",1.8,uM,=,0.255272505103306,1,O=c1ccn(CC2(c3ccccc3)CCCC2)cc1
4971,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(-c4ccc(F)cc4F)cc3)ccc2C(=O)N1O,"6-((2',4'-Difluoro-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.0,uM,=,0.3010299956639812,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4972,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCNc1cccnc1N(C)C1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,{4-[(3-Ethylamino-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-(1H-indol-2-yl)-methanone,2.2,uM,=,0.3424226808222063,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
4973,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,C#CCCOc1ccc(OC)cc1CCNC(=S)Nc1ccc(Br)cn1,1-(2-(but-3-ynyloxy)-5-methoxyphenethyl)-3-(5-bromopyridin-2-yl)thiourea,0.0038,uM,=,-2.42021640338319,0,S=C(NCCc1ccccc1)Nc1ccccn1
4974,806933,10.1016/j.ejmech.2012.01.056,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type Human immunodeficiency virus 1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.003,uM,=,-2.5228787452803374,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
4975,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCC2CCCO2)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-(((tetrahydrofuran-2-yl)methyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.44,uM,=,-0.3565473235138126,0,c1ccc(Nc2nc(NCC3CCCO3)cc(Oc3ccccc3)n2)cc1
4976,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cncnc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-pyrimidin-5-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.54,uM,=,-0.2676062401770315,0,O=C1Nc2cccnc2Nc2ncc(CCc3cncnc3)cc21
4977,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccc(N)cc4)cc3F)n2)cc1,"4-((4-((4'-amino-3,5-difluoro-[1,1'-biphenyl]-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.037,uM,=,-1.431798275933005,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4978,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCC(NS(C)(=O)=O)C3)cc2)nc2c1COC2,"(E)-N-(1-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)phenyl)pyrrolidin-3-yl)methanesulfonamide",0.18,uM,=,-0.744727494896694,0,c1ccc(Oc2nc(Nc3ccc(N4CCCC4)cc3)nc3c2COC3)cc1
4979,1467341,10.1016/j.ejmech.2015.01.042,,,,"Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA after 1 hr using poly(A) x oligo(dT)15 template/primer hybrid, digoxigenin and biotin-labeled nucleotides",Cc1cc(C)c(Oc2cc(NC3CCN(Cc4ccc(S(C)(=O)=O)cc4)CC3)nc3ncnn23)c(C)c1,"7-(Mesityloxy)-N-(1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)-[1,2,4]triazolo [1,5-a]pyrimidin-5-amine",0.5,uM,=,-0.3010299956639812,0,c1ccc(CN2CCC(Nc3cc(Oc4ccccc4)n4ncnc4n3)CC2)cc1
4980,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(/C=C/c3ccncc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-((E)-2-pyridin-4-yl-vinyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",3.0,uM,=,0.4771212547196624,1,O=C1Nc2cccnc2Nc2ncc(/C=C/c3ccncc3)cc21
4981,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCC(=O)OC)cc2C(=O)N(C)c2cccnc21,"3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-propionic acid methyl ester",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2cccnc2Nc2ncccc21
4982,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(=O)O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid",3.8,uM,=,0.5797835966168101,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4983,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(NC(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"{3-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-phenyl}-urea",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
4984,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2cccc(F)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3'-fluoro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.012,uM,=,-1.9208187539523751,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
4985,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CCC(c1ccccc1)c1cc(O)nc(SC(C)C)n1,2-Isopropylsulfanyl-6-(1-phenyl-propyl)-3H-pyrimidin-4-one,2.3,uM,=,0.3617278360175928,1,c1ccc(Cc2ccncn2)cc1
4986,642450,10.1016/j.bmc.2010.05.036,,,,Inhibition of HIV1 reverse transcriptase,COc1cc2cc(C#N)ccc2cc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,6-(2-(4-Cyanophenylamino)pyrimidin-4-yloxy)-7-methoxy-2-naphthonitrile,1.3227426595136842,uM,=,0.1214753601178747,1,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
4987,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(2-Amino-pyridin-4-yl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4988,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2CCCC2)c1,"1-(2-cyclopentylethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.234,uM,=,-0.6307841425898572,0,O=c1cc(Oc2ccccc2)n(CCC2CCCC2)c(=O)[nH]1
4989,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCCC2)C2c3ccccc3SC12C(=O)OC,"(R,R/S,S)-dimethyl-1-(1-piperidynyl)cyclobuta[b][1]benzothiophene-2,2a(7bH)-dicarboxylate",1.2,uM,=,0.0791812460476248,1,C1=C(N2CCCC2)C2c3ccccc3SC12
4990,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(Cl)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-[(1R,2R)-2-(6-Chloro-3-ethoxy-2-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea",0.02,uM,=,-1.6989700043360187,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
4991,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,CC(C)c1ccc(O)c(=O)c(O)c1,"(2E,4Z,6E)-2,7-dihydroxy-4-isopropylcyclohepta-2,4,6-trienone",1.98,uM,=,0.2966651902615311,1,O=c1cccccc1
4992,1339445,10.1016/j.bmc.2014.02.030,,,,Inhibition of wild-type HIV1 reverse transcriptase p66/p51 after 40 mins by spectrophotometry,CC(O)(c1cccc(Br)c1)c1ccnc(Nc2ccc(C#N)cc2)n1,4-((4-(1-(3-Bromophenyl)-1-hydroxyethyl)pyrimidin-2-yl)amino)benzonitrile,0.39,uM,=,-0.4089353929735008,0,c1ccc(Cc2ccnc(Nc3ccccc3)n2)cc1
4993,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCOCC3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-morpholinoethyl)-1H-indole-2-carboxamide",0.063,uM,=,-1.2006594505464183,0,O=C(NCCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
4994,2278448,10.1021/acs.jmedchem.2c00576,,,,Inhibition of wild type recombinant HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate assessed as inhibition of biotin-labelled UTP incorporation incubated for 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.01,uM,=,-2.0,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
4995,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1O,"6-([1,1'-Biphenyl]-4-ylmethyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.6,uM,=,0.2041199826559248,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
4996,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-[2-(2-methyl-pyridin-4-yl)-ethyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
4997,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2=CCCC2)c1,"1-(2-cyclopentenylethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",1.54,uM,=,0.1875207208364631,1,O=c1cc(Oc2ccccc2)n(CCC2=CCCC2)c(=O)[nH]1
4998,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCC1=C(Sc2cc(C)cc(C)c2)C(COCCO)C(=O)NC1=O,"4-(3,5-dimethylphenylthio)-5-ethyl-3-((2-hydroxyethoxy)methyl)pyridine-2,6(1H,3H)-dione",0.08,uM,=,-1.0969100130080565,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
4999,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(Cc3ccccc3)cc2C(=O)N(C)c2cccnc21,"2-Benzyl-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.2,uM,=,0.0791812460476248,1,O=C1Nc2cccnc2Nc2ncc(Cc3ccccc3)cc21
5000,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)CC2C(=O)NCc2ccc(-c3ccccc3)cc2)cc1,"N-([1,1'-biphenyl]-4-ylmethyl)-1-((4-aminophenyl)sulfonyl)-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.34,uM,=,-0.4685210829577448,0,O=C(NCc1ccc(-c2ccccc2)cc1)C1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccccc1
5001,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCCO)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-(3-hydroxy-propyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.3,uM,=,-0.5228787452803376,0,O=C1Nc2cccnc2Nc2ncccc21
5002,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3Br)cc2C(=O)N(C)c2cccnc21,"3-Bromo-4-[2-(5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-benzoic acid",0.018,uM,=,-1.744727494896694,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5003,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCN(C)C)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-(dimethylamino)ethyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.01,uM,=,-2.0,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5004,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(\c1cccc(C#N)c1)c1cc(C)c2onc(OC)c2c1,(E)-6-(3-Cyano-phenyl)-6-(3-methoxy-7-methyl-benzo[d]isoxazol-5-yl)-hex-5-enoic acid methyl ester,5.7,uM,=,0.7558748556724915,1,C=C(c1ccccc1)c1ccc2oncc2c1
5005,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc(NS(C)(=O)=O)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"N-{4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-phenyl}-methanesulfonamide",0.56,uM,=,-0.2518119729937995,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5006,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(/c1cc(C)c2on(C)c(=O)c2c1)c1cc(C)c2oc(=O)n(C)c2c1,"methyl 6-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-6-(2,7-dimethyl-3-oxo-2,3-dihydrobenzo[d]isoxazol-5-yl)hex-5-enoate",49.2,uM,=,1.6919651027673603,1,C=C(c1ccc2oc(=O)[nH]c2c1)c1ccc2o[nH]c(=O)c2c1
5007,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,C[C@@H](/N=C(\S)Nc1ccc(Cl)cn1)C1CCCCC1,1-(5-Chloro-pyridin-2-yl)-3-((R)-1-cyclohexyl-ethyl)-thiourea,1.4,uM,=,0.1461280356782379,1,C(=NCC1CCCCC1)Nc1ccccn1
5008,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,CCCc1c(C)sc2nc(-c3ccc(O)c(O)c3)[nH]c(=O)c12,"2-(3,4-dihydroxyphenyl)-6-methyl-5-propylthieno[2,3-d]pyrimidin-4(3H)-one",0.49,uM,=,-0.3098039199714864,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
5009,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,C=CCNc1cc(Oc2c(C)cc(/C=C/C#N)cc2C)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(Allylamino)-6-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)benzonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5010,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C)c(Oc2nc(Nc3ccc([N+](=O)[O-])cc3)cn3ccnc23)c(C)c1,"8-(mesityloxy)-N-(4-nitrophenyl)imidazo[1,2-a]pyrazin-6-amine",4.7,uM,=,0.6720978579357175,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5011,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1O,"6-Benzyl-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.7,uM,=,0.2304489213782739,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
5012,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)/C=C/c6ccc(O)cc6)CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,aleuritolic acid 3-p-hydroxycinnamate,11.5,uM,=,1.0606978403536118,1,O=C(/C=C/c1ccccc1)O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C1
5013,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CC(C)c1c(Oc2ccccc2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-5-isopropyl-6-phenoxypyrimidine-2,4(1H,3H)-dione",4.91,uM,=,0.6910814921229685,1,O=c1cc(Oc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
5014,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.048,uM,=,-1.3187587626244128,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5015,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1S[C@H]2[C@H](O)[C@H](O)[C@H](O)CN2C1=O,"(6R,7R,8R,8aS)-tetrahydro-6,7,8-trihydroxy-5H-thiazolo[3,2-a]pyridine-2,3-dione",4.22,uM,=,0.6253124509616739,1,O=C1S[C@H]2CCCCN2C1=O
5016,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)C2=CN3C=CSC3N=C2)c(O)c(OC)c2occc12,"(6-hydroxy-4,7-dimethoxybenzofuran-5-yl)(8aH-thiazolo[3,2-a]pyrimidin-6-yl)methanone",15.26,uM,=,1.1835545336188618,1,O=C(C1=CN2C=CSC2N=C1)c1ccc2occc2c1
5017,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-prolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",6.6,uM,=,0.8195439355418687,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5018,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5019,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2ccccc2)n(CC2CC=CC2)c(=O)[nH]c1=O,"6-benzoyl-1-(cyclopent-3-enylmethyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.256,uM,=,-0.5917600346881504,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC=CC1
5020,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCO)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-(2-hydroxy-ethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.5,uM,=,0.3979400086720376,1,O=C1Nc2cccnc2Nc2ncccc21
5021,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(3-Amino-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5022,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2cccc(C#N)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3',5'-dimethyl-(1,1'-biphenyl)-3-carbonitrile",0.011,uM,=,-1.958607314841775,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5023,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CCCCOC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid butyl ester",0.672,uM,=,-0.1726307269461747,0,O=C1Nc2ccccc2NC1C#CC1CC1
5024,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,C=CCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C)cc1C,N-allyl-6-((4-cyanophenyl)amino)-4-(mesityloxy)nicotinamide,0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5025,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2CC=CC2)c1,"1-(2-(cyclopent-3-enyl)ethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.176,uM,=,-0.7544873321858502,0,O=c1cc(Oc2ccccc2)n(CCC2CC=CC2)c(=O)[nH]1
5026,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCC(NS(N)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-N-(1-(4-((4-(4-(2-Cyanoyinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)phenyl)piperidin-4-yl)aminosuffonamide",1.32,uM,=,0.1205739312058498,1,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3c2COC3)cc1
5027,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC(C)C)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(isobutylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.25,uM,=,-0.6020599913279624,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5028,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1COC2,"(E)-4-((4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide",0.14,uM,=,-0.8538719643217619,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
5029,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C(/C=C/CO)=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-(3-hydroxy-propenyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",4.8,uM,=,0.6812412373755872,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5030,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(O)c(O)c2)nc2sc3c(c12)CCC3,"2-(3,4-Dihydroxy-phenyl)-3,5,6,7-tetrahydro-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one",0.32,uM,=,-0.494850021680094,0,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCC3
5031,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NCC2CC2)c(C)c1,6-((4-Cyanophenyl)amino)-N-(cyclopropylmethyl)-4-(mesityloxy)nicotinamide,0.68,uM,=,-0.1674910872937636,0,O=C(NCC1CC1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
5032,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2cc(C)cc(C)c2)c(I)c(=O)[nH]c1=O,"6-(3,5-Dimethylbenzyl)-1-ethoxymethyl-5-iodouracil",0.11,uM,=,-0.958607314841775,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5033,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4cccnc4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(pyridin-3-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.058,uM,=,-1.2365720064370629,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccnc4)cc3)n2)cc1
5034,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCC3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(pyrrolidin-1-ylmethyl)-1H-indole-2-carboxamide",0.012,uM,=,-1.9208187539523751,0,O=C(NCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5035,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3,"2-Phenyl-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",4.1,uM,=,0.6127838567197355,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5036,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccc(C#N)cc4)cc3F)n2)cc1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3',5'-difluoro-[1,1'-biphenyl]-4-carbonitrile",0.0047,uM,=,-2.3279021420642825,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5037,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(NS(N)(=O)=O)cc3)CC2)nc2c1COC2,"(E)-N-(4-(4-((4-(4-(2 Cyanovinyl)-2,6-dimethylphenozy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)phenyl)-aminosulfonamide",0.12,uM,=,-0.9208187539523752,0,c1ccc(Oc2nc(NC3CCN(c4ccccc4)CC3)nc3c2COC3)cc1
5038,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCC1=C(Sc2ccccc2)C(COCC2CCCCC2)C(=S)NC1=O,"5-((cyclohexylmethoxy)methyl)-3-ethyl-4-(phenylthio)-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.375,uM,=,-0.4259687322722811,0,O=C1C=C(Sc2ccccc2)C(COCC2CCCCC2)C(=S)N1
5039,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,COc1cc2nc([S+]([O-])CC(=O)Nc3ccc(C#N)cc3)nc(Nc3c(C)cc(/C=C/C#N)cc3C)c2cc1OC,"(E)-N-(4-cyanophenyl)-2-{4-[4-(2-cyanovinyl)-2,6-dimethylphenylamino]-6,7-dimethoxyquinazolin-2-yl}sulfinyl acetamide",0.0057,uM,=,-2.2441251443275085,0,O=C(C[SH+]c1nc(Nc2ccccc2)c2ccccc2n1)Nc1ccccc1
5040,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.0008,uM,=,-3.096910013008056,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5041,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NCCN(C)C)c(C)c1,6-((4-Cyanophenyl)amino)-N-(2-(dimethylamino)ethyl)-4-(mesityloxy)nicotinamide,3.45,uM,=,0.5378190950732742,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5042,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CC2=CCCC2)c1,"1-(cyclopentenylmethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.079,uM,=,-1.1023729087095586,0,O=c1cc(Sc2ccccc2)n(CC2=CCCC2)c(=O)[nH]1
5043,545624,10.1021/np0003995,,,,Inhibition of HIV1 reverse transcriptase,CC(C)=CCOc1c(CC=C(C)C)c(O)nc2ccccc12,3-(3-methyl-2-butenyl-4-[(3-methyl-2-butenyl)oxy]-2(1H)-quinolinone,8.0,uM,=,0.9030899869919436,1,c1ccc2ncccc2c1
5044,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)C2=CN3C=CNC=C3N=C2)c(O)c(OC)c2occc12,"(6-hydroxy-4,7-dimethoxybenzofuran-5-yl)(8H-pyrazino[1,2-a]pyrimidin-3-yl)methanone",14.6,uM,=,1.1643528557844371,1,O=C(C1=CN2C=CNC=C2N=C1)c1ccc2occc2c1
5045,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(O)cc2)nc2sc3c(c12)CCCCC3,"2-(4-Hydroxy-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",3.2,uM,=,0.505149978319906,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5046,722008,10.1128/aac.00800-09,,,,Inhibition of Human immunodeficiency virus 1 subtype B reverse transcriptase DNA-dependent DNA polymerase activity by gel-based primer extension assay,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-[4-(2,4,6-Trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",0.322,uM,=,-0.4921441283041691,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
5047,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,O=[N+]([O-])c1ccc(Nc2cn3ccnc3c(Oc3c(F)cc(F)cc3F)n2)cc1,"N-(4-nitrophenyl)-8-(2,4,6-trifluorophenoxy)imidazo[1,2-a]pyrazin-6-amine",11.0,uM,=,1.0413926851582251,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5048,1900980,10.1016/j.ejmech.2019.111566,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA,COc1ccc2c(c1)CCCN2CCC(=O)N1CCN(c2ccccc2C)CC1,"3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(4-o-tolylpiperazin-1-yl)propan-1-one",12.485961963287414,uM,=,1.0964220075807305,1,O=C(CCN1CCCc2ccccc21)N1CCN(c2ccccc2)CC1
5049,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.4,uM,=,0.380211241711606,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5050,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cccc(C)c1Oc1nc(Nc2ccc(C#N)cc2)cn2ccnc12,"4-((8-(2,6-dimethylphenoxy)imidazo[1,2-a]pyrazin-6-yl)amino)benzonitrile",0.82,uM,=,-0.0861861476162833,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5051,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N=C(N)N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"N-[(5R,6R,8R,9R)-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-8-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-4-yl]-guanidine",3.8,uM,=,0.5797835966168101,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5052,197448,10.1021/jm9704210,,,,Compound was evaluated for 50% inhibition of HIV-RT (HIV reverse transcriptase),Cc1cn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)nc1N,Triphosphoric acid-[3-fluoro-5-(4-amino-5-methyl-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester 4M triethyl amine,0.6,uM,=,-0.2218487496163563,0,O=c1ncccn1[C@@H]1CCCO1
5053,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,O=S(=O)(c1ccc(Cl)cc1)n1ccc(C(O)c2ccc(Cl)cc2Cl)c1,"[1-(4-Chloro-benzenesulfonyl)-1H-pyrrol-3-yl]-(2,4-dichloro-phenyl)-methanol",17.0,uM,=,1.230448921378274,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
5054,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccccc2N(Cc2ccccc2)C1(C#CC1CC1)C(F)(F)F,"4-Benzyl-3-cyclopropylethynyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",1.818,uM,=,0.2595938788859486,1,O=C1Nc2ccccc2N(Cc2ccccc2)C1C#CC1CC1
5055,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-alanylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",5.4,uM,=,0.7323937598229685,1,O=c1ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5056,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CC2CC2)c(=O)[nH]c1=O,"1-(cyclopropylmethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.016,uM,=,-1.7958800173440752,0,O=c1cc(Oc2ccccc2)n(CC2CC2)c(=O)[nH]1
5057,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,COC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid methyl ester",0.504,uM,=,-0.2975694635544747,0,O=C1Nc2ccccc2NC1C#CC1CC1
5058,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1sccc1S(=O)(=O)N1c2cc(F)ccc2NC(=O)C1C,"6-Fluoro-3-methyl-4-(2-methyoxycarbonylthiophene-3-sulfonyl)-3,4-dihydroquinoxa-lin-2-(1H)-one",0.2,uM,=,-0.6989700043360187,0,O=C1CN(S(=O)(=O)c2ccsc2)c2ccccc2N1
5059,666602,10.1128/aac.01795-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by filter-based filtration assay,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-[4-(2,4,6-Trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",0.019,uM,=,-1.7212463990471711,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
5060,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CCOC(=O)c1c(OC2CCCCC2)cc(Cc2ccccc2)[nH]c1=O,"Ethyl 6-Benzyl-4-(cyclohexyloxy)-2-oxo-1,2-dihydropyridine-3-carboxylate",80.99,uM,=,1.9084313989660064,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5061,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccccc3N)cc2C(=O)N(C)c2cccnc21,"2-[2-(2-Amino-phenyl)-ethyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.7,uM,=,0.2304489213782739,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5062,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCCN2CCOCC2)nc(Nc2ccc(C#N)cc2)c1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((3-morpholinopropyl)amino)pyridin-2-yl)amino)benzonitrile",0.97,uM,=,-0.0132282657337551,0,c1ccc(Nc2cc(Oc3ccccc3)cc(NCCCN3CCOCC3)n2)cc1
5063,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc(C(F)(F)F)c2)C(COCCO)C(=O)NC1=O,"3-((2-hydroxyethoxy)methyl)-5-methyl-4-(3-(trifluoromethyl)phenylthio)pyridine-2,6(1H,3H)-dione",0.00052,uM,=,-3.283996656365201,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5064,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2CCCN2C(=O)CN)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[glycyl-prolylamino]propyl]thymine]-3'-spiro-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",13.0,uM,=,1.1139433523068367,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5065,427351,10.1128/aac.00749-06,,,,Inhibition of reverse transcriptase activity in HIV1 NL4-3 infected MT4 cells before dialysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.0,uM,=,0.3010299956639812,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5066,196376,10.1021/jm030255y,,,,Inhibitory concentration against wild-type reverse transcriptase of HIV-1,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.00075,uM,=,-3.1249387366083,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5067,1339445,10.1016/j.bmc.2014.02.030,,,,Inhibition of wild-type HIV1 reverse transcriptase p66/p51 after 40 mins by spectrophotometry,CC(O)(c1ccccc1)c1ccnc(Nc2ccc(C#N)cc2)n1,4-((4-(1-Hydroxy-1-phenylethyl)pyrimidin-2-yl)amino)benzonitrile,2.0,uM,=,0.3010299956639812,1,c1ccc(Cc2ccnc(Nc3ccccc3)n2)cc1
5068,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CC2CCCCC2)c(=O)[nH]c1=O,"1-(cyclohexylmethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.132,uM,=,-0.8794260687941501,0,O=c1cc(Oc2ccccc2)n(CC2CCCCC2)c(=O)[nH]1
5069,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(Br)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)cn2ccnc12,"4-((8-(4-bromo-2,6-dimethylphenoxy)imidazo[1,2-a]pyrazin-6-yl)amino)benzonitrile",0.41,uM,=,-0.3872161432802645,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5070,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)cn2ccnc12,"4-((6-((4-cyanophenyl)amino)imidazo[1,2-a]pyrazin-8-yl)oxy)-3,5-dimethylbenzonitrile",0.26,uM,=,-0.585026652029182,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5071,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2Cc2ccccc2)c1,"1-benzyl-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.137,uM,=,-0.8632794328435932,0,O=c1cc(Sc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
5072,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCC(N)=O)cc2C(=O)N(C)c2cccnc21,"3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-propionamide",0.62,uM,=,-0.2076083105017461,0,O=C1Nc2cccnc2Nc2ncccc21
5073,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C3CCCN(S(C)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(4-(1-(methylsulfonyl)azepan-4-yl)phenylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.23,uM,=,-0.6382721639824072,0,c1ccc(Oc2nc(Nc3ccc(C4CCCNCC4)cc3)nc3c2COC3)cc1
5074,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCCC3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(piperidin-1-ylmethyl)-1H-indole-2-carboxamide",0.008,uM,=,-2.096910013008056,0,O=C(NCN1CCCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5075,546667,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by NCI assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)/C=C/c6ccc(O)cc6)CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,aleuritolic acid 3-p-hydroxycinnamate,60.0,uM,=,1.7781512503836436,1,O=C(/C=C/c1ccccc1)O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C1
5076,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),O=C(Nc1ccc(Cl)cn1)N[C@@H]1C[C@@H]1c1c(F)cccc1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(2,6-difluoro-phenyl)-cyclopropyl]-urea",0.12,uM,=,-0.9208187539523752,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
5077,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2ccccc2)C(COCc2ccccc2)C(=O)NC1=O,"3-(benzyloxymethyl)-5-methyl-4-(phenylthio)pyridine-2,6(1H,3H)-dione",0.111,uM,=,-0.9546770212133424,0,O=C1C=C(Sc2ccccc2)C(COCc2ccccc2)C(=O)N1
5078,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,COC(=O)P(=O)([O-])OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O.[Na+],"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-[[[(methoxycarbonyl)hydroxyphosphonyl]oxy]-propyl]thymine]-3''-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide); Sodium ion",4.7,uM,=,0.6720978579357175,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5079,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(Oc3c(F)cc(-c4ccc(C#N)cc4)cc3F)n2)cc1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3',5'-difluoro-[1,1'-biphenyl]-4-carbonitrile",0.0132,uM,=,-1.8794260687941504,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5080,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CCC2CCCC2)c(=O)[nH]c1=O,"1-(2-cyclopentylethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.119,uM,=,-0.9244530386074692,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1CCCC1
5081,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CCC(c1ccccc1)c1cc(O)nc(SC2CCCCC2)n1,2-Cyclohexylsulfanyl-6-(1-phenyl-propyl)-3H-pyrimidin-4-one,3.7,uM,=,0.568201724066995,1,c1ccc(Cc2ccnc(SC3CCCCC3)n2)cc1
5082,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(CC(=O)O)cc3C)cc2C(=O)N(C)c2cccnc21,"{4-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-phenyl}-acetic acid",0.023,uM,=,-1.6382721639824072,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5083,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione (TASO-m3T)",3.1,uM,=,0.4913616938342727,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5084,196947,10.1016/S0960-894X(01)80437-6,,,,The compound was evaluated as inhibitor of recombinant HIV-l reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.2366883767252327,uM,=,-0.6258230688475864,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5085,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5086,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)c1cc(/C(=C\CCN2CCOC2=O)c2cc(C)c3on(C)c(=O)c3c2)cc(C)c1OC,"(Z)-5-[1-(2,3-dihydro-2,7-dimethyl-3-oxobenzo[d]isoxazol-5-yl)-4-(2-oxooxazolidin-3-yl)but-1-enyl]-2-methoxy-3-methylbenzoic acid methyl ester",9.86,uM,=,0.9938769149412112,1,O=C1OCCN1CC/C=C(\c1ccccc1)c1ccc2o[nH]c(=O)c2c1
5087,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=C(O)c1ccc(-c2nc3sc4c(c3c(=O)[nH]2)CCCCC4)cc1,"4-(4-Oxo-3,5,6,7,8,9-hexahydro-4H-10-thia-1,3-diaza-benzo[a]azulen-2-yl)-benzoic acid",1.9,uM,=,0.2787536009528289,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5088,1721403,10.1021/acsmedchemlett.7b00361,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,CC(=O)Nc1ccc(S(=O)(=O)NC2CCC(Nc3nc(Oc4c(C)cc(C#N)cc4C)c4sccc4n3)CC2)cc1,"N-(4-(N-(4-((4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)cyclohexyl)sulfamoyl)phenyl)acetamide",1.041,uM,=,0.0174507295105361,1,O=S(=O)(NC1CCC(Nc2nc(Oc3ccccc3)c3sccc3n2)CC1)c1ccccc1
5089,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(O[C@H]2CCCC[C@H]2C)cc(CCc2ccccc2)[nH]c1=O,(+/-)-cis-3-Isopropyl-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one,1.31,uM,=,0.1172712956557642,1,O=c1cc(OC2CCCCC2)cc(CCc2ccccc2)[nH]1
5090,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC(C)(C)C)nc(Nc2ccc(C#N)cc2)n1,"6-((6-(tert-butylamino)-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.31,uM,=,-0.5086383061657274,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5091,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccc(Cl)c([N+](=O)[O-])c3)[nH]c(=O)c2c1C,"2-(4-chloro-3-nitrophenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",12.0,uM,=,1.0791812460476249,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
5092,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cc(O)c(O)cc3O)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(2,4,5-trihydroxyphenyl)thieno[2,3-d]pyrimidin-4(3H)-one",1.6,uM,=,0.2041199826559248,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
5093,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(3-Amino-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5094,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc(N)cc3)cc2C(=O)N(C)c2cccnc21,"2-[2-(4-Amino-phenyl)-ethyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.2,uM,=,-0.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5095,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC2CO2)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-3-oxiranylmethyl-1H-pyrimidine-2,4-dione",2.4,uM,=,0.380211241711606,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)n1CC1CO1
5096,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc(O)c2)C(COCCO)C(=O)NC1=O,"3-((2-hydroxyethoxy)methyl)-4-(3-hydroxyphenylthio)-5-methylpyridine-2,6(1H,3H)-dione",0.0069,uM,=,-2.161150909262745,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5097,770448,10.1016/j.bmc.2011.08.060,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cc(C)c(Nc2ccc(=O)n(Nc3ccc(C#N)cc3)c2)c(C)c1,4-(5-(Mesitylamino)-2-oxopyridin-1(2H)-ylamino)benzonitrile,760.0,uM,=,2.880813592280792,1,O=c1ccc(Nc2ccccc2)cn1Nc1ccccc1
5098,770448,10.1016/j.bmc.2011.08.060,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cc(C)c(Oc2ccc(=O)n(Nc3ccc(C#N)cc3)n2)c(C)c1,4-(3-(Mesityloxy)-6-oxopyridazin-1(6H)-ylamino)benzonitrile,100.0,uM,=,2.0,1,O=c1ccc(Oc2ccccc2)nn1Nc1ccccc1
5099,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(I)nc21,"5-Ethyl-7-iodo-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.18,uM,=,-0.744727494896694,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5100,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,O=c1[nH]c(=O)n(COCc2ccccc2)c(Cc2cc(F)cc(F)c2)c1I,"6-(3,5-Difluorobenzyl)-1-benzyloxymethyl-5-iodouracil",0.015,uM,=,-1.8239087409443189,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5101,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)Oc1cccnc1N(C)C1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,(1H-Indol-2-yl)-{4-[(3-isopropoxy-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-methanone,2.0,uM,=,0.3010299956639812,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
5102,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(cyclobutylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.11,uM,=,-0.958607314841775,0,c1ccc(Nc2nc(NC3CCC3)cc(Oc3ccc4ccccc4c3)n2)cc1
5103,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CCOC(=O)c1c(OC2CC(C)CC(C)C2)cc(Cc2ccccc2)[nH]c1=O,"Ethyl 6-Benzyl-4-(3,5-dimethylcyclohexyloxy)-2-oxo-1,2-dihydropyridine-3-carboxylate",73.54,uM,=,1.866523625532844,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5104,1900980,10.1016/j.ejmech.2019.111566,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.0127294695663874,uM,=,-1.895189692904908,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5105,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,O=C(O)c1cn(Cc2cccc3ccccc23)cc(O)c1=O,"5-Hydroxy-1-(naphthalen-1-ylmethyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid",8.5,uM,=,0.9294189257142929,1,O=c1ccn(Cc2cccc3ccccc23)cc1
5106,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CCC2=CCCC2)c(=O)[nH]c1=O,"1-(2-cyclopentenylethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",10.32,uM,=,1.0136796972911926,1,O=c1cc(Oc2ccccc2)n(CCC2=CCCC2)c(=O)[nH]1
5107,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCCC2=CCCCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((2-(cyclohex-1-en-1-yl)ethyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.28,uM,=,-0.5528419686577808,0,C1=C(CCNc2cc(Oc3ccc4ccccc4c3)nc(Nc3ccccc3)n2)CCCC1
5108,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN2CCCCC2)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(40-OH) MeLeu]4-CsA derivatives,0.0195,uM,=,-1.709965388637482,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](SCCN2CCCCC2)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5109,1900980,10.1016/j.ejmech.2019.111566,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA,COc1ccccc1C(=O)CC1(O)C(=O)Nc2ccc(Cl)cc21,5-chloro-3-hydroxy-3-(2-(2-methoxyphenyl)-2-oxoethyl)indolin-2-one,0.27,uM,=,-0.5686362358410126,0,O=C(CC1C(=O)Nc2ccccc21)c1ccccc1
5110,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid amide",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5111,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN2CCCCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.072,uM,=,-1.1426675035687317,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](SCCN2CCCCC2)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5112,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(F)c(CCNC(=O)Nc2ccc(Br)cn2)c1Cl,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluoro-phenyl)-ethyl]-urea,0.24,uM,=,-0.619788758288394,0,O=C(NCCc1ccccc1)Nc1ccccn1
5113,715432,10.1016/j.ejmech.2010.10.020,,,,Inhibition of HIV1 reverse transcriptase,Cc1ccc2c(c1)/C(=N/NC(=S)NO)C(=O)N2CN1CCN(c2ccc(Cl)cc2)CC1,"2-(1-{[4-(4-Chlorophenyl)tetrahydropyrazin-1(2H)-yl]methyl}-5-methyl-2-oxo-1,2-dihydro-3H-indol-3-yliden)-N-hydroxyhydrazine-1-carbothioamide",23.4,uM,=,1.3692158574101427,1,N=C1C(=O)N(CN2CCN(c3ccccc3)CC2)c2ccccc21
5114,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CC(=O)O)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[aspartyl-prolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",7.2,uM,=,0.8573324964312685,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5115,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(OC)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[(1R,2R)-2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-cyclopropyl]-urea",0.09,uM,=,-1.0457574905606752,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
5116,195198,10.1021/jm00096a011,,,,Concentration required to inhibit HIV reverse transcriptase,Cc1cn([C@H]2CC(F)(F)[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4,4-Difluoro-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",8.8,uM,=,0.9444826721501688,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5117,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCC(NS(C)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-N-(1-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)phenyl)piperidin-4-yl)methanesulfonamide",0.46,uM,=,-0.3372421683184259,0,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3c2COC3)cc1
5118,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C)c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-[2-(2-methyl-pyridin-4-yl)-ethyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.03,uM,=,-1.5228787452803376,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5119,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccccc3C)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-o-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.2,uM,=,-0.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5120,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CCOC(=O)c1c(OC2CCCCC2C)cc(Cc2ccccc2)[nH]c1=O,"Ethyl 6-Benzyl-4-(2-methylcyclohexyloxy)-2-oxo-1,2-dihydropyridine-3-carboxylate",5.29,uM,=,0.7234556720351858,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5121,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccnc(F)c4F)cc3F)n2)cc1,"4-((4-((4-(2,3-difluoropyridin-4-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0083,uM,=,-2.0809219076239263,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5122,1858686,10.1021/acs.jmedchem.0c00117,,,,"Inhibition of HIV1 RT in presence of reconstituted template and viral nucleotides [digoxigenin (DIG)-dUTP, biotin-dUTP and dTTP] incubated for 1 hr by ELISA method",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.012,uM,=,-1.9208187539523751,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5123,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,CCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-3-propyl-1H-pyrimidine-2,4-dione",0.5,uM,=,-0.3010299956639812,0,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5124,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)c1cc(/C(=C\CCN2CCOC2=O)c2ccc(OC)c(OC)c2)cc(C)c1OC,"5-[(E)-1-(3,4-Dimethoxy-phenyl)-4-(2-oxo-oxazolidin-3-yl)-but-1-enyl]-2-methoxy-3-methyl-benzoic acid methyl ester",1.0,uM,=,0.0,0,O=C1OCCN1CCC=C(c1ccccc1)c1ccccc1
5125,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CC=CC2)C2c3ccccc3SC12C(=O)OC,"(R,R/S,S)-2-(2,5-dihydro-pyrrol-1-yl)-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",5.1,uM,=,0.7075701760979364,1,C1=CCN(C2=CC3Sc4ccccc4C23)C1
5126,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(Br)cc(C)c1Oc1nc(Nc2ccc([N+](=O)[O-])cc2)cn2ccnc12,"8-(4-Bromo-2,6-dimethylphenoxy)-N-(4-nitrophenyl)imidazo[1,2-a]pyrazin-6-amine",4.1,uM,=,0.6127838567197355,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5127,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(Cl)cc2C(=O)N(C)c2cccnc21,"2-Chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.54,uM,=,-0.2676062401770315,0,O=C1Nc2cccnc2Nc2ncccc21
5128,1721403,10.1021/acsmedchemlett.7b00361,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.39,uM,=,0.143014800254095,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5129,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(N2CCC(O)C2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(3-hydroxypyrrolidin-1-yl)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.1,uM,=,-1.0,0,c1ccc(Nc2nc(Oc3ccc4ccccc4c3)cc(N3CCCC3)n2)cc1
5130,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2cc(Cl)cc(Cl)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3',5'-dichloro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.046,uM,=,-1.337242168318426,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5131,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1cc(-c2ccc(C#N)cc2)ccc1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3'-methoxy-[1,1'-biphenyl]-4-carbonitrile",0.006,uM,=,-2.2218487496163566,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5132,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,CCCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C#N)cc1C,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-propylnicotinamide",4.14,uM,=,0.617000341120899,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5133,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CCOC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid ethyl ester",0.045,uM,=,-1.3467874862246565,0,O=C1Nc2ccccc2NC1C#CC1CC1
5134,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COc1ccc(/C(=C\CCN2CCOC2=O)c2cc(F)cc(C(F)(F)F)c2)cc1OC,"3-[(E)-4-(3,4-Dimethoxy-phenyl)-4-(3-fluoro-5-trifluoromethyl-phenyl)-but-3-enyl]-oxazolidin-2-one",97.8,uM,=,1.9903388547876013,1,O=C1OCCN1CCC=C(c1ccccc1)c1ccccc1
5135,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,N#Cc1ccc(Nc2cn3ccnc3c(Oc3c(F)cc(F)cc3F)n2)cc1,"4-((8-(2,4,6-trifluorophenoxy)imidazo[1,2-a]pyrazin-6-yl)amino)benzonitrile",0.47,uM,=,-0.3279021420642826,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5136,1795828,10.1016/j.ejmech.2018.09.013,,,,Inhibition of CCR5 tropic HIV1 ADA5 reverse transcriptase infected in human TZM-bl cells,Cc1cc(C)c(Nc2nc(N)nc(Nc3ccc(C#N)nc3)n2)c(C)c1.Cl,"5-(4-amino-6-(mesitylamino)-1,3,5-triazin-2-ylamino)picolinonitrile hydrochloride",0.0001831779233004,uM,=,-3.737126868913351,0,c1ccc(Nc2ncnc(Nc3cccnc3)n2)cc1
5137,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccncc4F)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(3-fluoropyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0091,uM,=,-2.0409586076789066,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5138,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1C(=O)NCCN(C)C,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-(2-(dimethylamino)ethyl)nicotinamide",25.77,uM,=,1.4111144185509048,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5139,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,CC(C)c1ccc(S(=O)(=O)n2ccc(C(O)c3ccc(Cl)cc3Cl)c2)cc1,"(2,4-Dichloro-phenyl)-[1-(4-isopropyl-benzenesulfonyl)-1H-pyrrol-3-yl]-methanol",2.5,uM,=,0.3979400086720376,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
5140,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCC1=C(Sc2ccccc2)C(COC2CCCCC2)C(=S)NC1=O,"5-(cyclohexyloxymethyl)-3-ethyl-4-(phenylthio)-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.24,uM,=,-0.619788758288394,0,O=C1C=C(Sc2ccccc2)C(COC2CCCCC2)C(=S)N1
5141,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,COC(CNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C#N)cc1C)OC,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-(2,2-dimethoxyethyl)nicotinamide",11.37,uM,=,1.0557604646877348,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5142,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCn3cccc3)[nH]c3ccc(Cl)c(F)c23)c1,"N-[2-(1H-Pyrrol-1-yl)ethyl]-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-1H-indole-2-carboxamide",0.018,uM,=,-1.744727494896694,0,O=C(NCCn1cccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5143,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1C[S+]([O-])[C@H]2[C@H](O)[C@H](O)[C@H](O)CN12,"(6R,7R,8R,8aS)-6,7,8-Trihydroxy-1-oxo-hexahydro-1lambda*4*-thiazolo[3,2-a]pyridin-3-one",10.19,uM,=,1.0081741840064264,1,O=C1C[SH+][C@H]2CCCCN12
5144,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,O=c1[nH]c(=O)n(COCc2ccccc2)c(Cc2ccccc2)c1Br,6-Benzyl-1-benzyloxymethyl-5-bromouracil,1.521,uM,=,0.1821292140529984,1,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5145,80143,10.1016/0960-894X(95)00401-E,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)CCCP(=O)(O)O)O2)c(=O)[nH]c1=O,"3-{[(2S,3R,5R)-3-Azido-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethoxy]-hydroxy-phosphoryl}-propane-1-phosphonic acid anion",39.0,uM,=,1.591064607026499,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
5146,484694,10.1021/np50109a004,,,,Inhibition of drug-resistant HIV1 reverse transcriptase,C=C(Cc1ccc2c(c1)OCO2)C(=C)Cc1ccc(O)cc1O,"2-(2',4'-dihydroxybenzyl)-3-(3'',4''-methylenedioxybenzyl)-1,3-butadiene",341.8026119029073,uM,=,2.533775377081868,1,C=C(Cc1ccccc1)C(=C)Cc1ccc2c(c1)OCO2
5147,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)C(C)C)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-prolyl-valylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",4.4,uM,=,0.6434526764861874,1,O=C(CNC(=O)[C@@H]1CCCN1)NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O
5148,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CCC2C=CCC2)c1,"1-(2-(cyclopent-2-enyl)ethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.023,uM,=,-1.6382721639824072,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1C=CCC1
5149,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CCC2CC=CC2)c(=O)[nH]c1=O,"1-(2-(cyclopent-3-enyl)ethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",1.14,uM,=,0.0569048513364725,1,O=c1cc(Oc2ccccc2)n(CCC2CC=CC2)c(=O)[nH]1
5150,642450,10.1016/j.bmc.2010.05.036,,,,Inhibition of HIV1 reverse transcriptase,N#Cc1ccc(Nc2nccc(Oc3cc4ccc(C#N)cc4cc3Br)n2)cc1,7-bromo-6-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-2-naphthonitrile,1.1337289479336208,uM,=,0.0545092357848914,1,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5151,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cccc(C)c1Oc1nc(Nc2ccc(CC#N)cc2)cn2ccnc12,"2-(4-((8-(2,6-dimethylphenoxy)imidazo[1,2-a]pyrazin-6-yl)amino)phenyl)acetonitrile",5.7,uM,=,0.7558748556724915,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5152,1661651,10.1016/j.bmcl.2017.03.009,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer after 40 mins by ELISA,CCOC(=O)C(=O)CC(=O)c1cccc(Oc2ccnc(Nc3ccc(C#N)cc3)n2)c1,"ethyl 4-(3-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)phenyl)-2,4-dioxobutanoate",6.059,uM,=,0.7824009524965299,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5153,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)Nc3cccc(N)c3)[nH]c3ccc(Cl)cc23)c1,"N-(3-Aminophenyl)-5-chloro-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide",0.019,uM,=,-1.7212463990471711,0,O=C(Nc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5154,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=CCN1c2cc(OC)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"4-Allyl-3-cyclopropylethynyl-6-methoxy-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.123,uM,=,-0.910094888560602,0,O=C1Nc2ccccc2NC1C#CC1CC1
5155,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2cccc(Cl)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3'-chloro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5156,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc4ccccc4c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-naphthalen-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.02,uM,=,0.0086001717619175,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccc4ccccc4c3)cc21
5157,195511,10.1016/s0960-894x(01)00012-9,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2cc(O)c(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,"6-Chloro-4-cyclopropylethynyl-7-hydroxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",2.45,uM,=,0.3891660843645325,1,O=C1Nc2ccccc2C(C#CC2CC2)O1
5158,1763340,10.1016/j.ejmech.2018.03.007,,,,Inhibition of HIV1 reverse transcriptase RNase H using RNA-DNA hybrid duplex after 30 mins by FRET-based microplate fluorescence assay,COc1ccc2ccccc2c1/C=N/NC(=O)c1ccc(O)c(O)c1,"3,4-dihydroxy-N'-((2-methoxynaphthalen-1-yl)methylene)benzohydrazide",0.5,uM,=,-0.3010299956639812,0,O=C(N/N=C/c1cccc2ccccc12)c1ccccc1
5159,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,Cc1cc(-c2cc(F)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(F)c2)ccn1,"4-((4-((2,6-difluoro-4-(2-methylpyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.029,uM,=,-1.537602002101044,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5160,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCCNc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(propylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.11,uM,=,-0.958607314841775,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5161,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCCCOC(C)C)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((3-isopropoxypropyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.32,uM,=,-0.494850021680094,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5162,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NC2CC2)c(C)c1,6-((4-Cyanophenyl)amino)-N-cyclopropyl-4-(mesityloxy)nicotinamide,0.23,uM,=,-0.6382721639824072,0,O=C(NC1CC1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
5163,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(Cl)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)cn2ccnc12,"4-((8-(4-chloro-2,6-dimethylphenoxy)imidazo[1,2-a]pyrazin-6-yl)amino)benzonitrile",1.1,uM,=,0.041392685158225,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5164,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"N-Benzyl-3-[(3,5-dimethylphenyl)sulfonyl]-5-nitro-1H-indole-2-carboxamide",0.017,uM,=,-1.769551078621726,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5165,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(O)c(O)c2)nc2sc3c(c12)CCCCCC3,"2-(3,4-Dihydroxy-phenyl)-5,6,7,8,9,10-hexahydro-3H-11-thia-1,3-diaza-cycloocta[a]inden-4-one",0.26,uM,=,-0.585026652029182,0,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCCC3
5166,195658,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at low (~0.1 pfu/cell) multiplicity of injection (moi),Nc1ncnc2c1ncn2/C=C1\CC1CO,{2-[1-(6-Amino-purin-9-yl)-meth-(E)-ylidene]-cyclopropyl}-methanol,14.0,uM,=,1.146128035678238,1,C(=C1CC1)n1cnc2cncnc21
5167,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(C)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-m-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5168,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCCC3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(piperidin-1-ylmethyl)-1H-indole-2-carboxamide",0.03,uM,=,-1.5228787452803376,0,O=C(NCN1CCCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5169,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,COc1ccc(CNC(=O)C2CN(S(=O)(=O)c3ccc(N)cc3)CCN2C(=O)c2cc(O)c(O)c(O)c2)cc1,"4-((4-aminophenyl)sulfonyl)-N-(4-methoxybenzyl)-1-(3,4,5-trihydroxycyclohexa-1,3-diene-1-carbonyl)piperazine-2-carboxamide",0.27,uM,=,-0.5686362358410126,0,O=C(NCc1ccccc1)C1CN(S(=O)(=O)c2ccccc2)CCN1C(=O)c1ccccc1
5170,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(2-Amino-pyridin-4-yl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5171,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,COCCNc1cc(Oc2c(C)cc(/C=C/C#N)cc2C)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-methoxyethyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5172,195511,10.1016/s0960-894x(01)00012-9,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2c(OS(=O)(=O)O)cc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1.c1ccncc1,"Sulfuric acid mono-((S)-6-chloro-4-cyclopropylethynyl-2-oxo-4-trifluoromethyl-1,4-dihydro-2H-benzo[d][1,3]oxazin-8-yl) ester; compound with pyridine",12.5,uM,=,1.0969100130080565,1,O=C1Nc2ccccc2C(C#CC2CC2)O1.c1ccncc1
5173,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3c[nH]c4ncccc34)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrolo[2,3-b]pyridin-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2ccc(-c3c[nH]c4ncccc34)nc2Nc2ncccc21
5174,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(C)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.75,uM,=,-0.1249387366082999,0,O=C1Nc2cccnc2Nc2ncccc21
5175,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(CC)CC)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(40-OH) MeLeu]4-CsA derivatives,0.047,uM,=,-1.3279021420642825,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5176,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4cncnc4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(pyrimidin-5-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.087,uM,=,-1.0604807473813815,0,c1ccc(Nc2nccc(Nc3ccc(-c4cncnc4)cc3)n2)cc1
5177,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(\c1cccc(C#N)c1)c1cc(C)c2oc(=O)n(C)c2c1,"(Z)-6-(3-cyanophenyl)-6-(2,3-dihydro-3,7-dimethyl-2-oxobenzoxazol-5-yl)hex-5-enoic acid methyl ester",26.4,uM,=,1.421603926869831,1,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
5178,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(\c1cccc(C#N)c1)c1cc(Cl)c(OC)c(C(=O)OC)c1,3-Chloro-5-[(E)-1-(3-cyano-phenyl)-5-methoxycarbonyl-pent-1-enyl]-2-methoxy-benzoic acid methyl ester,0.75,uM,=,-0.1249387366082999,0,C=C(c1ccccc1)c1ccccc1
5179,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(N)=O)c1=O,"2-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetamide",1.7,uM,=,0.2304489213782739,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5180,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccsc4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(thiophen-3-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.011,uM,=,-1.958607314841775,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccsc4)cc3)n2)cc1
5181,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@H]2CCCN2C(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-D-prolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",22.0,uM,=,1.3424226808222062,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@H]1CCCN1
5182,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2cccc(C(F)(F)F)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3,5-dimethyl-3'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.058,uM,=,-1.2365720064370629,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5183,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2=CCCC2)c1,"1-(2-cyclopentenylethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",2.36,uM,=,0.3729120029701065,1,O=c1cc(Sc2ccccc2)n(CCC2=CCCC2)c(=O)[nH]1
5184,196376,10.1021/jm030255y,,,,Inhibitory concentration against wild-type reverse transcriptase of HIV-1,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5185,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,C=CCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C#N)cc1C,"N-allyl-4-(4-cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)nicotinamide",2.85,uM,=,0.4548448600085102,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5186,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(N=[N+]=[N-])c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(3-Azido-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5187,642450,10.1016/j.bmc.2010.05.036,,,,Inhibition of HIV1 reverse transcriptase,N#Cc1ccc(Nc2nccc(Oc3ccc4cc(C#N)ccc4c3)n2)cc1,6-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)-2-naphthonitrile,8.730088546742687,uM,=,0.941018648650211,1,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5188,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1C(=O)NCCC#N,"4-(4-Cyano-2,6-dimethylphenoxy)-N-(2-cyanoethyl)-6-((4-cyanophenyl)amino)nicotinamide",3.94,uM,=,0.5954962218255742,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5189,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-leucylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",4.6,uM,=,0.6627578316815741,1,O=c1ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5190,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(F)c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-[2-(3-fluoro-phenyl)-ethyl]-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5191,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCOc3ccccc3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-(2-phenoxyethyl)-1H-indole-2-carboxamide",0.95,uM,=,-0.0222763947111522,0,O=C(NCCOc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5192,546667,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by NCI assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,aleuritolic acid 3-p-hydroxybenzoate,200.0,uM,=,2.3010299956639813,1,O=C(O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C1)c1ccccc1
5193,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,Cc1ccc(Cc2cc(OC3CCCCC3C)c(C(C)C)c(=O)[nH]2)cc1,6-(4-Methylbenzyl)-3-isopropyl-4-(2-methylcyclohexyloxy)-pyridin-2(1H)-one,0.059,uM,=,-1.2291479883578558,0,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5194,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,CCc1ccc(S(=O)(=O)n2ccc(C(O)c3ccc(Cl)cc3Cl)c2)cc1,"(2,4-Dichloro-phenyl)-[1-(4-ethyl-benzenesulfonyl)-1H-pyrrol-3-yl]-methanol",22.0,uM,=,1.3424226808222062,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
5195,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)cc2)cc(Cl)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"5'-chloro-4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.0108,uM,=,-1.9665762445130504,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5196,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCCC2)c1,"1-(cyclopentylmethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.129,uM,=,-0.889410289700751,0,O=c1cc(Sc2ccccc2)n(CC2CCCC2)c(=O)[nH]1
5197,1924024,10.1016/j.bmcl.2016.06.065,,,,Inhibition of HIV1 RT E138K using 17-mer DNA/Alexa Fluor 488 5'-end labeled DNA/Alexa Fluor 555-aha-dUTP as primer/template/substrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay,CC(=O)c1c(C)nc2c(c(C#N)cn2Cc2ccccc2)c1-c1ccc([N+](=O)[O-])cc1,"5-acetyl-1-benzyl-6-methyl-4-(4-nitrophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile",59.0,uM,=,1.7708520116421442,1,c1ccc(Cn2ccc3c(-c4ccccc4)ccnc32)cc1
5198,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(Cl)cc3)ccc2C(=O)N1O,"6-(4-Chlorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",3.8,uM,=,0.5797835966168101,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
5199,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(NS(C)(=O)=O)cc3)CC2)nc2c1COC2,"(E)-N-(4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)piperidin-1-yl)phenyl)methanesulfonamide",0.15,uM,=,-0.8239087409443188,0,c1ccc(Oc2nc(NC3CCN(c4ccccc4)CC3)nc3c2COC3)cc1
5200,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C(C)(C)C)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(40-OH) MeLeu]4-CsA derivatives,0.043,uM,=,-1.3665315444204136,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5201,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,N#Cc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"4'-((2-Hydroxy-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)-methyl)-[1,1'-biphenyl]-4-carbonitrile",0.75,uM,=,-0.1249387366082999,0,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
5202,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.62,uM,=,-0.2076083105017461,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5203,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,COc1ccc(Cc2cc(OC3CCCCC3C)c(C(C)C)c(=O)[nH]2)cc1,6-(4-Methoxybenzyl)-3-isopropyl-4-(2-methylcyclohexyloxy)-pyridin-2(1H)-one,0.033,uM,=,-1.4814860601221125,0,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5204,856670,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 25 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,COc1ccc2nc3cc(Cl)ccc3c(NCCCNCCCCNCCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)c2c1,Acridine dimer,12.9,uM,=,1.110589710299249,1,c1ccc2c(NCCCNCCCCNCCCNc3c4ccccc4nc4ccccc34)c3ccccc3nc2c1
5205,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1sc(I)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,"Methyl 3-(7-chloro-2-methyl-3-oxo-3,4-dihydroquinoxalin-1(2H)-ylsulfonyl)-5-iodothiophene-2-carboxylate",0.075,uM,=,-1.1249387366083,0,O=C1CN(S(=O)(=O)c2ccsc2)c2ccccc2N1
5206,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)C(=O)c1c2c(c3oc(=O)cc(-c4ccccc4)c3c1O)C=CC(C)(C)O2,"5-Hydroxy-6-isobutyryl-8,8-dimethyl-4-phenyl-8H-pyrano[2,3-f]chromen-2-one",32.1,uM,=,1.506505032404872,1,O=c1cc(-c2ccccc2)c2ccc3c(c2o1)C=CCO3
5207,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2cc(O)ccc2O)nc2sc3c(c12)CCCCC3,"2-(2,5-Dihydroxy-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",1.7,uM,=,0.2304489213782739,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5208,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3)cc2C(=O)N(C)c2cccnc21,"4-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-benzoic acid",0.095,uM,=,-1.0222763947111522,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5209,1281238,10.1016/j.bmc.2013.10.033,,,,Inhibition of wild-type HIV1 reverse transcriptase assessed as incorporation of biotin-labeled dUTP,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.071,uM,=,-1.1487416512809248,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5210,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCCC3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-(pyrrolidin-1-ylmethyl)-1H-indole-2-carboxamide",0.034,uM,=,-1.4685210829577449,0,O=C(NCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5211,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2[C@@H](O)[C@@H](O)CN2C(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[(2S,3R,4S)-3,4-dihydroxyprolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",4.8,uM,=,0.6812412373755872,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5212,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1C(O)S[C@H]2[C@H](O)[C@H](O)[C@H](O)CN12,"(6R,7R,8R,8aS)-tetrahydro-2,6,7,8-tetrahydroxy-2H-thiazolo[3,2-a]pyridin-3(5H)-one",1.74,uM,=,0.2405492482825997,1,O=C1CS[C@H]2CCCCN12
5213,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](n2nncc2C(N)=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@]12OS(=O)(=O)C=C2N,"3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3H-[1,2,3]triazole-4-carboxylic acid amide",8.4,uM,=,0.9242792860618816,1,O=S1(=O)C=C[C@]2(CO[C@@H](n3ccnn3)C2)O1
5214,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C3CCCN(S(N)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)phenyl)azepane-1-sulfonamide",0.09,uM,=,-1.0457574905606752,0,c1ccc(Oc2nc(Nc3ccc(C4CCCNCC4)cc3)nc3c2COC3)cc1
5215,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCCCC2)c1,"1-(cyclohexylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.008,uM,=,-2.096910013008056,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CCCCC1
5216,197424,10.1021/jm0209984,,,,Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptase,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,4.2,uM,=,0.6232492903979004,1,S=C(NCCc1ccccn1)Nc1ccccn1
5217,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.48,uM,=,-0.3187587626244128,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5218,195511,10.1016/s0960-894x(01)00012-9,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2c(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(2S,3S,4S,5R,6S)-6-((S)-6-Chloro-4-cyclopropylethynyl-2-oxo-4-trifluoromethyl-1,4-dihydro-2H-benzo[d][1,3]oxazin-8-yloxy)-3,4,5-trihydroxy-tetrahydro-pyran-2-carboxylic acid",9.489,uM,=,0.9772204466353852,1,O=C1Nc2c(O[C@H]3CCCCO3)cccc2C(C#CC2CC2)O1
5219,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCCC3)[nH]c3ccc(Cl)c(F)c23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-N-[2-(pyrrolidin-1-yl)ethyl]-1H-indole-2-carboxamide",0.158,uM,=,-0.8013429130455774,0,O=C(NCCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5220,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COc1noc2c(C)cc(/C(=C\CCN3CCOC3=O)c3cc(C)c4on(C)c(=O)c4c3)cc12,"(E)-5-[1-(3-methoxy-7-methyl-benzo[d]isoxazol-5-yl)-4-(2-oxooxazolidin-3-yl)but-1-enyl]-2,7-dimethylbenzo[d]isoxazol-3-one",7.6,uM,=,0.8808135922807914,1,O=C1OCCN1CC/C=C(\c1ccc2oncc2c1)c1ccc2o[nH]c(=O)c2c1
5221,770448,10.1016/j.bmc.2011.08.060,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cc(C)c(Nc2ccc(=O)n(Nc3ccc(C#N)cc3)n2)c(C)c1,4-(3-(Mesitylamino)-6-oxopyridazin-1(6H)-ylamino)benzonitrile,547.0,uM,=,2.737987326333431,1,O=c1ccc(Nc2ccccc2)nn1Nc1ccccc1
5222,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,COc1ccc(OCCO)c(CCNC(=S)Nc2ccc(Br)cn2)c1,N-(5-Bromo-2-pyridinyl)]-N0-{2-[2-(2-hydroxyethoxy)-5-methoxyphenyl]ethyl}-thiourea,0.019,uM,=,-1.7212463990471711,0,S=C(NCCc1ccccc1)Nc1ccccn1
5223,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CC(C)Sc1nc(O)cc(C(C)c2ccccc2)n1,2-Isopropylsulfanyl-6-(1-phenyl-ethyl)-3H-pyrimidin-4-one,2.3,uM,=,0.3617278360175928,1,c1ccc(Cc2ccncn2)cc1
5224,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(F)cc3)ccc2C(=O)N1O,"6-(4-Fluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.3,uM,=,0.3617278360175928,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
5225,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(/C=C\CO)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-hydroxy-propenyl)-5-methyl-1H-pyrimidine-2,4-dione",1.6,uM,=,0.2041199826559248,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5226,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccc(O)c(O)c3)[nH]c(=O)c2c1C,"2-(3,4-dihydroxyphenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",0.26,uM,=,-0.585026652029182,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
5227,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(S(C)(=O)=O)cc3)CC2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(1-(4-(methylsulfonyl)phenyl)piperidin-4-ylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.07,uM,=,-1.154901959985743,0,c1ccc(Oc2nc(NC3CCN(c4ccccc4)CC3)nc3c2COC3)cc1
5228,195836,10.1016/s0960-894x(01)00635-7,,,,The compound was evaluated for inhibition of HIV-1 wild types GluL38-Lys recombinant reverse transcriptase,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[3-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-4-hydroxy-tetrahydro-furan-2-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",138.0,uM,=,2.1398790864012365,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5229,1721403,10.1021/acsmedchemlett.7b00361,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",1.0,uM,=,0.0,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5230,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cc(O)c(O)c(O)c3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(3,4,5-trihydroxyphenyl)thieno[2,3-d]pyrimidin-4(3H)-one",0.69,uM,=,-0.1611509092627447,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
5231,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC,(2S)-1-oleoyl-2-palmitoyl-3-O-beta-D-galactopyranosyl glycerol,65.0,uM,=,1.812913356642856,1,C1CCOCC1
5232,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CCC2C=CCC2)c(=O)[nH]c1=O,"1-(2-(cyclopent-2-enyl)ethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.128,uM,=,-0.8927900303521317,0,O=c1cc(Sc2ccccc2)n(CCC2C=CCC2)c(=O)[nH]1
5233,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)CC2C(=O)NCc2cccc3ccccc23)cc1,"1-((4-aminophenyl)sulfonyl)-N-(naphthalen-1-ylmethyl)-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.22,uM,=,-0.6575773191777937,0,O=C(NCc1cccc2ccccc12)C1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccccc1
5234,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](CO[C@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC.[Na+],"sodium ((2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((S)-3-((9Z,12Z)-octadeca-9,12-dienoyloxy)-2-(palmitoyloxy)propoxy)tetrahydro-2H-pyran-2-yl)methanesulfonate",0.077,uM,=,-1.1135092748275182,0,C1CCOCC1
5235,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC2)c1,"1-(cyclopropylmethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.003,uM,=,-2.5228787452803374,0,O=c1cc(Sc2ccccc2)n(CC2CC2)c(=O)[nH]1
5236,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCCN)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[lysyl-prolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",4.7,uM,=,0.6720978579357175,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5237,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(Br)cc3)ccc2C(=O)N1O,"6-(4-Bromobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.5,uM,=,0.1760912590556812,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
5238,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,Cc1ccc(Cc2ccc3c(c2)CC(=O)N(O)C3=O)cc1,"2-Hydroxy-6-(4-methylbenzyl)isoquinoline-1,3(2H,4H)-dione",2.0,uM,=,0.3010299956639812,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
5239,805873,10.1016/j.ejmech.2012.02.019,,,,Inhibition of HIV1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rA)-oligo(dT),CNc1nc(Nc2c(C)cc(C)cc2C)nc(NC2CCN(Cc3ccccc3)CC2)n1,"N2-(1-Benzylpiperidin-4-yl)-N4-mesityl-N6-methyl-1,3,5-triazine-2,4,6-triamine",2.46,uM,=,0.3909351071033791,1,c1ccc(CN2CCC(Nc3ncnc(Nc4ccccc4)n3)CC2)cc1
5240,1737186,10.1016/j.ejmech.2018.03.059,,,,Inhibition of wild-type HIV1 reverse transcriptase assessed as decrease in digoxigenin and biotin-dUTP incorporation in to DNA using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NCc2cn(CC(=O)N3CCCC3)nn2)c(C)c1,"6-((4-cyanophenyl)amino)-4-(mesityloxy)-N-((1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-1H-1,2,3-triazol-4-yl)methyl)nicotinamide",2.7,uM,=,0.4313637641589873,1,O=C(NCc1cn(CC(=O)N2CCCC2)nn1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
5241,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(\c1cccc(C#N)c1)c1cc(C)c(OC)c(C(=O)OC)c1,5-[(E)-1-(3-Cyano-phenyl)-5-methoxycarbonyl-pent-1-enyl]-2-methoxy-3-methyl-benzoic acid methyl ester,0.84,uM,=,-0.0757207139381183,0,C=C(c1ccccc1)c1ccccc1
5242,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)Oc1cccnc1N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,(1H-Indol-2-yl)-[4-(3-isopropoxy-pyridin-2-yl)-piperazin-1-yl]-methanone,1.8,uM,=,0.255272505103306,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5243,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,NCc1ccc(-c2ccc(Cn3cc(O)c(=O)c(C(=O)O)c3)cc2)cc1,"1-((4'-(Aminomethyl)-[1,1'-biphenyl]-4-yl)methyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid",3.2,uM,=,0.505149978319906,1,O=c1ccn(Cc2ccc(-c3ccccc3)cc2)cc1
5244,757888,10.1016/j.bmc.2011.05.024,,,,Inhibition of HIV1 wild type RT using poly(rA)/oligo(dT)15 homopolymer template after 1 hrs by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.4,uM,=,0.6434526764861874,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5245,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(/c1ccc(OC)c(OC)c1)c1cc(C)c(OC)c(C(=O)OC)c1,"methyl 5-[1-(3,4-dimethoxyphenyl)-5-methyloxycarbonyl-1-pentenyl]-2-methoxy-3-methylbenzoate",0.074,uM,=,-1.1307682802690238,0,C=C(c1ccccc1)c1ccccc1
5246,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(/C=C/CO)c1=O,"1-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-((E)-3-hydroxy-propenyl)-5-methyl-1H-pyrimidine-2,4-dione",0.5,uM,=,-0.3010299956639812,0,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5247,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCC[C@H]2C)[C@@H]2c3ccccc3S[C@]12C(=O)OC,"(2aS,7aS)-2-((R)-2-methyl-pyrrolidin-1-yl)-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",11.0,uM,=,1.0413926851582251,1,C1=C(N2CCCC2)[C@@H]2c3ccccc3SC12
5248,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccccn3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(pyridin-2-yl)thieno[2,3-d]pyrimidin-4(3H)-one",4.2,uM,=,0.6232492903979004,1,O=c1[nH]c(-c2ccccn2)nc2sccc12
5249,197448,10.1021/jm9704210,,,,Compound was evaluated for 50% inhibition of HIV-RT (HIV reverse transcriptase),O=c1ccn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1,(beta-D) FdUTPTriphosphoric acid-[3-fluoro-5-(4-hydroxy-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester 4M triethyl amine,0.07,uM,=,-1.154901959985743,0,O=c1ccn([C@@H]2CCCO2)c(=O)[nH]1
5250,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,Cc1ccc(C(O)c2ccn(S(=O)(=O)c3ccc(C)cc3)c2)cc1,[1-(Toluene-4-sulfonyl)-1H-pyrrol-3-yl]-p-tolyl-methanol,4.7,uM,=,0.6720978579357175,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
5251,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CC(C)=CCN1Cc2cccc3nc(S)n(c23)C(Cl)[C@@H]1C,"(S)-9-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9a-triaza-benzo[cd]azulene-1-thione",12.0,uM,=,1.0791812460476249,1,c1cc2c3c(c1)ncn3CCNC2
5252,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)cc2)ccc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.0055,uM,=,-2.2596373105057563,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5253,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@H](C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"((R)-5-chloro-3-(3,5-dimethylphenylsulfonyl)-N-(1-(pyridin-4-yl)ethyl)-1H-indole-2-carboxamide",0.018,uM,=,-1.744727494896694,0,O=C(NCc1ccncc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5254,545624,10.1021/np0003995,,,,Inhibition of HIV1 reverse transcriptase,O=C(O[C@@H]1C[C@](OC(=O)c2cc(O)c(O)c(O)c2)(C(=O)O)C[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,"1,3,4,5-tetra(3,4,5-trihydroxyphenylcarbonyloxy)-1-cyclohexanecarboxylic acid",0.8,uM,=,-0.0969100130080563,0,O=C(OC1C[C@@H](OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C1)c1ccccc1
5255,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCC(C)Nc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((6-(sec-butylamino)-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.26,uM,=,-0.585026652029182,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5256,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(\c1cccc(C#N)c1)c1cc(C)c(OC)c(C(=O)OC)c1,5-[(E)-1-(3-Cyano-phenyl)-5-methoxycarbonyl-pent-1-enyl]-2-methoxy-3-methyl-benzoic acid methyl ester,0.54,uM,=,-0.2676062401770315,0,C=C(c1ccccc1)c1ccccc1
5257,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)cc2F)ccc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-2-fluoro-3'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.0087,uM,=,-2.0604807473813813,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5258,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(OC2CCCCC2C)cc(Cc2ccccc2)[nH]c1=O,6-Benzyl-3-isopropyl-4-(2-methylcyclohexyloxy)pyridin-2(1H)-one,0.41,uM,=,-0.3872161432802645,0,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5259,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,Cc1c(C(C)c2c(F)cccc2F)nc(SC2CCCC2)[nH]c1=O,"[-]-2-Cyclopentylsulfanyl-6-[1-(2,6-difluoro-phenyl)-ethyl]-5-methyl-3H-pyrimidin-4-one",0.008,uM,=,-2.096910013008056,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
5260,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCC1=C(Sc2ccccc2)C(COCc2ccc(C)cc2)C(=S)NC1=O,"3-ethyl-5-((4-methylbenzyloxy)methyl)-4-(phenylthio)-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.422,uM,=,-0.3746875490383261,0,O=C1C=C(Sc2ccccc2)C(COCc2ccccc2)C(=S)N1
5261,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5262,195836,10.1016/s0960-894x(01)00635-7,,,,The compound was evaluated for inhibition of HIV-1 wild types GluL38-Lys recombinant reverse transcriptase,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)c(=O)n(CC(=O)O)c1=O,"{3-[4-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-3-hydroxy-tetrahydro-furan-2-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",207.0,uM,=,2.315970345456918,1,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5263,805873,10.1016/j.ejmech.2012.02.019,,,,Inhibition of HIV1 reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rA)-oligo(dT),COc1nc(Nc2c(C)cc(C)cc2C)nc(NC2CCN(Cc3ccc(C#N)cc3)CC2)n1,"4-((4-(4-(mesitylamino)-6-methoxy-1,3,5-triazin-2-ylamino)piperidin-1-yl)methyl)benzonitrile",1.77,uM,=,0.2479732663618066,1,c1ccc(CN2CCC(Nc3ncnc(Nc4ccccc4)n3)CC2)cc1
5264,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CO)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-hydroxymethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncccc21
5265,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3nccs3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-thiazol-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2cccnc2Nc2ncc(CCc3nccs3)cc21
5266,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,COc1cccc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)c1,"4-((4-((3'-methoxy-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.027,uM,=,-1.5686362358410126,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5267,1467341,10.1016/j.ejmech.2015.01.042,,,,"Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA after 1 hr using poly(A) x oligo(dT)15 template/primer hybrid, digoxigenin and biotin-labeled nucleotides",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.089,uM,=,-1.0506099933550872,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5268,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,COc1ccc(OCCCO)c(CCNC(=S)Nc2ccc(Br)cn2)c1,N-(5-Bromo-2-pyridinyl)]-N0-{2-[2-(3-hydroxypropyl-1-oxy)-5-methoxyphenyl]ethyl}-thiourea,0.024,uM,=,-1.619788758288394,0,S=C(NCCc1ccccc1)Nc1ccccn1
5269,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,O=C(O)P(=O)(O)O,Foscarnet,24.0,uM,=,1.380211241711606,1,
5270,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-phenylalanylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",6.8,uM,=,0.8325089127062363,1,O=C(CCc1ccccc1)NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O
5271,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=C(C)OC(=O)N1c2cc(Cl)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"7-Chloro-2-cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropenyl ester",0.315,uM,=,-0.5016894462103995,0,O=C1Nc2ccccc2NC1C#CC1CC1
5272,939436,10.1021/jm301271j,,,,Inhibition of wild type HIV-1 reverse transcriptase knuckles site after 30 mins by fluorescence assay,Oc1ccc(OC(F)(F)F)cc1,4-(trifluoromethoxy)phenol,600.0,uM,=,2.778151250383644,1,c1ccccc1
5273,503079,10.1021/np960399y,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O,"[3-azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl triphosphate",0.051,uM,=,-1.2924298239020635,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5274,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)N[C@@H](C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"(S)-5-chloro-3-(3,5-dimethylphenylsulfonyl)-N-(1-(pyridin-4-yl)ethyl)-1H-indole-2-carboxamide",0.04,uM,=,-1.3979400086720375,0,O=C(NCc1ccncc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5275,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCOCC3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-(3,5-Dimethylphenylsulfonyl)-N-(2-morpholinoethyl)-5-nitro-1H-indole-2-carboxamide",0.055,uM,=,-1.259637310505756,0,O=C(NCCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5276,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccc(O)cc3)[nH]c(=O)c2c1C,"2-(4-hydroxyphenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",0.79,uM,=,-0.1023729087095585,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
5277,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(O[C@H]2CCCC[C@@H]2C)cc(CCc2ccccc2)[nH]c1=O,(+/-)-trans-3-Isopropyl-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one,0.003,uM,=,-2.5228787452803374,0,O=c1cc(OC2CCCCC2)cc(CCc2ccccc2)[nH]1
5278,140631,10.1016/s0960-894x(01)00011-7,,,,Inhibitory activity against non-nucleoside reverse transcriptase inhibitors (NNRTI) -resistant HIV-1 strain A17 with a Y181C mutation in RT (reverse transcriptase),CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,50.0,uM,=,1.6989700043360187,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5279,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2ccccc2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-5-ethyl-6-(phenylthio)pyrimidine-2,4(1H,3H)-dione",0.366,uM,=,-0.4365189146055893,0,O=c1cc(Sc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
5280,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC(O)CO)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((2,3-dihydroxypropyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.08,uM,=,-1.0969100130080565,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5281,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC(F)(F)F)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((2,2,2-trifluoroethyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.14,uM,=,-0.8538719643217619,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5282,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCOc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Ethoxy-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,3.4,uM,=,0.5314789170422551,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
5283,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,COc1cc2nc(SCC(=O)Nc3ccc(C#N)cc3)nc(Nc3c(C)cc(/C=C/C#N)cc3C)c2cc1OC,"(E)-N-(4-cyanophenyl)-2-{4-[4-(2-cyanovinyl)-2,6-dimethylphenylamino]-6,7-dimethoxyquinazolin-2-yl}thioacetamide",3.63,uM,=,0.5599066250361125,1,O=C(CSc1nc(Nc2ccccc2)c2ccccc2n1)Nc1ccccc1
5284,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.38,uM,=,-0.4202164033831898,0,O=c1cc(Oc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
5285,503079,10.1021/np960399y,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@@H](C)[C@H](C)[C@@H]3O,"(10S,11R,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",0.29,uM,=,-0.5376020021010439,0,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
5286,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CCC2CCCC2)c(=O)[nH]c1=O,"1-(2-cyclopentylethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.549,uM,=,-0.260427655549908,0,O=c1cc(Oc2ccccc2)n(CCC2CCCC2)c(=O)[nH]1
5287,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CC2CCCC2)c(=O)[nH]c1=O,"1-(cyclopentylmethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.169,uM,=,-0.7721132953863264,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CCCC1
5288,197426,10.1021/jm0211063,,,,Activity to inhibit HIV-1 Reverse transcriptase activity in WT IIIB,NC(=O)c1[nH]c2ccc(Cl)cc2c1S(=O)(=O)c1ccccc1,3-Benzenesulfonyl-5-chloro-1H-indole-2-carboxylic acid amide,0.025,uM,=,-1.6020599913279625,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
5289,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc4ccccc4c3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(2-naphthalen-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccc4ccccc4c3)cc21
5290,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc4ccccc4c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-naphthalen-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.88,uM,=,0.4593924877592308,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccc4ccccc4c3)cc21
5291,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cc(O)ccc3O)[nH]c(=O)c2c1C,"2-(2,5-dihydroxyphenyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one",9.3,uM,=,0.9684829485539352,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
5292,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCCC2)[C@H]2c3ccccc3S[C@@]12C(=O)OC,"(R,R)-dimethyl-1-(1-piperidynyl)cyclobuta[b][1]benzothiophene-2,2a(7bH)-dicarboxylate",0.8,uM,=,-0.0969100130080563,0,C1=C(N2CCCC2)[C@H]2c3ccccc3SC12
5293,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(N)cc3)CC2)nc2c1COC2,"(E)-3-(4-(2-(1-(4-aminobenzyl)piperidin-4-ylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)acrylonitrile",0.19,uM,=,-0.721246399047171,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
5294,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCCc3ccccc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(3-phenyl-propyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.17,uM,=,0.0681858617461616,1,O=C1Nc2cccnc2Nc2ncc(CCCc3ccccc3)cc21
5295,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,C=CCNc1cc(Oc2c(C)cc(/C=C/C#N)cc2C)cc(Nc2ccc(C#N)cc2)n1,"(E)-4-((6-(Allylamino)-4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyridin-2-yl)amino)benzonitrile",0.27,uM,=,-0.5686362358410126,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5296,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc(Br)c2)C(COCCO)C(=O)NC1=O,"4-(3-bromophenylthio)-3-((2-hydroxyethoxy)methyl)-5-methylpyridine-2,6(1H,3H)-dione",0.0031,uM,=,-2.508638306165728,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5297,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC(C)C(I)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"3-Cyclopropylethynyl-4-(1-iodo-2-methyl-propyl)-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2ccccc2NC1C#CC1CC1
5298,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CCC2CC=CC2)c(=O)[nH]c1=O,"1-(2-(cyclopent-3-enyl)ethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.179,uM,=,-0.7471469690201069,0,O=c1cc(Sc2ccccc2)n(CCC2CC=CC2)c(=O)[nH]1
5299,666602,10.1128/aac.01795-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by filter-based filtration assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.068,uM,=,-1.1674910872937636,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5300,770448,10.1016/j.bmc.2011.08.060,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-[4-(2,4,6-Trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile",2.5,uM,=,0.3979400086720376,1,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
5301,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2ccccc2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-5-ethyl-6-phenoxypyrimidine-2,4(1H,3H)-dione",2.62,uM,=,0.4183012913197454,1,O=c1cc(Oc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
5302,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CC(c1ccccc1)c1cc(O)nc(SC2CCCC2)n1,2-Cyclopentylsulfanyl-6-(1-phenyl-ethyl)-3H-pyrimidin-4-one,2.1,uM,=,0.3222192947339193,1,c1ccc(Cc2ccnc(SC3CCCC3)n2)cc1
5303,2201741,10.1016/j.ejmech.2022.114217,,,,Inhibition of HIV-1 reverse transcriptase using ABTS as substrate and RNA template primed with oligo(dT)12-18 in presence of digoxigenin/biotin-labeled nucleotides by ELISA,COC(=O)/C=C\c1c(-c2cccs2)[nH]c2ccccc12,(Z)-Methyl-3-(2-(thiophen-2-yl)-1H-indol-3-yl)acrylate,0.00938,uM,=,-2.027797161620936,0,c1csc(-c2cc3ccccc3[nH]2)c1
5304,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC2)c1,"1-(cyclopropylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",1.967,uM,=,0.2938043599193367,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC1
5305,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(N)cc2C(=O)N(C)c2cccnc21,"2-Amino-5-ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncccc21
5306,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,N#Cc1ccc(Nc2nccc(Oc3ccc(-c4ccc(C#N)cc4)cc3Cl)n2)cc1,"3'-chloro-4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-[1,1'-biphenyl]-4-carbonitrile",0.0083,uM,=,-2.0809219076239263,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5307,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)c3cccs3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(thiophen-2-yl)-ethyl)-1H-indole-2-carboxamide",0.027,uM,=,-1.5686362358410126,0,O=C(NCc1cccs1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5308,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3ccccc3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"3-[(3,5-Dimethylphenyl)sulfonyl]-5-nitro-N-phenethyl-1H-indole-2-carboxamide",0.06,uM,=,-1.2218487496163564,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5309,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc4ccccc4c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-naphthalen-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccc4ccccc4c3)cc21
5310,195836,10.1016/s0960-894x(01)00635-7,,,,The compound was evaluated for inhibition of HIV-1 wild types GluL38-Lys recombinant reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)CC2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[3-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-2-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",33.8,uM,=,1.5289167002776547,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
5311,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCNc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Ethylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,2.7,uM,=,0.4313637641589873,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5312,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CN(C)c1ccc(F)c(CCNC(=O)Nc2ccc(Br)cn2)c1F,"1-(5-Bromo-pyridin-2-yl)-3-[2-(3-dimethylamino-2,6-difluoro-phenyl)-ethyl]-urea",1.5,uM,=,0.1760912590556812,1,O=C(NCCc1ccccc1)Nc1ccccn1
5313,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N(C)C)C2c3ccccc3SC12C(=O)OC,"(R,R/S,S)-2-dimethylamino-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",50.0,uM,=,1.6989700043360187,1,C1=CC2c3ccccc3SC12
5314,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CNc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(methylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.24,uM,=,-0.619788758288394,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5315,197424,10.1021/jm0209984,,,,Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",6.0,uM,=,0.7781512503836436,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5316,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC[C@H]1CCCN1C1=C(C(=O)OC)[C@]2(C(=O)OC)Sc3ccccc3[C@H]12,"(2aR,7aR)-2-((R)-2-methoxymethyl-pyrrolidin-1-yl)-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",38.0,uM,=,1.57978359661681,1,C1=C(N2CCCC2)[C@H]2c3ccccc3SC12
5317,306158,10.1021/jm040071z,,,,Concentration required for 50% inhibition of wild type human immunodeficiency virus type 1 reverse transcriptase,CCCc1c(SC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6-Chloro-4-cyclohexylsulfanyl-3-propyl-1H-quinolin-2-one,0.24,uM,=,-0.619788758288394,0,O=c1cc(SC2CCCCC2)c2ccccc2[nH]1
5318,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2C[C@@H](OCc3ccccc3)CN2C(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-(2S,4R)-4-O-benzyloxyprolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",28.0,uM,=,1.4471580313422192,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1C[C@@H](OCc2ccccc2)CN1
5319,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CN(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,6-Benzyl-1-benzyloxymethyl-5-dimethylaminouracil,0.012,uM,=,-1.9208187539523751,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5320,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4cccs4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(thiophen-2-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.0059,uM,=,-2.229147988357856,0,c1ccc(Nc2nccc(Nc3ccc(-c4cccs4)cc3)n2)cc1
5321,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(cyclopropylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.08,uM,=,-1.0969100130080565,0,c1ccc(Nc2nc(NC3CC3)cc(Oc3ccc4ccccc4c3)n2)cc1
5322,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,Cc1cc(C)cc(Cc2c(Br)c(=O)[nH]c(=O)n2COCc2ccccc2)c1,"6-(3,5-Dimethylbenzyl)-1-benzyloxymethyl-5-bromouracil",0.043,uM,=,-1.3665315444204136,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5323,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CCOC(=O)c1c(OC2CCCC(C)C2)cc(Cc2ccccc2)[nH]c1=O,"Ethyl 6-Benzyl-4-(3-methylcyclohexyloxy)-2-oxo-1,2-dihydropyridine-3-carboxylate",19.81,uM,=,1.2968844755385471,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5324,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(C#N)nc21,"5-Ethyl-10-methyl-11-oxo-2-(2-pyridin-4-yl-ethyl)-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cycloheptene-7-carbonitrile",0.46,uM,=,-0.3372421683184259,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5325,591809,10.1021/jm901167t,,,,Inhibition of HIV1 reverse transcriptase p66/p51 using poly(rC)-oligo)dG) as template,COC(=O)CCCC=C(c1cc(C#N)c(OC)c(C(=O)OC)c1)c1cc(C#N)c(OC)c(C(=O)OC)c1,methyl 3-cyano-5-[1-(3-cyano-4-methoxy-5-methyloxycarbonylphenyl)-5-methyloxycarbonyl-1-pentenyl]-2-methoxybenzoate,0.38,uM,=,-0.4202164033831898,0,C=C(c1ccccc1)c1ccccc1
5326,757888,10.1016/j.bmc.2011.05.024,,,,Inhibition of HIV1 wild type RT using poly(rA)/oligo(dT)15 homopolymer template after 1 hrs by ELISA,CCc1c(CN2CCCc3ccccc32)nc(SCC(=O)c2ccccc2)[nH]c1=O,"5-Ethyl-2-phenylcarbonylmethylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-one",30.68,uM,=,1.4868553552769437,1,O=C(CSc1nc(CN2CCCc3ccccc32)cc(=O)[nH]1)c1ccccc1
5327,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,CCCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C)cc1C,6-((4-Cyanophenyl)amino)-4-(mesityloxy)-N-propylnicotinamide,0.32,uM,=,-0.494850021680094,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5328,197426,10.1021/jm0211063,,,,Activity to inhibit HIV-1 Reverse transcriptase activity in WT IIIB,Cc1cc(C)cc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-(3,5-dimethyl-benzenesulfonyl)-1H-indole-2-carboxylic acid amide",0.031,uM,=,-1.5086383061657274,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
5329,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2ccccc2)c(I)c(=O)[nH]c1=O,6-Benzyl-1-ethoxymethyl-5-iodouracil,0.114,uM,=,-0.9430951486635274,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5330,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,COc1ccc(CNC(=O)C2CN(C(=O)c3cc(O)c(O)c(O)c3)CCN2S(=O)(=O)c2ccc(N)cc2)cc1,"1-((4-aminophenyl)sulfonyl)-N-(4-methoxybenzyl)-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.14,uM,=,-0.8538719643217619,0,O=C(NCc1ccccc1)C1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccccc1
5331,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCOc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Ethoxy-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,1.9,uM,=,0.2787536009528289,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5332,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(Cl)nc(Nc2ccc(C#N)cc2)c1,"(E)-4-((6-chloro-4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyridin-2-yl)amino)benzonitrile",0.18,uM,=,-0.744727494896694,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5333,545624,10.1021/np0003995,,,,Inhibition of HIV1 reverse transcriptase,C=CC(C)(C)C1(CC=C(C)C)C(=O)Nc2ccccc2C1=O,buchapine,10.0,uM,=,1.0,1,O=C1CC(=O)c2ccccc2N1
5334,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCCC2)c1,"1-(cyclopentylmethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.157,uM,=,-0.8041003475907662,0,O=c1cc(Oc2ccccc2)n(CC2CCCC2)c(=O)[nH]1
5335,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,Fc1ccccc1CC/N=C(\S)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-[2-(2-fluoro-phenyl)-ethyl]-thiourea,0.6,uM,=,-0.2218487496163563,0,C(=NCCc1ccccc1)Nc1ccccn1
5336,195836,10.1016/s0960-894x(01)00635-7,,,,The compound was evaluated for inhibition of HIV-1 wild types GluL38-Lys recombinant reverse transcriptase,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",3.6,uM,=,0.5563025007672873,1,O=c1ccn([C@H]2CC3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5337,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2Cc2ccccc2)c1,"1-benzyl-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.114,uM,=,-0.9430951486635274,0,O=c1cc(Oc2ccccc2)n(Cc2ccccc2)c(=O)[nH]1
5338,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccnc(C#N)c4F)cc3F)n2)cc1,"4-(4-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-difluorophenyl)-3-fluoropicolinonitrile",0.011,uM,=,-1.958607314841775,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5339,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc4cc(C(=O)O)ccc4c3)cc2C(=O)N(C)c2cccnc21,"6-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-naphthalene-2-carboxylic acid",0.014,uM,=,-1.853871964321762,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccc4ccccc4c3)cc21
5340,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC,(2S)-1-linoleoyl-2-palmitoyl-3-O-beta-D-galactopyranosylglycerol,38.0,uM,=,1.57978359661681,1,C1CCOCC1
5341,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,CNC(=O)CCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"5-{3-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-pentanoic acid methylamide",3.2,uM,=,0.505149978319906,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5342,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](CO[C@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC.[Na+],"sodium ((2S,3S,4S,5R,6S)-3-hydroxy-6-((S)-3-((9Z,12Z)-octadeca-9,12-dienoyloxy)-2-(palmitoyloxy)propoxy)-4,5-bis(palmitoyloxy)tetrahydro-2H-pyran-2-yl)methanesulfonate",2.95,uM,=,0.469822015978163,1,C1CCOCC1
5343,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CC2CCCC2)c(=O)[nH]c1=O,"1-(cyclopentylmethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.126,uM,=,-0.8996294548824371,0,O=c1cc(Sc2ccccc2)n(CC2CCCC2)c(=O)[nH]1
5344,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(OC2CCCCC2C)cc(Cc2ccc(F)cc2)[nH]c1=O,6-(4-Fluorobenzyl)-3-isopropyl-4-(2-methylcyclohexyloxy)-pyridin-2(1H)-one,0.13,uM,=,-0.8860566476931633,0,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5345,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,O=c1[nH]c(=O)n(COCc2ccccc2)c(Cc2ccccc2)c1I,6-Benzyl-1-benzyloxymethyl-5-iodouracil,0.01,uM,=,-2.0,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5346,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC(C)C)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(isopropylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.14,uM,=,-0.8538719643217619,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5347,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2sc3c(c12)CCCCC3,"2-(4-Trifluoromethyl-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",3.1,uM,=,0.4913616938342727,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5348,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc4ccccc4c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-naphthalen-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccc4ccccc4c3)cc21
5349,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CCC2CC=CC2)c1,"1-(2-(cyclopent-3-enyl)ethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.011,uM,=,-1.958607314841775,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1CC=CC1
5350,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,COc1ccc(OC)c(CCNC(=S)Nc2ccc(Br)cn2)c1,"1-(5-Bromo-pyridin-2-yl)-3-[2-(2,5-dimethoxy-phenyl)-ethyl]-thiourea",0.028,uM,=,-1.5528419686577808,0,S=C(NCCc1ccccc1)Nc1ccccn1
5351,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2ccc(C3=CCC=N3)nc21,"5-Ethyl-10-methyl-2-phenethyl-7-(4H-pyrrol-2-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.52,uM,=,-0.2839966563652008,0,O=C1Nc2ccc(C3=CCC=N3)nc2Nc2ncc(CCc3ccccc3)cc21
5352,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCCC(CCC)Nc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(heptan-4-ylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.61,uM,=,-0.2146701649892329,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5353,197424,10.1021/jm0209984,,,,Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptase,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1cccs1)c1ccc(Cl)cc1,"(4-Chloro-phenyl)-(thiophene-2-carbonyl)-thiocarbamic acid O-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl] ester",2.5,uM,=,0.3979400086720376,1,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1cccs1)c1ccccc1
5354,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CC2CC=CC2)c(=O)[nH]c1=O,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.21,uM,=,-0.6777807052660807,0,O=c1cc(Sc2ccccc2)n(CC2CC=CC2)c(=O)[nH]1
5355,1737186,10.1016/j.ejmech.2018.03.059,,,,Inhibition of wild-type HIV1 reverse transcriptase assessed as decrease in digoxigenin and biotin-dUTP incorporation in to DNA using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.75,uM,=,-0.1249387366082999,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5356,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(\c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c2on(C)c(=O)c2c1,"5-[1-(2,3-dihydro-2,7-dimethyl-3-oxobenzo[d]isoxazol-5-yl)-5-methoxycarbonylpent-1-enyl]-2-methoxy-3-methylbenzoic acid methyl ester",2.0,uM,=,0.3010299956639812,1,C=C(c1ccccc1)c1ccc2o[nH]c(=O)c2c1
5357,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2cc(C)cc(C)c2)c(N(C)C)c(=O)[nH]c1=O,"6-(3,5-Dimethylbenzyl)-5-dimethylamino-1-ethoxymethyluracil",0.039,uM,=,-1.408935392973501,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5358,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C(C)(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.024,uM,=,-1.619788758288394,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5359,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),CC(=O)NC1=CC(=O)c2ccc(-c3[nH]c(C(N)=O)cc4c5ccccc5nc3-4)nc2C1=O,"1-(7-Acetylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-9H-beta-carboline-3-carboxylic acid amide",12.7,uM,=,1.1038037209559568,1,O=C1C=CC(=O)c2nc(-c3[nH]ccc4c5ccccc5nc3-4)ccc21
5360,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCN2CCOCC2)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-morpholinoethyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.14,uM,=,-0.8538719643217619,0,c1ccc(Nc2nc(NCCN3CCOCC3)cc(Oc3ccccc3)n2)cc1
5361,1661651,10.1016/j.bmcl.2017.03.009,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer after 40 mins by ELISA,N#Cc1ccc(Nc2nccc(Oc3ccc(C(=O)CC(=O)C(=O)O)cc3)n2)cc1,"4-(4-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)phenyl)-2,4-dioxobutanoic acid",25.208,uM,=,1.4015383901659433,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5362,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3c[nH]c4cnccc34)nc21,"5-Ethyl-10-methyl-7-(1H-pyrrolo[2,3-c]pyridin-3-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.044,uM,=,-1.3565473235138126,0,O=C1Nc2ccc(-c3c[nH]c4cnccc34)nc2Nc2ncccc21
5363,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)CC(=O)c1c2c(c3oc(=O)cc(-c4ccccc4)c3c1O)C=CC(C)(C)O2,"5-Hydroxy-8,8-dimethyl-6-(3-methyl-butyryl)-4-phenyl-8H-pyrano[2,3-f]chromen-2-one",123.8,uM,=,2.0927206446841,1,O=c1cc(-c2ccccc2)c2ccc3c(c2o1)C=CCO3
5364,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccccc2C(F)(F)F)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3,5-dimethyl-2'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.046,uM,=,-1.337242168318426,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5365,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1,[4-(3-Ethylamino-pyridin-2-yl)-piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)-methanone,10.0,uM,=,1.0,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5366,546667,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by NCI assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@H](O)[C@@H](OC(=O)c6ccc(O)cc6)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,3alpha-hydroxyaleuritolic acid 2beta-p-hydroxybenzoate,40.0,uM,=,1.6020599913279625,1,O=C(O[C@@H]1CC[C@@H]2CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]3C2C1)c1ccccc1
5367,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(CC)CC)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.0025,uM,=,-2.6020599913279625,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5368,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCCC(NS(C)(=O)=O)C3)cc2)nc2c1COC2,"(E)-N-(1-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)phenyl)piperidin-3-yl)methanesulfonamide",1.24,uM,=,0.093421685162235,1,c1ccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)nc3c2COC3)cc1
5369,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,Cc1c(C(C)c2c(F)cccc2F)nc(SC2CCCC2)[nH]c1=O,"[-]-2-Cyclopentylsulfanyl-6-[1-(2,6-difluoro-phenyl)-ethyl]-5-methyl-3H-pyrimidin-4-one",0.005,uM,=,-2.3010299956639813,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
5370,2278448,10.1021/acs.jmedchem.2c00576,,,,Inhibition of wild type recombinant HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate assessed as inhibition of biotin-labelled UTP incorporation incubated for 1 hr by ELISA,N#C/C=C/c1cc(F)c(Oc2nc(Nc3ccc(C#N)c(F)c3)nc3c2COC3)c(F)c1,"(E)-4-((4-(4-(2-cyanovinyl)-2,6-difluorophenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)-2-fluorobenzonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)COC3)cc1
5371,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)C[C@@H](O)[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,1beta-hydroxyaleuritolic acid-3-p-hydroxybenzoate,3.7,uM,=,0.568201724066995,1,O=C(O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C1)c1ccccc1
5372,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC[C@H]1C(=O)Nc2ccc(F)cc2N1C(=O)OC(C)C,"(S)-2-Ethyl-7-fluoro-3-oxo-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester",0.179,uM,=,-0.7471469690201069,0,O=C1CNc2ccccc2N1
5373,306158,10.1021/jm040071z,,,,Concentration required for 50% inhibition of wild type human immunodeficiency virus type 1 reverse transcriptase,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.3,uM,=,-0.5228787452803376,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5374,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccnc(F)c4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(2-fluoropyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.011,uM,=,-1.958607314841775,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5375,2278448,10.1021/acs.jmedchem.2c00576,,,,Inhibition of wild type recombinant HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate assessed as inhibition of biotin-labelled UTP incorporation incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)c(F)c2)nc2c1COC2,"(E)-4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)-2-fluorobenzonitrile",0.05,uM,=,-1.3010299956639813,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)COC3)cc1
5376,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3C)cc2C(=O)N(C)c2ccc(OC)nc21,"4-[2-(5-Ethyl-7-methoxy-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-benzoic acid",0.015,uM,=,-1.8239087409443189,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5377,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.0195,uM,=,-1.709965388637482,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5378,1279770,10.1016/j.bmcl.2013.10.059,,,,Inhibition of recombinant HIV1 reverse transcriptase using poly rA:dT as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1cc(NC2CCN(Cc3ccncc3)CC2)nc(Nc2ccc(C#N)cc2)n1,"4-(2-(4-cyanophenylamino)-6-(1-(pyridin-4-ylmethyl)piperidin-4-ylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile",33.0,uM,=,1.5185139398778875,1,c1ccc(Nc2nc(NC3CCN(Cc4ccncc4)CC3)cc(Oc3ccccc3)n2)cc1
5379,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,1-(5-Bromo-pyridin-2-yl)-3-(2-pyridin-2-yl-ethyl)-thiourea,0.8,uM,=,-0.0969100130080563,0,S=C(NCCc1ccccn1)Nc1ccccn1
5380,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1F,"6-((3'-Fluoro-4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",1.9,uM,=,0.2787536009528289,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
5381,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,CCCc1c(CC)sc2nc(-c3ccc(O)c(O)c3)[nH]c(=O)c12,"2-(3,4-dihydroxyphenyl)-6-ethyl-5-propylthieno[2,3-d]pyrimidin-4(3H)-one",0.59,uM,=,-0.2291479883578558,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
5382,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,CCOCn1c(C)c(CNc2cc(C)ccc2C)c(=O)[nH]c1=O,"1-(ethoxymethyl)-5-[(2,5-dimethyl-phenylamino)-methyl]-6-methyluracil",26.2,uM,=,1.4183012913197457,1,O=c1[nH]cc(CNc2ccccc2)c(=O)[nH]1
5383,642450,10.1016/j.bmc.2010.05.036,,,,Inhibition of HIV1 reverse transcriptase,COc1cc2cc(C#N)ccc2c(OC)c1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"6-(2-(4-Cyanophenylamino)pyrimidin-4-yloxy)-5,7-dimethoxy-2-naphthonitrile",0.0945328934914944,uM,=,-1.0244170488855864,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5384,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),COc1ccc(C(C)=O)c(F)c1CCNC(=O)Nc1ccc(Cl)cn1,1-[2-(3-Acetyl-2-fluoro-6-methoxy-phenyl)-ethyl]-3-(5-chloro-pyridin-2-yl)-urea,10.0,uM,=,1.0,1,O=C(NCCc1ccccc1)Nc1ccccn1
5385,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCOc3ccccc3)[nH]c3ccc(Cl)c(F)c23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-N-(2-phenoxyethyl)-1H-indole-2-carboxamide",0.066,uM,=,-1.1804560644581312,0,O=C(NCCOc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5386,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C)c(Oc2nc(Nc3ccc(Cl)cc3)cn3ccnc23)c(C)c1,"N-(4-chlorophenyl)-8-(mesityloxy)imidazo[1,2-a]pyrazin-6-amine",5.9,uM,=,0.7708520116421442,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5387,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,CCCCc1c(C)sc2nc(-c3ccc(O)c(O)c3)[nH]c(=O)c12,"5-butyl-2-(3,4-dihydroxyphenyl)-6-methylthieno[2,3-d]pyrimidin-4(3H)-one",0.42,uM,=,-0.3767507096020995,0,O=c1[nH]c(-c2ccccc2)nc2sccc12
5388,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CC(c1cc(O)nc(SC2CCCCC2)n1)c1cccc2ccccc12,2-Cyclohexylsulfanyl-6-(1-naphthalen-1-yl-ethyl)-3H-pyrimidin-4-one,2.6,uM,=,0.414973347970818,1,c1ccc2c(Cc3ccnc(SC4CCCCC4)n3)cccc2c1
5389,1900980,10.1016/j.ejmech.2019.111566,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA,COc1ccc2c(c1)CCCN2CCC(=O)N1CCN(c2ccccc2)CC1,"3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(4-phenylpiperazin-1-yl)propan-1-one",24.25994144363252,uM,=,1.3848897482726,1,O=C(CCN1CCCc2ccccc21)N1CCN(c2ccccc2)CC1
5390,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CCC(C)Sc1nc(O)c(C)c(C(C)c2c(F)cccc2F)n1,"2-sec-Butylsulfanyl-6-[1-(2,6-difluoro-phenyl)-ethyl]-5-methyl-3H-pyrimidin-4-one",0.02,uM,=,-1.6989700043360187,0,c1ccc(Cc2ccncn2)cc1
5391,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1ccc(NCc2c(C)n(COCc3ccccc3)c(=O)[nH]c2=O)cc1,1-(benzyloxymethyl)-5-(p-tolylamino-methyl)-6-methyluracil,13.8,uM,=,1.1398790864012365,1,O=c1[nH]c(=O)n(COCc2ccccc2)cc1CNc1ccccc1
5392,195064,10.1021/jm990383f,,,,In vitroir ability to inhibit wild type resistant (WT) reverse transcriptase,CC#Cc1c(C)nn(-c2ccccc2)c1-c1ccccc1,"3-Methyl-1,5-diphenyl-4-prop-1-ynyl-1H-pyrazole",13.4,uM,=,1.1271047983648077,1,c1ccc(-c2ccnn2-c2ccccc2)cc1
5393,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,N#Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)C(C(=O)NCc3ccc(-c4ccccc4)cc3)C2)cc1,"N-([1,1'-biphenyl]-4-ylmethyl)-4-((4-cyanophenyl)sulfonyl)-1-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.41,uM,=,-0.3872161432802645,0,O=C(NCc1ccc(-c2ccccc2)cc1)C1CN(S(=O)(=O)c2ccccc2)CCN1C(=O)c1ccccc1
5394,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CCC(c1cc(O)nc(SC2CCCCC2)n1)c1cccc2ccccc12,2-Cyclohexylsulfanyl-6-(1-naphthalen-1-yl-propyl)-3H-pyrimidin-4-one,1.4,uM,=,0.1461280356782379,1,c1ccc2c(Cc3ccnc(SC4CCCCC4)n3)cccc2c1
5395,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccnc(Cl)c4Cl)cc3F)n2)cc1,"4-((4-((4-(2,3-dichloropyridin-4-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.016,uM,=,-1.7958800173440752,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5396,80143,10.1016/0960-894X(95)00401-E,,,,Inhibitory activity against HIV-1 reverse transcriptase,Cc1cn(C2CC(N=[N+]=[N-])C(COP(=O)(O)CP(=O)(O)CP(=O)(O)O)O2)c(=O)[nH]c1=O,"{[(2S,3R,5R)-3-Azido-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethoxy]-hydroxy-phosphorylmethyl}-phosphonomethyl-phosphinic acid anion",48.0,uM,=,1.6812412373755872,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
5397,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-tert-Butylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,4.8,uM,=,0.6812412373755872,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5398,508747,10.1074/jbc.m608274200,,,,Inhibition of HIV1 RT mediated DNA-dependent DNA polymerization using chimeric substrate with RNA PPT primer extended at 3' end with upto 9 deoxyribonucleotides,CCc1cc(NCc2nc3c(Cl)ccc(Cl)c3o2)c(O)nc1C,"3-[(4,7-Dichloro-benzooxazol-2-ylmethyl)-amino]-5-ethyl-6-methyl-1H-pyridin-2-one",0.32,uM,=,-0.494850021680094,0,c1cncc(NCc2nc3ccccc3o2)c1
5399,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(C)c3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-m-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5400,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)ccc2C(=O)N1O,"6-((2',4'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",6.5,uM,=,0.8129133566428556,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
5401,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,O=S(=O)(c1ccccc1)n1ccc(C(O)c2ccccc2Cl)c1,(1-Benzenesulfonyl-1H-pyrrol-3-yl)-(2-chloro-phenyl)-methanol,29.5,uM,=,1.469822015978163,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
5402,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,CCc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-ethyl-1H-pyrimidine-2,4-dione",3.4,uM,=,0.5314789170422551,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5403,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCO)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.07,uM,=,-1.154901959985743,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5404,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(/c1cc(F)cc(C(F)(F)F)c1)c1cc(C)c(OC)c(C(=O)OC)c1,5-[(E)-1-(3-Fluoro-5-trifluoromethyl-phenyl)-5-methoxycarbonyl-pent-1-enyl]-2-methoxy-3-methyl-benzoic acid methyl ester,55.3,uM,=,1.7427251313046983,1,C=C(c1ccccc1)c1ccccc1
5405,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CC2CCC2)c(=O)[nH]c1=O,"1-(cyclobutylmethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",2.402,uM,=,0.3805730030668873,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CCC1
5406,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCC(CC)Nc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(pentan-3-ylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.6,uM,=,-0.2218487496163563,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5407,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc2c1COC2,"(E)-4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)benzonitrile",0.06,uM,=,-1.2218487496163564,0,c1ccc(Nc2nc3c(c(Oc4ccccc4)n2)COC3)cc1
5408,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(N)cc3)CC2)nc2c1COC2,"(E)-3-(4-(2-(1-(4-aminophenyl)piperidin-4-ylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)-3,5-dimethylphenyl)acrylonitrile",0.18,uM,=,-0.744727494896694,0,c1ccc(Oc2nc(NC3CCN(c4ccccc4)CC3)nc3c2COC3)cc1
5409,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,CC(C)COC(=O)N1c2ccccc2NC(=O)[C@H]1C,"(R)-isobutyl 2-methyl-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate",64.0,uM,=,1.806179973983887,1,O=C1CNc2ccccc2N1
5410,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC=CC2)c1,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.651,uM,=,-0.186419011431808,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC=CC1
5411,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,COc1cc(-c2cc(F)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(F)c2)ccn1,"4-((4-((2,6-difluoro-4-(2-methoxypyridin-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5412,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(NC(N)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"{3-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-phenyl}-urea",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5413,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1ccc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)cc1,"4-((4-((3,4',5-trimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.019,uM,=,-1.7212463990471711,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5414,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC(C)OC(=O)N1c2cc(F)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-7-fluoro-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester",0.13,uM,=,-0.8860566476931633,0,O=C1Nc2ccccc2NC1C#CC1CC1
5415,503079,10.1021/np960399y,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51,CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O,"(10R,11S,12S)-12-Hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-6H,10H-dipyrano[2,3-f,2',3'-h]chromen-2-one",0.32,uM,=,-0.494850021680094,0,O=c1ccc2c3c(c4c(c2o1)CCCO4)C=CCO3
5416,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CC2CC2)c(=O)[nH]c1=O,"1-(cyclopropylmethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.018,uM,=,-1.744727494896694,0,O=c1cc(Sc2ccccc2)n(CC2CC2)c(=O)[nH]1
5417,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),CCCCOC(=O)c1cc2c([nH]c3ccccc32)c(-c2ccc3c(n2)C(=O)C(NC(=O)CCC)=CC3=O)n1,"1-(7-Butyrylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-9H-beta-carboline-3-carboxylic acid butyl ester",5.8,uM,=,0.7634279935629373,1,O=C1C=CC(=O)c2nc(-c3nccc4c3[nH]c3ccccc34)ccc21
5418,1891828,10.1021/acs.jmedchem.8b00843,,,,Inhibition of HIV1 reverse transcriptase,CCOC1(c2ccccc2)c2cc(Cl)ccc2NC(=S)N1C,"6-chloro-4-ethoxy-3-methyl-4-phenyl-3,4-dihydroquinazoline-2(1H)-thione",0.056,uM,=,-1.2518119729937995,0,S=C1Nc2ccccc2C(c2ccccc2)N1
5419,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cccc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)c1,"4-((4-((3,3',5-trimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.03,uM,=,-1.5228787452803376,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5420,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCC2)c1,"1-(cyclobutylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.068,uM,=,-1.1674910872937636,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CCC1
5421,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2cc(F)cc(F)c2)c(I)c(=O)[nH]c1=O,"6-(3,5-Difluorobenzyl)-1-ethoxymethyl-5-iodouracil",11.85,uM,=,1.0737183503461227,1,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5422,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCn3cccc3)[nH]c3ccc(Cl)cc23)c1,"N-[2-(1H-Pyrrol-1-yl)ethyl]-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.014,uM,=,-1.853871964321762,0,O=C(NCCn1cccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5423,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)C1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(40-OH)MeLeu]4-Cyclosporin A,0.1375,uM,=,-0.8616973018337185,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5424,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccnc(CO)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-[2-(2-hydroxymethyl-pyridin-4-yl)-ethyl]-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.28,uM,=,-0.5528419686577808,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5425,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CCC(c1cc(O)nc(SC(C)C)n1)c1cccc2ccccc12,2-Isopropylsulfanyl-6-(1-naphthalen-1-yl-propyl)-3H-pyrimidin-4-one,0.8,uM,=,-0.0969100130080563,0,c1ccc2c(Cc3ccncn3)cccc2c1
5426,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCn3cccc3)[nH]c3ccc([N+](=O)[O-])cc23)c1,"N-[2-(1H-Pyrrol-1-yl)ethyl]-3-[(3,5-dimethylphenyl)sulfonyl]-5-nitro-1H-indole-2-carboxamide",0.034,uM,=,-1.4685210829577449,0,O=C(NCCn1cccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5427,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccc(F)cc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4'-fluoro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.017,uM,=,-1.769551078621726,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5428,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.002,uM,=,-2.6989700043360187,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5429,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCCCCO)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((4-hydroxybutyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.08,uM,=,-1.0969100130080565,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5430,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(N)c3)cc2C(=O)N(C)c2cccnc21,"2-[2-(3-Amino-phenyl)-ethyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.04,uM,=,-1.3979400086720375,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5431,197448,10.1021/jm9704210,,,,Compound was evaluated for 50% inhibition of HIV-RT (HIV reverse transcriptase),Nc1ccn([C@@H]2C[C@@H](F)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)n1,Triphosphoric acid-[3-fluoro-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl] ester 4M triethyl amine,0.5,uM,=,-0.3010299956639812,0,O=c1ncccn1[C@@H]1CCCO1
5432,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2cc(=O)[nH]c(=O)n2CC2CC=CC2)c1,"1-(cyclopent-3-enylmethyl)-6-(3,5-dimethylbenzoyl)pyrimidine-2,4(1H,3H)-dione",119.2,uM,=,2.076276255404218,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC=CC1
5433,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCC2)c1,"1-(cyclobutylmethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.02,uM,=,-1.6989700043360187,0,O=c1cc(Sc2ccccc2)n(CC2CCC2)c(=O)[nH]1
5434,546667,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by NCI assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)[C@H](OC(=O)c6ccc(O)cc6)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,"2alpha-hydroxyaleuritolic acid 2,3-bis(p-hydroxybenzoate)",60.0,uM,=,1.7781512503836436,1,O=C(O[C@@H]1CC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C[C@H]1OC(=O)c1ccccc1)c1ccccc1
5435,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC1CCCCC1Oc1cc(CCc2ccccc2)[nH]c(=O)c1Br,3-Bromo-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one,0.65,uM,=,-0.1870866433571444,0,O=c1cc(OC2CCCCC2)cc(CCc2ccccc2)[nH]1
5436,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2-hydroxy-2-oxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-hydroxy-propyl)-5-methyl-1H-pyrimidine-2,4-dione",8.1,uM,=,0.9084850188786496,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5437,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)CC(=O)c1c(O)cc(O)c2c(-c3ccccc3)cc(=O)oc12,"5,7-Dihydroxy-8-(3-methyl-butyryl)-4-phenyl-chromen-2-one",6.9,uM,=,0.8388490907372553,1,O=c1cc(-c2ccccc2)c2ccccc2o1
5438,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1F,"1-(5-Chloro-pyridin-2-yl)-3-[(1R,2R)-2-(3-ethoxy-2,6-difluoro-phenyl)-cyclopropyl]-urea",0.015,uM,=,-1.8239087409443189,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
5439,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC2)c1,"1-(cyclopropylmethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.012,uM,=,-1.9208187539523751,0,O=c1cc(Oc2ccccc2)n(CC2CC2)c(=O)[nH]1
5440,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCc3ccccc3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-phenethyl-1H-indole-2-carboxamide",0.128,uM,=,-0.8927900303521317,0,O=C(NCCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5441,658209,10.1016/j.ejmech.2010.05.070,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",13.2,uM,=,1.1205739312058498,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5442,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCCCCNc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(pentylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5443,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,Cc1cc(C)cc(Cc2c(I)c(N)nc(=O)n2COCc2ccccc2)c1,"4-Amino-1-benzyloxymethyl-6-(3,5-dimethylbenzyl)-5-iodouracil",7.217,uM,=,0.8583567052977734,1,O=c1nccc(Cc2ccccc2)n1COCc1ccccc1
5444,195511,10.1016/s0960-894x(01)00012-9,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.047,uM,=,-1.3279021420642825,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5445,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,Cc1cc(-c2ccc(C#N)cc2)c(Cl)cc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"6'-chloro-4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methyl-[1,1'-biphenyl]-4-carbonitrile",0.0188,uM,=,-1.7258421507363202,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5446,306158,10.1021/jm040071z,,,,Concentration required for 50% inhibition of wild type human immunodeficiency virus type 1 reverse transcriptase,CCCc1c(O)nc2ccc(Cl)cc2c1[S+]([O-])C1CCCCC1,6-Chloro-4-cyclohexanesulfinyl-3-propyl-1H-quinolin-2-one,0.38,uM,=,-0.4202164033831898,0,c1ccc2c([SH+]C3CCCCC3)ccnc2c1
5447,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCCC(C)Nc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(pentan-2-ylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.4,uM,=,-0.3979400086720376,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5448,552634,10.1016/j.bmc.2008.05.010,,,,Inhibition of HIV1 virion-associated reverse transcriptase,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.02,uM,=,-1.6989700043360187,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5449,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCN)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-amino-propyl)-5-methyl-1H-pyrimidine-2,4-dione",4.4,uM,=,0.6434526764861874,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5450,197426,10.1021/jm0211063,,,,Activity to inhibit HIV-1 Reverse transcriptase activity in WT IIIB,Cc1ccc(S(=O)(=O)c2c(C(N)=O)[nH]c3ccc(Cl)cc23)cc1,5-Chloro-3-(toluene-4-sulfonyl)-1H-indole-2-carboxylic acid amide,0.072,uM,=,-1.1426675035687317,0,O=S(=O)(c1ccccc1)c1c[nH]c2ccccc12
5451,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCC(NS(N)(=O)=O)C3)cc2)nc2c1COC2,"(E)-N-(1-(4-((4-(4-(2-Cyanoyinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)phenyl)pyrrolidin-3-yl)aminosulfonamide",1.06,uM,=,0.0253058652647702,1,c1ccc(Oc2nc(Nc3ccc(N4CCCC4)cc3)nc3c2COC3)cc1
5452,364650,10.1016/j.bmcl.2006.02.049,,,,Inhibition of wild type HIV1 reverse transcriptase in 293T cells,COC(=O)C1=C(N2CCCCC2)[C@H]2c3ccccc3S[C@@]12C(=O)OC,"(2aR,7aR)-2-piperidin-1-yl-2aH-7-thia-cyclobuta[a]indene-1,7a-dicarboxylic acid dimethyl ester",7.7,uM,=,0.8864907251724818,1,C1=C(N2CCCCC2)[C@H]2c3ccccc3SC12
5453,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCOCC3)[nH]c3ccc(Cl)c(F)c23)c1,"5-Chloro-3-(3,5-dimethylphenylsulfonyl)-4-fluoro-N-(morpholinomethyl)-1H-indole-2-carboxamide",0.08,uM,=,-1.0969100130080565,0,O=C(NCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5454,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](CO[C@@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@H](O)[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC,(2S)-1-linoleoyl-2-palmitoyl-3-O-[alpha-D-galactopyranosyl-(1''''->6''')-3''''-palmitoyl-O-beta-D-galactopyranosyl]glycerol,99.4,uM,=,1.9973863843973128,1,C1CC[C@@H](CO[C@@H]2CCCCO2)OC1
5455,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,O=C(O)c1cn(Cc2ccc(-c3ccccc3)cc2)cc(O)c1=O,"1-([1,1'-Biphenyl]-4-ylmethyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid",2.2,uM,=,0.3424226808222063,1,O=c1ccn(Cc2ccc(-c3ccccc3)cc2)cc1
5456,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,C[C@@H](/N=C(\S)Nc1ccc(Br)cn1)C1CCCCC1,1-(5-Bromo-pyridin-2-yl)-3-((R)-1-cyclohexyl-ethyl)-thiourea,1.2,uM,=,0.0791812460476248,1,C(=NCC1CCCCC1)Nc1ccccn1
5457,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,(1H-Indol-2-yl)-{4-[(3-isopropylamino-pyridin-2-yl)-methyl-amino]-piperidin-1-yl}-methanone,2.0,uM,=,0.3010299956639812,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
5458,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCC(N)=O)cc2C(=O)N(C)c2cccnc21,"3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-propionamide",6.1,uM,=,0.785329835010767,1,O=C1Nc2cccnc2Nc2ncccc21
5459,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3)[nH]c3ccc(Cl)c(F)c23)c1,"N-Benzyl-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-4-fluoro-1H-indole-2-carboxamide",0.04,uM,=,-1.3979400086720375,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5460,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)Oc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropoxy-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,1.1,uM,=,0.041392685158225,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5461,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(c3ccc(C(N)=O)cc3)CC2)nc2c1COC2,"(E)-4-(4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)benzamide",0.06,uM,=,-1.2218487496163564,0,c1ccc(Oc2nc(NC3CCN(c4ccccc4)CC3)nc3c2COC3)cc1
5462,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCOCC1C(=O)NC(=O)C(CC)=C1Sc1ccccc1,"3-(ethoxymethyl)-5-ethyl-4-(phenylthio)pyridine-2,6(1H,3H)-dione",0.1,uM,=,-1.0,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5463,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCCCC2)c1,"1-(cyclohexylmethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.164,uM,=,-0.7851561519523022,0,O=c1cc(Sc2ccccc2)n(CC2CCCCC2)c(=O)[nH]1
5464,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc(C)cc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-p-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.1,uM,=,-1.0,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5465,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccccn3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-pyridin-2-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.19,uM,=,-0.721246399047171,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccn3)cc21
5466,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,C#CCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C#N)cc1C,"4-(4-Cyano-2,6-dimethylphenoxy)-6-((4-cyanophenyl)amino)-N-(prop-2-yn-1-yl)nicotinamide",1.29,uM,=,0.1105897102992489,1,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5467,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc(F)c2)C(COCCO)C(=O)NC1=O,"4-(3-fluorophenylthio)-3-((2-hydroxyethoxy)methyl)-5-methylpyridine-2,6(1H,3H)-dione",0.0017,uM,=,-2.7695510786217263,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5468,856670,10.1016/j.bmcl.2012.05.041,,,,Inhibition of HIV-1 reverse transcriptase using 25 ug/mL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21,SID26752991,2.2,uM,=,0.3424226808222063,1,c1ccc(-c2[nH+]c3ccccc3c3ccccc23)cc1
5469,549454,10.1021/np970585j,,,,Inhibition of HIV1 reverse transcriptase activity assessed as residual enzyme activity by poly(rA)n.oligo(dT)12-18-directed incorporation of [3H]dTTP into DNA,O=S(=O)([O-])C[C@H]1O[C@H](OC[C@H](O)CO)[C@H](O)[C@@H](O)[C@@H]1O.[Na+],"sodium ((2S,3S,4S,5R,6S)-6-((R)-2,3-dihydroxypropoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methanesulfonate",75.0,uM,=,1.8750612633917,1,C1CCOCC1
5470,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC(C)OC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester",0.108,uM,=,-0.9665762445130504,0,O=C1Nc2ccccc2NC1C#CC1CC1
5471,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CCC2C=CCC2)c(=O)[nH]c1=O,"1-(2-(cyclopent-2-enyl)ethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.21,uM,=,-0.6777807052660807,0,O=c1cc(Oc2ccccc2)n(CCC2C=CCC2)c(=O)[nH]1
5472,484679,10.1021/np50109a004,,,,Inhibition of HIV1 reverse transcriptase,C=C(Cc1ccc(O)cc1)C(=C)Cc1ccc(O)cc1,"2,3-bis(4-hydroxybezyl)-1,3-butadiene",4028.096274887096,uM,=,3.605099842008825,1,C=C(Cc1ccccc1)C(=C)Cc1ccccc1
5473,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC2CCOC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(((tetrahydrofuran-3-yl)methyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.06,uM,=,-1.2218487496163564,0,c1ccc(Nc2nc(NCC3CCOC3)cc(Oc3ccc4ccccc4c3)n2)cc1
5474,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3ccc([N+](=O)[O-])o3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(5-nitrofuran-2-yl)thieno[2,3-d]pyrimidin-4(3H)-one",16.9,uM,=,1.2278867046136734,1,O=c1[nH]c(-c2ccco2)nc2sccc12
5475,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4cc(F)nc(F)c4)cc3F)n2)cc1,"4-((4-((4-(2,6-difluoropyridin-4-yl)-2,6-difluorophenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.013,uM,=,-1.8860566476931635,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5476,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCC#N)cc2C(=O)N(C)c2cccnc21,"3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-propionitrile",2.16,uM,=,0.3344537511509309,1,O=C1Nc2cccnc2Nc2ncccc21
5477,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CCCC2)c1,"1-(cyclopentylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.147,uM,=,-0.8326826652518239,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CCCC1
5478,1339445,10.1016/j.bmc.2014.02.030,,,,Inhibition of wild-type HIV1 reverse transcriptase p66/p51 after 40 mins by spectrophotometry,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.038,uM,=,-1.42021640338319,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5479,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,NS(=O)(=O)c1ccc(-c2ccc(Cn3cc(O)c(=O)c(C(=O)O)c3)cc2)cc1,"5-Hydroxy-4-oxo-1-((4'-sulfamoyl[1,1'-biphenyl]-4-yl)-methyl)-1,4-dihydropyridine-3-carboxylic Acid",1.2,uM,=,0.0791812460476248,1,O=c1ccn(Cc2ccc(-c3ccccc3)cc2)cc1
5480,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCCCNc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((6-(butylamino)-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5481,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)C(C(=O)NCc3ccco3)C2)cc1,"4-((4-aminophenyl)sulfonyl)-N-(furan-2-ylmethyl)-1-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.067,uM,=,-1.1739251972991736,0,O=C(NCc1ccco1)C1CN(S(=O)(=O)c2ccccc2)CCN1C(=O)c1ccccc1
5482,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(Cl)cc(C)c1Oc1nc(Nc2ccc([N+](=O)[O-])cc2)cn2ccnc12,"8-(4-Chloro-2,6-dimethylphenoxy)-N-(4-nitrophenyl)imidazo[1,2-a]pyrazin-6-amine",1.3,uM,=,0.1139433523068367,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5483,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5484,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc([N+](=O)[O-])cc2)cn2ccnc12,"3,5-Dimethyl-4-((6-((4-nitrophenyl)amino)imidazo[1,2-a]pyrazin-8-yl)oxy)benzonitrile",14.0,uM,=,1.146128035678238,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5485,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc(C)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-p-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.23,uM,=,-0.6382721639824072,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5486,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c2occc2c(OC)c2c(=O)c(C=O)coc12,"4,9-dimethoxy-5-oxo-5H-furo[3,2-g]chromene-6-carbaldehyde",17.53,uM,=,1.243781916093795,1,O=c1ccoc2cc3occc3cc12
5487,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc(C)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-(2-p-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.18,uM,=,0.0718820073061253,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5488,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)CC2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)O)c1=O,"{3-[3-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-2-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetic acid",5.7,uM,=,0.7558748556724915,1,O=c1ccn(C2CCCO2)c(=O)[nH]1
5489,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)[C@H](OC(=O)c6ccc(O)cc6)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,"2alpha-hydroxyaleuritolic acid 2,3-bis(p-hydroxybenzoate)",7.9,uM,=,0.8976270912904415,1,O=C(O[C@@H]1CC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C[C@H]1OC(=O)c1ccccc1)c1ccccc1
5490,1891828,10.1021/acs.jmedchem.8b00843,,,,Inhibition of HIV1 reverse transcriptase,CC1O[C@](C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2NC1=O,"(5S)-7-chloro-5-(cyclopropylethynyl)-3-methyl-5-(trifluoromethyl)-3,5-dihydrobenzo[e][1,4]oxazepin-2(1H)-one",0.082,uM,=,-1.0861861476162833,0,O=C1COC(C#CC2CC2)c2ccccc2N1
5491,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SC)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.084,uM,=,-1.0757207139381184,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5492,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCOCC3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(morpholinomethyl)-1H-indole-2-carboxamide",0.168,uM,=,-0.7746907182741372,0,O=C(NCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5493,1855821,10.1021/acs.jmedchem.9b01446,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 incubated for 40 mins by picogreen dye-based spectrofluorometric analysis,COc1cc(-c2ccc(C#N)cc2)ccc1Oc1ccnc(Nc2ccc(C#N)cc2)n1,"4'-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methoxy-[1,1'-biphenyl]-4-carbonitrile",0.0093,uM,=,-2.0315170514460648,0,c1ccc(Nc2nccc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
5494,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1c(CNC2CCCCC2)c(=O)[nH]c(=O)n1COCc1ccccc1,1-(benzyloxymethyl)-5-(cyclohexylaminomethyl)-6-methyluracil,5.09,uM,=,0.7067177823367587,1,O=c1[nH]c(=O)n(COCc2ccccc2)cc1CNC1CCCCC1
5495,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccccc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.016,uM,=,-1.7958800173440752,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5496,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,COCCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C)cc1C,6-((4-Cyanophenyl)amino)-4-(mesityloxy)-N-(2-methoxyethyl)nicotinamide,0.52,uM,=,-0.2839966563652008,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5497,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(\c1cc(F)cc(C(F)(F)F)c1)c1cc(C)c2onc(OC)c2c1,(Z)-6-(3-Fluoro-5-trifluoromethyl-phenyl)-6-(3-methoxy-7-methyl-benzo[d]isoxazol-5-yl)-hex-5-enoic acid methyl ester,0.9,uM,=,-0.0457574905606751,0,C=C(c1ccccc1)c1ccc2oncc2c1
5498,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CC2CCC2)c(=O)[nH]c1=O,"1-(cyclobutylmethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.02,uM,=,-1.6989700043360187,0,O=c1cc(Sc2ccccc2)n(CC2CCC2)c(=O)[nH]1
5499,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,CCCc1c(C)sc2nc(-c3cccc(O)c3O)[nH]c(=O)c12,"2-(2,3-dihydroxyphenyl)-6-methyl-5-propylthieno[2,3-d]pyrimidin-4(3H)-one",1.7,uM,=,0.2304489213782739,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
5500,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CC(C)COC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isobutyl ester",1.142,uM,=,0.0576661039098292,1,O=C1Nc2ccccc2NC1C#CC1CC1
5501,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CC(C)c1c(C(=O)c2ccccc2)n(CC2CC=CC2)c(=O)[nH]c1=O,"6-benzoyl-1-(cyclopent-3-enylmethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.18,uM,=,-0.744727494896694,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1CC=CC1
5502,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3cccc4c(C(=O)O)cccc34)cc2C(=O)N(C)c2cccnc21,"5-[2-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-naphthalene-1-carboxylic acid",0.06,uM,=,-1.2218487496163564,0,O=C1Nc2cccnc2Nc2ncc(CCOc3cccc4ccccc34)cc21
5503,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2C=CCC2)c1,"1-(2-(cyclopent-2-enyl)ethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.246,uM,=,-0.6090648928966209,0,O=c1cc(Sc2ccccc2)n(CCC2C=CCC2)c(=O)[nH]1
5504,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2=CCCC2)c1,"1-(cyclopentenylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.02,uM,=,-1.6989700043360187,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1=CCCC1
5505,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC1CCCCC1Oc1cc(CCc2ccccc2)[nH]c(=O)c1I,3-Iodo-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(1H)-one,0.15,uM,=,-0.8239087409443188,0,O=c1cc(OC2CCCCC2)cc(CCc2ccccc2)[nH]1
5506,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,COc1c(C(=O)CC(C)C)c(O)c(CC=C(C)C)c2oc(=O)cc(-c3ccccc3)c12,7-Hydroxy-5-methoxy-8-(3-methyl-but-2-enyl)-6-(3-methyl-butyryl)-4-phenyl-chromen-2-one,22.2,uM,=,1.3463529744506386,1,O=c1cc(-c2ccccc2)c2ccccc2o1
5507,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NCCC#N)c(C)c1,N-(2-cyanoethyl)-6-((4-cyanophenyl)amino)-4-(mesityloxy)nicotinamide,0.19,uM,=,-0.721246399047171,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5508,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)=CCc1c(O)c(C(=O)C(C)C)c2oc(=O)cc(-c3ccccc3)c2c1O,"5,7-Dihydroxy-8-isobutyryl-6-(3-methyl-but-2-enyl)-4-phenyl-chromen-2-one",31.9,uM,=,1.5037906830571812,1,O=c1cc(-c2ccccc2)c2ccccc2o1
5509,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc(C)cc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-p-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.25,uM,=,-0.6020599913279624,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5510,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2ccccc2)c(Br)c(=O)[nH]c1=O,6-Benzyl-5-bromo-1-ethoxymethyluracil,1.825,uM,=,0.2612628687924935,1,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5511,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2cc(O)cc(O)c2)nc2sc3c(c12)CCCCC3,"2-(3,5-Dihydroxy-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",2.6,uM,=,0.414973347970818,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5512,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,O=C1Nc2ccccc2N(CC2CC2)C1(C#CC1CC1)C(F)(F)F,"3-Cyclopropylethynyl-4-cyclopropylmethyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.127,uM,=,-0.8961962790440431,0,O=C1Nc2ccccc2N(CC2CC2)C1C#CC1CC1
5513,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,C#CCNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1Oc1c(C)cc(C)cc1C,6-((4-Cyanophenyl)amino)-4-(mesityloxy)-N-(prop-2-yn-1-yl)nicotinamide,0.07,uM,=,-1.154901959985743,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5514,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc(NS(C)(=O)=O)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"N-{4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-phenyl}-methanesulfonamide",0.33,uM,=,-0.4814860601221125,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5515,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-(2S,4R)-4-hydroxyprolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",16.0,uM,=,1.2041199826559248,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5516,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cccc([N+](=O)[O-])c3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(3-nitrophenyl)thieno[2,3-d]pyrimidin-4(3H)-one",1.5,uM,=,0.1760912590556812,1,O=c1[nH]c(-c2ccccc2)nc2sccc12
5517,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,CC(C)COC(=O)N1c2ccccc2NC(=O)[C@H]1CC(C)C,"(R)-isobutyl 2-isobutyl-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate",67.0,uM,=,1.8260748027008264,1,O=C1CNc2ccccc2N1
5518,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(OC2CCCCC2C)cc(Cc2ccc(Cl)cc2)[nH]c1=O,6-(4-Chlorobenzyl)-3-isopropyl-4-(2-methylcyclohexyloxy)-pyridin-2(1H)-one,0.16,uM,=,-0.7958800173440752,0,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5519,1858686,10.1021/acs.jmedchem.0c00117,,,,"Inhibition of HIV1 RT in presence of reconstituted template and viral nucleotides [digoxigenin (DIG)-dUTP, biotin-dUTP and dTTP] incubated for 1 hr by ELISA method",Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2sccc12,"(E)-4-((4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)thieno[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzenesulfonamide",0.114,uM,=,-0.9430951486635274,0,c1ccc(CN2CCC(Nc3nc(Oc4ccccc4)c4ccsc4n3)CC2)cc1
5520,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC(C)=CCc1c(O)cc(O)c2c(-c3ccccc3)cc(=O)oc12,"5,7-Dihydroxy-8-(3-methyl-but-2-enyl)-4-phenyl-chromen-2-one",11.2,uM,=,1.0492180226701815,1,O=c1cc(-c2ccccc2)c2ccccc2o1
5521,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC(C)C1=C(Sc2ccccc2)C(COCCO)C(=O)NC1=O,"3-((2-hydroxyethoxy)methyl)-5-isopropyl-4-(phenylthio)pyridine-2,6(1H,3H)-dione",0.031,uM,=,-1.5086383061657274,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5522,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(Cc2ccccc2)c(=O)[nH]c1=O,"1-benzyl-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.025,uM,=,-1.6020599913279625,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1Cc1ccccc1
5523,1463329,10.1016/j.bmc.2015.01.002,,,,Inhibition of HIV1 ribonuclease H pre-incubated with compound before enzyme addition using using RNA/DNA heteroduplex and measured after 60 mins by picogreen based spectrofluorometry,O=C(Cn1ccc(=O)n(Cc2cc(Cl)cc(Cl)c2)c1=O)Nc1ccccc1Cl,"N-(2-Chlorophenyl)-2-(3-(3,5-dichlorobenzyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide",149.2,uM,=,2.17376882313665,1,O=C(Cn1ccc(=O)n(Cc2ccccc2)c1=O)Nc1ccccc1
5524,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CC(C)Sc1nc(O)cc(C(C)c2cccc3ccccc23)n1,2-Isopropylsulfanyl-6-(1-naphthalen-1-yl-ethyl)-3H-pyrimidin-4-one,5.8,uM,=,0.7634279935629373,1,c1ccc2c(Cc3ccncn3)cccc2c1
5525,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1sccc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,"6-Chloro-3-methyl-4-(2-methyoxycarbonylthiophene-3-sulfonyl)-3,4-dihydroquinoxa-lin-2-(1H)-one",0.2,uM,=,-0.6989700043360187,0,O=C1CN(S(=O)(=O)c2ccsc2)c2ccccc2N1
5526,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](O)[C@H](OC(=O)c6ccc(O)cc6)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,2alpha-hydroxyaleuritolic acid 2-p-hydroxybenzoate,52.0,uM,=,1.7160033436347992,1,O=C(O[C@H]1CC[C@@H]2CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]3C2C1)c1ccccc1
5527,195198,10.1021/jm00096a011,,,,Concentration required to inhibit HIV reverse transcriptase,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.04,uM,=,-1.3979400086720375,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5528,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(N)=O)c(C)c1,6-((4-Cyanophenyl)amino)-4-(mesityloxy)nicotinamide,0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2cc(Oc3ccccc3)ccn2)cc1
5529,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4ccco4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(furan-2-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.01,uM,=,-2.0,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccco4)cc3)n2)cc1
5530,1281238,10.1016/j.bmc.2013.10.033,,,,Inhibition of wild-type HIV1 reverse transcriptase assessed as incorporation of biotin-labeled dUTP,Cc1cc(C#N)cc(C)c1Oc1ccc([N+](=O)[O-])c(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)c1,"3,5-Dimethyl-4-(3-(1-(4-(methylsulfonyl)benzyl)piperidin-4-ylamino)-4-nitrophenoxy)benzonitrile",0.36,uM,=,-0.4436974992327127,0,c1ccc(CN2CCC(Nc3cccc(Oc4ccccc4)c3)CC2)cc1
5531,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1S[C@@H]2[C@H](O)[C@H](O)[C@H](O)CN2C1=O,"(6R,7R,8R,8aR)-tetrahydro-6,7,8-trihydroxy-5H-thiazolo[3,2-a]pyridine-2,3-dione",5.2,uM,=,0.7160033436347992,1,O=C1S[C@@H]2CCCCN2C1=O
5532,195054,10.1016/s0960-894x(00)00398-x,,,,Compound was evaluated for its inhibitory activity against recombinant HIV-1 Reverse transcriptase using cell free RT inhibition assay,C[C@@H](/N=C(\S)Nc1ccc(Cl)cn1)c1ccccc1,1-(5-Chloro-pyridin-2-yl)-3-((R)-1-phenyl-ethyl)-thiourea,1.2,uM,=,0.0791812460476248,1,C(=NCc1ccccc1)Nc1ccccn1
5533,196372,10.1021/jm0342109,,,,Inhibitory activity against HIV-1 reverse transcriptase was determined,O=C(O)C(=O)CC(=O)c1ccccc1,"2,4-Dioxo-4-phenyl-butyric acid",54.0,uM,=,1.7323937598229686,1,c1ccccc1
5534,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2CCCC2)c1,"1-(2-cyclopentylethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.233,uM,=,-0.632644078973981,0,O=c1cc(Sc2ccccc2)n(CCC2CCCC2)c(=O)[nH]1
5535,722008,10.1128/aac.00800-09,,,,Inhibition of Human immunodeficiency virus 1 subtype B reverse transcriptase DNA-dependent DNA polymerase activity by gel-based primer extension assay,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,"4-[6-Amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile",0.097,uM,=,-1.0132282657337552,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5536,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2ccc(C3=CCC=N3)nc21,"5-Ethyl-10-methyl-2-phenethyl-7-(4H-pyrrol-2-yl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.59,uM,=,-0.2291479883578558,0,O=C1Nc2ccc(C3=CCC=N3)nc2Nc2ncc(CCc3ccccc3)cc21
5537,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(NC(N)=O)cc2C(=O)N(C)c2cccnc21,"(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-urea",1.1,uM,=,0.041392685158225,1,O=C1Nc2cccnc2Nc2ncccc21
5538,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCCCCC(C)Nc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(heptan-2-ylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",1.2,uM,=,0.0791812460476248,1,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5539,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CC2=CCCC2)c(=O)[nH]c1=O,"1-(cyclopentenylmethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.088,uM,=,-1.055517327849831,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CC1=CCCC1
5540,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CCC2CC=CC2)c(=O)[nH]c1=O,"1-(2-(cyclopent-3-enyl)ethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.018,uM,=,-1.744727494896694,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1CC=CC1
5541,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(Cc3ccccc3)cc2C(=O)N(C)c2cccnc21,"2-Benzyl-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2cccnc2Nc2ncc(Cc3ccccc3)cc21
5542,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc([N+](=O)[O-])c2)C(COCCO)C(=O)NC1=O,"3-((2-hydroxyethoxy)methyl)-5-methyl-4-(3-nitrophenylthio)pyridine-2,6(1H,3H)-dione",0.0054,uM,=,-2.2676062401770314,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5543,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,CC(C)(C)OC(=O)N1CCC2(CCN(C(=O)C3CN(C(=O)c4cc(O)c(O)c(O)c4)CCN3S(=O)(=O)c3ccc(N)cc3)C2)C1,"Tert-butyl 7-(1-((4-aminophenyl)sulfonyl)-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carbonyl)-2,7-diazaspiro[4.4]nonane-2-carboxylate",0.18,uM,=,-0.744727494896694,0,O=C(c1ccccc1)N1CCN(S(=O)(=O)c2ccccc2)C(C(=O)N2CCC3(CCNC3)C2)C1
5544,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)c3ccccn3)[nH]c3ccc(Cl)cc23)c1,"rac-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(pyridin-2-yl)-ethyl)-1H-indole-2-carboxamide",0.064,uM,=,-1.193820026016113,0,O=C(NCc1ccccn1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5545,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCCO)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-(3-hydroxy-propyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.9,uM,=,0.4623979978989561,1,O=C1Nc2cccnc2Nc2ncccc21
5546,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCNc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(ethylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.06,uM,=,-1.2218487496163564,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5547,715432,10.1016/j.ejmech.2010.10.020,,,,Inhibition of HIV1 reverse transcriptase,CONC(=S)N/N=C1\C(=O)N(CN2CCN(c3ccc(Cl)cc3)CC2)c2ccc(F)cc21,2-(1-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-5-fluoro-2-oxoindolin-3-ylidene)-N-methoxyhydrazinecarbothioamide,16.7,uM,=,1.2227164711475833,1,N=C1C(=O)N(CN2CCN(c3ccccc3)CC2)c2ccccc21
5548,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,CCOCn1c(C)c(CNc2cc(Cl)c(Cl)cc2Cl)c(=O)[nH]c1=O,"1-(ethoxymethyl)-5-[(2,4,5-trichloro-phenylamino)-methyl]-6-methyluracil",0.82,uM,=,-0.0861861476162833,0,O=c1[nH]cc(CNc2ccccc2)c(=O)[nH]1
5549,2201741,10.1016/j.ejmech.2022.114217,,,,Inhibition of HIV-1 reverse transcriptase using ABTS as substrate and RNA template primed with oligo(dT)12-18 in presence of digoxigenin/biotin-labeled nucleotides by ELISA,COC(=O)/C=C/c1c(-c2cccs2)[nH]c2ccccc12,(E)-Methyl-3-(2-(thiophen-2-yl)-1H-indol-3-yl)acrylate,0.72,uM,=,-0.1426675035687315,0,c1csc(-c2cc3ccccc3[nH]2)c1
5550,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3cccc(NS(C)(=O)=O)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"N-{3-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-phenyl}-methanesulfonamide",0.14,uM,=,-0.8538719643217619,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5551,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,N#Cc1ccc(Nc2nccc(Nc3c(F)cc(-c4cn[nH]c4)cc3F)n2)cc1,"4-((4-((2,6-difluoro-4-(1H-pyrazol-4-yl)phenyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.043,uM,=,-1.3665315444204136,0,c1ccc(Nc2nccc(Nc3ccc(-c4cn[nH]c4)cc3)n2)cc1
5552,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,CCC(C)CNc1cc(Oc2c(OC)cc3cc(C#N)ccc3c2OC)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((2-methylbutyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.27,uM,=,-0.5686362358410126,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5553,195658,10.1021/jm9705723,,,,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at low (~0.1 pfu/cell) multiplicity of injection (moi),Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,"1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione",0.003,uM,=,-2.5228787452803374,0,O=c1ccn([C@H]2CCCO2)c(=O)[nH]1
5554,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,COc1ccc(-c2ccc(Cc3ccc4c(c3)CC(=O)N(O)C4=O)cc2)cc1,"2-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)methyl)-isoquinoline-1,3(2H,4H)-dione",2.5,uM,=,0.3979400086720376,1,O=C1Cc2cc(Cc3ccc(-c4ccccc4)cc3)ccc2C(=O)N1
5555,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,CCOC(=O)N1c2ccccc2NC(=O)[C@]1(C#CC1CC1)C(F)(F)F,"(R)-ethyl 2-(cyclopropylethynyl)-3-oxo-2-(trifluoromethyl)-3,4-dihydroquinoxaline-1(2H)-carboxylate",0.045,uM,=,-1.3467874862246565,0,O=C1Nc2ccccc2NC1C#CC1CC1
5556,195511,10.1016/s0960-894x(01)00012-9,,,,Inhibitory activity against HIV-1 reverse transcriptase,O=C1Nc2c(O)cc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-8-hydroxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",2.341,uM,=,0.3694014136966244,1,O=C1Nc2ccccc2C(C#CC2CC2)O1
5557,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,COc1cccc(SC2=C(C)C(=O)NC(=O)C2COCCO)c1,"3-((2-hydroxyethoxy)methyl)-4-(3-methoxyphenylthio)-5-methylpyridine-2,6(1H,3H)-dione",0.02,uM,=,-1.6989700043360187,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5558,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccc(N)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(4-Amino-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5559,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CC2=CCCC2)c(=O)[nH]c1=O,"1-(cyclopentenylmethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.122,uM,=,-0.9136401693252518,0,O=c1cc(Oc2ccccc2)n(CC2=CCCC2)c(=O)[nH]1
5560,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC1CCCCC1Oc1cc(Cc2ccccc2)[nH]c(=O)c1Br,6-Benzyl-3-bromo-4-(2-methylcyclohexyloxy)pyridin-2(1H)-one,1.21,uM,=,0.08278537031645,1,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5561,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CC2CCCCC2)c(=O)[nH]c1=O,"1-(cyclohexylmethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.152,uM,=,-0.8181564120552275,0,O=c1cc(Sc2ccccc2)n(CC2CCCCC2)c(=O)[nH]1
5562,666602,10.1128/aac.01795-09,,,,Inhibition of RNA-dependent DNA polymerase activity of wild type HIV1 subtype B reverse transcriptase by filter-based filtration assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.1,uM,=,0.6127838567197355,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5563,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCN2CCN(C)CC2)nc(Nc2ccc(C#N)cc2)c1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2-(4-methylpiperazin-1-yl)ethyl)amino)pyridin-2-yl)amino)benzonitrile",2.19,uM,=,0.3404441148401183,1,c1ccc(Nc2cc(Oc3ccccc3)cc(NCCN3CCNCC3)n2)cc1
5564,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(N3CCN(S(N)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-4-(4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-ylamino)phenyl)piperazine-1-sulfonamide",0.71,uM,=,-0.1487416512809247,0,c1ccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3c2COC3)cc1
5565,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(CO)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-2-[2-(2-hydroxymethyl-pyridin-4-yl)-ethyl]-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.16,uM,=,-0.7958800173440752,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5566,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCc1cc(C(=O)O)ccc1OCCc1cnc2c(c1)C(=O)N(C)c1cccnc1N2CC,"3-Ethyl-4-[2-(5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-benzoic acid",0.019,uM,=,-1.7212463990471711,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5567,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccc(N)cc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"2-[2-(4-Amino-phenyl)-ethyl]-7-chloro-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.36,uM,=,-0.4436974992327127,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5568,1473731,10.1021/jm501132s,,,,Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry,O=C1Cc2cc(Cc3ccc(F)cc3F)ccc2C(=O)N1O,"6-(2,4-Difluorobenzyl)-2-hydroxyisoquinoline-1,3(2H,4H)-dione",2.3,uM,=,0.3617278360175928,1,O=C1Cc2cc(Cc3ccccc3)ccc2C(=O)N1
5569,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CC2=CCCC2)c1,"1-(cyclopentenylmethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.032,uM,=,-1.494850021680094,0,O=c1cc(Oc2ccccc2)n(CC2=CCCC2)c(=O)[nH]1
5570,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)C2=CN3C(=CN=C2)Nc2ccccc23)c(O)cc2occc12,"(11H-Benzo[4,5]imidazo[1,2-a][1,4]diazepin-4-yl)(6-hydroxy-4-methoxy-benzofuran-5-yl)methanone",47.55,uM,=,1.6771505212734328,1,O=C(C1=CN2C(=CN=C1)Nc1ccccc12)c1ccc2occc2c1
5571,195067,10.1016/s0960-894x(99)00486-2,,,,Activity against whole cell using anti-infectivity assay,COc1cc(Cl)cc2c1NC(=O)OC2(C#CC1CC1)C(F)(F)F,"6-Chloro-4-cyclopropylethynyl-8-methoxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.122,uM,=,-0.9136401693252518,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5572,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CCOC(=O)N1c2cc(Cl)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"7-Chloro-2-cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid ethyl ester",0.127,uM,=,-0.8961962790440431,0,O=C1Nc2ccccc2NC1C#CC1CC1
5573,910150,10.1007/s00044-007-9004-0,,,,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 recombinant reverse transcriptase expressed in Escherichia coli using poly(rA)oligo(dT) template primer after 30 min,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.5,uM,=,-0.3010299956639812,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5574,306158,10.1021/jm040071z,,,,Concentration required for 50% inhibition of wild type human immunodeficiency virus type 1 reverse transcriptase,CCCc1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O,6-Chloro-4-cyclohexyloxy-3-propyl-1H-quinolin-2-one,0.71,uM,=,-0.1487416512809247,0,O=c1cc(OC2CCCCC2)c2ccccc2[nH]1
5575,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC(C)(C)C)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-(neopentylamino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.51,uM,=,-0.2924298239020636,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5576,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=CCN1c2cc(F)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"4-Allyl-3-cyclopropylethynyl-6-fluoro-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.124,uM,=,-0.906578314837765,0,O=C1Nc2ccccc2NC1C#CC1CC1
5577,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,aleuritolic acid 3-p-hydroxybenzoate,10.6,uM,=,1.0253058652647702,1,O=C(O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C1)c1ccccc1
5578,1339445,10.1016/j.bmc.2014.02.030,,,,Inhibition of wild-type HIV1 reverse transcriptase p66/p51 after 40 mins by spectrophotometry,CC(O)(c1cccc(F)c1)c1ccnc(Nc2ccc(C#N)cc2)n1,4-((4-(1-(3-Fluorophenyl)-1-hydroxyethyl)pyrimidin-2-yl)amino)benzonitrile,0.63,uM,=,-0.2006594505464183,0,c1ccc(Cc2ccnc(Nc3ccccc3)n2)cc1
5579,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5580,1661651,10.1016/j.bmcl.2017.03.009,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer after 40 mins by ELISA,N#Cc1ccc(Nc2nccc(Oc3cccc(C(=O)CC(=O)C(=O)O)c3)n2)cc1,"4-(3-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)phenyl)-2,4-dioxobutanoic acid",5.93,uM,=,0.7730546933642626,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5581,503079,10.1021/np960399y,,,,Inhibition of DNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51,C[C@H]1[C@H](C)Oc2c3c(c4c(-c5ccccc5)cc(=O)oc4c2[C@H]1O)OC(C)(C)C=C3,Soulattrolide,0.34,uM,=,-0.4685210829577448,0,O=c1cc(-c2ccccc2)c2c3c(c4c(c2o1)CCCO4)C=CCO3
5582,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)CNC(=O)[C@@H](N)C(C)C)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[valyl-glycylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",3.8,uM,=,0.5797835966168101,1,O=c1ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5583,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(/c1cccc(C#N)c1)c1cc(C)c2oc(=O)n(C)c2c1,"(Z)-6-(3-cyanophenyl)-6-(2,3-dihydro-3,7-dimethyl-2-oxobenzoxazol-5-yl)hex-5-enoic acid methyl ester",2.8,uM,=,0.4471580313422192,1,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
5584,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,C#CCCCOc1ccc(OC)cc1CCNC(=S)Nc1ccc(Br)cn1,N-(5-Bromo-2-pyridinyl)-N0-{2-[5-methoxy-2-(4-pentynyl-1-oxy)phenyl]ethyl}-thiourea,0.027,uM,=,-1.5686362358410126,0,S=C(NCCc1ccccc1)Nc1ccccn1
5585,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCOc3ccccc3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-phenoxyethyl)-1H-indole-2-carboxamide",4.719,uM,=,0.6738499773429494,1,O=C(NCCOc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5586,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC1CCCCC1Oc1cc(Cc2ccccc2)[nH]c(=O)c1I,6-Benzyl-3-iodo-4-(2-methylcyclohexyloxy)pyridin-2(1H)-one,0.59,uM,=,-0.2291479883578558,0,O=c1cc(OC2CCCCC2)cc(Cc2ccccc2)[nH]1
5587,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,Cl.Cl.NCc1nc2ccccc2[nH]1,(1H-benzo[d]imidazol-2-yl)methanamine dihydrochloride,5.1,uM,=,0.7075701760979364,1,c1ccc2[nH]cnc2c1
5588,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1CS[C@H]2[C@H](O)[C@H](O)[C@H](O)CN12,"(6R,7R,8R,8aS)-tetrahydro-6,7,8-trihydroxy-2H-thiazolo[3,2-a]pyridin-3(5H)-one",13.01,uM,=,1.1142772965615864,1,O=C1CS[C@H]2CCCCN12
5589,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Oc2cc(C)cc(C)c2)n(CC2CCC2)c(=O)[nH]c1=O,"1-(cyclobutylmethyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.235,uM,=,-0.6289321377282637,0,O=c1cc(Oc2ccccc2)n(CC2CCC2)c(=O)[nH]1
5590,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCc2ccccc2)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-3-phenethyl-1H-pyrimidine-2,4-dione",0.8,uM,=,-0.0969100130080563,0,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)n1CCc1ccccc1
5591,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,COc1ccc2c(c1)N(CC1CC1)C(C#CC1CC1)(C(F)(F)F)C(=O)N2,"3-Cyclopropylethynyl-4-cyclopropylmethyl-6-methoxy-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.109,uM,=,-0.9625735020593764,0,O=C1Nc2ccccc2N(CC2CC2)C1C#CC1CC1
5592,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(C(=O)c2cc(C)cc(C)c2)n(CCC2=CCCC2)c(=O)[nH]c1=O,"1-(2-cyclopentenylethyl)-6-(3,5-dimethylbenzoyl)-5-ethylpyrimidine-2,4(1H,3H)-dione",2.0,uM,=,0.3010299956639812,1,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1=CCCC1
5593,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,COC(Nc1cc(Oc2c(C)cc(/C=C/C#N)cc2C)nc(Nc2ccc(C#N)cc2)n1)OC,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-((2,2-dimethoxyethyl)amino)pyrimidin-2-yl)amino)benzonitrile",0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5594,195201,10.1016/S0960-894X(97)00340-5,,,,Inhibition of HIV-1 recombinant reverse transcriptase,Cc1ccccc1S(=O)(=O)n1ccc(C(O)c2ccc(Cl)cc2Cl)c1,"(2,4-Dichloro-phenyl)-[1-(toluene-2-sulfonyl)-1H-pyrrol-3-yl]-methanol",27.0,uM,=,1.4313637641589874,1,O=S(=O)(c1ccccc1)n1ccc(Cc2ccccc2)c1
5595,2278448,10.1021/acs.jmedchem.2c00576,,,,Inhibition of wild type recombinant HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate assessed as inhibition of biotin-labelled UTP incorporation incubated for 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)nc2)nc2c1COC2,"(E)-5-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)amino)picolinonitrile",0.04,uM,=,-1.3979400086720375,0,c1ccc(Oc2nc(Nc3cccnc3)nc3c2COC3)cc1
5596,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2cc(C)cc(C)c2)c(Br)c(=O)[nH]c1=O,"6-(3,5-Dimethylbenzyl)-5-bromo-1-ethoxymethyluracil",0.21,uM,=,-0.6777807052660807,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5597,770448,10.1016/j.bmc.2011.08.060,,,,Inhibition of wild type HIV1 reverse transcriptase,Cc1cc(C)c(Oc2nn(Nc3ccc(C#N)cc3)c(=O)c3ccccc23)c(C)c1,4-(4-(Mesityloxy)-1-oxophthalazin-2(1H)-ylamino)benzonitrile,928.0,uM,=,2.967547976218862,1,O=c1c2ccccc2c(Oc2ccccc2)nn1Nc1ccccc1
5598,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C#CCN1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"3-Cyclopropylethynyl-4-prop-2-ynyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",1.807,uM,=,0.2569581525609318,1,O=C1Nc2ccccc2NC1C#CC1CC1
5599,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=C(C)OC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropenyl ester",0.169,uM,=,-0.7721132953863264,0,O=C1Nc2ccccc2NC1C#CC1CC1
5600,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),NC(=O)c1cc2c([nH]c3ccccc32)c(-c2ccc3c(n2)C(=O)C(NC=O)=CC3=O)n1,"1-(7-Formylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-9H-beta-carboline-3-carboxylic acid amide",20.5,uM,=,1.3117538610557542,1,O=C1C=CC(=O)c2nc(-c3nccc4c3[nH]c3ccccc34)ccc21
5601,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(1-(4-(methylsulfonyl)benzyl)piperidin-4-ylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.15,uM,=,-0.8239087409443188,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
5602,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NN(C)c3ccccc3)[nH]c3ccc(Cl)cc23)c1,"5-chloro-3-(3,5-dimethylphenylsulfonyl)-N'-methyl-N'-phenyl-1H-indole-2-carbohydrazide",0.016,uM,=,-1.7958800173440752,0,O=C(NNc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5603,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(CC#N)cc2)cn2ccnc12,"4-((6-((4-(cyanomethyl)phenyl)amino)imidazo[1,2-a]pyrazin-8-yl)oxy)-3,5-dimethylbenzonitrile",0.17,uM,=,-0.7695510786217261,0,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5604,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(/c1cccc(C#N)c1)c1cc(C)c2on(C)c(=O)c2c1,"(E)-6-(3-cyanophenyl)-6-(2,3-dihydro-2,7-dimethyl-3-oxobenzo[d]isoxazol-5-yl)hex-5-enoic acid methyl ester",49.6,uM,=,1.6954816764901974,1,C=C(c1ccccc1)c1ccc2o[nH]c(=O)c2c1
5605,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccccc3N)cc2C(=O)N(C)c2cccnc21,"2-[2-(2-Amino-phenyl)-ethyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5606,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCC2CCCO2)nc(Nc2ccc(C#N)cc2)c1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-(((tetrahydrofuran-2-yl)methyl)amino)pyridin-2-yl)amino)benzonitrile",0.63,uM,=,-0.2006594505464183,0,c1ccc(Nc2cc(Oc3ccccc3)cc(NCC3CCCO3)n2)cc1
5607,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=CCOC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid allyl ester",0.147,uM,=,-0.8326826652518239,0,O=C1Nc2ccccc2NC1C#CC1CC1
5608,882099,10.1016/j.bmcl.2012.09.100,,,,Inhibition of HIV1 reverse transcriptase incubated for 1 hr by colorimetric assay,O=C1CS[C@@H]2[C@H](O)[C@H](O)[C@H](O)CN12,"(6R,7R,8R,8aR)-tetrahydro-6,7,8-trihydroxy-2H-thiazolo[3,2-a]pyridin-3(5H)-one",18.99,uM,=,1.2785249647370176,1,O=C1CS[C@@H]2CCCCN12
5609,321416,10.1016/j.bmcl.2005.07.041,,,,Inhibitory concentration against recombinant human immunodeficiency virus 1 reverse transcriptase,CC1CN(C2CC(N=[N+]=[N-])[C@@H](CO)C2)C(=O)NC1=O,"1-((S)-3-Azido-4-hydroxymethyl-cyclopentyl)-5-methyl-dihydro-pyrimidine-2,4-dione",0.01,uM,=,-2.0,0,O=C1CCN(C2CCCC2)C(=O)N1
5610,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CCOCn1c(Cc2ccccc2)c(N(C)C)c(=O)[nH]c1=O,6-Benzyl-5-dimethylamino-1-ethoxymethyluracil,0.162,uM,=,-0.790484985457369,0,O=c1cc(Cc2ccccc2)[nH]c(=O)[nH]1
5611,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.11,uM,=,-0.958607314841775,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5612,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,COc1cc2nc(SCC(=O)Nc3ccc([N+](=O)[O-])cc3)nc(Nc3c(C)cc(/C=C/C#N)cc3C)c2cc1OC,"(E)-2-{4-[4-(2-cyanovinyl)-2,6-dimethylphenylamino]-6,7-dimethoxyquinazolin-2-yl}thio-N-(4-nitrophenyl)acetamide",4.0,uM,=,0.6020599913279624,1,O=C(CSc1nc(Nc2ccccc2)c2ccccc2n1)Nc1ccccc1
5613,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CC2=CCCC2)c(=O)[nH]c1=O,"1-(cyclopentenylmethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",0.138,uM,=,-0.8601209135987634,0,O=c1cc(Sc2ccccc2)n(CC2=CCCC2)c(=O)[nH]1
5614,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CC1=C(Sc2cccc(I)c2)C(COCCO)C(=O)NC1=O,"3-((2-hydroxyethoxy)methyl)-4-(3-iodophenylthio)-5-methylpyridine-2,6(1H,3H)-dione",0.004,uM,=,-2.397940008672037,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5615,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)[nH]c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-1H-pyrimidine-2,4-dione",1.0,uM,=,0.0,0,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5616,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCC1=C(Sc2ccccc2)C(COCc2ccc(Cl)cc2)C(=S)NC1=O,"5-((4-chlorobenzyloxy)methyl)-3-ethyl-4-(phenylthio)-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.404,uM,=,-0.393618634889395,0,O=C1C=C(Sc2ccccc2)C(COCc2ccccc2)C(=S)N1
5617,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CSc1nc(O)c(C)c(C(C)c2c(F)cccc2F)n1,"6-[1-(2,6-Difluoro-phenyl)-ethyl]-5-methyl-2-methylsulfanyl-3H-pyrimidin-4-one",0.02,uM,=,-1.6989700043360187,0,c1ccc(Cc2ccncn2)cc1
5618,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,CCc1c(Sc2cc(C)cc(C)c2)n(CCC2=CCCC2)c(=O)[nH]c1=O,"1-(2-cyclopentenylethyl)-6-(3,5-dimethylphenylthio)-5-ethylpyrimidine-2,4(1H,3H)-dione",2.16,uM,=,0.3344537511509309,1,O=c1cc(Sc2ccccc2)n(CCC2=CCCC2)c(=O)[nH]1
5619,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCC2CC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((cyclopropylmethyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.09,uM,=,-1.0457574905606752,0,c1ccc(Nc2nc(NCC3CC3)cc(Oc3ccc4ccccc4c3)n2)cc1
5620,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3C)cc2C(=O)N(C)c2ccc(F)nc21,"4-[2-(5-Ethyl-7-fluoro-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-benzoic acid",0.015,uM,=,-1.8239087409443189,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5621,1363204,10.1021/jm500109z,,,,Inhibition of recombinant HIV-1 reverse transcriptase-associated RNase H activity using [3H]-labeled RNA as substrate after 10 mins,COc1ccc2c(C(=O)NCc3ccc(F)cc3)c(O)n(O)c(=O)c2c1,"N-(4-Fluorobenzyl)-2,3-dihydroxy-7-nitro-1-oxo-1,2-dihydroisoquinoline-4-carboxamide",4.8,uM,=,0.6812412373755872,1,O=C(NCc1ccccc1)c1c[nH]c(=O)c2ccccc12
5622,197424,10.1021/jm0209984,,,,Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptase,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1ccnc(Cl)c1)c1ccc(Cl)cc1,"(4-Chloro-phenyl)-(2-chloro-pyridine-4-carbonyl)-thiocarbamic acid O-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl] ester",2.0,uM,=,0.3010299956639812,1,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1ccncc1)c1ccccc1
5623,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Oc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2C=CCC2)c1,"1-(2-(cyclopent-2-enyl)ethyl)-6-(3,5-dimethylphenoxy)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.027,uM,=,-1.5686362358410126,0,O=c1cc(Oc2ccccc2)n(CCC2C=CCC2)c(=O)[nH]1
5624,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)C2=CN3OC(C)=NC3N=C2)c(O)c(OC)c2occc12,"(6-hydroxy-4,7-dimethoxybenzofuran-5-yl)(2-methyl-3aH-[1,2,4]oxadiazolo[2,3-a]pyrimidin-6-yl)methanone",3.0,uM,=,0.4771212547196624,1,O=C(C1=CN2OC=NC2N=C1)c1ccc2occc2c1
5625,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(CN3CCN(S(C)(=O)=O)CC3)cc2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(4-((4-(methylsulfonyl)piperazin-1-yl)methyl)phenylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.15,uM,=,-0.8239087409443188,0,c1ccc(Oc2nc(Nc3ccc(CN4CCNCC4)cc3)nc3c2COC3)cc1
5626,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(F)c([C@H]2C[C@H]2NC(=O)Nc2ccc(Cl)cn2)c1Cl,"1-[(1R,2R)-2-(2-Chloro-3-ethoxy-6-fluoro-phenyl)-cyclopropyl]-3-(5-chloro-pyridin-2-yl)-urea",0.05,uM,=,-1.3010299956639813,0,O=C(Nc1ccccn1)N[C@@H]1C[C@@H]1c1ccccc1
5627,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCO)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(40-OH) MeLeu]4-CsA derivatives,0.08,uM,=,-1.0969100130080565,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5628,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,Cc1cc(C)cc(Cc2c(N(C)C)c(=O)[nH]c(=O)n2COCc2ccccc2)c1,"6-(3,5-Dimethylbenzyl)-1-benzyloxymethyl-5-dimethylaminouracil",0.021,uM,=,-1.6777807052660807,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5629,1900980,10.1016/j.ejmech.2019.111566,,,,Inhibition of HIV-1 reverse transcriptase after 1 hr by ELISA,COc1ccc2c(c1)CCCN2CCC(=O)N1CCN(c2cccc(Cl)c2)CC1,"1-(4-(3-chlorophenyl)piperazin-1-yl)-3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)propan-1-one",18.58722542210651,uM,=,1.269214566006418,1,O=C(CCN1CCCc2ccccc21)N1CCN(c2ccccc2)CC1
5630,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCOCC3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-morpholinoethyl)-1H-indole-2-carboxamide",0.099,uM,=,-1.00436480540245,0,O=C(NCCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5631,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCO)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-2-(2-hydroxy-ethyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.43,uM,=,-0.3665315444204134,0,O=C1Nc2cccnc2Nc2ncccc21
5632,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN2CCOCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.101,uM,=,-0.9956786262173574,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](SCCN2CCOCC2)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5633,195529,10.1021/jm960837y,,,,Inhibitory concentration against HIV-1 wild type reverse transcriptase,CCN1c2ncccc2C(=O)N(C)c2ccc(-c3c[nH]c4ccccc34)nc21,"5-Ethyl-7-(1H-indol-3-yl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.028,uM,=,-1.5528419686577808,0,O=C1Nc2ccc(-c3c[nH]c4ccccc34)nc2Nc2ncccc21
5634,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,Cc1sc2nc(-c3cccnc3)[nH]c(=O)c2c1C,"5,6-dimethyl-2-(pyridin-3-yl)thieno[2,3-d]pyrimidin-4(3H)-one",8.3,uM,=,0.919078092376074,1,O=c1[nH]c(-c2cccnc2)nc2sccc12
5635,197424,10.1021/jm0209984,,,,Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptase,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1ccco1)c1ccc(Cl)cc1,"(4-Chloro-phenyl)-(furan-2-carbonyl)-thiocarbamic acid O-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl] ester",2.3,uM,=,0.3617278360175928,1,O=C1c2ccccc2C(=O)N1CCOC(=S)N(C(=O)c1ccco1)c1ccccc1
5636,1927894,10.1016/j.bmc.2016.09.025,,,,Inhibition of recombinant HIV1 non-nucleoside reverse transcriptase,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide,0.036,uM,=,-1.4436974992327127,0,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5637,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",31.0,uM,=,1.4913616938342726,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5638,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(C)cc(-c2cc(C)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(C)c2)c1,"4-((4-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.116,uM,=,-0.9355420107730816,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5639,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,COC(=O)COc1ccc(OC)cc1CCNC(=S)Nc1ccc(Br)cn1,N-(5-Bromo-2-pyridinyl)-N0-[2-(2-methoxycarbonylmethyloxy-5-methoxyphenyl)ethyl]-thiourea,0.1,uM,=,-1.0,0,S=C(NCCc1ccccc1)Nc1ccccn1
5640,886109,10.1016/j.bmc.2012.09.058,,,,Inhibition of HIV1 recombinant reverse transcriptase assessed as incorporation of biotin-dUTP into poly(rC)-oligo(dG) by colorimetric analysis,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",2.7,uM,=,0.4313637641589873,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5641,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CC(c1cc(O)nc(SC2CCCC2)n1)c1cccc2ccccc12,2-Cyclopentylsulfanyl-6-(1-naphthalen-1-yl-ethyl)-3H-pyrimidin-4-one,0.4,uM,=,-0.3979400086720376,0,c1ccc2c(Cc3ccnc(SC4CCCC4)n3)cccc2c1
5642,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(N2CCOCC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-morpholinopyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.25,uM,=,-0.6020599913279624,0,c1ccc(Nc2nc(Oc3ccc4ccccc4c3)cc(N3CCOCC3)n2)cc1
5643,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(40-OH) MeLeu]4-CsA derivatives,0.045,uM,=,-1.3467874862246565,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5644,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",10.6,uM,=,1.0253058652647702,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5645,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3cccc(N)c3)cc2C(=O)N(C)c2cccnc21,"2-[2-(3-Amino-phenyl)-ethyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.07,uM,=,-1.154901959985743,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5646,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCO)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2-hydroxy-2-oxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3-(3-hydroxy-propyl)-5-methyl-1H-pyrimidine-2,4-dione",0.7,uM,=,-0.1549019599857432,0,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5647,195368,10.1021/jm010853h,,,,Inhibitory activity against HIV-1 recombinant reverse transcriptase.,CC(c1cc(=O)[nH]c(SC2CCCC2)n1)c1c(F)cccc1F,"2-Cyclopentylsulfanyl-6-[1-(2,6-difluoro-phenyl)-ethyl]-3H-pyrimidin-4-one",0.05,uM,=,-1.3010299956639813,0,O=c1cc(Cc2ccccc2)nc(SC2CCCC2)[nH]1
5648,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(/c1cc(C)c(OC)c(C(=O)OC)c1)c1cc(C)c2oc(=O)n(C)c2c1,"methyl 5-(1-(3,7-dimethyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-6-methoxy-6-oxohex-1-enyl)-2-methoxy-3-methylbenzoate",0.02,uM,=,-1.6989700043360187,0,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
5649,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",4.45,uM,=,0.6483600109809317,1,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5650,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,CN(C(=O)C1CN(S(=O)(=O)c2ccc(N)cc2)CCN1C(=O)c1cc(O)c(O)c(O)c1)c1ccccc1,"4-((4-aminophenyl)sulfonyl)-N-methyl-N-phenyl-1-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.99,uM,=,-0.00436480540245,0,O=C(Nc1ccccc1)C1CN(S(=O)(=O)c2ccccc2)CCN1C(=O)c1ccccc1
5651,559681,10.1016/j.bmc.2008.10.048,,,,Inhibition of HIV1 3B reverse transcriptase,C#CCOCCOc1ccc(OC)cc1CCNC(=S)Nc1ccc(Br)cn1,N-(5-Bromo-2-pyridinyl)]-N0-{2-[5-methoxy-2-(2-propargyloxyethoxy)phenyl]ethyl}-thiourea,0.041,uM,=,-1.3872161432802643,0,S=C(NCCc1ccccc1)Nc1ccccn1
5652,196517,10.1016/s0960-894x(98)00249-2,,,,Inhibitory effect on recombinant HIV- 1 reverse transcriptase which has a mutation Tyr 181 to Cys 181 (clone 90),CCOc1ccc(OC)c(CCNC(=O)Nc2ccc(Cl)cn2)c1F,1-(5-Chloro-pyridin-2-yl)-3-[2-(3-ethoxy-2-fluoro-6-methoxy-phenyl)-ethyl]-urea,0.5,uM,=,-0.3010299956639812,0,O=C(NCCc1ccccc1)Nc1ccccn1
5653,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(CC(=O)N[C@@H](C)C(=O)O)c1=O,"(S)-2-(2-{3-[(5R,6R,8R,9R)-4-amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-5-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl}-acetylamino)-propionic acid",3.1,uM,=,0.4913616938342727,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5654,1467341,10.1016/j.ejmech.2015.01.042,,,,"Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA after 1 hr using poly(A) x oligo(dT)15 template/primer hybrid, digoxigenin and biotin-labeled nucleotides",Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.58,uM,=,-0.2365720064370627,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5655,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,"(4aS,6bR,8aS,10S,12R,12aR,12bS,14aS,14bR)-10,12-dihydroxy-2,2,6b,9,9,12a,14a-heptamethyl-1,2,3,4,4a,5,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-icosahydropicene-4a-carboxylic acid",4.9,uM,=,0.6901960800285137,1,C1=C2C(CC[C@H]3C2CC[C@H]2CCCCC23)[C@H]2CCCCC2C1
5656,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)c3ccncc3)[nH]c3ccc(Cl)cc23)c1,"rac-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(pyridin-4-yl)-ethyl)-1H-indole-2-carboxamide",0.04,uM,=,-1.3979400086720375,0,O=C(NCc1ccncc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5657,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,COc1ccccc1-c1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,"4-((4-((2'-methoxy-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.021,uM,=,-1.6777807052660807,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5658,1816897,10.1016/j.ejmech.2019.111874,,,,Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66/p51 expressed in Escherichia coli JM109 using poly(rA)/oligo(dT)16 as template/primer incubated for 40 mins by pico-green based spectrofluorometric analysis,COc1cc2nc([S+]([O-])CC(=O)Nc3ccc([N+](=O)[O-])cc3)nc(Nc3c(C)cc(/C=C/C#N)cc3C)c2cc1OC,"(E)-2-{4-[4-(2-cyanovinyl)-2,6-dimethylphenylamino]-6,7-dimethoxyquinazolin-2-yl}sulfinyl-N-(4-nitrophenyl)acetamide",0.011,uM,=,-1.958607314841775,0,O=C(C[SH+]c1nc(Nc2ccccc2)c2ccccc2n1)Nc1ccccc1
5659,1281238,10.1016/j.bmc.2013.10.033,,,,Inhibition of wild-type HIV1 reverse transcriptase assessed as incorporation of biotin-labeled dUTP,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.67,uM,=,-0.1739251972991735,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5660,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(NCCC#N)nc(Nc2ccc(C#N)cc2)n1,"(E)-4-((4-((2-Cyanoethyl)amino)-6-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)pyrimidin-2-yl)amino)benzonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5661,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3)[nH]c3ccc(Br)cc23)c1,"N-Benzyl-5-bromo-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",1.054,uM,=,0.0228406108765278,1,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5662,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NC2CCOC2)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((tetrahydrofuran-3-yl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.18,uM,=,-0.744727494896694,0,c1ccc(Nc2nc(NC3CCOC3)cc(Oc3ccc4ccccc4c3)n2)cc1
5663,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccnc(C(=O)OC)c3)cc2C(=O)N(C)c2ccc(Cl)nc21,"4-[2-(7-Chloro-5-ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethyl]-pyridine-2-carboxylic acid methyl ester",0.15,uM,=,-0.8239087409443188,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5664,501126,10.1016/j.bmcl.2009.03.069,,,,Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay,COc1c(C(=O)c2cnc3nc4ccccc4n3c2)c(O)c(OC)c2occc12,"(6-Hydroxy-4,7-dimethoxybenzofuran-5-yl)(benzo[4,5]imidazo[1,2-a]pyrimidin-3-yl)methanone",25.66,uM,=,1.4092566520389096,1,O=C(c1ccc2occc2c1)c1cnc2nc3ccccc3n2c1
5665,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=CCN1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"4-Allyl-3-cyclopropylethynyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.601,uM,=,-0.2211255279972604,0,O=C1Nc2ccccc2NC1C#CC1CC1
5666,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(NCCCO)nc(Nc2ccc(C#N)cc2)n1,"6-((2-((4-cyanophenyl)amino)-6-((3-hydroxypropyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.19,uM,=,-0.721246399047171,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5667,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@H](O)[C@@H](OC(=O)c6ccc(O)cc6)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,3alpha-hydroxyaleuritolic acid 2beta-p-hydroxybenzoate,15.0,uM,=,1.1760912590556811,1,O=C(O[C@@H]1CC[C@@H]2CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]3C2C1)c1ccccc1
5668,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCC#N)cc2C(=O)N(C)c2cccnc21,"3-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-propionitrile",0.21,uM,=,-0.6777807052660807,0,O=C1Nc2cccnc2Nc2ncccc21
5669,939432,10.1021/jm301271j,,,,Inhibition of wild type HIV-1 reverse transcriptase 507 site incubated after 30 mins by fluorescence assay,CN(CC(=O)N1CCCc2ccccc21)Cc1nc(=O)c2ccccc2[nH]1,"2-(((2-(3,4-dihydroquinolin-1(2H)-yl)-2-oxoethyl)(methyl)amino)-methyl)quinazolin-4(1H)-one",150.0,uM,=,2.1760912590556813,1,O=C(CNCc1nc(=O)c2ccccc2[nH]1)N1CCCc2ccccc21
5670,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(O)c(O)c2)nc2sc3c(c12)CCCCC3,"2-(3,4-Dihydroxy-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",0.29,uM,=,-0.5376020021010439,0,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5671,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCOCC1C(=S)NC(=O)C(CC)=C1Sc1ccccc1,"5-(ethoxymethyl)-3-ethyl-4-(phenylthio)-6-thioxo-5,6-dihydropyridin-2(1H)-one",0.137,uM,=,-0.8632794328435932,0,O=C1C=C(Sc2ccccc2)CC(=S)N1
5672,306910,10.1021/jm050255t,,,,"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 wild type reverse transcriptase (1-2 nM) by using [3H]dGTP (71 nM) as substrate, 50 mM Tris/HCl buffer, pH 7.8, incubated for 1 h at 37 degrees C",CCN1c2ncc(CCOc3ccc(C(=O)O)cc3C)cc2C(=O)N(C)c2ccc(C)nc21,"4-[2-(5-Ethyl-7,10-dimethyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-2-yl)-ethoxy]-3-methyl-benzoic acid",0.019,uM,=,-1.7212463990471711,0,O=C1Nc2cccnc2Nc2ncc(CCOc3ccccc3)cc21
5673,946838,10.1021/jm400102x,,,,Inhibition of HIV1 reverse transcriptase after 1 hr by colorimetric assay,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"6-Benzyl-1-benzyloxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.088,uM,=,-1.055517327849831,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5674,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccccc3)[nH]c3ccc(Cl)cc23)c1,"N-Benzyl-5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxamide",0.021,uM,=,-1.6777807052660807,0,O=C(NCc1ccccc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5675,722008,10.1128/aac.00800-09,,,,Inhibition of Human immunodeficiency virus 1 subtype B reverse transcriptase DNA-dependent DNA polymerase activity by gel-based primer extension assay,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.018,uM,=,-1.744727494896694,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5676,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(O)c(O)c2)nc2sc3c(c12)CCCC3,"2-(3,4-Dihydroxy-phenyl)-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d]pyrimidin-4-one",0.37,uM,=,-0.431798275933005,0,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCC3
5677,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCN3CCOCC3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-(morpholinomethyl)-1H-indole-2-carboxamide",0.054,uM,=,-1.2676062401770316,0,O=C(NCN1CCOCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5678,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)C(C(=O)Nc3ccccc3)C2)cc1,"4-((4-aminophenyl)sulfonyl)-N-phenyl-1-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.33,uM,=,-0.4814860601221125,0,O=C(Nc1ccccc1)C1CN(S(=O)(=O)c2ccccc2)CCN1C(=O)c1ccccc1
5679,1721403,10.1021/acsmedchemlett.7b00361,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase using DIG-labeled dUTP/biotin-labeled dUTP and dTTP as template and viral nucleotides assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCC(NS(=O)(=O)c3ccc(C#N)cc3)CC2)nc2ccsc12,"4-cyano-N-(4-((4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)cyclohexyl)benzenesulfonamide",1.138,uM,=,0.0561422620590523,1,O=S(=O)(NC1CCC(Nc2nc(Oc3ccccc3)c3sccc3n2)CC1)c1ccccc1
5680,2201577,10.1016/j.ejmech.2021.114085,,,,Inhibition of HIV1 reverse transcriptase,COC(=O)c1sc(Cl)cc1S(=O)(=O)N1c2cc(Cl)ccc2NC(=O)C1C,"Methyl 5-chloro-3-(7-chloro-2-methyl-3-oxo-3,4-dihydroquinoxalin-1(2H)-ylsulfonyl)thiophene-2-carboxylate",0.07,uM,=,-1.154901959985743,0,O=C1CN(S(=O)(=O)c2ccsc2)c2ccccc2N1
5681,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CCOc1cccnc1N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1,[4-(3-Ethoxy-pyridin-2-yl)-piperazin-1-yl]-(1H-indol-2-yl)-methanone,2.1,uM,=,0.3222192947339193,1,O=C(c1cc2ccccc2[nH]1)N1CCN(c2ccccn2)CC1
5682,385312,10.1021/jm060449o,,,,Inhibition of recombinant HIV1 reverse transcriptase measured as inhibition of incorporation of [32P]GTP in rCDG primer,COC(=O)CCC/C=C(/c1ccc(C#N)cc1)c1cc(C)c2oc(=O)n(C)c2c1,"(Z)-6-(4-cyanophenyl)-6-(2,3-dihydro-3,7-dimethyl-2-oxobenzoxazol-5-yl)hex-5-enoic acid methyl ester",1.2,uM,=,0.0791812460476248,1,C=C(c1ccccc1)c1ccc2oc(=O)[nH]c2c1
5683,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(Sc2c(C(C)C)c(=O)[nH]c(=O)n2CCC2CC=CC2)c1,"1-(2-(cyclopent-3-enyl)ethyl)-6-(3,5-dimethylphenylthio)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.254,uM,=,-0.595166283380062,0,O=c1cc(Sc2ccccc2)n(CCC2CC=CC2)c(=O)[nH]1
5684,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCCC3)[nH]c3ccc(Br)cc23)c1,"5-Bromo-3-[(3,5-dimethylphenyl)sulfonyl]-N-(2-(pyrrolidin-1-yl)ethyl)-1H-indole-2-carboxamide",0.065,uM,=,-1.1870866433571443,0,O=C(NCCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5685,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)C1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](CO)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,[(D)MeSer]3-[(40-OH) MeLeu]4-Cyclosporin A,0.095,uM,=,-1.0222763947111522,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5686,1770527,10.1016/j.bmc.2018.03.003,,,,Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)nc(NC2CC2)c1,"(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenoxy)-6-(cyclopropylamino)pyridin-2-yl)amino)benzonitrile",0.35,uM,=,-0.4559319556497244,0,c1ccc(Nc2cc(Oc3ccccc3)cc(NC3CC3)n2)cc1
5687,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-phenethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5688,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cccc(C)c1Oc1nc(Nc2ccc(Cl)cc2)cn2ccnc12,"N-(4-chlorophenyl)-8-(2,6-dimethylphenoxy)imidazo[1,2-a]pyrazin-6-amine",15.0,uM,=,1.1760912590556811,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5689,1849528,10.1016/j.bmc.2019.06.044,,,,Inhibition of HIV1 Reverse transcriptase polymerase assessed as decrease in digoxigenin and biotin-dUTP incorporation into DNA using poly(A)/oligo(dT)15 as template/primer by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-{4-[4-((E)-2-Cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile",0.001,uM,=,-3.0,0,c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1
5690,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2cc(F)cc(F)c2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3',5'-difluoro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.052,uM,=,-1.2839966563652008,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5691,195079,10.1021/jm960269m,,,,In vitro for inhibition of HIV-1 reverse transcriptase.,CC(C)Nc1cccnc1N(C)C1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,N-(2-{4-[(3-Isopropylamino-pyridin-2-yl)-methyl-amino]-piperidine-1-carbonyl}-1H-indol-5-yl)-methanesulfonamide,2.2,uM,=,0.3424226808222063,1,O=C(c1cc2ccccc2[nH]1)N1CCC(Nc2ccccn2)CC1
5692,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.035,uM,=,-1.4559319556497243,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5693,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccccc3C)cc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-2-(2-o-tolyl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",1.6,uM,=,0.2041199826559248,1,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5694,552634,10.1016/j.bmc.2008.05.010,,,,Inhibition of HIV1 virion-associated reverse transcriptase,O=C1c2ccccc2C(=O)N1CCO/C(=N\c1ccc(Br)cc1)SS/C(=N/c1ccc(Br)cc1)OCCN1C(=O)c2ccccc2C1=O,"2-[2-({({[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-ethoxy][(4-bromophenyl)imino]methyl}dithio)[(4-bromophenyl)-imino]methyl}oxy)ethyl]-1,3-dioxoisoindoline",0.74,uM,=,-0.1307682802690238,0,O=C1c2ccccc2C(=O)N1CCO/C(=N\c1ccccc1)SS/C(=N/c1ccccc1)OCCN1C(=O)c2ccccc2C1=O
5695,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCc3ccncn3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(pyrimidin-4-ylmethyl)-1H-indole-2-carboxamide",0.042,uM,=,-1.3767507096020994,0,O=C(NCc1ccncn1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5696,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccccc2F)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((2'-fluoro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.009,uM,=,-2.0457574905606752,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5697,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncccc2C(=O)N(C)c2cccnc21,"5-Ethyl-10-methyl-5,10-dihydro-4,6,10-triaza-dibenzo[a,d]cyclohepten-11-one",0.09,uM,=,-1.0457574905606752,0,O=C1Nc2cccnc2Nc2ncccc21
5698,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,Cc1cc(C)cc(SC2=C(C(C)C)C(=O)NC(=O)C2COCCO)c1,"4-(3,5-dimethylphenylthio)-3-((2-hydroxyethoxy)methyl)-5-isopropylpyridine-2,6(1H,3H)-dione",0.054,uM,=,-1.2676062401770316,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5699,1435796,10.1021/jm5011622,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as reduction in enzyme activity,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC(C)c3cccnc3)[nH]c3ccc(Cl)cc23)c1,"rac-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-(pyridin-3-yl)-ethyl)-1H-indole-2-carboxamide",0.1,uM,=,-1.0,0,O=C(NCc1cccnc1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5700,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O,"6-Benzyl-1-benzyloxymethyl-5-isopropyl-1H-pyrimidine-2,4-dione",0.02,uM,=,-1.6989700043360187,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5701,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=C(C)OC(=O)N1c2cc(F)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-7-fluoro-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropenyl ester",0.183,uM,=,-0.7375489102695706,0,O=C1Nc2ccccc2NC1C#CC1CC1
5702,2148991,10.1021/acs.jmedchem.1c00708,,,,Inhibition of recombinant wild-type HIV1 p66/p51 reverse transcriptase assessed as inhibition of [3H]dGTP incorporation using poly (rA) as templates incubated for 40 mins by spectrofluorometer,Cc1cc(-c2cc(F)c(Nc3ccnc(Nc4ccc(C#N)cc4)n3)c(F)c2)cc(C)n1,"4-(4-(4-(2,6-dimethylpyridin-4-yl)-2,6-difluorophenylamino)pyrimidin-2-ylamino)benzonitrile",0.336,uM,=,-0.4736607226101559,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccncc4)cc3)n2)cc1
5703,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C#N)cc(C)c1Oc1cc(Nc2ccc(C#N)cc2)ncc1C(=O)NCC1CCCO1,"4-(4-cyano-2,6-dimethylphenoxy)-6-(4-cyanophenylamino)-N-((tetrahydrofuran-2-yl)methyl)nicotinamide",10.92,uM,=,1.0382226383687183,1,O=C(NCC1CCCO1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
5704,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)Cc2ccc(O)cc2)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[tyrosyl-prolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",8.1,uM,=,0.9084850188786496,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1C(=O)CCc1ccccc1
5705,2204627,10.1016/j.ejmech.2022.114563,,,,Inhibition of wild-type recombinant HIV-1 group M subtype B BH10 reverse transcriptase RNase-associated RNase H activity expressed in Escherichia coli XL1 blue using 32P-labeled 5'-UUUUUUUUUAGGAUACAUAUGGUUAAAGUAU-3'/5'-ATACTTTAACCATATGTATCC-3' RNA/DNA template-primer as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by phosphorimaging analysis,Nc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(O)c(O)c(O)c3)CC2C(=O)NCc2ccco2)cc1,"1-((4-aminophenyl)sulfonyl)-N-(furan-2-ylmethyl)-4-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide",0.13,uM,=,-0.8860566476931633,0,O=C(NCc1ccco1)C1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1ccccc1
5706,195361,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 Y181C reverse transcriptase.,CCN1c2ncc(CCc3ccncc3)cc2C(=O)N(C)c2ccc(F)nc21,"5-Ethyl-7-fluoro-10-methyl-2-(2-pyridin-4-yl-ethyl)-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.08,uM,=,-1.0969100130080565,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccncc3)cc21
5707,823533,10.1021/jm201506e,,,,Inhibition of HIV1 reverse transcriptase using poly(ra)/oligo(dT)15 homopolymer template as substrate after 1 hr,Cc1cc(C)cc(Cc2c(I)c(=O)[nH]c(=O)n2COCc2ccccc2)c1,"1-Benzyloxymethyl-6-(3,5-dimethylbenzyl)-5-iodouracil",0.003,uM,=,-2.5228787452803374,0,O=c1cc(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]1
5708,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccc(Cl)cc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((4'-chloro-3,5-dimethyl-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.026,uM,=,-1.585026652029182,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5709,722008,10.1128/aac.00800-09,,,,Inhibition of Human immunodeficiency virus 1 subtype B reverse transcriptase DNA-dependent DNA polymerase activity by gel-based primer extension assay,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,"5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.7,uM,=,-0.1549019599857432,0,O=C1Nc2cccnc2N(C2CC2)c2ncccc21
5710,195221,10.1016/j.bmcl.2003.09.042,,,,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SC)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,Cyclosporin A analogue,0.0655,uM,=,-1.183758700008217,0,O=C1CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
5711,735834,10.1016/j.ejmech.2010.12.022,,,,Inhibition of Human immunodeficiency virus 1 reverse transcriptase,CCOCC1C(=O)NC(=O)C(CC)=C1Sc1cc(Cl)cc(Cl)c1,"4-(3,5-dichlorophenylthio)-3-(ethoxymethyl)-5-ethylpyridine-2,6(1H,3H)-dione",0.597,uM,=,-0.2240256688706309,0,O=C1C=C(Sc2ccccc2)CC(=O)N1
5712,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,O=C(NCc1ccc(F)cc1F)c1cn(Cc2ccc(F)cc2)cc(O)c1=O,"N-(2,4-Difluorobenzyl)-1-(4-fluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxamide",2.4,uM,=,0.380211241711606,1,O=C(NCc1ccccc1)c1cn(Cc2ccccc2)ccc1=O
5713,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cccc(C)c1Oc1nc(Nc2ccc([N+](=O)[O-])cc2)cn2ccnc12,"8-(2,6-dimethylphenoxy)-N-(4-nitrophenyl)imidazo[1,2-a]pyrazin-6-amine",334.0,uM,=,2.523746466811565,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5714,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2cccc(O)c2O)nc2sc3c(c12)CCCCC3,"2-(2,3-Dihydroxy-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",1.8,uM,=,0.255272505103306,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5715,196363,10.1021/jm0304414,,,,Inhibitory activity against HIV-reverse transcriptase (HIV-RT),COC(=O)c1[nH]c(-c2ccc3c(n2)C(=O)C(NC(C)=O)=CC3=O)c2nc3ccccc3c-2c1C,"1-(7-Acetylamino-5,8-dioxo-5,8-dihydro-quinolin-2-yl)-4-methyl-9H-beta-carboline-3-carboxylic acid methyl ester",15.1,uM,=,1.1789769472931697,1,O=C1C=CC(=O)c2nc(-c3[nH]ccc4c5ccccc5nc3-4)ccc21
5716,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,CC(c1cccc2ccccc12)n1cc(O)c(=O)c(C(=O)O)c1,"5-Hydroxy-1-(1-(naphthalen-1-yl)ethyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid",19.0,uM,=,1.2787536009528289,1,O=c1ccn(Cc2cccc3ccccc23)cc1
5717,1737186,10.1016/j.ejmech.2018.03.059,,,,Inhibition of wild-type HIV1 reverse transcriptase assessed as decrease in digoxigenin and biotin-dUTP incorporation in to DNA using poly(A)/oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NCc2cn(CC(=O)N3CCOCC3)nn2)c(C)c1,"6-((4-cyanophenyl)amino)-4-(mesityloxy)-N-((1-(2-morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-yl)methyl)nicotinamide",1.57,uM,=,0.1958996524092337,1,O=C(NCc1cn(CC(=O)N2CCOCC2)nn1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
5718,1661651,10.1016/j.bmcl.2017.03.009,,,,Inhibition of recombinant wild type HIV-1 reverse transcriptase p66/p51 using poly(rA)/oligo(dT)16 as template/primer after 40 mins by ELISA,CCOC(=O)C(=O)CC(=O)c1ccc(Oc2ccnc(Nc3ccc(C#N)cc3)n2)cc1,"ethyl 4-(4-(2-(4-cyanophenylamino)pyrimidin-4-yloxy)phenyl)-2,4-dioxobutanoate",5.864,uM,=,0.7681939616330715,1,c1ccc(Nc2nccc(Oc3ccccc3)n2)cc1
5719,969007,10.1021/jm400405z,,,,Inhibition of RNase H activity of wild type HIV-1 reverse transcriptase using 18 nucleotide 3'-fluorescein-labeled RNA/18 nucleotide 5'-dabsyl-labeled DNA hybrid as substrate after 10 mins by fluorescence spectrometric analysis,O=c1[nH]c(-c2ccc(O)cc2O)nc2sc3c(c12)CCCCC3,"2-(2,4-Dihydroxy-phenyl)-3,5,6,7,8,9-hexahydro-10-thia-1,3-diaza-benzo[a]azulen-4-one",9.3,uM,=,0.9684829485539352,1,O=c1[nH]c(-c2ccccc2)nc2sc3c(c12)CCCCC3
5720,579309,10.1128/aac.00972-07,,,,Inhibition of wild type HIV1 reverse transcriptase assessed as 32P-labeled GMP incorporation into nascent DNA strand,Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CCC2CCCC2)c1,"1-(2-cyclopentylethyl)-6-(3,5-dimethylbenzoyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione",0.065,uM,=,-1.1870866433571443,0,O=C(c1ccccc1)c1cc(=O)[nH]c(=O)n1CCC1CCCC1
5721,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(1-(4-(trifluoromethyl)benzyl)piperidin-4-ylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.36,uM,=,-0.4436974992327127,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
5722,1435391,10.1016/j.ejmech.2014.09.054,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-dUTP incorporation using poly(rA)-oligo(dT) as template/primer and digoxigenin-/biotin-labeled dUTP nucleotides incubated for 1 hr,Cc1cc(C)c(Oc2cc(Nc3ccc(C#N)cc3)ncc2C(=O)NCC2CCCO2)c(C)c1,6-(4-cyanophenylamino)-4-(mesityloxy)-N-((tetrahydrofuran-2-yl)methyl)nicotinamide,1.2,uM,=,0.0791812460476248,1,O=C(NCC1CCCO1)c1cnc(Nc2ccccc2)cc1Oc1ccccc1
5723,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,C=CCN1c2cc(Cl)ccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"4-Allyl-6-chloro-3-cyclopropylethynyl-3-trifluoromethyl-3,4-dihydro-1H-quinoxalin-2-one",0.65,uM,=,-0.1870866433571444,0,O=C1Nc2ccccc2NC1C#CC1CC1
5724,195659,10.1016/s0960-894x(00)00321-8,,,,Inhibitory concentration for 50% inhibition of HIV-1 reverse transcriptase,CCOC(=O)N1c2ccccc2NC(=O)C1(C#CC1CC1)C(F)(F)F,"2-Cyclopropylethynyl-3-oxo-2-trifluoromethyl-3,4-dihydro-2H-quinoxaline-1-carboxylic acid ethyl ester",0.118,uM,=,-0.9281179926938746,0,O=C1Nc2ccccc2NC1C#CC1CC1
5725,2153349,10.1016/j.ejmech.2021.113868,,,,Inhibition of wild type HIV1 reverse transcriptase using oligo(dT)16 as primer measured after 40 mins by picogreen-dye based spectrofluorimetric analysis,COc1cc2cc(C#N)ccc2c(OC)c1Oc1cc(N)nc(Nc2ccc(C#N)cc2)n1,"6-((6-amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-5,7-dimethoxy-2-naphthonitrile",0.02,uM,=,-1.6989700043360187,0,c1ccc(Nc2nccc(Oc3ccc4ccccc4c3)n2)cc1
5726,1585639,10.1021/acs.jmedchem.6b00465,,,,Inhibition of HIV-1 RT RNA-dependent DNA polymerase activity expressed in Escherichia coli JM109 using [3H]TTP/ poly(rA)-oligo(dT)16 as substrate incubated for 20 mins by liquid scintillation spectrometric analysis,O=C(O)c1cn(Cc2ccc(-c3cnc4ccccc4c3)cc2)cc(O)c1=O,"5-Hydroxy-4-oxo-1-(4-(quinolin-3-yl)benzyl)-1,4-dihydropyridine-3-carboxylic Acid",1.1,uM,=,0.041392685158225,1,O=c1ccn(Cc2ccc(-c3cnc4ccccc4c3)cc2)cc1
5727,195374,10.1021/jm9707028,,,,Inhibitory activity against HIV-1 wild-type reverse transcriptase.,CCN1c2ncc(CCc3ccccc3)cc2C(=O)N(C)c2ccc(Cl)nc21,"7-Chloro-5-ethyl-10-methyl-2-phenethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",0.05,uM,=,-1.3010299956639813,0,O=C1Nc2cccnc2Nc2ncc(CCc3ccccc3)cc21
5728,2157173,10.1021/acs.jmedchem.1c01885,,,,Inhibition of wild type HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate incubated for 2 hrs by ELISA,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)nc2c1COC2,"(E)-3-(3,5-dimethyl-4-(2-(1-(4-nitrobenzyl)piperidin-4-ylamino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yloxy)phenyl)acrylonitrile",0.18,uM,=,-0.744727494896694,0,c1ccc(CN2CCC(Nc3nc4c(c(Oc5ccccc5)n3)COC4)CC2)cc1
5729,741511,10.1021/jm101614j,,,,Inhibition of HIV1 wild type reverse transcriptase expressed in Escherichia coli assessed as incorporation of [3H]dTTP into poly(rA)/oligo(dT) by scintillation counting,Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCN3CCCC3)[nH]c3ccc(Cl)cc23)c1,"5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-N-[2-(pyrrolidin-1-yl)ethyl]-1H-indole-2-carboxamide",0.08,uM,=,-1.0969100130080565,0,O=C(NCCN1CCCC1)c1[nH]c2ccccc2c1S(=O)(=O)c1ccccc1
5730,1471243,10.1016/j.ejmech.2015.02.022,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(Cl)cc2)cn2ccnc12,"4-((6-((4-chlorophenyl)amino)imidazo[1,2-a]pyrazin-8-yl)oxy)-3,5-dimethylbenzonitrile",5.5,uM,=,0.7403626894942439,1,c1ccc(Nc2cn3ccnc3c(Oc3ccccc3)n2)cc1
5731,806936,10.1016/j.ejmech.2012.01.056,,,,Inhibition of ribonuclease H activity of wild type Human immunodeficiency virus 1 reverse transcriptase,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccc(O)c(O)c2)cs1,"3-(2-(4-(3,4-dihydroxyphenyl)thiazol-2-yl)hydrazono)indolin-2-one",3.6,uM,=,0.5563025007672873,1,O=C1Nc2ccccc2/C1=N/Nc1nc(-c2ccccc2)cs1
5732,386501,10.1021/jm0606490,,,,Inhibition of recombinant HIV1 reverse transcriptase,Cc1cn(C2OC(CO[Si](C)(C)C(C)(C)C)C3(OS(=O)(=O)C=C3N)C2O[Si](C)(C)C(C)(C)C)c(=O)n(CCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CC(N)=O)c1=O,"[1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[3-N'-[asparaginyl-prolylamino]propyl]thymine]-3'-spiro-5''-[4''-amino-1'',2''-oxathiole-2'',2''-dioxide]",4.0,uM,=,0.6020599913279624,1,O=C(NCCCn1c(=O)ccn(C2CC3(C=CS(=O)(=O)O3)CO2)c1=O)[C@@H]1CCCN1
5733,1872146,10.1016/j.bmcl.2018.12.027,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of calf thymus DNA by scintillation counting method,NCC1NC(=O)C[C@@H](C(N)=O)NC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC1=O,"((20S)-20-carbamoyl-3,6,9,12,15,18,22-heptaoxo-5,17-bis((quinoxaline-2-carboxamido)methyl)-1,4,7,10,13,16,19-heptaazacyclodocosan-2-yl)methanaminium",21.8,uM,=,1.3384564936046048,1,O=C1CCNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CNC(=O)c2cnc3ccccc3n2)NC(=O)CN1
5734,1731684,10.1016/j.ejmech.2018.01.016,,,,Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay,Cc1cc(-c2ccc(C(F)(F)F)cc2)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,"4-((4-((3,5-dimethyl-4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)amino)pyrimidin-2-yl)amino)benzonitrile",0.067,uM,=,-1.1739251972991736,0,c1ccc(Nc2nccc(Nc3ccc(-c4ccccc4)cc3)n2)cc1
5735,449954,10.1016/j.bmc.2007.07.058,,,,Inhibition of HIV1 reverse transcriptase by ELISA,CCOCn1c(C)c(CNc2ccccn2)c(=O)[nH]c1=O,1-(ethoxymethyl)-5-(pyridin-2-ylaminomethyl)-6-methyluracil,54.7,uM,=,1.737987326333431,1,O=c1[nH]cc(CNc2ccccn2)c(=O)[nH]1
5736,321537,10.1021/jm050452s,,,,Inhibition of recombinant HIV-1 reverse transcriptase activity,COC(=O)CCC/C=C(\c1cccc(C#N)c1)c1cc(Cl)ccc1OC,(E)-6-(5-Chloro-2-methoxy-phenyl)-6-(3-cyano-phenyl)-hex-5-enoic acid methyl ester,7.58,uM,=,0.8796692056320535,1,C=C(c1ccccc1)c1ccccc1
5737,378455,10.1021/jm0604575,,,,Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity,Cc1cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c(=O)n(C)c1=O,"1-[4-Amino-9-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dioxo-1,7-dioxa-2lambda*6*-thia-spiro[4.4]non-3-en-8-yl]-3,5-dimethyl-1H-pyrimidine-2,4-dione (TASO-m3T)",1.3,uM,=,0.1139433523068367,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5738,196374,10.1021/jm031045o,,,,Inhibitory concentration against wild type HIV-1 reverse transcriptase (RT) using poly rC.dG as the template or primer,CCOC(=O)P(=O)(O)OCCCn1c(=O)c(C)cn([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O,"[1-[2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N-[(3-[[[(ethyloxycarbonyl)hydroxyphosphonyl]-oxy]propyl]thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)",6.3,uM,=,0.7993405494535817,1,O=c1ccn([C@H]2C[C@@]3(C=CS(=O)(=O)O3)CO2)c(=O)[nH]1
5739,1279770,10.1016/j.bmcl.2013.10.059,,,,Inhibition of recombinant HIV1 reverse transcriptase using poly rA:dT as template/primer after 1 hr by ELISA,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,"(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one",0.12,uM,=,-0.9208187539523752,0,O=C1Nc2ccccc2C(C#CC2CC2)O1
5740,546666,10.1021/np50121a008,,,,Inhibition of HIV1 recombinant reverse transcriptase by UIC assay,CC1(C)CC[C@]2(C(=O)O)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)c6ccc(O)cc6)[C@H](O)C[C@]5(C)[C@H]4CC[C@@]3(C)[C@H]2C1,2alpha-hydroxyaleuritolic acid 3-p-hydroxybenzoate,14.4,uM,=,1.1583624920952498,1,O=C(O[C@H]1CCC2[C@@H](CCC3C4=CCC5CCCC[C@@H]5C4CC[C@@H]32)C1)c1ccccc1
